<SEC-DOCUMENT>0001213900-23-028401.txt : 20230410
<SEC-HEADER>0001213900-23-028401.hdr.sgml : 20230410
<ACCEPTANCE-DATETIME>20230410082956
ACCESSION NUMBER:		0001213900-23-028401
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		110
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230410
DATE AS OF CHANGE:		20230410

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Jeffs' Brands Ltd
		CENTRAL INDEX KEY:			0001885408
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-MISCELLANEOUS RETAIL [5900]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41482
		FILM NUMBER:		23809748

	BUSINESS ADDRESS:	
		STREET 1:		7 MEZADA STREET
		CITY:			BNEI BRAK
		STATE:			L3
		ZIP:			5126112
		BUSINESS PHONE:		0097236899124

	MAIL ADDRESS:	
		STREET 1:		7 MEZADA STREET
		CITY:			BNEI BRAK
		STATE:			L3
		ZIP:			5126112
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>f20f2022_jeffsbrands.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 10 08:08:30 UTC 2023 -->
<html xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:jfbr="http://www.jeffsbrands.com/20221231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type" />
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <ix:nonNumeric contextRef="c0" name="dei:DocumentType">20-F</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentRegistrationStatement">&#9744;</ix:nonNumeric>&#160;REGISTRATION
STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric> ANNUAL REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For the fiscal year ended
<ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate">December 31</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus">2022</ix:nonNumeric></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric> TRANSITION REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>OR</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentShellCompanyReport">&#9744;</ix:nonNumeric> SHELL COMPANY REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Commission File No.: <ix:nonNumeric contextRef="c0" name="dei:EntityFileNumber">001-41482</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName">Jeffs&#8217; Brands Ltd</ix:nonNumeric><br/>
</b><i>(Exact name of registrant as specified in its charter)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>Translation of registrant&#8217;s
name into English: Not applicable</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><ix:nonNumeric contextRef="c0" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode">Israel</ix:nonNumeric> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>(Jurisdiction of incorporation
or organization)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine1">7 Mezada Street.</ix:nonNumeric> </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><ix:nonNumeric contextRef="c0" name="dei:EntityAddressAddressLine2">Bnei Brak</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown">Israel</ix:nonNumeric> <ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode">5126112</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry"><b>Israel</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>(Address of principal
executive offices)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelName"><ix:nonNumeric contextRef="c0" name="dei:ContactPersonnelName">Viki Hakmon</ix:nonNumeric></ix:nonNumeric><br/>
Chief Executive Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Tel: +<ix:nonNumeric contextRef="c1" name="dei:CityAreaCode">972</ix:nonNumeric>-<ix:nonNumeric contextRef="c1" name="dei:LocalPhoneNumber">3-7713520</ix:nonNumeric></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c1" name="dei:ContactPersonnelEmailAddress"><b>victor@jeffsbrands.com</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine1">7 Mezada Street</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" name="dei:EntityAddressAddressLine2">Bnei Brak</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" name="dei:EntityAddressCityOrTown"><ix:nonNumeric contextRef="c1" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Israel</ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric contextRef="c1" name="dei:EntityAddressPostalZipCode">5126112</ix:nonNumeric>
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><i>&#160;(Name, Telephone, E-mail and/or Facsimile
number and Address of Company Contact Person)</i></p><div>

</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Securities registered or to be registered pursuant to Section 12(b)
of the Act:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 32%; border-bottom: black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Title of each class</b></p></td> <td style="white-space: nowrap; width: 2%">&#160;</td> <td style="white-space: nowrap; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td> <td style="white-space: nowrap; width: 2%">&#160;</td> <td style="white-space: nowrap; width: 32%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which <br/> registered</b></span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:Security12bTitle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares, no par value per share</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><ix:nonNumeric contextRef="c0" name="dei:TradingSymbol"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">JFBR</span></ix:nonNumeric></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Capital Market</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants to Purchase Ordinary Shares</span></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">JFBRW</span></td> <td style="text-align: center">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq Capital Market</span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Securities registered or to be registered pursuant
to Section 12(g) of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Securities for which there is a reporting obligation
pursuant to Section 15(d) of the Act: None</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate the number of outstanding
shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares">8,074,217</ix:nonFraction>
ordinary shares as of December 31, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark if
the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Yes &#9744;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric> &#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If this report is an annual
or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the
Exchange Act of 1934.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Yes &#9744;&#160;&#160;&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric>
&#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether
the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months
(or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements
for the past 90 days.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric> &#9746;&#160;&#160;&#160;No
&#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether
the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding
12 months.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric> &#9746;&#160;&#160;&#160;No
&#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition
of &#8220;large accelerated filer, &#8220;accelerated filer,&#8221; and emerging growth company&#8221; in Rule 12b-2 of the Exchange
Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="white-space: nowrap; vertical-align: top; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer &#9744;</span></td> <td style="white-space: nowrap; vertical-align: bottom; width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer &#9744;</span></td> <td style="white-space: nowrap; vertical-align: bottom; width: 25%"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</span></ix:nonNumeric></td> <td style="white-space: nowrap; vertical-align: bottom; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td></tr> <tr style="vertical-align: top"> <td style="white-space: nowrap">&#160;</td> <td style="white-space: nowrap">&#160;</td> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company</span></td> <td style="white-space: nowrap"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If an emerging growth company
that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use
the extended transition period for complying with any new or revised financial accounting standards &#8224; provided pursuant to Section
13(a) of the Exchange Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#8224;The term &#8220;new
or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting
Standards Codification after April 5, 2012.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether
the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control
over financial reporting under Section 404(b) of the Sarbanes Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm
that prepared or issued its audit report. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If securities are registered
pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing
reflect the correction of an error to previously issued financial statements. &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of
the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark which
basis of accounting the registrant has used to prepare the financial statements included in this filing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" name="dei:DocumentAccountingStandard">U.S. GAAP</ix:nonNumeric> &#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">International Financial Reporting Standards as
issued by the International Accounting Standards Board &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If &#8220;Other&#8221; has
been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to
follow.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#9744; Item 17&#160;&#160;&#160;&#9744;
Item 18</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If this is an annual report, indicate by check
mark whether the registrant is a shell company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Yes &#9744;&#160;&#160;&#160;No
<ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If securities are registered
pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing
reflect the correction of an error to previously issued financial statements. &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Indicate by check mark whether
any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of
the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 9%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 80%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b>&#160;</span><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="3"><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INTRODUCTION</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</span></td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="3"><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY NOTE REGARDING FORWARD-LOOKING
    STATEMENTS</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="5" style="text-align: center"><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART I</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 2.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OFFER STATISTICS AND EXPECTED TIMETABLE.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 3.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">KEY INFORMATION.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: justify"><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Reserved]</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization and Indebtedness.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reasons for the Offer and Use of Proceeds.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary Risk Factors</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION ON THE COMPANY.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">37</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">History and Development of the Company.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">37</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_014"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Overview.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organizational Structure.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, Plants and Equipment.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">56</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNRESOLVED STAFF COMMENTS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">56</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 5.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OPERATING AND FINANCIAL REVIEW AND PROSPECTS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">57</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Results.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity and Capital Resources.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">60</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research and development, patents and licenses, etc.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trend information.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">63</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Critical Accounting Estimates.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">64</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 6.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_024"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_025"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors and Senior Management.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">65</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_026"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensation.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">68</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_027"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_027"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board Practices.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">70</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_028"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_028"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_029"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Ownership.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_030">F.</a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_030"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure of a registrant&#8217;s action to recover
    erroneously awarded compensation.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_031"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 7.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_031"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">86</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_032"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_032"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major Shareholders.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">86</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_033"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_033"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related Party Transactions.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">88</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_034"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_034"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interests of Experts and Counsel.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">90</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_035"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 8.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_035"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL INFORMATION.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_036"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_036"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements and Other Financial Information.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">90</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_037"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_037"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant Changes.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_038"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_038"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE OFFER AND LISTING.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_039"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_039"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offer and Listing Details.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_040"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_040"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_041"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_041"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Markets.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_042"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_042"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling Shareholders.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_043"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_043"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_044"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_044"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses of the Issue.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">91</td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 3 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 9%"><a href="#a_045"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 10.</span></a></td>
    <td style="width: 1%">&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 80%"><a href="#a_045"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ADDITIONAL INFORMATION.</span></a></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: center; width: 9%">91</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_046"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_046"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Capital.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">91</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_047"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_047"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Memorandum and Articles of Association.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_048"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_048"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material Contracts.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">92</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_049"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_049"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Controls.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">92</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_050"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_050"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_051"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_051"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends and Paying Agents.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_052"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_052"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statement by Experts.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_053"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_053"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documents on Display.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">102</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_054"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_054"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary Information.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_055"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">J.</span></span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_055"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Annual Report to Security Holders.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_056"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 11.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_056"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET
    RISK.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">103</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_057"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 12.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_057"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_058"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_058"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt Securities.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">104</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_059"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_059"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants and rights.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">104</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_060"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_060"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Securities.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">104</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="5" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_061">PART II</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="5">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_062"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 13.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_062"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">105</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_063"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 14.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_063"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS
    AND USE OF PROCEEDS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">105</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_064"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 15.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_064"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTROLS AND PROCEDURES.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">105</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_065"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM&#160;16. </span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_065"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[RESERVED]</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">106</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_066"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16A.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_066"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AUDIT COMMITTEE FINANCIAL EXPERT.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">106</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_067"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16B.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_067"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CODE OF ETHICS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">106</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_068"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16C.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_068"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRINCIPAL ACCOUNTANT FEES AND SERVICES.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">106</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_069"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16D.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_069"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_070"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16E.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_070"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED
    PURCHASERS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">108</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_071"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16F.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_071"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">108</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_072"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16G.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_072"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORPORATE GOVERNANCE.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">108</td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_073"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16H.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_073"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MINE SAFETY DISCLOSURE.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">110</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_074"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16I</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_074"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT
    INSPECTIONS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">110</td></tr>
  <tr style="vertical-align: top; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="5" style="text-align: center"><a href="#a_075"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART III</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="5">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_076"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 17.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_076"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL STATEMENTS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td></tr>
  <tr style="vertical-align: top; ">
    <td><a href="#a_077"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 18.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_077"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL STATEMENTS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">111</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><a href="#a_078"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 19.</span></a></td>
    <td>&#160;</td>
    <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#a_078"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBITS.</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td></tr>
  <tr style="vertical-align: top; ">
    <td colspan="3"><a href="#a_079"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</span></a></td>
    <td>&#160;</td>
    <td style="text-align: center">115</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 4 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INTRODUCTION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In this Annual Report on Form 20-F, &#8220;we,&#8221;
&#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; and &#8220;JFBR&#8221; refer to Jeffs&#8217; Brands Ltd.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
are an e-commerce consumer products goods, or CPG, company, operating primarily on the Amazon.com marketplace, or Amazon. We were incorporated
in Israel in March 2021, under the name Jeffs&#8217; Brands Ltd, to serve as the holding company of three other e-commerce companies that
operate online stores for the sale of various consumer products on Amazon, utilizing the Fulfillment by Amazon, or FBA, model &#8212;
Smart Repair Pro, purex Corp, or Purex, and Top Rank Ltd, or Top Rank. As of the date on this Annual Report on Form 20-F, we have five
wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank, Fort Products Ltd., or Fort, and Jeffs&#8217; Brands Holdings Inc., or
Jeffs&#8217; Brands Holdings.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">In
addition to executing the FBA business model, we utilize artificial intelligence, or A.I., and machine learning technologies to analyze
sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and
growth, and for maximizing sales of existing proprietary products. We also use our own skills, know-how and profound familiarity with
Amazon&#8217;s algorithm and all the tools that the FBA platform FBA has to offer. In some circumstances we scale the products and improve
them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 30, 2022, we&#160;completed
our initial public offering, or IPO, pursuant to the Company&#8217;s registration statement on Form F-1 (Registration No<i>.</i> 333-
262835) originally filed with the SEC on February 18, 2022, which was declared effective by the Securities and Exchange Commission, or
the SEC, on August 25, 2022, of (A) 3,717,473 units, or Units, at a public offering price of $4.16 per Unit, with each Unit consisting
of one of our ordinary shares, no par value per share, or Ordinary Shares, and one warrant, or Warrant, to purchase one Ordinary Share,
at an initial exercise price of $4.04 per Ordinary Share (and an exercise price of $2.02 following the Exercise Price Adjustment, as defined
below), (B) warrants issued to Aegis Capital Corp., the underwriter in the offering, or Aegis or the Underwriter, to purchase up to 185,873
Ordinary Shares, at an exercise price of $5.20 per Ordinary Share, or the Underwriter&#8217;s Warrants, and (C) Warrants to purchase up
to 425,912 Ordinary Shares issued to the Underwriter pursuant to its over-allotment option. The Ordinary Shares and Warrants were immediately
separable from the units and were issued separately. The Ordinary Shares and Warrants began trading on the Nasdaq Capital Market on August
26, 2022 under the symbols &#8220;JFBR&#8221; and &#8220;JFBRW,&#8221; respectively. We received gross proceeds of approximately $15.5
million before deducting underwriting discounts and commissions and before offering expenses ($13.4 million net proceeds after deducting
approximately $1.05 million of underwriting discounts and commissions and approximately $1.05 million after deducting other offering costs).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 7, 2022, the
Company&#8217;s volume weighted average stock price was less than the exercise floor of $4.04 for the Warrants. Accordingly, effective
after the closing of trading on November 28, 2022 (the 90th calendar day immediately following the issuance date of the Warrants), the
Warrants were adjusted pursuant to their terms, including, but not limited to, to adjust the exercise price of the Warrants to $2.02,
or the Exercise Price Adjustment. In addition, in connection with the Exercise Price Adjustment, the Company issued additional warrants,
or the Additional Warrants, to purchase up to 2,824,525 Ordinary Shares to Qualified Holders (as defined in the Warrant)</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our reporting currency and
functional currency is the U.S. dollar. Unless otherwise expressly stated or the context otherwise requires, references in this Annual
Report on Form 20-F to &#8220;NIS&#8221; are to New Israeli Shekels, and references to &#8220;dollars&#8221; or &#8220;$&#8221; mean
U.S. dollars.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">&#160;&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">This
Annual Report on Form 20-F includes statistical, market and industry data and forecasts which we obtained from publicly available information
and independent industry publications and reports that we believe to be reliable sources. These publicly available industry publications
and reports generally state that they obtain their information from sources that they believe to be reliable, but they do not guarantee
the accuracy or completeness of the information. Although we believe that these sources are reliable, we have not independently verified
the information contained in such publications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All trademarks or trade names
referred to in this Annual Report on Form 20-F are the property of their respective owners. Solely for convenience, the trademarks and
trade names in this Annual Report on Form 20-F are referred to without the &#174; and &#8482; symbols, but such references should not
be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights
thereto. We do not intend the use or display of other companies&#8217; trademarks and trade names to imply a relationship with, or endorsement
or sponsorship of us by, any other companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For periods beginning on and after January 1,
2022, we report our financial statements in accordance with generally accepted accounting principles in the United States, or U.S. GAAP.
Historical filings of our consolidated financial statements were previously prepared in accordance with International Financial Reporting
Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 5 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain information included
or incorporated by reference in this Annual Report on Form 20-F may be deemed to be &#8220;forward-looking statements&#8221;. Forward-looking
statements are often characterized by the use of forward-looking terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221;
&#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;believe,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221;
&#8220;project&#8221; or other similar words, but are not the only way these statements are identified.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">These forward-looking statements
may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections
of results of operations or of financial condition, expected capital needs, and expenses, statements relating to the research, development,
completion and use of our products, and all statements (other than statements of historical facts) that address activities, events or
developments that we intend, expect, project, believe or anticipate will or may occur in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Forward-looking statements
are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on
assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions,
expected future developments, and other factors they believe to be appropriate.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Important factors that could
cause actual results, developments, and business decisions to differ materially from those anticipated in these forward-looking statements
include, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 0.5in">&#160;</td>
    <td style="vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to raise capital through the issuance of
    additional securities; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our belief that our existing
    cash and cash equivalents as of December 31, 2022, will be sufficient to fund our operations through the next twelve months;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to adapt to significant future alterations
    in Amazon&#8217;s policies; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to sell our
    existing products and grow our brands and product offerings, including by acquiring new brands and expanding into new territories;
    &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to meet our expectations regarding the
    revenue growth and the demand for e-commerce; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to enter into definitive agreements for
    our current letters of intent and term sheet; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the overall global economic environment;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact of competition and new e-commerce technologies;
    &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general market, political and economic conditions in
    the countries in which we operate; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">projected capital expenditures and liquidity; &#160;</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 0.5in">&#160;</td>
    <td style="vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to retain key executive members;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;the impact of possible changes in Amazon&#8217;s
    policies and terms of use; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">projected capital expenditures and liquidity; &#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our expectations regarding our tax classifications;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">how long we will qualify as an emerging growth company
    or a foreign private issuer;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interpretations of current laws and the passages of
    future laws;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in our strategy;&#160;&#160;&#160;</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation; and</span></td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">&#160;</td>
    <td>&#160;</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other risks and uncertainties, including those factors
    referred to in &#8220;Item 3. Key Information &#8211; D. Risk Factors,&#8221; &#8220;Item 4. Information on the Company,&#8221; and
    &#8220;Item 5. Operating and Financial Review and Prospects&#8221;, as well as in this Annual Report on Form 20-F generally. &#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Readers are urged to carefully
review and consider the various disclosures made throughout this Annual Report on Form 20-F which are designed to advise interested parties
of the risks and factors that may affect our business, financial condition, results of operations and prospects.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">You should not put undue
reliance on any forward-looking statements. Any forward-looking statements in this Annual Report on Form 20-F are made as of the date
hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law.&#160;&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>

</div><div><a id="a_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART I</b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_004"></a></div><p style="margin: 0"><b>ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable. &#160;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_005"></a></div><p style="margin: 0"><b>ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_006"></a></div><p style="margin: 0"><b>ITEM 3. KEY INFORMATION</b></p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_007"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in">A.</td><td style="text-align: justify">[Reserved]</td>
</tr></table><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_008"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.5in; text-align: left">B.</td><td style="text-align: justify">Capitalization and Indebtedness</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_009"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.5in; text-align: left">C.</td><td style="text-align: justify">Reasons for the Offer and
                                            Use of Proceeds.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Not applicable.</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_010"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.5in; text-align: left">D.</td><td style="text-align: justify">Risk Factors.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our business faces significant
risks. You should carefully consider the risks described below, together with all of the other information in this Annual Report on Form
20-F. The risks described below are not the only risks facing us. Additional risks and uncertainties not currently known to us or that
we currently deem to be immaterial may also materially and adversely affect our business operations. If any of these risks actually occurs,
our business and financial condition could suffer and the price of our securities could decline. This Annual Report on Form 20-F also
contains forward-looking statements that involve risks and uncertainties. Our results could materially differ from those anticipated
in these forward-looking statements, as a result of certain factors including the risks described below and elsewhere in this report
and our other Securities and Exchange Commission, or SEC, filings. See &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221;
above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary Risk Factors</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Our Businesses, Strategies,
Technology, and Industry</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
                                            have a short operating history in an evolving industry and, as a result, our past results
                                            may not be indicative of future operating performance;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
                                            may not be able to manage our growth effectively, and such rapid growth may adversely affect
                                            our corporate culture&#160;;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
                                            e-commerce operations are reliant on Amazon and FBA and changes to Amazon, Amazon&#8217;s
                                            services and their terms of use may harm our business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
                                            rely on data provided by third parties, the loss of which could limit the functionality of
                                            our platforms, cause us to invest in the wrong product or disrupt our business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"></p><div>

</div><!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
                                            rely on other information technologies and systems to operate our business and to maintain
                                            our competitiveness, and any failure to invest in and adapt to technological developments
                                            and industry trends could harm our business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
                                            we fail to keep up with rapid technological changes, our future success may be adversely
                                            affected;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
                                            business depends on our ability to build and maintain strong product listings on e-commerce
                                            platforms. We may not be able to maintain and enhance our product listings if we receive
                                            a substantial number of customer complaints, negative publicity or otherwise fail to live
                                            up to customers&#8217; expectations, which could materially adversely affect our business,
                                            results of operations and growth prospects;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
                                            efforts to acquire or retain customers, and our efforts to sell new products or increase
                                            sales of our existing products, may not be successful, which could prevent us from maintaining
                                            or increasing our sales;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
                                            we fail to acquire new customers or retain existing customers, or fail to do so in a cost-effective
                                            manner, we may not be able to achieve profitability;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
                                            efforts to expand our business into new brands, products, services, technologies and geographic
                                            regions will subject us to additional business, legal, financial and competitive risks and
                                            may not be successful;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Potential
                                            growth of our businesses is based on international expansion, making us susceptible to risks
                                            associated with international sales and operations;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Use
                                            of social media and email may adversely impact our reputation or subject us to fines or other
                                            penalties;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
                                            our emails are not delivered and accepted or are routed by email providers less favorably
                                            than other emails, or our sites or mobile applications are not accessible or are treated
                                            disadvantageously by Internet service providers, our business may be substantially harmed;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
                                            we are unable to manage our inventory effectively, our operating results could be adversely
                                            affected;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Information Technology</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Assertions
                                            by third parties of infringement or misappropriation by us of their intellectual property
                                            rights or confidential know how could result in significant costs and substantially harm
                                            our business and results of operations;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
                                            inability to acquire, use or maintain our marks and domain names for our sites could substantially
                                            harm our business and operating results;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Any
                                            significant disruption in service on our websites or in our computer systems, a number of
                                            which are currently hosted or provided by third-party providers, could materially affect
                                            our ability to operate, damage our reputation and result in a loss of customers, which would
                                            harm our business and results of operations;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Legal and Regulatory Matters</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
                                            may be subject to general litigation, regulatory disputes and government inquiries;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A
                                            failure to comply with current laws, rules and regulations or changes to such laws, rules
                                            and regulations and other legal uncertainties may adversely affect our business, financial
                                            performance, results of operations or business growth;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
                                            are subject to U.S.&#160;governmental regulations and other legal obligations related to
                                            privacy, data protection and information security. If we are unable to comply with these,
                                            we may be subject to governmental enforcement actions, litigation, fines and penalties or
                                            adverse publicity;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
                                            amended and restated articles of association provide that unless we consent to an alternate
                                            forum, the federal district courts of the United&#160;States shall be the exclusive forum
                                            of resolution of any claims arising under the Securities Act;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Increased regulatory
                                            scrutiny of nutritional supplements as well as new regulations that are being adopted in
                                            some of our markets with respect to nutritional supplements could result in more restrictive
                                            regulations and harm our results if our supplements or advertising activities are found to
                                            violate existing or new regulations or if we are not able to effect necessary changes to
                                            our products in a timely and efficient manner to respond to new regulations;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to our Operations in Israel</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Political,
                                            economic and military instability in Israel may impede our ability to operate and harm our
                                            financial results;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Exchange
                                            rate fluctuations between foreign currencies and the U.S.&#160;Dollar may negatively affect
                                            our earnings;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks Related to Our Status as a Public
Company and Ownership of our Ordinary Shares and Warrants</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
                                            incur significant increased costs as a result of operating as a public company. Our management
                                            is required to devote substantial time to new compliance initiatives as well as compliance
                                            with ongoing U.S. requirements;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Our internal control
                                            over financial reporting may not meet all of the standards contemplated by Section 404 of
                                            the Sarbanes-Oxley Act, and failure to achieve and maintain effective internal control over
                                            financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act could have a
                                            material adverse effect on our business<span style="font-family: Times New Roman, Times, Serif">;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Future
                                            sales of our Ordinary Shares and Warrants could reduce the market price of our Ordinary Shares
                                            and/or Warrants;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
                                            a &#8220;foreign private issuer&#8221; we are permitted, and intend, to follow certain home
                                            country corporate governance practices instead of otherwise applicable SEC and Nasdaq requirements,
                                            which may result in less protection than is accorded to investors under rules applicable
                                            to domestic U.S.&#160;issuers;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
                                            estimates of market opportunity, market size and forecasts of market growth included in our
                                            publicly filed documents may prove to be inaccurate, and even if the market in which we compete
                                            achieves the forecasted growth, our business could fail to grow at similar rates, if at all;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Our
                                            management team has limited experience managing a public company;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As
                                            of December 31, 2022, our principal shareholders, officers and directors beneficially owned
                                            approximately 66.13% of our outstanding Ordinary Shares and as such they will therefore be
                                            able to exert significant control over matters submitted to our shareholders for approval;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We
                                            are an emerging growth company and a smaller reporting company, and any decision on our part
                                            to comply only with certain reduced reporting and disclosure requirements applicable to emerging
                                            growth companies or smaller reporting companies could make our securities less attractive
                                            to investors; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify; text-indent: -27pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
                                            market price of our Ordinary Shares and/or Warrants may be volatile. Market volatility may
                                            affect the value of an investment in our Ordinary Shares and/or Warrants and could subject
                                            us to litigation.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Risks Related to Our Businesses, Strategies,
Technology, and Industry</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a short operating history in an
evolving industry and, as a result, our past results may not be indicative of future operating performance.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have a short operating
history in a rapidly evolving industry that may not develop in a manner favorable to our business. Our relatively short operating history
makes it difficult to assess our future performance. You should consider our business and prospects in light of the risks and difficulties
we may encounter.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future success will depend
in large part upon our ability to, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">manage our inventory
                                            and supply chain effectively;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">successfully develop,
                                            retain and expand our consumer product offerings and geographic reach;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">compete effectively;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">anticipate and
                                            respond to macroeconomic changes;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">effectively manage
                                            our growth;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">hire, integrate
                                            and retain talented people at all levels of our organization;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">avoid interruptions
                                            in our business from information technology downtime, cybersecurity breaches or labor stoppages;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">maintain the quality
                                            of our technology infrastructure; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">develop new features
                                            to enhance functionality.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not be able to manage our growth
effectively, and such rapid growth may adversely affect our corporate culture.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to rapidly and
significantly expand our operations and anticipate expanding further as we pursue our growth strategies. Such expansion increases the
complexity of our business and places a significant strain on our management, operations, technical systems, financial resources and
internal control over financial reporting functions. Our current and planned personnel, systems, procedures and controls may not be adequate
to support and effectively manage our future operations, especially as we employ personnel in several geographic locations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are currently in the process
of transitioning certain of our business and financial systems to systems on a scale reflecting the increased size, scope and complexity
of our operations, and the process of migrating our legacy systems could disrupt our ability to timely and accurately process information,
which could adversely affect our results of operations and cause harm to our reputation. As a result, we may not be able to manage our
expansion effectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our entrepreneurial and collaborative
culture is important to us, and we believe it has been a major contributor to our success. We may have difficulties maintaining our culture
or adapting it sufficiently to meet the needs of our future and evolving operations as we continue to grow, in particular as we grow
internationally.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we are currently
in the process of developing and maintaining our culture as a public company, with the attendant changes in policies, practices, corporate
governance and management requirements. Failure to successfully develop or maintain such a culture could have a material adverse effect
on our business, results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our e-commerce operations are reliant on
Amazon and FBA and changes to Amazon, Amazon&#8217;s services and their terms of use may harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products are sold predominantly
on Amazon and orders are fulfilled entirely by Amazon utilizing the fulfilled by Amazon, or FBA, model. In order to continue to utilize
Amazon and FBA, we must comply with the applicable policies and terms of use relating to these services. Such policies and terms of use
may be altered or amended at Amazon&#8217;s sole discretion, including changes regarding the cost of securing these services, and changes
that increase the burden of compliance with its requirements, may cause us to significantly alter our business model or incur additional
costs in order to comply, which could negatively impact our results of operations. Non-compliance with applicable terms of use and policies
can result in the removal of one or more products from the marketplace and suspension of fulfillment services either of which could have
a material adverse effect on our business and results of our operations. Although we exert efforts in order to ensure ongoing compliance
and no notices of non-compliance have been received to date, we cannot assure you that events of this kind will not occur in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely on other information technologies
and systems to operate our business and to maintain our competitiveness, and any failure to invest in and adapt to technological developments
and industry trends could harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We depend on sophisticated
information technologies and systems, technology and systems used for websites and apps, customer service, logistics and fulfillment,
supplier connectivity, communications and administration. As our operations grow in size, scope and complexity, we will need to continuously
improve and upgrade our systems and infrastructure to offer an increasing number of consumer-enhanced services, features and functionalities,
while maintaining and improving the reliability and integrity of our systems and infrastructure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our future success also depends
on our ability to use A.I. tools and infrastructure, including logistics and fulfillment platform which leverages, to meet rapidly evolving
e-commerce trends and demands. The emergence of alternative platforms may require us to continue to invest in new and costly technology.
We may not be successful, or we may be less successful than our competitors, in adopting technologies that operate effectively across
multiple e-commerce platforms, which would negatively impact our business and financial performance. New developments in other areas,
such as cloud computing providers, could also make it easier for competitors to enter our markets due to lower up-front technology costs.
In addition, we may not be able to maintain our existing systems or replace our current systems or introduce new technologies and systems
as quickly or cost effectively as we would like. Failure to invest in and adapt to technological developments and industry trends may
have a material adverse effect on our business, results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely on data provided by third parties,
the loss of which could limit the functionality of our platforms, cause us to invest in the wrong product or disrupt our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We use third party software
to determine market trends and what markets to enter into. Our ability to successfully use this software depends on our ability to analyze
and utilize data, including search engine results, provided by unaffiliated third parties, primarily, Google and Amazon. Some of this
data is provided to us pursuant to third-party data sharing policies and terms of use, under data sharing agreements by third-party providers
or by customer consent. The majority of this data is sourced for free or for de minimis amounts. These sources of data allow us, along
with A.I. tools, to determine trends, performance and consumer sentiment on products and searches within e-commerce platforms. This functionality
allows us to help determine which products to market, in some cases manufacture through contract manufacturers, import and sell on e-commerce
marketplaces. The connection to multiple e-commerce platforms through application programming interfaces, or APIs, allows us to develop
the automation of the purchase of marketing and automate the change of pricing of product listings on those e-commerce platforms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the future, any of these
third parties could change its data sharing policies, including making them more restrictive, charging fees or altering its algorithms
that determine the placement, display and accessibility of search results and social media updates, any of which could result in the
loss of, or significant impairment to, our ability to collect useful data. These third parties could also interpret our, or our service
providers&#8217;, data collection policies or practices as being inconsistent with their policies, which could result in the loss of
our ability to collect this data. Privacy concerns may cause end users to resist providing the personal data necessary to allow us to
determine market trends as well as our ability to effectively retain existing customers. Privacy advocacy groups and the technology and
other industries are considering various new, additional or different self-regulatory standards that may place additional burdens on
us. Any such changes could impair our ability to use data and could adversely impact select functionality of our proprietary software,
impairing our ability to use this data to anticipate customer demand and market trends, as well as adversely affecting our business and
our ability to generate revenue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we fail to keep up with rapid technological
changes, our future success may be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.I. and machine learning
technologies are subject to rapid changes and our technology is yet to be fully automated. Our future success will depend on our ability
to respond to rapidly changing technologies, to adapt and further develop our own functionality or our services to our evolving industry
and to improve the performance and reliability of our systems. Our failure to adapt to such changes could harm our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the widespread
adoption of new internet, networking or telecommunications technologies or other technological changes could require substantial expenditures
to modify or adapt our products, services or infrastructure. If we fail to keep up with rapid technological changes to remain competitive
in our rapidly evolving industry, our future success may be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business depends on our ability to
build and maintain strong product listings on e-commerce platforms. We may not be able to maintain and enhance our product listings if
we receive a substantial number of customer complaints, negative publicity or otherwise fail to live up to customers&#8217; expectations,
any of which could materially adversely affect our business, results of operations and growth prospects.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Maintaining and enhancing
our product listings is critical in expanding and growing our business. However, a significant portion of our perceived performance to
the customer depends on third parties outside of our control, including suppliers and logistics providers such as FedEx, UPS, postal
services and other third-party delivery agents and online retailers, mainly Amazon. Because our agreements with our online retail partners
are generally terminable at will, we may be unable to maintain these relationships, and our results of operations could fluctuate significantly
from period to period. Because we rely on third party logistics companies, like FedEx, to deliver our products, we are subject to shipping
delays or disruptions caused by inclement weather, natural disasters, labor activism, health epidemics or bioterrorism. In addition,
because we rely on national, regional and local transportation companies for the delivery of some of our other products, we are also
subject to risks of breakage or other damage during delivery by any of these third parties. If these third parties do not meet our or
our customers&#8217; expectations, our brands may suffer irreparable damage. In addition, maintaining and enhancing our current and future
brands may require us to make substantial investments, and these investments may not be yield sufficient returns. If we fail to promote
and maintain our brands, or if we incur excessive expenses in this effort, our business, operating results and financial condition may
be materially adversely affected. We anticipate that, as our market becomes increasingly competitive, maintaining and enhancing our brands
may become increasingly difficult and expensive. Maintaining and enhancing our brands will depend largely on our ability to anticipate
market trends and customer demand and to provide high quality products to our customers and a reliable, trustworthy and profitable sales
channel to our suppliers, which we may not be able to do successfully.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A substantial number of customer
complaints or negative publicity about our sites, products, delivery times, customer data handling and security practices or customer
support, especially on blogs, social media websites or our sites, could rapidly and severely diminish consumer views of our products
and result in harm to our brands. Customers may also make safety-related claims regarding products sold through our online retail partners,
such as Amazon, which may result in an online retail partner removing the product from its marketplace. Such removal may materially impact
our financial results depending on the product that is removed and length of time that it is removed. We also use and rely on other services
from third parties, such as our telecommunications services, and those services may be subject to outages and interruptions that are
not within our control.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our efforts to acquire or retain customers,
and our efforts to sell new products or increase sales of our existing products, may not be successful, which could prevent us from maintaining
or increasing our sales.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we do not successfully
promote and sustain our new and/or existing product listings and brands through marketing and other tools, we may fail to maintain or
increase our sales. Promoting and positioning our brands and product listings will depend largely on the success of our marketing efforts,
our ability to attract customers cost effectively and our ability to consistently provide a high-quality product and maintain consumer
satisfaction. We also use promotions to drive sales, which may not be effective and may adversely affect our gross margins. Our investments
in marketing may not effectively reach potential customers, potential customers may decide not to buy our products or the spending of
customers that purchase from us may not yield the intended return on investment, any of which could negatively affect our financial results.
The failure of our marketing activities could also adversely affect our ability to promote our product listings and sell our products,
and to develop and maintain relationships with our customers, retailers and brands, which may have a material adverse effect on our business,
results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we fail to acquire new customers or
retain existing customers, or fail to do so in a cost-effective manner, we may not be able to achieve profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success depends on our
ability to acquire and retain customers in a cost-effective manner. In order to expand our customer base, we must appeal to and acquire
customers who have historically used other channels to purchase the wide variety of products we offer and may prefer alternatives to
our offerings, such as those offered by other vendors on Amazon, traditional brick-and-mortar retailers and the websites of our competitors
or our suppliers&#8217; own websites. We expect competition in e-commerce generally to continue to increase. Competitors have introduced
lower cost or differentiated products that are perceived to compete with our products. If we are unable to correctly anticipate market
trends and customer demand, our ability to sell our products could be impaired. If we fail to deliver quality products, or if customers
do not perceive the products we offer to be of high value and quality, we may not be able to acquire new customers. If we are unable
to acquire new customers who purchase products in numbers sufficient to grow our business, we may not be able to generate the scale necessary
to drive beneficial network effects with our suppliers, our net revenue may decrease and our business, financial condition and operating
results may be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe new customers
can originate from word-of-mouth and other non-paid referrals from existing customers. Therefore, we must ensure that our existing customers
remain loyal to us in order to continue receiving those referrals. If our efforts to satisfy our existing customers are not successful,
we may lose these customers or we may not be able to acquire new customers in sufficient numbers to continue to grow our business, or
we may be required to incur significantly higher marketing expenses in order to acquire new customers. For example, since 2016, Amazon
has maintained a policy whereby they will purge all reviews they believe are paid for. While we do not ask customers to leave a positive
review or change a review, some of our reviews may be purged by Amazon in accordance with this policy if Amazon believes they were questionable
or not authentic. If Amazon purges reviews or if we are unable to maintain our positive reviews, it may adversely affect our ability
to acquire new customers or retain existing ones.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we believe that
Amazon has, from time to time, placed limitations on the daily volume of reviews that may be provided for any specific product listing.
This limitation or others relating to customer engagement with our product listings could impact the success of our product listings,
which could adversely impact our financial performance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we fail to offer high-quality customer
support, our business and reputation may suffer.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">High-quality education and
training of customer support personnel to deliver high-quality customer support are important for the successful retention of existing
customers. Providing this education, training and support requires that our support personnel have specific knowledge and expertise of
our products and markets, making it more difficult for us to hire experienced personnel and to scale up our support operations. The importance
of high-quality customer support will increase as we expand our business and pursue new customers. If we do not provide effective and
timely ongoing support, our ability to retain existing customers may suffer, and our reputation with existing or potential customers
may be harmed, which would have a material adverse effect on our business, results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our efforts to expand our business into
new brands, products, services, technologies and geographic regions will subject us to additional business, legal, financial and competitive
risks and may not be successful.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business success depends
to some extent on our ability to expand our consumer offerings by launching new brands, products and services and by expanding our existing
offerings into new geographic regions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our strategy is to use our
skills to determine which markets to enter and optimize the mix of products and services that we offer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Launching new brands, products
and services requires significant upfront investments, including investments in marketing (namely digital marketing and PPC (Pay Per
Click), information technology and additional personnel. We operate in highly competitive industries with relatively low barriers to
entry and must compete successfully in order to grow our business. We may not be able to generate satisfactory revenue from these efforts
to offset these costs. Any lack of market acceptance of our efforts to launch new brands, products or services or to expand our existing
offerings could have a material adverse effect on our business, prospects, financial condition and results of operations. Further, as
we continue to expand our fulfillment capability or add new businesses with different requirements, our logistics networks will become
increasingly complex and operating them will become more challenging. There can be no assurance that we will be able to operate our networks
effectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have also entered and
may continue to enter new markets and provide product offerings in which we have limited or no experience, which may not be successful
or appealing to our customers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The CPG industry is subject
to evolving standards and practices, as well as changing consumer needs, requirements and preferences. Our ability to attract new customers
and increase revenue from existing customers depends, in part, on our ability to enhance and improve our existing tools that enable us
to pinpoint new markets and introduce new products. The success of any enhancements or new instruments depends on, in part, market-accepted
pricing levels and overall market acceptance. We may not be successful in these efforts, which could result in significant expenditures
that could impact our revenue or distract management&#8217;s attention from current offerings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Increased emphasis on the
sale of new products could distract us from sales of our existing products in existing markets, negatively affecting our overall sales.
We have invested and expect to continue to invest in new businesses, products, features, services and technologies. Such endeavors may
involve significant risks and uncertainties, including insufficient revenue from such investments to offset any new liabilities assumed
and expenses associated with these new investments, inadequate return of capital on our investments, distraction of management from current
operations and unidentified issues not discovered in our due diligence of such investments that could cause us to fail to realize the
anticipated benefits of such investments and incur unanticipated liabilities. Because these new strategies and offerings are inherently
risky, no assurance can be given that they will be successful. Our new features or enhancements could fail to attain sufficient market
acceptance for many reasons, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">delays in introducing
                                            products in new markets;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">failure to accurately
                                            predict market demand or end consumer preferences;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">introduction of
                                            competing products;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">poor financial
                                            conditions for our customers or poor general macroeconomic conditions;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">changes in legal
                                            or regulatory requirements, or increased legal or regulatory scrutiny, adversely affecting
                                            our products;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">failure of our
                                            brands and products digital promotion activities or negative publicity about the performance
                                            or effectiveness of our existing brands and products; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">disruptions or
                                            delays in the online retailers and, or in addition to, logistics providers distributing our
                                            products.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There is no assurance that
we will successfully identify new opportunities or develop and bring new products to market on a timely basis, which could materially
and adversely affect our business and operating results and compromise our ability to generate revenue.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Potential growth of our businesses is based
on international expansion, making us susceptible to risks associated with international sales and operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have historically mainly
sold products in the United&#160;States, and in 2021 also began selling products in the United Kingdom and Germany. We intend to expand
our operations to reach new markets and localities. For example, since the completion of the IPO, we have expanded to Sweden and Belgium
and we expect to increase our sales in the United Kingdom and Germany and have completed the requisite processes in order to offer certain
of our products through Amazon in other major European countries, including Sweden and Belgium, Singapore and Australia. We may not be
successful in increasing our sales in the United Kingdom and Germany and currently do not have an estimated starting date for sales in
these other major European countries. Conducting international operations subjects us to certain risks, which include localization of
solutions and products and adapting them to local practices and regulatory requirements, exchange rate fluctuations and unexpected changes
in tax, trade laws, tariffs, governmental controls and other trade restriction. To the extent that we do not succeed in expanding our
operations internationally and managing the associated legal and operational risks, our results of operations may be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of social media and email may adversely
impact our reputation or subject us to fines or other penalties.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We use social media and email
as part of our digital marketing efforts. As laws and regulations rapidly evolve to govern the use of these channels, the failure by
us, our employees or third parties acting at on our behalf to abide by applicable laws and regulations in the use of these channels could
adversely affect our reputation or subject us to fines or other penalties. In addition, our employees or third parties acting on our
behalf may knowingly or inadvertently make use of social media in ways that could lead to the loss or infringement of intellectual property,
as well as the public disclosure of proprietary, confidential or sensitive personal information of our business, employees, customers
or others. Any such inappropriate use of social media or email could also cause reputational damage.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Customers value readily available
information concerning retailers and their goods and services and often act on such information without further investigation and with
no regard to its accuracy. Our customers may engage with us online through our social media platforms, including Facebook and Instagram,
by providing feedback and public commentary about all aspects of our business. Information concerning us or our retailers and brands,
whether accurate or not, may be posted on social media platforms at any time and may have a disproportionately adverse impact on our
brand, reputation or business. The harm may be immediate without affording us an opportunity for redress or correction and could have
a material adverse effect on our business, results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our emails are not delivered and accepted
or are routed by email providers less favorably than other emails, or our sites or mobile applications are not accessible or are treated
disadvantageously by Internet service providers, our business may be substantially harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If email providers or Internet
service providers, or ISPs, implement new restrictive email or content delivery or accessibility policies, including with respect to
net neutrality, or begin enforcement of existing policies, it may become more difficult to deliver emails to our customers or for customers
to access our sites, products and services. For example, certain email providers, including Google, categorize our emails as &#8220;promotional&#8221;,
and these emails are directed to an alternate, and less readily accessible, section of a customer&#8217;s inbox. If email providers materially
limit or halt the delivery of our emails, or if we fail to deliver emails to customers in a manner compatible with email providers&#8217;
email handling or authentication technologies, our ability to contact customers through email could be significantly restricted. In addition,
if we are placed on &#8220;spam&#8221; lists or lists of entities that have been involved in sending unwanted, unsolicited emails, our
operating results and financial condition could be substantially harmed. Further, if ISPs prioritize or provide superior access to our
competitors&#8217; content, our business and results of operations may be negatively impacted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are unable to manage our inventory
effectively, our operating results could be adversely affected.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To ensure timely delivery
of products, we generally enter into purchase orders in advance with manufacturers. As a result, we are vulnerable to demand and pricing
shifts and to suboptimal selection and timing of product purchases. We rely on our procurement team to order products and we rely on
our data analytics to inform the levels of inventory we purchase, including when to reorder items that are selling well and when to write
off items that are not selling well. In these instances, we may be unable to always predict the appropriate demand for our products by
customers with accuracy, which may result in inventory shortages, inventory write offs and lower gross margins.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our sales and procurement
teams do not predict demand well or if our algorithms do not help us reorder the right products or write off the right products timely,
we may not effectively manage our inventory, which could result in inventory excess or shortages, and our operating results and financial
condition could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business, including our costs and supply
chain, is subject to risks associated with sourcing, importing and warehousing.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We source the products we
offer from third-party vendors and, as a result, we may be subject to price fluctuations or demand disruptions. Our operating results
could be negatively impacted by increases in the prices of our products, and we have no guarantees that prices will not rise. In addition,
as we expand into new categories and types of products, we expect that we may not have strong purchasing power in these new areas, which
could lead to higher costs than we have historically seen in our current product categories and types. We may not be able to pass increased
costs on to customers, which could adversely affect our operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we cannot guarantee
that products we receive from vendors will be of sufficient quality or free from damage or defects, or that such merchandise will not
be damaged during shipping or storage. While we take measures to ensure product quality and avoid damage, including evaluating vendor
facilities, operations and product samples, conducting inventory inspections and inspecting returned products, we cannot control merchandise
while it is out of our possession or prevent all damage while in our distribution centers. We may incur additional expenses and our reputation
could be harmed if or current or potential customers believe that our merchandise is not of high quality or may be damaged.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risks associated with the suppliers from
whom our products are sourced could materially adversely affect our financial performance, as well as our reputation and brand.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We depend on our ability
to provide our customers with a wide range of products from high quality suppliers in a timely and efficient manner. Our agreements with
most of our suppliers do not provide for the long-term availability of merchandise or the continuation of particular pricing practices,
nor do they usually restrict such suppliers from selling products to other buyers or directly themselves. There can be no assurance that
our current suppliers will continue to seek to sell us products on current terms or that we will be able to establish new or otherwise
extend current supply relationships to ensure product acquisitions in a timely and efficient manner and on acceptable commercial terms.
Our ability to develop and maintain relationships with reputable suppliers and offer high quality products to our customers is critical
to our success. If we are unable to develop and maintain relationships with suppliers that would allow us to offer a sufficient amount
and variety of quality products on acceptable commercial terms, our ability to satisfy our customers&#8217; needs, and therefore our
long-term growth prospects, would be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also are unable to predict
whether any of the countries in which our suppliers&#8217; products are currently manufactured or may be manufactured in the future will
be subject to trade restrictions imposed by the U.S.&#160;or foreign governments or the likelihood, type or effect of any such restrictions.
Any event causing a disruption or delay of imports from suppliers with international manufacturing operations, including the imposition
of additional import restrictions, restrictions on the transfer of funds or increased tariffs or quotas, could increase the cost or reduce
the supply of merchandise available to our customers and materially adversely affect our financial performance as well as our reputation
and brand. Our competitors may have greater existing inventory positions and other advantages that may allow them to price more competitively
relative to our products. Furthermore, some or all of our suppliers&#8217; foreign operations may be adversely affected by political
and financial instability, resulting in the disruption of trade from exporting countries, restrictions on the transfer of funds or other
trade disruptions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Manufacturing risks, including risks related
to manufacturing in China, may adversely affect our ability to manufacture our products and could reduce our gross margin and our profitability.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We rely on third party manufacturers
in China to manufacture our products. As a result, our business is subject to risks associated with doing business in China, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">trade protection
                                            measures, such as tariff increases, and import and export licensing and control requirements;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">potentially negative
                                            consequences from changes in tax laws;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">difficulties associated
                                            with the Chinese legal system, including increased costs and uncertainties associated with
                                            enforcing contractual obligations in China;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">historically lower
                                            protection of intellectual property rights;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">unexpected or unfavorable
                                            changes in regulatory requirements; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">changes and volatility
                                            in currency exchange rates.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Economic regulation, trade restrictions,
and increasing manufacturing costs in China could adversely impact our business and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We contract with manufacturing
facilities in the People&#8217;s Republic of China. For many&#160;years, the Chinese economy has experienced periods of rapid growth.
An increase in the cost of labor or taxes on wages in China may lead to an increase in the cost of goods manufactured in China. Significant
increases in wages or wage taxes paid by contract manufacturing facilities may increase the cost of goods manufactured in China which
could have a material adverse effect on the Company&#8217;s profit margins and profitability. Additionally, government trade policies,
including the imposition of tariffs, export restrictions, sanctions or other retaliatory measures could limit our ability to source materials
and products from China at acceptable prices or at all. For example, both the United&#160;States and China have implemented several rounds
of tariffs and retaliations with respect to certain products imported from the other country, some of which may impact certain products
we import. Moreover, the U.S.&#160;Congress recently passed the Uyghur Forced Labor Prevention Act in an effort to prevent what it views
as forced labor and human rights abuses in the Xinjiang Uyghur Autonomous Region, or XUAR.&#160;If it is determined that our third-party
suppliers and manufacturers mine, produce or manufacture our products wholly or in part from the XUAR, then we could be prohibited from
importing such products into the U.S.&#160;In addition, Chinese trade regulations are in a state of flux, and we may become subject to
other forms of taxation, tariffs and duties in China. We do not currently have arrangements with contract manufacturers in other countries
that may be acceptable substitutes. We cannot predict what actions may ultimately be taken with respect to tariffs, export controls,
countermeasures, or other trade measures between the U.S.&#160;and China or other countries and what products may be subject to such
actions. To the extent such actions inhibit our transactions with contract manufacturing facilities and suppliers in China, our business
may be materially adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Shipping is a critical part of our business
and any changes in shipping costs or any interruptions in shipping could adversely affect our operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we are not able to negotiate
acceptable pricing and other terms with vendors or if vendors experience performance problems or other difficulties, it could negatively
impact our operating results and our customers&#8217; experience. We are also subject to volatility in ocean freight rates that are driven,
in part, by seasonality, capacity availability and other factors, including fuel-related regulations affecting the shipping industry.
In addition, our ability to receive inbound inventory efficiently and ship merchandise to clients may be negatively affected by inclement
weather, fire, flood, power loss, earthquakes, labor disputes, acts of war or terrorism and similar factors. We are also subject to risk
of damage or loss during delivery by our shipping vendors. If our products are not delivered in a timely fashion or are damaged or lost
during the delivery process, our customers could become dissatisfied and cease using our products or services, which would adversely
affect our business and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We depend on highly skilled personnel,
including senior management, and if we are unable to retain or motivate key personnel or hire, retain and motivate qualified personnel,
our business could be harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe our past success
has depended, and our future success depends, on the efforts and talents of our senior management and our highly skilled team members.
Our future success depends on our continuing ability to attract, develop, motivate and retain highly qualified and skilled employees.
The loss of one or more of our key personnel or the inability to promptly identify a suitable successor to a key role could have an adverse
effect on our business. In particular, our Founder and Chief Executive Officer has unique and valuable experience leading our Company
from our inception through today. If he were to depart or otherwise reduce his focus on our Company, our business may be disrupted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Competition for key personnel
is strong, especially in Israel where our headquarters are located, and we cannot be sure that we will be able to attract and retain
a sufficient number of qualified personnel in the future, or that the compensation costs of doing so will not adversely affect our operating
results. Similarly, competition for well-qualified employees in all aspects of our business is intense globally. We do not have long-term
employment or non-competition agreements with any of our employees. If we do not succeed in attracting well-qualified employees or retaining
and motivating existing employees and key senior management with the appropriate skills at cost-effective compensation levels, or if
changes to our business adversely affect morale or retention, our business, results of operations, financial condition and prospects
may be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, in making employment
decisions, job candidates often consider the value of the stock options or other equity incentives they are to receive in connection
with their employment. If the price of our shares declines, or experiences significant volatility, our ability to attract or retain key
employees may be adversely affected. Also, as employee options vest and the lock-up agreements expire, we may have difficulty retaining
key employees. If we fail to attract new personnel or fail to retain and motivate our current personnel, our growth prospects could be
severely harmed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not accurately forecast revenues,
profitability and appropriately plan our expenses.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We base our current and future
expense levels on our operating forecasts and estimates of future income and operating results. Income and operating results are difficult
to forecast because they generally depend on the volume and timing of orders, which are uncertain. Additionally, our business is affected
by general economic and business conditions around the world. A softening in income, whether caused by changes in consumer preferences
or a weakening in global economies, may result in decreased net revenue levels, and we may be unable to adjust our spending in a timely
manner to compensate for any unexpected shortfall in income. This inability could cause our income (loss) from operations after tax in
a given quarter to be lower or higher than expected. We also make certain assumptions when forecasting the amount of expense we expect
related to our share-based payments, which includes the expected volatility of our share price, and the expected life of equity awards
granted. These assumptions are partly based on historical results. If actual results differ from our estimates, our operating results
in a given quarter may be lower than expected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our operating results are subject to seasonal
fluctuations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The e-commerce business is
seasonal in nature and the fourth quarter is a significant period for our operating results due to the holiday season. As a result, revenue
generally declines and loss from operations generally increases in the first quarter sequentially from the fourth quarter of the previous
year. Any disruption in our ability to process and fulfill customer orders during the fourth quarter could have a negative effect on
our quarterly and annual operating results. For example, if a large number of customers purchase our products in a short period of time
due to increased holiday demand, inefficient management of our inventory may prevent us from efficiently fulfilling orders, which may
reduce sales and harm our brands.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General economic factors may adversely
affect our business, financial performance and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business, financial performance
and results of operations depend significantly on worldwide macroeconomic economic conditions and their impact on consumer spending.
Recessionary economic cycles, higher interest rates, volatile fuel and energy costs, inflation, levels of unemployment, conditions in
the residential real estate and mortgage markets, access to credit, consumer debt levels, unsettled financial markets and other economic
factors that may affect consumer spending or buying habits could materially and adversely affect demand for our products. In addition,
volatility in the financial markets has had and may continue to have a negative impact on consumer spending patterns. A reduction in
consumer spending or disposable income may affect us more significantly than companies in other industries and companies with a more
diversified product offering. In addition, negative national or global economic conditions may materially and adversely affect our suppliers&#8217;
financial performance, liquidity and access to capital. This may affect their ability to maintain their inventories, production levels
and/or product quality and could cause them to raise prices, lower production levels or cease their operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Economic factors such as
increased commodity prices, shipping costs, higher costs of labor, insurance and healthcare, and changes in or interpretations of other
laws, regulations and taxes may also increase our cost of goods sold and our selling, general and administrative expenses, and otherwise
adversely affect our financial condition and results of operations. Global inflation has risen in 2022. To date, we have not been subject
to inflationary pressures. However, to mitigate any identified potential inflationary pressures, the Company purchased more inventory
at the beginning of the year in order to avoid price increases that may be caused by the increase in inflation or shipping costs. We
cannot assure you that we will not be adversely affected in the future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any significant increases
in costs may affect our business disproportionately than our competitors. Changes in trade policies or increases in tariffs, may have
a material adverse effect on global economic conditions and the stability of global financial markets and may reduce international trade.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Natural disasters or other unexpected events
may adversely affect our operations, particularly our merchandise supply chain and shipping efforts.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Natural disasters, such as
earthquakes, hurricanes, tornadoes, floods and other adverse weather and climate conditions; unforeseen public health crises, such as
pandemics and epidemics; political crises, such as terrorist attacks, war and other political instability; or other catastrophic events,
whether occurring in Israel or internationally, could disrupt our operations in any of our offices and fulfillment centers or the operations
of one or more of our third-party providers or vendors. In particular, these types of events could impact our merchandise supply chain,
including our ability to ship merchandise to customers from or to the impacted region, and could impact our ability or the ability of
third parties to operate our sites and ship merchandise. In addition, these types of events could negatively impact consumer spending
in the impacted regions. To the extent any of these events occur, our business and operating results could be adversely affected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are currently operating in a period
of economic uncertainty and capital markets disruption, which has been significantly impacted by geopolitical instability due to the
ongoing military conflict between Russia and Ukraine. Our business, financial condition and results of operations may be materially adversely
affected by any negative impact on the global economy and capital markets resulting from the conflict in Ukraine or any other geopolitical
tensions.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">U.S. and global markets are
experiencing volatility and disruption following the escalation of geopolitical tensions and the start of the military conflict between
Russia and Ukraine. On February 24, 2022, a full-scale military invasion of Ukraine by Russian troops was reported. Although the length
and impact of the ongoing military conflict is highly unpredictable, the conflict in Ukraine could lead to market disruptions, including
significant volatility in credit and capital markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, Russia&#8217;s
prior annexation of Crimea, recent recognition of two separatist republics in the Donetsk and Luhansk regions of Ukraine and subsequent
military interventions in Ukraine have led to sanctions and other penalties being levied by the United States, European Union and other
countries against Russia, Belarus, the Crimea Region of Ukraine, the so-called Donetsk People&#8217;s Republic, and the so-called Luhansk
People&#8217;s Republic, including agreement to remove certain Russian financial institutions from the Society for Worldwide Interbank
Financial Telecommunication payment system. Additional potential sanctions and penalties have also been proposed and/or threatened. Russian
military actions and the resulting sanctions could adversely affect the global economy and financial markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any of the abovementioned
factors could affect our business, prospects, financial condition, and operating results. The extent and duration of the military action,
sanctions and resulting market disruptions are impossible to predict, but could be substantial. Any such disruptions may also magnify
the impact of other risks described in this Annual Report on Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may acquire other companies or technologies,
which could divert our management&#8217;s attention, result in additional dilution to our shareholders and otherwise disrupt our operations
and adversely affect our operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may in the future seek
to acquire or invest in businesses, features or technologies that we believe could complement or expand our market, enhance our technical
capabilities or otherwise offer growth opportunities. The pursuit of potential acquisitions may divert the attention of management and
cause us to incur various expenses in identifying, investigating and pursuing suitable acquisitions, whether or not they are consummated.
In addition, to the extent that we enter into any term sheets or agreements or otherwise announce any intention to acquire any businesses,
features or technologies, any such acquisition would generally be subject to completion of due diligence and required approvals, and
there can be no assurance that any such acquisition will occur or be completed in a timely manner, or at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we acquire additional
businesses, we may not be able to integrate the acquired personnel, operations, existing contracts and technologies successfully or effectively
manage the combined business following the acquisition. We also may not achieve the anticipated benefits from any future acquired business
due to a number of factors, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">failure to identify
                                            all of the issues, liabilities or other shortcomings or challenges of an acquired company
                                            or technology, including issues related to intellectual property, regulatory compliance practices,
                                            revenue recognition or other accounting practices, or employee or client issues;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">difficulty incorporating
                                            acquired technology and rights into our existing algorithm and operations and of maintaining
                                            quality and security standards consistent with our brands;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">inability to generate
                                            sufficient revenue to offset acquisition or investment costs;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">incurrence of acquisition-related
                                            costs or equity dilution associated with funding the acquisition;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">difficulties and
                                            additional expenses associated with supporting legacy products and hosting infrastructure
                                            of the acquired business;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">risks of entering
                                            new markets or new product categories in which we have limited or no experience;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">difficulty converting
                                            the customers of the acquired business into our customers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">diversion of our
                                            management&#8217;s attention from other business concerns;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"></p><div>

</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">adverse effects
                                            to our existing business relationships as a result of the acquisition;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">potential loss
                                            of key employees, customers, vendors and suppliers from either our current business or an
                                            acquired company&#8217;s business;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">use of resources
                                            that are needed in other parts of our business;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">possible write
                                            offs or impairment charges relating to acquired businesses;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">compliance with
                                            regulatory matters related to the acquired business or its products; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">use of substantial
                                            portions of our available cash to consummate the acquisition.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, a significant
portion of the purchase price of companies we acquire may be allocated to acquired goodwill and intangible assets, which must be assessed
for impairment at least annually. In the future, if our acquisitions do not yield expected returns, we may be required to take charges
to our operating results based on this impairment assessment process, which could adversely affect our results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Acquisitions could also result
in dilutive issuances of equity securities or the incurrence of debt, which could adversely affect our operating results. If an acquired
business fails to meet our expectations, our business, operating results and financial condition may suffer.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Risks Related to Information Technology</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Assertions by third parties of infringement
or misappropriation by us of their intellectual property rights or confidential know how could result in significant costs and substantially
harm our business and results of operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business relies on sophisticated
and experienced use and know-how of Amazon&#8217;s A.I. market tracker. Third parties may in the future assert that we have infringed
or misappropriated their trademarks, copyrights, confidential know how, trade secrets, patents or other intellectual property rights.
We cannot predict whether any such assertions or claims arising from such assertions will substantially harm our business and results
of operations, whether or not they are successful. If we are forced to defend against any infringement or other claims relating to the
trademarks, copyright, confidential know how, trade secrets, patents or other intellectual property rights of third parties, whether
they are with or without merit or are determined in our favor, we may face costly litigation or diversion of technical and management
personnel. Furthermore, the outcome of a dispute may be that we would need to cease use of some portion of our systems. Any such assertions
or litigation could materially adversely affect our business, results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The e-commerce industry is
characterized by vigorous protection and pursuit of intellectual property rights, which has resulted in protracted and expensive litigation
for many companies. Some companies, including some of our competitors, own large numbers of patents, copyrights and trademarks, which
they may use to assert claims against us. In addition, because patent applications can take&#160;years to issue and are often afforded
confidentiality for some period of time, there may currently be pending applications, unknown to us, that later result in issued patents
that could cover one or more of the technologies we use.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain third parties have
substantially greater resources than we have and may be able to sustain the costs of intellectual property litigation for longer periods
of time than we can. Even if we were to prevail in such a dispute, any litigation regarding the way we operate and utilize our technologies,
could be costly and time-consuming and divert the attention of our management and key personnel from our business operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The inability to acquire, use or maintain
our marks and domain names for our sites could substantially harm our business and operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We currently have registered
trademarks for our brands in numerous jurisdictions and have registered the Internet domain names for our websites, as well as various
related domain names. However, we have not registered our trademarks or domain names in all major international jurisdictions. Domain
names generally are regulated by Internet regulatory bodies. If we do not have, or cannot obtain on reasonable terms, the ability to
use our marks in a particular country or to use or register any of our domain names, we could be forced either to incur significant additional
expenses to market our products within that country, including the development of a new brand and the creation of new promotional materials
and packaging, or to elect not to sell products in that country. Either result could materially adversely affect our business, financial
condition and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, the regulations
governing domain names and laws protecting marks and similar proprietary rights could change in ways that block or interfere with our
ability to use relevant domains or our current brand names. Furthermore, we might not be able to prevent third parties from registering,
using or retaining domain names that interfere with our consumer communications or infringe or otherwise decrease the value of our marks,
domain names and other proprietary rights. Regulatory bodies also may establish additional generic or country-code top-level domains
or may allow modifications of the requirements for registering, holding or using domain names. As a result, we may not be able to register,
use or maintain the domain names that utilize the name Jeffs&#8217; Brands or our other brands in all of the countries in which we currently
or intend to conduct business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Any significant disruption in service on
our websites or in our computer systems, a number of which are currently hosted or provided by third-party providers, could materially
affect our ability to operate, damage our reputation and result in a loss of customers, which would harm our business and results of
operations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to sell and market
our products relies on FBA platform whose functionality relies upon a number of third-party related services, including those relating
to cloud infrastructure, technology services, servers, open-source libraries and vendor APIs. Any disruption or loss of any of these
third-party services could have a negative effect on our business, results of operations, financial condition and prospects. We may experience
interruptions in our systems, including server failures that temporarily slow down or interfere with the performance of our platforms
and the ability to sell on e-commerce marketplaces.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Interruptions in these systems,
whether due to system failures, human input errors, computer viruses or physical or electronic break-ins, and denial-of-service attacks
on us, third-party vendors or communications infrastructure, could affect the availability of our services on our platform and prevent
or inhibit the ability of selling our products. Volume of traffic and activity on e-commerce marketplaces spikes on certain&#160;days,
such as during a Black Friday promotion, and any such interruption would be particularly problematic if it were to occur at such a high-volume
time. Problems with the reliability of our systems or third-party marketplaces could prevent us from earning revenue and could harm our
reputation. Damage to our reputation, any resulting loss of customers, e-commerce confidence and the cost of remedying these problems
could negatively affect our business, results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our ability to maintain communications,
network and computer hardware in the countries in which they are used may in the future be subject to regulatory review and licensing,
and the failure to obtain any required licenses could negatively affect our business. Our systems and infrastructure are predominately
reliant on third parties. Problems faced by our third-party service providers with the telecommunications network providers with whom
they contract or with the systems by which they allocate capacity among their users, including us, could adversely affect the experience
of our customers. Our third-party service providers could decide to close their facilities without adequate notice. Any financial difficulties,
such as bankruptcy or reorganization, faced by our third-party service providers or any of the service providers with whom they contract
may have negative effects on our business, the nature and extent of which are difficult to predict. If our third-party service providers
are unable to keep up with our needs for capacity, this could have an adverse effect on our business. Any errors, defects, disruptions
or other performance problems with our services could harm our reputation and may have a material adverse effect on our business, results
of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our failure or the failure of third parties
to protect our sites, networks and systems against security breaches, or otherwise to protect our confidential information and practices,
could damage our reputation and brands and substantially harm our business and operating results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We collect, maintain, transmit
and store data about our customers, brands and others, including personally identifiable information, as well as other confidential information.
We also engage third parties that store, process and transmit these types of information on our behalf. We rely on encryption and authentication
technology licensed from third parties in an effort to securely transmit confidential and sensitive information, including credit card
numbers. Advances in computer capabilities, new technological discoveries or other developments may result in the whole or partial failure
of this technology to protect transaction data or other confidential and sensitive information from being breached or compromised. In
addition, our brand&#8217;s e-commerce websites are often attacked through compromised credentials, including those obtained through
phishing and credential stuffing. Our security measures, and those of our third-party service providers, may not detect or prevent all
attempts to breach our systems, denial-of-service attacks, viruses, malicious software, break-ins, phishing attacks, social engineering,
security breaches or other attacks and similar disruptions that may jeopardize the security of information stored in or transmitted by
our websites, networks and systems or that we or such third parties otherwise maintain, including payment card systems, which may subject
us to fines or higher transaction fees or limit or terminate our access to certain payment methods. We and such third parties may not
anticipate or prevent all types of attacks until after they have already been launched. Further, techniques used to obtain unauthorized
access to or sabotage systems change frequently and may not be known until launched against us or our third-party service providers.
In addition, security breaches can occur as a result of non-technical issues, including intentional or inadvertent breaches by our employees
or by third parties. These risks may increase over time as the complexity and number of technical systems and applications we use also
increases.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 23; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Breaches of our security
measures or those of our third-party service providers or cyber security incidents could result in unauthorized access to our sites,
networks, systems and accounts; unauthorized access to, and misappropriation of, consumer information, including customers&#8217; personally
identifiable information, or other confidential or proprietary information of ourselves or third parties; viruses, worms, spyware or
other malware being served from our sites, networks or systems; deletion or modification of content or the display of unauthorized content
on our sites; interruption, disruption or malfunction of operations; costs relating to breach remediation, deployment of additional personnel
and protection technologies, response to governmental investigations and media inquiries and coverage; engagement of third-party experts
and consultants; or litigation, regulatory action and other potential liabilities. In the past, we have experienced social engineering,
phishing, malware and similar attacks and threats of denial-of-service attacks; however, such attacks could in the future have a material
adverse effect on our operations. If any of these breaches of security should occur, our reputation and brand could be damaged, our business
may suffer, we could be required to expend significant capital and other resources to alleviate problems caused by such breaches, and
we could be exposed to a risk of loss, litigation or regulatory action and possible liability. We cannot guarantee that recovery protocols
and backup systems will be sufficient to prevent data loss. Actual or anticipated attacks may cause us to incur increasing costs, including
costs to deploy additional personnel and protection technologies, train employees and engage third-party experts and consultants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may experience periodic
system interruptions from time to time. In addition, continued growth in our transaction volume, as well as surges in online traffic
and orders associated with promotional activities or seasonal trends in our business, place additional demands on our marketplace platforms
and could cause or exacerbate slowdowns or interruptions. If there is a substantial increase in the volume of traffic on our sites or
the number of orders placed by customers, we will be required to further expand and upgrade our technology, transaction processing systems
and network infrastructure. There can be no assurance that we will be able to accurately project the rate or timing of increases, if
any, in the use of our sites or expand and upgrade our systems and infrastructure to accommodate such increases on a timely basis. In
order to remain competitive, we must continue to enhance and improve the responsiveness, functionality and features of our sites, which
is particularly challenging given the rapid rate at which new technologies, customer preferences and expectations and industry standards
and practices are evolving in the e-commerce industry. Accordingly, we redesign and enhance various functions on our sites on a regular
basis, and we may experience instability and performance issues as a result of these changes. Our disaster recovery plan may be inadequate,
and our business interruption insurance may not be sufficient to compensate us for the losses that could occur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any compromise or breach
of our security measures, or those of our third-party service providers, could violate applicable privacy, data protection, data security,
network and information systems security and other laws and cause significant legal and financial exposure, adverse publicity and a loss
of confidence in our security measures, which could have a material adverse effect on our business, results of operations, financial
condition and prospects. We continue to devote significant resources to protect against security breaches, or we may need to devote significant
resources in the future to address problems caused by breaches, including notifying affected subscribers and responding to any resulting
litigation, which in turn, diverts resources from the growth and expansion of our business. To date, we are not aware of any material
compromises or breaches of our networks or systems.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Risks Related to Legal and Regulatory Matters</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to general litigation,
regulatory disputes and government inquiries.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a growing company with
expanding operations, we may in the future increasingly face the risk of claims, lawsuits, government investigations and other proceedings
involving competition and antitrust, intellectual property, privacy, consumer protection, accessibility claims, securities, tax, labor
and employment, commercial disputes, services and other matters. The number and significance of these disputes and inquiries have increased
as the political and regulatory landscape changes, and as we have grown larger and expanded in scope and geographic reach, and our services
have increased in complexity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot predict the outcome
of such disputes and inquiries with certainty. Regardless of the outcome, these can have an adverse impact on us because of legal costs,
diversion of management resources and other factors. Determining reserves for any litigation is a complex, fact-intensive process that
is subject to judgment calls. It is possible that a resolution of one or more such proceedings could require us to make substantial payments
to satisfy judgments, fines or penalties or to settle claims or proceedings, any of which could harm our business. These proceedings
could also result in reputational harm, criminal sanctions, consent decrees or orders preventing us from offering certain products or
services or requiring a change in our business practices in costly ways or requiring development of non-infringing or otherwise altered
products or technologies. Litigation and other claims and regulatory proceedings against us could result in unexpected expenses and liabilities,
which could have a material adverse effect on our business, results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 24; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A failure to comply with current laws,
rules and regulations or changes to such laws, rules and regulations and other legal uncertainties may adversely affect our business,
financial performance, results of operations or business growth.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business and financial
performance could be adversely affected by unfavorable changes in or interpretations of existing laws, rules and regulations or the promulgation
of new laws, rules and regulations applicable to us and our businesses, including those relating to the internet and e-commerce, internet
advertising and price display, consumer protection, anti-corruption, antitrust and competition, economic and trade sanctions, energy
usage and emissions, tax, banking, data security, network and information systems security, data protection and privacy. As a result,
regulatory authorities could prevent or temporarily suspend us from carrying on some or all of our activities or otherwise penalize us
if our practices were found not to comply with applicable regulatory or licensing requirements or any binding interpretation of such
requirements. Unfavorable changes or interpretations could decrease demand for our products or services, limit marketing methods and
capabilities, affect our margins, increase costs or subject us to additional liabilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For example, there are, and
will likely continue to be, an increasing number of laws and regulations pertaining to the internet and e-commerce that may relate to
liability for information retrieved from or transmitted over the internet, display of certain taxes and fees, online editorial and consumer-generated
content, user privacy, data security, network and information systems security, behavioral targeting and online advertising, taxation,
liability for third-party activities and the quality of services. Furthermore, the growth and development of e-commerce may prompt calls
for more stringent consumer protection laws and more aggressive enforcement efforts, which may impose additional burdens on online businesses
generally.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our products experience any recalls,
product liability claims, or government, customer or consumer concerns about product safety, our reputation and operating results could
be harmed.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products are subject
to regulation by the U.S.&#160;Consumer Product Safety Commission, or the CPSC, and similar state and international regulatory authorities,
and could be subject to involuntary recalls and other actions by these authorities. Concerns about product safety including concerns
about the safety of products manufactured in developing countries, could lead us to recall selected products. Recalls and government,
customer or consumer concerns about product safety could harm our reputation and reduce sales, either of which could have a material
adverse effect on our business, results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may also be subject to
product liability claims if people or property are harmed by the products we sell. Some of the products we sell may expose us to product
liability claims and litigation (including class actions) or regulatory action relating to safety, personal injury, death or environmental
or property damage.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we maintain liability
insurance, we cannot be certain that our coverage will be adequate for liabilities actually incurred or that insurance will continue
to be available to us on economically reasonable terms, or at all. Some of our agreements with members of our supply chain may not indemnify
us from product liability claims for a particular product, and some members of our supply chain may not have sufficient resources or
insurance to satisfy their indemnity and defense obligations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 25; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Any failure by us or our vendors to comply
with product safety, labor or other laws, or our standard vendor terms and conditions, or to provide safe factory conditions for our
or their workers may damage our reputation and brand and harm our business.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The products we sell to our
customers are subject to regulation by the CPSC, the Federal Trade Commission, or the FTC, and similar state and international regulatory
authorities. As a result, such products could be in the future subject to recalls and other remedial actions. Product safety, labeling
and licensing concerns may require us to voluntarily remove selected merchandise from our inventory. Such recalls or voluntary removal
of merchandise can result in, among other things, suspension of our seller accounts on Amazon and other online marketplaces, lost sales,
diverted resources, potential harm to our reputation and increased client service costs and legal expenses, which could have a material
adverse effect on our operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some of the products we sell
may expose us to product liability claims and litigation or regulatory action relating to personal injury or environmental or property
damage. Although we maintain liability insurance and implemented a quality assurance program that includes obtaining necessary certifications,
we cannot be certain that our coverage will be adequate for liabilities actually incurred or that insurance will continue to be available
to us on economically reasonable terms or at all. In addition, some of our agreements with our vendors may not indemnify us from product
liability claims for a particular vendor&#8217;s products or our vendors may not have sufficient resources or insurance to satisfy their
indemnity and defense obligations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to U.S.&#160;governmental
regulation and other legal obligations related to privacy, data protection and information security. If we are unable to comply with
these, we may be subject to governmental enforcement actions, litigation, fines and penalties or adverse publicity.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We collect personally identifiable
information and other data from our customers and prospective customers. We collect this info automatically through the automated sales
processes with e-commerce marketplaces. We, at times, may use this information to provide, support, expand and improve our business and
tailor our digital marketing and advertising efforts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our handling of data is subject
to a variety of laws and regulations, including regulation by various government agencies, such as the FTC, and various state, local
and foreign agencies. Our data handling also is subject to contractual obligations and industry standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The U.S.&#160;federal and
various state and foreign governments have adopted or proposed limitations on the collection, distribution, use and storage of data relating
to individuals, including the use of contact information and other data for digital marketing, advertising and other communications with
individuals and businesses. In the United&#160;States, various laws and regulations apply to the collection, processing, disclosure and
security of certain types of data. Additionally, the FTC and many state attorneys general are interpreting federal and state consumer
protection laws as imposing standards for the online collection, use, dissemination and security of data. The laws and regulations relating
to privacy and data security are evolving, can be subject to significant change and may result in ever-increasing regulatory and public
scrutiny and escalating levels of enforcement and sanctions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the United&#160;States,
federal and various state governments have adopted or are considering laws, guidelines or rules for the collection, distribution, use
and storage of information collected from or about customers or their devices. For example, five U.S. states have passed comprehensive
privacy legislation intended to provide consumers with greater transparency and control over their personal information by providing
consumers with certain rights, such as the right to know what personal information is being collected about them, and the right to access,
delete, correct, or opt out of the sale of their personal information. The original California Consumer Privacy Act became effective
in 2020, with amendments in the California Privacy Rights Act effective in 2023. Similar laws in Colorado, Connecticut, Utah and Virginia
are effective over the course of 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, the FTC and
many state attorneys general are applying federal and state consumer protection laws to impose standards for the online collection, use
and dissemination of data. Furthermore, these obligations may be interpreted and applied inconsistently from one jurisdiction to another
and may conflict with other requirements or our practices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Numerous data protection
regimes apply based on where a customer is located, and as we expand and new laws are enacted or existing laws change, we may be subject
to new laws, regulations or standards or new interpretations of existing laws, regulations or standards, which could require us to incur
additional costs and restrict our business operations. Any failure or perceived failure by us to comply with rapidly evolving privacy
or security laws, policies (including our own stated privacy policies), legal obligations or industry standards or any security incident
that results in the unauthorized release or transfer of personally identifiable information or other consumer data may result in governmental
enforcement actions, litigation (including consumer class actions), fines and penalties or adverse publicity and could cause our customers
to lose trust in us, which could have a material adverse effect on our business, results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>In Europe, where we expect to expand our
business operations in the future as part of our growth, the data privacy and information security regime recently underwent a significant
change and continues to evolve and is subject to increasing regulatory scrutiny.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The General Data Protection
Regulation, or GDPR, which came into force on May&#160;25, 2018, implemented more stringent operational requirements for our use of personal
data. These more stringent requirements include expanded disclosures to tell our customers about how we may use their personal data,
increased controls on profiling customers and increased rights for customers to access, control and delete their personal data. In addition,
there are mandatory data breach notification requirements and significantly increased penalties of the greater of &#8364;20&#160;million
or 4% of global turnover for the preceding financial year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The U.K.&#8217;s Network
and Information Systems Regulations 2018, or NID Regulations, which came into force on May&#160;10, 2018, apply to us as an online marketplace
and place additional network and information systems security obligations on us, as well as mandatory security incident notification
in certain circumstances with penalties of up to &#163;17&#160;million.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In recent&#160;years, U.S.&#160;and
European lawmakers and regulators have expressed concern over the use of third-party cookies and similar technologies for online behavioral
advertising, and laws in this area are also under reform. Such regulations may have a negative effect on businesses, including ours,
that collect and use online usage information for consumer acquisition and marketing, it may increase the cost of operating a business
that collects or uses such information and undertakes online marketing, it may also increase regulatory scrutiny and increase potential
civil liability under data protection or consumer protection laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We could incur substantial
costs to comply with these regulations. The changes could require significant systems changes, limit the effectiveness of our marketing
activities, adversely affect our margins, increase costs and subject us to additional liabilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Amendments to existing tax laws, rules
or regulations or enactment of new unfavorable tax laws, rules or regulations could have an adverse effect on our business and financial
performance.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Many of the laws, rules or
regulations imposing taxes and other similar obligations were established before the growth of the internet and e-commerce. Tax authorities
in non-U.S.&#160;jurisdictions, including Israel, and at the U.S.&#160;federal, state and local levels are currently reviewing the appropriate
treatment of companies engaged in e-commerce and considering changes to existing tax or other laws that could regulate our transmissions
and/or levy sales, income, consumption, use or other taxes relating to our activities, and/or impose obligations on us to collect such
taxes. For example, in March&#160;2018, the European Commission proposed new rules for taxing digital business activities in the EU.&#160;In
addition, state and local taxing authorities in the United&#160;States and taxing authorities in other countries have identified e-commerce
platforms as a means to calculate, collect and remit indirect taxes for transactions taking place over the internet. Multiple U.S.&#160;states
have enacted related legislation and other states are now considering such legislation. Furthermore, the U.S.&#160;Supreme Court recently
has held in <i>South Dakota v. Wayfair</i> that a U.S.&#160;state may require an online retailer to collect sales taxes imposed by that
state, even if the retailer has no physical presence in that state, thus permitting a wider enforcement of such sales tax collection
requirements. Such legislation could require us or our retailers and brands to incur substantial costs in order to comply, including
costs associated with legal advice, tax calculation, collection, remittance and audit requirements, which could make selling in such
markets less attractive and could adversely affect our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot predict the effect
of current attempts to impose taxes on commerce over the internet. If such tax or other laws, rules or regulations were amended, or if
new unfavorable laws, rules or regulations were enacted, the results could increase our tax payments or other obligations, prospectively
or retrospectively, subject us to interest and penalties, decrease the demand for our products if we pass on such costs to the consumer,
result in increased costs to update or expand our technical or administrative infrastructure or effectively limit the scope of our business
activities if we decided not to conduct business in particular jurisdictions. As a result, these changes may have a material adverse
effect on our business, results of operations, financial condition and prospects.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to anti-corruption, anti-bribery,
anti-money laundering and similar laws, and non-compliance with such laws can subject us to criminal penalties or significant fines and
harm our business and reputation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Israel Money Laundering and
Terror Financing Prohibition Authority, the SEC, the U.S.&#160;Department of Justice, the U.S.&#160;Treasury Department&#8217;s Office
of Foreign Assets Controls, or OFAC, the U.S.&#160;Department of State, and other foreign regulatory authorities, continue to enforce
economic and trade regulations and anti-corruption laws across industries. U.S.&#160;trade sanctions relate to transactions with designated
foreign countries and territories, including Cuba, Iran, North Korea, Syria and the Crimea region of Ukraine, or Crimea, as well as specifically
targeted individuals and entities that are identified on U.S.&#160;and other blacklists, and those owned by them or those acting on their
behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Anti-corruption laws, including
the U.S.&#160;Foreign Corrupt Practices Act, or the FCPA, the U.K.&#160;Bribery Act, or the Bribery Act, and Israel Penal Code section
291a, generally prohibit direct or indirect corrupt payments to government officials and, under certain laws, private persons to obtain
or retain business or an improper business advantage. Some of our international operations are conducted in parts of the world where
it is common to engage in business practices that are prohibited by these laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we comply with laws
and regulations, especially as we expand our operations in existing and new jurisdictions which proportionately adds risks of non-compliance
with applicable laws and regulations, our employees, partners or agents could take actions that violate applicable laws or regulations.
As regulations continue to develop and regulatory oversight continues to focus on these areas, we cannot ensure compliance at all times
with all applicable laws or regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event our controls
should fail, or we are found to be not in compliance for other reasons, we could be subject to monetary damages, civil and criminal monetary
penalties, withdrawal of business licenses or permits, litigation and damage to our reputation and the value of our brand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As we expand our operations
in existing and new jurisdictions internationally, we will need to increase the scope of our compliance programs to address the risks
relating to the potential for violations of the FCPA and the Bribery Act and other anti-bribery and anti-corruption laws. Further, the
promulgation of new laws, rules and regulations, or the new interpretation of existing laws, rules and regulations, in each case that
restrict or otherwise unfavorably impact the ability or manner in which we or our retailers and brands conduct business could require
us to change certain aspects of our business, operations and commercial relationships to ensure compliance, which could decrease demand
for products or services, reduce net revenue, increase costs or subject us to additional liabilities. Anti-corruption and anti-bribery
laws have been enforced aggressively in recent&#160;years, are interpreted broadly and prohibit companies and their employees and agents
from promising, authorizing, making, offering, soliciting or accepting improper payments or other benefits to or from government officials
and others in the private sector. As we increase our international sales and business, particularly in countries with a low score on
the Corruptions Perceptions Index by Transparency International and increase our use of third-party business partners such as sales agents,
distributors, resellers or consultants, our risks under these laws may increase. Under these laws, we could be held liable for the corrupt
or other illegal activities of our employees, representatives, contractors, business partners and agents, even if we do not explicitly
authorize or have actual knowledge of such activities. Noncompliance with these laws could subject us to investigations, sanctions, settlements,
prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions,
suspension or debarment from contracting with certain persons, the loss of export privileges, whistle-blower complaints, reputational
harm, adverse media coverage and other collateral consequences. If any subpoenas or investigations are launched, or governmental or other
sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our business, results of operations and
financial condition could be materially harmed. In addition, responding to any action will likely result in a materially significant
diversion of management&#8217;s attention and resources and significant defense and compliance costs and other professional fees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In certain cases, enforcement
authorities may even require us to appoint an independent compliance monitor, which can result in added costs and administrative burdens.
Any investigations, actions, sanctions or other previously mentioned harm could have a material negative effect on our business, operating
results and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our amended and restated articles of association
provide that unless we consent to an alternate forum, the federal district courts of the United&#160;States shall be the exclusive forum
of resolution of any claims arising under the Securities Act.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated
articles of association provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts
of the United&#160;States shall be the sole and exclusive forum for any claim asserting a cause of action arising under the Securities
Act. Section&#160;22 of the Securities Act of 1933, as amended, or the Securities Act, creates concurrent jurisdiction for federal and
state courts over all such Securities Act actions. Accordingly, both U.S.&#160;state and federal courts have jurisdiction to entertain
such claims. This choice of forum provision may limit a shareholder&#8217;s ability to bring a claim in a judicial forum that it finds
favorable for disputes with us or our directors, officers or other employees and may increase the costs associated with such lawsuits,
which may discourage such lawsuits against us and our directors, officers and employees. Alternatively, if a court were to find these
provisions of our amended and restated articles of association inapplicable to, or unenforceable in respect of, one or more of the specified
types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could
adversely affect our business and financial condition. Any person or entity purchasing or otherwise acquiring any interest in our share
capital shall be deemed to have notice of and to have consented to the choice of forum provisions of our amended and restated articles
of association described above. This provision would not apply to suits brought to enforce a duty or liability created by the Securities
Exchange Act of 1934, as amended, or the Exchange&#160;Act, or any other claim for which the U.S.&#160;federal courts have exclusive
jurisdiction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Even following receipt of any regulatory
approval for our&#160; pest control products,&#160;we&#160;will continue to be&#160;subject&#160;to&#160;regulation&#160;of&#160;our
advertising practices.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a seller of pest control
products, we are subject to continual government oversight by the U.S.&#160;Environmental Protection Agency, or EPA, and other regulatory
authorities. The EPA strictly regulates the advertising and promotion of pest control products, and these pest control products may only
be marketed or promoted for their EPA approved uses, consistent with the product&#8217;s approved labeling. Advertising and promotion
of any product candidate that obtains approval in the U.S.&#160;will be heavily scrutinized by the EPA, other applicable state regulatory
agencies and the public. Violations, including promotion of our products for unapproved or off-label&#160;uses, are subject to enforcement
actions, inquiries and investigations, and civil, criminal and/or administrative sanctions imposed by the EPA.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our&#160;operations are&#160;subject&#160;to&#160;environmental&#160;laws&#160;and
regulations that may increase costs of operations and impact or limit&#160;our&#160;business plans.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to environmental
laws and regulations affecting many aspects of our present and potential future operations, including a wide variety of EPA labeling
and other state regulatory agency requirements. For example, under the Federal Insecticide, Fungicide, and Rodenticide Act, we are required
to register with the EPA and certain state regulatory authorities as a seller of disinfectants, and we are subject to EPA labeling requirements.
Compliance with these laws and regulations may result in increased costs and delays as a result of administrative proceedings and certain
reporting obligations. Public officials and entities may seek injunctive relief or other remedies to enforce applicable environmental
laws and regulations. If we are found to not have complied with these laws and are unable to sell out products, our business and financial
results will be negatively impacted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><b><i>Increased regulatory
scrutiny of nutritional supplements as well as new regulations that are being adopted in some of our markets with respect to nutritional
supplements could result in more restrictive regulations and harm our results if our supplements or advertising activities are found
to violate existing or new regulations or if we are not able to effect necessary changes to our products in a timely and efficient manner
to respond to new regulations. </i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There has been an increasing
movement in the United States and other markets to increase the regulation of&#160;dietary&#160;supplements, which could impose additional
restrictions or requirements on us and increase the cost of doing business. On February 11, 2019, the U.S. Food and Drug Administration,
or FDA, issued a statement from FDA Commissioner, Dr. Scott Gottlieb, regarding the agency&#8217;s efforts to strengthen the regulation
of&#160;dietary&#160;supplements. The FDA will be prioritizing and focusing resources on misbranded products bearing unproven claims
to treat, cure, or mitigate disease. Commissioner Gottlieb established a&#160;Dietary&#160;Supplement Working Group tasked with reviewing
the agency&#8217;s organizational structure, process, procedures, and practices to identify opportunities to modernize the oversight
of&#160;dietary&#160;supplements. Additionally, on December 21, 2015, the FDA created the Office of&#160;Dietary&#160;Supplements, or
ODSP. The creation of this new office elevates the FDA&#8217;s program from its previous status as a division under the Office of Nutrition
and&#160;Dietary&#160;Supplements. ODSP will continue to monitor the safety of&#160;dietary&#160;supplements. In August 2016, the FDA
published its revised draft guidance on&#160;Dietary&#160;Supplements: New&#160;Dietary&#160;Ingredient Notifications and Related Issues.
If a company sells a&#160;dietary&#160;supplement containing an ingredient that FDA considers either not a&#160;dietary&#160;ingredient
or a new&#160;dietary&#160;ingredient, or NDI, that needs an NDI notification, the agency may threaten or initiate enforcement against
such company. For example, it might send a warning letter that can trigger consumer lawsuits, demand a product recall, or even work with
the Department of Justice to bring a criminal action. Our operations could be harmed if new guidance or regulations require us to reformulate
products or effect new registrations, if regulatory authorities make determinations that any of our products do not comply with applicable
regulatory requirements, if the cost of complying with regulatory requirements increases materially, or if we are not able to effect
necessary changes to our products in a timely and efficient manner to respond to new regulations. In addition, our operations could be
harmed if governmental laws or regulations are enacted that restrict the ability of companies to market or distribute nutritional supplements
or impose additional burdens or requirements on nutritional supplement companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt; "></p><div>

</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Risks Related to our Operations in Israel</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Political, economic and military instability
in Israel may impede our ability to operate and harm our financial results.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our offices and management
team are located in Israel. Accordingly, political, economic, and military conditions in Israel and the surrounding region may directly
affect our business and operations. In recent&#160;years, Israel has been engaged in sporadic armed conflicts with Hamas, an Islamist
terrorist group that controls the Gaza Strip, with Hezbollah, an Islamist terrorist group that controls large portions of southern Lebanon,
and with Iranian-backed military forces in Syria. In addition, Iran has threatened to attack Israel and may be developing nuclear weapons.
Some of these hostilities were accompanied by missiles being fired from the Gaza Strip against civilian targets in various parts of Israel,
including areas in which our employees and some of our consultants are located, and negatively affected business conditions in Israel.
Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its trading partners could adversely
affect our operations and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our commercial insurance
does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently
covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, we cannot assure you that this
government coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us
could have a material adverse effect on our business. Any armed conflicts or political instability in the region would likely negatively
affect business conditions and could harm our results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Israeli government is
currently pursuing extensive changes to Israel&#8217;s judicial system. In response to the foregoing developments, individuals, organizations
and institutions, both within and outside of Israel, have voiced concerns that the proposed changes may negatively impact the business
environment in Israel including due to reluctance of foreign investors to invest or transact business in Israel as well as to increased
currency fluctuations, downgrades in credit rating, increased interest rates, increased volatility in security markets, and other changes
in macroeconomic conditions. To the extent that any of these negative developments do occur, they may have an adverse effect on our business,
our results of operations and our ability to raise additional funds, if deemed necessary by our management and board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, in the past, the
State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business with the State
of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating results, financial
condition or the expansion of our business. A campaign of boycotts, divestment and sanctions has been undertaken against Israel, which
could also adversely impact our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, many Israeli
citizens are obligated to perform several&#160;days, and in some cases more, of annual military reserve duty each year until they reach
the age of 40 (or older, for reservists who are military officers or who have certain occupations) and, in the event of a military conflict,
may be called to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military
reservists. It is possible that there will be military reserve duty call-ups in the future. Our operations could be disrupted by such
call-ups, which may include the call-up of members of our management. Such disruption could materially adversely affect our business,
prospects, financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Exchange rate fluctuations between foreign
currencies and the U.S.&#160;Dollar may negatively affect our earnings.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our reporting and functional
currency is the U.S.&#160;dollar. Our revenues are currently primarily payable in U.S.&#160;dollars and we expect our future revenues
to be denominated primarily in U.S.&#160;dollars. However, certain amounts of our revenues and expenses is also in NIS, GBP and Euro.
As a result, we are exposed to the currency fluctuation risks relating to the recording of our expenses in U.S.&#160;dollars.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 31; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>It may be difficult to enforce a judgment
of a U.S.&#160;court against us and our executive officers and directors and the Israeli experts named in this Annual Report on Form
20-F in Israel or the United&#160;States, to assert U.S.&#160;securities laws claims in Israel or to serve process on our executive officers
and directors and these experts.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are incorporated in Israel.
All of our executive officers and directors reside outside of the United&#160;States, and all of our assets and most of the assets of
these persons are located outside of the United&#160;States. Therefore, a judgment obtained against us, or any of these persons, including
a judgment based on the civil liability provisions of the U.S.&#160;federal securities laws, may not be collectible in the United&#160;States
and may not be enforced by an Israeli court. It also may be difficult for you to effect service of process on these persons in the United&#160;States
or to assert U.S.&#160;securities law claims in original actions instituted in Israel. Additionally, it may be difficult for an investor,
or any other person or entity, to initiate an action with respect to U.S.&#160;securities laws in Israel. Israeli courts may refuse to
hear a claim based on an alleged violation of U.S.&#160;securities laws reasoning that Israel is not the most appropriate forum in which
to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S.&#160;law
is applicable to the claim. If U.S.&#160;law is found to be applicable, the content of applicable U.S.&#160;law must be proven as a fact
by expert witnesses, which can be a time consuming and costly process. Certain matters of procedure will also be governed by Israeli
law. There is little binding case law in Israel that addresses the matters described above. As a result of the difficulty associated
with enforcing a judgment against us in Israel, you may not be able to collect any damages awarded by either a U.S.&#160;or foreign court.
See &#8220;Enforceability of Civil Liabilities&#8221; for additional information on your ability to enforce a civil claim against us
and our executive officers or directors named in this Annual Report on Form 20-F.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Your rights and responsibilities as a shareholder
will be governed in key respects by Israeli laws, which differ in some material respects from the rights and responsibilities of shareholders
of U.S.&#160;companies.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
rights and responsibilities of the holders of our Ordinary Shares are governed by our amended and restated articles of association and
by Israeli law. These rights and responsibilities differ in some material respects from the rights and responsibilities of shareholders
in U.S.&#160;companies. In particular, a shareholder of an Israeli company has a duty to act in good faith and in a customary manner
in exercising its rights and performing its obligations towards the company and other shareholders, and to refrain from abusing its power
in such company, including, among other things, in voting at a general meeting of shareholders on matters such as amendments to a company&#8217;s
articles of association, increases in a company&#8217;s authorized share capital, mergers and acquisitions and related party transactions
requiring shareholder approval, as well as a general duty to refrain from discriminating against other shareholders. In addition, a controlling
shareholder of an Israeli company or a shareholder who is aware that it possesses the power to determine the outcome of a vote at a meeting
of the shareholders or to appoint or prevent the appointment of a director or executive officer in the company, or has other powers,
has a duty of fairness towards the company. </span>Israeli law does not define the substance of this duty of fairness. <span style="font-family: Times New Roman, Times, Serif">There
is limited case law available to assist us in understanding the nature of these duties or the implications of these provisions. These
provisions may be interpreted to impose additional obligations and liabilities on holders of our ordinary shares that are not typically
imposed on shareholders of U.S.&#160;companies. </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Certain provisions of our amended and restated
articles of association may be deemed to have an anti-takeover effect.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain provisions of our
amended and restated articles of association may make a change in control of us more difficult to effect. Our amended and restated articles
of association provide for a staggered board of directors consisting of three classes of directors. Directors of each class are chosen
for three-year terms upon the expiration of their current terms and each year one class of our directors will be elected by our shareholders.
This classified board provision could have the effect of making the replacement of incumbent directors more time consuming and difficult.
At least two annual meetings of shareholders, instead of one, will generally be required to effect a change in a majority of our board
of directors. Thus, the classified board provision could increase the likelihood that incumbent directors will retain their positions.
The staggered terms of directors may delay, defer or prevent an attempt to change control of us, even though a change in control might
be considered by our shareholders to be in their best interest.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 32; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Risks Related to Our Status as a Public Company
and Ownership of our Ordinary Shares and Warrants</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We incur significant increased costs as
a result of operating as a public company. Our management is required to devote substantial time to new compliance initiatives as well
as compliance with ongoing U.S. requirements.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a public company, we incur
significant legal, accounting and other expenses that we did not incur as a private company. For example, we subject to the reporting
requirements of the Exchange&#160;Act, and are required to comply with the applicable requirements of the Sarbanes-Oxley Act and the
Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as the rules and regulations subsequently implemented by the SEC,
including the establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Compliance with these requirements
will increase our legal and financial compliance costs and will make some activities more time consuming and costly. In addition, our
management and other personnel might need to divert attention from operational and other business matters to devote substantial time
to these public company requirements. In particular, we expect to incur significant expenses and devote substantial management effort
toward ensuring compliance with the requirements of Section&#160;404 of the Sarbanes-Oxley Act which will increase when we are no longer
an emerging growth company, as defined by the JOBS Act. We will need to hire additional accounting and financial staff with appropriate
public company experience and technical accounting knowledge and maintain an internal audit function. We cannot predict or estimate the
amount of additional costs we may incur as a result of operating as a public company or the timing of such costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that being a public
company makes it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage
or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain
qualified members of our board of directors, particularly to serve on our audit committee and compensation committee, and skilled executive
officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of disclosure
of information in our publicly-filed documents, our business and financial condition became more visible, which we believe may result
in threatened or actual litigation, including by competitors and other third parties. If such claims are successful, our business and
results of operations could be materially adversely affected, and even if the claims do not result in litigation or are resolved in our
favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and materially
adversely affect our business, financial condition and operating results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif"><b><i>Our
internal control over financial reporting may not currently meet all of the standards contemplated by Section 404 of the Sarbanes-Oxley
Act, and failure to achieve and maintain effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley
Act could have a material adverse effect on our business.</i></b></span>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">We
are in the process of documenting our internal control procedures to satisfy the requirements of Section 404 (a) of the Sarbanes-Oxley
Act, which requires an annual management assessment of the effectiveness of our internal control over financial reporting. We are in the
process of addressing our internal control over financial reporting and we will establish formal policies, processes and practices related
to financial reporting and identify key financial reporting risks, including an assessment of the potential impact and linkage of those
risks to specific areas and activities within our organization.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 33; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">We are required to comply with the
requirements of Sections&#160;302 and 404 of the Sarbanes-Oxley Act, which require our management to certify financial and other information
in our annual reports and will require that we provide an annual management report on the effectiveness of control over financial reporting.
Though we will be required to disclose material changes in internal control over financial reporting on an annual basis, we will not
be required to make our first annual assessment of our internal control over financial reporting pursuant to Section&#160;404 until the
year following our first filing of an Annual Report on Form 20-F, i.e. beginning with our report for the year ended December 31, 2023.
Additionally, while we remain an emerging growth company, we will not be required to include an attestation report on internal control
over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section&#160;404 within
the prescribed period, we will be engaged in a process to document and evaluate our internal control over financial reporting, which
is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants
and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve
control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting
and improvement process for internal control over financial reporting. We expect to comply with Section&#160;404 of the Sarbanes-Oxley
by the end of 2023.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; ">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">As
a public entity, we are required to complete our initial assessment in a timely manner. If we are not able to implement and document
the necessary policies, processes and controls to mitigate financial reporting risks, we may not be able to comply with the requirements
of Sections 404(a) in a timely manner or with adequate compliance. Matters impacting our internal controls may cause us to be unable
to report our financial information on a timely basis and thereby subject us to adverse regulatory consequences, including sanctions
by the SEC or violations of applicable stock exchange listing rules. There could also be a negative reaction in the financial markets
due to a loss of investor confidence in our company and the reliability of our financial statements. Confidence in the reliability of
our financial statements could also suffer if we were to report a material weakness in our internal control over financial reporting.
This could materially adversely affect us and lead to a decline in the price of our securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Future sales of our Ordinary Shares and
Warrants could reduce the market price of our Ordinary Shares and Warrants.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Substantial sales of our
Ordinary Shares and Warrants on Nasdaq, may cause the market price of our Ordinary Shares and/or Warrants to decline. Sales by us or
our security holders of substantial amounts of our Ordinary Shares and/or Warrants, or the perception that these sales may occur in the
future, could cause a reduction in the market price of our Ordinary Shares and/or Warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The issuance of any additional
Ordinary Shares or any securities that are exercisable for or convertible into Ordinary Shares, may have an adverse effect on the market
price of our Ordinary Shares and will have a dilutive effect on our existing shareholders and holders of Ordinary Shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>As a &#8220;foreign private issuer&#8221;
we are permitted, and intend, to follow certain home country corporate governance practices instead of otherwise applicable SEC and Nasdaq
requirements, which may result in less protection than is accorded to investors under rules applicable to domestic U.S.&#160;issuers.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our status as a foreign private
issuer also exempts us from compliance with certain SEC laws and regulations and certain regulations of Nasdaq, including the proxy rules,
the short-swing profits recapture rules, and certain governance requirements such as independent director oversight of the nomination
of directors and executive compensation. In addition, we will not be required under the Exchange&#160;Act to file current reports and
financial statements with the SEC as frequently or as promptly as U.S.&#160;domestic companies whose securities are registered under
the Exchange&#160;Act and we will generally be exempt from filing quarterly reports with the SEC.&#160;Also, although the Israeli Companies
Law,&#160;5759-1999, or the Companies Law, requires us to disclose the annual compensation of our five most highly compensated senior
officers on an individual basis (rather than on an aggregate basis), this disclosure will not be as extensive as that required of a U.S.&#160;domestic
issuer. Furthermore, as a foreign private
issuer, we are also not subject to the requirements of Regulation&#160;FD (Fair Disclosure) promulgated under the Exchange&#160;Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 34; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These exemptions and leniencies
will reduce the frequency and scope of information and protections to which you are entitled as an investor.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The determination of foreign
private issuer status is made annually on the last business&#160;day of an issuer&#8217;s most recently completed second fiscal quarter
and, accordingly, the next determination will be made with respect to us on June&#160;30, 2023. In the future, we would lose our foreign
private issuer status if a majority of our shareholders, directors or management are U.S.&#160;citizens or residents and we fail to meet
additional requirements necessary to avoid loss of foreign private issuer status. The regulatory and compliance costs to us under U.S.&#160;securities
laws as a U.S.&#160;domestic registrant may be significantly higher.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The estimates of market opportunity, market
size and forecasts of market growth included in this Annual Report on Form 20-F and our other publicly filed documents may prove to be
inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at similar rates,
if at all.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Market opportunity, size
estimates and growth forecasts included in this Annual Report on Form 20-F and our other publicly filed documents are subject to significant
uncertainty and are based on assumptions and estimates that may not prove to be accurate. For example, several of the reports and data
on which our estimates and forecasts are based rely on projections of consumer adoption and incorporate data from secondary sources,
such as company websites as well as industry, trade and government publications.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Net revenue and operating
results are difficult to forecast because they generally depend on the volume, timing and type of orders we receive, all of which are
uncertain. We base our expense levels and investment plans on our estimates of total net revenue and gross margins using human judgment
combined with our machine learning, natural language processing and data analytics. We cannot be sure the same growth rates, trends and
other key performance metrics are meaningful predictors of future growth. If our assumptions and calculations prove to be wrong, we may
spend more than we anticipate acquiring and retaining customers or may generate less net revenue per active customer than anticipated,
any of which could have a negative impact on our business and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, as we enter
a new consumer product markets in the future, we may initially provide discounts to customers to gain market traction, and the amount
and effect of these discounts may vary greatly. No such discounts have been given to date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Finally, we are evaluating
our total addressable market with respect to new product offerings and new markets. These estimates of total addressable market and growth
forecasts are subject to significant uncertainty, are based on assumptions and estimates that may not prove to be accurate and are based
on data published by third parties that we have not independently verified. Even if the market in which we compete meets the size estimates
and growth forecasted in this Annual Report on Form 20-F, our business could fail to grow at similar rates, if at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business is also affected
by general economic and business conditions in international markets.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we experience
seasonal trends in our business, and our mix of product offerings is highly variable from&#160;day-to-day and quarter-to-quarter. This
variability makes it difficult to predict sales and could result in significant fluctuations in our net revenue from period-to-period.
A significant portion of our expenses is fixed, and as a result, we may be unable to adjust our spending in a timely manner to compensate
for any unexpected shortfall in net revenue. Any failure to accurately predict net revenue or gross margins could cause our operating
results to be lower than expected, which could materially adversely affect our financial condition and share price.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 35; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our management team has limited experience
managing a public company.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Most members of our management
team have limited experience managing a public company, interacting with public company investors and complying with the increasingly
complex laws pertaining to public companies. Accordingly, our management team, as a whole, may not successfully or efficiently manage
the transition to being a public company subject to significant regulatory oversight and reporting obligations under the federal securities
laws and the continuous scrutiny of securities analysts and investors. These new obligations and constituents will require significant
attention from our senior management, particularly from our chief executive officer, and could divert their attention away from the&#160;day-to-day
management of our business, which could adversely affect our business, operating results and financial condition.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>As of December 31, 2022, our principal
shareholders, officers and directors beneficially owned approximately 66.13% of our outstanding Ordinary Shares and as such they will
therefore be able to exert significant control over matters submitted to our shareholders for approval.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2022,
our principal shareholders, officers and directors, in the aggregate beneficially owned approximately 66.13% of our outstanding Ordinary
Shares. This significant concentration of share ownership may adversely affect the trading price for our Ordinary Shares because investors
often perceive disadvantages in owning shares in companies with controlling shareholders. As a result, these shareholders, if they acted
together, will be able to exercise a significant level of control over all matters requiring shareholder approval, including the election
of directors, amendment of our articles of association and approval of significant corporate transactions. The interests of these shareholders
may not always coincide with our interests or the interests of other shareholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are an emerging growth company and any
decision on our part to comply only with certain reduced reporting and disclosure requirements applicable to emerging growth companies
could make our Ordinary Shares and Warrants less attractive to investors.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an emerging growth
company and, for as long as we continue to be an emerging growth company, we may choose to take advantage of exemptions from various
reporting requirements applicable to other public companies but not to &#8220;emerging growth companies,&#8221; including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">not being required
                                            to have our independent registered public accounting firm audit our internal control over
                                            financial reporting under Section&#160;404 of the Sarbanes-Oxley Act;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">permission to delay
                                            adopting new or revised accounting standards until such time as those standards apply to
                                            private companies;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reduced disclosure
                                            obligations regarding executive compensation in our periodic reports and annual report on
                                            Form&#160;20-F; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">exemptions from
                                            the requirements of holding non-binding advisory votes on executive compensation and shareholder
                                            approval of any golden parachute payments not previously approved.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may take advantage some
or all of these and other exemptions until we are no longer an &#8220;emerging growth company&#8221;. We could be an emerging growth
company up to the end of the fiscal year in which the fifth anniversary of the completion of our IPO, or 2027, although we expect to
not be an emerging growth company sooner. Our status as an emerging growth company will end as soon as any of the following take place:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the last&#160;day
                                            of the fiscal year in which we have more than $1.235&#160;billion in annual revenue;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the date we qualify
                                            as a &#8220;large accelerated filer,&#8221; with at least $700&#160;million of equity securities
                                            held by non-affiliates;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the date on which
                                            we have issued, in any three-year period, more than $1.0&#160;billion in non-convertible
                                            debt securities; or</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the last&#160;day
                                            of the fiscal year ending after the fifth anniversary after we become a public company.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 36; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We cannot predict if investors
will find our Ordinary Shares or Warrants less attractive if we choose to rely on any of the exemptions afforded emerging growth companies.
If some investors find our Ordinary Shares or Warrants less attractive because we rely on any of these exemptions, there may be a less
active trading market for our Ordinary Shares and/or Warrants and the market price of our Ordinary Shares and/or Warrants may be more
volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, under the JOBS
Act, &#8220;emerging growth companies&#8221; can delay adopting new or revised accounting standards until such time as those standards
apply to private companies. We have elected to avail ourselves of this exemption and, as a result, our financial statements may not be
comparable to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards
that are applicable to public companies. Section&#160;107 of the JOBS Act provides that we can elect to opt out of the extended transition
period at any time, which election is irrevocable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Even after we no longer qualify
as an emerging growth company, we may qualify as a &#8220;smaller reporting company&#8221;, which would allow us to take advantage of
many of the same exemptions from disclosure requirements (excluding the exemption from compliance with the auditor attestation requirements
of Section&#160;404 of the Sarbanes-Oxley Act) and reduced disclosure obligations regarding executive compensation in our periodic reports
and proxy statements. However, as a foreign private issuer we are not eligible to use the requirements for smaller reporting companies
unless we use the forms and rules designated for domestic issuers and provide financial statements prepared in accordance with U.S.&#160;generally
accepted accounting principles. We cannot predict if investors will find our Ordinary Shares and/or Warrants less attractive because
we may rely on either of these exemptions. If some investors find our Ordinary Shares and/or Warrants less attractive as a result, there
may be a less active trading market for our Ordinary Shares and/or Warrants and our share price may be more volatile.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The market price of our Ordinary Shares
and/or Warrants may be volatile. Market volatility may affect the value of an investment in our Ordinary Shares and/or Warrants and could
subject us to litigation.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Technology shares have historically
experienced high levels of volatility. There has been and could continue to be significant volatility in the market price and trading
volume of equity securities. The market price of our Ordinary Shares and/or Warrants could be subject to wide fluctuations in response
to many risk factors listed in this section, and others beyond our control, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">actual or anticipated
                                            fluctuations in our financial condition and operating results;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the financial projections
                                            we may provide to the public, and any changes in projected operational and financial results;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">addition or loss
                                            of significant customers;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">changes in laws
                                            or regulations applicable to our products;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">actual or anticipated
                                            changes in our growth rate relative to our competitors;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">announcements of
                                            technological innovations or new offerings by us or our competitors;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">announcements by
                                            us or our competitors of significant acquisitions, strategic partnerships, joint ventures
                                            or capital-raising activities or commitments;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"></p><div>

</div><!-- Field: Page; Sequence: 37; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">additions or departures
                                            of key personnel;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">changes in our
                                            financial guidance or securities analysts&#8217; estimates of our financial performance;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">discussion of us
                                            or our share price by the financial press and in online investor communities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reaction to our
                                            press releases and filings with the SEC;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">changes in accounting
                                            principles;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">lawsuits threatened
                                            or filed against us;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">fluctuations in
                                            operating performance and the valuation of companies perceived by investors to be comparable
                                            to us;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">sales of our Ordinary
                                            Shares by us or our shareholders;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">share price and
                                            volume fluctuations attributable to inconsistent trading volume levels of our Ordinary Shares;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">price and volume
                                            fluctuations in the overall stock market, including as a result of trends in the economy
                                            as a whole;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">changes in laws
                                            or regulations applicable to our business;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">changes in our
                                            capital structure, such as future issuances of debt or equity securities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">short sales, hedging
                                            and other derivative transactions involving our shares;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the expiration
                                            of contractual lock-up periods;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">other events or
                                            factors, including those resulting from war, incidents of terrorism or responses to these
                                            events; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">general economic
                                            and market conditions.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, in recent&#160;years,
the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices
of equity securities of many companies, and technology companies in particular. These fluctuations often have been unrelated or disproportionate
to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political
and market conditions such as recessions, interest rate changes or international currency fluctuations, may negatively impact the market
price of our Ordinary Shares or Warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the past, companies that
have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the
target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management&#8217;s
attention from other business concerns, which could also harm our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 38; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our investors&#8217; ownership in the Company
may be diluted in the future.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the future, we may issue
additional authorized but previously unissued equity securities, resulting in the dilution of ownership interests of our present shareholders.
Furthermore, we may issue equity awards to management, employees and other eligible persons in the future under our 2022 Incentive Option
Plan, or our 2022 Incentive Plan. Additional Ordinary Shares issued by us in the future will dilute an investor&#8217;s investment in
the Company. In addition, we may seek shareholder approval to increase the amount of the Company&#8217;s authorized shares, which would
create the potential for further dilution of current investors.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our amended and restated articles of association
provide that, unless we consent to an alternative forum, the federal district courts of the United&#160;States shall be the exclusive
forum for resolution of any complaint asserting a cause of action arising under the Securities Act, which could limit our shareholders&#8217;
ability to choose the judicial forum for disputes with us, our directors, shareholders, or other employees. In addition, the agreements
governing the Warrants provide that disputes shall be brought in the state and federal courts sitting in the City of New&#160;York, Borough
of Manhattan, and that a claim under the U.S.&#160;federal securities laws may be made in any federal district court.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#160;22 of the Securities
Act creates concurrent jurisdiction for U.S.&#160;federal and state courts over all such Securities Act actions. Accordingly, both U.S.&#160;state
and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the
threat of inconsistent or contrary rulings by different courts, among other considerations, our articles of association provide that,
unless we consent in writing to the selection of an alternative forum, the federal district courts of the United&#160;States shall be
the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This exclusive
forum provision will not apply to suits brought to enforce any liability or duty created by the Exchange&#160;Act, and our shareholders
cannot and will not be deemed to have waived our compliance with the U.S.&#160;federal securities laws and the rules and regulations
thereunder as a result of our exclusive forum provision. Any person or entity purchasing or otherwise acquiring any interest in any of
our securities shall be deemed to have notice of and consented to the foregoing provision of our articles of association.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Similarly, the agreements
governing the Warrants provide that, and by purchasing Warrants in our IPO, investors agreed that, all legal proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or
their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New&#160;York, irrevocably submit to the exclusive jurisdiction of the state and
federal courts sitting in the City of New&#160;York, Borough of Manhattan for the adjudication of any such dispute and irrevocably waive,
and agree not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. The warrant agent agreement
has similar provisions with respect to the Company and the warrant agent. The agreement governing the Warrants and the warrant agent
agreement provide that the foregoing provisions do not limit or restrict the federal district court in which a party may bring a claim
under the U.S.&#160;federal securities laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">However, the enforceability
of similar forum provisions (including exclusive federal forum provisions for actions, suits, or proceedings asserting a cause of action
arising under the Securities Act) in other companies&#8217; organizational documents and similar agreements has been challenged in legal
proceedings, and there is uncertainty as to whether courts would enforce the exclusive forum provision in our articles of association
or the agreements governing the Warrants. If a court were to find the exclusive forum provision contained in our articles of association
or the agreements governing the Warrants to be inapplicable or unenforceable in an action, we may incur additional costs associated with
resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and results
of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we believe the exclusive
forum provision benefit us by providing increased consistency in the application of U.S.&#160;federal securities laws, the Companies
Law, or New&#160;York law, as applicable, in the types of lawsuits to which they apply, such exclusive forum provision may limit a shareholder&#8217;s
ability to bring a claim in the judicial forum of their choosing for disputes with us or any of our directors, shareholders, officers,
or other employees, which may discourage lawsuits with respect to such claims against us and our current and former directors, shareholders,
officers, or other employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 39; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If securities or industry analysts either
do not publish research about us or publish inaccurate or unfavorable research about us, our business or our market, or if they change
their recommendations regarding our Ordinary Shares or Warrants adversely, the trading price or trading volume of our Ordinary Shares
could decline.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The trading market for our
Ordinary Shares and Warrants will be influenced in part by the research and reports that securities or industry analysts may or may not
publish about us, our business, our market or our competitors. If one or more of the analysts do not publish research about us or initiate
research with an unfavorable rating or downgrade our Ordinary Shares, provide a more favorable recommendation about our competitors or
publish inaccurate or unfavorable research about our business, the market prices of our Ordinary Shares would likely decline. If any
analyst who may cover us were to cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial
markets, which in turn could cause the trading price or trading volume of our Ordinary Shares to decline.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>FINRA sales practice requirements may limit
a shareholder&#8217;s ability to buy and sell our Ordinary Shares.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Financial Industry Regulatory
Authority, Inc., or FINRA, has adopted rules requiring that, in recommending an investment to a customer, a broker-dealer must have reasonable
grounds for believing that the investment is suitable for that customer. Prior to recommending speculative or low-priced securities to
their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer&#8217;s financial
status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA has indicated its belief
that there is a high probability that speculative or low-priced securities will not be suitable for at least some customers. If these
FINRA requirements are applicable to us or our securities, they may make it more difficult for broker-dealers to recommend that at least
some of their customers buy our Ordinary Shares, which may limit the ability of our shareholders to buy and sell our Ordinary Shares
and could have an adverse effect on the market for and price of our Ordinary Shares.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may become a &#8220;passive foreign
investment company&#8221;, or PFIC, for U.S.&#160;federal income tax purposes in the current taxable year or may become one in any subsequent
taxable year. There generally would be negative tax consequences for U.S.&#160;taxpayers that are holders of the Ordinary Shares if we
are or were to become a PFIC.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the projected composition
of our income and valuation of our assets, we do not expect to be a PFIC for 2022, and we do not expect to become a PFIC in the future,
although there can be no assurance in this regard. The determination of whether we are a PFIC is made on an annual basis and will depend
on the composition of our income and assets from time to time. We will be treated as a PFIC for U.S.&#160;federal income tax purposes
in any taxable year in which either (1)&#160;at least 75% of our gross income is &#8220;passive income&#8221; or (2)&#160;on average
at least 50% of our assets by value produce passive income or are held for the production of passive income. Passive income for this
purpose generally includes, among other things, certain dividends, interest, royalties, rents and gains from commodities and securities
transactions and from the sale or exchange of property that gives rise to passive income. Passive income also includes amounts derived
by reason of the temporary investment of funds, including those raised in a public offering. In determining whether a non-U.S.&#160;corporation
is a PFIC, a proportionate share of the income and assets of each corporation in which it owns, directly or indirectly, at least a 25%
interest (by value) is taken into account. The tests for determining PFIC status are applied annually, and it is difficult to make accurate
projections of future income and assets which are relevant to this determination. In addition, our PFIC status may depend in part on
the market value of the Ordinary Shares. Accordingly, there can be no assurance that we currently are not or will not become a PFIC in
the future. If we are a PFIC in any taxable year during which a U.S.&#160;taxpayer holds the Ordinary Shares, such U.S.&#160;taxpayer
would be subject to certain adverse U.S.&#160;federal income tax rules. In particular, if the U.S.&#160;taxpayer did not make an election
to treat us as a &#8220;qualified electing fund&#8221;, or QEF, or make a &#8220;mark-to-market&#8221; election, then &#8220;excess distributions&#8221;
to the U.S.&#160;taxpayer, and any gain realized on the sale or other disposition of the Ordinary Shares by the U.S.&#160;taxpayer: (1)&#160;would
be allocated ratably over the U.S.&#160;taxpayer&#8217;s holding period for the Ordinary Shares; (2)&#160;the amount allocated to the
current taxable year and any period prior to the first&#160;day of the first taxable year in which we were a PFIC would be taxed as ordinary
income; and (3)&#160;the amount allocated to each of the other taxable&#160;years would be subject to tax at the highest rate of tax
in effect for the applicable class of taxpayer for that year, and an interest charge for the deemed deferral benefit would be imposed
with respect to the resulting tax attributable to each such other taxable year. In addition, if the U.S.&#160;Internal Revenue Service,
or the IRS, determines that we are a PFIC for a year with respect to which we have determined that we were not a PFIC, it may be too
late for a U.S.&#160;taxpayer to make a timely QEF or mark-to-market election. U.S.&#160;taxpayers that have held the Ordinary Shares
during a period when we were a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC in subsequent&#160;years, subject
to exceptions for U.S.&#160;taxpayer who made a timely QEF or mark-to-market election. A U.S.&#160;taxpayer can make a QEF election by
completing the relevant portions of and filing IRS Form&#160;8621 in accordance with the instructions thereto. We do not intend to notify
U.S.&#160;taxpayers that hold the Ordinary Shares if we believe we will be treated as a PFIC for any taxable year in order to enable
U.S.&#160;taxpayers to consider whether to make a QEF election. In addition, we do not intend to furnish such U.S.&#160;taxpayers annually
with information needed in order to complete IRS Form&#160;8621 and to make and maintain a valid QEF election for any year in which we
or any of our subsidiaries are a PFIC.&#160;U.S.&#160;taxpayers that hold the Ordinary Shares are strongly urged to consult their tax
advisors about the PFIC rules, including tax return filing requirements and the eligibility, manner, and consequences to them of making
a QEF or mark-to-market election with respect to the Ordinary Shares in the event that we are a PFIC.&#160;See &#8220;Taxation&#160;&#8212;&#160;U.S.&#160;Federal
Income Tax Considerations&#160;&#8212;&#160;Passive Foreign Investment Companies&#8221; for additional information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 40; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>As a public company in the United&#160;States,
our management is required to devote substantial time to new compliance initiatives as well as compliance with ongoing U.S.&#160;requirements.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a public company in the
United&#160;States, we incur additional significant accounting, legal and other expenses that we did not incur before the offering. We
also incurred costs associated with corporate governance requirements of the SEC, as well as requirements under Section&#160;404 and
other provisions of the Sarbanes-Oxley Act. These rules and regulations increased our legal and financial compliance costs, introduced
new costs such as investor relations, stock exchange listing fees and shareholder reporting, and made some activities more time consuming
and costly. The implementation and testing of such processes and systems required us to hire outside consultants and incur other significant
costs. Any future changes in the laws and regulations affecting public companies in the United&#160;States, including Section&#160;404
and other provisions of the Sarbanes-Oxley Act, and the rules and regulations adopted by the SEC, for so long as they apply to us, will
result in increased costs to us as we respond to such changes. These laws, rules and regulations could make it more difficult or more
costly for us to obtain certain types of insurance, including director and officer liability insurance, and we may be forced to accept
reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. The impact of these requirements
could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees,
or as executive officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to securities litigation,
which is expensive and could divert management attention.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the past, companies that
have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the
target of this type of litigation in the future. Litigation of this type could result in substantial costs and diversion of management&#8217;s
attention and resources, which could seriously hurt our business. Any adverse determination in litigation could also subject us to significant
liabilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>General Risk Factors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we are not able to attract and retain
highly skilled managerial, technical and marketing personnel, we may not be able to implement our business model successfully.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our success depends in part
on our continued ability to attract, retain and motivate highly qualified management. We are highly dependent upon our senior management
as well as other employees and consultants. Our management team must be able to act decisively to apply and adapt our business model
in the rapidly changing markets in which we will compete. In addition, we will rely upon technical employees or third-party contractors
to effectively establish, manage and grow our business. Consequently, we believe that our future viability will depend largely on our
ability to attract and retain highly skilled managerial, sales and technical personnel. In order to do so, we may need to pay higher
compensation or fees to our employees or consultants than currently expected and such higher compensation payments may have a negative
effect on our operating results. Competition for experienced, high-quality personnel in the digital video and data transfer technologies
field is intense. We may not be able to hire or retain the necessary personnel to implement our business strategy. Our failure to hire
and retain quality personnel on acceptable terms could impair our ability to develop new products and services and manage our business
effectively.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we engage in future acquisitions or
strategic partnerships, this may increase our capital requirements, dilute our shareholders, cause us to incur debt or assume contingent
liabilities, and subject us to other risks.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have engaged in various
acquisitions and may continue to evaluate various acquisition opportunities and strategic partnerships, including licensing or acquiring
complementary products, intellectual property rights, technologies or businesses. Any potential acquisition or strategic partnership
may entail numerous risks, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">increased operating
                                            expenses and cash requirements;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the assumption
                                            of additional indebtedness or contingent liabilities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the issuance of
                                            our equity securities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in"></p><div>


</div><!-- Field: Page; Sequence: 41; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">assimilation of
                                            operations, intellectual property and products of an acquired company, including difficulties
                                            associated with integrating new personnel;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the diversion of
                                            our management&#8217;s attention from our existing product programs and initiatives in pursuing
                                            such a strategic merger or acquisition;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">retention of key
                                            employees, the loss of key personnel and uncertainties in our ability to maintain key business
                                            relationships;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">risks and uncertainties
                                            associated with the other party to such a transaction, including the prospects of that party
                                            and their existing products or product candidates and marketing approvals; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our inability to
                                            generate revenue from acquired technology and/or products sufficient to meet our objectives
                                            in undertaking the acquisition or even to offset the associated acquisition and maintenance
                                            costs.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to certain U.S.&#160;and
foreign anticorruption, anti-money laundering, export control, sanctions and other trade laws and regulations. We can face serious consequences
for violations.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Among other matters, U.S.&#160;and
foreign anticorruption, anti-money laundering, export control, sanctions and other trade laws and regulations, which are collectively
referred to as Trade Laws, prohibit companies and their employees, agents, legal counsel, accountants, consultants, contractors and other
partners from authorizing, promising, offering, providing, soliciting or receiving, directly or indirectly, corrupt or improper payments
or anything else of value to or from recipients in the public or private sector. Violations of Trade Laws can result in substantial criminal
fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax reassessments, breach of contract and fraud litigation,
reputational harm, and other consequences. We have direct or indirect interactions with officials and employees of government agencies
or government-affiliated hospitals, universities and other organizations. We also expect our non-U.S.&#160;activities to increase over
time. We can be held liable for the corrupt or other illegal activities of our personnel, agents or partners, even if we do not explicitly
authorize or have prior knowledge of such activities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business and operations might be adversely
affected by security breaches, including any cybersecurity incidents.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We depend on the efficient
and uninterrupted operation of our computer and communications systems, and those of our consultants, contractors and vendors, which
we use for, among other things, sensitive company data, including our intellectual property, financial data and other proprietary business
information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While certain of our operations
have business continuity and disaster recovery plans and other security measures intended to prevent and minimize the impact of IT-related
interruptions, our IT infrastructure and the IT infrastructure of our consultants, contractors and vendors are vulnerable to damage from
cyberattacks, computer viruses, unauthorized access, electrical failures and natural disasters or other catastrophic events. We could
experience failures in our information systems and computer servers, which could result in an interruption of our normal business operations
and require substantial expenditure of financial and administrative resources to remedy. System failures, accidents or security breaches
can cause interruptions in our operations. To the extent that any disruption or security breach were to result in a loss of, or damage
to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur regulatory investigations
and redresses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Even though we believe we
carry commercially reasonable business interruption and liability insurance, we might suffer losses as a result of business interruptions
that exceed the coverage available under our insurance policies or for which we do not have coverage. For example, we are not insured
against terrorist attacks or cyberattacks. Any natural disaster or catastrophic event could have a significant negative impact on our
operations and financial results.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Sales of a significant number of our Ordinary
Shares in the public markets or significant short sales of our Ordinary Shares, or the perception that such sales could occur, could
depress the market price of our Ordinary Shares and impair our ability to raise capital.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales of a substantial number
of our Ordinary Shares or other equity-related securities in the public markets, could depress the market price of our Ordinary Shares.
If there are significant short sales of our Ordinary Shares, the price decline that could result from this activity may cause the share
price to decline more so, which, in turn, may cause long holders of the Ordinary Shares to sell their shares, thereby contributing to
sales of Ordinary Shares in the market. Such sales also may impair our ability to raise capital through the sale of additional equity
securities in the future at a time and price that our management deems acceptable, if at all.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 42; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><div><a id="a_012"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM 4. INFORMATION ON THE COMPANY &#160; &#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div><a id="a_013"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><b>A.</b></td><td style="text-align: justify"><b>History and Development of the Company</b></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In December&#160;2017, Smart
Repair Pro, a California corporation, was founded by our Chief Executive Officer, Viki Hakmon, and began operating in June&#160;2019.
Following its acquisition of the KnifePlanet brand, Smart Repair Pro began selling the KnifePlanet brand on Amazon, using the FBA model.
In August&#160;2019, Smart Repair Pro acquired the CC-Exquisite store, which owns the DARTS<sup>&#174;</sup> brand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April&#160;2020, Purex
was incorporated in California for the purpose of purchasing an online store. At that time, Purex was 100% owned by affiliates of Mr.&#160;Hakmon.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October&#160;2020, Medigus
Ltd., or Medigus, a publicly traded company (Nasdaq: MDGS) incorporated under the laws of the State of Israel, entered into a share purchase
agreement to acquire 50.01% of Smart Repair Pro and 50.03% of Purex. This acquisition closed on January&#160;4, 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In March&#160;2021, Jeffs&#8217;
Brands was formed as a wholly owned subsidiary of Medigus.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April&#160;2021, Top Rank,
an Israeli company, was formed as a wholly owned subsidiary of Jeffs&#8217; Brands. On May&#160;10, 2021, pursuant to the Stock Exchange
and Plan of Restructuring Agreement, or the SEA, entered into by and between the Company, Medigus and Mr.&#160;Hakmon, Purex and Smart
Repair Pro became wholly-owned subsidiaries of Jeffs&#8217; Brands. Pursuant to the SEA, Medigus and Mr.&#160;Hakmon, as shareholders
of Smart Repair Pro and Purex, contributed all of the equity interests they owned in Smart Repair Pro and Purex to Jeffs&#8217; Brands
in exchange for Ordinary Shares, or the Contribution Transactions. Following the closing of the Contribution Transactions pursuant to
the SEA, Jeffs&#8217; Brands held all of the outstanding shares of Smart Repair Pro and Purex, Medigus held 50.03% of the outstanding
Ordinary Shares and Mr.&#160;Hakmon, our Chief Executive Officer, held the remaining 49.97% of our outstanding Ordinary Shares. Mr.&#160;Hakmon&#8217;s
affiliates, who were minority shareholders of Smart Repair Pro and Purex, transferred all their holdings in Smart Repair Pro and Purex
to Mr.&#160;Hakmon, effective immediately prior to the Contribution Transactions pursuant to a Share Transfer Deed dated May&#160;10,
2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The result of the Contribution
Transactions is reflected in the following diagram:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_001.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">We, including through our
subsidiaries, manage six online brands which are marketed and sold to consumers in the United&#160;States and on EU market. Our strategy
is to achieve organic growth and profitability by improving the profitability of new and existing stores using sophisticated analytical
tools to achieve supply chain and inventory management optimization, identifying and purchasing of brands with high growth potential.
Expanding to new geographic regions, for existing products, development of new products and new private label brands. We have completed
processes with Amazon, which allow us to open our stores for sale to consumers in the United Kingdom, Germany, France, Spain, Italy and
Australia.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">Our principal executive offices
are located at 7 Mezada Street, Bnei Brak, Israel 5126112. Our telephone number in Israel is +972-3-7713520. Our website address is <i>www.jeffsbrands.com</i>.
The information contained on our website or available through our website is not incorporated by reference into and should not be considered
a part of this Annual Report on Form 20-F, and the reference to our website in this Annual Report on Form 20-F is an inactive textual
reference only.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 43; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Puglisi &amp; Associates
is our agent in the United States and its address is 850 Library Avenue, Suite 204, Newark, Delaware 19711. The SEC maintains an Internet
website that contains reports and other information regarding issuers that file electronically with the SEC. Our filings with the SEC
are also available to the public through the SEC&#8217;s website at www.sec.gov.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are an &#8220;emerging
growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act as modified by the JOBS Act. As such, we are eligible to,
and intend to, take advantage of certain exemptions from various reporting requirements applicable to other public companies that are
not &#8220;emerging growth companies&#8221; such as not being required to comply with the auditor attestation requirements of Section&#160;404
of the Sarbanes-Oxley Act. We could remain an &#8220;emerging growth company&#8221; for up to five years, or until the earliest of (a)&#160;the
last day of the first fiscal year in which our annual gross revenues exceeds $1.235&#160;billion, (b)&#160;the date that we become a
&#8220;large accelerated filer&#8221; as defined in Rule&#160;12b-2 under the Exchange Act, which would occur if the market value of
our Ordinary Shares that is held by non-affiliates exceeds $700&#160;million as of the last business day of our most recently completed
second fiscal quarter, or (c)&#160;the date on which we have issued more than $1&#160;billion in nonconvertible debt during the preceding
three-year period.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We are a foreign private
issuer as defined by the rules under the Securities Act and the Exchange Act. Our status as a foreign private issuer also exempts us
from compliance with certain laws and regulations of the SEC and certain regulations of Nasdaq, including the proxy rules, the short-swing
profits recapture rules, and certain governance requirements such as independent director oversight of the nomination of directors and
executive compensation. In addition, we are not required to file annual, quarterly and current reports and financial statements with
the SEC as frequently or as promptly as U.S. domestic companies registered under the Exchange Act.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For years ended December
31, 2022 and 2021, our capital expenditures were $42 thousand and $1 thousand, respectively. Our current capital expenditures are primarily
for equipment, computers, software and office improvements substantially all in Israel, and we expect to finance these expenditures primarily
from cash on hand.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On August 30, 2022, we&#160;completed
our IPO pursuant to the Company&#8217;s registration statement on Form F-1 (Registration No. 333- 262835) originally filed with the SEC
on February 18, 2022, which was declared effective by the SEC on August 25, 2022, of (A) 3,717,473 Units, at a public offering price
of $4.16 per Unit, with each Unit consisting of one Ordinary Share and one Warrant to purchase one Ordinary Share, at an initial exercise
price of $4.04 per Ordinary Share (and an exercise price of $2.02 following the Exercise Price Adjustment), (B) Underwriter&#8217;s Warrants
to purchase up to 185,873 Ordinary Shares, at an exercise price of $5.20 per Ordinary Share, and (C) Warrants to purchase up to 425,912
Ordinary Shares issued to the Underwriter pursuant to its over-allotment option. The Ordinary Shares and Warrants were immediately separable
from the Units and were issued separately.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Ordinary Shares and Warrants
began trading on the Nasdaq Capital Market on August 26, 2022 under the symbols &#8220;JFBR&#8221; and &#8220;JFBRW,&#8221; respectively.
The Company received net proceeds of $13.4 million, after deducting underwriting discounts and commissions and other estimated offering
expenses.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 7, 2022, the
Company&#8217;s volume weighted average stock price was less than the exercise floor of $4.04 for the Warrants. Accordingly, effective
after the closing of trading on November 28, 2022 (the 90th calendar day immediately following the issuance date of the Warrants), the
Warrants were adjusted pursuant to their terms, including, but not limited to, to adjust the exercise price of the Warrants to $2.02.
In addition, in connection with the Exercise Price Adjustment, the Company issued Additional Warrants to purchase up to 2,824,525 Ordinary
Shares to Qualified Holders (as defined in the Warrant)</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_014"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><b>B.</b></td><td style="text-align: justify"><b>Business Overview</b></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an e-commerce CPG company, operating primarily on Amazon. We
were incorporated in Israel in March&#160;2021, under the name Jeffs&#8217; Brands Ltd, to serve as the holding company of three other
e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon
online marketplace, utilizing the FBA model. Under the FBA model, sellers&#8217; products are stored in Amazon fulfillment centers in
order to take advantage of Amazon&#8217;s fulfillment infrastructure and allow their products to be eligible for Amazon promotional activities,
including free shipping to Prime subscribers. These products are subject to the same inventory control, fulfillment and shipping processes
as Amazon owned products; and for multiple item shipments are included in the same box as Amazon owned inventory. As of the date on this
Annual Report on Form 20-F, we have five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank , Fort and Jeffs&#8217; Brands Holdings.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 44; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to executing
the FBA business model, we utilize A.I. and machine learning technologies to analyze sales data and patterns on Amazon in order to identify
existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary
products. We also use our own skills, know-how and profound familiarity with Amazon algorithm and all the tools that the FBA platform
FBA has to offer. In some circumstances we scale the products and improve them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Stores, Brands and Products</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this Annual
Report on Form 20-F:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Smart Repair Pro
                                            operates three stores on Amazon, which sell 12 products under the KnifePlanet, CC-Exquisite
                                            and PetEvo brands. Under the KnifePlanet brand, we offer a complete premium stone knife-sharpening
                                            sets, sharpeners and nonslip rubber bases. Under the CC-Exquisite brand, we offer professional
                                            steel-tip dart sets. Under the PetEvo brand, we offer car door pet scratches protectors;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Jeffs&#8217; Brands
                                            operates one store on Amazon, which sells six products under the Whoobli brand. Under the
                                            Whoobli brand, we offer punching bag sets, including adjustable stands and boxing gloves,
                                            and party supply kits for children;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Purex operates
                                            one store on Amazon, which sells one product under the Zendora brand used for filtering and
                                            purifying air in vehicles;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Top Rank operates
                                            one store on Amazon, which sells six products under the Wellted brand. Under the Wellted
                                            brand, we offer reusable, self-cleansing pet hair removers for cats and dogs;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Jeffs&#8217; Brands Holdings, owns a minority interest in SciSparc
Nutraceuticals Inc., or SciSparc U.S., a majority-owned subsidiary of SciSparc Ltd., or SciSparc, that owns and operates Wellution, an
Amazon food supplements and cosmetics brand; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Fort, a company that sells pest control products primarily through Amazon.uk.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this Annual
Report on Form 20-F, our material stores on the Amazon platform, brands and products consist of the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Whoobli Store</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our revenues from sales on
the Whoobli store for the year ended December&#160;31, 2022 were approximately $3,319 thousand, or 56.6%, of our total revenues for such
period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Whoobli store sells the
following products:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">Whoobli Adjustable Kids
                                            Punching Bag with Stand (for&#160;3-10 year olds);</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">2.</td><td style="text-align: justify">Whoobli Ninja Inflatable
                                            Kids Punching Bag;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">3.</td><td style="text-align: justify">Whoobli Unicorn Birthday
                                            Party Supplies (Serves 16);</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">4.</td><td style="text-align: justify">Whoobli Mermaid Party
                                            Supplies (Serves 16);</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">5.</td><td style="text-align: justify">Whoobli Dinosaur Party
                                            Supplies (Serves 16); and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">6.</td><td style="text-align: justify">Whoobli Construction
                                            Birthday Party Supplies (Serves 16).</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>KnifePlanet Store</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our revenues from sales on
the KnifePlanet store for the year ended December&#160;31, 2022 were approximately $2,070, or 35.3%, of our total revenues for such period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The KnifePlanet store sells
the following products:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">CC-Exquisite Professional
                                            Steel Tip Darts Set. This darts set contains brass barrels with 12 flights, 12&#160;aluminum
                                            shafts, 12 o-rings, dart tool, dart sharpener and case;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 45; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">2.</td><td style="text-align: justify">Premium Knife Sharpening
                                            Stone Set. This knife sharpening stone set includes dual-grit wet stone kit has high-density
                                            single whetstones with different coarseness masterfully developed on both sides of the same
                                            water stone;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">3.</td><td style="text-align: justify">Coarse Flattening Stone.
                                            This is a flattening stone to flatten sharpening stones and whetstones;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">4.</td><td style="text-align: justify">Whetstone Knife Sharpening
                                            Stone Set. This is a deluxe high-density dual-grit wet sharpener waterstone for knives complete
                                            with angle guide and non-slip base for chef level results (blue with bamboo base);</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">5.</td><td style="text-align: justify">Premium Whetstone Set.
                                            This set contains dual grit stone bamboo base, leather honing strop, leather razor strop,
                                            compound and honing guide;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">6.</td><td style="text-align: justify">Leather Strop and Stropping
                                            Compound Set. This is a complete knife strop block kit for sharpening knives and chisels
                                            with green&#160;&amp; white honing compounds for chef level results;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">7.</td><td style="text-align: justify">Whetstone Knife Sharpening
                                            Stone Set. This is a high-density dual-grit wet sharpener waterstone for knives complete
                                            with honing guide, premium holder base and angle tool for chef level results;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">8.</td><td style="text-align: justify">Honing Guide and Angle
                                            Tool Set. This is a chisel sharpening jig&#160;&amp; knife sharpener angle toolkit for all
                                            knives and wood chisels 1/8&#8221; to&#160;1-7/8&#8221;, hand planer blades&#160;1-3/8&#8221;;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">9.</td><td style="text-align: justify">CC-Exquisite Professional
                                            Steel Tip Darts Set. This darts set contains steel barrels with 20 flights standard, 12 aluminum
                                            shafts 35/48mm, 12 o-rings, dart sharpener and case;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">10.</td><td style="text-align: justify">CC-Exquisite Dart Caddy.
                                            This is a wooden dart caddy;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">11.</td><td style="text-align: justify">Car Door Protector
                                            | Set of 2. This car door protector fits any vehicle and is anti-scratch waterproof, safe
                                            for large dogs; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">12.</td><td style="text-align: justify">Whetstone Knife Sharpening
                                            Stone Set. This stone set is a deluxe high-density dual-grit wet sharpener waterstone for
                                            knives with angle guide and non-slip base for chef level results (red and green).</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Customers</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our customers are primarily
individual online consumers who purchase our products primarily on the Amazon U.S.&#160;and Amazon EU marketplaces, which contributed
to our increase in sales year over year.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2022 and 2021, approximately
95% to 100% of our revenue was through or with Amazon sales platform.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Like any other e-commerce
business, we are affected by the high season shopping, which is from October through December. Our business model is to take into consideration
this sales cycle and introduce new products right before high season.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our Competitive Strengths</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that our competitive
strengths include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Senior and experienced
                                            management team;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Sophisticated know-how
                                            regarding use of data analysis technology platforms;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Strong logistical
                                            capabilities, using sophisticated BI tools to optimize the supply chain management;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Strong proactive
                                            approach in purchasing new brands and active stores with law performance and high potential
                                            growth; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Procurement of
                                            well targeted products.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 46; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that these strengths,
as further described below, differentiate us from our competitors and provide us with numerous advantages:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><b>Senior and experienced
                                            management team:&#160;&#160;&#160;&#160;</b>We are led by Mr.&#160;Viki Hakmon, our Chief
                                            Executive Officer.&#160;Mr.&#160;Hakmon has vast experience in the retail markets, having
                                            served in various capacities over the past 25&#160;years, 15 of which were in U.S.&#160;markets.
                                            Mr.&#160;Hakmon also has a profound understanding and knowledge of developing and discovering
                                            products and leveraging their growing market demand.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">Mr.&#160;Naor Bergman, our Chief
Operating Officer, is responsible for all the operations and logistics of our business. Prior to joining the Company, Mr.&#160;Bergman
established and led Amazon&#8217;s FBA logistics and warehousing department at Unicargo Global Logistic Ltd.&#160;and was part of the
management team that transformed Unicargo to become a leader in the field of outsourcing Amazon&#8217;s FBA warehousing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">In October&#160;2022, we hired Mr.&#160;Ronen
Zalayet as our Chief Financial Officer effective October&#160;24, 2022. Mr.&#160;Zalayet has over 20&#160;years of experience working
in financial leadership positions in private and public companies, including in growing fintech and technology companies. Mr.&#160;Zalayet
holds a B.A. in Economics and Accounting and an MBA from Tel Aviv University, Israel, and is a certified public accountant in Israel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><b>Sophisticated
                                            know-how of data analysis technology platforms:&#160;&#160;&#160;&#160;</b>We believe our
                                            use of research data and deep analysis software tools enables us to successfully identify
                                            new product opportunities, execute a fast and efficient procurement process and offer and
                                            sell our goods at a competitive yet lucrative price. Our deep knowledge of analyzing Amazon
                                            is one of our company&#8217;s key competitive advantages in the fast-changing online CPG
                                            market. We are able to identify product opportunities, including relevant product specifications,
                                            based on consumer preferences, product trends and attributes and competitive landscape analysis.
                                            We also have profound familiarity with Amazon&#8217;s algorithm and all the tools that its
                                            FBA platform has to offer.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><b>&#9679;</b></td><td style="text-align: justify"><b>Strong
                                            logistical capabilities, using sophisticated BI tools to optimize the supply chain management:&#160;&#160;&#160;&#160;</b>Our
                                            logistical capabilities were formulated prior to the establishment of our Company. We view
                                            the logistical aspect of our business as a main and important factor to our success and we
                                            work hard to achieve it. Every product opportunity that we encounter is handled with strong
                                            and efficient logistical tools and no opportunity will be neglected due to lack of logistical
                                            capabilities or low profitability.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><b>&#9679;</b></td><td style="text-align: justify"><b>Strong
                                            proactive approach in purchasing new brands and active stores with law performance and high
                                            potential growth:&#160;&#160;&#160;&#160;</b>Our goal-oriented team consists of people with
                                            a combined business experience and Amazon&#8217;s knowledge, along with a competitive culture
                                            and attitude, which allow us to identify low performance brands with high growth potential.
                                            We believe in our improvement capabilities to increase brands sales and profitability.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><b>Procurement
                                            of well targeted products reduces risk and costs:&#160;&#160;&#160;&#160;</b>We believe our
                                            approach of identifying products, procuring and handling all logistics fast and efficiently
                                            and selling products when they are most desirable reduces risks of not reaching sales targets
                                            and also reduces the cost of brand development and the process of introducing a new product
                                            to the market. We believe a company like ours should only move forward with products following
                                            thorough market research and analysis. We do not proceed before that, hence, we believe allowing
                                            us to sell products that the market is already looking for.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 32%; text-align: center"><img alt="" src="image_002.jpg"/></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="width: 32%; text-align: center"><img alt="" src="image_003.jpg"/></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="width: 34%; text-align: center"><img alt="" src="image_004.jpg"/></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Searching and Identifying
    +</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchasing +</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling and Shipping</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 47; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Industry Overview and Market Opportunity</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The e-commerce market is
expected to continue growing. According to analysis published by technavio in December 2022, the e-commerce market is estimated to grow&#160;at
a&#160;compound annual growth rate, or CAGR, of 27.15%&#160;from 2022 to 2027. The size of the market is forecast to increase by&#160;approximately
$12,952 billion. The growth of the market depends on several factors, including&#160;the advantages of e-commerce platforms, advanced
targeting options, and the rise in online spending and smartphone penetration. One of the key factors driving growth in the e-commerce
market is the advantages of e-commerce platforms.&#160;The growth of the global e-commerce market is fueled by the shift of consumers
to e-commerce platforms. Online shopping portals not only offer a wide range of B2C online shopping products, but also a convenient experience.
The entry of offline merchants into the online platform is also shaping the business to consumer, or B2C, e-commerce market, which is
expected to grow significantly during the forecast period. Therefore, according to Technavio the aforementioned benefits of e-commerce
platforms will focus on the growth of the market during the forecast period.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe, this new normal
creates a huge opportunity for e-commerce players, such as Jeffs&#8217; Brands, which has the capability&#160;to respond to the current
demand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, Amazon, which is
the primary platform that our business is based on, continues to rise and grow. In 2022, Amazon&#8217;s sales were approximately: $356.1
billion in the United States; $33.6 billion in Germany; $30 in the U.K.; $24.4 in Japan; and $69.8 in rest of the world. Amazon&#8217;s
sales, however, are not necessarily indicative of our current or future sales, as Amazon sells vast and varied quantities of products
on its platforms, whereas we sell only a limited quantity of products on Amazon and are not otherwise affiliated with Amazon. While our
sales represent a small fraction of the sales on Amazon, we believe that Amazon provides us with a unique opportunity to grow our sales.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Annual Net Sales of Amazon in Selected Leading
Markets from 2014 to 2022 (in billion U.S.&#160;dollars)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_005.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Source: Statista&#160;&#8212;&#160;Annual net
sales of Amazon in selected leading markets from 2014 to 2022</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Note that Amazon&#8217;s
net sales presented in this chart are not necessarily indicative of our current or future sales.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 48; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Annual Sales of Amazon 2004 to 2022 (in billion
U.S.&#160;dollars)</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_006.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Source: Statista, Projected global revenue of
Amazon from 2004 to 2022</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Note that Amazon&#8217;s
sales presented in this chart are not necessarily indicative of our current or future sales.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that doing business
in the online consumer product market requires a profound understating of material trends and factors impacting the market and this can
only be done by analyzing massive amounts of data. Adopting new business models that are using high-end technologies for data analysis
is considered by us as the only competitive way to succeed in this market. We see our data driven approach combined with our other capabilities
and advantages as our strengths in succeeding in this market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Many CPG companies have yet to evolve and
adopt new technology, especially in the wake of COVID-19</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to Boston Consulting
Group (BCG) in CPG Companies Face an E-Commerce Tsunami, (July&#160;2020) and How CPG Companies Can Catch Up as Online Sales Take Off
(February&#160;2019), large CPG companies continue to lag in e-commerce, presenting weaker performance in the online arena than they
do in brick-and-mortar stores. Especially in the wake of the COVID-19 pandemic, CPG companies are facing a radically, permanently and
less familiar sales environment. If these companies wish to succeed, they must nurture and adopt new business approaches and strategies
and partnerships. BCG forecasts that CPG companies that are unable to move quickly and nimbly to change the way they view and respond
to a changing sales environment, will find themselves struggling to survive.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Even before COVID-19 hit
the global markets, the traditional brick-and-mortar CPG industry has been slow to react to changing consumer needs in the digital age.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 49; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">BCG also notes that CPG companies
have generally been slow to devote significant resources to e-commerce for several reasons, including that online sales have not taken
off as quickly in CPG as they have in other categories, such as books and consumer electronics. According to the article posted by Nielsen,
titled &#8220;E-Commerce Measurements a Comprehensive View of Online Sales and Shopper Behavior&#8221;, the online channel accounted
for 5% of overall CPG sales, with penetration varying by product category. In the article titled &#8220;Online CPG Sales in the US are
Booming But There&#8217;s Still Room for Growth, February&#160;2021&#8221; posted by Nielsen, approximately 8.5% of revenues in the pet
care category, for example, came from online sources, while the revenue attributable to household care was just about 7.4%. Given the
relatively slow takeoff in most categories, companies have simply not been forced to adapt as quickly in the CPG space as they have in
some other sectors. In addition, slow growth in the CPG industry in general has created financial pressure on companies, including the
need to cut costs. As a result, CPG players have not had the financial flexibility to direct major energy and resources to the small&#160;&#8212;&#160;but
fast growing&#160;&#8212;&#160;e-commerce channel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We see this gap in adopting
the needed technology and strategies by CGPs as a great opportunity for us. The competitive landscape allows us to take advantage of
our unique capacities to capture the massive opportunity that the e-commerce market has to offer. We do that by better understanding
what consumers are looking for in real time and by making our products visible to consumers at the relevant virtual shelves and at extremely
valuable costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Amazon&#8217;s algorithm is a crucial factor
in the success of CPG companies, and we believe we have a profound understating of it</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to BCG, top-selling
brands on Amazon, often differ significantly from top sellers in brick-and-mortar stores. We believe this highlights how distinct Amazon&#8217;s
market is and how critical it is for CPG companies to understand how Amazon algorithms drive traffic.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe our way of analyzing
and understanding the consumer trends, searches and preferences enable us to react in the most optimum way. We ensure the availability
of the most desired products on the market and we leverage it from buying to selling the product. We are able to do that by analyzing
the data and to react to the insights we generate of it in the fastest way possible to us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our unique process</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe in a 3-phase process
of our business lifecycle:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 48%; padding-bottom: 2.25pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">Phase&#160;I:&#160;Search
                                            and Identification</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_007.jpg" style="width: 32px; height: 30px"/></p></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="width: 51%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our sophisticated,
    know-how use of an advanced software, enables us to search and identify high value products. This analysis includes product history,
    client trends, etc.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 2.25pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">Phase&#160;II:&#160;Acquisition
                                       of identified products</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-indent: -10pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_008.jpg"/></p></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We then quickly and efficiently
    acquire identified products using our strong logistical capacities.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 0pt; text-indent: 0pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phase&#160;III:&#160;Sell
                                            and Ship</span></p>
                                                    <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
                                                       <p style="text-align: center; margin-top: 0; margin-bottom: 0"><img alt="" src="image_009.jpg"/></p></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We then sell the most desired
    products to our consumers, maximizing our positioning for high profitability (with minimal marketing required, offering the optimum
    price being both lucrative and competitive).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 50; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Below are recent examples
of products that were identified by our process and offered to consumers, which significantly contributed to our increase in sales year
over year:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Product
    Name and Description</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 51%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Illustration</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Whoobli Store offers the Whoobli punching bag, adjustable stand and boxing gloves for children aged&#160;3-8&#160;years old.</span></td>
    <td style="padding-bottom: 3pt; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 3pt; text-align: center"><img alt="" src="image_010.jpg"/></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    KnifePlanet Store offers a complete premium stone knife-sharpening set, which includes flattening stone, bamboo base, and two nonslip
    rubber bases.</span></td>
    <td style="padding-bottom: 3pt; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 3pt; text-align: center"><img alt="" src="image_011.jpg"/></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Wellted Store offers the Pet Hair Remover for cats and dogs. It&#8217;s reusable, self-cleansing and includes a brush for cleaning
    furniture, carpets, clothing, car seats, etc.</span></td>
    <td style="padding-bottom: 3pt; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 3pt; text-align: center"><img alt="" src="image_012.jpg"/></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    CC-Exquisite Store offers CC-exquisite professional steel-tip darts sets.</span></td>
    <td style="padding-bottom: 3pt; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 3pt; text-align: center"><img alt="" src="image_013.jpg"/></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-bottom: 3pt; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    PetEvo Store offers car door protectors in sets of two that fit any vehicle and protects from pet scratches and is also waterproof.</span></td>
    <td style="padding-bottom: 3pt; white-space: nowrap">&#160;</td>
    <td style="padding-bottom: 3pt; text-align: center"><img alt="" src="image_014.jpg"/></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Strategy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Growth Strategy</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The key elements of our growth
strategy include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">High-end search
                                            and identification of high value products and their markets;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Frequent introduction
                                            of new products to our customers in various geographical markets;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Effective use of
                                            our competitive advantage&#160;&#8212;&#160;our know-how uses of software-based technology;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Leverage of our
                                            logistical capabilities and knowledge to reduce costs and increase purchasing power; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Continued monetarization
                                            of our competitors to ensure we maintain our competitive differentiation and advantages.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Acquisition Strategy</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our growth, as described
above, will be generated mainly by our strategic acquisition of high demand products. We also intend to supplement our acquisitions by
growing our logistical capabilities, which we believe will bolster our competitive advantage. We recently completed the acquisition of
two Amazon marketplace brands. In March 2023, we completed the acquisition of Fort, a company that sells pest control products, and in
March 2023, we completed the acquisition of approximately 49% (subject to a hold back) of the issued and outstanding shares of common
stock&#160; of SciSparc U.S., a company that operates and owns the Wellution brand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also intend to pursue
growth through strategic acquisitions of digital brands&#160;that&#160;have the potential to be efficiently and quickly integrated into
our line of business and generate successful results. When examining new potential product categories and potential acquisition targets,
we use AI analysis-based technology platform combined with our experienced assessment of the&#160;risks and costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We intend to execute on acquisitions
when all the relevant factors and criteria fit our goals and business aspirations. We will target businesses that have built significant
market share. We will aim for products with strong unit economics and high product quality. These products will also have to achieve
significant positive customer reviews and high search ranking for relevant key words and are in product categories where frequent product
improvement is not required.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that acquisitions
fitting the above criteria will contribute our revenue growth and operational efficiency, while reducing the risk involved in executing
our process.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Intellectual Property</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">As
of April 10, 2023, we owned 13 trademarks: KnifePlanet, CC-Exquisite, Zendora, Whoobli, PetEvo, Wellted, Roshield, Entopest, Rempro, Birdgo,
ProPest, Topperama and Seaheaven.</span>&#160;&#160;</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Competition</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The consumer goods and e-commerce
market is a highly competitive environment. Our competitive landscape consists of various types of companies such as: traditional and
non-traditional consumer good companies; discount stores; traditional retailers; independent retail stores; the online platforms of these
traditional retail competitors; and e-commerce companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Among CPG companies, our
competitors include: Thrasio Holdings, Inc.; Aterian, Inc. (Nasdaq: ATER); Amazon; Helen of Troy Ltd., Newell Brands&#160;(Nasdaq:&#160;NWL);
Frigidaire Appliance Company; and Trademark Global Inc. Despite the seemingly harsh competitive landscape, we believe that our technology
and experience enable us to successfully compete and achieve our financial goals.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Category</b></span></td>
    <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 63%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Companies</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Main
    competition</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thrasio Holdings, Inc.,
    Aterian, Inc. (Nasdaq: ATER)</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    CPG competitors</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Helen of Troy Ltd., Newell
    Brands (Nasdaq:&#160;NWL), Frigidaire Appliance Company, Trademark Global Inc., and other CPG players who are operating on Amazon</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 52; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that our competitive
advantages include:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Senior and experienced
                                            management team;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Strong logistical
                                            capabilities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Skillful use of
                                            sophisticated data analytics software;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Fast and proactive
                                            approach to changes in the market; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">Well targeted products
                                            which we believe reduces risk and costs.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Development</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After executing our procurement
process and owning new products and brands, we then invest in additional development of the procured products. Our development is focused
on upgrading the existing products and/or adding additional value and features to them, such as additional colors or shapes, new design
or version. Our developments remain within the product history ranking and overviews on Amazon, hence, the upgraded products are being
promoted under the same brand and its positioning on Amazon.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An example of such product
development are the new parts added to our KnifePlanet product:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_015.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Third-Party Manufacturing&#160;and Logistics</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our products are currently
produced by third party manufacturers in China and the United Kingdom pursuant to manufacturing agreements. These agreements generally
provide that the manufacturers will manufacture and deliver to us the relevant products in accordance with our orders and subject to
our timely payment. The manufacturing services under such contracts are on a non-exclusive basis, provided, however, that the manufacturers
are not allowed to manufacture or supply the manufactured product to any third party. The products manufactured thereby are subject to
our successful completion of testing and assembly checks before shipment. We may terminate these contracts at any time with an advance
notice. We have strong and long-term relationships with these manufacturers and we believe we have a safe and stable supply chain.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this Annual
Report on Form 20-F, we use third party warehouses to fulfill direct-to-consumer orders, through agreements or terms of services.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this Annual
Report on Form 20-F, we have warehousing and distribution agreements with four warehouses in the United States, one in Canada, one in
the United Kingdom and one in Germany, which generally provide that the service provider will provide warehousing services at its warehousing
facility and distribution services for our products. Through these third parties and until we have our own warehouses, we believe we
can deliver products within two&#160;days of the order being placed on Amazon through ground shipment across approximately 95% of the
U.S.&#160;market.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Marketing, Distribution Methods and Sales</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe our <b>marketing
</b>expenses are lower and more efficient than our competitors since we are only engaged with well established brands that are already
familiar to many of our customers and potential customers on Amazon. In addition, we expect to hire managers to handle our digital marketing
and advertising efforts.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With respect to <b>distribution</b>,
we see logistics as a main and important consideration and we prioritize creating an effective and efficient distribution channel. Every
product opportunity that we encounter will be handled with strong and efficient logistical tools and no opportunity will be left out
due to lack of logistical capabilities or low profitability. Furthermore, we plan to own warehouses in the future in lieu of relying
on Amazon or other third-party warehouses, which would improve our distribution channel.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our <b>sales</b> phase, as
further described above, is the third phase after a deep analysis is conducted by our software, identification and procurement process.
Using the most advanced software, provides us with all the data needed to launch and to operate our Amazon brands in the highest levels.
We believe that this knowledge will bring significant competitive advantages for our products. Our spending and approach on advertising
is aimed to be as low as possible given the resources we spent prior to the actual sale on selecting the different products depending
on the life cycle of products on our platform.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Government Regulation and Product Approval</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not anticipate any
significant problems in obtaining future required licenses, permits or approvals that are necessary to expand our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to a variety
of U.S.&#160;federal, state and local laws, as well as international laws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These laws are defining and
governing the legal ways to process payments, consumer protection, the privacy of consumer information and other laws regarding unfair
and deceptive trade practices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The products sold by us in
the U.S.&#160;are also subject to regulation in the United&#160;States by governmental agencies, including the U.S.&#160;Consumer Product
Safety Commission, the Federal Trade Commission, United&#160;States Food and Drug Administration, and similar state and international
regulatory authorities. We do not engage in the sale of illegal, unsafe, or other high-risk products that are restricted or strictly
prohibited.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As necessary, our carriers
impose additional restrictions on dangerous products. Our carriers require compliance with international air regulations, such as the
International Air Transport Association (IATA) Dangerous Goods Regulations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also subject to environmental
laws, rules and regulations, including but not limited to California&#8217;s Proposition 65, Management of Hazardous Wastes Removed from
Discarded Appliances and Lead Poisoning Prevention Act. We are subject to state and municipality regulations on plastic bag warning labels.
Statements we make on labels, packages and advertisements are truthful, not deceptive or unfair, and evidence-based.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As required by applicable
law, we list and register our products with the appropriate governmental authorities, and obtain necessary authorizations and approvals
therefrom. We require that our foreign and domestic facilities engaged in manufacturing, processing, packing, or warehousing submit additional
registration information, such as good manufacturing practice (GMP) and other related quality management requirements. We request certificates
and clearances as proof of compliance with the existing laws and regulations. We also declare, certify and conduct testing in reputable
or accredited testing laboratories. For some products, we set out written warranties in compliance with the mandatory requirements of
the Magnuson-Moss Warranty Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 54; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some chemicals pose perceived
or real risks to the environment and human health. We require our products that contain chemicals regulated by the EPA to comply with
certification reporting and other requirements of imposed by the EPA.&#160;Products with emission standards for formaldehyde from wood
products are compliant with EPA and California Air Resources Board (CARB).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Moreover, on March&#160;2021,
we received an update from Amazon regarding a new EPA regulation. Following the new EPA regulation, Amazon categorized one of our products
as a pesticide product. Amazon requires that pesticide products be filed with evidence of an EPA registration number and/or EPA establishment
number or certification that the product is exempt from EPA regulation, otherwise the existing listing (of the product) may be subject
to removal. The revenue from the sale of these products is immaterial to the Company and the Company does not currently expect to continue
to sell such products on Amazon unless they can be sold absent these restrictions and will instead look to sell such products outside
of Amazon.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not estimate any significant
capital expenditures for environmental control matters either in the current fiscal year or in the near future.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also subject to regulations
relating to our supply chain. For example, the California Transparency in Supply Chains Act requires retail sellers that do business
in California to disclose their efforts to eradicate slavery and human trafficking in their supply chains. As part of our vendor qualification
process, we review supplier&#8217;s operations with respect to compliance with applicable labor and workplace standards and other applicable
laws, including laws prohibiting child labor, forced labor and unsafe working conditions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we have not suffered
any material restriction from doing business in the past due to government regulation, legal issues with potential implications may arise
in the future as we expand our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, we dispose
of obsolete inventory, which is disposed of or destroyed in compliance with applicable laws and regulations, such as extended producer
responsibility (EPR) or product stewardship legislation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>China Government Regulation</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Regulations Relating to Environmental Protection</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">China&#160;has adopted extensive
environmental laws and regulations with national and local standards for emissions control, discharge of wastewater and storage and transportation,
treatment and disposal of waste materials. At the national level, the relevant environmental protection laws and regulations include
the Chinese Environmental Protection Law, the Chinese Law on the Prevention and Control of Air Pollution, the Chinese Law on the Prevention
and Control of Water Pollution, the Chinese Law on the Promotion of Clean Production, the Chinese Law on the Prevention and Control of
Noise Pollution, the Chinese Law on the Prevention and Control of Solid Waste Pollution, the Chinese Recycling Economy Promotion Law,
the Chinese Law on Environmental Impact Assessment, the Administrative Regulations on the Levy and Use of Discharge Fees and the Measures
for the Administration of the Charging Rates for Pollutant Discharge Fees. In recent&#160;years, the Chinese Government has introduced
a series of new policies designed to generally promote the protection of the environment. For instance, on November&#160;10, 2016, the
General Office of the State Council has released the Implementing Plan for the Permit System for Controlling the Discharge of Pollutants,
or the Plan. The Plan proposes the need of instituting a system for enterprises and public institutions to control their respective total
amount of pollutants discharged, which shall be connected with the environmental impact assessment system organically. The Plan also
stipulates that it is necessary to regulate the orderly issuance of pollutant discharge permits, to make a name list to manage the permission
of pollutant discharge, to promote the administration of such permission system per industry and to impose severer administration and
control over enterprises and public institutions located at such places where environment quality fails to reach relevant standards.
Furthermore, the Plan requires that a national pollutant discharge permit management information platform shall be established by 2017
to strengthen the information disclosure and social supervision.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Regulations Relating to&#160;Intellectual&#160;Property&#160;Rights</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><i>Patents</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Patent Law
of China and its implementation rules, patents in China fall into three categories, namely invention patent, utility model and design
patent. Invention patent refers to a new technical solution proposed in respect of a product, method or its improvement; utility model
refers to a new technical solution that is practicable for application and proposed in respect of the shape, structure or a combination
of both of a product; and design patent refers to the new design of a certain product in shape, pattern or a combination of both and
in color, shape and pattern combinations aesthetically suitable for industrial application. Under the Patent Law of China, the term of
patent protection starts from the date the patent was filed. Patents relating to inventions are effective for twenty&#160;years from
the initial date the patent application was filed, and the term for utility model and designed patents is ten&#160;years from the initial
date the patent application was filed. The Patent Law of China adopts the principle of &#8220;first to file,&#8221; which means where
more than one person files a patent application for the same invention, a patent will be granted to the person who first filed the application.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 55; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Existing patents can become
invalid or unenforceable due to a number of factors, including known or unknown prior art, deficiencies in patent application and lack
of novelty in technology. In China, a patent must have novelty, innovation and practical application. Under the Patent Law of China,
novelty means that before a patent application is filed, no identical invention or utility model has been publicly disclosed in any publication
in China or abroad or has been publicly used or made known to the public by any other means, whether in or outside of&#160;China, nor
has any other person filed with the patent authority an application that describes an identical invention or utility model and is published
after the filing date. Patents in China are filed with the State&#160;Intellectual&#160;Property&#160;Office, or SIPO.&#160;Normally,
the SIPO publishes an application for a pharmaceutical invention 18&#160;months after the application is filed, which may be shortened
upon request by the applicant. The applicant must apply to the SIPO for a substantive examination within three&#160;years from the date
the application is filed.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Article&#160;20 of the Patent
Law of China provides that, for an invention or utility model completed in&#160;China, any applicant (not just Chinese companies and
individuals), before filing a patent application outside of&#160;China, must first submit it to the SIPO for a confidential examination.
Failure to comply with this requirement will result in the denial of any Chinese patent for the subject invention. This added requirement
of confidential examination by the SIPO has raised concerns by foreign companies who conduct research and development activities in China
or outsource research and development activities to service providers in China.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Patent Enforcement</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unauthorized use of patents
without consent from owners of patents, forgery of the patents belonging to other persons, or engagement in other infringement acts against
patent rights, will subject the infringers to tortious liabilities. Serious offences may be subject to criminal penalties.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">When a dispute arises as
a result of infringement of the patent owner&#8217;s patent right, Chinese law requires that the parties first attempt to settle the
dispute through consultation between them. However, if the dispute cannot be settled through consultation, the patent owner, or an interested
party who believes the patent is being infringed, may either file a civil legal suit or file an administrative complaint with the relevant
patent administration authority under the SIPO.&#160;A Chinese court may issue a preliminary injunction upon the patent owner&#8217;s
or an interested party&#8217;s request before instituting any legal proceedings or during the proceedings. Damages for infringement are
calculated as either the loss suffered by the patent holder arising from the infringement or the benefit gained by the infringer from
the infringement. If it is difficult to ascertain damages in this manner, damages may be determined by using a reasonable multiple of
the license fee under a contractual license. As in other jurisdictions, with one notable exception, the patent owner in China has the
burden of proving that the patent is being infringed. However, if the owner of a manufacturing process patent alleges infringement of
its patent, the alleged infringer has the burden of proving that it has not infringed. To our knowledge, there are no disputes as to
our infringement of any third party&#8217;s patent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><i>Trade Secrets</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">According to the Anti-Unfair
Competition Law of the China, the term &#8220;trade secrets&#8221; refers to technical information and business information that is unknown
to the public, that has utility and may create business interest or profit for its legal owners or holders, and that is maintained as
a secret by its legal owners or holders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under this law, business
persons are prohibited from employing the following methods to infringe trade secrets: (1)&#160;obtaining the trade secrets from the
legal owners or holders by any unfair methods such as stealing, solicitation or coercion; (2)&#160;disclosing, using or permitting others
to use the trade secrets obtained illegally under item (1)&#160;above; or (3)&#160;disclosing, using or permitting others to use the
trade secrets, in violation of any contractual agreements or any requirements of the legal owners or holders to keep such trade secrets
in confidence. If a third party knows or should have known of the above-mentioned illegal conduct but nevertheless obtains, uses or discloses
trade secrets of others, the third party may be deemed to have committed a misappropriation of the others&#8217; trade secrets. The parties
whose trade secrets are being misappropriated may petition for administrative corrections, and regulatory authorities may stop any illegal
activities and fine infringing parties in the amount of RMB 10,000 &#8212;&#160;200,000. Alternatively, persons whose trade secrets are
being misappropriated may file lawsuits in a Chinese court for loss and damages caused by the misappropriation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 56; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The measures to protect trade
secrets include oral or written agreements or other reasonable measures to require the employees of, or persons in business contact with,
legal owners or holders to keep trade secrets confidential. Once the legal owners or holders have asked others to keep trade secrets
confidential and have adopted reasonable protection measures, the requested persons bear the responsibility for keeping the trade secrets
confidential.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Recently Issued Policies on the Protection
of&#160;Intellectual&#160;Property&#160;Rights</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November&#160;4, 2016,
the Central Committee of the Communist Party of&#160;China&#160;and the State Council jointly issued a Guideline on Improving the Property
Rights Protection System and Providing&#160;Law-based&#160;Protection to Property Rights, or the Guideline, effective on the date of
its release. The Guideline proposes that the country will provide equal, comprehensive and&#160;law-based&#160;protection to all kinds
of property rights and requires that the punishment of&#160;intellectual&#160;property&#160;rights violations should be strengthened
and the limits on compensation for violating&#160;intellectual&#160;property&#160;rights laws should be increased. In addition, the Guideline
proposes to explore the establishment of infringement punitive compensation system for such&#160;intellectual&#160;property&#160;rights
as patent and copyright, including allowing for punitive damages for serious malicious tort. The Guideline also stipulates to perfect
the foreign-related&#160;intellectual&#160;property&#160;rights enforcement mechanism, and strengthen the international cooperation in
criminal case enforcement and investigation in foreign-related&#160;intellectual&#160;property&#160;crimes. On November&#160;28, 2016,
the Supreme People&#8217;s Court released the Implementation Opinions on Appropriately and Lawfully Handling Long-standing Historical
Property Rights Cases and the Opinions on Giving Full Play to Judicial Functions to Enhance Judicial Protection of Property Rights, or
the Opinions, effective on the date of their releases. The Opinions stipulate that, among others, efforts shall be made to crack down
on&#160;intellectual&#160;property&#160;rights infringement and crimes in accordance with relevant laws and regulations, provide stronger
judicial protection to&#160;intellectual&#160;property&#160;rights, introduce judicial interpretations and guiding cases in due time,
promote the lawful application of the punitive compensation system, and impose severer punishments on chain-type and industrialized crimes
against&#160;intellectual&#160;property&#160;rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Foreign Exchange Regulation</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Foreign Exchange Administration
Regulations, most recently amended in August&#160;2008, are the principal regulations governing foreign currency exchange in&#160;China.
Under the Chinese foreign exchange regulations, payments of current account items, such as profit distributions and&#160;trade&#160;and
service-related foreign exchange transactions, may be made in foreign currencies without prior approval from the State Administration
of Foreign Exchange, or SAFE, by complying with certain procedural requirements. In contrast, approval from or registration with appropriate
government authorities is required when Chinese Renminbi, or RMB, is converted into a foreign currency and remitted out of&#160;China&#160;to
pay capital expenses such as the repayment of foreign currency-denominated loans.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2012, SAFE
promulgated the Circular of Further Improving and Adjusting Foreign Exchange Administration Policies on Foreign Direct Investment, which
substantially amends and simplifies the foreign exchange procedure. Pursuant to this circular, the opening of various special purpose
foreign exchange accounts, such as pre-establishment expenses accounts, foreign exchange capital accounts and guarantee accounts, the
reinvestment of RMB proceeds by foreign investors in&#160;China, and remittance of foreign exchange profits and dividends by a foreign-invested
enterprise to its foreign shareholders no longer require the approval or verification of SAFE, and multiple capital accounts for the
same entity may be opened in different provinces, which was not previously possible. In addition, SAFE promulgated the Circular on Printing
and Distributing the Provisions on Foreign Exchange Administration over Domestic Direct Investment by Foreign Investors and the Supporting
Documents in May&#160;2013, which specifies that the administration by the SAFE or its local branches over direct investment by foreign
investors in&#160;China&#160;will be conducted by way of registration, and banks must process foreign exchange business relating to the
direct investment in&#160;China&#160;based on the registration information provided by SAFE and its branches.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Circular of the
SAFE on Further Improving and Adjusting the Policies for Foreign Exchange Administration under Capital Accounts promulgated by the SAFE
on January&#160;10, 2014 and effective from February&#160;10, 2014, administration over the outflow of the profits by domestic institutions
has been further simplified. In principle, a bank is no longer required to examine transaction documents when handling the outflow of
profits of no more than the equivalent of $50,000 by a domestic institution. When handling the outflow of profits exceeding the equivalent
of $50,000, the bank, in principle, is no longer required to examine the financial audit report and capital verification report of the
domestic institution, provided that it must examine, according to the principle of transaction authenticity, the profit distribution
resolution of the board of directors (or the profit distribution resolution of the partners) relating to this profit outflow and the
original copy of its tax record-filing form. After each profit outflow, the bank must affix its seal to and endorsements on the original
copy of the relevant tax record-filing form to indicate the actual amount of the profit outflow and the date of the outflow.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 57; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;30, 2015, SAFE
promulgated the Circular on Reforming the Management Approach regarding the Settlement of Foreign Exchange Capital of Foreign-invested
Enterprises, or SAFE Circular 19, which became effective on June&#160;1, 2015. According to SAFE Circular 19, the foreign exchange capital
of foreign-invested enterprises may be settled on a discretionary basis, meaning that the foreign exchange capital in the capital account
of a foreign-invested enterprise for which the rights and interests of monetary contribution has been confirmed by the local foreign
exchange bureau (or the book-entry registration of monetary contribution by the banks) can be settled at the banks based on the actual
operational needs of the foreign-invested enterprise. The proportion of such discretionary settlement is temporarily determined as 100%.
The RMB converted from the foreign exchange capital will be kept in a designated account, and if a foreign-invested enterprise needs
to make further payment from such account, it still must provide supporting documents and go through the review process with the banks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, SAFE Circular
19 stipulates that the use of capital by foreign-invested enterprises must adhere to the principles of authenticity and self-use within
the business scope of enterprises. The capital of a foreign-invested enterprise and capital in RMB obtained by the foreign-invested enterprise
from foreign exchange settlement must not be used for the following purposes:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">directly or indirectly
                                            used for the payment beyond the business scope of the enterprises or the payment prohibited
                                            by relevant laws and regulations;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">directly or indirectly
                                            used for investment in securities, unless otherwise provided by relevant laws and regulations;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">directly or indirectly
                                            used for granting the entrusted loans in RMB, unless permitted by the scope of business,
                                            repaying the inter-enterprise borrowing (including advances by the third party), or repaying
                                            the bank loans in RMB that have been sub-lent to the third party; and/or</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">paying the expenses
                                            related to the purchase of real estate that is not for self-use, except for the foreign-invested
                                            real estate enterprises.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;9, 2016, SAFE
issued the Notice to Reform and Regulate the Administration Policies of Foreign Exchange Capital Settlement to further reform foreign
exchange capital settlement nationwide.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Regulations Relating to&#160;Data Privacy&#160;and
Security</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Regulations, legislation
or self-regulation relating to privacy, data collection&#160;and protection, e-commerce and internet advertising and uncertainties regarding
the application or interpretation of existing or newly adopted laws and regulations, could harm our&#160;business and subject us to significant
legal liability for non-compliance.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our business is conducted
through the internet and therefore, among other things, we are subject to the laws and regulations that apply to e-commerce and online
businesses around the world. These laws and regulations are becoming more prevalent in the United States, Europe, Israel and elsewhere
and may impede the growth our services. These regulations and laws may cover privacy, data collection and protection, location of data
storage and processing, cybersecurity, e-commerce, content, use of &#8220;cookies&#8221;, pricing, advertising, marketing, distribution
of products, consumer protection, taxation and online payment services.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For example, we collect,
use, maintain and otherwise process certain data about consumers of our products, partners, candidates and employees, consultants, and
leads&#160;. Our ability to collect, use, maintain or otherwise process personal data has been, and could be further, restricted by existing
and new laws and regulations relating to privacy and data collection and protection, including the EU General Data Protection Regulation
2016/5679, or the GDPR, the Israeli Privacy Protection Law, 1981 and the regulations thereunder, or the Israeli Privacy Law, as well
as other applicable laws, including in the United States. These laws and regulations generally define personal data or personal information
to include identifying information such as full name, email address, physical address, phone number and others, as well as, location
data and online identifiers, which are commonly used and collected parameters in digital advertising and, among other things, impose
stringent user consent requirements and permit data subjects to request we discontinue using certain data. In addition, some countries
are considering or have enacted legislation requiring local storage and processing of data that could increase the cost and complexity
of delivering our services.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 58; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If we were found in violation
of any applicable laws or regulations relating to privacy, data protection, or security, in any jurisdiction, including in jurisdictions
where we operate remotely (such as by selling to shoppers residing in such jurisdictions), our business may be materially and adversely
affected and we would be liable for any damages and regulatory fines and would likely have to change our business practices. In addition,
these laws and regulations could impose significant costs on us and could constrain our ability to use and process data in manners that
may be commercially desirable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While it is generally the
laws of the jurisdiction in which a business is located that apply, there is a risk that data protection regulators of other countries
may seek jurisdiction over our remotely activities in locations in which we process data or serve shoppers but do not have an operating
entity. Where the local data protection and privacy laws of a jurisdiction apply, we may be required to register our operations in that
jurisdiction or make changes to our business so that shopper data is only collected and processed in accordance with applicable local
law. In addition, because our services are accessible&#160; worldwide, certain foreign jurisdictions may claim that we are required to
comply with their privacy and data protection laws, including in jurisdictions where we have no local entity, employees or infrastructure.
In such cases, we may require additional legal review and resources to ensure compliance with any applicable privacy or data protection
laws and regulations. In addition, in many jurisdictions there may in the future be new legislation that may affect our business and
require additional legal review.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also expect that there
will continue to be new laws, regulations, and industry standards concerning privacy, data protection, and information security proposed
and enacted in various jurisdictions. For example, in the European Economic Area, or the EEA, we are subject to the GDPR, which imposes
stringent operational requirements regarding, among others, data use, sharing and processing, data breach notifications, data subject
rights, documentation, and cross-border data transfers for EEA entities as well as non-EEA entities that offer goods or services to,
or monitor, individuals in the EEA. Failure to comply with the GDPR could result in penalties for noncompliance (including possible fines
of up to the greater of &#8364;20 million and 4% of our global annual turnover for the preceding financial year for the most serious violations,
as well as the right to compensation for financial or non-financial damages claimed by individuals under Article 82 of the GDPR).&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the GDPR,
we are subject to the United Kingdom&#8217;s privacy regime, or the UK privacy laws, that imposes obligations and penalties similar to
the GDPR including fines up to the greater of &#163;17.5 million or 4% of global turnover. EEA and UK privacy laws are constantly developing,
including through case law and regulatory guidance, which increases our compliance costs and regulatory exposure.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also subject to evolving
EEA and the UK privacy laws on cookies, tracking technologies and e-marketing. In the EEA and the UK under national laws, derived from
the Directive 2002/58 on Privacy and Electronic Communications, or the ePrivacy Directive, informed and freely given consent is required
for the placement of cookies and similar technologies on shoppers&#8217; devices, website users and imposes restrictions on electronic
marketing. The GDPR and UK regime also impose conditions on obtaining valid consent for cookies, such as a prohibition on pre-checked
consents. If and when it comes into effect, proposed legislation known as the Regulation of Privacy and Electronic Communications, or
the ePrivacy Regulation, would replace the current ePrivacy Directive, and significantly increase fines for non-compliance. Recent European
court and regulatory decisions are driving increased attention to cookies and tracking technologies, which could lead to substantial
costs, require significant systems changes, limit the effectiveness of our marketing activities, divert the attention of our technology
personnel, adversely affect our margins, increase costs and subject us to additional liabilities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additionally, we are or may
soon be subject to the California Consumer Privacy Act, or the CCPA, as amended by the California Privacy Rights Act, or the CPRA, which
came into effect on January 1, 2020 and, imposes heightened transparency obligations, adds restrictions on the &#8220;sale&#8221; or
&#8220;share&#8221; of personal information (which it defines broadly), and creates new data privacy rights for California residents
and carries significant enforcement penalties for non-compliance. The California Attorney General enforces the CCPA and can seek an injunction
and civil penalties up to $7,500 per intentional violation and $2,500 per other violation. The CCPA also provides California consumers
a private right of action for certain data breaches where they can recover up to $750 per incident, per consumer or actual damages, whichever
is greater, and which is expected to increase data breach litigation. The CCPA may require us to modify our data practices and policies
and to incur substantial costs and expenses in order to comply. In addition, on November 3, 2020, California voters passed the CPRA into
law, which took effect on January 1, 2023 with enforcement beginning on July 1, 2023. The CPRA also creates obligations with respect
to certain data relating to consumers as of January 1, 2022. The CPRA will significantly modify the CCPA by introducing additional obligations
such as data minimization and storage limitations, granting additional rights to consumers, such as correction of personal information
and additional opt-out rights, and create a new state agency that will be vested with authority to implement and enforce the CCPA and
the CPRA, potentially resulting in further uncertainty and requiring us to incur additional costs and expenses in an effort to comply.
Additional U.S. states have implemented, or are in the process of implementing, similar new laws or regulation (for example, the Virginia
Consumer Data Protection Act, or the VCDPA, that went into effect on January 1, 2023 and the Colorado Privacy Act, or the CPA, which
will go into effect on July 1, 2023) that impose new privacy rights and obligations. Further, laws in all 50 states require businesses
to provide notice to consumers whose personal information has been disclosed as a result of a data breach. More generally, some observers
have noted the CCPA and CPRA could mark the beginning of a trend toward more stringent privacy legislation in the US, including similar
laws in other US states and a potential federal privacy law, all of which could increase our potential liability and adversely affect
our business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 59; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we are also
subject to the Israeli Privacy Law, and its regulations, including the Israeli Privacy Protection Regulations (Data Security) 2017, or
the Data Security Regulations, which came into effect in Israel in May 2018 and impose obligations with respect to the manner personal
data is processed, maintained, transferred, disclosed, accessed and secured, as well as the guidelines of the Israeli Privacy Protection
Authority. In this respect, the Data Security Regulations may require us to adjust our data protection and data security practices, information
security measures, certain organizational procedures, applicable positions (such as an information security manager) and other technical
and organizational security measures. Failure to comply with the Israeli Privacy Law, its regulations and guidelines issued by the Privacy
Protection Authority, may expose us to administrative fines, civil claims (including class actions) and in certain cases criminal liability.
Current pending legislation may result in a change of the current enforcement measures and sanctions. The Israeli Privacy Protection
Authority may initiate administrative inspection proceedings, from time to time, without any suspicion of any particular breach of the
Israeli Privacy Law, as the Israeli Privacy Protection Authority has done in the past with respect to dozens of Israeli companies in
various business sectors. In addition, to the extent that any administrative supervision procedure is initiated by the Israeli Privacy
Protection Authority that reveals certain irregularities with respect to our compliance with the Israeli Privacy Law, in addition to
our exposure to administrative fines, civil claims (including class actions) and in certain cases criminal liability, we may also need
to take certain remedial actions to rectify such irregularities, which may increase our costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any failure or perceived
failure by our subsidiaries or by us to comply with our posted privacy policies, our privacy-related obligations to users or other third
parties, or any other legal obligations or regulatory requirements relating to privacy, data protection, or data security may result
in governmental investigations or enforcement actions, litigation, claims, or public statements against us by consumer advocacy groups
or others and could result in significant liability, cause our users to lose trust in us, and otherwise materially and adversely affect
our reputation and business. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations, other obligations,
and policies that are applicable to the businesses of our users may limit the adoption and use of, and reduce the overall demand for,
our e-commerce platforms and websites. Further, public scrutiny of, or complaints about, technology and e-commerce platform companies
or their data handling or data protection practices, even if unrelated to our business, industry, or operations, may lead to increased
scrutiny of technology and e-commerce platform companies, including us, and may cause government agencies to enact additional regulatory
requirements, or to modify their enforcement or investigation activities, which may increase our costs and risks.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Recent Developments</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><i>&#160;</i></p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><i>Bonus Shares
Issuance and Reverse Share Splits</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February&#160;17, 2022,
our board of directors approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments
for subsequent reverse share splits) Ordinary Shares for each Ordinary Share issued and outstanding as of the close of business on February&#160;17,
2022 (provided that any fractional shares be rounded down to the nearest whole number), pursuant to which holders of our Ordinary Shares
received 664.0547 (prior to adjustments for subsequent reverse share splits) Ordinary Shares for every one Ordinary Share held as of
such date, resulting in an aggregate issuance by the Company of 6,630,547 (prior to adjustments for subsequent reverse share splits)
Ordinary Shares on such date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May&#160;3, 2022, our
board of directors approved a 0.806-for-1 reverse split of our issued and outstanding Ordinary Shares, effective as of May&#160;3, 2022,
pursuant to which holders of our Ordinary Shares received .806 of an Ordinary Share for every one Ordinary Share held as of such date.
The reverse stock split proportionally reduced the number of authorized share capital.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 60; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;16, 2022, our
board of directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June&#160;16, 2022,
pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85&#160;Ordinary Shares held as of such date.
The reverse stock split proportionally reduced the number of authorized share capital.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the context expressly
dictates otherwise, all references to share and per share amounts referred to herein give effect to the bonus shares issuance and the
reverse share splits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><i>&#160;</i></p><div>

</div><p style="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><i>Expansion of
Sales into New E-commerce Platforms</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In November&#160;2022, we
entered into an agreement with Pure NJ Logistics LLC, or Pure Logistics, a U.S.&#160;based storage and logistics center, intended to
support our plans to sell our brands&#8217; products directly to consumers and launch new e-commerce platforms. The Company intends to
offer fulfilled by merchant, or FBM, services in which instead of paying a service fee and providing shipping inventory to Amazon to
fulfill sales, the seller uses its resources and sends the items directly to its customers. By using FBM, a seller takes complete control
of the entire process, from purchasing to shipping and receiving.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The storage and logistics
center is located near the second largest port in the United&#160;States and Newark Airport in New Jersey and is close to JFK Airport
in New&#160;York. The center offers an aggregate of 100,000 square feet with 20 loading docks for loading and unloading container and
trucks. The center handles supply chain, inventory and order processing as well as shipping directly to end customers. Mr. Eliyahu Yoresh,
a director of the Company, is also a director of Pure Logistics. As of December 31, 2022, we paid $300,000 to Pure Logistics pursuant
to the agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Expansion into the Nutritional Supplements
Market </i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 23, 2023, we and
Jeffs&#8217; Brands Holdings entered into a stock purchase agreement with SciSparc, or the Wellution Agreement, as amended on March 22,
2023 by Addendum No. 1 to the Wellution Agreement, or the Addendum, pursuant to which, on March 22, 2023, Jeffs&#8217; Brands Holdings
acquired from SciSparc 57 &#160;shares of common stock of SciSparc U.S., a wholly-owned subsidiary of SciSparc that owns and operates
Wellution, a top-selling Amazon food supplements and cosmetics brand, subject to the holdback by SciSparc of 11 shares as described below,
representing approximately 49% of the issued and outstanding shares of common stock of SciSparc U.S., for approximately $3.0 million in
cash (including the Price Adjustment, as defined below), of which approximately $2.5 million was paid at the closing, or the Wellution
Transaction. The Addendum provided for the payment by us to SciSparc of an additional amount of $489,330 in cash for the purchase price
adjustments, or the Price Adjustment, related to inventory and working capital, payable in five equal installments of $97,866 on the tenth
day of each consecutive calendar month, beginning in May 2023. As collateral for the payment in full of the Price Adjustment, SciSparc
held back 11 shares of common stock of SciSparc U.S, which will be released to Jeffs&#8217; Brands Holdings once the final payment is
made.&#160;&#160;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the Wellution Agreement, in connection with the closing of the Wellution Transaction, on March 22, 2023, we entered into a consulting
agreement with SciSparc U.S., or the SciSparc Consulting Agreement, pursuant to which we will provide management services to SciSparc
U.S. for the Wellution brand for a monthly fee of $20,000, and will receive </span>&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">a
one-time signing bonus in the amount of $51,000. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated
by either party with 30 days advance notice.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Also
pursuant to the Wellution Agreement, in connection with the closing of the Wellution Transaction, effective as of March 22, 2023, we
issued 247,415 Ordinary Shares to SciSparc and on March 29, 2023, SciSparc issued 360,297 of its ordinary shares to us in a mutual share
exchange, or, collectively, the Exchange Shares, representing approximately 2.97% and 4.99%, respectively, of the Company&#8217;s and
SciSparc&#8217;s issued and outstanding ordinary shares. The number of Exchange Shares acquired by each company was calculated by dividing
$288,238, which was adjusted from $300,000, pursuant to the 4.99% ownership limitation included in the Wellution Agreement, by the average
closing price of the relevant company&#8217;s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third
trading day immediately prior to the closing date.</span></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 61; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><i>Expansion into the Market of Pest
Control Products </i></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March 2, 2023, we entered
into a share purchase agreement, or the Fort SPA, with the holders, or the Fort Sellers, of all of the issued and outstanding share capital
of Fort, a company incorporated under the laws of England and Wales and sells pest control products primarily through Amazon.uk, pursuant
to which on March 9, 2023, we acquired all of the issued and outstanding share capital of Fort, for approximately &#163;2,000,000 (approximately
$2,400,000), or the Fort Acquisition. The Fort SPA provides that for a period of three years from closing, or until March 9, 2026 the
Fort Sellers will not compete with Fort&#8217;s business.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the closing
of the Fort Acquisition, on March 9, 2023, we and Fort entered into settlement agreements with all of Fort&#8217;s employees, including
the Fort Sellers, by which such employees&#8217; employment with Fort will terminate three months following March 9, 2023 and certain
other customary conditions. During this three-month period, the Company intends to carry out operational changes in Fort&#8217;s business
that will allow Fort to wind down the activities conducted in its leased warehouse and to move all such operations to warehouses operated
by Amazon.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also in connection with the
closing of the Fort Acquisition, on March 9, 2023, we and the Fort Sellers entered into a consulting agreement, pursuant to which the
Fort Sellers will provide us with consultancy services for a period of six months following the closing, at monthly fee of &#163;2,500
(approximately $3,000).</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_015"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><b>C.</b></td><td style="text-align: justify"><b>Organizational Structure</b></td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have five wholly-owned
subsidiaries: Smart Repair Pro, Purex, Top Rank and Fort, e-commerce companies that operate online stores for the sale of various consumer
products on the Amazon marketplace and Jeffs&#8217; Brands Holdings, a holding company that owns approximately 49% (subject to holdback)
of the issued and outstanding shares of common stock <span style="font-family: Times New Roman, Times, Serif">of</span> SciSparc U.S.,
which owns and operates Wellution, a food supplements and cosmetics brand.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_016"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.5in; text-align: left"><b>D.</b></td><td style="text-align: justify"><b>Property, Plant and Equipment</b></td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our principal executive offices
are located at 7 Mezada Street, Bnei Brak, Israel 5126112, and our telephone number is +972.3.7713520. This facility comprises approximately
24 square meters, or 2,594 square feet, of space. Our current lease, which we entered into on September 16, 2022, effective as of October
1, 2022, expires on September 30, 2025 with an option to extend the lease on the same terms for an additional two years. Our monthly
rent payment as of December 31, 2022, was approximately NIS 15,665 (approximately $4,350). We consider that our current office space
is sufficient to meet our anticipated needs for the foreseeable future and is suitable for the conduct of our business.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have contracts with third
party warehouses in four locations in the United States, one location in Canada, one location in the United Kingdom, and one location
in Germany. These facilities are used for storage of the products prior to the shipment of such products to Amazon&#8217;s warehouses,
based on availability.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <b>ITEM 4A. UNRESOLVED STAFF COMMENTS</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None.</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 62; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_018"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM 5. OPERATING
AND FINANCIAL REVIEW AND PROSPECTS</p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF<br/>
FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_019"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.5in; text-align: left">A.</td><td style="text-align: justify">Operating Results</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>The following discussion
and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the
related notes included elsewhere in this Annual Report on Form 20-F. The discussion below contains forward-looking statements that are
based upon our current expectations and are subject to uncertainty and changes in circumstances. Actual results </i>may <i>differ materially
from these expectations due to inaccurate assumptions and known or unknown risks and uncertainties, including those identified in &#8220;Cautionary
Note Regarding Forward-Looking Statements&#8221; and under &#8220;Risk Factors&#8221; elsewhere in this Annual Report on Form 20-F. Our
discussion and analysis of our operating results for the years ended December 31, 2020 and December 31, 2021 can be found in our prospectus
dated August 25, 2022, filed with the SEC on August 30, 2022 (Registration No. 333- 262835).</i></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>The amounts below are
in in thousands of U.S. dollars.</i></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Overview</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">We are a fast-growing e-commerce
CPG company, operating primarily on Amazon. We were incorporated in Israel in March&#160;2021, under the name Jeffs&#8217; Brands Ltd,
to serve as the holding company of three other e-commerce companies that operate online stores for the sale of various consumer products
on Amazon online marketplace, utilizing the FBA model&#160;&#8212;&#160;Smart Repair Pro, Purex and Top Rank. As a result of the Contribution
Transactions which occurred in May&#160;2021 and discussed above, Smart Repair Pro and Purex became wholly owned subsidiaries of Jeffs&#8217;
Brands. As the Contribution Transactions were consummated among entities under common control, <i>i.e.,</i> there was no change in the
ownership percentages of Medigus and Mr.&#160;Hakmon before and after the Contribution Transactions, Jeffs&#8217; Brands accounted for
the Contribution Transactions as a pooling of interests, resulting in the comparative financial information of the Company being replaced
with the combined financial information of Smart Repair Pro and Purex, the carrying values of asset and liabilities being retained, and
no purchase accounting applied. Therefore this Annual Report on Form 20-F includes the audited financial statements of Jeffs&#8217; Brands
as of and for the year ended December 31, 2022, with the financial information in these financial statements being the combined financial
information of Smart Repair Pro and Purex based on the pooling method of accounting.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">In
addition to executing the FBA business model, we utilize A.I. and machine learning technologies to analyze sales data and patterns on
Amazon in order to identify existing stores, niches and products that have the potential for development and growth, as well as maximize
sales of its existing proprietary products. We also use our own skills, know-how and profound familiarity with Amazon algorithm and all
the tools that the FBA platform FBA has to offer. In some circumstances we scale the products and improve them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Initial Public Offering</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">On
August 30, 2022, we completed our IPO and received gross proceeds of approximately $15.5 million before deducting underwriting discounts
and commissions and before offering expenses ($13.4 million net proceeds after deducting approximately $1.05 million of underwriting
discounts and commissions and approximately $1.05 million after deducting other offering costs).&#160; In connection with the IPO, we
issued and sold: (i) 3,717,473 Ordinary Shares, (ii) Warrants to purchase up to 4,143,385 Ordinary Shares (after giving effect to the
partial exercise of the Underwriter&#8217;s over-allotment option), and (iii) Underwriter&#8217;s Warrants to purchase up to 185,873
Ordinary Shares. The Ordinary Shares and Warrants were approved for listing on the Nasdaq Capital Market and commenced trading under
the symbol &#8220;JFBR&#8221; and &#8220;JFBRW,&#8221; respectively, on August 26, 2022.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September 7, 2022, the
Company&#8217;s volume weighted average stock price was less than the exercise floor of $4.04 for the Warrants. Accordingly, effective
after the closing of trading on November 28, 2022 (the 90th calendar day immediately following the issuance date of the Warrants), the
Warrants have been adjusted pursuant to their terms, including, but not limited to, to adjust the exercise price of the Warrants to $2.02.
In addition, in connection with the Exercise Price Adjustment, the Company issued Additional Warrants to purchase up to 2,824,525 Ordinary
Shares to Qualified Holders (as defined in the Warrant).</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "></p><div>

</div><!-- Field: Page; Sequence: 63; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>Comparison of the Results for the Year
Ended December 31, 2022 and 2021</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Results of Operations</i></b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; font-style: italic; border-bottom: Black 1.5pt solid">U.S.&#160;dollars in thousands</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">5,859</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,509</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,060</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,560</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross Profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">799</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,949</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,198</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,314</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,113</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,480</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">87</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Operating Profit (loss)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,512</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(932</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Financial expense, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,305</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">629</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net profit (loss) </td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,201</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,540</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Profit (Loss) attributable to holders of Ordinary Shares</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,201</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,540</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Revenues</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our revenues consist of revenue derived from sales
on Amazon. The following table discloses the breakdown of our revenues, cost of sales and gross profit for the periods set forth below:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic"></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b><i>U.S.&#160;dollars in thousands</i></b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">5,809</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6,509</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,060</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,560</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; text-align: left">Gross profit</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">799</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,949</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Our
revenues for the year ended December&#160;31, 2022 were $5,809 compared to $6,509 for the year ended December&#160;31, 2021, a decrease
of $700</span>, or <span style="font-family: Times New Roman, Times, Serif">10.8</span>%<span style="font-family: Times New Roman, Times, Serif">.
The decrease is mainly attributable to increase in competition.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Cost of goods sold</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our cost of goods sold consist
of the purchase of finished goods, freight, cost of commissions to Amazon and change in inventory.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table discloses
the breakdown of cost of goods sold for the periods set forth below:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Purchases of finished goods</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,738</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,050</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt">Freight</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">691</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">553</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">Storage</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">634</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt">Cost of commissions</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,561</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,406</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">increase in inventory</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(564</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(449</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">5,060</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,560</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 64; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Fright and storage expenses
&#160;&#160;for the year ended December&#160;31, 2022, amounted $1,325, compared to $553 for the year ended December&#160;31, 2021, an
increase of $772 or 72%. The increase is mainly due to Company's concerns regarding the quarantines in China and the decision to accelerate
its purchase of goods to the first part of 2022 and store it for a longer period in external warehouses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Gross Profit</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our gross profit for the year
ended December&#160;31, 2022, was $799, compared to gross profit of $1,949 for the year ended December&#160;31, 2021, a decrease of $1,150,
or 59%. The decrease is mainly attributable to the increase in fees charged by Amazon resulted in higher cost of sales and decrease in revenue due to higher
competition in 2022 compared to 2021.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Operating Expenses</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our current operating expenses consist of three
components&#160;&#8212;&#160;cost of goods sold, marketing and sales expenses and general and administrative expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Marketing and Sales Expenses</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">Our marketing and sales expenses consist primarily
of Amazon marketing fees, consultants and other marketing and sales expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table discloses the breakdown of
marketing and sales expenses for the periods set forth below:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold; font-style: italic">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-indent: -10pt; padding-left: 10pt">Advertising</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,163</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,211</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Wages, salaries and related expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Other</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">27</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,198</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,314</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The decrease of $116, or 8.8%
for the year ended December&#160;31, 2022, as compared to the year ended December&#160;31, 2021 is mainly attributable to the overall
decreases in advertising, wages, salaries and other expenses.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>General and Administrative Expenses</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our general and administrative expenses consist
primarily of salaries and related expenses, professional service fees for accounting, legal and bookkeeping, facilities, amortization
of intellectual property assets and other general and administrative expenses.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The increase of $2,633, or
178% for the year ended December&#160;31, 2022, as compared to the year ended December&#160;31, 2021 is mainly attributable to professional
services and consulting fees related to services provided in connection with the IPO.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table discloses the breakdown of
our general and administrative expenses for the periods set forth below:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold; font-style: italic"></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><b><i>U.S.&#160;dollars in thousands</i></b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Payroll and related expenses</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">831</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">448</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Subcontractors</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">39</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">78</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Professional services and consulting fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,314</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">297</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Rent and office maintenance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">570</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">524</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">Other expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">284</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">96</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,113</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">1,480</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 65; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Operating Profit (Loss)</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our operating loss for the
year ended December&#160;31, 2022 was $4,512, compared to an operating loss of $932 for the year ended December&#160;31, 2021, an increase
of $3,880, or 284%. The decrease is mainly attributable to the increase in fees charged by Amazon and professional services and consulting
fees related to services provided in connection with the IPO.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Financial Expense and Income</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Financial expense consists of mainly interest on related party loans
and third-party loans, bank fees, revaluation of derivatives and other transactional costs.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Our
financial income, net was $2,305 for the year ended December&#160;31, 2022, compared to net financial expenses of $629 for the year ended
December&#160;31, 2021, a decrease of $2,934</span>, or <span style="font-family: Times New Roman, Times, Serif">266</span>%<span style="font-family: Times New Roman, Times, Serif">.
The decrease was primarily attributable to a revaluation of derivatives in the total amount of $2,822.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Net profit (loss) and total comprehensive profit (loss)</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Our
net loss and total comprehensive loss for the year ended December&#160;31, 2022 was $2,201, compared to net loss and total comprehensive
loss of $1,540 for the year ended December&#160;31, 2020, an increase of $661</span>, or <span style="font-family: Times New Roman, Times, Serif">42</span>%<span style="font-family: Times New Roman, Times, Serif">.
The increase was primarily attributable to the increase in the costs of sales and general and administrative costs, including increase
in fees charged by Amazon and shipment and storage costs.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_020"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left">B.</td><td style="text-align: justify">Liquidity and Capital Resources</td>
</tr></table><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Overview</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since Jeffs&#8217; Brands inception in March 2021
and since the earlier inception of our subsidiaries, Smart Repair Pro and Purex in 2019 and 2020, respectively, to date, we have financed
our operations primarily through funds we received from loans and proceeds from sales on Amazon (after deducting FBA fees and advertising
fees) and the issuance of Ordinary Shares and warrants. As of December&#160;31, 2022 and 2021, we had approximately $8,137 and $393,
respectively, in cash and cash equivalents.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below presents
our cash flow for the periods indicated:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year Ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; font-style: italic">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Net cash used in operating activities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,840</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(863</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(41</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(4,730</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net cash provided by financing activities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,695</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Net increase in cash and cash equivalents</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">7,744</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">102</td><td style="text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We expect that for the foreseeable
future we will finance our activities using the proceeds we received at the IPO or from additional related party or investor loans and
proceeds from sales on Amazon of our existing and future new brands.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Operating Activities</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our net cash used in operating
activities was $4,840 for the year ended December&#160;31, 2022, as compared to net cash from operating activities of $863 for the year
ended December&#160;31, 2021. The increase in net loss and increase in the proceeds used in operating activities is mainly attributable
to changes in fair value of derivative liabilities.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Investing Activities</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our net cash used in investing
activities was $41 for the year ended December&#160;31, 2022, as compared to net cash used in investment activities of $4,730 for the
year ended December&#160;31, 2021. The change is mainly attributable to no investments in intangible assets during 2022, compared to
investment of $4,728, in intangible assets during 2021.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 66; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Financing Activities</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our net cash provided by
financing activities was $12,625 for the year ended December&#160;31, 2022, as compared to net cash provided by investing activities
of $5,695 for the year ended December&#160;31, 2021. The increase is mainly attributable to issuance of Ordinary shares and additional
paid in capital offset with repayment of short term loans.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Financial Arrangements</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May&#160;23, 2019, Smart
Repair Pro entered into loan agreements, or the May&#160;2019 Loans, with a relative of its then operating manager and controlling shareholder,
Viki Hakmon, and L.I.A.&#160;Pure Capital Ltd., or Pure Capital, a company owned by this family relative, or collectively, the Investors.
The May&#160;2019 Loans bore interest at an annual rate of 4% (which was paid quarterly commencing on December&#160;2020) and was due
on August&#160;13, 2022. The May&#160;2019 Loans were secured by a pledge of 50% on the issued share capital of Smart Repair Pro held
by its shareholders. During July and August&#160;2019, Smart Repair Pro entered into additional loan agreements with the Investors, or
the August&#160;2019 Loans, on the same terms. The total amount of loans made during 2019 was $1,106. During April and May&#160;2020,
additional loans, or the May&#160;2020 Loans, were provided to Smart Repair Pro by the Investors in the aggregate sum of $105, on the
same terms. During the first quarter of 2021, an amount of approximately $1,102 was repaid to the Investors, and additional amount of
$109 was converted into 31,535&#160;Ordinary Shares.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On September&#160;11, 2019,
Smart Repair Pro entered into a loan agreement with Amazon, or the Amazon Loan. Pursuant to the Amazon Loan, Smart Repair Pro borrowed
from Amazon an aggregate amount of $193. The Amazon Loan matured within 12&#160;months and bore interest at a rate of 16.72% per year.
In order to secure the Amazon Loan, Smart Repair Pro pledged its financial balances on its Amazon account and its inventories held in
Amazon&#8217;s warehouses, in favor of Amazon. In January&#160;2020, the loan was fully repaid.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March&#160;1, 2020, Smart
Repair Pro, entered into a loan agreement, or the March&#160;1, 2020 Loan Agreement, with Purex. Pursuant to the March&#160;1, 2020 Loan
Agreement, Smart Repair Pro loaned Purex an aggregate amount of $135. The loan was due on July&#160;13, 2021 and bore interest at a rate
of 4% per year. In order to secure the loan until its full repayment, Purex pledged its full rights in the seller account on Amazon,
in Smart Repair Pro&#8217;s favor. The loan was fully repaid on May 3, 2021.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On October&#160;8, 2020,
Smart Repair Pro and Purex and their then shareholders, entered into a share purchase agreement, or the Medigus SPA, with Medigus. Pursuant
to the Medigus SPA, Medigus and Smart Repair Pro&#8217;s shareholders committed to transfer funds, as loans to Smart Repair Pro, in order
to finance its&#160;day-to-day&#160;operations in exchange for its shares. During October and November&#160;2020, an amount of $250 was
transferred to Smart Repair Pro, on account of the loans. The loans bear an annual interest rate of 4%. On January&#160;4, 2021, the
terms and conditions to the Medigus SPA were satisfied and Medigus advanced approximately $1,100 on behalf of a loan from investors,
which the first principal was borrowed on October&#160;2020 and in exchange for the repayment of the loan, Smart Repair Pro issued to
Medigus 5,572 of its shares of common stock. Also on January&#160;4, 2021, Purex issued 557&#160;shares of its common stock to Medigus
in exchange for its payment of $150.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In February&#160;2021, Smart
Repair Pro, received additional loans under the Medigus SPA, on the same terms (annual interest rate of 4% and repayment after five&#160;years).
Subsequently, on February&#160;3, 2021, Medigus transferred to Smart Repair Pro an amount of $560 as a controlling shareholder loan,
in order to finance the purchase of two additional Amazon stores, PetEvo and Wellted.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, according to
the terms of the Medigus SPA, the minority shareholders (Mr.&#160;Hakmon&#8217;s affiliates, as detailed below) are obligated to keep
a 20:80 ratio with Medigus for amounts transferred to Smart Repair Pro by Medigus for the purpose of purchasing two stores. To illustrate,
when a new store is being purchased, Medigus is obligated to invest 80% of the purchase price, and Mr.&#160;Hakmon&#8217;s affiliates
are obligated to invest 20% of the purchase price. Therefore, on March&#160;5, 2021 and on April&#160;29, 2021, a total sum of $140 was
transferred from the minority shareholders to the broker in the store purchase transaction, on account of the loan to Smart Repair Pro.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 67; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On February&#160;2, 2021,
Smart Repair Pro acquired a virtual store pursuant to a purchase agreement entered into with a third party, or the Whoobli Seller. Pursuant
to the agreement, Smart Repair Pro purchased the Whoobli Seller&#8217;s seller account which operates on Amazon under the name &#8220;Whoobli&#8221;,
which markets a private label of basketball hoops, children&#8217;s punching bags and related party decorations, including, the intellectual
property attributed to it and including trademarks attributed to products sold on the account&#8217;s sales page, for a total of $4,000.
In addition, in accordance with the agreement, Smart Repair Pro purchased from the Whoobli Seller the remaining inventory for a total
amount of approximately $350, at its original cost. In order to finance the purchase of the Whoobli store, Smart Repair Pro received
an additional loan from its shareholders at a ratio of 20:80, as described above, whereby Medigus transferred directly to the Whoobli
Seller an amount of approximately $3,200 and the minority shareholders transferred an amount of approximately $800.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April&#160;8, 2021, Smart
Repair Pro entered into a loan agreement with Amazon. Pursuant to the loan agreement, Smart Repair Pro loaned from Amazon an aggregate
amount of $78. The loan matured within six&#160;months and bore interest at a rate of 10.99% per year. In order to secure the loan, Smart
Repair Pro pledged its financial balances on its Amazon account and its inventories held in Amazon&#8217;s warehouses, in favor of Amazon.
As the date of this Annual Report on Form 20-F, the loan was fully repaid.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective as of May&#160;10,
2021, pursuant to the transactions contemplated by the SEA, Purex and Smart Repair Pro became wholly-owned&#160;subsidiaries of Jeffs&#8217;
Brands and the Contribution Transactions were completed. Pursuant to the SEA, Medigus and Mr.&#160;Hakmon, as the shareholders of Smart
Repair Pro and Purex, contributed all of the equity interests they owned in Smart Repair Pro and Purex to Jeffs&#8217; Brands in exchange
for Ordinary Shares. Following the closing of the Contribution Transactions and pursuant to the SEA, Jeffs&#8217; Brands held all of
the outstanding shares of Smart Repair Pro and Purex, Medigus held 50.03% of our outstanding Ordinary Shares and Mr.&#160;Hakmon, our
Chief Executive Officer, held the remaining 49.97% of our outstanding Ordinary Shares. Mr.&#160;Hakmon&#8217;s affiliates, who were minority
shareholders of Smart Repair Pro and Purex, transferred all their holdings in Smart Repair Pro and Purex to Mr.&#160;Hakmon, effective
immediately prior to the Contribution Transactions pursuant to a Share Transfer Deed dated May&#160;10, 2021.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;1, 2021, Smart
Repair Pro entered into a loan agreement, which was amended on November&#160;23, 2021, or the July&#160;1 Loan Agreement, with Tamrid
Ltd., or Tamrid. On July&#160;6, 2021, the loan principal of $375 was received. The July&#160;1 Loan Agreement bore an annual interest
rate of 10% and became payable upon our IPO, in NIS or U.S. dollar currency at the Company&#8217;s option. Smart Repair Pro had the right
to extend the loan period by an additional sixty&#160;days, while the interest rate would be 1% per&#160;month, and such right was exercised
on November 23, 2021. In addition, pursuant to the July&#160;1 Loan Agreement, upon our IPO, we issue to Tamrid warrants to purchase
30,048&#160;Ordinary Shares having an aggregate value of $125, based on the IPO price per share, exercisable for a three-year period
beginning on the closing date of the IPO.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">On
July&#160;5, 2021, Smart Repair Pro entered into a loan agreement, which was amended on November&#160;23, 2021, or the July&#160;5 Loan
Agreement, with M.R.M.&#160;Merhavit Holdings and Management Ltd., or MRM, pursuant to which on July 9, 2021, MRM loaned to the Company
principal amount of $375. The July 5 Loan Agreement bore interest at an annual rate of 10%. Pursuant to the July 5 Loan Agreement, the
principal was payable upon the closing of the IPO, in NIS or U.S. dollars currency at the Company&#8217;s option. Smart Repair Pro had
the right to extend the loan period by an additional sixty&#160;days, at a monthly interest rate of 1%, and such right was exercised
on November 23, 2021. In addition, pursuant to the July&#160;5 Loan Agreement, in the event of an initial public offering, Jeffs&#8217;
Brands shall issue to MRM, warrants to purchase Ordinary Shares with aggregate value of $125, based on the initial public offering price
per share, exercisable for a three year period beginning on the closing date of such initial public offering.&#160;On July&#160;9, 2021,
the loan principal of $375 was received. In accordance with the July&#160;5 Loan Agreement, following the completion of the IPO, warrants
to purchase up to 30,048&#160;Ordinary Shares was issued to MRM on August 30, 2022, exercisable at any time up to the date that is three
years after their original issuance, at an exercise price of </span>$4.04 per Ordinary Share<span style="font-family: Times New Roman, Times, Serif">.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September&#160;22, 2021,
Smart Repair Pro entered into a loan agreement with Amazon, pursuant to which, Smart Repair Pro received from Amazon an aggregate amount
of $153. The loan matured on May 09, 2022 and bore an interest at an annual rate of 9.99%. In order to secure the loan, Smart Repair Pro
pledged its financial balances on its Amazon account and its inventories held in Amazon&#8217;s warehouses, in favor of Amazon.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 9,2022 Smart Repair Pro entered into a loan agreement with Amazon,
pursuant to which, Smart Repair Pro received from Amazon an aggregate amount of $153. &#160;The loan bares an interest at an annual rate
of 9.99%. In order to secure the loan, Smart Repair Pro pledged its financial balances on its Amazon account and its inventories held
in Amazon&#8217;s warehouses, in favor of Amazon. As of December 31, 2022, the remaining loan balance to Amazon was $86.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 68; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">On May&#160;3, 2022, we entered
into Assignments to Loan Agreements, or the Assignment Agreements, with Smart Repair Pro, Medigus, Mr.&#160;Hakmon and Pure Capital,
pursuant to which we assumed Smart Repair Pro&#8217;s obligations under the outstanding loans and we agreed that unless earlier repaid
pursuant to the terms of the respective loan agreements with such parties, effective immediately upon the consummation of the IPO, all
outstanding principal due to each such party automatically converted into a number of Ordinary Shares equal to the quotient obtained
by dividing the outstanding principal amount due to such party, by the per Ordinary Share price of $3.46 per share, obtained by dividing
$10,000 by the issued and outstanding Ordinary Shares immediately prior to the completion of the IPO.&#160;As of August&#160;30, 2022,
Smart Repair Pro had outstanding loans to Medigus, Mr.&#160;Hakmon and Pure Capital of $4,010, $940 and $109, respectively. In accordance
with the Assignment Agreement, on August&#160;30, 2022, the outstanding amounts due to Medigus, Mr.&#160;Hakmon and Pure Capital were
converted into 1,160,133&#160;Ordinary Shares, 271,951&#160;Ordinary Shares and 31,535&#160;Ordinary Shares, respectively. Any accrued
and unpaid interest due to each such party at that time was paid in cash.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">On February&#160;22, 2022,
we entered into a loan agreement with Bank Leumi Le-Israel, or&#160;Bank Leumi, to provide for a line of credit in an aggregate amount
of up to $1.0&#160;million, to be drawn in two tranches at our request, but in no event after July&#160;21, 2022. Pursuant to the loan
agreement, amounts drawn bore interest at a rate of Secured Overnight Financing Rate, or SOFR plus 3.25% per annum. Unless otherwise
provided with respect to a particular draw, any unpaid principal together with accrued and unpaid interest under the line of credit was
required to be repaid no later than August&#160;21, 2022. In order to induce Bank Leumi to provide the loan, the Company and certain
of our shareholders entered into a controlling shareholders&#8217; comfort letter, subordination agreements and a negative pledge. On
March&#160;3, 2022, we drew $0.4&#160;million under the line of credit. On June&#160;2, 2022 we drew another $0.2&#160;million under
the line of credit. Following an agreement with Bank Leumi, the loan was extended until October&#160;31, 2022. All amounts outstanding
under the line of credit were fully repaid on September&#160;6, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;29, 2022 and
August&#160;24, 2022, Medigus advanced $80 and $70, respectively, to the Company for certain working capital matters, which the Company
fully repaid on September&#160;6, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b><i>Current Outlook</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">As
of December 31, 2022, our cash and cash equivalents were $8,137. We expect that our existing cash and cash equivalents as of December
31, 2022, will be sufficient to fund our current operations for the next twelve months. </span>In addition, our operating plans may change
as a result of many factors that may currently be unknown to us, and we may need to seek additional funds sooner than planned. Our future
capital requirements will depend on many factors, including:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 0.5in"></td><td style="width: 0.25in; text-align: justify">&#9679;</td><td style="text-align: justify">the
                                            progress and costs of purchasing new brands and their development plans;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 0.5in"></td><td style="width: 0.25in; text-align: justify">&#9679;</td><td style="text-align: justify">the
                                            costs of manufacturing and shipment of our products;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 0.5in"></td><td style="width: 0.25in; text-align: justify">&#9679;</td><td style="text-align: justify">the
                                            costs of filing, prosecuting, enforcing and defending patent claims and other intellectual
                                            property rights;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 0.5in"></td><td style="width: 0.25in; text-align: justify">&#9679;</td><td style="text-align: justify">the
                                            potential costs of contracting with third parties to provide marketing and distribution services
                                            for us or for building such capacities internally; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="text-align: justify; width: 0.5in"></td><td style="width: 0.25in; text-align: justify">&#9679;</td><td style="text-align: justify">the
                                            magnitude of our general and administrative expenses.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_021"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left">C.</td><td style="text-align: justify">Research and development, patents and licenses, etc.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">For a description of our
research and development programs and the amounts that we have incurred over the last two years pursuant to those programs, please see
&#8220;Item 5.A. Operating Results&#8212; Operating Expenses&#8212; Research and Development Expenses, net&#8221; and &#8220;Item 5.A.
Results of Operations&#8212; Comparison of the years ended December 31, 2022 and December 31, 2021&#8212; Research and Development Expenses,
net.&#8221;</p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_022"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left">D.</td><td style="text-align: justify">Trend information</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">Effective
January 1, 2022, we prepare our financial statements in accordance with U.S. GAAP. There are certain differences between U.S. GAAP and
IFRS, including differences related to lease accounting and accounting treatment related to derivative liabilities.&#160;</span>&#160;</p><div>



</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 69; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><div><a id="a_023"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><b>E.</b></td><td style="text-align: justify"><b>Critical Accounting Estimates</b></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We describe our significant
accounting policies more fully in Note 2 to our financial statements included elsewhere in this Annual Report on Form 20-F. We believe
that the accounting policies described below and in Note 2 to our financial statements are critical in order to fully understand and evaluate
our financial condition and results of operations.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial
statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and
income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following
critical accounting policies:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Determining the fair value of related party and shareholder loans</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the fiscal years 2020
and 2021, the Company received loans from related parties, as described in &#8220;Item 7.B. Related Party Transactions &#8211; Loans and
Shareholder Agreements&#8221;. On the borrowing date, the Company estimates the value of the benefit granted to it as the difference between
the interest rate that the Company is required to pay to investors for the loans provided by them and secured by such lien and the interest
rate required to pay for similar unsecured loans to non-related parties. The value of the benefit is recorded within equity on the borrowing
date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Warrants</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We account for the Additional Warrants as liability-classified
instruments based on an assessment of the warrant&#8217;s specific terms and applicable authoritative guidance in the Financial Accounting
Standards Board&#8217;s (FASB) Accounting Standards Codification, or ASC, Topic 480, &#8220;Distinguishing Liabilities from Equity&#8221;,
or ASC Topic 480, and ASC Topic 815, &#8220;Derivatives and Hedging&#8221;, or ASC Topic 815. The assessment considers whether the warrants
are freestanding financial instruments pursuant to ASC Topic 480, meet the definition of a liability pursuant to ASC Topic 480, and whether
the warrants meet all of the requirements for equity classification under ASC Topic 815, including whether the warrants are indexed to
our own ordinary shares and whether the warrant holders could potentially require &#8220;net cash settlement&#8221; in a circumstance
outside of our control, among other conditions for equity classification. Based on their contractual terms, the Additional Warrants are
accounted for as a derivative liability</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The estimated fair value of the Additional Warrants
is determined using Level 3 inputs (as described in the notes to financial statements accompanying this Annual Report on Form 20-F). The
Additional Warrants were calculated according to the binomial model under the following assumptions: expected stock-price volatility,
expected life, dividend yield and risk-free interest rate and revenue forecast over the life of the Additional Warrants.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 70; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_024"></a></div><p style="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</p><div>



</div><p style="text-align: justify; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_025"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left">A.</td><td style="text-align: justify">Directors and Senior Management</td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
information regarding our executive officers, key employees and directors as of April 10, 2023:</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Name</b></p></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Age</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Position</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Class</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%; text-align: left; text-indent: -10pt; padding-left: 10pt">Viki Hakmon</td><td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: center">46</td><td style="width: 1%">&#160;</td>
    <td style="width: 44%; text-align: left">Chief Executive Officer and Director</td><td style="width: 1%">&#160;</td>
    <td style="width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&#160;III<sup>(5)</sup></span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Ronen Zalayet</td><td>&#160;</td>
    <td style="text-align: center">54</td><td>&#160;</td>
    <td style="text-align: left">Chief Financial Officer</td><td>&#160;</td>
    <td>N/A</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Naor Bergman</td><td>&#160;</td>
    <td style="text-align: center">32</td><td>&#160;</td>
    <td style="text-align: left">Chief Operating Officer</td><td>&#160;</td>
    <td>N/A</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Oz Adler</td><td>&#160;</td>
    <td style="text-align: center">36</td><td>&#160;</td>
    <td style="text-align: left">Chairman of the Board of Directors</td><td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&#160;III<sup>(5)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Eliyahu Yoresh</td><td>&#160;</td>
    <td style="text-align: center">52</td><td>&#160;</td>
    <td>Director</td><td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&#160;II<sup>(6)</sup></span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Liron Carmel</td><td>&#160;</td>
    <td style="text-align: center">38</td><td>&#160;</td>
    <td>Director</td><td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&#160;II<sup>(6)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Tali Dinar</td><td>&#160;</td>
    <td style="text-align: center">51</td><td>&#160;</td>
    <td>Director</td><td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&#160;I<sup>(7)</sup></span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moshe
    Revach<sup>(1)(2)(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: center">46</td><td>&#160;</td>
    <td>Director</td><td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&#160;I<sup>(7)</sup></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Amitay Weiss</td><td>&#160;</td>
    <td style="text-align: center">60</td><td>&#160;</td>
    <td>Director</td><td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Class&#160;I<sup>(7)</sup></span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tomer
    Etzyoni<sup>(1)(2)(3)(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: center">42</td><td>&#160;</td>
    <td style="text-align: left">External Director</td><td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asaf
    Itzhaik<sup>(1)(2)(3)(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: center">50</td><td>&#160;</td>
    <td style="text-align: left">External Director</td><td>&#160;</td>
    <td>&#160;</td></tr>
  </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 24pt"></td><td></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-indent: -24pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Independent Director
                                            (as defined under Nasdaq listing rules)</td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">Member of the Audit Committee</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">Member of the Compensation
                                            Committee</td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">External Director (as
                                            defined under Israeli law)</td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"></td><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: justify">Class&#160;III directors
                                            shall hold office until the annual general meeting to be held in 2025 and until their successors
                                            shall have&#160;been elected and qualified.</td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0pt"></td><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: justify">Class&#160;II directors
                                            shall hold office until the annual general meeting to be held in 2024 and until their successors
                                            shall have been elected and qualified.</td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(7)</td><td style="text-align: justify">Class&#160;I directors
                                            shall hold office until the annual general meeting to be held in 2023 and until their successors
                                            shall have&#160;been elected and qualified.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Viki Hakmon, Founder and Chief Executive Officer and Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mr.&#160;Hakmon has served
as our Chief Executive Officer since our inception on March&#160;7, 2021 and as one of our directors since September&#160;2021. Mr.&#160;Hakmon
serves as Smart Repair Pro&#8217;s operating manager since its inception in December&#160;2017. Mr.&#160;Hakmon has served as Purex&#8217;s
operating manager since its inception in April&#160;2020. Prior to founding Smart Repair Pro and Purex, from April&#160;2014 to April&#160;2017,
Mr.&#160;Hakmon owned and managed six businesses including two retail stores and four kiosks for computing hardware and software services,
in various cities in California, including Pleasanton, San Jose and Palo Alto. We believe that Mr.&#160;Hakmon is qualified to serve as
a member of our board of directors because of his vast business, management and leadership experience.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Ronen Zalayet, Chief Financial Officer</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mr.&#160;Zalayet has served
as our Chief Financial Officer since October 2022. Mr. Zalayet has over 20&#160;years of experience working in financial leadership positions
in private and public companies, including in growing fintech and technology companies. Mr. Zalayet has served as the chief executive
officer and director of Shemen Oil and Gas Resources Ltd, an Israeli company listed on the Tel Aviv Stock Exchange (TASE:&#160;SOG) that
explores oil and natural gas since July&#160;2021. From November&#160;2019 to June&#160;2021, Mr.&#160;Zalayet served as the chief financial
officer of Colugo Systems Ltd., a company operating in the transportation field, and from 2016 to 2020, he served as a consultant, director
and head of the Israeli office of Access Capital Markets Limited, a finance boutique company headquartered in the United Kingdom. Ms.
Zalayet holds a B.A. in Economics and Accounting and an MBA from Tel Aviv University, Israel, and is a certified public accountant in
Israel.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Naor Bergman, Chief Operating Officer</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mr.&#160;Bergman has served
as our Chief Operating Officer since April&#160;2021. From September&#160;2018 to April&#160;2021, Mr.&#160;Bergman established and led
Amazon&#8217;s FBA logistics and warehousing department at Unicargo, which has 11 warehouses in the United States, Canada, England and
Europe and was part of the management team that transformed Unicargo to become a leader in the field of outsourcing Amazon&#8217;s FBA
warehousing. Unicargo is a one-stop-shop to FBA specializing in logistics services for Amazon sellers and e-commerce. From September&#160;2017
to September&#160;2018, Mr.&#160;Bergman was a strategic customer manager at Pick&#160;&amp; Pack Ltd., a company fully owned by Israel
Cargo Logistics Ltd, an international shipping company. Mr.&#160;Bergman holds a B.A. in Economics&#160;and Sustainability from Reichman
University, Israel.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 71; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Oz Adler, Chairman of the Board of Directors</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mr. Adler has served as one
of our directors since September 2021. Mr. Adler has served as the chief financial officer of SciSparc since April 2018, as the chief
executive officer of SciSparc since January 2022. Form March 2918 to April 2018 Mr. Adler served as vice president of finance of SciSparc
and from September 2017 to Mach 2018 as controller of SciSparc. Mr. Adler has experience in a wide variety of managerial, financial, tax
and accounting roles. Mr. Adler currently serves as a member of the board of directors of numerous private and public companies, including
Charging Robotics Ltd., Elbit Imaging Ltd. (TASE: EMITF) and Clearmind (CSE: CMND), (OTC: CMNDF), (FSE: CWY), and previously served as
the chief financial officer of Medigus Ltd. (Nasdaq: MDGS) from December 2020 to April 2021. From 2012 until 2017, Mr. Adler worked in
the audit department of Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global. Mr. Adler is a certified public accountant
in Israel and holds a B.A. degree in Accounting and Business Management from The College of Management, Israel. We believe that Mr. Adler
is qualified to serve as a member of our board of directors because of his diverse business, management, and leadership experience.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Eliyahu Yoresh, Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mr.&#160;Yoresh&#160;has served
as one of our directors since September&#160;2021. Mr. Yoresh has served as chairman of the board of directors of Medigus since February&#160;2020
and as chief financial officer of Foresight Autonomous Holdings Ltd.&#160;(Nasdaq, TASE:&#160;FRSX) since March&#160;2010. Mr.&#160;Yoresh
has also served as a member of the board of directors of Gix Internet Ltd. (TASE:&#160;GIX) since November&#160;2020, Elbit Imaging Ltd.
(TASE:&#160;EMITF) since August&#160;2021 and Viewvix Inc. (Nasdaq: VBIX) since September 2022. From August&#160;2014 to February&#160;2020,
Mr. Yoresh served as a member of the board of directors of Nano Dimension Ltd.&#160;(Nasdaq:&#160;NNDM) and from August&#160;2005 to July&#160;2008
as the chief executive officer of Tomcar Global Holdings Ltd., a global manufacturer of off-road vehicles, from.&#160;Mr.&#160;Yoresh
is an Israeli Certified Public Accountant and holds a B.A. in business administration from the Business College, Israel and an M.A. in
Law Study from Bar-Ilan University, Israel. We believe that Mr.&#160;Yoresh is qualified to serve as a member of our board of directors
due to his financial background and expertise and experience in positions as officer and director of public companies.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liron Carmel, Director</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mr.&#160;Carmel&#160;has served
as one of our directors since September&#160;2021. Mr. Carmel has served as chief executive officer of Medigus (Nasdaq: MDGS) since April&#160;2019.
Mr.&#160;Carmel has vast experience in business and leadership across multiple industries, including bio pharma, internet technology,
oil&#160;and gas exploration&#160;and production, real estate and financial services. Since June&#160;2018 Mr. Carmel has served as chairman
of the Israel Tennis Table Association. Since September 2022 Mr. Carmel has served as a member of the board of directors of Viewbix Inc.
(Nasdaq: VBIX). From January&#160;2017 to May&#160;2018, Mr.&#160;Carmel served as the chief executive officer and director of CannaPowder
(PINK:&#160;CAPD), a bio-pharma company dedicated to developing and applying innovative technology in the cannabinoid field. From January&#160;2018
to April&#160;2019, Mr.&#160;Carmel served as a director of Chiron Refineries Ltd. (TASE:&#160;CHR), a company engaged in consulting and
initiation of transactions in the refineries field, and as a member of the board of directors of Gix Internet Ltd. (TASE:&#160;GIX) which
operates in the field of software development, marketing and distribution to internet users. From May&#160;2016 to 2018, he served as
vice president, business development at Yaad Givatayim Development, a municipal corporation dedicated to initiate, develop and establish
projects of public importance. From 2013 to 2015, Mr.&#160;Carmel served as an investment manager and as a research and strategy analyst
at Excellence Nessuah Investment House, a wealth management firm. We believe that Mr.&#160;Carmel is qualified to serve as a member of
our board of directors because of his diverse business, management and leadership experience.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b>Tali Dinar, Director </b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mrs. Dinar has served as one
of our directors since September&#160;2021. Mrs. Dinar is a senior executive with a two-decade track record in public and private companies
in a global environment. Mrs. Dinar has served as chief financial officer of Medigus (Nasdaq: MDGS) since June 2021. Mrs.&#160;Dinar served
as chief financial officer of MICT Inc., a Nasdaq-listed company (Nasdaq:&#160;MICT) from May&#160;2009 to January&#160;2019, and as chief
financial officer of Enertec Systems (2001)&#160;Ltd. (previously a subsidiary of MICT), an industrial company in the defense market from
November&#160;2009 to May&#160;2014. Mrs. Dinar has served as a director of Micronet Ltd. (TASE:&#160;MCRNT) (subsidiary of MICT), a company
engaged in computer systems and terminals for the management of vehicle fleets since July&#160;2016. Mrs. Dinar has served as a director
of Canzon Israel Ltd. (TASE:&#160;CNZN) since August&#160;2020. Mrs. Dinar holds a B.A. in Accounting and Business Administration from
The College of Management, Israel. We believe that Mrs. Dinar is qualified to serve as a member of our board of directors because of her
diverse business, management and proven leadership skills in managing global finance, holding and industrial organizations.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 72; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Moshe Revach, Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mr.&#160;Revach&#160;has served
as one of our directors since September&#160;2021. Mr.&#160;Revach serves as deputy mayor of the city of Ramat Gan, Israel, has headed
both the sports and government relations portfolios in the Ramat Gan, Israel municipality since 2013, and previously served in various
other municipality positions since 2008. Mr.&#160;Revach currently serves as a member of the board of directors of L.L.N IT solutions,
a wholly-owned subsidiary of the Jewish Agency for Israel and of Biomedico Hadarim Ltd. Mr.&#160;Revach previously served as a member
of the board of directors of the RPG Economic Society and Jewish Experience Company on behalf of the Jewish Agency. Mr.&#160;Revach holds
an LL.B from the Ono Academic College, Israel, and a B.A. in management and economics from the University of Derby. We believe that Mr.&#160;Revach
is qualified to serve as a member of our board of directors because of his diverse management and leadership experience.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Amitay Weiss, Director</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mr.&#160;Weiss has served as
one of our directors since August&#160;2022. Mr.&#160;Weiss has a vast experience serving on boards of directors and other high positions.
He has served as chairman of the board of directors of Save Foods Inc. (Nasdaq:&#160;SVFD) since August&#160;2020, chairman of the board
of directors of Infimer Ltd. (Maintaince) (TASE: INFR-M) since July&#160;2021 and chairman of the board of directors of Upsellon Brands
Holdings Ltd. (previously Chiron Ltd.) (TASE:&#160;UPSL) since June&#160;2019. He has also served as a member of the board of directors
of Automax Motors Ltd. (TASE:&#160;AMX) since March&#160;2021, Gix Internet Ltd. (previously Algomizer Ltd.) (TASE:&#160;GIX) since March&#160;2019,
Clearmind Medicine Inc. (previously Cyntar Ventures Inc.) (CSE:&#160;CMND) since August&#160;2019, Perihelion Capital Ltd. (PCL.P:&#160;CVE)
since June&#160;2021, as an external director of Cofix Group Ltd. (TASE:&#160;CFCS) since August&#160;2015 and as a member of the board
of directors of SciSparc since August&#160;2020. Mr. Weiss served as chief executive officer of SciSparc from August 2020 to January 2022.
He also previously served as chairman of the board of directors of Value Capital One Ltd. (previously P.L.T Financial Services Ltd.) (TASE:&#160;VALU)
from April&#160;2016 to February&#160;2021 and of Matomy Media Group Ltd. (LSE:&#160;MTMY, TASE:&#160;MTMY.TA) from May&#160;2020 to March&#160;2021.
In April&#160;2016, Mr.&#160;Weiss founded Amitay Weiss Management Ltd., an economic consulting company, and now serves as its chief executive
officer. Mr.&#160;Weiss holds a B.A in economics from New England College, an M.B.A. in business administration and an LL.B. from Ono
Academic College, Israel. We believe that Mr.&#160;Weiss is qualified to serve as a member of our board of directors because of his diverse
business, management and leadership experience.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Tomer Etzyoni, External Director</b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mr.&#160;Etzyoni has served
as one of our external directors since August&#160;2022. Mr.&#160;Etzyoni has served as a fitness and health instructor at Wingate College
since September&#160;2016, professional course, as workshop instructor at Wingate College since March&#160;2012 and as therapist at Dr.&#160;Gill
Solberg&#8217;s Muscle and Motion Clinic since January&#160;2012. Mr. Etzyoni previously served as fitness and health instructor and diagnostician
at Wingate College, Si&#8217;im Campus from August&#160;2012 to July&#160;2016. Mr.&#160;Etzyoni holds a B.A in Physical Education and
Movement, majoring in posture from Kibbutzim College, Israel, a certificate in gym and health clubs instructor from Wingate Institute,
Israel, posture and kinesiology specialty certificate from Wingate Institute, Israel, Yir Karni&#8217;s neuration course, Wingate Institute,
Israel, Thai stretches course, from Broshim Campus, Israel athletics instructor certificate from Kibbutzim College, Israel and a certificate
in ergonomics and posture specialty from Kibbutzim College, Israel. We believe that Mr.&#160;Etzyoni is qualified to serve as a member
of our board of directors because of his diverse fitness and health knowledge and his vast experience in fitness and health&#160;&#8212;&#160;issues
that are related to the brands we sell or will sell in the future.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b>Asaf Itzhaik, External Director</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 36pt">Mr.&#160;Itzhaik has served
as one of our external directors since August&#160;2022. Mr.&#160;Itzhaik has served as the chief executive officer of A.K.A Optics Ltd.,
a manufacturer of adaptive optics, since 1994 and as a member of the board of directors of A.K.A Optics Ltd. since 1998. Mr.&#160;Itzhaik
has also served as a member of the board of directors of Tzmicha Ltd. since August&#160;2021 and as a member of the board of directors
of Gix Internet Ltd. since August&#160;2021. Mr.&#160;Itzhaik is a certified optometrist and graduated a program in corporate board leadership
in Merkaz Hashilton Hamkomi, Israel. We believe that Mr.&#160;Itzhaik is qualified to serve as a member of our board of directors because
of his diverse business experience and leadership skills.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 73; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Family Relationships</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no family relationships
between any members of our executive management and our directors.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Arrangements for Election of Directors
and Members of Management</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no arrangements
or understandings with major shareholders, customers, suppliers or others pursuant to which any of our executive management or our directors
were selected. See &#8220;Related Party Transactions&#8221; for additional information.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><div><a id="a_026"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left">B.</td><td style="text-align: justify">Compensation</td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table presents
in the aggregate all compensation we paid to all of our directors and senior management as a group for the year ended December 31, 2022.
The table does not include any amounts we paid to reimburse any of such persons for costs incurred in providing us with services during
this period.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All amounts reported in the
tables below reflect the cost to the Company, in thousands of U.S. dollars, for the year ended December 31, 2022. Amounts paid in NIS
are translated into U.S. dollars at the rate of NIS 3.36 = U.S. $1.00, based on the average representative rate of exchange between the
NIS and the U.S. dollar as reported by the Bank of Israel during such period of time.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Salary, <br/> bonuses and <br/> Related <br/> Benefits</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Pension, <br/> Retirement <br/> and Other <br/> Similar
    <br/> Benefits</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share
    <br/> Based <br/> Compensation<sup>(1)</sup></b></span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    directors and senior management as a group, consisting of&#160;13 persons for the year ended December 31, 2022<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">851,648</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">62,728</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0in">&#160;</td>
    <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) </span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes Haim Ratzabi who
    served as Chief Financial Officer from May 23, 2021 until May 31, 2022 and Moran Shamian who served as Chief Financial Officer from
    May 31, 2022 until October 24, 2022. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For so long as we qualify
as a foreign private issuer, we will not be required to comply with the proxy rules applicable to U.S. domestic companies regarding disclosure
of the compensation of certain executive officers on an individual basis. In accordance with the Israeli Companies Law, we are required
to disclose the compensation granted to our five most highly compensated officers. The table below reflects the compensation granted
during or with respect to the year ended December 31, 2022.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive Officer</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary<br/>
and&#160;Related<br/>
Benefits<sup>(1)</sup></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus<br/>
Payments,<br/>
Benefits <br/>
and<br/>
Perquisites</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share-Based<br/>
Compensation<sup>(2)</sup></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viki Hakmon</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">218,653</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">139,779</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;0</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">358,432</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronen Zalayet <sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,085</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,085</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moran Shamian<sup>(4)</sup></span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73,258</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,782</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103,040</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Naor Bergman</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150,585</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,738</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,324</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haim Ratzabi<sup>(5)</sup></span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,076</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,076</span></td>
    <td>&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents the directors&#8217; and senior management&#8217;s gross salary plus payment of mandatory social benefits made by the company on behalf of such persons. Such benefits may include, to the extent applicable to the executive, payments, contributions and/or allocations for savings funds, education funds (referred to in Hebrew as &#8220;Keren Hishtalmut&#8221;), pension, severance, risk insurances (e.g., life or work disability insurance) and payments for social security.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation includes the cost of our non-cash share-based compensation in 2022.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ronen Zalayet has been serving as Chief Financial
    Officer since October 26, 2022.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moran Shamian served as Chief Financial Officer from May 31, 2022 until October 24, 2022.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haim Ratzabi served as Chief Financial Officer from May 23, 2021 until May 31, 2022.</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 74; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">E<b><i>mployment and Service Agreements with
Executive Officers</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have entered into written
employment and service agreements with each of our executive officers. All of these agreements contain customary provisions regarding
confidentiality of information and assignment of inventions. However, the enforceability of the noncompetition provisions may be limited
under applicable law. In addition, we have entered into our standard form of indemnification agreement, in the form filed as an exhibit
to this Annual Report on Form 20-F, with each of our directors and members of our senior management. Each such indemnification agreement
provides the indemnified person with indemnification to the maximum extent permitted under applicable law and up to a certain amount,
and to the extent that these liabilities are not covered by directors and officers insurance or other indemnification agreement. Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the
Act and is, therefore, unenforceable.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Directors&#8217; Service Contracts</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Other than with respect to
our directors that are also executive officers, we do not have written agreements with any director providing for benefits upon the termination
of his employment with the Company.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Incentive Option Plan</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our 2022 Incentive Option
Plan, or our 2022 Incentive Plan, was approved by our board of directors on January&#160;19, 2022. The 2022 Incentive Plan provides for
the grant of options to our directors, employees, officers, consultants and service providers who are our employees, officers, directors
or consultants, as well as those of our affiliated companies. As of April 10, 2023, no Ordinary Shares had been issued under our 2022 Incentive
Plan and the total number of Ordinary Shares reserved for the exercise of options granted under our 2022 Incentive Plan is 1,307,027.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our 2022 Incentive Plan is
administered by our board of directors, regarding the granting of options and the terms of option grants, including exercise price, method
of payment, vesting schedule, acceleration of vesting and the other matters necessary in the administration of this plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Eligible Israeli employees,
officers and directors, would qualify for provisions of Section&#160;102(b)(2)&#160;of the Israeli Income Tax Ordinance [New Version],
or the Tax Ordinance. Pursuant to such Section&#160;102(b)(2)&#160;of the Tax Ordinance, qualifying options and shares issued upon exercise
of such options are held in escrow and registered in the name of an escrow agent selected by the board of directors. The escrow agent
may not release these options or shares to the holders thereof for two&#160;years from the date of the registration of the options in
the name of the escrow agent. Under Section&#160;102 of the Tax Ordinance, any tax payable by an employee from the grant or exercise
of the options is deferred until the transfer of the options or Ordinary Shares by the escrow agent to the employee or upon the sale
of the options or Ordinary Shares, and gains may qualify to be taxed as capital gains at a rate equal to 25%, subject to compliance with
specified conditions. Under Israeli tax law, Israeli non-employee service providers and controlling shareholders may only be granted
options under Section&#160;3(9)&#160;of the Tax Ordinance, which does not provide the full tax benefits.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a default, our 2022 Incentive
Plan provides that upon termination of employment for any reason, other than in the event of death, retirement, disability or cause,
all unvested options will expire and all vested options will generally be exercisable for 90&#160;days following such termination, subject
to the terms of our 2022 Incentive Plan and the governing option agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 75; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
in the event the engagement is terminated for cause, including, <i>inter alia,</i> due to dishonesty toward the Company or its affiliate,
substantial malfeasance or nonfeasance of duty, unauthorized disclosure of confidential information, and conduct substantially prejudicial
to the business of the Company or affiliate; or any substantial breach by the optionee of his or her employment or service agreement,
all options granted to such optionee, whether vested or unvested, will not be exercisable and will terminate on the date of the termination
of his employment.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon termination of employment
due to death or disability, all the options vested at the time of termination and within 60&#160;days after the date of such termination,
will generally be exercisable for six (6)&#160;months, or such other period as determined by t<span style="font-family: Times New Roman, Times, Serif">he
plan administrator, subject to the terms of our 2022 Incentive Plan and the governing option agreement.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><div><a id="a_027"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left">C.</td><td style="text-align: justify">Board Practices</td>
</tr></table><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Introduction</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">Our board of directors presently
consists of nine members, including our two external directors appointed under the Companies Law. We believe that Tomer Etzyoni, Asaf
Itzhaik and Moshe Revach are &#8220;independent&#8221; for purposes of the Nasdaq listing rules and SEC rules and regulations. Our amended
and restated articles of association provide that the number of board of directors&#8217; members shall be no less than three and not
more than twelve (including the external directors). Pursuant to the Companies Law, the management of our business is vested in our board
of directors. Our board of directors may exercise all powers and may take all actions that are not specifically granted to our shareholders
or to management. Our executive officers are responsible for our&#160;day-to-day management and have individual responsibilities established
by our board of directors. Our Chief Executive Officer is appointed by, and serves at the discretion of, our board of directors, subject
to the employment agreement that we have entered into with him. All other executive officers are appointed by our Chief Executive Officer.
Their terms of employment are subject to the approval of the board of directors&#8217; compensation committee of the board of directors,
and are subject to the terms of any applicable employment agreements that we may enter into with them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each director, except external
directors, will hold office until the annual general meeting of our shareholders for the year in which such director&#8217;s term expires,
unless the tenure of such director expires earlier pursuant to the Companies Law or unless he or she is removed by the holders of at
least 70% of the total voting power of our shareholders or upon the occurrence of certain events, in accordance with the Companies Law
and our amended and restated articles of association. Our amended and restated articles of association provide that the directors are
classified, with respect to the term for which they each severally hold office, into three classes, as nearly equal in number as practicable,
and designated as Class&#160;I, Class&#160;II and Class&#160;III.&#160;The initial Class&#160;I directors shall hold office until the
first annual general meeting to be held in 2023 and until their successors shall have been elected and qualified. The initial Class&#160;II
directors shall hold office until the annual general meeting to be held in 2024 and until their successors shall have been elected and
qualified. The initial Class&#160;III directors shall hold office until the annual general meeting to be held in 2025 and until their
successors shall have been elected and qualified. The Board may assign members of the Board already in office to such classes at the
time such classification becomes effective. If the number of directors is changed, any newly created directors or decrease in directors
must be apportioned by the board among the classes to make them equal in number.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, under certain
circumstances, our amended and restated articles of association allow our board of directors to appoint directors to fill vacancies on
our board of directors or in addition to the acting directors (subject to the limitation on the number of directors), in one of the classes
and until the next annual general meeting according to the appropriate class in which directors may be appointed or terminated. External
directors may be elected for up to two additional three-year terms after their initial three-year term under the circumstances described
below, with certain exceptions as described in &#8220;External Directors&#8221; below. External directors may be removed from office
only under the limited circumstances set forth in the Companies Law. See &#8220;Item 6.C.&#160;Board Practices&#160;&#8212;&#160;External
Directors&#8221; below.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 76; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law,
any shareholder holding at least one percent of our outstanding voting power may ask to add nomination of a director for the approval
of the general meeting of shareholders. However, any such shareholder may make such a nomination only if a written notice of such shareholder&#8217;s
intent to make such nomination has been given to our board of directors. Any such notice must include certain information, including
the consent of the proposed director nominee to serve as our director if elected, and a declaration that the nominee signed declaring
that he or she possesses the requisite skills and has the availability to carry out his or her duties. Additionally, the nominee must
provide details of such skills, and demonstrate an absence of any limitation under the Companies Law that may prevent his or her election,
and affirm that all of the required election-information is provided to us, pursuant to the Companies Law.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law,
our board of directors must determine the minimum number of directors who are required to have accounting and financial expertise. In
determining the number of directors required to have such expertise, our board of directors must consider, among other things, the type
and size of the company and the scope and complexity of its operations. Our board of directors has determined that the minimum number
of directors of our company who are required to have accounting and financial expertise is one.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The board of directors must
elect one director to serve as the chairman of the board of directors to preside at the meetings of the board of directors, and may also
remove that director as chairman. Pursuant to the Companies Law, neither the chief executive officer nor any of his or her relatives
is permitted to serve as the chairman of the board of directors, and a company may not vest the chairman or any of his or her relatives
with the chief executive officer&#8217;s authorities. In addition, a person who reports, directly or indirectly, to the chief executive
officer may not serve as the chairman of the board of directors; the chairman may not be vested with authorities of a person who reports,
directly or indirectly, to the chief executive officer; and the chairman may not serve in any other position in the company or a controlled
company, but he or she may serve as a director or chairman of a controlled company. However, the Companies Law permits a company&#8217;s
shareholders to determine, for a period not exceeding three&#160;years from each such determination or five years following a company&#8217;s
initial public offering, that the chairman or his or her relative may serve as chief executive officer or be vested with the chief executive
officer&#8217;s authorities, and that the chief executive officer or his or her relative may serve as chairman or be vested with the
chairman&#8217;s authorities. Such determination of a company&#8217;s shareholders requires either: (1)&#160;the approval of at least
a majority of the shares of those shareholders present and voting on the matter (other than controlling shareholders and those having
a personal interest in the determination) (shares held by abstaining shareholders shall not be considered); or (2)&#160;that the total
number of shares opposing such determination does not exceed 2% of the total voting power in the company. We refer to this special majority
hereinafter as the Special Majority Approval. The chairman of our board of directors is Mr.&#160;Oz Adler.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The board of directors may,
subject to the provisions of the Companies Law, delegate any or all of its powers to committees of the board, and it may, from time to
time, revoke such delegation or alter the composition of any such committees, subject to certain limitations. Unless otherwise expressly
provided by the board of directors, the committees shall not be empowered to further delegate such powers. The composition and duties
of our audit committee and compensation committee are described below.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The board of directors oversees
how management monitors compliance with our risk management policies and procedures, and reviews the adequacy of the risk management
framework in relation to the risks faced by us. The board of directors is assisted in its oversight role by an internal auditor. The
internal auditor undertakes both regular and ad hoc reviews of risk management controls and procedures, the results of which are reported
to our audit committee.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>&#160;&#160;</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>External Directors</i></b></p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law,
an Israeli company whose shares have been offered to the public or whose shares are listed for trading on a stock exchange in or outside
of Israel is required to appoint at least two external directors to serve on its board of directors. External directors must meet stringent
standards of independence. On September&#160;29, 2022, we convened a Special General Meeting of Shareholders in which the Company&#8217;s
shareholders appointed Tomer Etzyoni and Asaf Itzhaik to serve as external directors on our board of directors for a three-year term.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">According to regulations
promulgated under the Companies law, at least one of the external directors is required to have &#8220;financial and accounting expertise,&#8221;
and the other external director or directors are required to have &#8220;professional expertise.&#8221; Our board of directors has determined
that Asaf Itzhaik has accounting and financial expertise.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 77; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A director with accounting
and financial expertise is a director who, due to his or her education, experience and skills, possesses a high degree of proficiency
in, and an understanding of, business&#160;&#8212;&#160;accounting matters and financial statements, such that he or she is able to understand
the financial statements of the company in depth and initiate a discussion about the manner in which financial data is presented. A director
is deemed to have &#8220;professional expertise&#8221; if he or she holds an academic degree in certain fields or has at least five&#160;years
of experience in certain senior positions.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">External directors are elected
by a majority vote at a shareholders&#8217; meeting, as long as either:</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">at least a majority
                                            of the shares held by shareholders who are not controlling shareholders and do not have personal
                                            interest in the appointment (excluding a personal interest that did not result from the shareholder&#8217;s
                                            relationship with the controlling shareholder) have voted in favor of the proposal (shares
                                            held by abstaining shareholders shall not be considered); which we refer to as a disinterested
                                            majority; or</td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the total number
                                            of shares voted by non-controlling shareholders and by shareholders who do not have a personal
                                            interest in the election of the external director, against the election of the external director,
                                            does not exceed 2% of the aggregate voting rights of the company.</td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The term &#8220;control&#8221;
is defined in the Companies Law as the ability to direct the activities of the company, other than by virtue of being an office holder.
A shareholder is presumed to be a controlling shareholder if the shareholder &#8220;holds&#8221; (within the meaning of the Companies
Law) 50% or more of the voting rights in a company or has the right to appoint 50% or more of the directors of the company or its general
manager. With respect to certain matters, a controlling shareholder is deemed to include a shareholder that holds 25% or more of the
voting rights in a public company if no other shareholder holds more than 50% of the voting rights in the company, but excludes a shareholder
whose power derives solely from his or her position as a director of the company or from any other position with the company. For the
purpose of determining the holding percentage stated above, two or more shareholders who have a personal interest in a transaction that
is brought for the company&#8217;s approval are deemed as joint holders.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law provides
for an initial three-year term for an external director. Thereafter, an external director may be re-elected by shareholders to serve
in that capacity for up to two additional three-year terms, provided that:</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">his or her service
                                            for each such additional term is recommended by one or more shareholders holding at least
                                            one percent of the company&#8217;s voting rights and is approved at a shareholders meeting
                                            by a disinterested majority, where the total number of shares held by non-controlling, disinterested
                                            shareholders voting for such re-election exceeds two percent of the aggregate voting rights
                                            in the company and subject to additional restrictions set forth in the Companies Law with
                                            respect to the affiliation of the external director nominee as described below;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">his or her service
                                            for each such additional term is recommended by the board of directors and is approved at
                                            a shareholders meeting by the same majority required for the initial election of an external
                                            director (as described above); or</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">the external director
                                            offered his or her service for each such additional term and was approved in accordance with
                                            the provisions of section (1)&#160;above.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The term of office for external
directors for Israeli companies traded on certain foreign stock exchanges, including the Nasdaq listing, may be extended indefinitely
in increments of additional three-year terms, in each case provided that the audit committee and the board of directors of the company
confirm that, in light of the external director&#8217;s expertise and special contribution to the work of the board of directors and
its committees, the re-election for such additional period(s)&#160;is beneficial to the company, and provided that the external director
is re-elected subject to the same shareholder vote requirements for the re-election of external directors (as described above). Prior
to the approval of the reelection- of the external director at a general shareholders meeting, the company&#8217;s shareholders must
be informed of the term previously served by him or her and of the reasons why the board of directors and audit committee recommended
the extension of his or her term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 78; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Companies Law provides
that a person is not qualified to serve as an external director if (i)&#160;the person is a relative of a controlling shareholder of
the company, or (ii)&#160;if that person or his or her relative, partner, employer, another person to whom he or she was directly or
indirectly subordinate, or any entity under the person&#8217;s control, has or had, during the two&#160;years preceding the date of appointment
as an external director: (a)&#160;any affiliation or other disqualifying relationship with the company, with any person or entity controlling
the company or a relative of such person, or with any entity controlled by or under common control with the company; or (b)&#160;in the
case of a company with no shareholder holding 25% or more of its voting rights, had at the date of appointment as an external director,
any affiliation or other disqualifying relationship with a person then serving as chairman of the board or chief executive officer, with
a holder of 5% or more of the issued share capital or voting power in the company or with the most senior financial officer.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The term &#8220;relative&#8221;
is defined under the Companies Law as a spouse, sibling, parent, grandparent or descendant; spouse&#8217;s sibling, parent or descendant;
and the spouse of each of the foregoing persons.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law,
the term &#8220;affiliation&#8221; and the similar types of disqualifying relationships include (subject to certain exceptions):</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">an employment relationship;</td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">a business or professional
                                            relationship even if not maintained on a regular basis (excluding insignificant relationships);</td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">control; and</td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">service as an office
                                            holder, excluding service as a director in a private company prior to the initial public
                                            offering of its shares if such director was appointed as a director of the private company
                                            in order to serve as an external director following the initial public offering.</td>
</tr></table><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The term &#8220;office holder&#8221;
is defined under the Companies Law as a general manager, chief business manager, deputy general manager, vice general manager, any other
person assuming the responsibilities of any of these positions regardless of that person&#8217;s title, a director and any other manager
directly subordinate to the general manager.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, no person may
serve as an external director if that person&#8217;s position or professional or other activities create, or may create, a conflict of
interest with that person&#8217;s responsibilities as a director or otherwise interfere with that person&#8217;s ability to serve as
a director or if the person is an employee of the Israel Securities Authority or of an Israeli stock exchange. A person may furthermore
not continue to serve as an external director if he or she received direct or indirect compensation from the company including amounts
paid pursuant to indemnification and/or exculpation contracts or commitments and insurance coverage, other than for his or her service
as an external director as permitted by the Companies Law and the regulations promulgated thereunder.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Following the termination
of an external director&#8217;s service on a board of directors, such former external director and his or her spouse and children may
not be provided a direct or indirect benefit by the company, its controlling shareholder or any entity under its controlling shareholder&#8217;s
control. This includes engagement as an office holder or director of the company or a company controlled by its controlling shareholder
or employment by, or provision of services to, any such company for consideration, either directly or indirectly, including through a
corporation controlled by the former external director. This restriction extends for a period of two&#160;years with regard to the former
external director and his or her spouse or child and for one year with respect to other relatives of the former external director.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">External directors may be
removed only by a special general meeting of shareholders called by the board of directors after the board has determined the occurrence
of circumstances allow such dismissal, at the same special majority of shareholders required for their election or by a court, only under
limited circumstances, including if the external directors cease to meet the statutory qualifications for their appointment or if they
violate their duty of loyalty to our company. An external director may also be removed by order of an Israeli court if, following a request
made by a director or shareholder of the company, the court finds that such external director has ceased to meet the statutory qualifications
for his or her appointment as stipulated in the Companies Law or has violated his or her duty of loyalty to the company. In the event
of a vacancy created by an external director which causes the company to have fewer than two external directors, the board of directors
is required under the Companies Law to call a shareholders meeting as soon as possible to appoint a replacement external director. Each
committee of the board of directors that exercises the powers of the board of directors must include at least one external director,
except that the audit committee and the compensation committee must include all external directors then serving on the board of directors
and an external director must serve as chair thereof.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 79; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under the Companies Law,
external directors of a company are prohibited from receiving, directly or indirectly, any compensation from the company other than for
their services as external directors pursuant to the Companies Law and the regulations promulgated thereunder. Compensation of an external
director is determined prior to his or her appointment in accordance with regulations adopted under the Companies Law and may not be
changed during his or her term subject to certain exceptions.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If at the time at which an
external director is appointed all members of the board of directors who are not controlling shareholders or relatives of controlling
shareholders of the company are of the same gender, the external director to be appointed must be of the other gender. A director of
a company may not be appointed as an external director of another company if at the same time a director of such other company is acting
as an external director of the first company.</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>

</div><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under regulations promulgated
pursuant to the Companies Law, a company with no controlling shareholder whose shares are listed for trading on specified exchanges outside
of Israel, including Nasdaq, may adopt exemptions from various corporate governance requirements of the Companies Law, so long as such
company satisfies the requirements of applicable foreign country laws and regulations, including applicable stock exchange rules, that
apply to companies organized in that country and relating to the appointment of independent directors and the composition of audit and
compensation committees. Such exemptions include an exemption from the requirement to appoint external directors and the requirement
that an external director be a member of certain committees, as well as exemption from limitations on directors&#8217; compensation.
We may use these exemptions in the future if we do not have a controlling shareholder.</p><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Unaffiliated
Directors Under the Companies Law</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
&#8220;unaffiliated director&#8221; is either an external director or a director who (i) meets the same non-affiliation criteria as an
external director, except for (y)&#160;the requirement that the director be an Israeli resident (which does not apply to companies such
as ours whose securities have been offered outside of Israel or are listed outside of Israel) and (z)&#160;the requirement for accounting
and financial expertise or professional qualifications, as determined by the audit committee, and (ii) who has not served as a director
of the company for more than nine consecutive&#160;years. For these purposes, ceasing to serve as a director for a period of two&#160;years
or less would not be deemed to sever the consecutive nature of such director&#8217;s service.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulations
promulgated pursuant to the Companies Law provide that a director in a public company whose shares are listed for trading on specified
exchanges outside of Israel, including Nasdaq, who qualifies as an independent director under the relevant non-Israeli rules and who
meets certain non-affiliation criteria, which are less stringent than those applicable to unaffiliated directors as set forth above,
would be deemed an &#8220;unaffiliated&#8221; director pursuant to the Companies Law provided: (i)&#160;he or she has not served as a
director for more than nine consecutive&#160;years; (ii)&#160;he or she has been approved as such by the audit committee; and (iii)&#160;his
or her remuneration shall be in accordance with the Companies Law and the regulations promulgated thereunder. For these purposes, ceasing
to serve as a director for a period of two&#160;years or less would not be deemed to sever the consecutive nature of such director&#8217;s
service.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
pursuant to these regulations, such company may reappoint a person as an unaffiliated director for additional terms, beyond nine&#160;years,
which do not exceed three&#160;years each, if each of the audit committee and the board of directors determine, in that order, that in
light of the unaffiliated director&#8217;s expertise and special contribution to the board of directors and its committees, the reappointment
for an additional term is in the company&#8217;s best interest.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Alternate
Directors</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated articles of association provide, as allowed by the Companies Law, that any director may, subject to the conditions
set thereto including approval of the nominee by our board of directors, appoint a person as an alternate to act in his place, to remove
the alternate and appoint another in his place and to appoint an alternate in place of an alternate whose office is vacated for any reason
whatsoever. Under the Companies Law, a person who is not qualified to be appointed as a director, a person who is already serving as
a director or a person who is already serving as an alternate director for another director, may not be appointed as an alternate director.
Nevertheless, a director who is already serving as a director may be appointed as an alternate director for a member of a committee of
the board of directors so long as he or she is not already serving as a member of such committee, and if the alternate director is to
replace an external director, he or she is required to be an external director and to have either &#8220;financial and accounting expertise&#8221;
or &#8220;professional expertise,&#8221; depending on the qualifications of the external director he or she is replacing. A person who
does not have the requisite &#8220;financial and accounting experience&#8221; or the &#8220;professional expertise,&#8221; depending
on the qualifications of the external director he or she is replacing, may not be appointed as an alternate director for an external
director. A person who is not qualified to be appointed as an unaffiliated director, pursuant to the Companies Law, may not be appointed
as an alternate director of an unaffiliated director qualified as such under the Companies Law. Unless the appointing director limits
the time or scope of the appointment, the appointment is effective for all purposes until the appointing director ceases to be a director
or terminates the appointment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 80; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Committees
of the Board of Directors</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has established two standing committees, the audit committee and the compensation committee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit committee is composed of Moshe Revach, Asaf Itzhaik and Tomer Etzyoni. Asaf Itzhaik is the chairman of the audit committee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Companies
Law Requirements </i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, we are required to appoint an audit committee. The audit committee must be composed of at least three directors, including
all of the external directors (one of whom must serve as chair of the committee). The audit committee may not include the chairman of
the board; a controlling shareholder of the company or a relative of a controlling shareholder; a director employed by or providing services
on a regular basis to the company, to a controlling shareholder or to an entity controlled by a controlling shareholder; or a director
who derives most of his or her income from a controlling shareholder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, a majority of the members of the audit committee of a publicly traded company must be &#8220;unaffiliated directors&#8221;
under the Companies Law. Each member of our audit committee is an unaffiliated director under the Companies Law, thereby fulfilling the
foregoing Israeli law requirement for the composition of the audit committee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Audit
Committee Role</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, our audit committee will be responsible for:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
                                            whether there are deficiencies in the business management practices of our company, and making
                                            recommendations to the board of directors to improve such practices;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
                                            whether to approve certain related party transactions (including transactions in which an
                                            office holder has a personal interest and whether such transaction is extraordinary or material
                                            under Companies Law) and establishing the approval process for certain transactions with
                                            a controlling shareholder or in which a controlling shareholder has a personal interest.
                                            See &#8220;Item 6.C. Board Practices&#160;&#8212;&#160;Fiduciary Duties and Approval of Related
                                            Party Transactions under Israeli law&#8221; for additional information;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
                                            the approval process for transactions that are &#8220;non-negligible&#8221; (i.e., transactions
                                            with a controlling shareholder that are classified by the audit committee as non-negligible,
                                            even though they are not deemed extraordinary transactions), as well as determining which
                                            types of transactions would require the approval of the audit committee, optionally based
                                            on criteria which may be determined annually in advance by the audit committee;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">examining
                                            our internal controls and internal auditor&#8217;s performance, including whether the internal
                                            auditor has sufficient resources and tools to dispose of its responsibilities;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">examining
                                            the scope of our auditor&#8217;s work and compensation and submitting a recommendation with
                                            respect thereto to our board of directors or shareholders, depending on which of them is
                                            considering the appointment of our auditor;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
                                            procedures for the handling of employees&#8217; complaints as to deficiencies in the management
                                            of our business and the protection to be provided to such employees; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">where
                                            the board of directors approves the working plan of the internal auditor, examining such
                                            working plan before its submission to the board of directors and proposing amendments thereto.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit committee may not conduct any discussions or approve any actions requiring its approval. See &#8220;Item 6.C.&#160; Board Practices&#160;&#8212;&#160;Fiduciary
Duties and Approval of Related Party Transactions under Israeli law&#8221; for additional information, unless at the time of the approval
a majority of the committee&#8217;s members are present, which majority consists of unaffiliated directors under the Companies Law, including
at least one external director.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 81; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors adopted an audit committee charter which was effective upon the listing of our Ordinary Shares on Nasdaq setting forth,
among others, the responsibilities of the audit committee consistent with the rules of the SEC and Nasdaq listing rules (in addition
to the requirements for such committee under the Companies Law), including, among others, the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">oversight
                                            of our independent registered public accounting firm and recommending the engagement, compensation
                                            or termination of engagement of our independent registered public accounting firm to the
                                            board of directors in accordance with Israeli law;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
                                            the engagement or termination of the person filling the office of our internal auditor, reviewing
                                            the services provided by our internal auditor and reviewing effectiveness of our system of
                                            internal control over financial reporting;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
                                            the terms of audit and non-audit services provided by the independent registered public accounting
                                            firm for pre-approval by our board of directors; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and monitoring, if applicable, legal matters with significant impact, finding of regulatory
                                            authorities&#8217; findings, receive reports regarding irregularities and legal compliance,
                                            acting according to &#8220;whistleblower policy&#8221; and recommend to our board of directors
                                            if so required.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nasdaq
Listing Rules for Audit Committee</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Nasdaq listing rules, we are required to maintain an audit committee consisting of at least three members, all of whom are independent
and are financially literate and one of whom has accounting or related financial management expertise.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
noted above, the members of our audit committee include Asaf Itzhaik and Tomer Etzyoni, who are external directors, and Moshe Revach,
each of whom is &#8220;independent,&#8221; as such term is defined in under Nasdaq listing rules and Rule&#160;10A-3 under the Exchange&#160;Act.
All members of our audit committee meet the requirements for financial literacy under the Nasdaq listing rules. Our board of directors
has determined that Moshe Revach is an audit committee financial expert as defined by the SEC rules and has the requisite financial experience
as defined by the Nasdaq listing rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Committee </i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation committee is composed of Moshe Revach, Tomer Etzyoni and Asaf Itzhaik. Asaf Itzhaik is the chairman of the compensation
committee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Companies
Law Requirements </i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, the board of directors of any public company must establish a compensation committee. The compensation committee must
be composed of at least three directors, including all of the external directors, who must constitute a majority of the members of the
compensation committee. The chairman of the compensation committee must be an external director. Each compensation committee member that
is not an external director must be a director whose compensation is determined pursuant to the Companies Law Regulations. The compensation
committee is subject to the same Companies Law restrictions as the audit committee as to: (a)&#160;who may not be a member of the committee;
and (b)&#160;who may not be present during committee deliberations as described above.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation committee acts pursuant to a written charter. Our compensation committee complies with the provisions of the Companies Law,
the regulations promulgated thereunder, and our amended and restated articles of association, on all aspects referring to its independence,
authorities and practice. Our compensation committee follows home country practice as opposed to complying with the compensation committee
membership and charter requirements prescribed under the Nasdaq listing rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nasdaq
Listing Rules for Compensation Committee</i></b>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the corporate governance rules of Nasdaq, we are required to maintain a compensation committee consisting of at least two independent
directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 82; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has determined that each member of our compensation committee is independent under the corporate governance rules
of Nasdaq, including the additional independence considerations applicable to the members of a compensation committee.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Committee Role</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation committee reviews and recommends to our board of directors: with respect to our executive officers&#8217; and directors&#8217;:
(1)&#160;annual base compensation (2)&#160;annual incentive bonus, including the specific goals and amounts; (3)&#160;equity compensation;
(4)&#160;employment agreements, severance arrangements, and change in control agreements and provisions; (5)&#160;retirement grants and/or
retirement bonuses; and (6)&#160;any other benefits, compensation, compensation policies or arrangements.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
duties of the compensation committee include the recommendation to the company&#8217;s board of directors of a policy regarding the terms
of engagement of office holders, to which we refer as a compensation policy. Such policy must be adopted by the company&#8217;s board
of directors, after considering the recommendations of the compensation committee. The compensation policy is then brought for approval
by our shareholders, which requires the approval of a special majority. See &#8220;Item 6.C.&#160;&#8212;&#160;Board Practices&#160;&#8212;&#160;Fiduciary
Duties and Approval of Related Party Transactions under Israeli law&#8221; for additional information. Under the Companies Law, the board
of directors may adopt the compensation policy if it is not approved by the shareholders, provided that after the shareholders oppose
the approval of such policy, the compensation committee and the board of directors revisit the matter and determine that adopting the
compensation policy would be in the best interests of the company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a company that initially offers its securities to the public, like us, adopts a compensation policy in advance of its initial public
offering, and describes it in its prospectus for such offering, then such compensation policy shall be deemed a validly adopted policy
in accordance with the Companies Law requirements described above. Furthermore, if the compensation policy is established in accordance
with the aforementioned relief, then it will remain in effect for a term of five years from the date such company becomes a public company.
Accordingly, our compensation policy will remain in effect for five years from our IPO, until August 25, 2027. The compensation policy
must serve as the basis for decisions concerning the financial terms of employment or engagement of executive officers and directors,
including exculpation, insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement.
The compensation policy must relate to certain factors, including advancement of the company&#8217;s objectives, the company&#8217;s
business and its long-term strategy, and creation of appropriate incentives for office holders. It must also consider, among other things,
the company&#8217;s risk management, size and the nature of its operations. The compensation policy must furthermore consider the following
additional factors:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            education, skills, expertise and accomplishments of the relevant officer holder;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            officer holder&#8217;s roles and responsibilities and prior compensation agreements with
                                            him or her;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            relationship between the cost of the terms of service of an office holder and the average
                                            median compensation of the other employees of the company (including those employed through
                                            manpower companies), in particular the ratio between such cost to the average and median
                                            salary of such employees of the company including the impact of disparities in salary upon
                                            work relationships in the company;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            the terms of employment include variable components the possibility of reducing variable
                                            compensation at the discretion of the board of directors; and the possibility of setting
                                            a limit on the exercise value of non-cash variable compensation; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            to severance compensation, the period of service of the office holder, the terms of his or
                                            her compensation during such service period, the company&#8217;s performance during that
                                            period of service, the person&#8217;s contribution towards the company&#8217;s achievement
                                            of its goals and the maximization of its profits, and the circumstances under which the person
                                            is leaving the company.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 83; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation policy must also include the following principles:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with
                                            the exception of office holders who report to the chief executive officer, a means of determining
                                            the variable components on the basis of long-term performance and measurable criteria; provided
                                            that the company may determine that an immaterial part of the variable components of the
                                            compensation package of an office holder shall be awarded based on non-measurable criteria,
                                            or if such amount is not higher than three months&#8217; salary per annum, taking into account
                                            such office holder&#8217;s contribution to the company;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            relationship between variable and fixed compensation, and the ceiling for the value of variable
                                            compensation at the time of payment, or in the case of equity-based compensation, at the
                                            time of grant;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            conditions under which an officer holder would be required to repay compensation paid to
                                            him or her if it was later shown that the data upon which such compensation was based was
                                            inaccurate and such data was restated in the company&#8217;s financial statements;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            minimum holding or vesting period for variable, equity-based compensation to be set in the
                                            terms of office or employment, as applicable, while taking into consideration long-term incentives;
                                            and; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">maximum
                                            limits for severance compensation.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation policy must also consider appropriate incentives from a long-term perspective.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation committee is responsible for: (1)&#160;recommending the compensation policy to a company&#8217;s board of directors for
its approval (and subsequent approval by the shareholders); and (2)&#160;duties related to the compensation policy and to the compensation
of a company&#8217;s office holders, including:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
                                            whether a compensation policy should continue in effect, if the then-current policy has a
                                            term of greater than three&#160;years (approval of either a new compensation policy or the
                                            continuation of an existing compensation policy must in any case occur every three&#160;years);</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
                                            to the board of directors periodic updates to the compensation policy;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">assessing
                                            implementation of the compensation policy;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
                                            whether the terms of compensation of certain office holders of the company need not be brought
                                            to approval of the shareholders; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
                                            whether to approve the terms of compensation of office holders that require the committee&#8217;s
                                            approval.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation policy is designed to promote our long-term goals, work plan and policy, retain, motivate and incentivize our directors
and executive officers, while considering the risks that our activities involve, our size, the nature and scope of our activities and
the contribution of an officer to the achievement of our goals and maximization of profits, and align the interests of our directors
and executive officers with our long-term performance. To that end, a portion of an executive officer compensation package is targeted
to reflect our short and long-term goals, as well as the executive officer&#8217;s individual performance. On the other hand, our compensation
policy includes measures designed to reduce the executive officer&#8217;s incentives to take excessive risks that may harm us in the
long-term, such as limits on the value of cash bonuses and equity-based compensation, limitations on the ratio between the variable and
the total compensation of an executive officer and minimum vesting periods for equity-based compensation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation policy also addresses our executive officer&#8217;s individual characteristics (such as his or her respective position,
education, scope of responsibilities and contribution to the attainment of our goals) as the basis for compensation variation among our
executive officers, and considers the internal ratios between compensation of our executive officers and directors and other employees.
Pursuant to our compensation policy, the compensation that may be granted to an executive officer may include: base salary, annual bonuses,
equity-based compensation, benefits and retirement and termination of service arrangements. All cash bonuses are limited to a maximum
amount linked to the executive officer&#8217;s base salary. In addition, our compensation policy provides for maximum permitted ratios
between the total variable (cash bonuses and equity based compensation) and non-variable (base salary) compensation components, in accordance
with an officer&#8217;s respective position with the company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 84; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
annual cash bonus may be awarded to executive officers upon the attainment of pre-set periodic objectives and individual targets. The
annual cash bonus that may be granted to executive officers other than our chairman or Chief Executive Officer may be based entirely
on a discretionary evaluation. Our Chief Executive Officer will be entitled to recommend performance objectives to such executive officers,
and such performance objectives will be approved by our compensation committee (and, if required by law, by our board of directors).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
performance measurable objectives of our chairman and Chief Executive Officer will be determined annually by our compensation committee
and board of directors. A less significant portion of the chairman&#8217;s and/or the Chief Executive Officer&#8217;s annual cash bonus
may be based on a discretionary evaluation of the chairman&#8217;s or the Chief Executive Officer&#8217;s respective overall performance
by the compensation committee and the board of directors based on quantitative and qualitative criteria.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
equity-based compensation under our compensation policy for our executive officers (including members of our board of directors) is designed
in a manner consistent with the underlying objectives in determining the base salary and the annual cash bonus, with its main objectives
being to enhance the alignment between the executive officers&#8217; interests with our long-term interests and those of our shareholders
and to strengthen the retention and the motivation of executive officers in the long term. Our compensation policy provides for executive
officer compensation in the form of share options or other equity-based awards, such as restricted shares and phantom, options, in accordance
with our share incentive plan then in place. Share options granted to executive officers shall be subject to vesting periods in order
to promote long-term retention of the awarded executive officers. The equity-based compensation shall be granted from time to time and
be individually determined and awarded according to the performance, educational background, prior business experience, qualifications,
role and the personal responsibilities of the executive officer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our compensation policy contains compensation recovery provisions which allows us under certain conditions to recover bonuses
paid in excess, enables our Chief Executive Officer to approve an immaterial change in the terms of employment of an executive officer
(provided that the changes of the terms of employment are in accordance our compensation policy) and allows us to exculpate, indemnify
and insure our executive officers and directors subject to certain limitations set forth thereto.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compensation policy also provides for compensation to the members of our board of directors either: (i)&#160;in accordance with the amounts
provided in the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director) of 2000, as amended by
the Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel) of 2000, as such regulations may be
amended from time to time; or (ii)&#160;in accordance with the amounts determined in our compensation policy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Internal
Auditor</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, the board of directors of an Israeli public company must appoint an internal auditor nominated by the audit committee.
The role of the internal auditor is to examine, among other things, whether a company&#8217;s actions comply with the law and proper
business procedure. The audit committee is required to oversee the activities, and to assess the performance of the internal auditor
as well as to review the internal auditor&#8217;s work plan. An internal auditor may not be an interested party or office holder, or
a relative of any interested party or office holder, and may not be a member of the company&#8217;s independent accounting firm or its
representative. The Companies Law defines an interested party as a holder of 5% or more of the outstanding shares or voting rights of
a company, any person or entity that has the right to appoint at least one director or the general manager of the company or any person
who serves as a director or as the general manager of a company. Daniel Shapira from Daniel Shapira Accountants was appointed by the
board of directors on December 13, 2022, to serve as the Internal Auditor of the Company.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Remuneration
of Directors</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, remuneration of directors is subject to the approval of the compensation committee, thereafter by the board of directors
and thereafter, unless exempted under the regulations promulgated under the Companies Law, by the general meeting of the shareholders.
In case the remuneration of the directors is in accordance with regulations applicable to remuneration of the external directors then
such remuneration shall be exempt from the approval of the general meeting. Where the director is also a controlling shareholder, the
requirements for approval of transactions with controlling shareholders apply.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 85; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiduciary
Duties and Approval of Related Party Transactions under Israeli Law</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Fiduciary
Duties of Office Holders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law imposes a duty of care and a duty of loyalty on all office holders of a company. An office holder is defined in the Companies
Law as a general manager, chief business manager, deputy general manager, vice general manager, any other person assuming the responsibilities
of any of these positions regardless of such person&#8217;s title, a director, and any other manager directly subordinate to the general
manager.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
duty of care requires an office holder to act with the level of care with which a reasonable office holder in the same position would
have acted under the same circumstances. The duty of care of an office holder includes a duty to use reasonable means to obtain:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">information
                                            on the advisability of a given action brought for his approval or performed by him by virtue
                                            of his position; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            other important information pertaining to these actions.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
duty of loyalty of an office holder requires an office holder to act in good faith and for the benefit of the company, and includes a
duty to:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain
                                            from any conflict of interest between the performance of his duties in the company and his
                                            performance of his other duties or personal affairs;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain
                                            from any action that is competitive with the company&#8217;s business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">refrain
                                            from exploiting any business opportunity of the company to receive a personal gain for himself
                                            or others; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">disclose
                                            to the company any information or documents relating to the company&#8217;s affairs which
                                            the office holder has received due to his position as an office holder.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Related
Party Transactions</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, we may approve an action by an office holder from which the office holder would otherwise have to refrain, as described
above, if:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            office holder acts in good faith and the act or its approval does not cause harm to the company;
                                            and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            office holder disclosed the nature of his or her interest in the transaction (including any
                                            significant fact or document) to the company sufficient time before the company&#8217;s approval
                                            of such matter.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
such approval is subject to the terms of the Companies Law, setting forth, among other things, the appropriate bodies of the company
required to provide such approval, and the methods of obtaining such approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disclosure
of Personal Interests of an Office Holder</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law requires that an office holder disclose to the company, promptly, and, in any event, not later than the board meeting at
which the transaction is first discussed, any direct or indirect personal interest that he or she may have and all related material information
known to him or her relating to any existing or proposed transaction by the company. A personal interest includes an interest of any
person in an act or transaction of a company, including a personal interest of one&#8217;s relative or of a corporate body in which such
person or a relative of such person is a 5% or greater shareholder, director, or general manager or in which such person has the right
to appoint at least one director or the general manager, but excluding a personal interest stemming solely from one&#8217;s ownership
of shares in the company. A personal interest includes the personal interest of a person for whom the office holder holds a voting proxy
or the personal interest of the office holder with respect to the officer holder&#8217;s vote on behalf of a person for whom he or she
holds a proxy even if such shareholder has no personal interest in the matter.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 86; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law does not specify to whom within us nor the manner in which required disclosures are to be made. We require our office holders
to make such disclosures to our board of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, unless the articles of association of a company provide otherwise, a transaction with an office holder or with a third
party in which the office holder has a personal interest, which is not an extraordinary transaction requires the approval of the board
of directors or a committee authorized by the board of directors. If the transaction is an extraordinary transaction in which an office
holder has a personal interest, first the audit committee and then the board of directors, in that order, must approve the transaction.
Under specific circumstances, shareholder approval may also be required.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, an extraordinary transaction is a transaction:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                            in the ordinary course of business;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">not
                                            on market terms; or</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
                                            is likely to have a material effect on the company&#8217;s profitability, assets or liabilities.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
a person who has a personal interest in a matter which is considered at a meeting of the board of directors or the audit committee may
not be present at such a meeting, or vote on this matter, unless the chairman of the audit committee or board of directors (as applicable)
determines that he or she should be present in order to present the transaction that is subject to approval. A director who has a personal
interest in a transaction, which is considered at a meeting of the board of directors or the audit committee, may not be present at this
meeting or vote on this matter, unless a majority of members of the board of directors or the audit committee, as the case may be, has
a personal interest. If a majority of the board of directors has a personal interest, then shareholder approval is generally also required.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disclosure
of Personal Interests of a Controlling Shareholder</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, certain disclosure requirements also apply to a controlling shareholder of a public company, in which a controlling
shareholder has a personal interest. For these purposes, a controlling shareholder is any shareholder that has the ability to direct
the company&#8217;s actions, including any shareholder holding 25% or more of the voting rights if no other shareholder owns more than
50% of the voting rights in the company. Two or more shareholders with a personal interest in the approval of the same transaction are
deemed to be one shareholder. Extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal
interest, including a private placement in which a controlling shareholder has a personal interest, as well as transactions for the provision
of services whether directly or indirectly by a controlling shareholder or his or her relative, or a company such controlling shareholder
controls, and transactions concerning the terms of engagement and compensation of a controlling shareholder or a controlling shareholder&#8217;s
relative, whether as an office holder or an employee, require the approval of (i) the audit committee or the compensation committee,
as the case may be, (ii) the board of directors and (iii) a majority of the shares voted by the shareholders of the company participating
and voting on the matter in a shareholders&#8217; meeting. In addition, the shareholder approval must fulfill one of the following requirements:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
                                            least a majority of the shares held by shareholders who are not controlling shareholders
                                            and have no personal interest in the transaction and are voting at the meeting must be voted
                                            in favor of approving the transaction, excluding abstentions; or</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            shares voted by shareholders who and non-controlling shareholders and have no personal interest
                                            in the transaction who vote against the transaction represent no more than 2% of the voting
                                            rights in the company.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, any extraordinary transaction with a controlling shareholder or in which a controlling shareholder has a personal interest
with a term of more than three&#160;years requires the abovementioned approval every three&#160;years; however, such transactions not
involving the receipt of services or compensation can be approved for a longer term, provided that the audit committee determines that
such longer term is reasonable under the circumstances. In addition, transactions with a controlling shareholder or a controlling shareholder&#8217;s
relative who serves as an executive officer in a company, directly or indirectly (including through a corporation under his control),
involving the receipt of services by a company or their compensation can have a term of five years from the company&#8217;s initial public
offering under certain circumstances.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 87; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law requires that every shareholder that participates, in person, by proxy or by voting instrument, in a vote regarding a transaction
with a controlling shareholder, must indicate in advance or in the ballot whether or not that shareholder has a personal interest in
the vote in question. Failure to so indicate will result in the invalidation of that shareholder&#8217;s vote for purposes of the Special
Majority Approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Approval
of the Compensation of Directors and Executive Officers</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
compensation of, or an undertaking to indemnify, insure or exculpate, an office holder who is not a director requires the approval of
the company&#8217;s compensation committee, followed by the approval of the company&#8217;s board of directors, and, if such compensation
arrangement or an undertaking to indemnify, insure or exculpate is inconsistent with the company&#8217;s stated compensation policy,
or if the said office holder is the chief executive officer of the company (subject to a number of specific exceptions), then such arrangement
is subject to the approval of our shareholders, subject to the Special Majority Approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Directors.&#160;</i>Under
the Companies Law, the compensation of our directors requires the approval of our compensation committee, the subsequent approval of
the board of directors and, unless exempted under the regulations promulgated under the Companies Law, the approval of the general meeting
of our shareholders. If the compensation of our directors is inconsistent with our stated compensation policy, then, provided that those
provisions that must be included in the compensation policy according to the Companies Law have been considered by the compensation committee
and board of directors, shareholder approval by the Special Majority Approval will be required.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Executive
officers other than the chief executive officer.&#160;</i>The Companies Law requires the approval of the compensation of a public company&#8217;s
executive officers (other than the chief executive officer and who does not also serve as a director) in the following order: (i)&#160;the
compensation committee, (ii)&#160;the company&#8217;s board of directors, and (iii)&#160;only if such compensation arrangement is inconsistent
with the company&#8217;s stated compensation policy, the company&#8217;s shareholders by the Special Majority Approval. However, if the
shareholders of the company do not approve a compensation arrangement with a non-director executive officer that is inconsistent with
the company&#8217;s stated compensation policy, the compensation committee and board of directors may override the shareholders&#8217;
decision if each of the compensation committee and the board of directors provide detailed reasons for their decision.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
amendment to an existing compensation arrangement with a non-director executive officer requires only the approval of the compensation
committee, if the compensation committee determines that the amendment is immaterial. However, if such non-director executive officer
is subordinate to the chief executive officer, an immaterial amendment to an existing compensation arrangement shall not require the
approval of the compensation committee if (i) such amendment is approved by the chief executive officer, (ii) the company&#8217;s compensation
policy allows for such immaterial amendments to be approved by the chief executive officer and (iii) the engagement terms are consistent
with the company&#8217;s compensation policy.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chief
executive officer.&#160;</i>Under the Companies Law, the compensation of a public company&#8217;s chief executive officer is required
to be in the following order approved by: (i)&#160;the company&#8217;s compensation committee; (ii)&#160;the company&#8217;s board of
directors, and (iii)&#160;the company&#8217;s shareholders by a Special Majority Approval (provided that with respect to a Chief Executive
Officer who is also a director of the company, the approval of the shareholders by a simple majority. is required). However, if the shareholders
of the company do not approve the compensation arrangement with the chief executive officer, the compensation committee and board of
directors may override the shareholders&#8217; decision if each of the compensation committee and the board of directors provides detailed
reasons for their decision, provided that the chief executive officer is not also a director of the company. In the case of a new chief
executive officer, the compensation committee may exempt the engagement terms of a candidate to serve as the chief executive officer
from shareholders&#8217; approval, if the compensation committee determines that the compensation arrangement is consistent with the
company&#8217;s stated compensation policy, that the chief executive officer did not have on the date of his appointment or during the
two-year period preceding his appointment, an &#8220;affiliation&#8221; (including an employment relationship, a business or professional
relationship or control) with the company or a controlling shareholder of the company or a relative thereof) and that subjecting the
approval to a shareholder vote would impede the company&#8217;s ability to attain the candidate to serve as the company&#8217;s chief
executive officer (and provide detailed reasons for the latter). However, if the chief executive officer candidate will serve as a member
of the board of directors, such candidate&#8217;s compensation terms as chief executive officer must be approved in accordance with the
rules&#160;applicable to approval of compensation of directors.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 88; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
approval of each of the compensation committee and the board of directors, with regard to the office holders and directors above, must
be in accordance with the company&#8217;s stated compensation policy; however, under special circumstances, the compensation committee
and the board of directors may approve compensation terms of a chief executive officer that are inconsistent with the company&#8217;s
compensation policy provided that they have considered those provisions that must be included in the compensation policy according to
the Companies Law and that shareholder approval was obtained by the Special Majority Approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Duties
of Shareholders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, a shareholder has a duty to refrain from abusing his power in the company and to act in good faith and in an customary
manner in exercising his rights and performing his obligations toward the company and other shareholders, including, among other things,
in voting at general meetings of shareholders (and at shareholder class meetings) on the following matters:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amendment
                                            of the articles of association;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
                                            in the company&#8217;s authorized share capital;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">merger;
                                            and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            approval of related party transactions and acts of office holders that require shareholder
                                            approval.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
shareholder also has a general duty to refrain from oppressing other shareholders. The remedies generally available upon a breach of
contract will also apply to a breach of the above-mentioned duties, and in the event of oppression of other shareholders, additional
remedies are available to the injured shareholder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, any controlling shareholder, any shareholder that knows that its vote can determine the outcome of a shareholder vote and any
shareholder that, under a company&#8217;s articles of association, has the power to appoint or prevent the appointment of an office holder,
or has another power with respect to a company, is under a duty to act with fairness towards the company. The Companies Law does not
describe the substance of this duty except to state that the remedies generally available upon a breach of contract will also apply in
the event of a breach of the duty to act with fairness, taking the shareholder&#8217;s position in the company into account.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exculpation,
Insurance and Indemnification of Directors and Officers </b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Insurance</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
permitted under the Companies Law, a company may obtain insurance for any of its office holders against the following liabilities incurred
due to acts he or she performed as an office holder, if and to the extent provided for in the company&#8217;s articles of association:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">breach
                                            of his or her duty of care to the company or to a third party, including a breach arises
                                            out of the negligent conduct of the office holder;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            breach of his or her duty of loyalty to the company, provided that the office holder acted
                                            in good faith and had reasonable cause to assume that his or her act would not prejudice
                                            the company&#8217;s interests; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            financial liability imposed upon him or her in favor of a third party.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">financial
                                            liability imposed on the office holder in favor of a third-party harmed by a breach in an
                                            administrative proceeding, pursuant to certain provisions of the Israeli Securities Law;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses
                                            incurred or to be incurred by an office holder in connection with an administrative proceeding,
                                            instituted against him or her, pursuant to certain provisions of the Israeli Securities Law,
                                            including reasonable litigation expenses, and including attorneys&#8217; fees; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other event in respect of which it is permitted and/or shall be permitted by Law to insure
                                            the liability of an officeholder.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 89; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated articles of association provide that we may incuse an office holder against the abovementioned liabilities. Accordingly,
we maintain directors&#8217; and officers&#8217; liability insurance, providing total coverage of $5&#160;million for the benefit of
all of our directors and officers, in respect of which we expect to pay a twelve-month premium of approximately $400 thousand, which
expires on August 23, 2023.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Indemnification</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law and the Israeli Securities Law,&#160;5728-1968, or the Securities Law, provide that a company may indemnify an office holder
against the following liabilities and expenses incurred for acts performed by him or her as an office holder, either pursuant to an undertaking
made in advance of an event or following an event, provided its articles of association include a provision authorizing such indemnification:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            financial liability imposed on him or her in favor of another person by any judgment concerning
                                            an act performed in his or her capacity as an office holder, including a settlement or arbitrator&#8217;s
                                            award approved by a court;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable
                                            litigation expenses, including attorneys&#8217; fees, expended by the office holder (a)&#160;as
                                            a result of an investigation or proceeding instituted against him or her by an authority
                                            authorized to conduct such investigation or proceeding, provided that (1)&#160;no indictment
                                            (as defined in the Companies Law) was filed against such office holder as a result of such
                                            investigation or proceeding; and (2)&#160;no financial liability as a substitute for the
                                            criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result
                                            of such investigation or proceeding, or, if such financial liability was imposed, it was
                                            imposed with respect to an offense that does not require proof of criminal intent; or (b)&#160;in
                                            connection with a monetary sanction;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable
                                            litigation expenses, including attorneys&#8217; fees, expended by the office holder or imposed
                                            on him or her by a court: (1)&#160;in proceedings that the company institutes, or that another
                                            person institutes on the company&#8217;s behalf, against him or her; (2)&#160;in a criminal
                                            proceedings of which he or she was acquitted; or (3)&#160;as a result of a conviction for
                                            a crime that does not require proof of criminal intent;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses
                                            incurred by an office holder in connection with an administrative procedure under the Securities
                                            Law, including reasonable litigation expenses and reasonable attorneys&#8217; fees. An &#8220;Administrative
                                            Procedure&#8221; is defined as a procedure pursuant to chapters H3 (Monetary Sanction by
                                            the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative
                                            Enforcement Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures
                                            subject to conditions) to the Securities Law; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other obligation or expense in respect of which it is permitted or will be permitted under
                                            the Companies Law, to indemnify an officer or director, subject to and in accordance with
                                            all applicable law.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law also permits a company to undertake in advance to indemnify an office holder, provided that if such indemnification relates
to financial liability imposed on him or her, as described above, then the undertaking should be limited and shall detail the following
foreseen events and amount or criterion:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
                                            events that in the opinion of the board of directors can be foreseen based on the company&#8217;s
                                            activities at the time that the undertaking to indemnify is made; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
                                            amount or criterion determined by the board of directors, at the time of the giving of such
                                            undertaking to indemnify, to be reasonable under the circumstances.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into our standard form of indemnification agreement, the form of which is filed as an exhibit to this Annual Report on Form
20-F, with each of our directors and with all members of our senior management. Each such indemnification agreement provides the indemnified
person with indemnification to the maximum extent permitted under applicable law and up to a certain amount, and to the extent that these
liabilities are not covered by directors and officers insurance or other indemnification agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 90; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exculpation</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, an Israeli company may not exculpate an office holder from liability for a breach of his or her duty of loyalty, but
may exculpate in advance an office holder from his or her liability to the company, in whole or in part, for damages caused to the company
as a result of a breach of his or her duty of care (other than in relation to distributions), but only if a provision authorizing such
exculpation is included in its articles of association. Our amended and restated articles of association provide that we may exculpate,
in whole or in part, any office holder from liability to us for damages caused to the company as a result of a breach of his or her duty
of care, but prohibit an exculpation from liability arising from a company&#8217;s transaction in which our controlling shareholder or
officer has a personal interest. Subject to the aforesaid limitations, under the indemnification agreements, we exculpate and release
our office holders from any and all liability to us related to any breach by them of their duty of care to us to the fullest extent permitted
by law. An Israeli company may not exculpate in advance a director from liability arising from a breach of his or her duty of care in
connection with a prohibited dividend or distribution to shareholders.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Limitations</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law provides that we may not exculpate or indemnify an office holder nor enter into an insurance contract that would provide
coverage for any liability incurred as a result of any of the following: (1)&#160;a breach by the office holder of his or her duty of
loyalty except for indemnification and insurance for a breach of loyalty to the extent the office holder acted in good faith and had
a reasonable basis to believe that the act would not prejudice us; (2)&#160;a breach by the office holder of his or her duty of care
if the breach was carried out intentionally or recklessly (as opposed to merely negligently); (3)&#160;any act or omission committed
with the intent to derive an illegal personal benefit; or (4)&#160;any fine, monetary sanction, penalty or forfeit levied against the
office holder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Companies Law, exculpation, indemnification and insurance of office holders in a public company must be approved by the compensation
committee and the board of directors and, with respect to directors, the chief executive officer or controlling shareholders, their relatives
and third parties in which controlling shareholders have a personal interest, also by the shareholders. However, under regulations promulgated
under the Companies Law, the insurance of office holders shall not require shareholder approval and may be approved by only the compensation
committee if the engagement terms are determined in accordance with the company&#8217;s compensation policy, which was approved by the
shareholders by the same special majority required to approve a compensation policy, provided that the insurance policy is on market
terms and the insurance policy is not likely to materially impact the company&#8217;s profitability, assets, or obligations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated articles of association permit us to exculpate (subject to the aforesaid limitation), indemnify and insure our office
holders to the fullest extent permitted or to be permitted by the Companies Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions summarize the material aspects and practices of our board of directors. For additional details, we also refer
you to the full text of the Companies Law, as well as of our amended and restated articles of association, which are filed as exhibits
to this Annual Report on Form 20-F and are incorporated herein by reference.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this Annual Report on Form 20-F, no claims for directors&#8217; and officers&#8217; liability insurance have been filed
under this policy and we are not aware of any pending or threatened litigation or proceeding involving any of our office holders, including
our directors, in which indemnification is sought.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_028"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees</span></td>
</tr></table><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of April 10, 2023, we had
nine full-time employees and two part time employee. None of our employees are members of a union or subject to the terms of a collective
bargaining agreement.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 91; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to increase the number of warehouses we use as discussed above, as well as, the number of employees and independent contractors,
which is expected to grow as we expand our business.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our employees are members of a union or subject to the terms of a collective bargaining agreement. However, in Israel, we are subject
to certain Israeli Labor laws, regulations and national labor court precedent rulings, as well as certain provisions of collective bargaining
agreements applicable to us by virtue of extension orders issued in accordance with relevant labor laws by the Israeli Industry and Economy
Office, and which apply such agreement provisions to our employees even though they are not part of a union that has signed a collective
bargaining agreement. We have never experienced labor related work stoppages&#160;or strikes and believe that our relations with our
employees are good.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our employment and consulting agreements include the employee&#8217;s and consultant&#8217;s undertaking with respect to assignment
to us of intellectual property rights developed in the course of employment and confidentiality provisions. The enforceability of such
provisions may be limited by Israeli law.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_029"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            Ownership</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Item 7.A. Major Shareholders&#8221; below.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_030"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
                                            of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_031"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</b></span></p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_032"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Major
                                            Shareholders</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
information regarding beneficial ownership of our Ordinary Shares as of April 10, 2023 by:</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    person, or group of affiliated persons, known to us to be the beneficial owner of more than 5% of our outstanding Ordinary Shares;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
    of our directors, and executive officers; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    of our directors, and executive officers as a group.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Beneficial ownership is determined in accordance with the rules of
the SEC and includes voting or investment power with respect to Ordinary Shares. Ordinary Shares issuable pursuant to outstanding options
or warrants to purchase Ordinary Shares that are exercisable, or securities that are convertible into Ordinary Shares, within 60 days
after April 10, 2023, are deemed outstanding for the purpose of computing the percentage ownership of the person holding the options,
warrants or convertible securities, but are not deemed outstanding for the purpose of computing the percentage ownership of any other
person. Percentage of shares beneficially owned is based on 8,321,632 Ordinary Shares outstanding on April 10, 2023.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not controlled by another corporation, by any foreign government or by any natural or legal persons except as set forth herein, and
there are no arrangements known to us which would result in a change in control of our company at a subsequent date. Except as indicated
in footnotes to this table, we believe that the shareholders named in this table have sole voting and investment power with respect to
all shares shown to be beneficially owned by them, based on information provided to us by such shareholders. Unless otherwise noted below,
each beneficial owner&#8217;s address is c/o Jeffs&#8217; Brands Ltd, 7 Mezada Street, Bnei Brak, Israel 5126112.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 92; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">No.&#160;of&#160;Shares Beneficially
    Owned</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"></td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percentage Owned</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Holders of 5% or more of our voting securities:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medigus Ltd.<sup>(1)(2)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">3,382,905</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">38.43</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viki Hakmon<sup>*(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,468,578</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">17.65</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.I.A.&#160;Pure Capital Ltd.<sup>(4)(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,352,142</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.99</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-align: left">Directors and named executive officers who are not 5% holders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Liron Carmel</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Eliyahu Yoresh</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tali Dinar</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Moshe Revach</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Ronen Zalayet</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Naor Bergman</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oz Adler<sup>(6)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,808</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.06</td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Amitay Wiess</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tomer Etzyoni</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Assaf Itzhaik</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">All directors and executive officers as a group (11 persons)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,606,178</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">66.13</td><td style="text-align: left">%</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
                                            officer and/or director of the Company.</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            Warrants to purchase up to 240,385&#160;Ordinary Shares and Additional Warrants to purchase
                                            up to 240,385 Ordinary Shares that are exercisable within 60&#160;days, at an exercise price
                                            of $2.02 per Ordinary Share following the Exercise Price Adjustment (see &#8220;Description
                                            of Share Capital&#160;&#8212;&#160;Warrants&#8221; for additional information).</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            on Schedule&#160;13D filed with the SEC on September&#160;13, 2022, Medigus has sole voting
                                            and dispositive power over all Ordinary Shares shown to be beneficially owned by it. The
                                            mailing address of Medigus is Omer Industrial Park No. 7A, P.O.&#160;Box 3030, 8496500, Israel.
                                            Medigus is a publicly traded company. To the best of our knowledge, no person has sole voting
                                            and sole investment power with respect to the shares.</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            on Schedule 13D/A filed with the SEC on November 8, 2022, Viki Hakmon has sole voting and
                                            dispositive power over all Ordinary Shares shown to be beneficially owned by it. The mailing
                                            address of Viki Hakmon is 7 Mezada Street, Bnei Brak, Israel 5126112.</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            Warrants to purchase up to 114,800 Ordinary Shares and Additional Warrants to purchase up
                                            to180,288&#160;Ordinary Shares exercisable within 60&#160;days, at an exercise price of $2.02
                                            per Ordinary Share following the Exercise Price Adjustment (see &#8220;Description of Share
                                            Capital&#160;&#8212;&#160;Warrants&#8221; for additional information), and an option to purchase
                                            up to 602,255&#160;Ordinary Shares, or the Call Option, exercisable within 60&#160;days,
                                            granted to Pure Capital pursuant to a Call Option Agreement with Viki Hakmon, dated November&#160;14,
                                            2021, or the Call Option Agreement.</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
                                            on Schedule&#160;13G filed with the SEC on September&#160;29, 2022 by Pure Capital, Kfir
                                            Silberman is the officer, sole director, chairman of the board of directors and control shareholder
                                            of Pure Capital, and has sole voting and dispositive power over all Ordinary Shares shown
                                            to be beneficially owned by Pure Capital. The mailing address of Pure Capital Ltd. and Kfir
                                            Silberman is 20 Raoul Wallenberg Street, Tel Aviv, Israel 6971916.</span></td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            Warrants to purchase up to 2,404&#160;Ordinary Shares exercisable within 60&#160;days, at
                                            an exercise price of $2.02 per Ordinary Share following the Exercise Price Adjustment (see
                                            &#8220;Description of Share Capital&#160;&#8212;&#160;Warrants&#8221; for additional information).</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Significant Changes in Percentage Ownership
by Major Shareholders</i></b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May&#160;10, 2021, pursuant to the SEA, Smart Repair Pro and Purex become wholly-owned&#160;subsidiaries of Jeffs&#8217; Brands. Pursuant
to the SEA, following the Contribution Transactions, Jeffs&#8217; Brands held all of the outstanding shares of Smart Repair Pro and Purex,
Medigus held 50.03% of our outstanding Ordinary Shares and Mr.&#160;Hakmon, our Chief Executive Officer, held the remaining 49.97% of
our outstanding Ordinary Shares. Mr.&#160;Hakmon&#8217;s affiliates, who were minority shareholders of Smart Repair Pro and Purex, transferred
all their holdings in Smart Repair Pro and Purex to Mr.&#160;Hakmon pursuant to the Share Transfer Deed dated May&#160;10, 2021, which
was effective immediately prior to the Contribution Transactions.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 93; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 30, 2022,
Medigus purchased in our IPO 240,385 Units comprised of 240,385 Ordinary Shares and Warrants to purchase up to 240,385 Ordinary
Shares for an aggregate purchase price of approximately $1,000,001. In addition, in connection with the IPO, on August 30, 2022, in
accordance with the Assignment Agreement, the outstanding principal amount of the loans due to Medigus were automatically converted
into 1,160,133 Ordinary Shares. Following that, Medigus held approximately 35.27% of our issued and outstanding share capital. In
addition, following the Exercise Price Adjustment, on November 28, 2022, Medigus was issued Additional Warrants to purchase up to
240,385 Ordinary Shares. Also in November 2022, Medigus purchased a total of 60,000 Ordinary Shares in open market transactions, at
an average price per share of $1.88. Following that, Medigus held approximately 39.61% of our issued and outstanding share capital.
In December 2022, Medigus sold a total of 5,813 Ordinary Shares in open market transactions, at an average price per share of $1.14.
Following that, Medigus held approximately 39.54% of our issued and outstanding share capital&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 30, 2022, Pure Capital
purchased in our IPO 180,288 Units comprised of 180,288 Ordinary Shares and Warrants to purchase up to 180,288 Ordinary Shares for an
aggregate purchase price of approximately $750,000. Also, on August 30, 2022, in accordance with the Assignment Agreement, the outstanding
principal amount of the loans due to Pure Capital were automatically converted into 31,535 Ordinary Shares. Following that, Pure Capital
held approximately 4.99&#160;% of our issued and outstanding share capital. In August 2022, Pure Capital sold a total of 65,202 Ordinary
Shares in open market transactions, at an average price per share of $2.86. Following that, Pure Capital held approximately 4.19% of our
issued and outstanding share capital.&#160;Also in August 2022, Pure Capital purchased a total of 89,600 Ordinary Shares in open market
transactions, at an average price per share of $1.4. Following that, Pure Capital held approximately 5.29% of our issued and outstanding
share capital.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2022, Viki Hakmon, our Chief Executive Officer, purchased 7,500 Ordinary Shares in an open market transaction, at a price
per share of $1.28. Following that, Mr. Hakmon held approximately 17.65% of our issued and outstanding share capital.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Record
Holders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of April 10, 2023, there
were 5 shareholders of record of our Ordinary Shares. This number is not representative of the number of beneficial holders of our shares
nor is it representative of where such beneficial holders reside, since many of these shares were held of record by brokers or other nominees.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not controlled by another corporation, by any foreign government or by any natural or legal persons except as set forth herein, and
there are no arrangements known to us which would result in a change in our control at a subsequent date.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_033"></a></div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Transactions</b></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Employment
and Service Agreements</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into written employment and service agreements with each of our executive officers. All of these agreements contain customary
provisions regarding confidentiality of information and assignment of inventions. However, the enforceability of the non-competition
provisions may be limited under applicable law. In addition, we have entered into agreements with each executive officer and director
pursuant to which we have agreed to indemnify each of them up to a certain amount and to the extent that these liabilities are not covered
by directors and officers insurance. Members of our senior management are eligible for bonuses each year. The bonuses are payable upon
meeting objectives and targets that are set by our Chief Executive Officer and approved annually by our board of directors that also
set the bonus targets for our Chief Executive Officer.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 94; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Shareholders
Agreements and Loans</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
our inception, we have entered into several shareholders&#8217; and loan agreements with our shareholders, our subsidiaries and our Chief
Executive Officer, in order to finance our activities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May&#160;23, 2019, our subsidiary, Smart Repair Pro, entered into the May&#160;2019 Loans, with a relative of Viki Hakmon, and&#160;Pure
Capital, a company owned by a family relative, or the Investors. On March&#160;1, 2020, Smart Repair Pro entered into the March&#160;1,
2020 Loan Agreement with Purex.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">On
October&#160;8, 2020, Smart Repair Pro and Purex and their then shareholders entered into the Medigus SPA, with Medigus. Medigus is our
controlling shareholder and holds 38.43% of our issued and outstanding share capital as of April 10, 2023. &#160;</span>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February&#160;2021, Smart Repair Pro received additional loans under the Medigus SPA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February&#160;2, 2021, Smart Repair Pro acquired the seller account &#8220;Whoobli&#8221;, pursuant to a purchase agreement. In order
to finance the purchase of the Whoobli store, Smart Repair Pro received an additional loan from its shareholders, whereby Medigus transferred
directly to the Whoobli Seller an amount of approximately $3,200,000 and the minority shareholders transferred an amount of approximately
$800,000.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of May&#160;10, 2021, pursuant to the transactions contemplated by the SEA, Purex and Smart Repair Pro became wholly-owned subsidiaries
of Jeffs&#8217; Brands and the Contribution Transactions were completed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Contribution Transactions, on May&#160;10, 2021, we issued 5,003 and 4,997, Ordinary Shares to Medigus and Mr.&#160;Hakmon, respectively,
in exchange for the equity interests they owned in Smart Repair Pro and Purex.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of August&#160;30, 2022, Smart Repair Pro had outstanding loans to Medigus, Mr.&#160;Hakmon and Pure Capital of $4,010,000, $940,000
and $109,000, respectively. On May&#160;3, 2022, we entered into the Assignment Agreement with Smart Repair Pro, Medigus, Mr.&#160;Hakmon
and Pure Capital.&#160;In accordance with the Assignment Agreement, on August&#160;30, 2022, the outstanding amounts due to Medigus,
Mr.&#160;Hakmon and Pure Capital converted into 1,160,133&#160;Ordinary Shares, 271,951&#160;Ordinary Shares and 31,535&#160;Ordinary
Shares, respectively. Any accrued and unpaid interest due to each such party at that time was paid in cash.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April&#160;29, 2022 and August&#160;24, 2022, Medigus advanced $80,000 and $70,000, respectively, to the Company for certain working
capital matters, which the Company fully repaid on September&#160;6, 2022.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further description on the agreements and loans described above, see &#8220;Item 5.B. Liquidity and Capital Resources &#8211; <i>Financial
Agreements</i>&#8221; above.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Consulting
Agreement with Pure Capital</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 26, 2022, we entered into a consulting agreement with Pure Capital, pursuant to which Pure Capital provides us with consultancy
services for a monthly fee of NIS 57,750 (approximately $16,042). In addition, we paid Pure Capital a one-time signing bonus in the amount
of NIS 425,000 (approximately $118,055) for their services to us from the day of our inception until the closing of the IPO. In addition
to the monthly payments, pursuant to the consultancy agreement, Pure Capital is also entitled to the following payments: (i) an amount
equal to 7% of the gross proceeds paid to the Company in connection with any exercise of warrants, whether or not currently outstanding;
and (ii) 8% of the total consideration paid in connection with any purchase of a new brand, businesses, or similar events initiated or
assisted by Pure Capital and approved by the Chief Executive Officer and chairman of the board of directors based on agreement with Pure
Capital. The consulting agreement is for an undefined period of time and may be terminated after three years from October 26, 2022 by
either party upon a 30 days of advance notice. As of December 31, 2022, we paid $218,000 to Pure Capital pursuant to the agreement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 95; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Agreement
with Pure Logistics </i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2022, we entered into an agreement with Pure Logistics, a U.S. based storage and logistics center, intended to support our plans
to sell our brands&#8217; products directly to consumers and launch new e-commerce platforms. Mr. Eliyahu Yoresh, a director of the Company,
is also a director of Pure Logistics. As of November 28, 2022, we paid $300,000 to Pure Logistics pursuant to the agreement. See &#8220;Item
4.B. Recent Developments &#8211; <i>Expansion of Sales into New E-commerce Platforms</i>&#8221; above for further information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
Purchase Agreement with SciSparc </i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On February 23, 2023, we and
Jeffs&#8217; Brands Holdings entered into the Wellution Agreement, as amended on March 22, 2023 by the Addendum, pursuant to which, on
March 22, 2023, Jeffs&#8217; Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S., a wholly-owned subsidiary
of SciSparc that owns and operates Wellution, a top-selling Amazon food supplements and cosmetics brand, subject to the holdback by SciSparc
of 11 shares as described below, representing approximately 49% of the issued and outstanding shares of common stock of SciSparc U.S.,
for approximately $3.0 million in cash (including the Price Adjustment), of which approximately $2.5 million was paid at the closing.
The Addendum provided for the payment by us to SciSparc of an additional amount of $489,330 in cash for the Price Adjustment related to
inventory and working capital, payable in five equal installments of $97,866 on the tenth day of each consecutive calendar month, beginning
in May 2023. As collateral for the payment in full of the Price Adjustment, SciSparc held back 11 shares of common stock of SciSparc U.S,
which will be released to Jeffs&#8217; Brands Holdings once the final payment is made.&#160;&#160;</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Wellution
Agreement, in connection with the closing of the Wellution Transaction, on March 22, 2023, we entered into the SciSparc Consulting Agreement,
pursuant to which we will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20,000, and will
receive a one-time signing bonus in the amount of $51,000. The SciSparc Consulting Agreement is for an undefined period of time and may
be terminated by either party with 30 days advance notice.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also pursuant to the Wellution
Agreement, in connection with the closing of the Wellution Transaction, effective as of March 22, 2023, we issued 247,415 Ordinary Shares
to SciSparc and on March 29, 2023, SciSparc issued 360,297 of its ordinary shares to us in a mutual share exchange, representing approximately
2.97% and 4.99%, respectively, of the Company&#8217;s and SciSparc&#8217;s issued and outstanding ordinary shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The number of Exchange Shares
acquired by each company was calculated by dividing $288,238, which was adjusted from $300,000, pursuant to the 4.99% ownership limitation
included in the Wellution Agreement, by the average closing price of the relevant company&#8217;s shares on the Nasdaq Capital Market
for the 30 consecutive trading days ending on the third trading day immediately prior to the closing date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Oz Adler, the Chairman
and a member of our board of directors is the chief executive officer and chief financial officer of SciSparc, Mr. Amitai Weiss, is the
chairman of the board of directors of SciSparc, and is a member of our board of directors, and Mr. Moshe Revach is a member of our board
of directors and SciSparc&#8217;s board of directors.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_034"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interests
                                            of Experts and Counsel</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_035"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 8. FINANCIAL INFORMATION.</b></span></p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_036"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
                                            Statements and Other Financial Information</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Item 18. Financial Statements.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we may become involved in legal proceedings that arise in the ordinary course of business. During the period covered by
the financial statements contained herein, we were not subject to any material legal proceedings that has had a material adverse effect
on our financial position. No assurance can be given that future litigation will not have a material adverse effect on our financial
position. When appropriate in management&#8217;s estimation, we may record reserves in our financial statements for pending litigation
and other claims.&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 96; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our Ordinary Shares and do not anticipate paying any cash dividends in the foreseeable
future. Payment of cash dividends, if any, in the future will be at the discretion of our board of directors and will depend on then-existing
conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects
and other factors our board of directors may deem relevant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Companies Law imposes certain restrictions on our ability to declare and pay dividends. See &#8220;Divided and Liquidation Rights&#8221;
in Exhibit 2.1 to this Annual Report for additional information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of dividends may be subject to Israeli withholding taxes. See &#8220;Item 10. E. Taxation&#8221; for additional information.&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_037"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant
                                            Changes</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
significant change, other than as otherwise described in this Annual Report on Form 20-F, has occurred in our operations since the date
of our consolidated financial statements included in this Annual Report on Form 20-F.&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_038"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 9. THE OFFER AND LISTING.</b></span></p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_039"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Offer
                                            and Listing Details</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Ordinary Shares and Warrants were approved for listing on the Nasdaq Capital Market and commenced trading under the symbol &#8220;JFBR&#8221;
and &#8220;JFBRW&#8221;, respectively, on August 26, 2022.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_040"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan
                                            of Distribution</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_041"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Markets</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Item 9A. Offer and Listing Details.&#8221;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_042"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
                                            Shareholders</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_043"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_044"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenses
                                            of the Issue</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_045"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 10. ADDITIONAL INFORMATION</b></span></p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_046"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
                                            Capital</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 97; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_047"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Memorandum
                                            and Articles of Association</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of our amended and restated articles of association is attached as Exhibit 1.1 to this Annual Report on Form 20-F.&#160;The information
called for by this Item is set forth in Exhibit 2.1 to this Annual Report and is incorporated by reference into this Annual Report on
Form 20-F.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_048"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material
                                            Contracts</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
a description of each material contract, other than material contracts entered into in the ordinary course of business, to which we are
or have been a party, for the two years immediately preceding the date of this Annual Report on Form 20-F, see &#8220;Item 4.A. History
and Development of the Company,&#8221; Item 4.B. Recent Developments &#8220;Item 4.B. Business Overview,&#8221; &#8220;Item 5.B. Liquidity
and Capital Resources &#8211; Financial Arrangements,&#8221; &#8220;Item 6.C Board Practices - Indemnification,&#8221; &#8220;Item 6.C
Share Ownership &#8211; Share Option Plan,&#8221; &#8220;Item 7.A. Major Shareholders,&#8221; and &#8220;Item 7.B. Related Party Transactions&#8221;
above.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_049"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange
                                            Controls</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are currently no Israeli currency control restrictions on payments of dividends or other distributions with respect to our Ordinary Shares
or the proceeds from the sale of the shares, except for the obligation of Israeli residents to file reports with the Bank of Israel regarding
certain transactions. However, legislation remains in effect pursuant to which currency controls can be imposed by administrative action
at any time.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ownership or voting of our Ordinary Shares by non-residents of Israel, except with respect to citizens of countries that are in a state
of war with Israel, is not restricted in any way by our memorandum of association or amended and restated articles of association or
by the laws of the State of Israel.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_050"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following description is not intended to constitute a complete analysis of all tax consequences relating to the ownership or disposition
of our Ordinary Shares. You should consult your own tax advisor </i>concerning <i>the tax consequences of your particular situation,
as well as any tax consequences that may arise under the laws of any state, local, foreign, including Israeli, or other taxing jurisdiction.</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Israeli
Tax Considerations and Government Programs</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a description of the material Israeli income tax consequences concerning the acquisition, ownership and disposition of our
Ordinary Shares. The following also contains a description of material relevant provisions of the current Israeli income tax structure
applicable to companies in Israel, with reference to its effect on us. This summary does not discuss all the aspects of Israeli tax law
that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors
subject to special treatment under Israeli law. Examples of such investors include residents of Israel or traders in securities who are
subject to special tax regimes not covered in this discussion. To the extent that the discussion is based on tax legislation which has
not been subject to judicial or administrative interpretation, there can be no assurance that the applicable tax authorities or the courts
will accept the views expressed in the discussion in question. The discussion below is subject to change, including due to amendments
under Israeli law or changes to the applicable judicial or administrative interpretations of Israeli law, which change could affect the
tax consequences described below. The discussion is not intended, and should not be taken, as legal or professional tax advice and is
not exhaustive of all possible tax considerations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following description is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership
or disposition of our Ordinary Shares. Shareholders should consult their own tax advisors concerning the tax consequences of their particular
situation, as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 98; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>General
Corporate Tax Structure in Israel</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli
companies are generally subject to corporate tax, currently at the rate of 23%. However, the effective tax rate payable by a company
that derives income from a Preferred Enterprise or Preferred Technological Enterprise (as discussed below)&#160;may be considerably less.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital
gains derived by an Israeli resident company are subject to tax at the regular corporate tax rate. Under Israeli tax legislation, a corporation
will be considered as an &#8220;Israeli resident company&#8221; if it meets one of the following criteria: (i)&#160;it was incorporated
in Israel; or (ii)&#160;the control and management of its business are exercised in Israel.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Law
for the Encouragement of Industry (Taxes), 5729-1969</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the Industry Encouragement Law, provides several tax
benefits for &#8220;Industrial Companies.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Industry Encouragement Law defines an &#8220;Industrial Company&#8221; as an Israeli resident-company incorporated in Israel, which has
90% or more of its income in any tax year, other than income from certain government loans, derived from an &#8220;Industrial Enterprise&#8221;
owned by it and located in Israel or in the &#8220;Area&#8221;, in accordance with the definition under section 3A of the Israeli Income
Tax Ordinance (New Version) 1961, referred to as the Ordinance. An &#8220;Industrial Enterprise&#8221; is defined as an enterprise which
is held by an Industrial Company whose principal activity in a given tax year is industrial production.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following corporate tax benefits, among others, are available to Industrial Companies:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amortization
    of the cost to purchase a patent, rights to use a patent or know-how, that were purchased in good faith and are used for the development
    or advancement of the Industrial Enterprise, over an eight-year period, commencing on the year in which such rights were first exercised;
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">under
    limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses
    related to a public offering are deductible in equal amounts over three years commencing on the year of the offering. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eligibility
for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Tax
Benefits and Grants for Research and Development</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General.&#160;</b>The
IIA, an independent publicly funded agency, was created to provide a variety of practical tools and funding platforms aimed at effectively
addressing the dynamic and changing needs of the local and international innovation ecosystem. The IIA acts under the Law for the Encouragement
of Research, Development and Technological Innovation in the Industry 1984 and the related IIA rules and regulations, or the Innovation
Law. Companies that receive funding from the IIA are subject to certain liabilities of the Innovation Law, mainly pertaining to the know-how
that was developed with the support of the IIA within the framework of an R&amp;D funding program, and/or its derivatives, or the IIA-supported
Know-how, and/or to the products derived from the technology that was developed with the support of the IIA within the framework of an
R&amp;D funding program, and/or its derivatives, or IIA-supported products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership
Structure.</b>&#160;Any change of ownership must be reported to the IIA prior to the execution of the acquisition. A change in the company&#8217;s
ownership, in which a foreign entity becomes a shareholder in the company, requires the IIA approval and the new shareholder signature
on an undertaking letter acknowledging the company&#8217;s liabilities to the Innovation Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 99; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Royalty
payment.</b>&#160;Companies supported by the IIA are required to pay royalties on income yielded from the IIA-supported products, until
full refund of the grant, which is linked to the US dollar and carries interest (the annual LIBOR interest for annual dollar deposits,
as published on the first day of trading of each year, or in an alternate publication according to the Bank of Israel&#8217;s announcement).
Until July 2017, the rate of the royalties refund was 3% of related income in the first three years, and 3.5% from the 4th year, onward.
As of July 2017, the rate of the royalties refund for companies with total revenues of under $70 million at the year preceding the application
date, has changed to 3%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Manufacturing
location.</b>&#160;Until 2003, manufacturing was considered to be done completely in Israel, and after this date, the manufacturing location
(including assembly) is determined based on the manufacturing declaration located in the grant application submitted for supporting R&amp;D,
or the Manufacturing Declaration. The transfer of manufacturing activity outside Israel may be subject to the prior approval of the IIA
and may result in an increased royalty payment rate and an increased total royalty payment, which will be calculated based on the deviation
from the company&#8217;s Manufacturing Declaration. Cumulative deviation of under 10% requires notification of the IIA, while 10% or
more requires pre-approval.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rate of royalty payment due to overseas manufacturing is increased as follows: If the foreign company will be given the rights to only
manufacture the IIA-supported products, an additional 1% will be incurred (e.g., instead of paying 3%, the company will pay 4%). However,
if the foreign company will be given the rights to both manufacture and distribute the IIA-supported products, the royalties rate may
be higher. The increased royalty rate will apply for revenues associated with manufacturing outside of Israel only. In general, royalties
will be paid from the final sale price to the client and not from the inter-company transfer price. The company will have to keep paying
royalties until it reaches the new royalty liability ceiling.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increased repayment is calculated according to the percentage of the manufacturing activities that are carried out outside of Israel
out of the total cumulative manufacturing activities both in Israel and abroad, as described in the following table:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage
                                            of manufacturing activities performed<br/>
                                            outside of Israel, cumulatively</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
    increased payment to the IIA</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
    to 50% </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120%
    of the received grants + interest </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
    50% and 90% </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">150%
    of the received grants + interest </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90%
    and more </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300%
    of the received grants + interest </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Know-how
location.</b>&#160;To the extent a company wishes to transfer its IIA-supported Know-how outside of Israel, the transfer must be preapproved
by the IIA and the company may be required to pay an additional payment to the IIA, or the Fee, as described below. This Fee (which also
relates to programs that are absolved of royalty payment) is calculated according to the ratio between the total grants received from
the IIA and the total financial R&amp;D expenses invested in the related know-how (including the received grants), multiplied by the
transaction price of the IIA-supported Know-how, or the IIA Know-how Basic Amount.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
IIA Know-how Basic Amount minus the received grants is depreciated at a rate of 1/7 per annum, as of the fourth year from the end of
the last supported file in each program. As a result, when transferring IIA-supported Know-how after 10 years or more, the maximum payment
to the IIA will be only the total sum of the received grants plus interest, minus paid royalties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 100; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_016.jpg"/></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
the aforementioned formula has a minimum and maximum limits. The minimum amount of the payment is the total sum of grants received plus
interest. The maximum amount shall be no higher than 6 times the total sum of grants received plus interest. In the case that the IIA-supported
company retains its R&amp;D center in Israel for at least 3 consecutive years, following the year of transferring the IIA-supported Know-how
outside of Israel, while maintaining at least 75% of its R&amp;D employment in Israel &#8211; the payment will be limited to 3 times
the total sum of grants received plus interest.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transferring
IIA-supported Know-how outside of Israel according to the Innovation Law (including paying the Fee where necessary) releases the IIA-supported
company from all liabilities to the IIA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer
of know-how to another Israeli entity is subject to signature of the recipient Israeli entity on a formal IIA issued undertaking document,
to comply with the provisions of the Innovation Law, including the restrictions on the transfer of know-how and the obligation to pay
royalties.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the above, these liabilities should be taken into account when we consider to outsource manufacturing, engage in change of control
transactions or otherwise transfer our know-how outside of Israel, and may require us to obtain the pre-approval of the IIA for certain
actions and transactions and pay additional payments to the IIA. In particular, any change of control and any change of ownership of
our Ordinary Shares that would make a non-Israeli citizen or resident an &#8220;interested party,&#8221; as defined in the Innovation
Law, requires a prior written notice to the IIA in addition to any payment that may be required of us for transfer of manufacturing or
know-how outside of Israel. If we fail to comply with the Innovation Law, we may be subject to criminal charges.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Tax
Benefits for Research and Development</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli
tax law allows, under certain conditions, a tax deduction for expenditures, including capital expenditures, for the year in which they
are incurred. Expenditures are deemed related to scientific research and development projects, if:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    expenditures are approved by the relevant Israeli government ministry, determined by the field of research; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    research and development must be for the promotion of the company; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    research and development is carried out by or on behalf of the company seeking such tax deduction. </span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific
research and development projects. No deduction under these research and development deduction rules is allowed if such deduction is
related to an expense invested in an asset depreciable under the general depreciation rules of the Tax Ordinance. Expenditures that are
not qualified under the conditions above are deductible in equal amounts over three years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 101; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time we may apply the Office of the Chief Scientist for approval to allow a tax deduction for all research and development expenses
during the year incurred. There can be no assurance that such application will be accepted.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Law
for the Encouragement of Capital Investments, 5719-1959</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Law for the Encouragement of Capital Investments, 5719-1959, generally referred to as the Investment Law, provides certain incentives
for capital investments in production facilities (or other eligible assets).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investment Law was significantly amended effective as of January&#160;1, 2011, or the 2011 Amendment, and as of January&#160;1, 2017,
or the 2017 Amendment. The 2011 Amendment introduced new benefits to replace those granted in accordance with the provisions of the Investment
Law in effect prior to the 2011 Amendment. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing
tax benefits.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
benefits under the 2011 Amendment</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2011 Amendment canceled the availability of the benefits granted under the Investment Law prior to 2011 and, instead, introduced new
benefits for income generated by a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise&#8221; (as such terms are
defined in the Investment Law) as of January&#160;1, 2011. The definition of a Preferred Company includes a company incorporated in Israel
that is not fully owned by a governmental entity, and that has, among other things, Preferred Enterprise status and is controlled and
managed from Israel. Pursuant to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 16% with respect
to its income derived from its Preferred Enterprise, unless the Preferred Enterprise is located in a specified development zone, in which
case the rate will be 7.5%. Income derived by a Preferred Company from a &#8220;Special Preferred Enterprise&#8221; (as such term is
defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or 5% if
the Special Preferred Enterprise is located in a certain development zone.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
distributed from income which is attributed to a &#8220;Preferred Enterprise&#8221; or a &#8220;Special Preferred Enterprise&#8221; should
generally be subject to withholding tax at source at the following rates: (i)&#160;Israeli resident&#160;corporations - 0%,&#160;(although,
if such dividends are subsequently distributed to individuals or a&#160;non-Israeli&#160;company the below rates detailed in sub sections
(ii)&#160;and (iii)&#160;shall apply), (ii)&#160;Israeli resident&#160;individuals - 20%&#160;and&#160;(iii)&#160;non-Israeli&#160;residents
(individuals and corporations) - subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate,
20%, or such lower rate as may be provided under the provisions of any applicable double tax treaty.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently do not intend to implement the 2011 Amendment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
benefits under the 2017 Amendment</i></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2017 Amendment was enacted as part of the Economic Efficiency Law that was published on December&#160;29, 2016, and is effective as of
January&#160;1, 2017. The 2017 Amendment provided new tax benefits for two types of &#8220;Technological Enterprises,&#8221; as described
below, and is in addition to the other existing tax beneficial programs under the Investment Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2017 Amendment provides that a technology company satisfying certain conditions should qualify as a Preferred Technological Enterprise,
or PTE, and thereby enjoy a reduced corporate tax rate of 12% on income that qualifies as &#8220;Preferred Technological Income&#8221;,
as defined in the Investment Law. The tax rate is further reduced to 7.5% for a PTE located in development zone &#8220;A&#8221;. In addition,
a PTE will enjoy a reduced corporate tax rate of 12% on capital gain derived from the sale of certain &#8220;Benefited Intangible Assets&#8221;
(as defined in the Investment Law) to a related foreign company if the Benefited Intangible Assets were acquired from a foreign company
after January&#160;1, 2017 for at least NIS 200&#160;million, and the sale received prior approval from the National Authority for Technological
Innovation previously known as the Israeli Office of the Chief Scientist), to which we refer as IIA.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 102; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2017 Amendment further provides that a technology company satisfying certain conditions (including a group turnover of at least NIS 10
billion) should qualify as a &#8220;Special Preferred Technological Enterprise&#8221; and will thereby enjoy a reduced corporate tax
rate of 6% on &#8220;Preferred Technological Income&#8221; regardless of the company&#8217;s geographic location within Israel. In addition,
a Special Preferred Technological Enterprise should enjoy a reduced corporate tax rate of 6% on capital gain derived from the sale of
certain &#8220;Benefited Intangible Assets&#8221; to a related foreign company if the Benefited Intangible Assets were either developed
by the Special Preferred Technological Enterprise or acquired from a foreign company after January&#160;1, 2017, and the sale received
prior approval from IIA. A Special Preferred Technological Enterprise that acquires Benefited Intangible Assets from a foreign company
for more than NIS 500&#160;million should be eligible for these benefits for at least ten years, subject to certain approvals as specified
in the Investment Law.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
distributed out of Preferred Technological Income to Israeli shareholders by a PTE or a Special Preferred Technological Enterprise, paid
out of Preferred Technological Income, should generally be subject to withholding tax at source at the rate of 20% (in the case of&#160;non-Israeli&#160;shareholders,
subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate, 20%, or such lower rate as may
be provided in an applicable tax treaty). However, if such dividends are paid to an Israeli company, no tax is generally required to
be withheld (although, if such dividends are subsequently distributed to individuals or a&#160;non-Israeli&#160;company, the aforesaid
should apply). If such dividends are distributed to a foreign company that holds solely or together with other foreign companies 90%
or more in the Israeli company and other conditions are met, the withholding tax rate should be 4% (or such lower rate as may be provided
in an applicable tax treaty, in either case, subject to the receipt in advance of a valid certificate from the ITA allowing for such
reduced tax rate).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are examining the potential impact of the 2017 Amendment and the degree to which we may qualify as a PTE, the amount of Preferred Technological
Income that we may have and other benefits that we may receive from the 2017 Amendment in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Taxation
of our Shareholders</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli
law generally imposes a capital gains tax on the sale of any capital assets by residents of Israel, as defined for Israeli tax purposes,
and on the sale of assets located in Israel, including shares of Israeli companies, by both residents and non-residents of Israel unless
a specific exemption is available or a tax treaty between Israel and the seller&#8217;s country of residence provides otherwise. The
Tax Ordinance distinguishes between real capital gain and inflationary surplus. The inflationary surplus is a portion of the total capital
gain equivalent to the increase of the relevant asset&#8217;s tax basis attributable to an increase in the Israeli consumer price index
or, in certain circumstances, a foreign currency exchange rate, between the date of purchase and the date of disposition. Inflationary
surplus is not currently subject to tax in Israel. The real capital gain is the excess of the total capital gain over the inflationary
surplus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capital
Gains Taxes Applicable to Non-Israeli Resident Shareholders</i>. A non-Israeli resident (whether an individual or a corporation) who
derives capital gains from the sale of shares in an Israeli resident company purchased upon or after the registration of the shares on
the TASE or on a regulated market outside of Israel (such as Nasdaq) should be exempt from Israeli tax unless the capital gain derived
from the sale of shares was attributed to a permanent establishment that the non-resident maintains in Israel. However, a non-Israeli
&#8220;body of persons&#8221; (as defined under the Tax Ordinance, which includes corporate entities, partnerships and other entities)
will not be entitled to the foregoing exemption if Israeli residents: (i) have a controlling interest of more than 25% in such non-Israeli
entity or (ii) are the beneficiaries of, or are entitled to, 25% or more of the revenues or profits of such non-Israeli entity, both,
whether directly or indirectly. In addition, such exemption is not applicable to a person whose gains from selling or otherwise disposing
of the shares are deemed business income.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
not exempt, a non-Israeli resident shareholder would generally be subject to tax on capital gain at the ordinary corporate tax rate as
specified in section 126 of the Tax Ordinance (23% in 2022), if generated by a company, or at a marginal tax rate according to section
121 of the Tax Ordinance but up to a rate of 25%, if generated by an individual, or 30%, if generated by an individual who is a &#8220;substantial
shareholder&#8221; (as defined under the Tax Ordinance), at the time of sale or at any time during the preceding 12-month period (or
if the shareholder claims a deduction for interest and linkage differences expenses in connection with the purchase and holding of such
shares). A &#8220;substantial shareholder&#8221; is generally a person who alone or together with such person&#8217;s relative or another
person who collaborates with such person on a permanent basis, holds, directly or indirectly, at least 10% of any of the &#8220;means
of control&#8221; of the corporation. &#8220;Means of control&#8221; generally include, among others, the right to vote, receive profits,
nominate a director or an executive officer, receive assets upon liquidation, or order someone who holds any of the aforesaid rights
how to act, regardless of the source of such right. Individual and corporate shareholders dealing in securities in Israel are taxed at
the tax rates applicable to business income (a corporate tax rate for a corporation as specified in section 126 of the Tax Ordinance
(23% in 2022) and a marginal tax rate (up to 47% for an individual in 2022) as specified in section 121 of the Tax Ordinance (excluding
excess tax as discussed below)) unless contrary provisions in a relevant tax treaty apply.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 103; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
a sale of securities by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax
treaty between Israel and the shareholder&#8217;s country of residence. For example, under Convention Between the Government of the United
States of America and the Government of the State of Israel with respect to Taxes on Income, as amended, or the United States-Israel
Tax Treaty, the sale, exchange or other disposition of shares by a shareholder who is a United States resident (for purposes of the treaty)
holding the shares as a capital asset and is entitled to claim the benefits afforded to such a resident by the United States-Israel Tax
Treaty, or a Treaty U.S. Resident, is generally exempt from Israeli capital gains tax unless: (i) the capital gain arising from such
sale, exchange or disposition is attributed to real estate located in Israel; (ii) the capital gain arising from such sale, exchange
or disposition is attributed to royalties; (iii) the capital gain arising from the such sale, exchange or disposition is attributed to
a permanent establishment that the shareholder maintains in Israel; (iv) such Treaty U.S. Resident holds, directly or indirectly, shares
representing 10% or more of the voting capital of the company during any part of the 12-month period preceding the disposition, subject
to certain conditions; or (v) such Treaty U.S. Resident is an individual and was present in Israel for a period or periods aggregating
to 183 days or more during the relevant taxable year. In each case, the sale, exchange or disposition of our ordinary shares would be
subject to Israeli tax, to the extent applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regardless
of whether our non-Israeli shareholders may be liable for Israeli capital gains tax on the sale of their Ordinary Shares, the payment
of the consideration may be subject to the withholding of Israeli tax at source. Shareholders may be required to demonstrate that they
are exempt from tax on their capital gains in order to avoid withholding at source at the time of sale. Specifically, in transactions
involving a sale of all of the shares of an Israeli resident company, in the form of a merger or otherwise, the ITA may require from
shareholders who are not liable for Israeli tax to sign declarations in forms specified by this authority or obtain a specific exemption
from the ITA to confirm their status as non-Israeli tax residents, and, in the absence of such declarations or exemptions, may require
the purchaser of the shares to withhold Israeli taxes at source.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Capital
Gains Taxes Applicable to Israeli Resident Shareholders</i>. An Israeli resident will generally be subject to a capital gains tax as
an individual on any real capital gain at the rate of 25%. However, where an individual shareholder claims a deduction for interest expenditures
or he is a &#8220;substantial shareholder&#8221; at the time of the sale or at any time during the preceding twelve&#160;months period,
such gain will be taxed at the rate of 30%. Individual holders dealing in securities in Israel for whom the income from the sale of securities
is considered &#8220;business income,&#8221; as defined in section 2(1) of the Ordinance, are taxed at the marginal tax rates applicable
to business income (up to 47% in 2022 excluding, excess tax, if applicable, as described below). </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Israeli resident corporation that derives capital gains from the sale of shares of an Israeli resident company will generally be subject
to tax on the real capital gain generated on such sale at the corporate tax rate of 23%.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of Non-Israeli Shareholders on Receipt of Dividends</i>. Non-Israeli residents (whether individuals or corporations) are generally subject
to Israeli income tax on the receipt of dividends paid on our Ordinary Shares at the rate of 25%, which tax will be withheld at source,
unless relief is provided in a treaty between Israel and the shareholder&#8217;s country of residence (provided that a certificate from
the ITA allowing for a reduced withholding tax rate or a tax exemption is obtained in advance). With respect to a person who is a &#8220;substantial
shareholder&#8221; (as detailed above) at the time of receiving the dividend or at any time during the preceding twelve months, the applicable
tax rate is 30%. Dividends paid on publicly traded shares, like our Ordinary Shares, to non-Israeli residents, are generally subject
to Israeli withholding tax at a rate of 25%, so long as the shares are registered with a nominee company (whether or not the recipient
is a substantial shareholder), unless a lower rate is provided under an applicable tax treaty (provided that a certificate from the ITA
allowing for a reduced withholding tax rate is obtained in advance). However, subject to the receipt in advance of a valid certificate
from the ITA allowing for a reduced withholding tax rate, a distribution of dividends to non-Israeli residents is generally subject to
withholding tax at source at a rate of 20% if the dividend is distributed from income attributed to a Preferred Enterpriseor PTE, unless
a reduced tax rate is provided under an applicable tax treaty. For example, under the United States-Israel Tax Treaty and subject to
the eligibility to the benefits under such treaty, the maximum rate of tax withheld at source in Israel on dividends paid to a holder
of our Ordinary Shares who is a Treaty U.S. Resident is 25%. However, generally, the maximum rate of withholding tax on dividends, not
generated by our Preferred Enterprise or PTE, that are paid to a United States corporation holding 10% or more of the outstanding voting
capital throughout the tax year in which the dividend is distributed as well as during the previous tax year, is 12.5%, provided that
not more than 25% of the gross income for such preceding year consists of certain types of dividends and interest. Notwithstanding the
foregoing, dividends distributed from income attributed to a Preferred Enterprise or PTE are not entitled to such reduction under the
tax treaty but are subject to a withholding tax rate of 20% for a shareholder that is a U.S. corporation, provided that the condition
related to our gross income for the previous year (as set forth in the previous sentence) is met. The aforementioned rates under the
United States-Israel Tax Treaty would not apply if the dividend income is derived through a permanent establishment of the U.S. resident
in Israel. If the dividend is attributable partly to income derived from a Preferred Enterprise or PTE, and partly to other sources of
income, the withholding rate will be a blended rate reflecting the relative portions of the two types of income. U.S. residents who are
subject to Israeli withholding tax on a dividend may be entitled to a credit or deduction for United States federal income tax purposes
in the amount of the taxes withheld, subject to detailed rules contained in the Code. We cannot assure you that we will designate the
profits that we may distribute in a way that will reduce shareholders&#8217; tax liability.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "></p><div>

</div><!-- Field: Page; Sequence: 104; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
non-Israeli resident who receives dividends from which tax was withheld is generally exempt from the obligation to file tax returns in
Israel with respect to such income, provided that (i) such income was not generated from business conducted in Israel by the taxpayer,
(ii) the taxpayer has no other taxable sources of income in Israel with respect to which a tax return is required to be filed, and (iii)
the taxpayer is not obligated to pay excess tax (as further explained below).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Taxation
of Israeli Shareholders on Receipt of Dividends</i>. An Israeli resident individual is generally subject to Israeli income tax on the
receipt of dividends paid on our ordinary shares at the rate of 25%. With respect to a person who is a &#8220;substantial shareholder&#8221;
at the time of receiving the dividend or on any time during the preceding twelve&#160;months, the applicable tax rate is 30%. Such dividends
are generally subject to Israeli withholding tax at a rate of 25% if the shares are registered with a nominee company (whether the recipient
is a substantial shareholder or not). If the recipient of the dividend is an Israeli resident corporation such dividend income will be
exempt from Israeli corporate tax provided the income from which such dividend is distributed was derived or accrued within Israel and
was received directly or indirectly from another corporation that is liable to Israeli corporate tax (although, if such dividends are
subsequently distributed to Israeli individuals or non-Israeli shareholders, the above shall apply). An exempt trust fund, pension fund
or other entity that is exempt from tax under Section 9(2) or Section 129(C)(a)(1) of the Ordinance is exempt from tax on dividend. &#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Excess
Tax</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individuals
who are subject to tax in Israel (whether any such individual is an Israeli resident or non-Israeli resident) are also subject to an
additional tax at a rate of 3% on annual income exceeding NIS 663,240 for 2022 (which amount is linked to the annual change in the Israeli
consumer price index), including, but not limited to, dividends, interest and capital gain.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Estate
and Gift Tax</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli
tax law presently does not impose estate or gift taxes.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
Federal Income Tax Considerations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
FOLLOWING SUMMARY IS INCLUDED HEREIN FOR GENERAL INFORMATION AND IS NOT INTENDED TO BE, AND SHOULD NOT BE CONSIDERED TO BE, LEGAL OR
TAX ADVICE. EACH U.S. HOLDER SHOULD CONSULT WITH HIS OR HER OWN TAX ADVISOR AS TO THE PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES
OF THE PURCHASE, OWNERSHIP AND SALE OF ORDINARY SHARES, <span style="text-transform: uppercase">the Warrants, and the Ordinary Shares
issued or issuable upon exercise of the Warrants</span>, INCLUDING THE EFFECTS OF APPLICABLE STATE, LOCAL, FOREIGN OR OTHER TAX LAWS
AND POSSIBLE CHANGES IN THE TAX LAWS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the limitations described in the next paragraph, the following discussion summarizes the material U.S. federal income tax consequences
to a &#8220;U.S. Holder&#8221; arising from the purchase, ownership and sale of the Ordinary Shares, the Warrants, and the Ordinary Shares
issued or issuable upon exercise of the Warrants, collectively, the &#8220;securities&#8221;. For this purpose, a &#8220;U.S. Holder&#8221;
is a holder of Ordinary Shares that is: (1) an individual citizen or resident of the United States, including an alien individual who
is a lawful permanent resident of the United States or meets the substantial presence residency test under U.S. federal income tax laws;
(2) a corporation (or entity treated as a corporation for U.S. federal income tax purposes) or a partnership (other than a partnership
that is not treated as a U.S. person under any applicable U.S. Treasury regulations) created or organized under the laws of the United
States or the District of Columbia or any political subdivision thereof; (3) an estate, the income of which is includable in gross income
for U.S. federal income tax purposes regardless of source; (4) a trust if a court within the United States is able to exercise primary
supervision over the administration of the trust and one or more U.S. persons have authority to control all substantial decisions of
the trust; or (5) a trust that has a valid election in effect to be treated as a U.S. person to the extent provided in U.S. Treasury
regulations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary is for general information purposes only and does not purport to be a comprehensive description of all of the U.S. federal income
tax considerations that may be relevant to a decision to purchase our securities. This summary generally considers only U.S. Holders
that will own our securities as capital assets. Except to the limited extent discussed below, this summary does not consider the U.S.
federal tax consequences to a person that is not a U.S. Holder, nor does it describe the rules applicable to determine a taxpayer&#8217;s
status as a U.S. Holder. This summary is based on the provisions of the Internal Revenue Code of 1986, as amended, or the Code, final,
temporary and proposed U.S. Treasury regulations promulgated thereunder, administrative and judicial interpretations thereof, (including
with respect to the Tax Cuts and Jobs Act of 2017), and the U.S.-Israel Income Tax Treaty, all as in effect as of the date hereof and
all of which are subject to change, possibly on a retroactive basis, and all of which are open to differing interpretations. We will
not seek a ruling from the IRS with regard to the U.S. federal income tax treatment of an investment in our securities by U.S. Holders
and, therefore, can provide no assurances that the IRS will agree with the conclusions set forth below.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 105; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion does not address all of the aspects of U.S. federal income taxation that may be relevant to a particular U.S. holder based
on such holder&#8217;s particular circumstances and in particular does not discuss any estate, gift, generation-skipping, transfer, state,
local, excise or foreign tax considerations. In addition, this discussion does not address the U.S. federal income tax treatment of a
U.S. Holder who is: (1) a bank, life insurance company, regulated investment company, or other financial institution or &#8220;financial
services entity;&#8221; (2) a broker or dealer in securities or foreign currency; (3) a person who acquired our securities in connection
with employment or other performance of services; (4) a U.S. Holder that is subject to the U.S. alternative minimum tax; (5) a U.S. Holder
that holds our securities as a hedge or as part of a hedging, straddle, conversion or constructive sale transaction or other risk-reduction
transaction for U.S. federal income tax purposes; (6) a tax-exempt entity; (7) real estate investment trusts or grantor trusts; (8) a
U.S. Holder that expatriates out of the United States or a former long-term resident of the United States; or (9) a person having a functional
currency other than the U.S. dollar. This discussion does not address the U.S. federal income tax treatment of a U.S. Holder that owns,
directly or constructively, at any time, securities representing 10% or more of our voting power. Additionally, the U.S. federal income
tax treatment of partnerships (or other pass-through entities) or persons who hold securities through a partnership or other pass-through
entity are not addressed.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
prospective investor is advised to consult his or her own tax adviser for the specific tax consequences to that investor of purchasing,
holding or disposing of our securities, including the effects of applicable state, local, foreign or other tax laws and possible changes
in the tax laws.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exercise
or Expiry of Warrants</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
gain or loss will be realized on the exercise of a Warrant. When a Warrant is exercised, the U.S. Holder&#8217;s cost of the common share
acquired thereby will be equal to the U.S. Holder&#8217;s adjusted cost basis of the Warrant plus the exercise price paid for the common
share. The expiry of an unexercised Warrant will generally give rise to a capital loss equal to the adjusted cost basis to the U.S. Holder
of the expired Warrant. The holding period of the common share acquired thru the exercise of a Warrant includes the holding period of
the Warrant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Taxation
of Dividends Paid on Securities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not intend to pay dividends in the foreseeable future and U.S. Holders of Warrants are not entitled to dividends. In the event that
we do pay dividends, and subject to the discussion under the heading &#8220;Passive Foreign Investment Companies&#8221; below and the
discussion of &#8220;qualified dividend income&#8221; below, a U.S. Holder, other than certain U.S. Holder&#8217;s that are U.S. corporations,
will be required to include in gross income as ordinary income the amount of any distribution paid on securities (including distributions
paid on Warrants if such warrants were to become entitled to dividends and the amount of any Israeli tax withheld on the date of the
distribution), to the extent that such distribution does not exceed our current and accumulated earnings and profits, as determined for
U.S. federal income tax purposes. The amount of a distribution which exceeds our earnings and profits will be treated first as a non-taxable
return of capital, reducing the U.S. Holder&#8217;s tax basis for the securities to the extent thereof, and then capital gain. We do
not expect to maintain calculations of our earnings and profits under U.S. federal income tax principles and, therefore, U.S. Holders
should expect that the entire amount of any distribution generally will be reported as dividend income.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, preferential tax rates for &#8220;qualified dividend income&#8221; and long-term capital gains are applicable for U.S. Holders
that are individuals, estates or trusts. For this purpose, &#8220;qualified dividend income&#8221; means, inter alia, dividends received
from a &#8220;qualified foreign corporation.&#8221; A &#8220;qualified foreign corporation&#8221; is a corporation that is entitled to
the benefits of a comprehensive tax treaty with the United States which includes an exchange of information program. The IRS has stated
that the U.S.-Israel Tax Treaty satisfies this requirement and we believe we are eligible for the benefits of that treaty.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our dividends will be qualified dividend income if our securities are readily tradable on the Nasdaq Capital Market or another
established securities market in the United States. Dividends will not qualify for the preferential rate if we are treated, in the year
the dividend is paid or in the prior year, as a PFIC, as described below under &#8220;Passive Foreign Investment Companies.&#8221; A
U.S. Holder will not be entitled to the preferential rate: (1) if the U.S. Holder has not held our securities for at least 61 days of
the 121 day period beginning on the date which is 60 days before the ex-dividend date, or (2) to the extent the U.S. Holder is under
an obligation to make related payments on substantially similar property. Any days during which the U.S. Holder has diminished its risk
of loss on our securities are not counted towards meeting the 61-day holding period. Finally, U.S. Holders who elect to treat the dividend
income as &#8220;investment income&#8221; pursuant to Code section 163(d)(4) will not be eligible for the preferential rate of taxation.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amount of a distribution with respect to our securities will be measured by the amount of the fair market value of any property distributed,
and for U.S. federal income tax purposes, the amount of any Israeli taxes withheld therefrom. Cash distributions paid by us in NIS will
be included in the income of U.S. Holders at a U.S. dollar amount based upon the spot rate of exchange in effect on the date the dividend
is includible in the income of the U.S. Holder, and U.S. Holders will have a tax basis in such NIS for U.S. federal income tax purposes
equal to such U.S. dollar value. If the U.S. Holder subsequently converts the NIS into U.S. dollars or otherwise disposes of it, any
subsequent gain or loss in respect of such NIS arising from exchange rate fluctuations will be U.S. source ordinary exchange gain or
loss.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Taxation
of the Disposition of Securities</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as provided under the PFIC rules described below under &#8220;Passive Foreign Investment Companies,&#8221; upon the sale, exchange or
other disposition of our securities, a U.S. Holder will recognize capital gain or loss in an amount equal to the difference between such
U.S. Holder&#8217;s tax basis for the securities in U.S. dollars and the amount realized on the disposition in U.S. dollar (or its U.S.
dollar equivalent determined by reference to the spot rate of exchange on the date of disposition, if the amount realized is denominated
in a foreign currency). The gain or loss realized on the sale, exchange or other disposition of securities will be long-term capital
gain or loss if the U.S. Holder has a holding period of more than one year at the time of the disposition. Individuals who recognize
long-term capital gains may be taxed on such gains at reduced rates of tax. The deduction of capital losses is subject to various limitations.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "></p><div>

</div><!-- Field: Page; Sequence: 106; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Passive
Foreign Investment Companies</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Special
U.S. federal income tax laws apply to U.S. taxpayers who own shares of a corporation that is a PFIC. We will be treated as a PFIC for
U.S. federal income tax purposes for any taxable year that either:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75%
    or more of our gross income (including our pro rata share of gross income for any company, in which we are considered to own 25%
    or more of the shares by value), in a taxable year is passive; or </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
    least 50% of our assets, averaged over the year and generally determined based upon fair market value (including our pro rata share
    of the assets of any company in which we are considered to own 25% or more of the shares by value) are held for the production of,
    or produce, passive income. </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
this purpose, passive income generally consists of dividends, interest, rents, royalties, annuities and income from certain commodities
transactions and from notional principal contracts. Cash is treated as generating passive income.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the projected composition of our income and valuation of our assets, we do not expect to be a PFIC for 2022, and we do not expect
to become a PFIC in the future, although there can be no assurance in this regard. The tests for determining PFIC status are applied
annually, and it is difficult to make accurate projections of future income and assets which are relevant to this determination. In addition,
our PFIC status may depend in part on the market value of our securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we currently are or become a PFIC, each U.S. Holder who has not elected to mark the shares to market (as discussed below), would, upon
receipt of certain distributions by us and upon disposition of our securities at a gain:&#160;(1) have such distribution or gain allocated
ratably over the U.S. Holder&#8217;s holding period for the securities, as the case may be; (2) the amount allocated to the current taxable
year and any period prior to the first day of the first taxable year in which we were a PFIC would be taxed as ordinary income; and (3)
the amount allocated to each of the other taxable years would be subject to tax at the highest rate of tax in effect for the applicable
class of taxpayer for that year, and an interest charge for the deemed deferral benefit would be imposed with respect to the resulting
tax attributable to each such other taxable year. In addition, when shares of a PFIC are acquired by reason of death from a decedent
that was a U.S. Holder, the tax basis of such shares would not receive a step-up to fair market value as of the date of the decedent&#8217;s
death, but instead would be equal to the decedent&#8217;s basis if lower, unless all gain were recognized by the decedent. Indirect investments
in a PFIC may also be subject to these special U.S. federal income tax rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PFIC rules described above would not apply to a U.S. Holder who makes a QEF election for all taxable years that such U.S. Holder has
held the securities while we are a PFIC, provided that we comply with specified reporting requirements. Instead, each U.S. Holder who
has made such a QEF election is required for each taxable year that we are a PFIC to include in income such U.S. Holder&#8217;s pro rata
share of our ordinary earnings as ordinary income and such U.S. Holder&#8217;s pro rata share of our net capital gains as long-term capital
gain, regardless of whether we make any distributions of such earnings or gain. In general, a QEF election is effective only if we make
available certain required information. The QEF election is made on a shareholder-by-shareholder basis and generally may be revoked only
with the consent of the IRS. We do not intend to notify U.S. Holders if we believe we will be treated as a PFIC for any tax year. In
addition, we do not intend to furnish U.S. Holders annually with information needed in order to complete IRS Form 8621 and to make and
maintain a valid QEF election for any year in which we or any of our subsidiaries are a PFIC. Therefore, the QEF election will not be
available with respect to our securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the PFIC rules described above would not apply if we were a PFIC and a U.S. Holder made a mark-to-market election. A U.S. Holder
of our securities which are regularly traded on a qualifying exchange, including the Nasdaq Capital Market, can elect to mark the securities
to market annually, recognizing as ordinary income or loss each year an amount equal to the difference as of the close of the taxable
year between the fair market value of the securities and the U.S. Holder&#8217;s adjusted tax basis in the securities. Losses are allowed
only to the extent of net mark-to-market gain previously included income by the U.S. Holder under the election for prior taxable years.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 107; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Holders who hold our securities during a period when we are a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC.
U.S. Holders are strongly urged to consult their tax advisors about the PFIC rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax
on Net Investment Income</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Holders who are individuals, estates or trusts will generally be required to pay a 3.8% Medicare tax on their net investment income (including
dividends on and gains from the sale or other disposition of our securities), or in the case of estates and trusts on their net investment
income that is not distributed. In each case, the 3.8% Medicare tax applies only to the extent the U.S. Holder&#8217;s total adjusted
income exceeds applicable thresholds.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Information
Reporting and Withholding</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
U.S. Holder may be subject to backup withholding at a rate of 24% with respect to cash dividends and proceeds from a disposition of securities.
In general, backup withholding will apply only if a U.S. Holder fails to comply with specified identification procedures. Backup withholding
will not apply with respect to payments made to designated exempt recipients, such as corporations and tax-exempt organizations. Backup
withholding is not an additional tax and may be claimed as a credit against the U.S. federal income tax liability of a U.S. Holder, provided
that the required information is timely furnished to the IRS.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to recently enacted legislation, a U.S. Holder with interests in &#8220;specified foreign financial assets&#8221; (including, among other
assets, our securities, unless such securities are held on such U.S. Holder&#8217;s behalf through a financial institution) may be required
to file an information report with the IRS if the aggregate value of all such assets exceeds $50,000 on the last day of the taxable year
or $75,000 at any time during the taxable year (or such higher dollar amount as may be prescribed by applicable IRS guidance); and may
be required to file a Report of Foreign Bank and Financial Accounts if the aggregate value of the foreign financial accounts exceeds
$10,000 at any time during the calendar year. You should consult your own tax advisor as to the possible obligation to file such information
report.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_051"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
                                            and Paying Agents</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_052"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">G.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statement
                                            by Experts</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_053"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documents
                                            on Display</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to certain information reporting requirements of the Exchange Act, applicable to foreign private issuers and under those
requirements will file reports with the SEC. The SEC maintains an Internet website that contains reports and other information regarding
issuers that file electronically with the SEC. Our filings with the SEC will also available to the public through the SEC&#8217;s website
at www.sec.gov.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a foreign private issuer, we are exempt from the rules under the Exchange Act related to the furnishing and content of proxy statements,
and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained
in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file annual, quarterly and current reports
and financial statements with the SEC as frequently or as promptly as U.S. domestic companies whose securities are registered under the
Exchange Act. However, we will file with the SEC, within 120 days after the end of each fiscal year, or such applicable time as required
by the SEC, an annual report containing financial statements audited by an independent registered public accounting firm, and may submit
to the SEC, on a Form 6-K, unaudited half-yearly financial information.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 108; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a corporate website <i>www.jeffsbrands.com</i>. Information contained on, or that can be accessed through, our website and the
other websites referenced above do not constitute a part of this Annual Report on Form 20-F. We have included these website addresses
in this Annual Report on Form 20-F solely as inactive textual references.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_054"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary
                                            Information</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_055"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">J.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annual
                                            Report to Security Holders</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_056"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</b></span></p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are exposed to market risks in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial
position due to adverse changes in financial market prices and rates. Our current investment policy is to invest available cash in bank
deposits with banks that have a credit rating of at least A-minus. Accordingly, some of our cash and cash equivalents is held in deposits
that bear interest. Given the current low rates of interest we receive, we will not be adversely affected if such rates are reduced.
Our market risk exposure is primarily a result of U.S. dollar/NIS exchange rates, which is discussed in detail in the following paragraph.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impact
of Inflation and Currency Fluctuations</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
functional and reporting currency is the U.S.&#160;dollar. We incur some of our expenses in other currencies. As a result, we are exposed
to the risk that the rate of inflation in countries in which we are active other than the United&#160;States will exceed the rate of
devaluation of such countries&#8217; currencies in relation to the dollar or that the timing of any such devaluation will lag behind
inflation in such countries.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Global
inflation has risen in 2022. To date, we have not been subject to inflationary pressures. However, to mitigate any identified potential
inflationary pressures, the Company purchased more inventory at the beginning of the year in order to avoid price increases that may
be caused by the increase in inflation or shipping costs. We cannot assure you that we will not be adversely affected in the future.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
annual rate of inflation in Israel was 5.3% in 2022 and 2.8% in 2021. The NIS revaluated against the U.S.&#160;dollar by approximately
1.13% in 2022 and 3.26% in 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impact
of Supply Chain Disruptions</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the COVID-19 pandemic, we have experienced occasional supply constraints, primarily in the form of increases in freight costs
from approximately $2,000 per container pre-COVID-19 to approximately $20,000 per container in the midst of the pandemic, and delays
in shipment of inventory. Shipping costs per container have decreased significantly during the year ended December 31, 2022 in comparison
to such costs during the year ended December&#160;31, 2021; therefore, we do not believe that the supply chain challenges will continue
to impact our business and profitability. Currently, the shipping costs are approximately $3,000 per container and we expect such costs
to further decrease. We have also experienced increases in the cost of certain products, as well as a decrease in promotions by some
manufacturers. The COVID-19 pandemic also impacted the supply chain of our brand partners, and our ability to timely fulfill orders and
deliver such orders to our customers, particularly as a result of mandatory shutdowns in different countries and cities to mitigate the
spread of the virus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 109; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this Annual Report on Form 20-F , we consider such events to be relatively minor and temporary, and our outlook and business
goals, as well as results of operations, capital resources and quantity, sales, profits, and/or liquidity are not materially adversely
affected by supply chain disruptions related to the COVID-19 pandemic. However, continued supply chain disruptions could lead to delayed
receipt of, or shortages in, inventory and higher costs, and negatively impact our sales. Therefore, we maintain a comprehensive network
of manufacturers. In order to mitigate such risks, in cases where certain components are purchased from single source manufacturers,
we have adjusted and modified designs based on different components from different suppliers, to allow for more versatility and flexibility.
We do not believe that such mitigation efforts have introduced any other new material risks, including but not limited to, those related
to product quality or reliability or regulatory approval of products.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as of the date of this Annual Report on Form 20-F, our business segments, products, lines of service, projects and operations
are not materially adversely affected by supply chain disruptions in light of Russia&#8217;s invasion of Ukraine and/or related geopolitical
tension, and we do not expect to be materially impacted by any supply chain disruptions in the future.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_057"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</b></span></p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_058"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt
                                            Securities.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_059"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
                                            and rights.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 30, 2022, we&#160;completed
our IPO of (A) 3,717,473 Units, at a public offering price of $4.16 per Unit, with each Unit consisting of one Ordinary Share and one
Warrant to purchase one Ordinary Share, at an initial exercise price of $4.04 per Ordinary Share (and an exercise price of $2.02 following
the Exercise Price Adjustment) exercisable until August 25, 2027, (B) Underwriter&#8217;s Warrants to purchase up to 185,873 Ordinary
Shares, at an exercise price of $5.20 per Ordinary Share, exercisable beginning on February 21, 2022 and until August 25, 2027, and (C)
Warrants to purchase up to 425,912 Ordinary Shares issued to the Underwriter pursuant to its over-allotment option. The Ordinary Shares
and Warrants were immediately separable from the units and were issued separately. In connection with the IPO we issued and sold 3,717,473
Ordinary Shares, Warrants to purchase up to 4,143,385 Ordinary Shares (after giving effect to the partial exercise of the Underwriter&#8217;s
over-allotment option), and Underwriter&#8217;s Warrants to purchase up to 185,873 Ordinary Shares.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of the Warrants, effective after the closing of trading on November 28, 2022 (the 90th calendar day immediately following the issuance
date of the Warrants), the Warrants were adjusted pursuant to their terms, including, but not limited to, to adjust the exercise price
of the Warrants to $2.02. In addition, in connection with the Exercise Price Adjustment, the Company issued Additional Warrants to purchase
up to 2,824,525 Ordinary Shares to Qualified Holders (as defined in the Warrant).</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the July 1 Loan Agreement and the July 5 Loan Agreement, effective as of August 30, 2022, we issued warrants to purchase
up to 30,048 Ordinary Shares at an exercise price of $4.04 per Ordinary Share, to each of Tamrid and MRM, which were exercisable immediately.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, effective as of August 30, 2022, we issued warrants to purchase up to 18,565 Ordinary Shares at an exercise price of $4.04
per Ordinary Share (and an exercise price of $2.02 following the Exercise Price Adjustment) to an advisor. The warrants were exercisable
immediately and are exercisable until August 30, 2027.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_060"></a></div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                            Securities</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">American
                                            Depositary Shares</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>


</div><!-- Field: Page; Sequence: 110; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_061"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_062"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_063"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the IPO (including a partial exercise of over-allotment option), the Company issued and sold 3,717,473 Ordinary Shares
and Warrants to purchase up to 4,143,385 Ordinary Shares and received gross proceeds of approximately $15.5 million before deducting
underwriting discounts and commissions and before offering expenses ($13.4 million net proceeds after deducting approximately $1.05 million
of underwriting discounts and commissions and approximately $1.05 million after deducting other offering costs).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net proceeds from the offering have been used, and are expected to continue to be used, for the following purposes:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
                                            $7.5&#160;million for the purchase of new Amazon brands, the development of new brands, and
                                            improvement of existing brands;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approximately
                                            $2.15&#160;million for the repayment of certain outstanding indebtedness; and</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            remainder for working capital and general corporate purposes, including potential acquisitions
                                            and collaborations and investments in warehouse, logistics software and facilities to strengthen
                                            our supply chain process.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_064"></a></div><p style="text-align: left; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM </b></span>15. CONTROLS AND PROCEDURES</p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
                                            Controls and Procedures</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain disclosure controls and procedures designed to provide reasonable assurance that information required to be disclosed in reports
filed under the Exchange Act is recorded, processed, summarized and reported within the specified time periods and accumulated and communicated
to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding
required disclosure.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">Our
management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our
disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31,
2022, or the Evaluation Date. Based on such evaluation, those officers have concluded that, as of the Evaluation Date, our disclosure
controls and procedures were effective.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management&#8217;s
                                            Annual Report on Internal Control over Financial Reporting</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 20-F does not include a report of management&#8217;s assessment regarding internal control over financial reporting
due to a transition period established by the rules of the SEC for newly public companies.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attestation
                                            Report of the Registered Public Accounting Firm</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 20-F does not include an attestation report of the company&#8217;s registered public accounting firm due to an
exemption for emerging growth companies under the JOBS Act.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p><div>

</div><!-- Field: Page; Sequence: 111; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
                                            in Internal Control over Financial Reporting</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Not applicable.</p><div>
</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_065"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 16. [RESERVED]</b></span></p><div>



</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_066"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has determined Moshe Revach is an audit committee financial expert as defined by the SEC rules and has the requisite
financial experience as defined by the Nasdaq listing rules. Each of the members of our audit committee is &#8220;independent&#8221;
as such term is defined in Rule 10A-3(b)(1) under the Exchange Act and satisfies the independent director requirements under the Nasdaq
Stock Market Listing Rules.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_067"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16B. CODE OF ETHICS</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Business Conduct and Ethics</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have adopted a written Code of Business and Ethics that applies to our officers and employees, including the Chief Executive Officer,
President, Chief Financial Officer, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer, Controller
and persons performing similar functions, as well as our directors. Our Code of Business Ethics is posted on our website at www.jeffsbrands.com.
Information contained on, or that can be accessed through, our website does not constitute a part of this Annual Report on Form 20-F
and is not incorporated by reference herein. If we make any amendment to the Code of Business Ethics or grant any waivers, including
any implicit waiver, from a provision of the code, we will disclose the nature of such amendment or waiver on our website to the extent
required by the rules and regulations of the SEC including the instructions to Item 16B of Form 20-F. Any waiver of this Code for any
Covered Person may be made only by the Board or the Audit Committee and will be promptly disclosed to stockholders and others, as required
by applicable law. The Company must disclose changes to and waivers of the Code in accordance with applicable law. We have not granted
any waivers under our Code of Business Conduct and Ethics.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_068"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM&#160;16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pre-Approval
of Auditors&#8217; Compensation</i></b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brightman
Almagor Zohar &amp; Co., a Firm in the Deloitte Global Network, an independent registered public accounting firm, or Brightman, has served
as our principal independent registered public accounting firm for each of the two years ended December 31, 2022 and 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 112; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information regarding fees paid by us to Brightman, including audit services, for the years ended December 31,
2022 and 2021.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit fees&#160;<sup>(1)</sup></span></td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">150</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">150</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-related fees&#160;<sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax fees <sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All other fees&#160;<sup>(4)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">0</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">17</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">195</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">182</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Includes professional services rendered in connection
                                            with the audit of our annual financial statements, review of our interim financial statements
                                            and tax returns.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">Includes comfort letter rendered in connection with
                                            the IPO.</td>
</tr></table><div>

</div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">Includes preparation of tax returns in the United
                                            States.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
     </table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">(4)</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Includes
                                            NIS 60 thousands (approximately $17 thousands) for the year ended December 31 , 2021 in connection
                                            with examination regarding transfer pricing.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pre-Approval
of Auditors&#8217; Compensation</i></b>&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors have adopted an audit committee charter setting forth, among others, the responsibilities of the audit committee consistent
with the rules of the SEC and Nasdaq Listing Rules (in addition to the requirements for such committee under the Companies Law), including,
among others, the following:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">oversight
                                            of our independent registered public accounting firm and recommending the engagement, compensation
                                            or termination of engagement of our independent registered public accounting firm to the
                                            board of directors in accordance with Israeli law;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 38.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
                                            the engagement or termination of the person filling the office of our internal auditor, reviewing
                                            the services provided by our internal auditor and reviewing effectiveness of our system of
                                            internal control over financial reporting&#160;;</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 38.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
                                            the terms of audit and non-audit services provided by the independent registered public accounting
                                            firm for pre-approval by our board of directors; and</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 38.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
                                            and monitoring, if applicable, legal matters with significant impact, finding of regulatory
                                            authorities&#8217; findings, receive reports regarding irregularities and legal compliance,
                                            acting according to &#8220;whistleblower policy&#8221; and recommend to our board of directors
                                            if so required.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_069"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 113; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_070"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2022, Medigus purchased 240,385 Units comprised of 240,385 Ordinary Shares and Warrants to purchase up to 240,385 Ordinary Shares
for an aggregate purchase price of approximately $1,000,001. Following that, Medigus held approximately 35.27&#160;% of our issued and
outstanding share capital. Following the Exercise Price Adjustment Medigus were issued Additional Warrants to purchase up to 240,385
Ordinary Shares. Following that, Medigus held approximately 35.27% of our issued and outstanding share capital. In addition, on August
30, 2022, in accordance with the Assignment Agreement, the outstanding principal amount of the loans due to Medigus were automatically
converted into 1,160,133 Ordinary Shares. Following that, Medigus held approximately 35.27&#160;% of our issued and outstanding share
capital.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 30, 2022, Pure
Capital purchased in our IPO 180,288 Units comprised of 180,288 Ordinary Shares and Warrants to purchase up to 180,288 Ordinary Shares
for an aggregate purchase price of approximately $750,000. Also, on August 30, 2022, in accordance with the Assignment Agreement, the
outstanding principal amount of the loans due to Pure Capital were automatically converted into 31,535 Ordinary Shares. Following that,
Pure Capital held approximately 4.99&#160;% of our issued and outstanding share capital. In August 2022, Pure Capital sold a total of
65,202 Ordinary Shares in open market transactions, at an average price per share of $2.86. Following that, Pure Capital held approximately
4.19% of our issued and outstanding share capital.&#160;Also in August 2022, Pure Capital purchased a total of 89,600 Ordinary Shares
in open market transactions, at an average price per share of $1.4. Following that, Pure Capital held approximately 5.29% of our issued
and outstanding share capital.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 30, 2022, Medigus
purchased in our IPO 240,385 Units comprised of 240,385 Ordinary Shares and Warrants to purchase up to 240,385 Ordinary Shares for an
aggregate purchase price of approximately $1,000,001. In addition, in connection with the IPO, on August 30, 2022, in accordance with
the Assignment Agreement, the outstanding principal amount of the loans due to Medigus were automatically converted into 1,160,133 Ordinary
Shares. Following that, Medigus held approximately 35.27% of our issued and outstanding share capital. In addition, following the Exercise
Price Adjustment, on November 28, 2022, Medigus was issued Additional Warrants to purchase up to 240,385 Ordinary Shares. Also in November 2022, Medigus purchased a total of 60,000 Ordinary
Shares in open market transactions, at an average price per share of $1.88. Following that,
Medigus held approximately 39.61% of our issued and outstanding share capital. In December 2022, Medigus sold a total of 5,813 Ordinary Shares in open market transactions,
at an average price per share of $1.14. Following that, Medigus held approximately 39.54% of our issued and outstanding share capital.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective as of March 22,
2023, pursuant to the Wellution Agreement, in connection with the closing of the Wellution Transaction, we issued 247,415 Ordinary Shares
to SciSparc and on March 29, 2023 SciSparc issued 360,297&#160; of its ordinary shares to us in a mutual share exchange, or, collectively,
the Exchange Shares, representing approximately 2.97% and 4.99%, respectively, of the Company&#8217;s and SciSparc&#8217;s issued and
outstanding ordinary shares. The number of Exchange Shares acquired by each company was calculated by dividing $288,238, which was adjusted
from $300,000, pursuant to the 4.99% ownership limit included in the Wellution Agreement, by the average closing price of the relevant
company&#8217;s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior
to the closing.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><div><a id="a_071"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_072"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 16G. CORPORATE GOVERNANCE</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sarbanes-Oxley Act, as well as related rules subsequently implemented by the SEC, require foreign private issuers, such as us, to comply
with various corporate governance practices. In addition, we are required to comply with the Nasdaq Listing Rules. Under those rules,
we may elect to follow certain corporate governance practices permitted under the Companies Law in lieu of compliance with corresponding
corporate governance requirements otherwise imposed by the Nasdaq Listing Rules for U.S. domestic issuers.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 114; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with Israeli law and practice and subject to the exemption set forth in Rule 5615 of the Nasdaq Listing Rules, we have elected
to follow the provisions of the Companies Law, rather than the Nasdaq Listing Rules, with respect to the following requirements:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Quorum</i>.
    While the Nasdaq Stock Market Listing Rules require that the quorum for purposes of any meeting of the holders of a listed company&#8217;s
    common voting stock, as specified in the company&#8217;s bylaws, be no less than 33 1/3% of the company&#8217;s outstanding common
    voting stock, under Israeli law, a company is entitled to determine in its articles of association the number of shareholders and
    percentage of holdings required for a quorum at a shareholders meeting. Our amended and restated articles of association provide
    that a quorum of two or more shareholders holding at least 25% of the voting rights in person or by proxy is required for commencement
    of business at a general meeting. However, the quorum set forth in our articles of association with respect to an adjourned meeting
    consists of at least one shareholders present in person or by proxy.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 119.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nomination
    of our directors. </i>With the exception of directors elected by our board of directors and external directors, our directors are
    elected by an annual meeting of our shareholders (i) to hold office until the next annual meeting following his or her election or
    (ii) for three-year term, as described below under &#8220;Item 6.C. Board Practices&#8212;External Directors.&#8221; The nominations
    for directors, which are presented to our shareholders by our board of directors, are generally made by the board of directors itself,
    in accordance with the provisions of our amended and restated articles of association and the Companies Law. Nominations need not
    be made by a nominating committee of our board of directors consisting solely of independent directors, as required under the Nasdaq
    Listing Rules.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compensation
    of officers. </i>Israeli law and our articles of association do not require that the independent members of our board of directors
    (or a compensation committee composed solely of independent members of our board of directors) determine an executive officer&#8217;s
    compensation, as is generally required under the Nasdaq Stock Market Listing Rules with respect to the chief executive officer and
    all other executive officers. Instead, compensation of executive officers is determined and approved by our compensation committee
    and our board of directors, and in certain circumstances by our shareholders, either in consistency with our office holder compensation
    policy or, in special circumstances in deviation therefrom, taking into account certain considerations stated in the Companies Law
    (see &#8220;Item 6.C. &#8212; Board Practices &#8212; Fiduciary Duties and Approval of Related Party Transactions under Israeli Law&#8221;
    for additional information).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#9679;</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Independent
    directors.</i>&#160;Israeli law does not require that a majority of the directors serving on our board of directors be &#8220;independent,&#8221;
    as defined under Nasdaq Listing Rule&#160;5605(a)(2), and rather requires we have at least two external directors who meet the requirements
    of the Companies Law, as described above under &#8220;Item 6.C. Board Practices&#8212;External Directors.&#8221; We are required,
    however, to ensure that all members of our Audit Committee are &#8220;independent&#8221; under the applicable Nasdaq and SEC criteria
    for independence (as we cannot exempt ourselves from compliance with that SEC independence requirement, despite our status as a foreign
    private issuer), and we must also ensure that a majority of the members of our Audit Committee are &#8220;unaffiliated directors&#8221;
    as defined in the Companies Law. We have established an Audit Committee and appointed external directors compliant with applicable
    rules. Furthermore, Israeli law does not require, nor do our independent directors conduct, regularly scheduled meetings at which
    only they are present, which the Nasdaq Listing Rules otherwise require.</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 115; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Shareholder
    approval. </i>We will seek shareholder approval for all corporate actions requiring such approval under the requirements of the Companies
    Law, rather than seeking approval for corporation actions in accordance with Nasdaq Listing Rule 5635. In particular, under this
    Nasdaq listing rule, shareholder approval is generally required for: (i) an acquisition of shares/assets of another company that
    involves the issuance of 20% or more of the acquirer&#8217;s shares or voting rights or if a director, officer or 5% shareholder
    has greater than a 5% interest in the target company or the consideration to be received; (ii) the issuance of shares leading to
    a change of control; (iii) adoption or amendment of equity compensation arrangements (although under the provisions of the Companies
    Law there is no requirement for shareholder approval for the adoption/amendment of the equity compensation plan); and (iv) issuances
    of 20% or more of the shares or voting rights (including securities convertible into, or exercisable for, equity) of a listed company
    via a private placement (and/or via sales by directors/officers/5% shareholders) if such equity is issued (or sold) at below the
    greater of the book or market value of shares. By contrast, we follow Israeli practice, which is to have equity compensation plans
    approved only by the compensation committee and board of directors, unless such arrangements are for the compensation of chief executive
    officer or directors, in which case they also require the approval of the shareholders. In addition, we follow Israeli law, under
    which a private placement of securities requires approval by our board of directors and shareholders if it will cause a person to
    become a controlling shareholder (generally presumed at 25% ownership) or if: (a) the securities issued amount to 20% or more of
    our outstanding voting rights before the issuance; (b) some or all of the consideration is other than cash or listed securities or
    the transaction is not on market terms; and (c) transaction will increase the relative holdings of a shareholder that holds 5% or
    more of our outstanding share capital or voting rights or will cause any person to become, as a result of the issuance, a holder
    of more than 5% of our outstanding share capital or voting rights.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Approval
    of Related Party Transactions</i>. All related party transactions are approved in accordance with the requirements and procedures
    for approval of interested party acts and transaction as set forth in the Companies Law, which requires the approval of the audit
    committee, or the compensation committee, as the case may be, the board of directors and shareholders, as may be applicable, for
    specified transactions, rather than approval by the audit committee or other independent body of our board of directors as required
    under the Nasdaq Listing Rules (see &#8220;Item 6.C.&#8212; Board Practices &#8212; Fiduciary Duties and Approval of Related Party
    Transactions under Israeli Law&#8221; for additional information).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Annual
    Shareholders Meeting. </i>As opposed to the Nasdaq listing Rule 5620(a), which mandates that a listed company hold its annual shareholders
    meeting within one year of the company&#8217;s fiscal year-end, we are required, under the Companies Law, to hold an annual shareholder
    meeting each calendar year and within 15 months of the last annual shareholders meeting.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distribution
    of periodic reports to shareholders; proxy solicitation. </i>As opposed to the Nasdaq Listing Rules, which require listed issuers
    to make such reports available to shareholders in one of a number of specific manners, Israeli law does not require us to distribute
    periodic reports directly to shareholders, and the generally accepted business practice in Israel is not to distribute such reports
    to shareholders but to make such reports available through a public website. In addition to making such reports available on a public
    website, we currently make our audited consolidated financial statements available to our shareholders at our offices and will only
    mail such reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC&#8217;s proxy solicitation
    rules.</span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><div><a id="a_073"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 16H. MINE SAFETY DISCLOSURE</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_074"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>


</div><!-- Field: Page; Sequence: 116; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><div><a id="a_075"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
III</b></span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_076"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 17. FINANCIAL STATEMENTS</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have elected to provide financial statements and related information pursuant to Item 18.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_077"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 18. FINANCIAL STATEMENTS</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements and the related notes required by this Item are included in this Annual Report on Form 20-F beginning on page F-1.</span></p><div>

</div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><div><a id="a_078"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 19. EXHIBITS</b></span></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents are filed as part of annual report.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; border-bottom: black 1.5pt solid; width: 91%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022052639/ea165186ex3-1_jeffsbrands.htm">Amended and Restated Articles of Association of Jeffs&#8217; Brands Ltd (filed as Exhibit 3.1 to Form 6-K (File No. 001-41482) filed on August 31, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex4-2_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant (filed as Exhibit 4.2 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex4-5_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Underwriter&#8217;s Warrant (filed as Exhibit 4.5 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022029294/ff12022a2ex4-2_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Additional Warrant (filed as Exhibit 4.2 to Form F-1 (File No. 333-262835) filed on May 24, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022075542/posam2022ex4-5_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Investor Warrant (filed as Exhibit 4.5 to Post Effective Amendment to Form F-1 (File No. 333-262835) filed on November 28, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.5*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="f20f2022ex2-5_jeffsbrands.htm">Description of Securities.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1<span style="background-color: #CCEEFF">+</span></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022075542/posam2022ex10-1_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Indemnification Agreement (filed as Exhibit 10.1 to Post Effective Amendment to Form F-1 (File No. 333-262835) filed on November 28, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex4-1_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant Agent Agreement (filed as Exhibit 4.1 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3<span style="background-color: #CCEEFF">+</span></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-21_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffs&#8217; Brands Ltd 2022 Incentive Option Plan (filed as Exhibit 10.21 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4#</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022008335/ff12022ex10-2_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock Purchase Agreement, dated October 8, 2020, by and between Smart Repair Pro, Purex Corp., the stockholders of Smart Repair Pro and Purex Corp., Viki Hakmon, and Medigus Ltd. (filed as Exhibit 10.2 to Form F-1 (File No. 333-262835) filed on February 18, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5#</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022008335/ff12022ex10-3_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment No. 1 to Common Stock Purchase Agreement, dated June 22, 2021, by and between Smart Repair Pro, Purex Corp., the stockholders of Smart Repair Pro and Purex Corp., Viki Hakmon, and Medigus Ltd. (filed as Exhibit 10.3 to Form F-1 (File No. 333-262835) filed on February 18, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022008335/ff12022ex10-4_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Exchange and Plan of Restructuring Agreement, dated May 10, 2021, by and between Jeffs&#8217; Brands Ltd, on one hand, and Viki Hakmon and Medigus Ltd., on the other hand. (filed as Exhibit 10.4 to Form F-1 (File No. 333-262835) filed on February 18, 2022 and incorporated herein by reference).</span></a></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 117; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 91%"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-5_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Agreement, dated May 23, 2019, by and between Smart Repair Pro and L.I.A. Pure Capital Ltd. (filed as Exhibit 10.5 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-6_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Agreement, dated March 1, 2020, by and between Smart Repair Pro and Purex Corp. (filed as Exhibit 10.6 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-7_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase Agreement, dated February 2, 2021, by and between Smart Repair Pro and Beard Revive Inc. (filed as Exhibit 10.7 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-8_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Agreement, dated April 8, 2021, by and between Smart Repair Pro and Amazon.com (filed as Exhibit 10.8 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-9_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unsecured Loan Agreement, dated July 1, 2021, by and between Smart Repair Pro and Tamrid Ltd. (English Translation) (filed as Exhibit 10.9 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-10_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amendment to Unsecured Loan Agreement, dated July 13, 2021, by and between Smart Repair Pro and Tamrid Ltd. (English Translation) (filed as Exhibit 10.10 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-11_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amendment to Unsecured Loan Agreement, dated November 23, 2021, by and between Smart Repair Pro and Tamrid Ltd. (English Translation) (filed as Exhibit 10.11 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-12_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan Agreement, dated July 5, 2021, by and between Smart Repair Pro and M.R.M MERHAVIT Holdings and Management Ltd. (English Translation) (filed as Exhibit 10.12 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-13_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">First Amendment to Loan Agreement, dated July 13, 2021, by and between Smart Repair Pro and M.R.M Merhavit Holdings and Management Ltd. (English Translation) (filed as Exhibit 10.13 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-14_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amendment to Loan Agreement, dated November 23, 2021, by and between Smart Repair Pro and M.R.M Merhavit Holdings and Management Ltd. (English Translation) (filed as Exhibit 10.14 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-15_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Assignment and Assumption Agreement (filed as Exhibit 10.15 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18<span style="background-color: #CCEEFF">+</span></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022008335/ff12022ex10-15_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: #CCEEFF">Employment Agreement, dated April&#160;1, 2021, by and between Jeffs&#8217; Brands Ltd and Naor Bergman</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(filed as Exhibit 10.15 to Form F-1 (File No. 333-262835) filed on February 18, 2022 and incorporated herein by reference).</span></a></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 118; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19<span style="background-color: #CCEEFF">+</span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 91%"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022008335/ff12022ex10-16_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services Agreement, dated November&#160;28, 2021, by and between Jeffs&#8217; Brands Ltd and Viki Hakmon</span> <span style="font-size: 10pt">(filed as Exhibit 10.16 to Form F-1 (File No. 333-262835) filed on February 18, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20<span style="background-color: #CCEEFF">+</span></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-20_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Services Agreement, dated May 4, 2022, by and between Jeffs&#8217; Brands Ltd and Viki Hakmon (filed as Exhibit 10.20 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21<span style="background-color: #CCEEFF">+</span></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022075542/posam2022ex10-20_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services Agreement, dated October&#160;24, 2022, by and between Jeffs&#8217; Brands Ltd and D.S.&#160;Blue White Assets (2006)&#160;Ltd. (filed as Exhibit 10.20 to Post Effective Amendment to Form F-1 (File No. 333-262835) filed on November 28, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.22</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-22_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Line of Credit Agreement, dated February&#160;22, 2022, between Jeffs&#8217; Brands Ltd and Bank Leumi Le-Israel Ltd. (English Translation) (filed as Exhibit 10.22 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.23</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022024068/ff12022ex10-23_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: #CCEEFF">Credit Request, dated March&#160;3, 2022, pursuant to the Line of Credit Agreement between Jeffs&#8217; Brands Ltd and Bank Leumi Le-Israel Ltd. (English Translation) </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(filed as Exhibit 10.23 to Form F-1 (File No. 333-262835) filed on May 5, 2022 and incorporated herein by reference)<span style="background-color: #CCEEFF">.</span></span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.24*+</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="f20f2022ex4-24_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement, dated October 26, 2022, between Jeffs&#8217; Brands Ltd and L.I.A. Pure Capital Ltd.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.25</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022075542/posam2022ex10-24_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse Services Agreement, dated October 31, 2022, between Pure NY Logistics LLC and Smart Repair Pro. (filed as Exhibit 10.24 to Post Effective Amendment to Form F-1 (File No. 333-262835) filed on November 28, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.26<span style="background-color: #CCEEFF">+</span></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390022075542/posam2022ex10-25_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: #CCEEFF">Compensation Policy for Executive Officers</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(filed as Exhibit 10.25 to Post Effective Amendment to Form F-1 (File No. 333-262835) filed on November 28, 2022 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.27</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390023014814/ea174331ex99-2_jeffsband.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Purchase Agreement, dated February 23, 2023, by and between Jeffs&#8217; Brands Ltd, Jeffs&#8217; Brands Holdings Inc. and SciSparc Ltd. (filed as Exhibit 99.2 to Form 6-K (File No. 001-41482) filed on February 27, 2023 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.28</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390023024983/ea176115ex10-2_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addendum No. 1 to Share Purchase Agreement, dated March 22, 2023, by and between the Company, Jeffs&#8217; Brands Holdings Inc. and SciSparc Ltd. (filed as Exhibit 10.2 to Form 6-K (File No. 001-41482) filed on March 31, 2023 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.29</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390023017932/ea174779ex2-1_jeffsbrands.htm">Share Purchase Agreement, dated March 22, 2023, by and between Jeffs&#8217; Brands Ltd, Jeffs&#8217; Brands Holdings Inc., Craig Philip Davies and Sarah Jane Davies-Broadhurst (filed as Exhibit 2.1 to Form 6-K (File No. 001-41482) filed on March 7, 2023 and incorporated herein by reference).</a></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.30<span style="background-color: #CCEEFF">+</span></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390023024983/ea176115ex10-3_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement, dated March 22, 2023, by and between Jeffs&#8217; Brands Ltd and SciSparc Nutraceuticals Inc. (filed as Exhibit 10.3 to Form 6-K (File No. 001-41482) filed on March 31, 2023 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.31<span style="background-color: #CCEEFF">+</span></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390023022197/ea175616ex10-3_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement, dated March 9, 2023, by and between Jeffs&#8217; Brands Ltd, Sarah Davies-Broadhurst and Craig Davies (filed as Exhibit 10.3 to Form 6-K (File No. 001-41482) filed on March 23, 2023 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.32</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="http://www.sec.gov/Archives/edgar/data/1885408/000121390023022197/ea175616ex10-2_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Settlement Agreement, dated March 9, 2023, by and between Jeffs&#8217; Brands Ltd, Fort Products Ltd. and the individual identified on the signature page thereto (filed as Exhibit 10.2 to Form 6-K (File No. 001-41482) filed on March 23, 2023 and incorporated herein by reference).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="f20f2022ex8-1_jeffsbrands.htm">List of Subsidiaries.</a></span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 119; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.1*</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: justify; width: 91%"><a href="f20f2022ex12-1_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Principal Executive Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.2*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><a href="f20f2022ex12-2_jeffsbrands.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of the Principal Financial and Accounting Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.1%</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="f20f2022ex13-1_jeffsbrands.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.2%</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="f20f2022ex13-2_jeffsbrands.htm">Certification of the Principal Financial and Accounting Officer pursuant to 18 U.S.C. 1350.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.1*</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="f20f2022ex15-1_jeffsbrands.htm">Consent of Brightman Almagor Zohar &amp; Co., a Firm in the Deloitte Global Network, an independent registered public accounting firm.</a>&#160;&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following financial information from the Registrant&#8217;s Annual Report on Form 20-F for the year ended December 31, 2022, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Report of Independent Registered Public Accounting Firm; (ii) Consolidated Balance Sheets; (iii) Consolidated Statements of Operations; (iv) Consolidated Statements of Changes in Convertible Preferred Shares and Shareholders&#8217; Equity (Deficit); (v) Consolidated Statements of Cash Flows; and (vi) Notes to the Consolidated Financial Statements, tagged as blocks of text and in detail.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEBFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished
    herewith.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compensatory
    arrangement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
    schedules and exhibits have been omitted pursuant to Item&#160;601(a)(5)&#160;of Regulation&#160;S-K.&#160;The Company agrees to
    furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 120; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>JEFFS&#8217;
BRANDS LTD</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>CONSOLIDATED
FINANCIAL STATEMENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>TABLE
OF CONTENTS</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 89%">&#160;</td> <td style="white-space: nowrap; width: 1%">&#160;</td> <td style="border-bottom: Black 1.5pt solid; width: 10%; text-align: center"><span style="font-size: 10pt"><b>Page</b></span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td> <td style="white-space: nowrap">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#f_001">Report of Independent Registered Public Accounting Firm (Firm Name: Brightman Almagor Zohar &amp; Co / PCAOB ID No.&#160;<ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId">1197</ix:nonNumeric>)</a></td> <td style="white-space: nowrap">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt; text-transform: uppercase">F-2</span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-size: 10pt"><a href="#f_002">Consolidated Balance Sheets as of December 31, 2022</a></span></td> <td style="white-space: nowrap">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt; text-transform: uppercase">F-3</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#f_003"><span style="font-size: 10pt">Consolidated Statements of Operations for the Years Ended December 31, 2022, 2021 and 2020</span></a></td> <td style="white-space: nowrap">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt; text-transform: uppercase">F-4</span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#f_004"><span style="font-size: 10pt">Consolidated Statements of Changes in Shareholders&#8217; Equity for the Years Ended December 31, 2022, 2021 and 2020</span></a></td> <td style="white-space: nowrap">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt; text-transform: uppercase">F-5</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#f_005"><span style="font-size: 10pt">Consolidated Statements of Cash Flows for the Years Ended December 31, 2022, 2021 and 2020</span></a></td> <td style="white-space: nowrap">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt; text-transform: uppercase">F-6</span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><a href="#f_006"><span style="font-size: 10pt">Notes to the Consolidated Financial Statements</span></a></td> <td style="white-space: nowrap">&#160;</td> <td style="text-align: center"><span style="font-size: 10pt; text-transform: uppercase">F-7&#160;&#8211;&#160;F-35</span></td></tr> </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 122; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>



</div><div><a id="f_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REPORT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>To the Shareholders and Board of Directors
of Jeffs&#8217; Brands Ltd</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Opinion on the Financial Statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have audited the accompanying
consolidated balance sheets of Jeffs&#8217; Brands Ltd and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022 and 2021,
and the related consolidated statements of operations, changes in shareholders&#8217; equity and cash flows for each of the three years
in the period ended December 31, 2022, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;).
In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company
as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended
December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Basis for Opinion</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These consolidated financial
statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting
Oversight Board (United&#160;States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance
with the U.S.&#160;federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the
PCAOB.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We conducted our audits in
accordance with the standards of the PCAOB.&#160;Those standards require that we plan and perform the audit to obtain reasonable assurance
about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is
not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our audits included performing
procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and
performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts
and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that
our audits provide a reasonable basis for our opinion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 104.45pt 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 104.45pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
<ix:nonNumeric contextRef="c0" name="dei:AuditorName">Brightman Almagor Zohar&#160;&amp; Co.</ix:nonNumeric></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 104.45pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brightman Almagor Zohar&#160;&amp; Co.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certified Public Accountants</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A Firm in the Deloitte Global Network</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><ix:nonNumeric contextRef="c0" name="dei:AuditorLocation">Tel Aviv, Israel</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April&#160;10, 2023</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Company&#8217;s auditor since 2021.</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 123; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>



</div><div><a id="f_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED BALANCE SHEETS<br/>
(in thousands, except share and per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Note</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">ASSETS</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">CURRENT ASSETS:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; width: 66%; text-align: left">Cash and cash equivalents</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">8,137</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd">393</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Trade receivables</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" unitRef="usd">327</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" unitRef="usd">366</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Other receivables</td><td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">3</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" unitRef="usd">779</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" unitRef="usd">36</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; padding-bottom: 1.5pt">Inventory</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">4</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" unitRef="usd">1,791</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNet" scale="3" unitRef="usd">1,227</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt"><b>Total
    current assets</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd">11,034</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd">2,022</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">NON-CURRENT ASSETS:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Deferred offering costs</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-0">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredCosts" scale="3" unitRef="usd">366</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">41</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd">3</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: center">5</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">4,452</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd">5,021</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Deferred taxes</td><td>&#160;</td>
    <td style="text-align: center">11</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" unitRef="usd">110</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-1">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Operating lease right-of-use assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">6</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd">138</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-2">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt"><b>Total
    non-current assets</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">4,741</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsNoncurrent" scale="3" unitRef="usd">5,390</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">TOTAL ASSETS</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd">15,775</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd">7,412</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">LIABILITIES AND EQUITY</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">CURRENT LIABILITIES:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Trade payables</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" unitRef="usd">131</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" unitRef="usd">167</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Other payables</td><td>&#160;</td>
    <td style="text-align: center">7</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLoansPayableCurrent" scale="3" unitRef="usd">391</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLoansPayableCurrent" scale="3" unitRef="usd">715</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Related party payables</td><td>&#160;</td>
    <td style="text-align: center">16</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" scale="3" unitRef="usd">32</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" scale="3" unitRef="usd">265</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Short-term loans</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">8</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="3" unitRef="usd">86</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="3" unitRef="usd">927</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt"><b>Total
    current liabilities</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd">640</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd">2,074</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">NON-CURRENT LIABILITIES:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Loans from shareholders</td><td>&#160;</td>
    <td style="text-align: center">10</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-3">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLoansPayableLongTerm" scale="3" unitRef="usd">3,634</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Derivative liabilities</td><td>&#160;</td>
    <td style="text-align: center">9</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" unitRef="usd">2,216</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" unitRef="usd">137</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Operating lease liabilities</td><td>&#160;</td>
    <td style="text-align: center">6</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd">98</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-4">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Deferred taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">11</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-5">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" unitRef="usd">314</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt"><b>Total
    non-current liabilities</b></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" unitRef="usd">2,314</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" unitRef="usd">4,085</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL LIABILITIES</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd">2,954</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd">6,159</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">SHAREHOLDERS&#8217; EQUITY:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in">Ordinary shares of <span style="-sec-ix-hidden: hidden-fact-8"><span style="-sec-ix-hidden: hidden-fact-9">no</span></span> par value per share - Authorized: <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">43,567,567</ix:nonFraction> and <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares">4,356,757</ix:nonFraction> shares as of December 31, 2022, and December 31, 2021, respectively; Issued and outstanding: <ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">8,074,217</ix:nonFraction></ix:nonFraction> shares as of December 31, 2022; <ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares">2,893,125</ix:nonFraction></ix:nonFraction> shares as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: center">12</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-6">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-7">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Additional paid-in-capital</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd">16,499</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" unitRef="usd">2,730</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd">3,678</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd">1,477</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL SHAREHOLDERS&#8217;
    EQUITY</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">12,821</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">1,253</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">TOTAL LIABILITIES
    AND EQUITY</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd">15,775</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd">7,412</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The accompanying notes are an integral part
of the consolidated financial statements</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 124; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>



</div><div><a id="f_003"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF OPERATIONS<br/>
(in thousands, except share and per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 54%">Revenues</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: center">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">5,859</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">6,509</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd">2,289</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt">Cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" unitRef="usd">5,060</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" unitRef="usd">4,560</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="3" unitRef="usd">1,165</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd">799</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd">1,949</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GrossProfit" scale="3" unitRef="usd">1,124</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operating expenses:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd">1,198</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd">1,314</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SellingAndMarketingExpense" scale="3" unitRef="usd">376</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">4,113</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">1,480</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" unitRef="usd">328</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">5</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-10">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" scale="3" unitRef="usd">87</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-11">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Operating profit
    (loss)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd">4,512</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" sign="-" unitRef="usd">932</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" unitRef="usd">420</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Financial (income) expenses, net</td><td>&#160;</td>
    <td style="text-align: center">14</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FinancialincomeExpensesNet" scale="3" unitRef="usd">2,305</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FinancialincomeExpensesNet" scale="3" sign="-" unitRef="usd">629</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FinancialincomeExpensesNet" scale="3" sign="-" unitRef="usd">232</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Profit (loss)
    before taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" sign="-" unitRef="usd">2,207</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" sign="-" unitRef="usd">1,561</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossAttributableToParent" scale="3" unitRef="usd">188</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Tax (benefit) expense</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 1.5pt">10</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd">6</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd">21</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd">76</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left; padding-bottom: 4pt">Net profit (loss)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">2,201</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">1,540</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd">112</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-14; -sec-ix-hidden: hidden-fact-13; -sec-ix-hidden: hidden-fact-12">Basic and diluted net profit (loss) attributable to shareholders per ordinary share</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="text-align: center; padding-bottom: 4pt">15</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.47</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" sign="-" unitRef="usdPershares">0.53</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares">0.04</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt"><div style="-sec-ix-hidden: hidden-fact-17; -sec-ix-hidden: hidden-fact-16; -sec-ix-hidden: hidden-fact-15">Weighted-average ordinary shares used in computing net profit (loss) per share, basic and diluted</div></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">4,643,879</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">2,892,347</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares">2,888,768</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>The accompanying notes
are an integral part of the consolidated financial statements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 125; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="f_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD
</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217;
EQUITY<br/>
(in thousands, except share and per share data)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Ordinary <br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Additional</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Retained <br/> earnings <br/> (Accumulated</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">paid-in-capital</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">deficit)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 45%; font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">BALANCE AT JANUARY 1, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">2,893,125</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-18">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">232</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right">(<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">49</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 8%; text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">183</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Profit for the year</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">-</td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd">112</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd">112</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Transactions with shareholders</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-19">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd">55</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-20">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd">55</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">BALANCE AT DECEMBER 31, 2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c13" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">2,893,125</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-21">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">287</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">63</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">350</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Loss for the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-22">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-23">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">1,540</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">1,540</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Share-based compensation to service provider</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-24">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd">75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-25">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" unitRef="usd">75</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in">Issuance of ordinary shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-26">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd">1,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-27">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd">1,250</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-28">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd">60</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-29">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" unitRef="usd">60</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Transactions with shareholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-30">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd">1,058</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd">1,058</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">BALANCE AT DECEMBER 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">2,893,125</ix:nonFraction></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">-</div></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c21" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">2,730</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">1,477</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">1,253</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Loss for the year</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">2,201</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">2,201</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Debt extinguishment of shareholders&#8217; loans (Note
    10d)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" scale="3" unitRef="usd">769</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" scale="3" unitRef="usd">769</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Issuance of ordinary shares upon initial public offering,
    net of issuance costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="INF" format="ixt:num-dot-decimal" name="jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares" scale="0" unitRef="shares">3,717,473</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" scale="3" unitRef="usd">6,194</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" scale="3" unitRef="usd">6,194</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Issuance of warrants to third party upon initial public
    offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" unitRef="usd">26</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" unitRef="usd">26</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Conversion of shareholder loans (Note 12i)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c23" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" scale="0" unitRef="shares">1,463,619</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" unitRef="usd">3,461</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" unitRef="usd">3,461</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Reclassification of derivative
    warrant liabilities to equity (Note 9c)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" unitRef="usd">3,319</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" unitRef="usd">3,319</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">BALANCE AT DECEMBER 31, 2022</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c26" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares">8,074,217</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><ix:nonFraction contextRef="c27" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">16,499</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd">3,678</ix:nonFraction></td><td style="font-style: normal; padding-bottom: 1.5pt; font-weight: normal; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="font-style: normal; border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd">12,821</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table><div>






</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The accompanying notes are an integral part
of the consolidated financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 126; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="f_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
CONSOLIDATED STATEMENTS OF CASH FLOWS<br/>
(in thousands)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold">CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">Net profit (loss)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">2,201</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">1,540</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd">112</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Adjustments to reconcile net profit
    (loss) to net cash from (used in) operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd">60</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Depreciation and amortization of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" unitRef="usd">570</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" unitRef="usd">524</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" unitRef="usd">104</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Impairment of intangible asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="3" unitRef="usd">87</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accrued interest and amortization of discount on third
    party loans (Note&#160;8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" unitRef="usd">95</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherDepreciationAndAmortization" scale="3" unitRef="usd">222</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Gain from debt extinguishment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" unitRef="usd">14</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Change in fair value of derivative liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" sign="-" unitRef="usd">2,822</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd">75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-52">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accrued interest and amortization of discount on related
    party and<br/>
    shareholders&#8217; loans (Note&#160;8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" scale="3" unitRef="usd">203</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" scale="3" unitRef="usd">324</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" scale="3" unitRef="usd">162</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Interest expense on short-term loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermLeasePayments" scale="3" unitRef="usd">25</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Benefit for deferred taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd">15</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd">115</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd">50</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Operating lease right-of-use assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" unitRef="usd">14</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Issuance costs on derivative liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:IssuanceCostsOnDerivativeLiabilities" scale="3" unitRef="usd">1,416</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Decrease (increase) in trade receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" sign="-" unitRef="usd">39</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" unitRef="usd">282</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" sign="-" unitRef="usd">43</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Decrease (increase) related party balance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToRelatedParties" scale="3" unitRef="usd">40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDueToRelatedParties" scale="3" sign="-" unitRef="usd">40</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Decrease (increase) in other receivables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" unitRef="usd">743</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" unitRef="usd">290</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" sign="-" unitRef="usd">96</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Decrease (increase) in inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" unitRef="usd">564</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" unitRef="usd">449</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" unitRef="usd">638</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Increase (decrease) related party liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" scale="3" sign="-" unitRef="usd">213</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" scale="3" unitRef="usd">241</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" scale="3" unitRef="usd">14</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Increase (decrease) accounts payable and other payables</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="3" sign="-" unitRef="usd">579</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="3" unitRef="usd">254</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" scale="3" unitRef="usd">323</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: left">Decrease in operating lease liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" sign="-" unitRef="usd">15</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-60">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-61">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net cash from (used in) operating activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd">4,840</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd">863</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" unitRef="usd">126</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">CASH FLOWS USED IN INVESTING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Purchase of property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">41</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">2</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd">1</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; text-align: left">Purchase of intangible assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-62">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" unitRef="usd">4,728</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" unitRef="usd">100</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net cash used in investing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd">41</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd">4,730</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd">101</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Short-term loan received</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromOtherShortTermDebt" scale="3" unitRef="usd">752</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromOtherShortTermDebt" scale="3" unitRef="usd">981</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-63">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Short-term loan repaid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfOtherShortTermDebt" scale="3" unitRef="usd">1,518</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfOtherShortTermDebt" scale="3" unitRef="usd">134</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfOtherShortTermDebt" scale="3" unitRef="usd">196</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Proceeds from initial public offering, net of issuance
    costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="3" unitRef="usd">13,391</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-64">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-65">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Loan received from shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromBankDebt" scale="3" unitRef="usd">4,800</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromBankDebt" scale="3" unitRef="usd">250</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Loan repaid to shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RepaymentsOfBankDebt" scale="3" unitRef="usd">100</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Loan received (repaid) from related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" scale="3" sign="-" unitRef="usd">1,102</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" scale="3" unitRef="usd">105</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">Issuance of ordinary shares</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" unitRef="usd">1,250</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-71; font-family: Times New Roman, Times, Serif; font-size: 10pt">(*</span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">Net cash from financing activities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd">12,625</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd">5,695</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd">159</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">NET INCREASE IN CASH AND CASH EQUIVALENTS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" unitRef="usd">7,744</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" unitRef="usd">102</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" unitRef="usd">184</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">CASH AND CASH EQUIVALENTS AT BEGINNING
    OF THE YEAR</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">393</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">291</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">107</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 0.125in; text-indent: -0.125in">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 0.125in; text-indent: -0.125in; font-weight: bold; text-align: left">CASH AND CASH EQUIVALENTS AT END OF
    THE YEAR</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">8,137</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">393</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">291</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"></p><div>

</div><!-- Field: Page; Sequence: 127; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="f_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
CONSOLIDATED STATEMENTS OF CASH FLOWS<br/>
(in thousands)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Supplemental disclosure of cash flow information:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Taxes paid</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" unitRef="usd">73</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" unitRef="usd">116</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" unitRef="usd">3</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Interest paid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd">477</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd">4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Supplemental disclosure of noncash
    investing and financing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Deferred offering costs included
    in other payables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-73">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:DeferredOfferingCostsIncludedInOtherPayables" scale="3" unitRef="usd">86</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-74">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Share-based compensation included
    in deferred offering costs</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-75">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:SharebasedCompensationIncludedInDeferredOfferingCosts" scale="3" unitRef="usd">75</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-76">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: 0pt; padding-left: 0pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Issuance of ordinary shares upon conversion of shareholders&#8217;
loans</p></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans" scale="3" unitRef="usd">2,839</ix:nonFraction></p></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: 0pt; padding-left: 0pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Substantial modification of shareholders&#8217; loans recorded in equity</p></td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:SubstantialModificationOfShareholdersLoansRecordedInEquity" scale="3" unitRef="usd">982</ix:nonFraction></p></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">&#160;</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.125in">Right of use assets obtained in exchange
    for lease liabilities</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" scale="3" unitRef="usd">152</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-77">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-78">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify"><ix:footnote id="ix_0_footnote" xml:lang="en-US">Amount less than $1 thousand</ix:footnote></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>The accompanying notes
are an integral part of the consolidated financial statements.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 128; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_1" escape="true" name="jfbr:GeneralInformationTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1 &#8212; GENERAL INFORMATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_2" id="jfbr_GeneralInformationTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify"><b>General</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_3" id="jfbr_GeneralInformationTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Jeffs&#8217; Brands Ltd (the &#8220;Company&#8221; or &#8220;Jeffs&#8217;
Brands&#8221;) was incorporated in Israel on March 7, 2021. As of the date of issuance of these financial statements the Company has five
wholly owned subsidiaries &#8212; Smart Repair Pro (&#8220;Smart Pro&#8221;), purex Corp. (&#8220;Purex&#8221;), Top Rank Ltd. (&#8220;Top
Rank&#8221;), Jeffs&#8217; Brands Holdings Inc. (&#8220;Jeffs&#8217; Brands Holdings&#8221;) and Fort Products Ltd. (&#8220;Fort&#8221;),
and together with Smart Pro, Purex, Top Rank and Jeffs&#8217; Brands Holdings, the &#8220;Subsidiaries&#8221;. The Company and the Subsidiaries
(&#8220;Group&#8221;) are engaged in the acquisition, improvement and operation of virtual stores (the &#8220;Brands&#8221;) mainly on
the Amazon.com (&#8220;Amazon&#8221;) website. Prior to consummation of the Stock Exchange and Plan of Restructuring Agreement (the &#8220;SEA&#8221;)
with Medigus Ltd., a publicly traded company incorporated under the laws of the State of Israel (&#8220;Medigus&#8221;), as described
below, all of the Company&#8217;s operations were carried under Smart Pro and Purex. References to the Company hereinafter, unless the
context otherwise provides, include Jeffs&#8217; Brands and the Subsidiaries on a consolidated basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_4" id="jfbr_GeneralInformationTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Smart Pro, a private corporation founded
in the State of California, was established on December&#160;20, 2017, and commenced its operations in June&#160;2019. As of December&#160;31,
2022, Smart Pro operated four brands on the Amazon website.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_5" id="jfbr_GeneralInformationTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Purex, a private corporation incorporated
in the State of California on April&#160;1, 2020, commenced its operations on that date. Purex was established for the purpose of purchasing
an online store. During 2022 Purex ceased its operation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_6" id="jfbr_GeneralInformationTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April&#160;2021, Top Rank Ltd.,
an Israeli company, was established as a wholly owned subsidiary of Jeffs&#8217; Brands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_7" id="jfbr_GeneralInformationTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In February 23, 2023, Jeffs&#8217;
Brands Holdings Inc., was established and registered in Delaware as a wholly owned subsidiary of Jeffs&#8217; Brands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_8" id="jfbr_GeneralInformationTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On March 9, 2023, the Company purchased
all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales. For additional information
see note 17.b.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_9" id="jfbr_GeneralInformationTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On January&#160;4, 2021, Medigus Ltd.,
acquired <ix:nonFraction contextRef="c29" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" unitRef="pure">50.01</ix:nonFraction>% of Smart Pro and <ix:nonFraction contextRef="c30" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" unitRef="pure">50.03</ix:nonFraction>% of Purex pursuant to a share purchase agreement entered into in October&#160;2020. On May&#160;10,
2021, pursuant to the SEA, Medigus and Viki&#160;Hakmon, the shareholders of Smart Pro and Purex immediately prior to closing of the
SEA (the &#8220;Previous Shareholders&#8221;), contributed all of their equity interests in Smart Pro and Purex to Jeffs&#8217; Brands
in exchange for ordinary shares of Jeffs&#8217; Brands (the &#8220;Contribution Transactions&#8221;). As a result of the Contribution
Transactions, Jeffs&#8217; Brands held all of the outstanding shares of Smart Pro and Purex. Additionally, immediately after the transaction,
Medigus held <ix:nonFraction contextRef="c31" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" scale="-2" unitRef="pure">50.03</ix:nonFraction>% of the outstanding ordinary shares of Jeffs&#8217; Brands and Mr.&#160;Hakmon held the remaining <ix:nonFraction contextRef="c32" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" scale="-2" unitRef="pure">49.97</ix:nonFraction>% of the outstanding
ordinary shares, resulting in Jeffs&#8217; Brands being wholly owned by the Previous Shareholders, at the same interest proportion as
held by the Previous Shareholders in Smart Pro and Purex prior to the Contribution Transactions. Mr.&#160;Hakmon&#8217;s affiliates,
who were minority shareholders of Smart Pro and Purex, transferred all their holdings in Smart Pro and Purex to Mr.&#160;Hakmon, effective
immediately prior to the Contribution Transactions pursuant to a Share Transfer Deed dated May&#160;10, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_10" id="jfbr_GeneralInformationTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As Smart Pro and Purex were owned solely by the Previous Shareholders
immediately prior to consummation of the Contribution Transactions and Jeffs&#8217; Brands was owned solely by the Previous Shareholders
immediately thereafter, the Contribution Transactions was accounted for in a manner similar to a transaction between entities under common
control. Accordingly, the Contribution Transactions were retrospectively applied to the prior periods, such that the combined financial
information of Smart Pro and Purex is presented in these financial statements for periods prior to the SEA, with share and per share data
in these financial statements being retrospectively adjusted based on the equivalent number of ordinary shares of Jeffs&#8217; Brands,
for the year ended December 31, 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 129; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1 &#8212; GENERAL INFORMATION</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_11" id="jfbr_GeneralInformationTextBlock-c0_cont_10"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify"><b>Initial public
                                            offering</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_12" id="jfbr_GeneralInformationTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August&#160;30, 2022, the Company
completed its initial public offering (&#8220;IPO&#8221;), In connection with the IPO, the Company sold <ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">3,717,473</ix:nonFraction> units at a public offering
price of $<ix:nonFraction contextRef="c34" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">4.16</ix:nonFraction> per unit, with each unit consisting of one of ordinary share, no par value per share (&#8220;Ordinary Share&#8221;), and
one warrant (&#8220;IPO Warrant&#8221;), to purchase one Ordinary Share, at an exercise price of $<ix:nonFraction contextRef="c35" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">4.04</ix:nonFraction> per Ordinary Share (and an exercise
price of $<ix:nonFraction contextRef="c35" decimals="2" format="ixt:num-dot-decimal" name="jfbr:ExercisePriceAdjustment" scale="0" unitRef="usdPershares">2.02</ix:nonFraction> following the Exercise Price Adjustment, as defined below). Pursuant to the terms of the IPO Warrant, investors that purchased
and held at least <ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares">120,192</ix:nonFraction> IPO Warrants on the 90th calendar day immediately following the issuance date of the IPO Warrants (each, a
&#8220;Qualified Buyer&#8221;), were entitled to additional warrants (&#8220;Additional Warrants&#8221;). Each Additional Warrant has
substantially the same terms as the As-Adjusted IPO Warrant (as defined below); provided, however, that the term of each Additional Warrant
is <ix:nonNumeric contextRef="c35" continuedAt="_WarrantsAndRightsOutstandingTerm-c35_cont_1" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm">five</ix:nonNumeric> (5)<ix:continuation id="_WarrantsAndRightsOutstandingTerm-c35_cont_1"> years</ix:continuation> from the issuance date and such Additional Warrant is not listed on any securities exchange. In addition, as long as
the Additional Warrants are outstanding, each holder of at least <ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="jfbr:ClassOfAdditionalWarrantOrRightOutstanding" scale="0" unitRef="shares">120,192</ix:nonFraction> IPO Warrants (each, a &#8220;Qualified Holder&#8221;) will receive
semi-annual payments based on the Group&#8217;s revenues, dependent on the amount of the Additional Warrants outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_13" id="jfbr_GeneralInformationTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Additionally, the Company issued warrants
to the underwriter to purchase up to <ix:nonFraction contextRef="c37" decimals="0" format="ixt:num-dot-decimal" name="jfbr:ClassOfAdditionalWarrantOrRightOutstanding" scale="0" unitRef="shares">185,873</ix:nonFraction> ordinary shares at an exercise price of $<ix:nonFraction contextRef="c38" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">5.20</ix:nonFraction> per Ordinary Share (&#8220;Underwriter&#8217;s
Warrants&#8221;). The underwriter partially exercised its right to purchase an additional <ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" unitRef="shares">425,912</ix:nonFraction> warrants for total consideration of
$<ix:nonFraction contextRef="c38" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" unitRef="usd">4</ix:nonFraction> thousands. The Company received total net proceeds of $<ix:nonFraction contextRef="c37" decimals="-5" format="ixt:num-dot-decimal" name="jfbr:NetProceedsOfWarrants" scale="6" unitRef="usd">13.4</ix:nonFraction>&#160;million after deducting issuance costs of $<ix:nonFraction contextRef="c37" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" unitRef="usd">2.1</ix:nonFraction>&#160;million.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_14" id="jfbr_GeneralInformationTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On September 7, 2022, the Company&#8217;s
volume weighted average stock price was less than the exercise floor of $<ix:nonFraction contextRef="c39" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">4.04</ix:nonFraction> for the IPO Warrants. Accordingly, and based on the contractual
terms of the IPO Warrants, effective after the closing of trading on November 28, 2022 (the 90th calendar day immediately following the
issuance date of the IPO Warrants), the IPO Warrants were adjusted (&#8220;As-Adjusted IPO Warrants&#8221;) pursuant to their terms,
including, but not limited to, to adjust the exercise price of the IPO Warrants to $<ix:nonFraction contextRef="c40" decimals="2" format="ixt:num-dot-decimal" name="jfbr:ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights" scale="0" unitRef="usdPershares">2.02</ix:nonFraction> (the &#8220;Exercise Price Adjustment&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_15" id="jfbr_GeneralInformationTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, in connection with the
Exercise Price Adjustment, Additional Warrants were issued to each Qualified Buyer who continued to hold at least <ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares">120,192</ix:nonFraction> IPO Warrants
as of November 28, 2022. Accordingly, the Company issued Additional Warrants to purchase up to <ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="jfbr:ClassOfAdditionalWarrantOrRightOutstanding" scale="0" unitRef="shares">2,824,525</ix:nonFraction> Ordinary Shares.As of December
31, 2022, the revenue payment to Qualified Holders was equal to approximately <ix:nonFraction contextRef="c2" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" unitRef="pure">2.3</ix:nonFraction>% of the Group&#8217;s revenues for the period ended
December 31,2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_16" id="jfbr_GeneralInformationTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In connection with the IPO, all loans
from shareholders then outstanding as of August 30, 2022 were converted into <ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" unitRef="shares">1,463,619</ix:nonFraction> ordinary shares. Additionally, all outstanding
loans from third-parties were repaid.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_17" id="jfbr_GeneralInformationTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Ordinary Shares and IPO Warrants
trade on the Nasdaq under the symbol &#8220;JFBR&#8221; and &#8220;JFBRW&#8221;, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 130; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1 &#8212; GENERAL INFORMATION</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_18" id="jfbr_GeneralInformationTextBlock-c0_cont_17"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify"><b>Bonus Shares
                                            and Reverse Share Split</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_19" id="jfbr_GeneralInformationTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February&#160;17, 2022, <ix:nonNumeric contextRef="c43" name="jfbr:BonusSharesAndReverseShareSplitDescription">the Company&#8217;s
Board of Directors approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments
for subsequent reverse share split) ordinary shares of the Company for each Ordinary Share issued and outstanding as of the close of
business on February&#160;17, 2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an
aggregate issuance by the Company as of such date of 6,630,547 (prior to adjustments for subsequent reverse share splits) Ordinary Shares.
Additionally, the Board approved an increase in the authorized share capital of the Company to 100,000,000 (43,567,567 after giving effect
to the two subsequent reverse share splits) ordinary shares.</ix:nonNumeric></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_20" id="jfbr_GeneralInformationTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On May&#160;3, 2022, <ix:nonNumeric contextRef="c44" name="us-gaap:StockholdersEquityReverseStockSplit">the Company&#8217;s
Board of Directors approved a 0.806-for-1&#160;reverse split of its issued and outstanding Ordinary Shares, effective as of May&#160;3,
2022, pursuant to which holders of the Company&#8217;s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share.</ix:nonNumeric></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_21" id="jfbr_GeneralInformationTextBlock-c0_cont_20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On June&#160;16, 2022, <ix:nonNumeric contextRef="c45" name="us-gaap:StockholdersEquityReverseStockSplit">the Company&#8217;s
Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June&#160;16, 2022,
pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85&#160;Ordinary Shares held as of such date.
The reverse stock split proportionally reduced the number of the Company&#8217;s authorized share capital.</ix:nonNumeric></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_22" id="jfbr_GeneralInformationTextBlock-c0_cont_21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All issued and outstanding Ordinary
Shares contained in these financial statements have been retroactively adjusted to reflect the bonus share issuance and the reverse share
splits for all periods presented, unless explicitly stated otherwise. (See note 12g).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -25.5pt"><b>&#160;</b></p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_23" id="jfbr_GeneralInformationTextBlock-c0_cont_22"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>d.</b></td><td style="text-align: justify"><b>Concentration
                                            risk</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_24" id="jfbr_GeneralInformationTextBlock-c0_cont_23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group&#8217;s activities are mainly
conducted through Amazon&#8217;s commercial platform. Any material change, whether temporary or permanent, including changes in Amazon&#8217;s
terms of use and/or its policies, may affect sales performance, and may have a material effect on the Group&#8217;s financial position
and the results of its operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_25" id="jfbr_GeneralInformationTextBlock-c0_cont_24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Group is engaged with
a small number of suppliers as part of the production process of its brands . Any material changes in the supply process, whether temporary
or permanent, may affect sales performance, and may have a material effect on the Group&#8217;s financial position and the results of
its operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_26" id="jfbr_GeneralInformationTextBlock-c0_cont_25"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>e.</b></td><td style="text-align: justify"><b>Liquidity</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_27" id="jfbr_GeneralInformationTextBlock-c0_cont_26"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the year ended December 31,
2022, the Group incurred a net loss of $&#160;<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" sign="-" unitRef="usd">2,201</ix:nonFraction> thousands and cash flows used in operating activities were $&#160;<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" sign="-" unitRef="usd">4,840</ix:nonFraction> thousand.
As of December 31, 2022, the Group had an accumulated deficit of approximately $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" sign="-" unitRef="usd">3,678</ix:nonFraction> thousand.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_28" id="jfbr_GeneralInformationTextBlock-c0_cont_27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group has funded its operations
to date through the sale of its products, through equity financings, loans from shareholders and other third parties, and sale of its
Ordinary Shares and warrants. The Company intends to continue to finance its operating activities through the sale of products via its
Brands and through raising additional capital, as needed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="jfbr_GeneralInformationTextBlock-c0_cont_29" id="jfbr_GeneralInformationTextBlock-c0_cont_28"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As detailed above, the Company completed
its IPO for total net proceeds of approximately $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" scale="6" unitRef="usd">13.4</ix:nonFraction> million in August 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="jfbr_GeneralInformationTextBlock-c0_cont_29"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">After the balance sheet date, the Company purchased Fort &#160;and
SciSparc Nutraceuticals Inc. (&#8220;SciSparc U.S.&#8221;) with proceeds from the IPO. Based on historical sales of Fort and SciSparc
Ltd. (&#8220;SciSparc&#8221;) brands and the ongoing revenues generated from previously purchased brands, management believes that expected
cash flows are sufficient to support the Group&#8217;s current operations for more than 12&#160;months from the issuance date of these
consolidated financial statements.</p></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 131; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 &#8212; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify"><b>Basis of preparation of the financial statements</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><ix:continuation continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_2" id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group&#8217;s consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) and include the accounts of Jeffs&#8217; Brands Ltd and its wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to 2022, the&#160;Group prepared
its financial statements in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting
Standards Board (IASB), as permitted in the United States based on the Company&#8217;s qualification as a &#8220;foreign private issuer&#8221;
under the rules and regulations of the U.S Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify"><b>Use of estimates</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_6" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:continuation id="_UseOfEstimates-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements
in conformity with U.S.&#160;GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the
reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances,
fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent
liabilities, among others.&#160;Such estimates are based on&#160;historical experience and on various other assumptions that are believed
to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group&#8217;s assets and
liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_7" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6"><ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify"><b>Functional and presentation currency</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_8" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7"><ix:continuation continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The functional and reporting currency
of the Group is the United States dollar (&#8220;U.S dollar&#8221;) as the U.S. dollar is the currency of the primary economic environment
in which the Group has operated and expects to continue to operate in the foreseeable future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_9" id="_SignificantAccountingPoliciesTextBlock-c0_cont_8"><ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group transactions and balances denominated in U.S. dollars are
presented at their original amounts. Non-U.S. dollar transactions and balances have been remeasured to U.S. dollars in accordance with
Accounting Standards Codification (&#8220;ASC&#8221;) 830, &#8220;Foreign Currency Transaction&#8221;. All transaction gains and losses
from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected in the statement of operations
as financial income or expenses foreign currency gain/loss, as appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_10" id="_SignificantAccountingPoliciesTextBlock-c0_cont_9"><ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>d.</b></td><td style="text-align: justify"><b>Cash and cash equivalents</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_11" id="_SignificantAccountingPoliciesTextBlock-c0_cont_10"><ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cash and cash equivalents include cash
in banks and short-term bank deposits (with original maturities of <span style="-sec-ix-hidden: hidden-fact-79">three</span>&#160;months or less) that are not restricted as to withdrawal
or use and are therefore considered to be cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_12" id="_SignificantAccountingPoliciesTextBlock-c0_cont_11"><ix:nonNumeric contextRef="c0" continuedAt="_TradeAndOtherAccountsReceivablePolicy-c0_cont_1" escape="true" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>e.</b></td><td style="text-align: justify"><b>Accounts receivable</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_13" id="_SignificantAccountingPoliciesTextBlock-c0_cont_12"><ix:continuation id="_TradeAndOtherAccountsReceivablePolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivables are stated at realizable value, net of an allowance
for credit losses. The Group evaluates its outstanding accounts receivable and establishes an allowance for credit losses based on information
available on their credit condition, current aging, historical experience and future economic and market conditions. These allowances
are reevaluated and adjusted periodically as additional information is available. Payments are made by customers immediately at the point
of sale, therefore, no provision for credit losses has been recorded as of December 31, 2022 and 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:continuation></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 132; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 &#8212; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_14" id="_SignificantAccountingPoliciesTextBlock-c0_cont_13"><ix:nonNumeric contextRef="c0" continuedAt="_InventoryPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InventoryPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>f.</b></td><td style="text-align: justify"><b>Inventories</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_15" id="_SignificantAccountingPoliciesTextBlock-c0_cont_14"><ix:continuation id="_InventoryPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories are stated at the lower
of cost and or market based on net realizable value. Inventories are adjusted for estimated excess and obsolescence and written down
to net realizable value based upon estimates of future demand, technology developments, and market conditions. Cost is determined in
accordance with first-in, first-out Method (&#8220;FIFO&#8221;) and the cost of inventory includes shipment and freight costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_16" id="_SignificantAccountingPoliciesTextBlock-c0_cont_15"><ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>g.</b></td><td style="text-align: justify"><b>Property and equipment</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_17" id="_SignificantAccountingPoliciesTextBlock-c0_cont_16"><ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment are stated at
historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition
of the items. Repairs and maintenance are charged to the statement of operations during the period in which they are incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_18" id="_SignificantAccountingPoliciesTextBlock-c0_cont_17"><ix:continuation continuedAt="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_3" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assets are depreciated using the
straight-line method to allocate their cost over their estimated useful lives, as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_19" id="_SignificantAccountingPoliciesTextBlock-c0_cont_18"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><ix:continuation id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; text-indent: -10pt; padding-left: 10pt">Computers equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 44%; text-align: center"><ix:nonFraction contextRef="c46" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure">33</ix:nonFraction></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt">Furniture</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonFraction contextRef="c47" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage" scale="-2" unitRef="pure">7</ix:nonFraction></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center"><ix:nonNumeric contextRef="c48" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">Shorter of remaining lease term or estimated useful life</ix:nonNumeric></td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt">&#160;</p></ix:continuation></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_20" id="_SignificantAccountingPoliciesTextBlock-c0_cont_19"><ix:nonNumeric contextRef="c0" continuedAt="_DeferredChargesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DeferredChargesPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>h.</b></td><td style="text-align: justify"><b>Deferred offering costs</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_21" id="_SignificantAccountingPoliciesTextBlock-c0_cont_20"><ix:continuation continuedAt="_DeferredChargesPolicyTextBlock-c0_cont_2" id="_DeferredChargesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company capitalized certain legal
and other third-party fees that were directly related to the Company&#8217;s IPO. As of December 31, 2021, there were $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredOfferingCosts" scale="3" unitRef="usd">366</ix:nonFraction> thousands
of deferred offering costs included in other non-current assets on the balance sheet.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_22" id="_SignificantAccountingPoliciesTextBlock-c0_cont_21"><ix:continuation id="_DeferredChargesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The total gross consideration from
the IPO was initially allocated to the derivative warrant liability based on its fair value and the remaining amount was allocated to
the Ordinary Shares issued and recognized as a component of equity. (refer to Note 12h below). Accordingly, issuance costs were allocated
between the warrant liability and Ordinary Shares based on their relative fair values.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>
</div><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 133; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 &#8212; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_23" id="_SignificantAccountingPoliciesTextBlock-c0_cont_22"><ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>i.</b></td><td style="text-align: justify"><b>Leases</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_24" id="_SignificantAccountingPoliciesTextBlock-c0_cont_23"><ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_2" id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with ASC 842, the Group
determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves
the use of a distinct identified asset, (2) whether the Group obtains the right to substantially all the economic benefits from the use
of the asset throughout the period, and (3) whether the Group has a right to direct the use of the asset. The Group elected the practical
expedient to not recognize a lease liability and a right-of-use (&#8220;ROU&#8221;) asset for leases with a term of <ix:nonNumeric contextRef="c2" format="ixt-sec:durwordsen" name="us-gaap:LesseeOperatingLeaseRenewalTerm">twelve months</ix:nonNumeric> or
less. The Group also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent
the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments
arising from the lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_25" id="_SignificantAccountingPoliciesTextBlock-c0_cont_24"><ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_3" id="_LesseeLeasesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ROU assets are initially measured at
amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred.
The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments
over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Group uses its Incremental
Borrowing Rate (&#8220;IBR&#8221;) based on the information available at commencement date in determining the present value of lease
payments. The Group&#8217;s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments
and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_26" id="_SignificantAccountingPoliciesTextBlock-c0_cont_25"><ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_4" id="_LesseeLeasesPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">An option to extend the lease is considered
in connection with determining the ROU asset and lease liability when it is reasonably certain that the Group will exercise that option.
An option to terminate is considered unless it is reasonably certain that the Group will not exercise the option.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_27" id="_SignificantAccountingPoliciesTextBlock-c0_cont_26"><ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Operating lease expense is recognized
on a straight-line basis over the lease term.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_28" id="_SignificantAccountingPoliciesTextBlock-c0_cont_27"><ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionCustomerAcquisitions-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionCustomerAcquisitions"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>j.</b></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Asset acquisition</b></p></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_29" id="_SignificantAccountingPoliciesTextBlock-c0_cont_28"><ix:continuation id="_RevenueRecognitionCustomerAcquisitions-c0_cont_1"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Group accounts for a transaction
as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable
asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs
are capitalized as part of the asset or assets acquired.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_30" id="_SignificantAccountingPoliciesTextBlock-c0_cont_29"><ix:nonNumeric contextRef="c0" continuedAt="_IntangibleAssetsFiniteLivedPolicy-c0_cont_1" escape="true" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>k.</b></td><td style="text-align: justify"><b>Intangible assets</b></td>
</tr></table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_31" id="_SignificantAccountingPoliciesTextBlock-c0_cont_30"><ix:continuation continuedAt="_IntangibleAssetsFiniteLivedPolicy-c0_cont_2" id="_IntangibleAssetsFiniteLivedPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Group&#8217;s intangible assets consist of its Brands. Intangible assets that are not considered to have an indefinite useful life are
amortized over their estimated useful lives. Each period the Group evaluates the estimated remaining useful lives of its intangible assets
and whether events or changes in circumstances warrant a revision to the remaining period of amortization.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p></ix:continuation></ix:continuation><div>



</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_32" id="_SignificantAccountingPoliciesTextBlock-c0_cont_31"><ix:continuation id="_IntangibleAssetsFiniteLivedPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The estimated useful lives of the Group&#8217;s
intangible assets (Brands) are <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">10</ix:nonNumeric> years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_33" id="_SignificantAccountingPoliciesTextBlock-c0_cont_32"><ix:nonNumeric contextRef="c0" continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>l.</b></td><td style="text-align: justify"><b>Impairment of long-lived assets</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_34" id="_SignificantAccountingPoliciesTextBlock-c0_cont_33"><ix:continuation continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_2" id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group&#8217;s long-lived&#160;assets
(assets group) to be held or used, including property and equipment, right of use assets and intangible assets subject to amortization
are reviewed for impairment in accordance with ASC 360, &#8220;Accounting for the Impairment or Disposal of Long-Lived Assets&#8221;,
whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The recoverability of
these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate.
If property and equipment, intangible assets or right of use assets are considered to be impaired, the impairment to be recognized equals
the amount by which the carrying value of the asset exceeds its fair market value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:continuation></ix:continuation><div>



</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_35" id="_SignificantAccountingPoliciesTextBlock-c0_cont_34"><ix:continuation id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining the fair values of long-lived
assets for the purpose of measuring impairment, the Group&#8217;s assumptions include those that market participants will consider in
valuations of similar assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:continuation></ix:continuation><div>



</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 134; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 &#8212; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_36" id="_SignificantAccountingPoliciesTextBlock-c0_cont_35"><ix:nonNumeric contextRef="c0" continuedAt="_PolicyLoansReceivablePolicy-c0_cont_1" escape="true" name="us-gaap:PolicyLoansReceivablePolicy"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>m.</b></td><td style="text-align: justify"><b>Loans from shareholders and related parties:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_37" id="_SignificantAccountingPoliciesTextBlock-c0_cont_36"><ix:continuation id="_PolicyLoansReceivablePolicy-c0_cont_1"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">On the borrowing date of loans received from shareholders or related
parties, the Group estimates the value of the benefit granted to it as the difference between the interest rate that the Group is required
to pay to investors for the loans provided by them and secured by such lien and the interest rate required to pay for similar unsecured
loans to non-related parties. The Group assesses changes to the term of loans with shareholders and related parties in accordance with
ASC 470, &#8220;Debt&#8221; (&#8220;ASC 470&#8221;), Subtopic 50&#8212; &#8220;Modifications and Extinguishments&#8221; (&#8220;ASC 470-50&#8221;).
For transactions accounted for as debt extinguishment, the difference between the reacquisition price of the debt and the net carrying
amount of the extinguished debt is recorded as an in-essence capital transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_38" id="_SignificantAccountingPoliciesTextBlock-c0_cont_37"><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>n.</b></td><td style="text-align: justify"><b>Income taxes</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_39" id="_SignificantAccountingPoliciesTextBlock-c0_cont_38"><ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for income taxes
in accordance with ASC 740, &#8220;Income Taxes&#8221;. ASC 740 prescribes the use of the liability method whereby deferred tax assets
and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities
and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Valuation
allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than
not to be realized. As of December 31, 2022 and 2021 a partial valuation allowance was recorded on the Group&#8217;s deferred tax assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_40" id="_SignificantAccountingPoliciesTextBlock-c0_cont_39"><ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group implements a two-step approach
to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax
return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical
merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second
step is to measure the tax benefit as the largest amount that is more than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" unitRef="pure">50</ix:nonFraction>% (cumulative basis) likely to be realized upon ultimate
settlement. As of December 31, 2022 and 2021, no liability for unrecognized tax positions has been recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_41" id="_SignificantAccountingPoliciesTextBlock-c0_cont_40"><ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>o.</b></td><td style="text-align: justify"><b>Revenue recognition</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_42" id="_SignificantAccountingPoliciesTextBlock-c0_cont_41"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_2" id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">The Group sells products
directly to customers mainly through its online Amazon stores.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_43" id="_SignificantAccountingPoliciesTextBlock-c0_cont_42"><ix:continuation continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_3" id="_RevenueRecognitionPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under the Group&#8217;s standard contract
terms, customers have a right of return within 30 until 90 days. For contracts with rights of return, the Group recognizes revenue based
on the amount of the consideration which the Group expects to receive for products which are not expected to be returned and recognizes
a refund liability for the amount not expected to be received. At the end of each reporting period, the Group updates its estimates of
expected product returns and adjusts the refund liabilities with a corresponding adjustment in revenues. The Group recorded an allowance
for returns in the amounts of $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" unitRef="usd">35</ix:nonFraction> thousand and $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" unitRef="usd">35</ix:nonFraction> thousand as of December 31, 2022, and 2021, respectively. The allowance for returns
is recorded as decrease in revenues against other payables.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_44" id="_SignificantAccountingPoliciesTextBlock-c0_cont_43"><ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group evaluates the criteria outlined
in ASC 606-10-55, &#8220;Principal versus Agent Considerations&#8221;, in determining whether it is appropriate to record the gross amount
of product sales and related costs or the net amount earned as commissions. The Group evaluates whether it is appropriate to recognize
revenue on a gross or net basis based upon its evaluation of whether the Company obtains control of the specified goods by considering
if it is primarily responsible for fulfillment of the promise, has inventory risk, and has the latitude in establishing pricing and selecting
suppliers, among other factors. Based on its evaluation of these factors, management has determined that it is the principal in these
arrangements; therefore, sales are recorded on a gross basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 135; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 &#8212; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_45" id="_SignificantAccountingPoliciesTextBlock-c0_cont_44"><ix:nonNumeric contextRef="c0" continuedAt="_CostOfSalesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CostOfSalesPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>p.</b></td><td style="text-align: justify"><b>Cost of sales</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_46" id="_SignificantAccountingPoliciesTextBlock-c0_cont_45"><ix:continuation continuedAt="_CostOfSalesPolicyTextBlock-c0_cont_2" id="_CostOfSalesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with Amazon&#8217;s terms
of use, the Group is obligated to pay to Amazon incremental costs, such as sales fulfillment commissions which are contingent on making
binding sales. Sales commissions would not have been incurred if the contract had not been obtained.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_47" id="_SignificantAccountingPoliciesTextBlock-c0_cont_46"><ix:continuation id="_CostOfSalesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cost of sales primarily consists of
expenses related to Amazon&#8217;s commissions, storage costs and freight.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_48" id="_SignificantAccountingPoliciesTextBlock-c0_cont_47"><ix:nonNumeric contextRef="c0" continuedAt="_AdvertisingCostsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>q.</b></td><td style="text-align: justify"><b>Advertising expenses</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_49" id="_SignificantAccountingPoliciesTextBlock-c0_cont_48"><ix:continuation id="_AdvertisingCostsPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt">The Group expenses
advertising costs as incurred. Advertising expenses, included within sales and marketing expenses, were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingAndMarketingExpense" scale="3" unitRef="usd">1,163</ix:nonFraction> thousands, $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingAndMarketingExpense" scale="3" unitRef="usd">1,211</ix:nonFraction> thousands,
and $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherSellingAndMarketingExpense" scale="3" unitRef="usd">371</ix:nonFraction> thousands for the years ended December 31, 2022, 2021 and 2020, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_50" id="_SignificantAccountingPoliciesTextBlock-c0_cont_49"><ix:nonNumeric contextRef="c0" continuedAt="_EmployeeStockOwnershipPlanESOPPolicy-c0_cont_1" escape="true" name="us-gaap:EmployeeStockOwnershipPlanESOPPolicy"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>r.</b></td><td style="text-align: justify"><b>Employee benefits</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_51" id="_SignificantAccountingPoliciesTextBlock-c0_cont_50"><ix:continuation continuedAt="_EmployeeStockOwnershipPlanESOPPolicy-c0_cont_2" id="_EmployeeStockOwnershipPlanESOPPolicy-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt">Pension
and severance pay obligations</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_52" id="_SignificantAccountingPoliciesTextBlock-c0_cont_51"><ix:continuation id="_EmployeeStockOwnershipPlanESOPPolicy-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Groups employees are employed by Jeffs&#8217;
Brands and subject to Israeli labor laws. Israeli labor law generally requires payment of severance pay upon dismissal of an employee
or upon termination of employment in certain other circumstances. Pursuant to Section&#160;14 of the Severance Compensation Act, 1963
(&#8220;Section&#160;14&#8221;), all of the Group&#8217;s employees in Israel are entitled to a monthly contribution, at a rate of <ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" unitRef="pure">8.33</ix:nonFraction>%
of their monthly salary, made in their name with insurance companies. Contributions under Section&#160;14 relieve the Group from any future
severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Group&#8217;s
balance sheet, and there is no liability recorded as the Group does not have a future obligation to make any additional payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_53" id="_SignificantAccountingPoliciesTextBlock-c0_cont_52"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>s.</b></td><td style="text-align: justify"><b>Fair value measurement</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_54" id="_SignificantAccountingPoliciesTextBlock-c0_cont_53"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group applies ASC 820, &#8220;Fair
Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;). Under this standard, fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability (i.e., the &#8220;exit price&#8221;) in an orderly transaction between market
participants at the measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_55" id="_SignificantAccountingPoliciesTextBlock-c0_cont_54"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining fair value, the Group
uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable
inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs
are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent
from the Group. Unobservable inputs are inputs that reflect the Group&#8217;s assumptions about the assumptions market participants would
use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken
down into three levels based on the inputs as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:continuation></ix:continuation><div>



</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_56" id="_SignificantAccountingPoliciesTextBlock-c0_cont_55"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 1 - Valuations based on quoted
prices in active markets for identical assets that the Group has the ability to access. Valuation adjustments and block discounts are
not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active
market, valuation of these products does not entail a significant degree of judgment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_57" id="_SignificantAccountingPoliciesTextBlock-c0_cont_56"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 2 - Valuations based on one or
more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_58" id="_SignificantAccountingPoliciesTextBlock-c0_cont_57"><ix:continuation continuedAt="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_6" id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 3 - Valuations based on inputs
that are unobservable and significant to the overall fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_59" id="_SignificantAccountingPoliciesTextBlock-c0_cont_58"><ix:continuation id="_FairValueMeasurementPolicyPolicyTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amounts of cash and cash equivalents, trade receivables,
other receivable, trade payables, other accounts payable and accrued expenses and payables to related parties approximate their fair value
due to the short-term maturity of such instruments. The Group&#8217;s derivative liabilities in respect of Additional Warrants are classified
within Level 3 of the fair value hierarchy because their fair values are estimated by utilizing valuation models and significant unobservable
inputs. For more details, see Note 9.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 136; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 &#8212; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_60" id="_SignificantAccountingPoliciesTextBlock-c0_cont_59"><ix:nonNumeric contextRef="c0" continuedAt="_DerivativesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DerivativesPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>t.</b></td><td style="text-align: justify"><b>Warrants</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_61" id="_SignificantAccountingPoliciesTextBlock-c0_cont_60"><ix:continuation continuedAt="_DerivativesPolicyTextBlock-c0_cont_2" id="_DerivativesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for warrants as either
equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific terms and applicable authoritative
guidance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_62" id="_SignificantAccountingPoliciesTextBlock-c0_cont_61"><ix:continuation continuedAt="_DerivativesPolicyTextBlock-c0_cont_3" id="_DerivativesPolicyTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assessment considers whether the
warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, &#8220;Distinguishing Liabilities and
Equity&#8221;, are indexed to the Group&#8217;s own stock and whether the warrants are eligible for equity classification under ASC 815
(&#8220;ASC 815&#8221;), &#8220;Derivatives and Hedging&#8221;, Subtopic 40 &#8220;Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC
815-40&#8221;). This assessment is conducted at the time of warrant issuance and as of each subsequent reporting period end date while
the warrants are outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_63" id="_SignificantAccountingPoliciesTextBlock-c0_cont_62"><ix:continuation id="_DerivativesPolicyTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Warrants that meet all the criteria for
equity classification, are recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity
classification, are recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value through earnings
at each balance sheet date thereafter.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_64" id="_SignificantAccountingPoliciesTextBlock-c0_cont_63"><ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>u.</b></td><td style="text-align: justify"><b>Legal and other contingencies</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_65" id="_SignificantAccountingPoliciesTextBlock-c0_cont_64"><ix:continuation id="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for its contingent
liabilities in accordance with ASC 450, &#8220;Contingencies&#8221;. A provision is recorded when it is both probable that a liability
has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, the Group reviews the status
of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable
and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Legal costs incurred in connection with
loss contingencies are expensed as incurred. As of December 31, 2022, and 2021, the Group is not a party to any litigation that could
have a material adverse effect on the Group&#8217;s business, financial position, results of operations or cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_66" id="_SignificantAccountingPoliciesTextBlock-c0_cont_65"><ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>v.</b></td><td style="text-align: justify"><b>Basic and diluted net loss per share.</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_67" id="_SignificantAccountingPoliciesTextBlock-c0_cont_66"><ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group calculates basic net profit
(loss) per share by dividing the net profit (loss) by the weighted-average number of Ordinary Shares outstanding during the period. Diluted
net loss per share is computed by giving effect to all potentially dilutive Ordinary Share equivalents outstanding for the period. All
outstanding share options and warrants for the years ended December 31, 2022 and 2021 have been excluded from the calculation of the diluted
net loss per share since all such securities were anti-dilutive. For the year ended December 31, 2020 there were no Ordinary Share equivalents
outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_68" id="_SignificantAccountingPoliciesTextBlock-c0_cont_67"><ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>w.</b></td><td style="text-align: justify"><b>Recently adopted and recently issued accounting pronouncements.</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_68"><ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In May 2021, the FASB issued ASU No.
2021-04 to ASC 260, ASC 470-50, ASC 718 &#8220;Compensation&#8212;Stock Compensation&#8221;, and ASC 815: &#8220;Issuer&#8217;s counting
for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#8221;. The amendments in ASU No. 2021-
modification or exchange. The amendments in this ASU No. 2021-04 were effective for after the Company beginning on January 1, 2022. The
adoption of the standard did not have material effect on Group&#8217;s results.</p></ix:continuation></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 137; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 &#8212; OTHER RECEIVABLES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock-c0_cont_2" id="_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfOtherCurrentAssetsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Advances to suppliers</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:Supplies" scale="3" unitRef="usd">641</ix:nonFraction></td><td style="width: 1%; text-align: left">(*)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Government institutions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GovernmentContractReceivable" scale="3" unitRef="usd">130</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GovernmentContractReceivable" scale="3" unitRef="usd">35</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivables" scale="3" unitRef="usd">8</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherReceivables" scale="3" unitRef="usd">1</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsAndOtherReceivablesNet" scale="3" unitRef="usd">779</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PremiumsAndOtherReceivablesNet" scale="3" unitRef="usd">36</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation id="_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock-c0_cont_2"><ix:continuation id="_ScheduleOfOtherCurrentAssetsTableTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(*) <ix:footnote id="ix_1_footnote" xml:lang="en-US">Includes $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAdditionalCapital" scale="3" unitRef="usd">228</ix:nonFraction> thousand to Pure Capital. See
Note 16 for additional information.</ix:footnote></p></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_InventoryDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 &#8212; INVENTORY</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_InventoryDisclosureTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Goods in transit</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherInventoryInTransit" scale="3" unitRef="usd">8</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherInventoryInTransit" scale="3" unitRef="usd">161</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoods" scale="3" unitRef="usd">1,783</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryFinishedGoods" scale="3" unitRef="usd">1,066</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryGross" scale="3" unitRef="usd">1,791</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryGross" scale="3" unitRef="usd">1,227</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 138; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 &#8212; INTANGIBLE ASSETS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_2" id="_IntangibleAssetsDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Total intangible assets consisted of
the following as of December&#160;31, 2022 and 2021:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_3" id="_IntangibleAssetsDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, 2022</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Gross Amount</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Accumulated Amortization</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Net Balance</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center"><b>U.S.&#160;dollars in thousands</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; width: 64%; text-align: left">Brands</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" unitRef="usd">5,783</ix:nonFraction></td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" sign="-" unitRef="usd">1,331</ix:nonFraction></td><td style="padding-bottom: 4pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" unitRef="usd">4,452</ix:nonFraction></td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><ix:continuation continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_4" id="_IntangibleAssetsDisclosureTextBlock-c0_cont_3"><ix:continuation id="_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, 2021</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Gross Amount</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Accumulated Amortization</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Net Balance</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center"><b>U.S.&#160;dollars in thousands</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; width: 64%; text-align: left">Brands</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" unitRef="usd">5,783</ix:nonFraction></td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(<ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" sign="-" unitRef="usd">762</ix:nonFraction></td><td style="padding-bottom: 4pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-size: 10pt"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" unitRef="usd">5,021</ix:nonFraction></span></td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_IntangibleAssetsDisclosureTextBlock-c0_cont_5" id="_IntangibleAssetsDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Amortization expense was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentForAmortization" scale="3" unitRef="usd">570</ix:nonFraction> thousand,
$<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentForAmortization" scale="3" unitRef="usd">524</ix:nonFraction> thousand, and $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentForAmortization" scale="3" unitRef="usd">104</ix:nonFraction> thousand, for the years ended December 31, 2022, 2021, and 2020, respectively. Estimated annual amortization expense
for each of the next five years is expected to be $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FiniteLivedIntangibleAssetAmortizationMethod" scale="3" unitRef="usd">570</ix:nonFraction> thousand.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_IntangibleAssetsDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In March&#160;2021, Purex received
an update from Amazon regarding a new Environmental Protection Agency (&#8220;EPA&#8221;) regulation. Following the new EPA regulation,
Amazon categorized Purex&#8217;s product as a pesticide product. Amazon requires that pesticide products be filed with evidence of an
EPA registration number and/or EPA Establishment number or certification that the product is exempt from EPA regulation, otherwise the
existing listing (of the product) may be subject to removal. The Group examined the related costs following the requirement to comply
with such regulations and decided to write off the intangible asset balance in a total amount of $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" scale="3" unitRef="usd">87</ix:nonFraction> thousands during 2021 following the
EPA regulation update.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 139; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 6 &#8212; LEASES:</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_2" id="_LesseeOperatingLeasesTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases office space with
a remaining useful life of less than <ix:nonNumeric contextRef="c0" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric> years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_3" id="_LesseeOperatingLeasesTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022, the Company&#8217;s
operating lease assets and lease liabilities (both the current and non-current portion) for operating leases totaled $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:OperatingLeaseAssets" scale="3" unitRef="usd">138</ix:nonFraction> thousands and
$<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd">141</ix:nonFraction> thousands, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_4" id="_LesseeOperatingLeasesTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company uses its incremental borrowing
rate as the discount rate for its leases, as the implicit rate in the lease is not readily determinable. As of December 31, 2022, the
Company&#8217;s operating leases had a weighted average remaining lease term of <ix:nonNumeric contextRef="c2" format="ixt-sec:duryear" name="us-gaap:LesseeFinanceLeaseRenewalTerm1">3</ix:nonNumeric> years and a weighted average borrowing rate of approximately
<ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="jfbr:WeightedAverageBorrowingRate" scale="-2" unitRef="pure">10</ix:nonFraction>%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_5" id="_LesseeOperatingLeasesTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Future lease payments under operating
leases as of December 31, 2022, were as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_LesseeOperatingLeasesTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" unitRef="usd">58</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">2024-2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" unitRef="usd">103</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total future operating lease payments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FutureOperatingLeasePayments" scale="3" unitRef="usd">161</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Less: imputed interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ReceivableWithImputedInterestDiscount" scale="3" unitRef="usd">20</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Present value of lease liability</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:PresentValueOfLeaseLiability" scale="3" unitRef="usd">141</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7 &#8212;&#160;OTHER PAYABLES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Government institutions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue" scale="3" unitRef="usd">36</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue" scale="3" unitRef="usd">100</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Employees and related benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd">49</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd">50</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" unitRef="usd">40</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Accrued Interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPayableCurrent" scale="3" unitRef="usd">294</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses and other payables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:AccruedExpensesAndOtherPayables" scale="3" unitRef="usd">266</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:AccruedExpensesAndOtherPayables" scale="3" unitRef="usd">271</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" scale="3" unitRef="usd">391</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" scale="3" unitRef="usd">715</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 140; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_ShortTermDebtTextBlock-c0_cont_1" escape="true" name="us-gaap:ShortTermDebtTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 8 &#8212;&#160;SHORT-TERM LOANS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_ShortTermDebtTextBlock-c0_cont_2" id="_ShortTermDebtTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShortTermDebtTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December&#160;31,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Loans with Amazon (8a)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LoansPayable" scale="3" unitRef="usd">86</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LoansPayable" scale="3" unitRef="usd">101</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Related party loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LoansAndLeasesReceivableRelatedParties" scale="3" unitRef="usd">111</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Third party loans (8b)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:ThirdPartyLoan" scale="3" unitRef="usd">715</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="3" unitRef="usd">86</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermBorrowings" scale="3" unitRef="usd">927</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ShortTermDebtTextBlock-c0_cont_3" id="_ShortTermDebtTextBlock-c0_cont_2"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September&#160;22, 2021, Smart Pro entered into a loan agreement with Amazon. Pursuant to the loan agreement, Smart Pro received an aggregate amount of $<ix:nonFraction contextRef="c51" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:AggregatesAmount" scale="3" unitRef="usd">153</ix:nonFraction> thousands from Amazon, of which $<ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForPreviousAcquisition" scale="3" unitRef="usd">14</ix:nonFraction> was repayment of a previous Amazon loan balance. The loan matures within nine&#160;months and bears annual interest at a rate of <ix:nonFraction contextRef="c51" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShortTermDebtPercentageBearingFixedInterestRate" scale="-2" unitRef="pure">9.99</ix:nonFraction>% per year. In order to secure the loan, Smart Pro pledged its financial balances on its Amazon account on Amazon and its inventories held in Amazon&#8217;s warehouses, in favor of Amazon. On May&#160;9, 2022, the loan was fully repaid. As of December 31, 2022, the remaining loan balance to Amazon was $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LoansPayable" scale="3" unitRef="usd">86</ix:nonFraction> thousand.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ShortTermDebtTextBlock-c0_cont_4" id="_ShortTermDebtTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On May&#160;9, 2022, Smart Pro entered
into a new loan agreement with Amazon. Pursuant to the loan agreement, Smart Pro received an aggregate amount of $<ix:nonFraction contextRef="c53" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:AggregatesAmount" scale="3" unitRef="usd">152</ix:nonFraction> thousands from Amazon.
The loan matures within 12&#160;months and bears annual interest at a rate of <ix:nonFraction contextRef="c53" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShortTermDebtPercentageBearingFixedInterestRate" scale="-2" unitRef="pure">9.99</ix:nonFraction>% per year. In order to secure the loan, Smart Pro pledged
its financial balances on its account on Amazon and its inventories held in Amazon&#8217;s warehouses, in favor of Amazon.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"></p><div>

</div><ix:continuation continuedAt="_ShortTermDebtTextBlock-c0_cont_5" id="_ShortTermDebtTextBlock-c0_cont_4"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July&#160;2021, Smart Pro entered into a loan agreement with two third parties. The loans bore annual interest rate of <ix:nonFraction contextRef="c54" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShortTermDebtPercentageBearingFixedInterestRate" scale="-2" unitRef="pure">10</ix:nonFraction>% and were payable in January&#160; 2022. Smart Pro was entitled to extend the loans by an additional sixty&#160;days, with additional interest of <ix:nonFraction contextRef="c54" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure">1</ix:nonFraction>% per month. In addition, pursuant to the loan agreement, in the event of an IPO of the Company, the lenders would be entitled to Ordinary Shares of the Company at an aggregate value of $<ix:nonFraction contextRef="c55" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:AggregateAmount" scale="3" unitRef="usd">250</ix:nonFraction> thousands with a conversion price at the IPO price. In July&#160;2021, the loan principal of $<ix:nonFraction contextRef="c55" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:PrincipalLoanAmount" scale="3" unitRef="usd">750</ix:nonFraction> thousands was received. The proceeds from the lenders were first allocated to the liability (see note 9.a) to issue a variable number of shares based on its fair value at the date of issuance in an amount of $<ix:nonFraction contextRef="c54" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShorttermDebtFairValue" scale="3" unitRef="usd">62</ix:nonFraction> thousands, with a corresponding discount recorded on the third-party loan. The derivate liability was revalued at each period-end and amounted to $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtCurrent" scale="3" unitRef="usd">137</ix:nonFraction> thousands as of December 31, 2021.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_ShortTermDebtTextBlock-c0_cont_6" id="_ShortTermDebtTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On November&#160;23, 2021, the loan
agreement was amended to extend the maturity date of the loans to the earlier of (i)&#160;March&#160;31, 2023, or (ii)&#160;the closing
of an IPO of the Company. Based on management&#8217;s assessment, the amendment resulted in a substantial modification to the loan in
accordance with ASC 470-50. As a result of the debt extinguishment, the Group recorded , a gain in the amount of $<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="3" unitRef="usd">14</ix:nonFraction> thousand within finance
expenses, net for the year ended December 31, 2021 as the difference between the net carrying value of the original loans and the fair
value of the loan bearing the modified terms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_ShortTermDebtTextBlock-c0_cont_7" id="_ShortTermDebtTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Following the IPO in 2022, the Group
repaid the third-party loan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 141; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 8 &#8212;&#160;SHORT-TERM LOANS </b>(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p><div>

</div><ix:continuation id="_ShortTermDebtTextBlock-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify">On February&#160;22, 2022, the Company entered into a loan
agreement with Bank Leumi Le-Israel&#160;(&#8220;Bank Leumi&#8221;) to provide for a line of credit in an aggregate amount of up to $<ix:nonFraction contextRef="c56" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:AggregateAmount" scale="3" unitRef="usd">1,000</ix:nonFraction>
thousands, which the Company may draw in two tranches at its request, but in no event after July&#160;21, 2022. Pursuant to the loan
agreement, amounts drawn bear interest at a rate of Secured Overnight Financing Rate (&#8220;SOFR&#8221;) plus <ix:nonFraction contextRef="c57" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShortTermDebtPercentageBearingVariableInterestRate" scale="-2" unitRef="pure">3.25</ix:nonFraction>% annually. On March
3, 2022, the Company drew $<ix:nonFraction contextRef="c58" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:ShortTermLineOfCredits" scale="3" unitRef="usd">400</ix:nonFraction> thousands under the line of credit. On June 2, 2022, the Company drew another $<ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LinesOfCreditCurrent" scale="3" unitRef="usd">200</ix:nonFraction> thousands million under
the line of credit. Following an agreement with Bank Leumi, the loan was extended until October 31, 2022. All amounts outstanding under
the line of credit were fully repaid on September 6, 2022.</td>
</tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 &#8212;&#160;DERIVATIVE LIABILITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_2" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_1"><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The following table presents changes in the fair value of
the derivative warrant liability during the year (in thousands)</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_3" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ConvertibleDebtTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Balance as of January 1, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd">0</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Fair value of warrant liability to be issued to third-party upon IPO (note 9a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FairValueOfWarrantLiabilityToBeIssuedToThirdparty" scale="3" unitRef="usd">62</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:ChangeInFairValue" scale="3" unitRef="usd">75</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Balance as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd">137</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of warrants in connection with the IPO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd">8,220</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:ChangeInFairValue" scale="3" sign="-" unitRef="usd">2,822</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Classification to additional paid in capital</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" sign="-" unitRef="usd">3,319</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">Balance as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" scale="3" sign="-" unitRef="usd">2,216</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_4" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As detailed in Note 8b , the Group received two loans of $<ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:ThirdPartyLoan" scale="3" unitRef="usd">375</ix:nonFraction> thousands each from third parties. As part of the loan agreements, the lenders were entitled to receive warrants in the event of an initial public offering at a conversion price equal to the IPO issuance price.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_5" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management determined that the obligation to issue a variable number
of shares represents a derivative liability. The proceeds from the lender were first allocated to the derivate liability based on its
fair value at the date of issuance in an amount of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" scale="3" unitRef="usd">62</ix:nonFraction> thousands, with a corresponding discount recorded on the third-party loan. The
derivate liability was revalued at each period-end and amounted to $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:DerivativeLiability" scale="3" unitRef="usd">137</ix:nonFraction> thousand as of December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 142; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 &#8212;&#160;DERIVATIVE LIABILITIES
(cont.)</b></p><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_6" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Effective
as of August 30, 2022, the closing date of the IPO, and pursuant to the loan agreements (the &#8220;Issuance Date&#8221;), the Company
issued warrants to the lenders to purchase up to <ix:nonFraction contextRef="c61" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" scale="0" unitRef="shares">60,096</ix:nonFraction> </span>&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">Ordinary
Shares, exercisable at an exercise price of $<ix:nonFraction contextRef="c62" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares">4.04</ix:nonFraction> per share, exercisable for three years following the IPO. The warrants have cashless
exercise mechanism.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_7" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On the issuance date of the warrants, all conditions for equity classification
under U.S. GAAP were met, and as such, the fair value of the warrants as of the issuance date were reclassified to equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_8" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>b</b></span><b>.</b></td><td style="text-align: justify">In connection with the IPO (including the partial exercise
of over-allotment option), the Company sold <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">3,717,473</ix:nonFraction> units at a public offering price of $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="jfbr:PublicOfferingPricePerShare" scale="0" unitRef="usdPershares">4.16</ix:nonFraction> per unit, with each unit consisting of
<ix:nonFraction contextRef="c26" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">one</ix:nonFraction> of ordinary share, no par value per share (&#8220;Ordinary Share&#8221;), and <ix:nonFraction contextRef="c60" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">one</ix:nonFraction> warrant (&#8220;IPO Warrant&#8221;), to purchase
<ix:nonFraction contextRef="c2" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ExcessStockSharesIssued" scale="0" unitRef="shares">one</ix:nonFraction> Ordinary Share, at an initial exercise price of $<ix:nonFraction contextRef="c23" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceDecrease" scale="0" unitRef="usdPershares">4.04</ix:nonFraction> per Ordinary Share. Additionally, the Company issued and sold <ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" unitRef="shares">3,717,473</ix:nonFraction> ordinary
shares, no par value per share (&#8220;Ordinary Shares&#8221;), warrants to purchase up to <ix:nonFraction contextRef="c23" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" scale="0" unitRef="shares">4,143,385</ix:nonFraction> Ordinary Shares (&#8220;IPO Warrants&#8221;)
and warrants issued to the underwriter in the offering to purchase up to <ix:nonFraction contextRef="c63" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" scale="0" unitRef="shares">185,873</ix:nonFraction> Ordinary Shares at an exercise price of $<ix:nonFraction contextRef="c63" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares">5.20</ix:nonFraction> per Ordinary
Share (&#8220;Underwriter&#8217;s Warrants&#8221;). The underwriter partially exercised its right to purchase an additional <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="jfbr:AdditionalWarrants" scale="0" unitRef="shares">425,912</ix:nonFraction> warrants
for total consideration of $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationContingentConsiderationAsset" scale="3" unitRef="usd">4</ix:nonFraction> thousands. The Company received net proceeds of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DerivativeCostOfHedgeNetOfCashReceived" scale="6" unitRef="usd">13.4</ix:nonFraction> million after deducting issuance costs of $<ix:nonFraction contextRef="c0" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" scale="6" unitRef="usd">2.1</ix:nonFraction> million.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-indent: -24pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_9" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On September 7, 2022, the Company&#8217;s
volume weighted average stock price was less than the exercise floor of $<ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" scale="0" unitRef="usdPershares">4.04</ix:nonFraction> for the Warrants. Accordingly, effective after the closing
of trading on November 28, 2022 (the 90th calendar day immediately following the issuance date of the IPO Warrants), the IPO Warrants
were adjusted (&#8220;As-Adjusted IPO Warrants&#8221;) pursuant to their terms, including, but not limited to, the reduction of the exercise
price of the IPO Warrants to $<ix:nonFraction contextRef="c64" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:WarrantExercisePriceIncrease" scale="0" unitRef="usdPershares">2.02</ix:nonFraction>. Additionally, Additional Warrants were issued to each qualified buyer who continued to hold at least
<ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="jfbr:AdditionalWarrants" scale="0" unitRef="shares">120,192</ix:nonFraction> IPO Warrants as of November 28, 2022. Accordingly, the Company issued Additional Warrants to purchase 2,824,525 Ordinary Shares.
Each Additional Warrant has substantially the same terms as the As-Adjusted IPO Warrant; provided, however, that the term of each Additional
Warrant will be five (5) years from the issuance date and such Additional Warrant will not be listed on any securities exchange. Each
Additional Warrant holder will receive semi-annual payments based on revenues during the period. The total annual payment depends on
the amount of the Additional Warrants outstanding. As of December 31, 2022, the payment will be equal to approximately <ix:nonFraction contextRef="c66" decimals="3" format="ixt:num-dot-decimal" name="jfbr:RevenuesPercentage" scale="-2" unitRef="pure">2.3</ix:nonFraction>% of the Company&#8217;s
revenues for the period November 28, 2022 until December 31,2022. The Company determined that the Additional Warrants preclude equity
classification. The derivative liability is recorded at fair value and amounted to $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:RelatedPartyFairValue" scale="3" unitRef="usd">2,216</ix:nonFraction> thousands as of December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 143; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 &#8212;&#160;DERIVATIVE LIABILITIES
(cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -1.65pt">&#160;</p><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_10" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Given their contractual terms, from
the issuance date and up until the 90th day immediately following issuance, the IPO warrants did not meet the U.S. GAAP definition for
equity classification. As such, they were classified as a liability up until November 28, 2022.Upon issuance, the IPO Warrants (which
included the right to issue Additional Warrants) were accounted for as derivative instrument which was classified as a liability and measured
at fair value through profit or loss. The fair value was $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="3" unitRef="usd">8,245</ix:nonFraction> thousands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_11" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On November 28, 2022, following the adjustment to the exercise price
and issuance of the Additional Warrants, the Company determined that all conditions for equity classification under U.S. GAAP were met
for the IPO Warrants, and as such, the fair value of the IPO warrants as of November 28, 2022 at the amount of $<ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="0" unitRef="usd">3,319</ix:nonFraction> thousands, was recorded
as a component of Company&#8217;s shareholder&#8217;s equity. The value of the IPO Warrants upon issuance and the Additional Warrants
upon issuance and at year-end was calculated based on the binomial option pricing model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_12" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During 2022, an amount of $<ix:nonFraction contextRef="c60" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="0" unitRef="usd">2,710</ix:nonFraction> thousands was recorded as finance
income to account for the change in the value of the IPO Warrants and Additional Warrants value during the period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_13" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following table lists the significant
unobservable inputs used for calculation of fair value of the IPO Warrants and Additional Warrants during the year:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_14" id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_13"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; text-align: left">Expected volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: center"><span style="font-size: 10pt"><ix:nonFraction contextRef="c68" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">77.57</ix:nonFraction>%-<ix:nonFraction contextRef="c69" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure">78.89</ix:nonFraction>%</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">$<ix:nonFraction contextRef="c70" decimals="-1" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="3" unitRef="usdPershares">2.02</ix:nonFraction>-<ix:nonFraction contextRef="c71" decimals="-1" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" scale="3" unitRef="usdPershares">4.04</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Share price</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">$<ix:nonFraction contextRef="c70" decimals="-1" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="3" unitRef="usdPershares">1.53</ix:nonFraction>-<ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharePrice" scale="3" unitRef="usdPershares">1.865</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt"><ix:nonFraction contextRef="c68" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">3.27</ix:nonFraction>%-<ix:nonFraction contextRef="c69" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure">4.04</ix:nonFraction>%</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-85">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt"><ix:nonNumeric contextRef="c68" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c69" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.74</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>WACC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt"><ix:nonFraction contextRef="c70" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:PercentageOfWeightedAverageCostInventory" scale="-2" unitRef="pure">21.5</ix:nonFraction>%-<ix:nonFraction contextRef="c71" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:PercentageOfWeightedAverageCostInventory" scale="-2" unitRef="pure">23.3</ix:nonFraction>%</span></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Additionally, the revenue forecast over
the life of the Additional Warrants is a significant input in determining the price of the Additional Warrants as of December 31, 2022.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 144; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DebtDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 10 &#8212;&#160;LOANS FROM SHAREHOLDERS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_2" id="_DebtDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify">Loans from shareholders consists of the following:</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_3" id="_DebtDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December&#160;31,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Loan amount</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LoansPayableCurrent" scale="3" unitRef="usd">4,950</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">Loan discount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" unitRef="usd">1,316</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" unitRef="usd">3,634</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_4" id="_DebtDisclosureTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October&#160;8, 2020, Smart Pro, together with its shareholders (the &#8220;Shareholders&#8221;), entered into a share purchase agreement (the &#8220;Purchase Agreement&#8221;) (see Note&#160;1a) with Medigus. As part of the Purchase Agreement, Medigus and the shareholders committed to transfer funds, as loans to Smart Pro, in order to finance Smart Pro&#8217;s&#160;day-to-day operations in exchange for Smart Pro shares. In accordance with the Purchase Agreement, the Shareholders agreed that all loans transferred to Smart Pro in order to finance the acquisition of additional online Amazon.com stores will be funded <ix:nonFraction contextRef="c72" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" unitRef="pure">20</ix:nonFraction>% by the shareholders and funded <ix:nonFraction contextRef="c73" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" unitRef="pure">80</ix:nonFraction>% by Medigus.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_5" id="_DebtDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Additionally, as a part of the Purchase Agreement, the Shareholders
&#160;agreed to provide a line of credit to the Smart Pro in the amount of $<ix:nonFraction contextRef="c74" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LineOfCredit" scale="3" unitRef="usd">1,000</ix:nonFraction> thousands to finance ongoing capital requirements as
needed from time to time.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>



</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_6" id="_DebtDisclosureTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During October and November&#160;2020,
an amount of $<ix:nonFraction contextRef="c75" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd"><ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd">250</ix:nonFraction></ix:nonFraction> thousands was transferred to Smart Pro on account of the loan. During 2021, Smart Pro received additional loans under
the same agreement. According to the loan agreement, the loans bear annual interest rate of <ix:nonFraction contextRef="c74" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure">4</ix:nonFraction>%. Smart Pro will repay the loans and all
accrued interest five&#160;years from October 8, 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_7" id="_DebtDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On October 8, 2020, the Group estimated
the value of the benefit granted to it by its shareholders as the difference between the interest rate that Smart Pro is required to pay
to the Shareholders for the loans provided by them and secured by such lien and the interest rate Smart Pro is required to pay for similar
unsecured loans to non-related parties. The value of the said benefit is estimated by the Group based on the weighted interest rate that
Smart Pro would have been required to pay if the loans had been granted to it by the bank and by Amazon, and which the Group management
estimates is the best estimate of Smart Pro&#8217;s interest rate close to receiving loans from investors. Accordingly, the value of the
benefit was estimated by the Group at approximately <ix:nonFraction contextRef="c74" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DefinedBenefitPlanFundedPercentage" scale="-2" unitRef="pure">8</ix:nonFraction>%, and as a result the effective interest rate for these loans is about <ix:nonFraction contextRef="c74" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" unitRef="pure">12</ix:nonFraction>%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_8" id="_DebtDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the first half of 2021, the loan
from the Shareholders was partially repaid.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 145; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 10 &#8212;&#160;LOANS FROM SHAREHOLDERS</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_9" id="_DebtDisclosureTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 2, 2021, Smart Pro entered into a purchase agreement of a virtual store &#8220;Whoobli&#8221; from a third party. As part of the agreement, Smart Pro purchased a seller account which operates on the Amazon website under the name &#8220;Whoobli&#8221;, which markets a private label of basketball shooting baskets, children&#8217;s punching bags and decoration for children&#8217;s birthday parties, including the intellectual property attributed to it and including trademarks attributed to products sold on the account&#8217;s sales page, for a total of $<ix:nonFraction contextRef="c77" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedTrademarksGross" scale="3" unitRef="usd">4,000</ix:nonFraction> thousands. In addition, in accordance with the agreement, Smart Pro purchased from the seller the remaining inventory for a total amount of approximately $<ix:nonFraction contextRef="c77" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InventoryNoncurrent" scale="3" unitRef="usd">350</ix:nonFraction> thousands, which is the cost of the inventory purchased by the seller. Additionally, purchased two additional Amazon stores &#8220;Wellted&#8221; and &#8220;PetEvo&#8221; (See Note&#160;5).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to finance the purchase of the store, Smart Pro received loan
from its shareholders in a ratio of 20:80, as described in section b above. Medigus transferred to Smart Pro an amount of approximately
$<ix:nonFraction contextRef="c78" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" scale="3" unitRef="usd">3,760</ix:nonFraction> thousands and the minority shareholders transferred an amount of approximately $<ix:nonFraction contextRef="c79" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherMinorityInterests" scale="3" unitRef="usd">940</ix:nonFraction> thousands. This Shareholders loans bore an
annual interest at a rate of <ix:nonFraction contextRef="c77" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure">4</ix:nonFraction>% and will be repaid after five&#160;years.</p></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt">&#160;</td> <td style="text-align: justify; font-size: 10pt">&#160;</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_10" id="_DebtDisclosureTextBlock-c0_cont_9"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On the borrowing date of the loans,
Smart Pro estimated the value of the benefit granted to it by Medigus and the minority shareholders as the difference between the interest
rate that Smart Pro is required to pay to Medigus and the minority shareholders for the loans and the interest rate required to pay for
similar unsecured loans to non-related parties, the capital reserve from the transaction on the borrowing date was $<ix:nonFraction contextRef="c80" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseOtherShortTermBorrowings" scale="3" unitRef="usd">1,026</ix:nonFraction> thousands. The
value of the said benefit was estimated by the Group based on the interest rate that Smart Pro is required to pay for the loan received
from Amazon and which the Company&#8217;s management considers to be the best estimate of Smart Pro&#8217;s interest rate close to the
date of receiving loans from investors. Accordingly, the value of the benefit was estimated by the Group at approximately <ix:nonFraction contextRef="c77" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:InvestmentInterestRate" scale="-2" unitRef="pure">8</ix:nonFraction>% and as a
result the effective interest rate for these loans was determined at <ix:nonFraction contextRef="c80" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:LoansReceivableBasisSpreadOnVariableRateDuringPeriod" scale="-2" unitRef="pure">11.79</ix:nonFraction>%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><b>&#160;</b></p></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 146; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 10 &#8212;&#160;LOANS FROM SHAREHOLDERS</b>
(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_11" id="_DebtDisclosureTextBlock-c0_cont_10"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of May&#160;3, 2022, Smart Pro had outstanding loans to Medigus, Mr.&#160;Hakmon and L.I.A.&#160;Pure Capital Ltd. (&#8220;Pure Capital&#8221;) of $<ix:nonFraction contextRef="c81" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrincipalAmountOutstandingOnLoansSecuritized" scale="3" unitRef="usd">4,010</ix:nonFraction> thousands, $<ix:nonFraction contextRef="c82" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrincipalAmountOutstandingOnLoansSecuritized" scale="3" unitRef="usd">940</ix:nonFraction> thousands and $<ix:nonFraction contextRef="c83" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrincipalAmountOutstandingOnLoansSecuritized" scale="3" unitRef="usd">109</ix:nonFraction> thousands, respectively. On May&#160;3, 2022, the Company entered into Assignments to Loan Agreements with Smart Pro, Medigus, Mr.&#160;Hakmon and Pure Capital, pursuant to which the Company assumed Smart Pro&#8217;s obligations under the outstanding loans and agreed that unless earlier repaid pursuant to the terms of the respective loan agreements with such parties, effective immediately upon the consummation of IPO, all outstanding principal due to each such party will be automatically converted into a number of Ordinary Shares equal to the quotient obtained by dividing the outstanding principal amount due to such party, by the per Ordinary Share price obtained by dividing $<ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DividendsCommonStock" scale="3" unitRef="usd">10,000</ix:nonFraction> thousands by the fully diluted issued and outstanding Ordinary Shares as of immediately prior to the closing of the IPO.&#160;Any accrued and unpaid interest due to such party as of such date will be paid in cash.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_12" id="_DebtDisclosureTextBlock-c0_cont_11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Based on management&#8217;s assessment,
the modified loan terms including an equity conversion feature upon IPO represented a substantial modification in accordance with ASC
470-50 and is accounted for as an extinguishment of the original financial liability in the amount of $<ix:nonFraction contextRef="c84" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" unitRef="usd">3,821</ix:nonFraction> thousands and the recognition
of a new financial instrument in the amount of $<ix:nonFraction contextRef="c84" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd">2,839</ix:nonFraction> thousands. The difference between the fair value of the instrument bearing the modified
terms and the carrying values of the original loans immediately prior to the modification, was recorded as an increase in equity in the
amount of $<ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquityPeriodIncreaseDecrease" scale="3" unitRef="usd">982</ix:nonFraction> thousands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_13" id="_DebtDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As the convertible note was not issued
with a substantial premium or with an embedded conversion feature required to be bifurcated under ASC 815, the convertible note was accounted
for as a liability in its entirety.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_DebtDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with such assignment agreements,
on August&#160;30, 2022, the outstanding amounts due to Medigus, Mr.&#160;Hakmon and Pure Capital at a total amount of $<ix:nonFraction contextRef="c85" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrincipalAmountOutstandingOnLoansSecuritized" scale="3" unitRef="usd">5,059</ix:nonFraction> thousands
were converted into an aggregate of <ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" unitRef="shares">1,463,619</ix:nonFraction>&#160;Ordinary Shares. In addition, accrued interest of $<ix:nonFraction contextRef="c86" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" scale="3" unitRef="usd">393</ix:nonFraction> thousands was paid.</p></ix:continuation><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 147; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 11 &#8212; TAXES ON INCOME:</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_2" id="_IncomeTaxDisclosureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Jeffs&#8217; Brands and Top Rank are
taxed according to Israeli tax laws. The corporate tax rate in Israel is <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" scale="-2" unitRef="pure">23</ix:nonFraction>%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_3" id="_IncomeTaxDisclosureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Smart Pro and Purex are taxed according
to US federal and California state laws. The blended corporate tax rate is <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure">28</ix:nonFraction>%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_4" id="_IncomeTaxDisclosureTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Capital gains are subject to capital
gain tax according to the corporate tax rate for the year during which the assets are sold.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_5" id="_IncomeTaxDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For financial reporting
purposes, income (loss) before taxes includes the following components:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 0.5in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_6" id="_IncomeTaxDisclosureTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Israel</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c87" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" sign="-" unitRef="usd">2,081</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c88" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" sign="-" unitRef="usd">1,096</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c90" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" sign="-" unitRef="usd">126</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c91" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" sign="-" unitRef="usd">465</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c92" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" unitRef="usd">188</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" sign="-" unitRef="usd">2,207</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" sign="-" unitRef="usd">1,561</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="3" unitRef="usd">188</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_7" id="_IncomeTaxDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Income tax expense
(benefit) was as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_8" id="_IncomeTaxDisclosureTextBlock-c0_cont_7"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended December&#160;31</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current:</span></td>
    <td>&#160;</td>
    <td colspan="10" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.&#160;dollars in thousands</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-90; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-91; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" unitRef="usd">12</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" unitRef="usd">94</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" unitRef="usd">126</ix:nonFraction></span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current income tax expense</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" unitRef="usd">12</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" unitRef="usd">94</ix:nonFraction></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" unitRef="usd">126</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 20pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-95; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 20pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd">18</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd">115</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd">50</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax income</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" sign="-" unitRef="usd">18</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" sign="-" unitRef="usd">115</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" sign="-" unitRef="usd">50</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total tax (benefit) expense</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd">6</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd">21</ix:nonFraction></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd">76</ix:nonFraction></span></td>
    <td>&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;<b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 148; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 11 &#8212; TAXES ON INCOME:</b> (cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_9" id="_IncomeTaxDisclosureTextBlock-c0_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A reconciliation of the Group&#8217;s
statutory income tax rate to effective income tax rate is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_10" id="_IncomeTaxDisclosureTextBlock-c0_cont_9"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="border: Black 1pt solid"><b>December 31,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>U.S.&#160;dollars in thousands</b></p></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Income (loss) before taxes on income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" sign="-" unitRef="usd">2,201</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" sign="-" unitRef="usd">1,561</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" unitRef="usd">188</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Statutory tax rate</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure">23</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure">23</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="pure">23</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax (tax benefit) computed at the statutory tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" sign="-" unitRef="usd">506</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" sign="-" unitRef="usd">359</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" unitRef="usd">43</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Increase (decrease) in taxes on income resulting from the following:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax rate differences applicable to subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" sign="-" unitRef="usd">110</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" sign="-" unitRef="usd">78</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" unitRef="usd">10</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Tax losses and timing differences for which deferred taxes were not recognized</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" unitRef="usd">610</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" unitRef="usd">416</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" unitRef="usd">23</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Taxes on income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd">6</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd">21</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd">76</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_11" id="_IncomeTaxDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Deferred taxes are comprised of the following components:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_12" id="_IncomeTaxDisclosureTextBlock-c0_cont_11"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 76%; text-align: left">Intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" unitRef="usd">110</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" unitRef="usd">56</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease right of use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" unitRef="usd">32</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Operating loss carryforward</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="3" unitRef="usd">890</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="3" unitRef="usd">172</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd">1,032</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd">228</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd">890</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd">172</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total deferred tax assets after valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" unitRef="usd">142</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" unitRef="usd">56</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Differences between tax basis and carrying value of loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:DifferencesBetweenTaxBasisAndCarryingValueOfLoans" scale="3" sign="-" unitRef="usd">370</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Operating lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" unitRef="usd">32</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total deferred tax liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" unitRef="usd">32</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" unitRef="usd">370</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Net deferred tax assets (liabilities)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" unitRef="usd">110</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" sign="-" unitRef="usd">314</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_13" id="_IncomeTaxDisclosureTextBlock-c0_cont_12"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Deferred tax assets on losses for tax
purposes carried forward to subsequent years are recognized if utilization of the related tax benefit against a future taxable income
is expected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_14" id="_IncomeTaxDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Carry forward tax losses of Jeffs&#8217;
Brands were $<ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" scale="3" unitRef="usd">3,870</ix:nonFraction> thousands and $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" scale="3" unitRef="usd">747</ix:nonFraction> thousands as of December 31, 2022 and 2021, respectively. Jeffs&#8217;&#160;Brands did not record
deferred tax assets in respect of these losses, as the utilization thereof is not expected to occur in the foreseeable future. There is
no expiration on net operating loss carryforwards in Israel.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_15" id="_IncomeTaxDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Smart Pro and Purex did not have any
net operating loss carryforwards as of December 31, 2022, and 2021. net deferred tax asset is with respect to Smart Pro.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_16" id="_IncomeTaxDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Deferred tax is the tax expected to be
payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding
tax bases used in the computation of taxable profit and is accounted for using the liability method. Deferred tax liabilities are generally
recognized for all taxable temporary differences and deferred tax assets are recognized to the extent that it is probable that taxable
profits will be available against which deductible temporary differences can be utilized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_IncomeTaxDisclosureTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Such assets and liabilities are not recognized
if the temporary difference arises from the initial recognition (other than in a business combination) of other assets and liabilities
in a transaction that affects neither the taxable profit nor the accounting profit.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 149; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 12 &#8212; SHARE CAPITAL:</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify">The share capital composed of ordinary shares as follows:</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of ordinary shares<br/>
 December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 4pt">Issued (*)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares">8,074,217</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares">2,893,125</ix:nonFraction></td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Authorized</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares">43,567,567</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares">4,356,757</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p></ix:nonNumeric></ix:continuation><div>




</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Retroactively adjusted. See Note&#160;1b</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Ordinary Shares confer upon their
holders the following rights: (i)&#160;the right to vote in any general meeting of the Company, (ii)&#160;the right to receive dividends,
if and when declared by the Board of Directors and (iii)&#160;the right to receive upon liquidation of the Company a sum equal to the
nominal value of the share, and if a surplus remains, to receive such surplus, subject to the rights conferred on any class of shares
which may be issued in the future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify">On October&#160;8, 2020, <ix:nonNumeric contextRef="c93" name="jfbr:AgreementDescription">Smart Pro entered into a definitive
agreement with Medigus. According to the agreement, Medigus will hold 50.01% of the issued and outstanding share capital of Smart Pro,
acquired through a combination of a cash investment in Smart Pro and an acquisition of additional shares from Smart Pro&#8217;s&#8217;
previous shareholders in consideration for restricted American Depository Shares (&#8220;ADS&#8221;) of Medigus and a cash component.
Medigus invested $1,100 thousands in Smart Pro in exchange of issuing 5,572 ordinary shares, pay $150 thousands in cash consideration
to the current shareholders and shall issue $500 thousands worth of restricted ADS of Medigus to the current shareholders of such company,
with the value of restricted ADS to be subject to downward adjustment based on Smart Pro&#8217;s 2020 results. In addition, Smart Pro&#8217;s
current shareholders shall be entitled to additional milestone allotments of up to an aggregate $750 thousands in restricted ADS subject
to Smart Pro &#8217;s achievement of certain milestones throughout 2021.</ix:nonNumeric> The closing of the transactions contemplated in the definitive
agreements are subject to customary closing conditions, which did not stand as of December&#160;31, 2020, and as such no shares were
issued and no cash or restricted ADS were received during the reporting period.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On January&#160;4, 2021, the terms and
conditions to the agreement with Medigus Ltd were completed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_8" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify">On October&#160;8, 2020, Purex signed on a definitive agreement
with Medigus. According to the agreement, Medigus will hold <ix:nonFraction contextRef="c93" decimals="4" format="ixt:num-dot-decimal" name="jfbr:IssuedAndOutstandingShareCapitalPercentage" scale="-2" unitRef="pure">50.01</ix:nonFraction>% of the issued and outstanding share capital of Purex, acquired through
a combination of a cash investment in Purex and asn acquisition of additional shares from the Purex&#8217;s previous shareholders in
consideration for restricted ADS of Medigus and a cash component. Medigus shall invest $<ix:nonFraction contextRef="c93" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:InvestAmount" scale="3" unitRef="usd">150</ix:nonFraction> thousands in Purex in exchange of issuing
<ix:nonFraction contextRef="c94" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">557</ix:nonFraction> ordinary shares. The closing of the transactions contemplated in the definitive agreements are subject to customary closing conditions,
which did not stand as of December&#160;31, 2020, and as such no shares were issued and no cash or restricted ADS were received during
the reporting period.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_9" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>d.</b></td><td style="text-align: justify">On May&#160;10, 2021, pursuant to the SEA, Medigus and the minority shareholders (see Note 1a)
                                                                                         contributed all of the equity interests they owned in Smart Pro and Purex to Jeffs&#8217; Brands. As of result of the Contribution
                                                                                         Transactions pursuant to the SEA, Jeffs&#8217; Brands holds all of the outstanding shares of Smart Pro and Purex</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p></ix:continuation><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 150; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 12 &#8212; SHARE CAPITAL: </b>(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_10" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_9"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>e.</b></td><td style="text-align: justify">On July 23, 2021, Medigus issued to the minority shareholder
<ix:nonFraction contextRef="c95" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">33,202</ix:nonFraction> ADS as a bonus for his services provided to the Group for the year-ended December 31, 2021 in the amount of $<ix:nonFraction contextRef="c96" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:MinorityShareholderAmount" scale="3" unitRef="usd">60</ix:nonFraction> thousands. Accordingly,
the Group recognized an amount of $<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent" scale="3" unitRef="usd">60</ix:nonFraction> thousands as additional payroll expenses and respectively a capital reserve as a benefit from Medigus
(the controlling shareholder).</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_11" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_10"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>f.</b></td><td style="text-align: justify">The Company engaged an advisor during 2021 in connection
with the IPO process. This advisor was entitled to receive a warrant upon the completion of the IPO to purchase up to a number of Ordinary
Shares equal to $<ix:nonFraction contextRef="c97" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDividendsCommonStock" scale="3" unitRef="usd">75</ix:nonFraction> thousands divided by the IPO price per Unit (as defined below), sold in the IPO, exercisable immediately upon issuance
for a period of <ix:nonNumeric contextRef="c97" format="ixt-sec:durwordsen" name="jfbr:IssuanceOfPeriodTerm">two years</ix:nonNumeric>, at an exercise price equal to the IPO price per unit. On August 30, 2022, following the closing of the IPO,
the Company issued to the Advisor warrants to purchase up to <ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="0" unitRef="shares">18,564</ix:nonFraction> Ordinary Shares exercisable <ix:nonNumeric contextRef="c33" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">5</ix:nonNumeric> years from the date of issuance at
an exercise price of $<ix:nonFraction contextRef="c34" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharesIssuedPricePerShare" scale="0" unitRef="usdPershares">4.04</ix:nonFraction> per Ordinary Share (the exercise price was adjusted to $<ix:nonFraction contextRef="c98" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">2.02</ix:nonFraction> per share on November 28, 2022 based on the terms
of the warrant). These warrants were treated as issuance costs, which amounted to $<ix:nonFraction contextRef="c97" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="3" unitRef="usd">12</ix:nonFraction> thousand based on a third-party valuation using
the Black &amp;Scholes Model and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_12" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_11"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>g.</b></td><td style="text-align: justify">On February&#160;17, 2022, the Company&#8217;s Board of Directors
approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of <ix:nonFraction contextRef="c99" decimals="4" format="ixt:num-dot-decimal" name="jfbr:IssuanceOfBonusShares" scale="0" unitRef="shares">664.0547</ix:nonFraction> (prior to adjustments for subsequent reverse
share split) Ordinary Shares of the Company for each Ordinary Share issued and outstanding as of the close of business on February&#160;17,
2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an aggregate issuance by the Company
as of such date of <ix:nonFraction contextRef="c99" decimals="0" format="ixt:num-dot-decimal" name="jfbr:AggregateIssuanceShares" scale="0" unitRef="shares">6,630,547</ix:nonFraction> (prior to adjustments for subsequent reverse share split) Ordinary Shares. (See also note 1c).</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_13" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_12"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>h.</b></td><td style="text-align: justify">On August&#160;30, 2022, the Company closed its IPO, and
the simultaneous partial exercise of the underwriter&#8217;s over-allotment&#160;option, for aggregate gross proceeds of approximately
$<ix:nonFraction contextRef="c100" decimals="-5" format="ixt:num-dot-decimal" name="jfbr:GrossProceeds" scale="6" unitRef="usd">15.5</ix:nonFraction>&#160;million, before deducting underwriting discounts and estimated offering expenses. The Company issued <ix:nonFraction contextRef="c101" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">3,717,473</ix:nonFraction> Ordinary Shares,
(&#8220;Ordinary Shares&#8221;) and IPO&#160;warrants to purchase up to <ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares">3,717,473</ix:nonFraction>&#160;Ordinary Shares. The Ordinary Shares and IPO Warrants
were sold together in the IPO as units (&#8220;Units&#8221;) at an initial public offering price of $<ix:nonFraction contextRef="c34" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">4.16</ix:nonFraction> per Unit.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_14" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The IPO Warrants had an initial exercise
price of $<ix:nonFraction contextRef="c102" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">4.04</ix:nonFraction>, and expire <ix:nonNumeric contextRef="c102" format="ixt-sec:durwordsen" name="jfbr:InitialExercisePriceExpire">five years</ix:nonNumeric> from the issuance day. The IPO Warrants became exercisable immediately after the completion of the
IPO (and until August 30, 2027). On the 90th day after completion of the IPO, the exercise price of the IPO Warrants was adjusted to be
equal to the lowest quoted share price during the 90 days. The daily quoted price used in the determination of such minimum was calculated
as the weighted average price of each day. The exercise price however may not be reduced to less than $<ix:nonFraction contextRef="c102" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">2.02</ix:nonFraction>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_15" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The IPO Warrants contain a down round
protection, so that for a period of two years from the date of issuance of the IPO Warrant, the exercise price is adjusted to the price
in subsequent fundings of the Company, if shares in these fundings are sold at a price per share below the warrant exercise price at the
time of such future fundings (or if other instruments with an exercise / conversion price at a price below the warrant exercise price
are sold). The exercise price however may not be reduced to less than $<ix:nonFraction contextRef="c86" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:StockOptionExercisePriceDecrease" scale="0" unitRef="usdPershares">2.02</ix:nonFraction>. On November 28, 2022, the IPO Warrant&#8217;s exercise price
was adjusted to $<ix:nonFraction contextRef="c103" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:StockOptionExercisePriceIncrease" scale="0" unitRef="usdPershares">2.02</ix:nonFraction>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 151; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 12 &#8212; SHARE CAPITAL: </b>(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_16" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, On November 28, 2022,
the Company issued Additional Warrants to purchase <ix:nonFraction contextRef="c104" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares">2,824,525</ix:nonFraction> Ordinary Shares. Each Additional Warrant has substantially the same
terms as the As-Adjusted IPO Warrant; provided, however, that the term of each Additional Warrant will be five (<ix:nonNumeric contextRef="c103" format="ixt-sec:duryear" name="jfbr:AdditionalWarrantTerm">5</ix:nonNumeric>) years from the
issuance date and such Additional Warrant will not be listed on any securities exchange. Each Additional Warrants holder will
receive semi-annual payments. The total annual payment depends on the amount of the Additional Warrants outstanding. As of December
31, 2022, the payment will be equal to approximately <ix:nonFraction contextRef="c103" decimals="3" format="ixt:num-dot-decimal" name="jfbr:RevenuesPercentage" scale="-2" unitRef="pure">2.3</ix:nonFraction>% of the Group &#8217;s revenues for the period from November 28, 2022 until
December 31,2022. The Additional Warrants may be redeemed by the Company at any time at a price equal to three times the Initial
Exercise Price, or $<ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockPricePerShare" scale="0" unitRef="usdPershares">6.06</ix:nonFraction>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_17" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As the IPO Warrants and the Additional
Warrants are not separable at the issuance date, the IPO Warrants and the Additional Warrants are accounted for as derivative instruments
which are classified as a liability and measured at fair value through profit or loss. The fair value of the warrants and the Additional
Warrants was calculated by an independent valuation expert and as of the issuance date the fair value was $<ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd">4,651</ix:nonFraction> thousands and $<ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd">3,594</ix:nonFraction>
thousands, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:nonNumeric contextRef="c103" name="jfbr:AdditionalWarrantsDescription"><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_18" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On November 28, 2022, following the issuance of the Additional warrants,
the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair
value of the IPO Warrants as of November 28, 2022 at the amount of $3,319 thousands which was calculated based on a third-party appraiser
valuation, was recorded as a component of Group&#8217;s shareholder&#8217;s equity. (Refer also to Note 9c). The total gross consideration
was 15.5&#160;million (including the exercise of the underwriter&#8217;s option at the amount of $4 thousands). $8,245 thousand was initially
attributed to the warrants based on their fair value and the remaining amount was attributed to the ordinary shares issued and recognized
as an equity component. Applicable issuance costs, amounting to $2,193 thousand, have been allocated in the same proportion as the allocation
of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and has been recorded in
profit or loss as finance expense, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand have been
recorded in equity as a reduction of the paid in capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation></ix:nonNumeric><div>
</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_19" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On November 28, 2022, following the issuance of the Additional Warrants,
the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair
value of the IPO Warrants as of November 28, 2022 at the amount of $<ix:nonFraction contextRef="c105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" unitRef="usd">3,319</ix:nonFraction> thousands, was recorded as a component of Group&#8217;s shareholder&#8217;s
equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_20" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As part of the IPO (see above), on August
30, 2022, the Company issued to the underwriter Warrants to purchase up to <ix:nonFraction contextRef="c102" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares">185,873</ix:nonFraction> Ordinary Shares (&#8220;Underwriters Warrants&#8221;)
exercisable at an exercise price of $<ix:nonFraction contextRef="c34" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" unitRef="usdPershares">5.20</ix:nonFraction>, and are exercisable beginning on February&#160;21, 2023 and will expire on August&#160;25,
2027. The Underwriter&#8217;s Warrants have a cashless exercise mechanism. The Underwriters Warrants were treated as issuance costs, which
amounted to $<ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" unitRef="usd">109</ix:nonFraction> thousand based on third party valuation, and have been allocated in the same proportion as the allocation of the gross
proceeds from the IPO. An amount of $<ix:nonFraction contextRef="c102" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:GrossProceeds" scale="3" unitRef="usd">58</ix:nonFraction> thousand was considered as issuance costs allocated to the warrants and has been recorded in profit
or loss as finance expense, while costs allocated as issuance costs of ordinary shares in the amount of $<ix:nonFraction contextRef="c42" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" unitRef="usd">51</ix:nonFraction> thousand have been recorded
in equity as a reduction of the additional paid in capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 152; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 12 &#8212; SHARE CAPITAL: </b>(cont.)</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_21" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_20"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>i.</b></td><td style="text-align: justify">On August 30, 2022, the underwriter (see Note 12h), partially
exercised its overallotment right to purchase additional IPO Warrants to purchase up to <ix:nonFraction contextRef="c100" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares">425,912</ix:nonFraction> Ordinary Shares for a total consideration
of $<ix:nonFraction contextRef="c86" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetAcquisitionConsiderationTransferred" scale="3" unitRef="usd">4</ix:nonFraction> thousands. These additional IPO Warrants were treated as issuance costs, which amounted to $<ix:nonFraction contextRef="c86" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" unitRef="usd">1</ix:nonFraction> thousand based on third party valuation,
and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO. An amount of $<ix:nonFraction contextRef="c33" decimals="-2" format="ixt:num-dot-decimal" name="jfbr:ConsideredAsIssuanceCosts" scale="3" unitRef="usd">0.5</ix:nonFraction> thousand was considered
as issuance costs allocated to the additional IPO Warrants and has been recorded in profit or loss as finance expense, while costs allocated
as issuance costs of Ordinary Shares in the amount of $<ix:nonFraction contextRef="c42" decimals="-2" format="ixt:num-dot-decimal" name="jfbr:ConsideredAsIssuanceCosts" scale="3" unitRef="usd">0.5</ix:nonFraction> thousand have been recorded in equity as a reduction of the paid in capital.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_21"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>j.</b></td><td style="text-align: justify">In accordance with an assignment agreement (see also Note
10d) and in connection with the IPO (see above), on August&#160;30, 2022, the Company converted outstanding amounts due to Medigus, Mr.&#160;Hakmon
and Pure Capital into <ix:nonFraction contextRef="c106" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares">1,463,619</ix:nonFraction>&#160;Ordinary Shares.</td>
</tr></table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 13 &#8212; SHARE INCENTIVE PLAN</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On January&#160;19, 2022, the Company&#8217;s
Board of Directors adopted the 2022 Incentive Option Plan (&#8220;Plan&#8221;). A total of <ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares" scale="0" unitRef="shares">1,307,027</ix:nonFraction>&#160;Ordinary Shares were reserved
and subject to the Plan. The Plan is intended as an incentive to retain directors, officers, employees, consultants and advisers of the
Company. As of December 31, 2022, the Company had not granted awards under the Plan.</p></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_InterestIncomeAndInterestExpenseDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 14 &#8212;&#160;FINANCE (INCOME) EXPENSE, NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><ix:continuation id="_InterestIncomeAndInterestExpenseDisclosureTextBlock-c0_cont_1"><ix:nonNumeric contextRef="c0" escape="true" name="jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Finance income:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Change in fair value of derivative liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="3" sign="-" unitRef="usd">2,822</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Gain from debt extinguishment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="3" sign="-" unitRef="usd">14</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-99">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total finance income</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="3" unitRef="usd">2,822</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestAndOtherIncome" scale="3" unitRef="usd">14</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-100">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Finance expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Finance expenses in respect of third-party loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FinanceExpensesInRespectOfThirdpartyLoan" scale="3" unitRef="usd">83</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FinanceExpensesInRespectOfThirdpartyLoan" scale="3" unitRef="usd">77</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-101">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value of derivative liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInDerivativeLiabilities" scale="3" unitRef="usd">75</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization of loan discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" unitRef="usd">37</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" unitRef="usd">85</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exchange rate changes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">156</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd">10</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense on loans from shareholders and related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseRelatedParty" scale="3" unitRef="usd">203</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseRelatedParty" scale="3" unitRef="usd">381</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseRelatedParty" scale="3" unitRef="usd">221</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Other finance expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingExpense" scale="3" unitRef="usd">38</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingExpense" scale="3" unitRef="usd">15</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingExpense" scale="3" unitRef="usd">11</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total finance expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherTaxExpenseBenefit" scale="3" unitRef="usd">517</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherTaxExpenseBenefit" scale="3" unitRef="usd">643</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherTaxExpenseBenefit" scale="3" unitRef="usd">232</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Finance (income) expense, net</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FinanceExpenseNet" scale="3" sign="-" unitRef="usd">2,305</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FinanceExpenseNet" scale="3" unitRef="usd">629</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:FinanceExpenseNet" scale="3" unitRef="usd">232</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table></ix:nonNumeric></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 153; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerShareTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 15 &#8212;&#160;NET INCOME (LOSS) PER
SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_EarningsPerShareTextBlock-c0_cont_2" id="_EarningsPerShareTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0pt">The following
table sets forth the computation of basic and diluted net income (loss) per share attributable to ordinary shareholders:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_EarningsPerShareTextBlock-c0_cont_3" id="_EarningsPerShareTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands (*)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Net income (loss) applicable
    to shareholders of ordinary shares</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" sign="-" unitRef="usd">2,201</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" sign="-" unitRef="usd">1,540</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" unitRef="usd">112</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-hidden: hidden-fact-108; -sec-ix-hidden: hidden-fact-107; -sec-ix-hidden: hidden-fact-106; font-size: 10pt">Shares of ordinary share used in computing basic and diluted net loss per share</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" scale="0" unitRef="shares">4,643,879</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" scale="0" unitRef="shares">2,892,347</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageBasicSharesOutstandingProForma" scale="0" unitRef="shares">2,888,768</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><div style="-sec-ix-hidden: hidden-fact-111; -sec-ix-hidden: hidden-fact-110; -sec-ix-hidden: hidden-fact-109">Net loss per share of ordinary share, basic and diluted</div></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDilutedProFormaAdjustment" scale="0" sign="-" unitRef="usdPershares">0.47</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDilutedProFormaAdjustment" scale="0" sign="-" unitRef="usdPershares">0.53</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDilutedProFormaAdjustment" scale="0" unitRef="usdPershares">0.04</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt">&#160;</p></ix:nonNumeric></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_EarningsPerShareTextBlock-c0_cont_4" id="_EarningsPerShareTextBlock-c0_cont_3"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0pt">The following potentially dilutive securities outstanding have been
excluded from the computation of diluted weighted average shares outstanding, because such securities had an antidilutive impact:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_EarningsPerShareTextBlock-c0_cont_5" id="_EarningsPerShareTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands (*)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">IPO Warrants and Additional Warrants (Note 12h)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="jfbr:IPOAndAdditionalWarrants" scale="0" unitRef="shares">6,541,998</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Underwriter warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="jfbr:UnderwriterWarrants" scale="0" unitRef="shares">611,785</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other warrants </td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="jfbr:OtherWarrants" scale="0" unitRef="shares">78,661</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="jfbr:TotalDilutedWeightedAverageSharesOutstanding" scale="0" unitRef="shares">7,232,444</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt">&#160;</p></ix:nonNumeric></ix:continuation><div>




</div><div>

</div><ix:continuation id="_EarningsPerShareTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">except share and per share data</td>
</tr></table></ix:continuation><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 16 &#8212;&#160;RELATED PARTIES&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_2" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify"><b>Transactions with interested and related parties:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_3" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_2"><ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Labor cost and related expenses (c1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LaborAndRelatedExpense" scale="3" unitRef="usd">358</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LaborAndRelatedExpense" scale="3" unitRef="usd">192</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Directors&#8217; fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoninterestExpenseDirectorsFees" scale="3" unitRef="usd">172</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consulting fees (c2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" unitRef="usd">218</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest expenses on loans from related parties and shareholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:InterestExpensesOnLoansFromRelatedPartiesAndShareholders" scale="3" unitRef="usd">203</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:InterestExpensesOnLoansFromRelatedPartiesAndShareholders" scale="3" unitRef="usd">381</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" unitRef="usd">951</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c4" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="3" unitRef="usd">573</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 154; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 16 &#8212;&#160;RELATED PARTIES (cont.)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_4" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify"><b>Balances with interested and related parties:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_5" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_4"><ix:nonNumeric contextRef="c0" escape="true" name="jfbr:ScheduleOfInterestedAndRelatedPartiesTableTextBlock"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="text-decoration:underline">Assets:</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Advances to suppliers (c2)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:AdvancesToSuppliers" scale="3" unitRef="usd">228</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssets" scale="3" unitRef="usd">228</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="text-decoration:underline">Liabilities:</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Related parties (c3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" scale="3" unitRef="usd">32</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DueToRelatedPartiesCurrentAndNoncurrent" scale="3" unitRef="usd">265</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loans from shareholders (Note 10),(c3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:LoansFromShareholders" scale="3" unitRef="usd">3,634</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loan from related parties (Note 9)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DueToOtherRelatedPartiesNoncurrent" scale="3" unitRef="usd">111</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c2" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilities" scale="3" unitRef="usd">32</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilities" scale="3" unitRef="usd">4,010</ix:nonFraction></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p></ix:nonNumeric></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_6" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_5"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify"><b>Additional information:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_7" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">On July&#160;23, 2021, Medigus issued to the minority Shareholder
and amount of <ix:nonFraction contextRef="c107" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharesIssued" scale="0" unitRef="shares">33,202</ix:nonFraction> ADS as a bonus for his services provided to the Group for the six&#160;months ended June&#160;30, 2021 in a value
of $<ix:nonFraction contextRef="c108" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:RelatedPartyFairValue" scale="3" unitRef="usd">60</ix:nonFraction> thousand. Accordingly, the Group recognized an amount of $<ix:nonFraction contextRef="c109" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccruedPayrollTaxesCurrent" scale="3" unitRef="usd">60</ix:nonFraction> thousand as additional payroll expenses and respectively a capital
reserve as a benefit from Medigus (the Group&#8217;s controlling shareholder).</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_8" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_7"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On August 3, 2022, the Company&#8217;s
Board of Directors approved the increase to Mr. Hakmon&#8217;s monthly salary to NIS <ix:nonFraction contextRef="c110" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SalariesWagesAndOfficersCompensation" scale="3" unitRef="ils">55</ix:nonFraction> thousand (approximately $<ix:nonFraction contextRef="c110" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SalariesWagesAndOfficersCompensation" scale="3" unitRef="usd">23</ix:nonFraction> thousands) plus applicable
value added taxes (&#8220;VAT&#8221;), retroactively from February 1, 2022. Effective on September 1, 2022, the Company&#8217;s Board
of Directors approved an increase to Mr. Hakmon&#8217;s monthly salary to NIS <ix:nonFraction contextRef="c111" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SalariesWagesAndOfficersCompensation" scale="3" unitRef="ils">80</ix:nonFraction> thousands (approximately $<ix:nonFraction contextRef="c111" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SalariesWagesAndOfficersCompensation" scale="3" unitRef="usd">23</ix:nonFraction> thousands) plus VAT and
a one-time bonus of NIS <ix:nonFraction contextRef="c112" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:Bonus" scale="3" unitRef="ils">480</ix:nonFraction> thousands (approximately $<ix:nonFraction contextRef="c112" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:Bonus" scale="3" unitRef="usd">140</ix:nonFraction> thousands).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_9" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_8"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">2.</td><td style="text-align: justify">On October 26, 2022, the Group and Pure Capital entered into
a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS <ix:nonFraction contextRef="c113" decimals="-2" format="ixt:num-dot-decimal" name="jfbr:ConsultancyServicesFees" scale="3" unitRef="ils">57.5</ix:nonFraction> thousands
(approximately $<ix:nonFraction contextRef="c113" decimals="-2" format="ixt:num-dot-decimal" name="jfbr:ConsultancyServicesFees" scale="3" unitRef="usd">16.5</ix:nonFraction> thousands) the Group paid Pure Capital a one-time signing bonus in the amount of NIS <ix:nonFraction contextRef="c113" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:Bonus" scale="3" unitRef="ils">425</ix:nonFraction> thousands (approximately
$<ix:nonFraction contextRef="c113" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:Bonus" scale="3" unitRef="usd">121</ix:nonFraction> thousands) for their services to the Group from the day of the Company&#8217;s inception until the closing of the IPO. Pure Capital is
also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to <ix:nonFraction contextRef="c113" decimals="2" format="ixt:num-dot-decimal" name="jfbr:PercentageOfGrossProceed" scale="-2" unitRef="pure">7</ix:nonFraction>% of the gross proceeds paid
to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) <ix:nonFraction contextRef="c113" decimals="2" format="ixt:num-dot-decimal" name="jfbr:PercentageOfTotalConsiderationPaid" scale="-2" unitRef="pure">8</ix:nonFraction>% of the total consideration
paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved
by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined
period of time and may be terminated after <ix:nonNumeric contextRef="c113" format="ixt-sec:duryear" name="jfbr:UndefinedPeriodOfTime">3</ix:nonNumeric> years from October 26, 2022 by either party upon 30 days of advance notice. Additionally
On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse
lease agreement located in the USA. As of December 31, 2022 the advances to suppliers comprised of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToSuppliers" scale="3" unitRef="usd">228</ix:nonFraction> thousands to Pure NJ Logistics
LLC.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p></ix:continuation><div>


</div><div>

</div><ix:continuation continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_10" id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_9"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">3.</td><td style="text-align: justify">On May 21, 2022, the Company has entered into a short-term
lease agreement for its offices from Medigus and participated in <ix:nonFraction contextRef="c114" decimals="2" format="ixt:num-dot-decimal" name="jfbr:PercentageLeaseAndMaintenanceExpensesRelated" scale="-2" unitRef="pure">50</ix:nonFraction>% of the lease and maintenance expenses related. The Company paid
$<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLaborRelatedExpenses" scale="3" unitRef="usd">86</ix:nonFraction> thousand plus VAT on December 30, 2022. The outstanding payable to Medigus as of December 31, 2022, was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="jfbr:OutstandingPayable" scale="3" unitRef="usd">32</ix:nonFraction> thousands plus VAT.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_10"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">During September 2022, the Group repaid:
(i) a related party balance to Medigus, in the amount of $<ix:nonFraction contextRef="c115" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyCosts" scale="0" unitRef="usd">150</ix:nonFraction> thousands and (ii) another related party balance in the amount of $<ix:nonFraction contextRef="c116" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:RelatedPartyTransactionDueFromToRelatedParty" scale="0" unitRef="usd">175</ix:nonFraction> thousands
and (iii) $<ix:nonFraction contextRef="c115" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestIncomeRelatedParty" scale="3" unitRef="usd">393</ix:nonFraction> thousand in accrued interest with respect to certain related party loans upon the conversion of such loans at the closing
of the IPO.</p></ix:continuation><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 155; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>JEFFS&#8217; BRANDS LTD<br/>
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>



</div><ix:nonNumeric contextRef="c0" continuedAt="_SubsequentEventsTextBlock-c0_cont_1" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 17 &#8212; SUBSEQUENT EVENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p></ix:nonNumeric><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_2" id="_SubsequentEventsTextBlock-c0_cont_1"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td> <td style="text-align: justify; font-size: 10pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><ix:nonNumeric contextRef="c117" name="us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription"><span style="font-family: Times New Roman, Times, Serif">On February 23, 2023, the Company and Jeffs&#8217; Brands Holdings entered into a stock purchase agreement with SciSparc (the &#8220;Wellution Agreement&#8221;), as amended on March 22, 2023 by Addendum No. 1 to the Wellution Agreement (the &#8220;Addendum&#8221;), pursuant which, on March 22, 2023, Jeffs&#8217; Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S., a wholly-owned subsidiary of SciSparc that owns and operates Wellution, a top-selling Amazon food supplements and cosmetics brand, subject to the holdback by SciSparc of 11 shares as described below, representing approximately 49% of the issued and outstanding common stock of SciSparc U.S., for approximately $3 million in cash (including the Price Adjustment, as defined below), of which approximately $2.5 million was paid at the closing (the &#8220;Wellution Transaction&#8221;). The Addendum provided for the payment by us to SciSparc of an additional amount of $489,330 in cash for the purchase price adjustments (the &#8220;Price Adjustment,&#8221;) related to inventory and working capital, payable in five equal installments of $97,866 on the tenth day of each consecutive calendar month, beginning in May 2023. As collateral for the payment in full of the Price Adjustment, SciSparc held back 11 shares of common stock of SciSparc U.S, which will be released to Jeffs&#8217; Brands Holdings once the final payment is made. Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Transaction, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S. (the &#8220;SciSparc Consulting Agreement&#8221;), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousands and the Company will receive a one-time signing bonus in the amount of $51 thousands. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice.</span></ix:nonNumeric></p></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_3" id="_SubsequentEventsTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Also pursuant to the Wellution Agreement,
in connection with the closing of the Wellution Transaction, effective as of March 22, 2023, the Company issued <ix:nonFraction contextRef="c118" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockOtherSharesOutstanding" scale="0" unitRef="shares">247,415</ix:nonFraction> of its Ordinary
Shares to SciSparc and on March 29, 2023 SciSparc issued <ix:nonFraction contextRef="c119" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockOtherSharesOutstanding" scale="0" unitRef="shares">360,297</ix:nonFraction> of its Ordinary Shares to the Company in a mutual share exchange (collectively,
the &#8220;Exchange Shares&#8221;), representing <ix:nonFraction contextRef="c120" decimals="4" format="ixt:num-dot-decimal" name="jfbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage" scale="-2" unitRef="pure">2.97</ix:nonFraction>% and <ix:nonFraction contextRef="c120" decimals="4" format="ixt:num-dot-decimal" name="jfbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage" scale="-2" unitRef="pure">4.99</ix:nonFraction>%, respectively, of the Company&#8217;s and SciSparc&#8217;s issued and
outstanding ordinary shares. The number of Exchange Shares acquired by each company was calculated by dividing $<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="0" unitRef="usd">288,238</ix:nonFraction>, which was adjusted
from $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="jfbr:AdditionalDividendsPayableSharesValue" scale="0" unitRef="usd">300,000</ix:nonFraction>, pursuant to the <ix:nonFraction contextRef="c121" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" unitRef="pure">4.99</ix:nonFraction>% ownership limitation included in the Wellution Agreement, by the average closing price of the relevant
company&#8217;s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior
to the closing date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 2.5pt">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_4" id="_SubsequentEventsTextBlock-c0_cont_3"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left">b.</td><td style="text-align: justify">On March 2, 2023, the Company entered into a share purchase
agreement (the &#8220;Fort SPA&#8221;), with the holders (the &#8220;Sellers&#8221;), of all of the issued and outstanding share capital
of Fort, a company incorporated under the laws of England and Wales and engaged in the sale of pest control products primarily through
Amazon.uk, pursuant to which on March 9, 2023, the Company acquired all of the issued and outstanding share capital of Fort, for approximately
&#163;<ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MembersCapital" scale="0" unitRef="usd">2,000,000</ix:nonFraction> (approximately $<ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:MembersCapital" scale="0" unitRef="eur">2,400</ix:nonFraction> thousands) in cash (the &#8220;Fort Acquisition&#8221;). The Fort SPA provides that for a period
of three years from closing, the Sellers will not compete with Fort&#8217;s business.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_5" id="_SubsequentEventsTextBlock-c0_cont_4"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Also in connection with the Fort Acquisition,
on March 9, 2023, the Company and Fort entered into settlement agreements with all of Fort&#8217;s employees, including the Sellers, providing
that such employees&#8217; employment with Fort will terminate three months following March 9, 2023 and certain other customary conditions.
During this three-month period, the Company intends to carry out operational changes in Fort&#8217;s business that will allow Fort to
wind down the activities conducted in its leased warehouse and to move all such operations to warehouses operated by Amazon. In connection
with the closing of the acquisition, on March 9, 2023, the Company and the Sellers entered into a consulting agreement, pursuant to which
the Sellers will provide us with consultancy services for a period of three months, in consideration for a monthly fee of &#163;<ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFeeAmount" scale="0" unitRef="eur">2,500</ix:nonFraction>
(approximately $<ix:nonFraction contextRef="c122" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFeeAmount" scale="0" unitRef="usd">3,000</ix:nonFraction>).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>
</div><div>

</div><ix:continuation continuedAt="_SubsequentEventsTextBlock-c0_cont_6" id="_SubsequentEventsTextBlock-c0_cont_5"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Fort acquisition was accounted for as an asset acquisition, as
substantially all of the fair value of the assets being acquired under the arrangement was concentrated in the brand name.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p></ix:continuation><div>

</div><div>

</div><ix:continuation id="_SubsequentEventsTextBlock-c0_cont_6"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023 the Company paid to Pure Capital $<ix:nonFraction contextRef="c123" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PartnersCapitalAccountReturnOfCapital" scale="0" unitRef="usd">352</ix:nonFraction> thousands in accordance with the consultant agreement in relation to the two purchases as described in note 17.a and note 17.b. For additional information see note 16.c.2.</span></td></tr> </table></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><div>


</div><!-- Field: Page; Sequence: 156; Options: NewSection; Value: 35 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><div><a id="a_079"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized
the undersigned to sign this Annual Report on Form 20-F filed on its behalf.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jeffs
    Brands Ltd</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    April 10, 2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap">/s/ Viki
    Hakmon</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viki
    Hakmon</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  </table><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">115</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><div>

</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c2" id="hidden-fact-0" name="us-gaap:DeferredCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-1" name="us-gaap:DeferredIncomeTaxAssetsNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-2" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-3" name="us-gaap:OtherLoansPayableLongTerm" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-4" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-6" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-7" name="us-gaap:CommonStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-8" name="us-gaap:CommonStockNoParValue" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-9" name="us-gaap:CommonStockNoParValue" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-10" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-11" name="us-gaap:OtherSellingGeneralAndAdministrativeExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="2" id="hidden-fact-12" name="us-gaap:EarningsPerShareDiluted" unitRef="usdPershares">0.04</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="2" id="hidden-fact-13" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">0.47</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="2" id="hidden-fact-14" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="usdPershares">0.53</ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="INF" id="hidden-fact-15" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">2888768</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="INF" id="hidden-fact-16" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">2892347</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="INF" id="hidden-fact-17" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="shares">4643879</ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-18" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c11" id="hidden-fact-19" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c10" id="hidden-fact-20" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-21" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-22" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c18" id="hidden-fact-23" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-24" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-25" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-26" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-27" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-28" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-29" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c17" id="hidden-fact-30" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-31" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-32" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-33" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-34" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-35" name="us-gaap:AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-36" name="us-gaap:AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-37" name="jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-38" name="jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-39" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-40" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-41" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-42" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-43" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-44" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-45" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-46" name="us-gaap:ShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-47" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-48" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-49" name="us-gaap:OtherDepreciationAndAmortization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-50" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-51" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-52" name="us-gaap:FairValueAdjustmentOfWarrants" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-53" name="us-gaap:ShortTermLeasePayments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-54" name="us-gaap:ShortTermLeasePayments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-55" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-56" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-57" name="jfbr:IssuanceCostsOnDerivativeLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-58" name="jfbr:IssuanceCostsOnDerivativeLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-59" name="us-gaap:IncreaseDecreaseInDueToRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-60" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-61" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-62" name="us-gaap:PaymentsToAcquireIntangibleAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-63" name="us-gaap:ProceedsFromOtherShortTermDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-64" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-65" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-66" name="us-gaap:ProceedsFromBankDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-67" name="us-gaap:RepaymentsOfBankDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-68" name="us-gaap:RepaymentsOfBankDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-69" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-70" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-71" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-72" name="us-gaap:InterestPaidNet" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-73" name="jfbr:DeferredOfferingCostsIncludedInOtherPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-74" name="jfbr:DeferredOfferingCostsIncludedInOtherPayables" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-75" name="jfbr:SharebasedCompensationIncludedInDeferredOfferingCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-76" name="jfbr:SharebasedCompensationIncludedInDeferredOfferingCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-77" name="jfbr:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-78" name="jfbr:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" id="hidden-fact-79" name="us-gaap:MaturityOfTimeDeposits">P3M</ix:nonNumeric>
<ix:nonFraction contextRef="c3" id="hidden-fact-80" name="us-gaap:Supplies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-81" name="us-gaap:OtherLiabilitiesCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-82" name="us-gaap:InterestPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-83" name="us-gaap:LoansAndLeasesReceivableRelatedParties" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-84" name="jfbr:ThirdPartyLoan" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-85" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="pure" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-86" name="us-gaap:LoansPayableCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-87" name="us-gaap:DebtInstrumentUnamortizedDiscount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-88" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c89" id="hidden-fact-89" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-90" name="jfbr:CurrentStateAndLocalTaxExpensesBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-91" name="jfbr:CurrentStateAndLocalTaxExpensesBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-92" name="jfbr:CurrentStateAndLocalTaxExpensesBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-93" name="jfbr:DeferredStateAndLocalIncomeTaxExpensesBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-94" name="jfbr:DeferredStateAndLocalIncomeTaxExpensesBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-95" name="jfbr:DeferredStateAndLocalIncomeTaxExpensesBenefit" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:footnote id="ix_2_footnote" xml:lang="en-US">Retroactively adjusted. See Note 1b</ix:footnote><!--Text not found in footnote sections assigned to Schedule of share capital composed of ordinary shares-->
<ix:nonFraction contextRef="c4" id="hidden-fact-96" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-97" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-98" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-99" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-100" name="us-gaap:InterestAndOtherIncome" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-101" name="jfbr:FinanceExpensesInRespectOfThirdpartyLoan" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-102" name="us-gaap:IncreaseDecreaseInDerivativeLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-103" name="us-gaap:IncreaseDecreaseInDerivativeLiabilities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-104" name="us-gaap:AmortizationOfFinancingCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-105" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="INF" id="hidden-fact-106" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" unitRef="shares">2888768</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="INF" id="hidden-fact-107" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" unitRef="shares">2892347</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="INF" id="hidden-fact-108" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" unitRef="shares">4643879</ix:nonFraction>
<ix:nonFraction contextRef="c5" decimals="2" id="hidden-fact-109" name="us-gaap:EarningsPerShareDilutedProFormaAdjustment" unitRef="usdPershares">0.04</ix:nonFraction>
<ix:nonFraction contextRef="c0" decimals="2" id="hidden-fact-110" name="us-gaap:EarningsPerShareDilutedProFormaAdjustment" sign="-" unitRef="usdPershares">0.47</ix:nonFraction>
<ix:nonFraction contextRef="c4" decimals="2" id="hidden-fact-111" name="us-gaap:EarningsPerShareDilutedProFormaAdjustment" sign="-" unitRef="usdPershares">0.53</ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-112" name="jfbr:IPOAndAdditionalWarrants" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-113" name="jfbr:IPOAndAdditionalWarrants" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-114" name="jfbr:UnderwriterWarrants" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-115" name="jfbr:UnderwriterWarrants" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-116" name="jfbr:OtherWarrants" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-117" name="jfbr:OtherWarrants" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-118" name="jfbr:TotalDilutedWeightedAverageSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-119" name="jfbr:TotalDilutedWeightedAverageSharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:footnote id="ix_3_footnote" xml:lang="en-US">except share and per share data</ix:footnote><!--Text not found in footnote sections assigned to Schedule of diluted weighted average shares outstanding-->
<ix:nonFraction contextRef="c4" id="hidden-fact-120" name="us-gaap:NoninterestExpenseDirectorsFees" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c4" id="hidden-fact-121" name="us-gaap:ProfessionalFees" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-122" name="jfbr:AdvancesToSuppliers" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c3" id="hidden-fact-123" name="us-gaap:OtherAssets" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-124" name="jfbr:LoansFromShareholders" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c2" id="hidden-fact-125" name="us-gaap:DueToOtherRelatedPartiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey">0001885408</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="jfbr-20221231.xsd" xlink:type="simple"></link:schemaRef></ix:references>
<ix:resources><ix:relationship fromRefs="hidden-fact-71" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_0_fact hidden-fact-80" toRefs="ix_1_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_1_fact ix_2_fact" toRefs="ix_2_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-112 hidden-fact-114 hidden-fact-116 hidden-fact-118" toRefs="ix_3_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jfbr:SmartProMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jfbr:PurexCorpMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-04</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jfbr:JeffsBrandsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-05-01</xbrli:startDate>
    <xbrli:endDate>2021-05-10</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jfbr:MrHakmonMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-05-01</xbrli:startDate>
    <xbrli:endDate>2021-05-10</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-01</xbrli:startDate>
    <xbrli:endDate>2022-08-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-08-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:IPOWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-08-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:IPOWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-01</xbrli:startDate>
    <xbrli:endDate>2022-08-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:UnderwritersWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:UnderwritersWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:IPOWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-07</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:IPOWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:IPOWarrantMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-01</xbrli:startDate>
    <xbrli:endDate>2022-08-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-02-01</xbrli:startDate>
    <xbrli:endDate>2022-02-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-05-01</xbrli:startDate>
    <xbrli:endDate>2022-05-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-06-01</xbrli:startDate>
    <xbrli:endDate>2022-06-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jfbr:ComputersEquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jfbr:BrandsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jfbr:BrandsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-02</xbrli:startDate>
    <xbrli:endDate>2022-09-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-05-09</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZqAlP1yOSc1A/ANEzuo53ddr/LMBLom9FlRSK3NKkyEbonVWG5HPDY+G1lW3BvjVh1hGR4TsEWxikRSd2CzczjxOi38/JBT4C/OcGQ5Ko7wX9cWbP+EcSCjzoKw5UOEXtltIx6qGM8m+WHjAhoKAqHXg9v/7inBQezt5KwYVPvHGi+aa1see5NyHSlbZi0i9Ss78wdPGTSwuIA8r8phWnb] CSR-->
  <xbrli:period>
    <xbrli:instant>2021-07-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-07-01</xbrli:startDate>
    <xbrli:endDate>2021-07-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-12</xbrli:startDate>
    <xbrli:endDate>2023-04-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-03-03</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-06-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">jfbr:IssuanceDateMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-30</xbrli:startDate>
    <xbrli:endDate>2022-08-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-30</xbrli:startDate>
    <xbrli:endDate>2022-08-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">jfbr:UnderwritersWarrantsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-11-28</xbrli:startDate>
    <xbrli:endDate>2022-11-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-11-29</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:AmazoncomMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-10-08</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MedigusMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-10-08</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-10-08</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-10-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-02-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MedigusMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-02-01</xbrli:startDate>
    <xbrli:endDate>2021-02-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MedigusMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-02-02</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-02-01</xbrli:startDate>
    <xbrli:endDate>2021-02-02</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MedigusMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-05-03</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jfbr:MrHakmonAndLIAMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-05-03</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">jfbr:PureCapitalLtdMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-05-03</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-05-03</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">jfbr:PureCapitalLtdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jfbr:MrHakmonAndLIAMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MedigusMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-08-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-01</xbrli:startDate>
    <xbrli:endDate>2022-08-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:IL</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-10-01</xbrli:startDate>
    <xbrli:endDate>2020-10-08</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-10-08</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:MajorityShareholderMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-07-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:MajorityShareholderMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-08-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-08-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-08-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-11-28</xbrli:startDate>
    <xbrli:endDate>2022-11-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-11-01</xbrli:startDate>
    <xbrli:endDate>2022-11-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-08-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MinorityShareholderMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-07-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-06-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-07-23</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-01</xbrli:startDate>
    <xbrli:endDate>2022-08-03</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-25</xbrli:startDate>
    <xbrli:endDate>2022-09-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-08-25</xbrli:startDate>
    <xbrli:endDate>2022-09-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-10-10</xbrli:startDate>
    <xbrli:endDate>2022-10-26</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-05-10</xbrli:startDate>
    <xbrli:endDate>2022-05-21</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-09-02</xbrli:startDate>
    <xbrli:endDate>2022-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-09-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-23</xbrli:startDate>
    <xbrli:endDate>2023-02-23</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-29</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-03-28</xbrli:startDate>
    <xbrli:endDate>2023-03-29</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:OwnershipAxis">jfbr:OwnershipMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-09</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001885408</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-03-01</xbrli:startDate>
    <xbrli:endDate>2023-03-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit id="ils">
  <xbrli:measure>iso4217:ILS</xbrli:measure>
</xbrli:unit><xbrli:unit id="eur">
  <xbrli:measure>iso4217:EUR</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.5
<SEQUENCE>2
<FILENAME>f20f2022ex2-5_jeffsbrands.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 2.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>DESCRIPTION OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Jeffs&rsquo; Brands Ltd has
two classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: ordinary shares, no par value
per share, or Ordinary Shares, and warrants to purchase ordinary shares, or IPO Warrants. References herein to &ldquo;we,&rdquo; &ldquo;us,&rdquo;
&ldquo;our&rdquo; and the &ldquo;Company&rdquo; refer to Jeffs&rsquo; Brands Ltd and not to any of its subsidiaries. The following description
may not contain all of the information that is important to you, and we therefore refer you to our amended and restated articles of association,
or Articles of Association, a copy of which is filed with the Securities and Exchange Commission, or the SEC, as an exhibit to this Annual
Report on Form 20-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2022, our
authorized share capital consisted of 43,567,567&nbsp;Ordinary Shares. All of our outstanding Ordinary Shares have been validly issued,
fully paid and non-assessable. Our Ordinary Shares are not redeemable and are not subject to any preemptive right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt">Our Ordinary Shares are listed
on the Nasdaq Capital Market, or Nasdaq, under the symbol &ldquo;JFBR&rdquo; since August 26, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Articles of Association</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Purposes and Objects of the Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our purpose as stated in our
Articles of Association includes every lawful purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The Powers of the Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors shall
direct our policy and shall supervise the performance of our Chief Executive Officer and his actions. Our board of directors may exercise
all powers that are not required under the Israeli Companies Law &ndash; 1999, or the Companies Law, or under our Articles of Association
to be exercised or taken by&nbsp;our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Rights Attached to Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Ordinary Shares shall confer
upon the holders thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">equal right to attend and to vote at all of our general meetings,
whether regular or special, with each Ordinary Share entitling the holder thereof, which attend the meeting and participate at the voting,
either in person or by a proxy or by a written ballot, to one vote;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">equal right to participate in distribution of dividends, if
any, whether payable in cash or in bonus shares, in distribution of assets or in any other distribution, on a per share pro rata basis;
and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">equal right to participate, upon our dissolution, in the distribution
of our assets legally available for distribution, on a per share pro rata basis.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Transfer of Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our fully paid Ordinary Shares
are issued in registered form and may be freely transferred under our Articles of Association, unless the transfer is restricted or prohibited
by another instrument, applicable law or the rules of the Nasdaq. The ownership or voting of Ordinary Shares by non-residents of Israel
is not restricted in any way by our Articles of Association, or the laws of the State of Israel, except for ownership by nationals of
some countries that are, have been, or will be, in a state of war with Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Election of Directors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under our Articles of Association,
our board of directors must consist of not less than three but no more than twelve directors. Each of our directors, other than the external
directors, for whom special election requirements apply under the Companies Law, are appointed by a simple majority vote of holders of
Ordinary Shares, participating and voting at an annual general meeting of our shareholders. Our directors are classified, with respect
to the term for which they each severally hold office, into three classes, as nearly equal in number as practicable, and designated as
Class&nbsp;I, Class&nbsp;II and Class&nbsp;III, with one class being elected each year at the annual general meeting of our shareholders,
and serve on our board of directors until the third annual general meeting following such election or re-election or until they are removed
by a vote of 70% of the total voting power of our shareholders at a general meeting of our shareholders or upon the occurrence of certain
events in accordance with the Companies Law and our Articles of Association.&nbsp;The initial Class&nbsp;I directors will hold office
until the first annual general meeting to be held in 2023 and until their successors have been elected and qualified. The initial Class&nbsp;II
directors will hold office until the annual general meeting to be held in 2024 and until their successors have been elected and qualified.
The initial Class&nbsp;III directors will hold office until the annual general meeting to be held in 2025 and until their successors have
been elected and qualified. The board of directors may assign members of the Board already in office to such classes at the time such
classification becomes effective. If the number of directors is changed, any newly created directors or decrease in directors must be
apportioned by the board among the classes to make them equal in number. In addition, our Articles of Association allow our board of directors
to appoint directors to fill vacancies and/or as an addition to the board of directors (subject to the maximum number of directors). A
director so appointed will hold office until the next annual general meeting of our shareholders for the election of the class of directors
in respect of which the vacancy was created, or in the case of a vacancy due to the number of directors being less than the maximum number
of directors, until the next annual general meeting of our shareholders for the election of the class of directors to which such director
was assigned by our board of directors. External directors are elected for an initial term of three&nbsp;years, may be elected for additional
terms of three&nbsp;years each under certain circumstances, and may be removed from office pursuant to the terms of the Companies Law.
See &ldquo;Item 6.C. &nbsp;Board Practices&nbsp;&mdash;&nbsp;External Directors&rdquo; in our Annual Report on Form 20-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Dividend and Liquidation Rights</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may declare a dividend
to be paid to the holders of Ordinary Shares in proportion to their respective shareholdings. Under the Companies Law, dividend distributions
are determined by the board of directors and do not require the approval of the shareholders of a company unless the company&rsquo;s articles
of association provide otherwise. Our Articles of Association do not require shareholder approval of a dividend distribution and provide
that dividend distributions may be determined by our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Companies
Law, the distribution amount is limited to the greater of retained earnings or earnings generated over the previous two years, according
to the Company&rsquo;s most recently reviewed or audited financial statements (less the amount of previously distributed dividends, if
not reduced from the earnings), provided that the end of the period to which the financial statements relate is not more than six months
prior to the date of the distribution. If we do not meet such criteria, then we may distribute dividends only with court approval. In
each case, we are only permitted to distribute a dividend if our board of directors and, if applicable, the court determines that there
is no reasonable concern that payment of the dividend will prevent us from satisfying our existing and foreseeable obligations as they
become due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of the Company&rsquo;s
liquidation, after satisfaction of liabilities to creditors, its assets will be distributed to the holders of Ordinary Shares in proportion
to their shareholdings. This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or
distribution rights to the holders of a class of shares with preferential rights which may be authorized in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exchange control</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are currently no Israeli
currency control restrictions on remittances of dividends on Ordinary Shares, proceeds from the sale of the Ordinary Shares or interest
or other payments to non-residents of Israel, except for shareholders who are subjects of countries that at the time are, or have been,
in a state of war with Israel.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Annual and Special Meetings</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Israeli law, we are
required to hold an annual general meeting of our shareholders once every calendar year, at such time and place which shall be determined
by our board of directors, that must be no later than 15&nbsp;months after the date of the previous annual general meeting. All meetings
other than the annual general meeting of shareholders are referred to as special general meetings. Our board of directors may call special
meetings whenever it sees fit, at such time and place, within or outside of Israel, as it may determine. In addition, the Companies Law
provides that our board of directors is required to convene a special general meeting of our shareholders upon the written request of:
(a)&nbsp;any two of our directors or such number of directors equal to one quarter of the directors then at office; and/or (b)&nbsp;one
or more shareholders holding, in the aggregate, (i)&nbsp;5% or more of our outstanding issued shares and 1% of our outstanding voting
power or (ii)&nbsp;5% or more of our outstanding voting power.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, one
or more shareholders holding at least 1% of the voting rights at the general meeting of shareholders may request that the board of directors
include a matter in the agenda of a general meeting of shareholders to be convened in the future, provided that it is appropriate to discuss
such a matter at the general meeting. Our Articles of Association contain procedural guidelines and disclosure items with respect to the
submission of shareholder proposals for general meetings. Subject to the provisions of the Companies Law and the regulations promulgated
thereunder, shareholders entitled to participate and vote at general meetings are the shareholders of record on a date to be decided by
the board of directors, which, as a company listed on an exchange outside Israel, may be between four and forty&nbsp;days prior to the
date of the meeting. Resolutions regarding the following matters must be passed at a general meeting of our shareholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">amendments to our Articles of Association;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the exercise of our board of director&rsquo;s powers by a
general meeting if our board of directors is unable to exercise its powers and the exercise of any of its powers is required for our
proper management;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">appointment or termination of our auditors;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">appointment of directors, including external directors;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">approval of acts and transactions requiring general meeting
approval pursuant to the provisions of the Companies Law (mainly certain related party transactions and certain compensation matters)
and any other applicable law;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">increases or reductions of our authorized share capital; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">a merger (as such term is defined in the Companies Law).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Notices</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law and our Articles
of Association require that a notice of any annual or special shareholders meeting be provided at least 14 or 21&nbsp;days prior to the
meeting (as applicable), and if the agenda of the meeting includes, among other things, the appointment or removal of directors, the approval
of transactions with office holders or interested or related parties, approval of the company&rsquo;s chief executive officer to serve
as the chairman of the board of directors or an approval of a merger, notice must be provided at least 35&nbsp;days prior to the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Quorum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As permitted under the Companies
Law, the quorum required for our general meetings consists of at least two shareholders present in person, by proxy, written ballot or
voting by means of electronic voting system, who hold or represent between them at least 25% of the total outstanding voting power. If
within half an hour of the time set forth for the general meeting a quorum is not present, the general meeting shall stand adjourned the
same&nbsp;day of the following week, at the same hour and in the same place, or to such other date, time and place as prescribed in the
notice to the shareholders and in such adjourned meeting, if no quorum is present within half an hour of the time arranged, any number
of shareholders participating in the meeting, shall constitute a quorum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">If a special general meeting
was summoned following the request of a shareholder, and within half an hour a legal quorum shall not have been formed, the meeting shall
be cancelled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Adoption of Resolutions</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Articles of Association
provide that all resolutions of our shareholders require a simple majority vote, unless otherwise required under the Companies Law or
our Articles of Association. A shareholder may vote in a general meeting in person, by proxy or by a written ballot.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Changing Rights Attached to Shares</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise provided by
the terms of the shares and subject to any applicable law, any modification of rights attached to any class of shares must be adopted
by the holders of a majority of the shares of that class present a general meeting of the affected class or by a written consent of all
the shareholders of the affected class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The enlargement of an existing
class of shares or the issuance of additional shares thereof, shall not be deemed to modify the rights attached to the previously issued
shares of such class or of any other class, unless otherwise provided by the terms of the shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Limitations on the Right to Own Securities
in Our Company</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no limitations on
the right to own our securities in our Articles of Association. In certain circumstances the IPO Warrants have restrictions upon the exercise
of such warrants if such exercise would result in the holders thereof owning more than 4.99% or 9.99% of our Ordinary Shares upon such
exercise, as further described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Access to Corporate Records</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, all
shareholders generally have the right to review minutes of our general meetings, our shareholder register (including with respect to material
shareholders), our Articles of Association, our financial statements, other documents as provided in the Companies Law, and any document
we are required by law to file publicly with the Israeli Registrar of Companies or the Israeli Securities Authority. Any shareholder who
specifies the purpose of its request may request to review any document in our possession that relates to any action or transaction with
a related party which requires shareholder approval under the Companies Law. We may deny a request to review a document if it determines
that the request was not made in good faith, that the document contains a commercial secret or a patent or that the document&rsquo;s disclosure
may otherwise impair its interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Anti-Takeover Provisions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Acquisitions under Israeli Law</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Full Tender Offer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A person wishing to acquire
shares of a public Israeli company who would, as a result, hold over 90% of the target company&rsquo;s voting rights or the target company&rsquo;s
issued and outstanding share capital (or of a class thereof), is required by the Companies Law to make a tender offer to all of the company&rsquo;s
shareholders for the purchase of all of the issued and outstanding shares of the company (or the applicable class). If (a) the shareholders
who do not accept the offer hold less than 5% of the issued and outstanding share capital of the company (or the applicable class) and
the shareholders who accept the offer constitute a majority of the offerees that do not have a personal interest in the acceptance of
the tender offer or (b) the shareholders who did not accept the tender offer hold less than 2% of the issued and outstanding share capital
of the company (or of the applicable class), all of the shares that the acquirer offered to purchase will be transferred to the acquirer
by operation of law. A shareholder who had its shares so transferred may petition an Israeli court within six months from the date of
acceptance of the full tender offer, regardless of whether such shareholder agreed to the offer, to determine whether the tender offer
was for less than fair value and whether the fair value should be paid as determined by the court. However, an offeror may provide in
the offer that a shareholder who accepted the offer will not be entitled to petition the court for appraisal rights as described in the
preceding sentence, as long as the offeror and the company disclosed the information required by law in connection with the full tender
offer. If the full tender offer was not accepted in accordance with any of the above alternatives, the acquirer may not acquire shares
of the company that will increase its holdings to more than 90% of the company&rsquo;s voting rights or the company&rsquo;s issued and
outstanding share capital (or of the applicable class) from shareholders who accepted the tender offer. Shares purchased in contradiction
to the full tender offer rules under the Companies Law will have no rights and will become dormant shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Special Tender Offer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law provides
that an acquisition of shares of an Israeli public company must be made by means of a special tender offer if as a result of the acquisition
the purchaser would become a holder of 25% or more of the voting rights in the company. This requirement does not apply if there is already
another holder of 25% or more of the voting rights in the company. Similarly, the Companies Law provides that an acquisition of shares
of an Israeli public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would become
a holder of more than 45% of the voting rights in the company, if there is no other shareholder of the company who holds more than 45%
of the voting rights in the company. These requirements do not apply if (i) the acquisition occurs in the context of a private placement
by the company that received shareholder approval as a private placement whose purpose is to give the purchaser 25% or more of the voting
rights in the company, if there is no person who holds 25% or more of the voting rights in the company or as a private placement whose
purpose is to give the purchaser 45% of the voting rights in the company, if there is no person who holds 45% of the voting rights in
the company, (ii) the acquisition was from a shareholder holding 25% or more of the voting rights in the company and resulted in the purchaser
becoming a holder of 25% or more of the voting rights in the company, or (iii) the acquisition was from a shareholder holding more than
45% of the voting rights in the company and resulted in the purchaser becoming a holder of more than 45% of the voting rights in the company.
A special tender offer must be extended to all shareholders of a company. A special tender offer may be consummated only if (i) at least
5% of the voting power attached to the company&rsquo;s outstanding shares will be acquired by the offeror and (ii) the number of shares
tendered in the offer exceeds the number of shares whose holders objected to the offer (excluding the purchaser, its controlling shareholders,
holders of 25% or more of the voting rights in the company and any person having a personal interest in the acceptance of the tender offer,
or anyone on their behalf, including any such person&rsquo;s relatives and entities under their control).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that a special
tender offer is made, a company&rsquo;s board of directors is required to express its opinion on the advisability of the offer, or shall
abstain from expressing any opinion if it is unable to do so, provided that it gives the reasons for its abstention. The board of directors
shall also disclose any personal interest that any of the directors has with respect to the special tender offer or in connection therewith.
An office holder in a target company who, in his or her capacity as an office holder, performs an action the purpose of which is to cause
the failure of an existing or foreseeable special tender offer or is to impair the chances of its acceptance, is liable to the potential
purchaser and shareholders for damages, unless such office holder acted in good faith and had reasonable grounds to believe he or she
was acting for the benefit of the company. However, office holders of the target company may negotiate with the potential purchaser in
order to improve the terms of the special tender offer, and may further negotiate with third parties in order to obtain a competing offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a special tender offer is
accepted, then shareholders who did not respond to or that had objected the offer may accept the offer within four days of the last day
set for the acceptance of the offer and they will be considered to have accepted the offer from the first day it was made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that a special
tender offer is accepted, then the purchaser or any person or entity controlling it or under common control with the purchaser or such
controlling person or entity at the time of the offer may not make a subsequent tender offer for the purchase of shares of the target
company and may not enter into a merger with the target company for a period of one year from the date of the offer, unless the purchaser
or such person or entity undertook to effect such an offer or merger in the initial special tender offer. Shares purchased in contradiction
to the special tender offer rules under the Companies Law will have no rights and will become dormant shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Merger</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law permits merger
transactions if approved by each party&rsquo;s board of directors and, unless certain conditions described under the Companies Law are
met, a simple majority of the outstanding shares of each party to the merger that are represented and voting on the merger. The board
of directors of a merging company is required pursuant to the Companies Law to discuss and determine whether in its opinion there exists
a reasonable concern that as a result of a proposed merger, the surviving company will not be able to satisfy its obligations towards
its creditors, such determination taking into account the financial status of the merging companies. If the board of directors determines
that such a concern exists, it may not approve a proposed merger. Following the approval of the board of directors of each of the merging
companies, the boards of directors must jointly prepare a merger proposal for submission to the Israeli Registrar of Companies. For purposes
of the shareholder vote of a merging company whose shares are held by the other merging company, or by a person or entity holding 25%
or more of the voting rights at the general meeting of shareholders of the other merging company, or by a person or entity holding the
right to appoint 25% or more of the directors of the other merging company, unless a court rules otherwise, the merger will not be deemed
approved if a majority of the shares voted on the matter at the general meeting of shareholders (excluding abstentions) that are held
by shareholders other than the other party to the merger, or by any person or entity who holds 25% or more of the voting rights of the
other party or the right to appoint 25% or more of the directors of the other party, or any one on their behalf including their relatives
or corporations controlled by any of them, vote against the merger. In addition, if the non-surviving entity of the merger has more than
one class of shares, the merger must be approved by each class of shareholders. If the transaction would have been approved but for the
separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court may still approve the
merger upon the request of holders of at least 25% of the voting rights of a company, if the court holds that the merger is fair and reasonable,
taking into account the valuation of the merging companies and the consideration offered to the shareholders. If a merger is with a company&rsquo;s
controlling shareholder or if the controlling shareholder has a personal interest in the merger, then the merger is instead subject to
the same special majority approval that governs all extraordinary transactions with controlling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, each
merging company must deliver to its secured creditors the merger proposal and inform its unsecured creditors of the merger proposal and
its content. Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger if it concludes
that there exists a reasonable concern that, as a result of the merger, the surviving company will be unable to satisfy the obligations
of a merging company, and may further give instructions to secure the rights of creditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">addition, a merger may not
be completed unless at least 50 days have passed from the date that a proposal for approval of the merger is filed with the Israeli Registrar
of Companies and 30 days from the date that shareholder approval of both merging companies is obtained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Anti-Takeover Measures</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law allows us
to create and issue shares having rights different from those attached to the Ordinary Shares, including shares providing certain preferred
rights with respect to voting, distributions or other matters and shares having preemptive rights. No preferred shares are authorized
under our Articles of Association. In the future, if we do authorize, create and issue a specific class of preferred shares, such class
of shares, depending on the specific rights that may be attached to it, may have the ability to frustrate or prevent a takeover or otherwise
prevent our shareholders from realizing a potential premium over the market value of the Ordinary Shares. The authorization and designation
of a class of preferred shares will require an amendment to our Articles of Association, which requires the prior approval of the holders
of a majority of the voting power attached to our issued and outstanding shares at a general meeting of our shareholders. The convening
of the meeting, the shareholders entitled to participate and the vote required to be obtained at such a meeting will be subject to the
requirements set forth in the Companies Law and our Articles of Association.&rdquo; In addition, as disclosed under &ldquo;&mdash;&nbsp;Election
of Directors,&rdquo; we have a classified board structure, which effectively limits the ability of any investor or potential investor
or group of investors or potential investors to gain control of our board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lastly, Israeli tax law treats
some acquisitions, such as stock-for-stock exchanges between an Israeli company and a foreign company, less favorably than U.S.&nbsp;tax
laws. For example, Israeli tax law may, under certain circumstances, subject a shareholder who exchanges his Ordinary Shares for shares
in another corporation to taxation prior to the sale of the shares received in such stock-for-stock swap.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Changes in Our Capital</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The general meeting may, by
a simple majority vote of the shareholders attending the general meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">increase our registered share capital by the creation of new
shares from the existing class or a new class, as determined by the general meeting;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">cancel any registered share capital which have not been taken
or agreed to be taken by any person;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">consolidate and divide all or any of our share capital into
shares of larger nominal value than our existing shares;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">subdivide our existing shares or any of them, our share capital
or any of it, into shares of smaller nominal value than is fixed; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">reduce our share capital and any fund reserved for capital
redemption in any manner, and with and subject to any incident authorized, and consent required, by the Companies Law.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exclusive Forum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24pt">Our Articles of Association
provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United&nbsp;States
shall be the sole and exclusive forum for any claim asserting a cause of action arising under the Securities Act of 1933, as amended,
or the Securities Act. Section&nbsp;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such
Securities Act actions. Accordingly, both U.S.&nbsp;state and federal courts have jurisdiction to entertain such claims. This choice of
forum provision may limit a shareholder&rsquo;s ability to bring a claim in a judicial forum that it finds favourable for disputes with
us or our directors, officers or other employees and may increase the costs associated with such lawsuits, which may discourage such lawsuits
against us and our directors, officers and employees. Alternatively, if a court were to find these provisions of our Articles of Association
inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional
costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial condition.
Any person or entity purchasing or otherwise acquiring any interest in our share capital shall be deemed to have notice of and to have
consented to the choice of forum provisions of our Articles of Association described above. This provision would not apply to suits brought
to enforce a duty or liability created by the Exchange&nbsp;Act or any other claim for which the U.S.&nbsp;federal courts have exclusive
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Transfer Agent and Registrar</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transfer agent and registrar
for our Ordinary Shares is VStock Transfer, LLC. Its address is 18 Lafayette Place, Woodmere, New York 11598.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2022, we
have issued and outstanding IPO Warrants to purchase up to 4,143,385&nbsp;Ordinary Shares, with an exercise price of $4.04 per Ordinary
Share ($2.02 per Ordinary Share following adjustment to the exercise price), issued as part of our initial public listing, or IPO, and
are listed on Nasdaq under the symbol &ldquo;JFBRW&rdquo; since August&nbsp;26, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of December 31, 2022, we
have issued and outstanding private warrants to purchase up to: (i) 2,824,525 Ordinary Shares, which warrants were issued in connection
with the adjustment to the exercise price), with an exercise price of $2.02 per share; (ii) 60,096 Ordinary Shares, which warrants were
issued to certain investors upon the closing of our IPO, with&nbsp;an&nbsp;exercise price of $4.04 per Ordinary Share, (iii) 18,565 Ordinary
Shares, which warrants were issued to an advisor upon the closing of our IPO, with&nbsp;an&nbsp;exercise price of $4.04 per Ordinary Share
($2.02 following adjustment to the exercise price), and (iv) 185,873&nbsp;Ordinary Shares, which warrants were issued to the underwriter
in our IPO, with an exercise price of $5.20 per Ordinary Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IPO Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exercisability. </I>The
IPO Warrants are exercisable at any time after their original issuance and at any time up to the date that is five&nbsp;years after their
original issuance. The IPO Warrants will be exercisable, at the option of each holder, in whole or in part by delivering to the Company
a duly executed exercise notice and, at any time a registration statement registering the issuance of the Ordinary Shares underlying the
IPO Warrants under the Securities Act is effective and available for the issuance of such shares, by payment in full in immediately available
funds for the number of Ordinary Shares purchased upon such exercise. If a registration statement registering the issuance of the Ordinary
Shares underlying the IPO Warrants under the Securities Act is not effective or available the holder may, in its sole discretion, elect
to exercise the Warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of Ordinary
Shares determined according to the formula set forth in the Warrant. No fractional shares will be issued in connection with the exercise
of an Warrant. In lieu of fractional shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the
exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exercise Limitation. </I>A
holder will not have the right to exercise any portion of the Warrant if the holder (together with its affiliates) would beneficially
own in excess of 4.99% of the number of Ordinary Shares outstanding immediately after giving effect to the exercise, as such percentage
ownership is determined in accordance with the terms of the IPO Warrants. However, any holder may increase or decrease such percentage
to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61&nbsp;days
following notice from the holder to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Exercise Price. </I>The
exercise price per whole Ordinary Share purchasable upon exercise of the IPO Warrants was $4.04 per share at initial issuance, or the
Initial Exercise Price. The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions,
stock splits, stock combinations, reclassifications or similar events affecting our Ordinary Shares and also upon any distributions of
assets, including cash, stock or other property to our stockholders. The exercise price will also be downward adjusted if we, or through
a subsidiary, sell or enter into an agreement to sell, grant an option to sell, reprice an outstanding security to acquire ordinary shares
at a price less than the exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The exercise price will also
be adjusted downward to the price of the newly issued security or adjusted price of the outstanding security, but will not adjust to
less than a floor price of 50% of the Initial Exercise Price, or $2.02, which is subject to adjustment for stock splits, combinations
and recapitalizations, as stated above. The downward adjustment will not be made for certain Excluded Securities (as defined in the Warrant),
including employment related option and similar security grants, exercise of such options and security grants, exercises of currently
outstanding securities so long as not repriced, and issuances for acquisitions and strategic transactions. In the event that such adjustment
shall cause the exercise price to be 50% of the Initial Exercise Price, then in connection with such adjustment, each holder of at least
120,192 IPO Warrants, shall receive one additional warrant for each IPO Warrant held by such holder on the date of adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The exercise price will also
be reset, if, on the date that is 90 calendar&nbsp;days immediately following the Issuance Date, the Reset Price, as defined below, is
less than the exercise price at such time. If so, the exercise price shall be decreased to the &ldquo;Reset Price&rdquo; which means the
greater of (i)&nbsp;50% of the&nbsp;Initial Exercise Price&nbsp;and (ii)&nbsp;100% of the lowest volume weighted average price of our
Ordinary Shares occurring during the 90 calendar&nbsp;days following the Issuance Date; provided that the Reset Price shall in no event
be less than a floor price of 50% of the initial public offering price of the Units&nbsp;in this offering, or $2.02.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On September&nbsp;7, 2022,
the Company&rsquo;s volume weighted average stock price was less than the exercise floor of $4.04 for the IPO Warrants. Accordingly, effective
after the closing of trading on November&nbsp;28, 2022 (the 90<SUP>th</SUP>&nbsp;calendar&nbsp;day immediately following the issuance
date of the IPO Warrants), the IPO Warrants were adjusted pursuant to their terms, including, but not limited to, to adjust the exercise
price of the IPO Warrants to $2.02.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Home Country Practice. </I>For
so long as any of the IPO Warrants remains outstanding, the Company will elect to follow home country practice in lieu of any rules and
regulations of the trading market that would limit the Company&rsquo;s ability to effect the provisions of the IPO Warrants, including
but not limited to shareholder approval rules related to the issuance of securities or adjustment of terms of this Warrant for the benefit
of warrant holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Transferability. </I>Subject
to applicable laws, the IPO Warrants may be offered for sale, sold, transferred or assigned without our consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Warrant Agent. </I>The
IPO Warrants were issued in registered form under a warrant agent agreement between VStock Transfer, LLC, as warrant agent, and the Company.
The IPO Warrants were initially represented only by one or more global warrants deposited with the warrant agent, as custodian on behalf
of The Depository Trust Company, or DTC, and registered in the name of Cede&nbsp;&amp; Co., a nominee of DTC, or as otherwise directed
by DTC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I></I></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Fundamental Transactions. </I>In
the event of a Fundamental Transaction (as defined in the Warrant) and generally including any reorganization, recapitalization or reclassification
of our Ordinary Shares, the sale, transfer or other disposition of all or substantially all of our properties or assets, our consolidation
or merger with or into another person, the acquisition of more than 50% of our outstanding Ordinary Shares, or any person or group becoming
the beneficial owner of 50% of the voting power represented by our outstanding Ordinary Shares, the holders of the IPO Warrants will be
entitled to receive upon exercise of the IPO Warrants the number of Ordinary Shares of the successor or acquiring corporation or of the
Company, if it is the surviving corporation, or depositary shares representing those shares, and any additional consideration receivable
as a result of such Fundamental Transaction by holders of the number of Ordinary Shares for which the IPO Warrants are exercisable immediately
prior to such Fundamental Transaction without regard to any limitations on exercise contained in the IPO Warrants. The holders of the
IPO Warrants may also require us or any successor entity to purchase the IPO Warrants from the holders by paying to the holder an amount
in cash (or other types or form of consideration in special circumstances listed in the Warrant) equal to the Black Scholes value of the
remaining unexercised portion of the Warrant on the date of the fundamental transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Rights as a Stockholder. </I>Except
as otherwise provided in the IPO Warrants or by virtue of such holder&rsquo;s ownership of our Ordinary Shares, the holder of an Warrant
does not have the rights or privileges of a holder of our Ordinary Shares, including any voting rights, until the holder exercises the
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Right of Participation. </I>Subject
to certain exceptions, a holder of at least 120,192 IPO Warrants as of the time the Company engages in a subsequent placement (as defined
in the Warrant) will be entitled to participate in such subsequent placement subject to the terms and conditions set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Governing Law. </I>The
IPO Warrants and the warrant agent agreement are governed by New&nbsp;York law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exclusive Forum</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The agreements governing the
IPO Warrants provide that, and by purchasing IPO Warrants in this offering investors will agree that, all legal proceedings concerning
the interpretations, enforcement and defense of the transactions contemplated by the Warrant (whether brought against a party hereto or
their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) will be commenced exclusively
in the state and federal courts sitting in the City of New&nbsp;York, irrevocably submit to the exclusive jurisdiction of the state and
federal courts sitting in the City of New&nbsp;York, Borough of Manhattan for the adjudication of any such dispute and irrevocably waive,
and agree not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding.&nbsp;The warrant agent agreement
has a similar provision. In addition, the warrant agent agreement provides that the Company and the warrant agent each waive the right
to a trial by jury in any action or proceeding arising out of or relating to the warrant agent agreement. Each of the agreement governing
the IPO Warrants and the warrant agent agreement provide that the foregoing provisions do not limit or restrict the federal district court
in which a party may bring a claim under the U.S.&nbsp;federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">10</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.24
<SEQUENCE>3
<FILENAME>f20f2022ex4-24_jeffsbrands.htm
<DESCRIPTION>CONSULTING AGREEMENT, DATED OCTOBER 26, 2022, BETWEEN JEFFS' BRANDS LTD AND L.I.A. PURE CAPITAL LTD
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 4.24</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSULTING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS AGREEMENT </B>(the &ldquo;<B>Agreement</B>&rdquo;)
is made on this 26 day of October 2022 between Jeffs Brands Ltd., whose address is at HaNechoshet St 3, Tel Aviv 6971068, Israel (the
&ldquo;<B>Company</B>&rdquo;) and L.I.A. Pure Capital Ltd., whose address is at 20 Raoul Wallenberg Street, Tel Aviv 6971916, Israel
(the &ldquo;<B>Consultant</B>&rdquo;). The Company <FONT STYLE="font-size: 10pt">and</FONT> together with the Consultant, each a &ldquo;<B>Party</B>&rdquo;
and collectively, the &ldquo;<B>Parties</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 71pt"><B>WHEREAS</B>:</TD><TD STYLE="text-align: justify">the Company wishes the Consultant
                                            to provide the Company with certain services and the Consultant wishes to render such services
                                            to the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -81pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 71pt"><B>WHEREAS</B>:</TD><TD STYLE="text-align: justify">the Consultant represents to the
                                            Company that it is ready, qualified, willing and able to carry out its obligations and undertakings
                                            towards the Company pursuant hereto; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -81pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 71pt"><B>WHEREAS</B>:</TD><TD STYLE="text-align: justify">the Company and the Consultant
                                            desire to regulate their relationship in accordance to the terms and conditions set forth
                                            in this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 81pt; text-align: justify; text-indent: -81pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NOW THEREFORE, </B>the parties hereto agree
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><B>1.</B></TD><TD STYLE="text-align: justify"><B><U>The Services</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: -1cm"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">1.1.</TD><TD STYLE="text-align: justify">The Company hereby engages the Consultant as an independent
consultant and the Consultant hereby agrees to serve as a consultant to the Company and provide business development, Investors and public
relations and strategic consulting services, including ongoing consulting to the Company, its management and its chief executive officer
in the following fields: M&amp;A, investment activities, Company's position in the capital markets, as well as additional services as
may be requested from time to time by the chief executive officer or chairman of the board of directors of the Company (the &ldquo;<B>Services</B>&rdquo;).
The engagement hereunder shall commence effective as of 1 September, 2022 (the &ldquo;<B>Effective Date</B>&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in">1.2.</TD><TD STYLE="text-align: justify">The
                                            Consultant shall cooperate on an ongoing basis with such employees, consultants and contractors
                                            of the Company as determined by the Company from time to time; the person within the Company
                                            who shall be in charge of the engagement of the Consultant shall be the chairman of the board
                                            of directors of the Company or such other person as determined by the Company from time to
                                            time. The Company may require the Consultant to provide reports or other types of ongoing
                                            information concerning the Services as determined from time to time, whether or not set forth
                                            herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in">1.3.</TD><TD STYLE="text-align: justify">The
                                            Consultant undertakes that the Services shall be performed personally and exclusively by
                                            Kfir Zilberman (&ldquo;<B>Consultant&rsquo;s Representative</B>&rdquo;). Each employee, consultant,
                                            manager or any other representative of the Consultant, including the Consultant&rsquo;s Representative
                                            shall be deemed to be personally bound by all the obligations and liabilities of the Consultant
                                            as if he was the Consultant hereunder. All references to the term the Consultant hereunder
                                            shall be deemed to refer to the Consultant and the Consultant&rsquo;s Representative jointly
                                            and severally. Any breach of this Agreement by the Consultant&rsquo;s Representative or by
                                            any other employee, consultant, manager or representative of the Consultant shall be deemed
                                            a breach by the Consultant.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in">1.4.</TD><TD STYLE="text-align: justify">The
                                            Consultant&rsquo;s Representative shall devote all the necessary time in performing its duties
                                            and responsibilities under this Agreement, as shall be reasonably required by the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in">1.5.</TD><TD STYLE="text-align: justify">The
                                            Consultant agrees to perform its duties described herein in a faithful, diligent and professional
                                            manner.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in">1.6.</TD><TD STYLE="text-align: justify">The
                                            Consultant shall be responsible for maintaining, at the Consultant&rsquo;s own expense, a
                                            place of work, any equipment and supplies necessary for the performance of the Services.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in">1.7.</TD><TD STYLE="text-align: justify">Nothing
                                            in this Agreement shall be interpreted as preventing or restricting the Company from obtaining
                                            or seeking from any other person services of the same nature as the Services, or otherwise
                                            from performing or seeking to perform any action or operation. Nothing in this Agreement
                                            shall be interpreted as preventing or restricting the Consultant from supplying services
                                            to any third party, as long as such services to third parties (i) do not conflict with any
                                            obligation or undertaking of the Consultant hereunder, and (ii) do not interfere with the
                                            performance of or restrict the ability of the Consultant to perform the Services hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><B>2.</B></TD><TD STYLE="text-align: justify"><B><U>Term and Termination</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: -1cm"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">2.1.</TD><TD STYLE="text-align: justify">This Agreement shall commence upon the Effective Date and
shall until terminated pursuant to Section &lrm;2.2 below.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">2.2.</TD><TD STYLE="text-align: justify">Notwithstanding the above, this Agreement may be terminated
at any time after the third (3) anniversary from the effective day by the Consultant or by the Company by giving the other party 30 days&rsquo;
advance notice in writing (the &ldquo;<B>Notice Period</B>&rdquo;), provided that the Company may terminate this Agreement forthwith
for Cause (as defined herein) without advance notice. A termination for &ldquo;Cause&rdquo; is a termination due to: (i) the Consultant&rsquo;s
Representative&rsquo;s conviction or indictment of any felony; (ii) a material breach of any provision of this Agreement or its exhibits
which is not cured (if deemed curable by the Company) within five (5) days of receipt of a written notice about such breach from the
Company; (iii) the Consultant&rsquo;s continuously disregarding of instructions of the Company with respect to the Consultant&rsquo;s
performance of the Services; (iv) a material breach of trust by the Consultant or embezzlement of funds of the Company or any Affiliate
(as defined in Section &lrm;7.1 below) thereof; (v) involvement of the Consultant&rsquo;s Representative in sexual harassment of any
employee of the Company or other party in connection with the performance of the Services; or (vi) causing grave injury to the business,
assets, operations or reputation of the Company or any Affiliate thereof. Nothing herein shall derogate from the Company&rsquo;s rights
with respect to such termination for Cause, including the right to set off damages against the Consultant&rsquo;s Consulting Fees (as
defined in Section &lrm;3.1 below).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">2.3.</TD><TD STYLE="text-align: justify">In the event of termination other than for Cause, the Consultant
shall be entitled to Consulting Fees only to the extent that it provides Services to the Company during the Notice Period.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><B>3.</B></TD><TD STYLE="text-align: justify"><B><U>Consideration</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: -1cm"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">3.1.</TD><TD STYLE="text-align: justify"><B><U>Consulting Fee</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.5in; text-align: left">3.1.1.</TD><TD STYLE="text-align: justify">In consideration for the Services rendered by the Consultant
pursuant to this Agreement, the Company shall pay the Consultant a monthly fee in the amount of NIS 57,750 (plus VAT, if required by
law) (the &ldquo;<B>Consulting Fee</B>&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -42.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.5in">3.1.2.</TD><TD STYLE="text-align: justify">All payments of Consulting Fee hereunder,
                                            subject to Section &lrm;3.1.1, shall be made on a monthly basis, within 10 days from, and
                                            subject to, receipt by the Company of a duly issued tax invoice(s) and receipt(s) by the
                                            Consultant for the amount due together with the required reports.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -42.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.5in">3.1.3.</TD><TD STYLE="text-align: justify">The Consulting Fees are inclusive
                                            of any and all taxes, and the Consultant shall bear full responsibility for all tax obligations
                                            of any kind or nature relating, directly or indirectly, to the Consulting Fee and otherwise
                                            to the Services hereunder. To the extent that any such taxes may be imposed upon the Company,
                                            the Company may deduct such amounts from any payments due to the Consultant. The Company
                                            shall be entitled to withhold and deduct from payments due hereunder any and all amounts
                                            as may be required from time to time under any applicable law. VAT shall be charged on all
                                            amounts payable hereunder, including any stock options, as required by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -42.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.5in">3.1.4.</TD><TD STYLE="text-align: justify">In addition to the monthly payments
                                            under Section &lrm;3.1.1, Consultant shall be entitled during the term of this Agreement
                                            to the following payment: (i) an amount equal to 7% of the gross proceeds paid to the Company
                                            in connection with any exercise of warrants, whether or not currently outstanding; and (ii)
                                            8% of any purchase of a new brand, businesses, or similar events initiated or assisted by
                                            the Consultant and approved by the Chief Executive Officer based on agreement with the Consultant.
                                            Payments under this Section shall be authorized by the Chief Executive Officer and Chairman
                                            of the Board. VAT shall be added on all amounts payable hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -42.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.5in">3.1.5.</TD><TD STYLE="text-align: justify">As of the Effective Date, the consultant
                                            shall be entitled to a one-time bonus payment of NIS 425,000 (plus VAT, if required by law)
                                            for his services provided to the company from the day the company was established until the
                                            completion of the IPO process on the Nasdaq Stock Exchange and based on the company's success
                                            in the IPO process.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -42.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.5in">3.1.6.</TD><TD STYLE="text-align: justify">Payments under this Section shall
                                            be authorized by the Chief Executive Officer and Chairman of the Board. VAT shall be added
                                            on all amounts payable hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -42.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.5in">3.1.7.</TD><TD STYLE="text-align: justify">In addition to the payments under
                                            Section &lrm;3.1.1, Consultant shall be entitled to warrants. The warrants are deemed earned
                                            upon issuance and are subject to board approval.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -42.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.6in"></TD><TD STYLE="width: 0.5in; text-align: left">3.1.8.</TD><TD STYLE="text-align: justify"></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -42.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -42.5pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 106.3pt; text-align: justify; text-indent: -42.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left"><B>3.2.</B></TD><TD STYLE="text-align: justify"><B><U>Reimbursement of Expenses</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.6in; text-align: justify">The Company shall reimburse Consultant
for necessary and customary business expenses incurred by Consultant, in accordance with the Company&rsquo;s policy, as amended from
time to time, up to $2,000 per month.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left"><B>3.3.</B></TD><TD STYLE="text-align: justify"><B><U>Bonus</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.6in; text-align: justify">Consultant shall be entitled to a
special bonus upon the consummation of an offering of securities of the Company , according to the below distribution, which is based
on gross proceeds: (i) between $5.0 million and $10.0 million, the Consultant shall be entitled to a bonus payment of $100,000; (ii)
above $10.0 million, the Consultant shall be entitled to a bonus payment of $150,000. Payments under this Section shall be authorized
by the Chief Executive Officer and Chairman of the Board. VAT will be added to the payments under this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left"><B>3.4.</B></TD><TD STYLE="text-align: justify"><B><U>Full Consideration</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.6in; text-align: justify">Other than the consideration specified
in this Section &lrm;3, which consideration constitutes full consideration for the Services rendered hereunder, the Consultant will not
be entitled to any other consideration for rendering the Services hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><B>4.</B></TD><TD STYLE="text-align: justify"><B><U>Confidentiality, Non-Competition and Invention Assignment
Undertaking</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: -1cm"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Simultaneously with the execution of
this Agreement, and a as condition hereto, the Consultant hereby executes the Undertaking attached hereto as <B><U>Schedule A</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><B>5.</B></TD><TD STYLE="text-align: justify"><B><U>Relationship of Parties</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: -1cm"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">5.1.</TD><TD STYLE="text-align: justify">The parties hereto hereby declare and approve, that this
Agreement is a Contractors Agreement within the meaning of the Israeli Contractors Law &ndash; 1974 (the &ldquo;<B>Contractors Law</B>&rdquo;),
and that nothing in this Agreement that shall be interpreted or construed as creating or establishing any partnership, joint venture,
employment relationship, franchise or agency or any other similar relationship between the Company or its Affiliates and the Consultant
or the Consultant&rsquo;s Representative, and it is specifically clarified that with respect to the Services, no employer-employee relationship
will be formed between the Company or its Affiliates and the Consultant or the Consultant&rsquo;s Representative, and the Consultant
is not entitled to any social or other benefits resulting from employer-employee relationship. Notwithstanding the above, the Consultant
hereby waives any right to a lien in accordance with Section 5 of the Contractors Law or any other law. The Consultant hereby acknowledges
that the Company is relying upon the truthfulness and accuracy of the representations set forth in this Section 5.2 in engaging the Consultant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">5.2.</TD><TD STYLE="text-align: justify">The Consultant shell bear and/or will defend, indemnify and
hold the Company, or any third party on its behalf, harmless from and against all claims, all damages, losses and expenses, including
reasonable fees and expenses of attorneys and other professionals, upon receipt of demand (i) relating to any obligation, future or past,
imposed upon the Company to pay any withholding tax payments regarding consulting services, social security, unemployment or disability
insurance or similar terms in connection with compensation received by the Consultant or, or which are based upon a stipulation by a
competent judicial authority that an employer - employee relationship was created between the Company or its Affiliates and the Consultant&rsquo;s
Representative; and (ii) resulting from any act, omission or negligence on the Consultant&rsquo;s or any of its employees&rsquo; part
in the performance or failure to perform the scope of work under this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">5.3.</TD><TD STYLE="text-align: justify">The Consultant acknowledges that the Consultant&rsquo;s Representative
has read and fully understood the terms of this structure of the relationship between the parties as an independent contractor and that
the Consultant&rsquo;s Representative has consulted and received advice of counsel regarding said structure of the relationship between
the parties hereto and has had sufficient opportunity to do so.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">5.4.</TD><TD STYLE="text-align: justify">It is hereby clarified that any right granted to the Company
to instruct and/or oversee the Services by the Consultant is granted in order to ensure the performance of the Services in full and not
to imply or justify an employer -employee relationship between the Company and the Consultant or the Consultant&rsquo;s Representative.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">5.5.</TD><TD STYLE="text-align: justify">The Consultant shall be responsible to pay any and all payments,
salary, taxes and all other benefits and any amounts due to any relevant social security or similar authority with respect to its employees
and/or the Services provided by the Consultant&rsquo;s Representative pursuant to this Agreement. The Consultant undertakes to acquire
for the Consultant&rsquo;s Representative pension coverage in a customary amount. The Consultant, hereby releases and forever discharges
the Company and its Affiliates, from any and all claims, which it ever had, now has, or may claim to have against the Company and/or
its Affiliates in connection with the existence of any employer - employee relationship between Company or its Affiliates and the Consultant
or the Consultant&rsquo;s Representative.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">5.6.</TD><TD STYLE="text-align: justify">In light of the above, should it be held by any competent
judicial authority that the relationship between the Consultant or the Consultant&rsquo;s Representative, and the Company (or any of
its Affiliates) in respect of the Services rendered by the Consultant pursuant to this Agreement is one of employer and employee, the
parties agree that the &ldquo;salary&rdquo; that the Consultant would be entitled to as an &ldquo;employee&rdquo; (including for the
purpose of social security and social benefits), for the provision of the Services within the framework of this Agreement, shall be 60%
of the average monthly Consulting Fee (the &ldquo;<B>Agreed Employee Compensation</B>&rdquo;).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">5.7.</TD><TD STYLE="text-align: justify">The Consultant will be obligated to return to the Company
all surplus payments that the Company paid beyond the Agreed Employee Compensation (the &ldquo;<B>Surplus Sum</B>&rdquo;), on the day
that a demand and/or claim which contradicts this Agreement is filed or on the day that a decision under Section 5.6 is made, pursuant
to which it is claimed or decided that the Consultant&rsquo;s Representative is a salaried employee of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">5.8.</TD><TD STYLE="text-align: justify">Any Surplus Sum that the Consultant is obligated to return
will be subject to interest linked to the last known Israeli Consumer Price Index on the date said Surplus Sum is to be returned to the
Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">5.9.</TD><TD STYLE="text-align: justify">The Company will be entitled to deduct from and set off against
amounts due to the Consultant pursuant to this Agreement and/or pursuant to any other agreement, law, or otherwise, any amounts, which
the Consultant is required to pay the Company pursuant to this Agreement (including the Surplus Sum), any other agreement, any law, or
otherwise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><B>6.</B></TD><TD STYLE="text-align: justify"><B><U>Warranties</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: -1cm"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Consultant represents and warrants
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">6.1.</TD><TD STYLE="text-align: justify">The Consultant does not have currently and shall not have
during the term of the provisions of the Services, any outstanding agreement or obligation that is or will be in conflict with any of
the provisions of this Agreement, or that would preclude the Consultant from complying with the provisions hereof or otherwise restrict
the Consultant in any way in performing the Services.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">6.2.</TD><TD STYLE="text-align: justify">The execution and delivery of this Agreement, the performance
of the Services and the fulfillment of the terms hereof will not: (a) constitute, in whole or in part, a default, violation or breach
under or conflict in any way with any agreement, obligation, undertaking or commitment to which the Consultant is a party or by which
it is bound, including without limitation, any confidentiality, invention assignment or non-competition agreement and (b) do not require
the consent, permission or authorization of or notification to any person or entity.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">6.3.</TD><TD STYLE="text-align: justify">The Consultant shall comply with all Company disciplinary
regulations, work rules, policies, procedures and objectives, which are relevant to the performance of the Services or otherwise to consultants
of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">6.4.</TD><TD STYLE="text-align: justify">The Company may monitor the Consultant&rsquo;s use of its
Systems (as defined below) and copy, transfer and disclose such electronic communications and content transmitted by or stored in such
Systems, in pursuit of the Company&rsquo;s legitimate business interests, all in accordance with the Company&rsquo;s policies in place
from time to time, and subject to applicable law. For the purposes of this Section, the term &ldquo;<B>Systems</B>&rdquo; includes all
of the Company&rsquo;s owned or leased computers (including laptops), mobile phones and other mobile devices, keys, PDAs, credit cards,
printers, card access to any company building, files, e-mails, tapes, programs, records and software, computer access codes or disks,
and other similar systems.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">6.5.</TD><TD STYLE="text-align: justify">The Consultant shall not solicit or accept in connection
with the performance of the Services or in connection with the Company, any gift, benefit, favor, loan, or any other thing of monetary
value, from a person who is or is possibly connected, directly or indirectly, to either the business of the Company, a competitor of
the Company or a potential competitor of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">6.6.</TD><TD STYLE="text-align: justify">The Consultant shall not make any representations or warranties
to anyone with respect to any contract or otherwise without the Company&rsquo;s prior written authorization.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">6.7.</TD><TD STYLE="text-align: justify">The Consultant shall at all times during the term of this
Agreement continue to be wholly owned, exclusively by the Consultant&rsquo;s Representative.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">6.8.</TD><TD STYLE="text-align: justify">The Consultant shall take all necessary precautions to prevent
the occurrence of any bodily injury or property damage, to the Company, its employees or any third party, arising out of or resulting
from the performance of the Services and shall be solely responsible, and liable, for any such bodily injury or property damage.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><B>7.</B></TD><TD STYLE="text-align: justify"><B><U>Miscellaneous</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: -1cm"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">7.1.</TD><TD STYLE="text-align: justify">In this Agreement the term &ldquo;<B>Affiliate</B>&rdquo;
shall mean, any person or entity that directly or indirectly controls, is controlled by, or is under common control with, a party to
this Agreement. For purposes hereof, the term &ldquo;control&rdquo; means the power to direct the management or affairs of a person or
entity through the ownership of voting securities, by contract, or otherwise.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">7.2.</TD><TD STYLE="text-align: justify">The preamble and the schedules hereto shall form an integral
part of this Agreement. All headings of the Sections and Subsections of this Agreement are intended for convenience of reference and
shall not be used in interpreting this Agreement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">7.3.</TD><TD STYLE="text-align: justify"><U>Assignment</U>. Neither this Agreement nor any interest
herein may be assigned by the Consultant without the prior written consent of the Company. The Company may assign or transfer this Agreement
or any of its rights and/or obligations under this Agreement without the Consultant&rsquo;s consent.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">7.4.</TD><TD STYLE="text-align: justify"><U>Entire Agreement; Amendments</U>. This Agreement constitutes
the entire agreement between the Consultant and the Company with respect to the subject matter hereof and supersedes any other arrangement,
understanding or agreement, verbal or otherwise, including the Prior Agreement. No amendment of or waiver of, or modification of any
obligation under this Agreement will be enforceable unless set forth in a writing signed by the parties hereto. No delay or failure to
require performance of any provision of this Agreement shall constitute a waiver of that provision as to that or any other instance.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">7.5.</TD><TD STYLE="text-align: justify"><U>Law; Jurisdiction</U>. This Agreement shall be governed
by the laws of the State of Israel (excluding its conflict of law principles) and the competent courts/tribunals of Tel-Aviv shall have
exclusive jurisdiction over any disputes arising hereunder.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">7.6.</TD><TD STYLE="text-align: justify"><U>No Waiver</U>. No failure or delay on the part of any
party hereto in exercising any right, power or remedy thereunder shall operate as a waiver thereof, nor shall any single or partial exercise
of any such right, power or remedy preclude any other or further exercise thereof or the exercise of any other right, power or remedy.
Any waiver granted thereunder must be in writing and shall be valid only in the specific instance in which given.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">7.7.</TD><TD STYLE="text-align: justify"><U>Severability</U>. If any provision of this Agreement is
held by a court of competent jurisdiction to be unenforceable under applicable law, then such provision shall be excluded from this Agreement
and the remainder of this Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance
with its terms; provided, however, that in such event this Agreement shall be interpreted so as to give effect, to the greatest extent
consistent with and permitted by applicable law, to the meaning and intention of the excluded provision as determined by such court of
competent jurisdiction.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">7.8.</TD><TD STYLE="text-align: justify"><U>Notices</U>. Any notice or other communication in connection
with this Agreement must be in writing to the address set forth in the preamble to this Agreement (or to such other address as shall
be specified by like notice) and will be deemed given: (i) if sent by a delivery service, on the date confirmed as the actual date of
delivery by such service; (ii) if sent by registered air mail, return receipt requested, within seven (7) days of mailing; or (iii) if
sent by facsimile or email with electronic confirmation of transmission, on the next business day after transmission, if not transmitted
on a business day, or on the day of transmission, if transmitted on a business day.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.35in; text-align: left">7.9.</TD><TD STYLE="text-align: justify"><U>Survival</U>. The provisions of Sections&nbsp;&lrm;4,
&lrm;5, and &lrm;6 of this Agreement, including the provisions of <B><U>Schedule A</U></B>, shall continue and remain in full force and
effect following the termination or expiration of this Agreement, for whatever reason.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63.8pt; text-align: justify; text-indent: -35.45pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">-Signature Page Follows-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IN WITNESS WHEREOF</B>, the parties have signed
this Agreement as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; width: 40%">/s/ Viki Hakmon</TD>
    <TD STYLE="text-align: left; width: 20%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; width: 40%">/s/ Kfir Zilberman</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Jeffs Brands Ltd.</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">L.I.A. Pure Capital Ltd.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">By: Viki Hakmon</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">By: Kfir Zilberman</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">Title: Chief Executive Officer</TD>
    <TD STYLE="text-align: left">&#9;</TD>
    <TD STYLE="text-align: left">Title: Chairman and Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I have read the provisions of the above Consulting
Agreement and I agree to be bound by and comply with such terms and perform the Services (as defined above) as if I was the Consultant.
I will be responsible towards Jeffs Brands Ltd. (the &ldquo;<B>Company</B>&rdquo;) for the compliance by the Consultant with all its
obligations under the Consulting Agreement and the Services and shall be further responsible and liable towards the Company for any breach
by the Consultant of any of its obligations under the Consulting Agreement and for any other liability of the Consultant under the Consulting
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I hereby acknowledge that it is known to me that
I am an employee of the Consultant and not of the Company. I hereby undertake not to make any claim asserting that I am an employee of
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">/s/ Kfir Zilberman</TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Kfir Silberman, the Consultant&rsquo;s Representative</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: <U>26 October, 2022</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDERTAKING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THIS UNDERTAKING</B> (&ldquo;<B>Undertaking</B>&rdquo;)
is entered into as of the 1st day of September 2022 by L.I.A. Pure Capital Ltd., whose address is at 20 Raoul Wallenberg Street, Tel
Aviv 6971916, Israel (the &ldquo;<B>Consultant</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 71pt"><B>WHEREAS</B>,</TD><TD STYLE="text-align: justify">the Consultant wishes to be engaged
                                            by Jeffs Brands Ltd., whose address is at HaNechoshet St 3, Tel Aviv 6971068, Israel (the
                                            &ldquo;<B>Company</B>&rdquo;); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 90pt; text-align: justify; text-indent: -90pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 71pt"><B>WHEREAS</B>,</TD><TD STYLE="text-align: justify">it is critical for the Company
                                            to preserve and protect its Confidential Information (as defined below) and its rights in
                                            Inventions (as defined below) and in all related intellectual property, and the Consultant
                                            is entering into this Undertaking as a condition to the Consultant&rsquo;s engagement with
                                            the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 90pt; text-align: justify; text-indent: -90pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 90pt; text-align: justify; text-indent: -90pt"><B>NOW, THEREFORE,
</B>the Consultant undertakes and warrants towards the Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 90pt; text-align: justify; text-indent: -90pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">References herein to the term &ldquo;<B>Company</B>&rdquo;
shall include any of the Company&rsquo;s direct or indirect parent, subsidiary and affiliated companies, and their respective successors
and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><B>1.</B></TD><TD STYLE="text-align: justify"><B><U>Confidentiality.</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">1.1.</TD><TD STYLE="text-align: justify">the Consultant acknowledges that the Consultant may have
access to information that relates to the Company, its business, assets, financial condition, affairs, activities, plans and projections,
customers, suppliers, partners, and other third parties with whom the Company agreed or agrees, from time to time, to hold information
of such party in confidence (the <B>&ldquo;Confidential Information&rdquo;</B>). Confidential Information shall include, without limitation,
information, whether or not marked or designated as confidential, concerning technology, products, research and development, patents,
copyrights, inventions, trade secrets, test results, formulae, processes, data, know-how, marketing, promotion, business and financial
plans, policies, practices, strategies, surveys, analyses and forecasts, financial information, customer lists, agreements, transactions,
undertakings and data concerning employees, consultants, officers, directors, and shareholders. Confidential Information includes information
in any form or media, whether documentary, written, oral, magnetic, electronically transmitted, through presentation or demonstration
or computer generated. Confidential Information shall not include information that: (i) has become part of the public domain not as a
result of a breach of any obligation owed by the Consultant to the Company; or (ii) is required to be disclosed by law or the binding
rules of any governmental organization, provided, however, that the Consultant gives the Company prompt notice thereof so that the Company
may seek a protective order or other appropriate remedy, and further provided, that in the event that such protective order or other
remedy is not obtained, the Consultant shall furnish only that portion of the Confidential Information which is legally required, and
shall exercise all reasonable efforts required to obtain confidential treatment for such information.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">1.2.</TD><TD STYLE="text-align: justify">The Consultant acknowledges and understands that the engagement
by the Company and the access to Confidential Information creates a relationship of confidence and trust with respect to such Confidential
Information.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">1.3.</TD><TD STYLE="text-align: justify">During the term of the Consultant&rsquo;s engagement and
at any time after termination or expiration thereof, for any reason, the Consultant shall keep in strict confidence and trust, shall
safeguard, and shall not disclose to any person or entity, nor use for the benefit of any party other than the Company, any Confidential
Information, other than with the prior express consent of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">1.4.</TD><TD STYLE="text-align: justify">All right, title and interest in and to Confidential Information
are and shall remain the sole and exclusive property of the Company or of the third party providing such Confidential Information to
the Company, as the case may be. Without limitation of the foregoing, the Consultant agrees and acknowledges that all memoranda, books,
notes, records, email transmissions, charts, formulae, specifications, lists and other documents (contained on any media whatsoever)
made, reproduced, compiled, received, held or used by the Consultant in connection with the engagement by the Company or that otherwise
relates to any Confidential Information (the &ldquo;<B>Confidential Material</B>&rdquo;), shall be the Company&rsquo;s sole and exclusive
property and shall be deemed to be Confidential Information. All originals, copies, reproductions and summaries of the Confidential Material
shall be delivered by the Consultant to the Company upon termination or expiration of the Consultant&rsquo;s engagement for any reason,
or at any earlier time at the request of the Company, without the Consultant retaining any copies thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">1.5.</TD><TD STYLE="text-align: justify">During the term of the Consultant&rsquo;s engagement with
the Company, the Consultant shall not remove from the Company&rsquo;s offices or premises any Confidential Material unless and to the
extent necessary in connection with the duties and responsibilities of the Consultant and permitted pursuant to then applicable policies
and regulations of the Company. In the event that such Confidential Material is duly removed from the Company&rsquo;s offices or premises,
the Consultant shall take all actions necessary in order to secure the safekeeping and confidentiality of such Confidential Material
and return the Confidential Material to their proper files or location as promptly as possible after such use.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">1.6.</TD><TD STYLE="text-align: justify">During the term of the Consultant&rsquo;s engagement with
the Company, the Consultant will not improperly use or disclose any proprietary or confidential information or trade secrets, and will
not bring onto the premises of the Company any unpublished documents or any property, belonging to any former employer or any other person
to whom the Consultant has an obligation of confidentiality and/or non-use (including, without limitation, any academic institution or
any entity related thereto), unless generally available to the public or consented to in writing by that person.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><B>2.</B></TD><TD STYLE="text-align: justify"><B><U>Ownership of Inventions.</U></B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: -1cm"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">2.1.</TD><TD STYLE="text-align: justify">The Consultant will notify and disclose in writing to the
Company, or any persons designated by the Company from time to time, all information, improvements, inventions, trademarks, works of
authorship, designs, trade secrets, formulae, processes, techniques, know-how, and data, whether or not patentable or registerable under
copyright or any similar laws, made or conceived or reduced to practice or learned by the Consultant, either alone or jointly with others,
during the Consultant&rsquo;s engagement with the Company (all such information, improvements, inventions, trademarks, works, designs,
trade secrets, formulae, processes, techniques, know-how, and data are hereinafter referred to as the &ldquo;<B>Invention(s)</B>&rdquo;)
immediately upon discovery, receipt or invention as applicable.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">2.2.</TD><TD STYLE="text-align: justify">Consultant agrees that all the Inventions are, upon creation,
Inventions of the Company, shall be the sole property of the Company and its assignees, and the Company and its assignees shall be the
sole owner of all title, rights and interest in and to any patents, copyrights, trade secrets and all other rights of any kind or nature,
including moral rights, in connection with such Inventions. the Consultant hereby irrevocably and unconditionally assigns to the Company
all the following with respect to any and all Inventions: (i) all title, rights and interest in and to any patents, patent applications,
and patent rights, including any and all continuations or extensions thereof; (ii) rights associated with works of authorship, including
copyrights and copyright applications, Moral Rights (as defined below) and mask work rights; (iii) rights relating to the protection
of trade secrets and confidential information; (iv) design rights and industrial property rights; (v) any other proprietary rights relating
to intangible property including trademarks, service marks and applications thereof, trade names and packaging and all goodwill associated
with the same; (vi) any and all title, rights and interest in and to any Invention; and (vii) all rights to sue for any infringement
of any of the foregoing rights and the right to all income, royalties, damages and payments with respect to any of the foregoing rights.
the Consultant also hereby forever waives and agrees never to assert any and all Moral Rights the Consultant may have in or with respect
to any Inventions, even after termination of engagement on behalf of the Company. &ldquo;<B>Moral Rights</B>&rdquo; means any right to
claim authorship of a work, any right to object to any distortion or other modification of a work, and any similar right, existing under
the law of any country in the world, or under any treaty.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">2.3.</TD><TD STYLE="text-align: justify">The Consultant further agrees to perform, during and after
the term of the Consultant&rsquo;s engagement with the Company, all acts deemed reasonably necessary or desirable by the Company to permit
and assist it, at the Company&rsquo;s expense, in obtaining, maintaining, defending and enforcing the Inventions in any and all countries.
Such acts may include, but are not limited to, execution of documents and assistance or cooperation in legal proceedings. the Consultant
hereby irrevocably designates and appoints the Company and its duly authorized officers and agents, as the Consultant&rsquo;s agents
and attorneys-in-fact to act for and on the Consultant&rsquo;s behalf and instead of the Consultant, to execute and file any documents
and to do all other lawfully permitted acts to further the above purposes with the same legal force and effect as if executed by the
Consultant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">2.4.</TD><TD STYLE="text-align: justify">The Consultant shall not be entitled to any monetary consideration
or any other consideration except as explicitly set forth in the Consulting Agreement. Without limitation of the foregoing, the Consultant
irrevocably confirms that the consideration explicitly set forth in the Consulting Agreement is in lieu of any rights for compensation
that may arise in connection with the Inventions under applicable law and waives any right to claim royalties or other consideration
with respect to any Invention, including under Section 134 of the Israeli Patent Law - 1967. Any oral understanding, communication or
agreement with respect to the matters set forth herein, not memorialized in writing and duly signed by the Company, shall be void.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">3.</TD><TD STYLE="text-align: justify"><B><U>General</U></B>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1cm; text-align: justify; text-indent: -1cm">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">3.1.</TD><TD STYLE="text-align: justify">The Consultant represents that the performance of all the
terms of this Undertaking and the Consultant&rsquo;s duties as a consultant of the Company does not and will not breach any invention
assignment, proprietary information, non-compete, confidentiality or similar agreements with, or rules, regulations or policies of, any
other party (including, without limitation, any academic institution or any entity related thereto). The Consultant acknowledges that
the Company is relying upon the truthfulness and accuracy of such representations in its decision to engage with the Consultant.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">3.2.</TD><TD STYLE="text-align: justify">The Consultant acknowledges that the provisions of this Undertaking
serve as an integral part of the terms of the Consulting Agreement and reflect the reasonable requirements of the Company in order to
protect its legitimate interests with respect to the subject matter hereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">3.3.</TD><TD STYLE="text-align: justify">The Consultant recognizes and acknowledges that in the event
of a breach or threatened breach of this Undertaking by the Consultant, the Company may suffer irreparable harm or damage and will, therefore,
be entitled to injunctive relief to enforce this Undertaking (without limitation to any other remedy at law or in equity).</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">3.4.</TD><TD STYLE="text-align: justify">This Undertaking is governed by and construed in accordance
with the laws of the State of Israel, without giving effect to its laws pertaining to conflict of laws. Any and all disputes in connection
with this Undertaking shall be submitted to the exclusive jurisdiction of the competent courts or tribunals, as relevant, located in
the city of Tel-Aviv-Jaffa, Israel.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">3.5.</TD><TD STYLE="text-align: justify">If any provision of this Undertaking is determined by any
court of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum
extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken
from this Undertaking only with respect to such jurisdiction in which such clause or provision cannot be enforced, and the remainder
of this Undertaking shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable)
never been contained in this Undertaking. In addition, if any particular provision contained in this Undertaking shall for any reason
be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by limiting and reducing
the scope of such provision so that the provision is enforceable to the fullest extent compatible with applicable law.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">3.6.</TD><TD STYLE="text-align: justify">The provisions of this Undertaking shall continue and remain
in full force and effect following the termination or expiration of the engagement between the Company and the Consultant, for whatever
reason. This Undertaking shall not serve in any manner so as to derogate from any of the Consultant&rsquo;s obligations and liabilities
under any applicable law.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">3.7.</TD><TD STYLE="text-align: justify">This Undertaking constitutes the entire agreement between
the Consultant and the Company with respect to the subject matter hereof and supersedes all prior agreements, proposals, understandings
and arrangements, if any, whether oral or written, with respect to the subject matter hereof. No amendment, waiver or modification of
any obligation under this Undertaking will be enforceable unless set forth in a writing signed by the Company. No delay or failure to
require performance of any provision of this Undertaking shall constitute a waiver of that provision as to that or any other instance.
No waiver granted under this Undertaking as to any one provision herein shall constitute a subsequent waiver of such provision or of
any other provision herein, nor shall it constitute the waiver of any performance other than the actual performance specifically waived.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left">3.8.</TD><TD STYLE="text-align: justify">This Undertaking, the rights of the Company hereunder, and
the obligations of the Consultant hereunder, will be binding upon and inure to the benefit of their respective successors, assigns, heirs,
executors, administrators and legal representatives. The Company may assign any of its rights under this Undertaking. The Consultant
may not assign, whether voluntarily or by operation of law, any of the Consultant&rsquo;s obligations under this Undertaking, except
with the prior written consent of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0cm">-Signature Page Follows-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>IN WITNESS WHEREOF</B>, the undersigned, has
executed this Undertaking as of the date first mentioned above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 23%; text-align: justify">Printed Name:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 27%; text-align: justify">L.I.A. Pure Capital Ltd.</TD>
    <TD STYLE="width: 2%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: justify">Signature:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%; text-align: justify">/s/ Kfir Silberman</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I have read the provisions of the above Undertaking
and I agree to be bound by such Undertaking and comply with such terms as if I was the Consultant. I will be responsible toward Jeffs
Brands Ltd. (the &ldquo;<B>Company</B>&rdquo;) or any of the Company&rsquo;s direct or indirect parent, subsidiary and affiliated companies,
and their respective successors and assigns for the compliance by the Consultant of its obligations under the Undertaking and shall be
further responsible and liable towards the Company for any breach by the Consultant of any of its obligations under the Undertaking and
for any other liability of the Consultant under the Undertaking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">/s/ Kfir Silberman</TD>
  <TD STYLE="width: 60%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Kfir Silberman, the Consultant&rsquo;s Representative</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: <U>26 October, 2022</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U></U></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>4
<FILENAME>f20f2022ex8-1_jeffsbrands.htm
<DESCRIPTION>LIST OF SUBSIDIARIES
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><BR>
Exhibit 21.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LIST OF SUBSIDIARIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="background-color: white; font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid"><B>Entity Name</B></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid"><B>Jurisdiction of Incorporation</B></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Smart Repair Pro</TD>
    <TD>&nbsp;</TD>
    <TD>California</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Purex Corp.</TD>
    <TD>&nbsp;</TD>
    <TD>California</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Top Rank Ltd</TD>
    <TD>&nbsp;</TD>
    <TD>Israel</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt">NewCo Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>Delaware</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt">SciSparc Nutraceuticals Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>Delaware</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt">Fort Products Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>England and Whales</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>5
<FILENAME>f20f2022ex12-1_jeffsbrands.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 12.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CERTIFICATION PURSUANT TO EXCHANGE ACT RULE
13a-14(a) or 15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Viki Hakmon, certify that:</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have reviewed this annual report on Form 20&ndash;F of Jeffs&rsquo; Brands Ltd;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) [language omitted in accordance with Exchange Act Rule 13a-14(a)] for the company
and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[paragraph
omitted in accordance with Exchange Act Rule 13a-14(a)];</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated
the effectiveness of the company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed
in this report any change in the company&rsquo;s internal control over financial reporting that occurred during the period covered by
the annual report that has materially affected, or is reasonably likely to materially affect, the company&rsquo;s internal control over
financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the company&rsquo;s auditors and the audit committee of the company&rsquo;s board of directors:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the company&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
fraud, whether or not material, that involves management or other employees who have a significant role in the company&rsquo;s internal
control over financial reporting.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 10, 2023</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Viki Hakmon</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viki Hakmon</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>6
<FILENAME>f20f2022ex12-2_jeffsbrands.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 12.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO EXCHANGE ACT RULE
13a-14(a) or 15d-14(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Ronen Zalayet, certify that:</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I
have reviewed this annual report on Form 20&ndash;F of Jeffs&rsquo; Brands Ltd;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered
by this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) [language omitted in accordance with Exchange Act Rule 13a-14(a)] for the company
and have:</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[paragraph omitted in accordance with Exchange Act Rule 13a-14(a)];</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated the effectiveness of the Company&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing the
equivalent function):</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 10, 2023</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ronen Zalayet</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronen Zalayet</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>7
<FILENAME>f20f2022ex13-1_jeffsbrands.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 13.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C.&nbsp;Section 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the filing
of the Annual Report on Form 20-F for the period ended December 31, 2022 (the &ldquo;Report&rdquo;) by Jeffs&rsquo; Brands Ltd (the &ldquo;Company&rdquo;),
the undersigned, as the Chief Executive Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 10, 2023</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Viki Hakmon</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Viki Hakmon</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>8
<FILENAME>f20f2022ex13-2_jeffsbrands.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 13.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C.&nbsp;Section 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the filing
of the Annual Report on Form 20-F for the period ended December 31, 2022 (the &ldquo;Report&rdquo;) by Jeffs&rsquo; Brands Ltd (the &ldquo;Company&rdquo;),
the undersigned, as the Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, that, to my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 10, 2023</FONT></TD>
    <TD STYLE="width: 40%; border-bottom: black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Ronen Zalayet</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ronen Zalayet</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>9
<FILENAME>f20f2022ex15-1_jeffsbrands.htm
<DESCRIPTION>CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO., A FIRM IN THE DELOITTE GLOBAL NETWORK, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 15.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">We consent to the incorporation by reference in the Registration Statement
on Form S-8 (No. 333-269119) of our report dated April 5, 2023, relating to the financial statements of Jeffs&rsquo; Brands Ltd, appearing
in its Annual Report on Form 20-F for the year ended December 31, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>/s/ Brightman Almagor Zohar &amp; Co.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Certified Public Accountants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>A Firm in the Deloitte Global Network</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tel Aviv, Israel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 10, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>jfbr-20221231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 10 08:08:28 UTC 2023 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2022" targetNamespace="http://www.jeffsbrands.com/20221231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:jfbr="http://www.jeffsbrands.com/20221231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="jfbr-20221231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="jfbr-20221231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="jfbr-20221231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="jfbr-20221231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet" id="jfbr_r_ConsolidatedBalanceSheet">
        <link:definition>001 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals" id="jfbr_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>002 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement" id="jfbr_r_ConsolidatedIncomeStatement">
        <link:definition>003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals" id="jfbr_r_ConsolidatedIncomeStatement_Parentheticals">
        <link:definition>004 - Statement - Consolidated Statements of Operations (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ShareholdersEquityType2or3" id="jfbr_r_ShareholdersEquityType2or3">
        <link:definition>005 - Statement - Consolidated Statements of Changes in Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ConsolidatedCashFlow" id="jfbr_r_ConsolidatedCashFlow">
        <link:definition>006 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/GeneralInformation" id="jfbr_r_GeneralInformation">
        <link:definition>007 - Disclosure - General Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies" id="jfbr_r_SummaryofSignificantAccountingPolicies">
        <link:definition>008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/Otherreceivables" id="jfbr_r_Otherreceivables">
        <link:definition>009 - Disclosure - Other receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/Inventory" id="jfbr_r_Inventory">
        <link:definition>010 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/IntangibleAssets" id="jfbr_r_IntangibleAssets">
        <link:definition>011 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/Leases" id="jfbr_r_Leases">
        <link:definition>012 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/OtherPayables" id="jfbr_r_OtherPayables">
        <link:definition>013 - Disclosure - Other Payables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ShortTermLoans" id="jfbr_r_ShortTermLoans">
        <link:definition>014 - Disclosure - Short-Term Loans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/DerivativeLiabilities" id="jfbr_r_DerivativeLiabilities">
        <link:definition>015 - Disclosure - Derivative Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/LoansfromShareholders" id="jfbr_r_LoansfromShareholders">
        <link:definition>016 - Disclosure - Loans from Shareholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/TaxesonIncome" id="jfbr_r_TaxesonIncome">
        <link:definition>017 - Disclosure - Taxes on Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ShareCapital" id="jfbr_r_ShareCapital">
        <link:definition>018 - Disclosure - Share Capital</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ShareIncentivePlan" id="jfbr_r_ShareIncentivePlan">
        <link:definition>019 - Disclosure - Share Incentive Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet" id="jfbr_r_FinanceIncomeExpenseNet">
        <link:definition>020 - Disclosure - Finance (Income) Expense, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholders" id="jfbr_r_NetIncomeLossPerShareAttributabletoOrdinaryShareholders">
        <link:definition>021 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/RelatedParties" id="jfbr_r_RelatedParties">
        <link:definition>022 - Disclosure - Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/SubsequentEvents" id="jfbr_r_SubsequentEvents">
        <link:definition>023 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy" id="jfbr_r_AccountingPoliciesByPolicy">
        <link:definition>024 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables" id="jfbr_r_SummaryofSignificantAccountingPoliciesTables">
        <link:definition>025 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/OtherreceivablesTables" id="jfbr_r_OtherreceivablesTables">
        <link:definition>026 - Disclosure - Other receivables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/InventoryTables" id="jfbr_r_InventoryTables">
        <link:definition>027 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/IntangibleAssetsTables" id="jfbr_r_IntangibleAssetsTables">
        <link:definition>028 - Disclosure - Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/LeasesTables" id="jfbr_r_LeasesTables">
        <link:definition>029 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/OtherPayablesTables" id="jfbr_r_OtherPayablesTables">
        <link:definition>030 - Disclosure - Other Payables (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ShortTermLoansTables" id="jfbr_r_ShortTermLoansTables">
        <link:definition>031 - Disclosure - Short-Term Loans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables" id="jfbr_r_DerivativeLiabilitiesTables">
        <link:definition>032 - Disclosure - Derivative Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/LoansfromShareholdersTables" id="jfbr_r_LoansfromShareholdersTables">
        <link:definition>033 - Disclosure - Loans from Shareholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/TaxesonIncomeTables" id="jfbr_r_TaxesonIncomeTables">
        <link:definition>034 - Disclosure - Taxes on Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ShareCapitalTables" id="jfbr_r_ShareCapitalTables">
        <link:definition>035 - Disclosure - Share Capital (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables" id="jfbr_r_FinanceIncomeExpenseNetTables">
        <link:definition>036 - Disclosure - Finance (Income) Expense, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables" id="jfbr_r_NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables">
        <link:definition>037 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/RelatedPartiesTables" id="jfbr_r_RelatedPartiesTables">
        <link:definition>038 - Disclosure - Related Parties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/GeneralInformationDetails" id="jfbr_r_GeneralInformationDetails">
        <link:definition>039 - Disclosure - General Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails" id="jfbr_r_SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>040 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable" id="jfbr_r_ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable">
        <link:definition>041 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/OtherreceivablesDetails" id="jfbr_r_OtherreceivablesDetails">
        <link:definition>042 - Disclosure - Other receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable" id="jfbr_r_ScheduleofotherreceivablesTable">
        <link:definition>043 - Disclosure - Other receivables (Details) - Schedule of other receivables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofinventoryTable" id="jfbr_r_ScheduleofinventoryTable">
        <link:definition>044 - Disclosure - Inventory (Details) - Schedule of inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/IntangibleAssetsDetails" id="jfbr_r_IntangibleAssetsDetails">
        <link:definition>045 - Disclosure - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable" id="jfbr_r_ScheduleoftotalintangibleassetsTable">
        <link:definition>046 - Disclosure - Intangible Assets (Details) - Schedule of total intangible assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/LeasesDetails" id="jfbr_r_LeasesDetails">
        <link:definition>047 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable" id="jfbr_r_ScheduleoffutureleasepaymentsunderoperatingleasesTable">
        <link:definition>048 - Disclosure - Leases (Details) - Schedule of future lease payments under operating leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable" id="jfbr_r_ScheduleofotherpayablesTable">
        <link:definition>049 - Disclosure - Other Payables (Details) - Schedule of other payables</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ShortTermLoansDetails" id="jfbr_r_ShortTermLoansDetails">
        <link:definition>050 - Disclosure - Short-Term Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable" id="jfbr_r_ScheduleofshorttermloansTable">
        <link:definition>051 - Disclosure - Short-Term Loans (Details) - Schedule of short term loans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZqAlP1yOSc1A/ANEzuo53ddr/LMBLom9FlRSK3NKkyEbonVWG5HPDY+G1lW3BvjVh1hGR4TsEWxikRSd2CzczjxOi38/JBT4C/OcGQ5Ko7wX9cWbP+EcSCjzoKw5UOEXtltIx6qGM8m+WHjAhoKAqHXg9v/7inBQezt5KwYVPvHGi+aa1see5Nnq1daHt5a30pL2aMLG8q7GTrHWAqJ38w] CSR-->
      <link:roleType roleURI="http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails" id="jfbr_r_DerivativeLiabilitiesDetails">
        <link:definition>052 - Disclosure - Derivative Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable" id="jfbr_r_ScheduleoffairvalueofthederivativewarrantliabilityTable">
        <link:definition>053 - Disclosure - Derivative Liabilities (Details) - Schedule of fair value of the derivative warrant liability</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" id="jfbr_r_ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable">
        <link:definition>054 - Disclosure - Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/LoansfromShareholdersDetails" id="jfbr_r_LoansfromShareholdersDetails">
        <link:definition>055 - Disclosure - Loans from Shareholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable" id="jfbr_r_ScheduleofloansfromshareholdersconsistsTable">
        <link:definition>056 - Disclosure - Loans from Shareholders (Details) - Schedule of loans from shareholders consists</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/TaxesonIncomeDetails" id="jfbr_r_TaxesonIncomeDetails">
        <link:definition>057 - Disclosure - Taxes on Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable" id="jfbr_r_ScheduleofincomelossbeforetaxesTable">
        <link:definition>058 - Disclosure - Taxes on Income (Details) - Schedule of income (loss) before taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable" id="jfbr_r_ScheduleofincometaxexpensebenefitTable">
        <link:definition>059 - Disclosure - Taxes on Income (Details) - Schedule of income tax expense (benefit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable" id="jfbr_r_ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable">
        <link:definition>060 - Disclosure - Taxes on Income (Details) - Schedule of statutory income tax rate to effective income tax rate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable" id="jfbr_r_ScheduleofdeferredtaxesassetsandliabilitiesTable">
        <link:definition>061 - Disclosure - Taxes on Income (Details) - Schedule of deferred taxes assets and liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ShareCapitalDetails" id="jfbr_r_ShareCapitalDetails">
        <link:definition>062 - Disclosure - Share Capital (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofsharecapitalcomposedofordinarysharesTable" id="jfbr_r_ScheduleofsharecapitalcomposedofordinarysharesTable">
        <link:definition>063 - Disclosure - Share Capital (Details) - Schedule of share capital composed of ordinary shares</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ShareIncentivePlanDetails" id="jfbr_r_ShareIncentivePlanDetails">
        <link:definition>064 - Disclosure - Share Incentive Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable" id="jfbr_r_ScheduleoffinanceincomeexpensesnetTable">
        <link:definition>065 - Disclosure - Finance (Income) Expense, Net (Details) - Schedule of finance (income) expenses, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable" id="jfbr_r_ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable">
        <link:definition>066 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals" id="jfbr_r_ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals">
        <link:definition>067 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable" id="jfbr_r_ScheduleofdilutedweightedaveragesharesoutstandingTable">
        <link:definition>068 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of diluted weighted average shares outstanding</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/RelatedPartiesDetails" id="jfbr_r_RelatedPartiesDetails">
        <link:definition>069 - Disclosure - Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable" id="jfbr_r_ScheduleoftransactionswithinterestedandrelatedpartiesTable">
        <link:definition>070 - Disclosure - Related Parties (Details) - Schedule of transactions with interested and related parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable" id="jfbr_r_ScheduleofbalanceswithinterestedandrelatedpartiesTable">
        <link:definition>071 - Disclosure - Related Parties (Details) - Schedule of balances with interested and related parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/SubsequentEventsDetails" id="jfbr_r_SubsequentEventsDetails">
        <link:definition>072 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.jeffsbrands.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd"/>
  <xs:element name="GeneralInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_GeneralInformationAbstract"/>
  <xs:element name="ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract"/>
  <xs:element name="ScheduleOfOtherReceivablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfOtherReceivablesAbstract"/>
  <xs:element name="ScheduleOfInventoryAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfInventoryAbstract"/>
  <xs:element name="ScheduleOfTotalIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfTotalIntangibleAssetsAbstract"/>
  <xs:element name="ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract"/>
  <xs:element name="ScheduleOfOtherPayablesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfOtherPayablesAbstract"/>
  <xs:element name="ScheduleOfShortTermLoansAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfShortTermLoansAbstract"/>
  <xs:element name="ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract"/>
  <xs:element name="ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract"/>
  <xs:element name="ScheduleOfLoansFromShareholdersConsistsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract"/>
  <xs:element name="ScheduleOfIncomeLossBeforeTaxesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfIncomeLossBeforeTaxesAbstract"/>
  <xs:element name="ScheduleOfIncomeTaxExpenseBenefitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract"/>
  <xs:element name="ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract"/>
  <xs:element name="ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract"/>
  <xs:element name="ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract"/>
  <xs:element name="ScheduleOfFinanceIncomeExpensesNetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract"/>
  <xs:element name="ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract"/>
  <xs:element name="ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract"/>
  <xs:element name="ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract"/>
  <xs:element name="ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract"/>
  <xs:element name="NonCurrentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_NonCurrentAssetsAbstract"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract"/>
  <xs:element name="LiabilitiesAndEquityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_LiabilitiesAndEquityAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract0"/>
  <xs:element name="NonCurrentLiabilitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_NonCurrentLiabilitiesAbstract"/>
  <xs:element name="UnlabeledAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract1"/>
  <xs:element name="UnlabeledAbstract2" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract2"/>
  <xs:element name="UnlabeledAbstract3" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract3"/>
  <xs:element name="UnlabeledAbstract4" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract4"/>
  <xs:element name="UnlabeledAbstract5" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract5"/>
  <xs:element name="UnlabeledAbstract6" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract6"/>
  <xs:element name="UnlabeledAbstract7" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract7"/>
  <xs:element name="UnlabeledAbstract8" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract8"/>
  <xs:element name="UnlabeledAbstract9" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract9"/>
  <xs:element name="UnlabeledAbstract10" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract10"/>
  <xs:element name="UnlabeledAbstract11" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract11"/>
  <xs:element name="UnlabeledAbstract12" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract12"/>
  <xs:element name="UnlabeledAbstract13" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract13"/>
  <xs:element name="UnlabeledAbstract14" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract14"/>
  <xs:element name="UnlabeledAbstract15" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract15"/>
  <xs:element name="UnlabeledAbstract16" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract16"/>
  <xs:element name="UnlabeledAbstract17" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract17"/>
  <xs:element name="UnlabeledAbstract18" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract18"/>
  <xs:element name="DeferredAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_DeferredAbstract"/>
  <xs:element name="IncreaseDecreaseInTaxesOnIncomeResultingFromTheFollowingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IncreaseDecreaseInTaxesOnIncomeResultingFromTheFollowingAbstract"/>
  <xs:element name="DeferredTaxAssetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_DeferredTaxAssetAbstract"/>
  <xs:element name="UnlabeledAbstract19" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract19"/>
  <xs:element name="UnlabeledAbstract20" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract20"/>
  <xs:element name="UnlabeledAbstract21" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract21"/>
  <xs:element name="FinanceIncomeAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_FinanceIncomeAbstract"/>
  <xs:element name="FinanceExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_FinanceExpenseAbstract"/>
  <xs:element name="NumeratorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_NumeratorAbstract"/>
  <xs:element name="UnlabeledAbstract22" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnlabeledAbstract22"/>
  <xs:element name="DenominatorAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_DenominatorAbstract"/>
  <xs:element name="AssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AssetsAbstract0"/>
  <xs:element name="FinancialincomeExpensesNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_FinancialincomeExpensesNet"/>
  <xs:element name="StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts"/>
  <xs:element name="StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares"/>
  <xs:element name="AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans"/>
  <xs:element name="IssuanceCostsOnDerivativeLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IssuanceCostsOnDerivativeLiabilities"/>
  <xs:element name="DeferredOfferingCostsIncludedInOtherPayables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_DeferredOfferingCostsIncludedInOtherPayables"/>
  <xs:element name="SharebasedCompensationIncludedInDeferredOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts"/>
  <xs:element name="IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans"/>
  <xs:element name="SubstantialModificationOfShareholdersLoansRecordedInEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity"/>
  <xs:element name="RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities"/>
  <xs:element name="GeneralInformationTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_GeneralInformationTextBlock"/>
  <xs:element name="IntangibleAssetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_IntangibleAssetsTable"/>
  <xs:element name="IntangibleAssetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IntangibleAssetsLineItems"/>
  <xs:element name="LeasesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_LeasesTable"/>
  <xs:element name="LeasesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_LeasesLineItems"/>
  <xs:element name="LoansfromShareholdersTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_LoansfromShareholdersTable"/>
  <xs:element name="LoansfromShareholdersLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_LoansfromShareholdersLineItems"/>
  <xs:element name="ShareIncentivePlanTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_ShareIncentivePlanTable"/>
  <xs:element name="ShareIncentivePlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ShareIncentivePlanLineItems"/>
  <xs:element name="FinanceIncomeExpenseNetTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_FinanceIncomeExpenseNetTable"/>
  <xs:element name="FinanceIncomeExpenseNetLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_FinanceIncomeExpenseNetLineItems"/>
  <xs:element name="IntangibleAssetsTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_IntangibleAssetsTablesTable"/>
  <xs:element name="IntangibleAssetsTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IntangibleAssetsTablesLineItems"/>
  <xs:element name="OtherPayablesTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_OtherPayablesTablesTable"/>
  <xs:element name="OtherPayablesTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_OtherPayablesTablesLineItems"/>
  <xs:element name="LoansfromShareholdersTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_LoansfromShareholdersTablesTable"/>
  <xs:element name="LoansfromShareholdersTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_LoansfromShareholdersTablesLineItems"/>
  <xs:element name="ScheduleOfFinanceIncomeExpensesNetTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock"/>
  <xs:element name="ScheduleOfInterestedAndRelatedPartiesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock"/>
  <xs:element name="FutureOperatingLeasePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_FutureOperatingLeasePayments"/>
  <xs:element name="PresentValueOfLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_PresentValueOfLeaseLiability"/>
  <xs:element name="AccruedExpensesAndOtherPayables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AccruedExpensesAndOtherPayables"/>
  <xs:element name="ThirdPartyLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ThirdPartyLoan"/>
  <xs:element name="FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue"/>
  <xs:element name="FairValueOfWarrantLiabilityToBeIssuedToThirdparty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty"/>
  <xs:element name="ChangeInFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ChangeInFairValue"/>
  <xs:element name="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"/>
  <xs:element name="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems"/>
  <xs:element name="TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable"/>
  <xs:element name="TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems"/>
  <xs:element name="CurrentStateAndLocalTaxExpensesBenefit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_CurrentStateAndLocalTaxExpensesBenefit"/>
  <xs:element name="DeferredStateAndLocalIncomeTaxExpensesBenefit" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit"/>
  <xs:element name="DifferencesBetweenTaxBasisAndCarryingValueOfLoans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans"/>
  <xs:element name="FinanceExpensesInRespectOfThirdpartyLoan" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_FinanceExpensesInRespectOfThirdpartyLoan"/>
  <xs:element name="FinanceExpenseNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_FinanceExpenseNet"/>
  <xs:element name="IPOAndAdditionalWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IPOAndAdditionalWarrants"/>
  <xs:element name="UnderwriterWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnderwriterWarrants"/>
  <xs:element name="OtherWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_OtherWarrants"/>
  <xs:element name="TotalDilutedWeightedAverageSharesOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_TotalDilutedWeightedAverageSharesOutstanding"/>
  <xs:element name="InterestExpensesOnLoansFromRelatedPartiesAndShareholders" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders"/>
  <xs:element name="AdvancesToSuppliers" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AdvancesToSuppliers"/>
  <xs:element name="LoansFromShareholders" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_LoansFromShareholders"/>
  <xs:element name="GeneralInformationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_GeneralInformationDetailsTable"/>
  <xs:element name="GeneralInformationDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_GeneralInformationDetailsLineItems"/>
  <xs:element name="ExercisePriceAdjustment" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ExercisePriceAdjustment"/>
  <xs:element name="ClassOfAdditionalWarrantOrRightOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ClassOfAdditionalWarrantOrRightOutstanding"/>
  <xs:element name="NetProceedsOfWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_NetProceedsOfWarrants"/>
  <xs:element name="ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights"/>
  <xs:element name="BonusSharesAndReverseShareSplitDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_BonusSharesAndReverseShareSplitDescription"/>
  <xs:element name="FiniteLivedIntangibleAssetAmortizationMethod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_FiniteLivedIntangibleAssetAmortizationMethod"/>
  <xs:element name="OperatingLeaseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_OperatingLeaseAssets"/>
  <xs:element name="WeightedAverageBorrowingRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="jfbr_WeightedAverageBorrowingRate"/>
  <xs:element name="AggregatesAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AggregatesAmount"/>
  <xs:element name="AggregateAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AggregateAmount"/>
  <xs:element name="PrincipalLoanAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_PrincipalLoanAmount"/>
  <xs:element name="ShortTermLineOfCredits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ShortTermLineOfCredits"/>
  <xs:element name="DerivativeLiabilitiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_DerivativeLiabilitiesDetailsTable"/>
  <xs:element name="DerivativeLiabilitiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_DerivativeLiabilitiesDetailsLineItems"/>
  <xs:element name="DerivativeLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_DerivativeLiability"/>
  <xs:element name="PublicOfferingPricePerShare" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_PublicOfferingPricePerShare"/>
  <xs:element name="AdditionalWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AdditionalWarrants"/>
  <xs:element name="RevenuesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_RevenuesPercentage"/>
  <xs:element name="RelatedPartyFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_RelatedPartyFairValue"/>
  <xs:element name="LoansfromShareholdersDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_LoansfromShareholdersDetailsTable"/>
  <xs:element name="LoansfromShareholdersDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_LoansfromShareholdersDetailsLineItems"/>
  <xs:element name="ShareCapitalDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_ShareCapitalDetailsTable"/>
  <xs:element name="ShareCapitalDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ShareCapitalDetailsLineItems"/>
  <xs:element name="AgreementDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AgreementDescription"/>
  <xs:element name="IssuedAndOutstandingShareCapitalPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IssuedAndOutstandingShareCapitalPercentage"/>
  <xs:element name="InvestAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_InvestAmount"/>
  <xs:element name="MinorityShareholderAmount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_MinorityShareholderAmount"/>
  <xs:element name="IssuanceOfPeriodTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IssuanceOfPeriodTerm"/>
  <xs:element name="IssuanceOfBonusShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IssuanceOfBonusShares"/>
  <xs:element name="AggregateIssuanceShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AggregateIssuanceShares"/>
  <xs:element name="GrossProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_GrossProceeds"/>
  <xs:element name="InitialExercisePriceExpire" type="xbrli:durationItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="jfbr_InitialExercisePriceExpire"/>
  <xs:element name="AdditionalWarrantTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AdditionalWarrantTerm"/>
  <xs:element name="AdditionalWarrantsDescription" type="xbrli:stringItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AdditionalWarrantsDescription"/>
  <xs:element name="ConsideredAsIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ConsideredAsIssuanceCosts"/>
  <xs:element name="RelatedPartiesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_RelatedPartiesDetailsTable"/>
  <xs:element name="RelatedPartiesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_RelatedPartiesDetailsLineItems"/>
  <xs:element name="Bonus" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_Bonus"/>
  <xs:element name="ConsultancyServicesFees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ConsultancyServicesFees"/>
  <xs:element name="PercentageOfGrossProceed" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_PercentageOfGrossProceed"/>
  <xs:element name="PercentageOfTotalConsiderationPaid" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_PercentageOfTotalConsiderationPaid"/>
  <xs:element name="UndefinedPeriodOfTime" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UndefinedPeriodOfTime"/>
  <xs:element name="PercentageLeaseAndMaintenanceExpensesRelated" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_PercentageLeaseAndMaintenanceExpensesRelated"/>
  <xs:element name="OutstandingPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_OutstandingPayable"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="jfbr_SubsequentEventsDetailsTable"/>
  <xs:element name="SubsequentEventsDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_SubsequentEventsDetailsLineItems"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage"/>
  <xs:element name="AdditionalDividendsPayableSharesValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AdditionalDividendsPayableSharesValue"/>
  <xs:element name="AmazoncomMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_AmazoncomMember"/>
  <xs:element name="BrandsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_BrandsMember"/>
  <xs:element name="ComputersEquipmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_ComputersEquipmentMember"/>
  <xs:element name="IPOWarrantMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IPOWarrantMember"/>
  <xs:element name="IssuanceDateMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_IssuanceDateMember"/>
  <xs:element name="JeffsBrandsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_JeffsBrandsMember"/>
  <xs:element name="MedigusMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_MedigusMember"/>
  <xs:element name="MinorityShareholderMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_MinorityShareholderMember"/>
  <xs:element name="MrHakmonAndLIAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_MrHakmonAndLIAMember"/>
  <xs:element name="MrHakmonMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_MrHakmonMember"/>
  <xs:element name="OwnershipMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_OwnershipMember"/>
  <xs:element name="PureCapitalLtdMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_PureCapitalLtdMember"/>
  <xs:element name="PurexCorpMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_PurexCorpMember"/>
  <xs:element name="SmartProMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_SmartProMember"/>
  <xs:element name="UnderwritersWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_UnderwritersWarrantsMember"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="jfbr_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>jfbr-20221231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 10 08:08:28 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedBalanceSheet" roleURI="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedIncomeStatement" roleURI="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedCashFlow" roleURI="http://www.jeffsbrands.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofotherreceivablesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofloansfromshareholdersconsistsTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofincometaxexpensebenefitTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofdilutedweightedaveragesharesoutstandingTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoftransactionswithinterestedandrelatedpartiesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofbalanceswithinterestedandrelatedpartiesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_InventoryNet" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_DeferredCosts" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLoansPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLoansPayableCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ShortTermBankLoansAndNotesPayable" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLoansPayableLongTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLoansPayableLongTerm"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OtherLoansPayableLongTerm" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GrossProfit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_SellingAndMarketingExpense" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="3" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense" order="4" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossAttributableToParent" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinancialincomeExpensesNet" xlink:href="jfbr-20221231.xsd#jfbr_FinancialincomeExpensesNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossAttributableToParent" xlink:to="jfbr_FinancialincomeExpensesNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossAttributableToParent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherDepreciationAndAmortization" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" xlink:href="jfbr-20221231.xsd#jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="8" weight="1"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZqAlP1yOSc1A/ANEzuo53ddr/LMBLom9FlRSK3NKkyEbonVWG5HPDY+G1lW3BvjVh1hGR4TsEWxikRSd2CzczjxOi38/JBT4C/OcGQ5Ko7wX9cWbP+EcSCjzoKw5UOEXtltIx6qGM8m+WHjAhoKAqHXg9v/7inBQezt5KwYVPvHGi+aa1see5Nnq1daHt5a30ipyLz3wTaQxpsH4mVO+wt] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceCostsOnDerivativeLiabilities" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceCostsOnDerivativeLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="jfbr_IssuanceCostsOnDerivativeLiabilities" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" order="12" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="13" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="14" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeasePayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShortTermLeasePayments" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="17" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="18" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="19" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromOtherShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherShortTermDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromOtherShortTermDebt" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromBankDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromBankDebt" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfOtherShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherShortTermDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfOtherShortTermDebt" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfBankDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfBankDebt" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PremiumsAndOtherReceivablesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Supplies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Supplies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PremiumsAndOtherReceivablesNet" xlink:to="us-gaap_Supplies" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentContractReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PremiumsAndOtherReceivablesNet" xlink:to="us-gaap_GovernmentContractReceivable" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PremiumsAndOtherReceivablesNet" xlink:to="us-gaap_OtherReceivables" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_LoansPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable">
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="jfbr_CurrentStateAndLocalTaxExpensesBenefit" xlink:href="jfbr-20221231.xsd#jfbr_CurrentStateAndLocalTaxExpensesBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="jfbr_CurrentStateAndLocalTaxExpensesBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <loc xlink:type="locator" xlink:label="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit" xlink:href="jfbr-20221231.xsd#jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable">
    <loc xlink:type="locator" xlink:label="jfbr_TotalDilutedWeightedAverageSharesOutstanding" xlink:href="jfbr-20221231.xsd#jfbr_TotalDilutedWeightedAverageSharesOutstanding"/>
    <loc xlink:type="locator" xlink:label="jfbr_IPOAndAdditionalWarrants" xlink:href="jfbr-20221231.xsd#jfbr_IPOAndAdditionalWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jfbr_TotalDilutedWeightedAverageSharesOutstanding" xlink:to="jfbr_IPOAndAdditionalWarrants" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnderwriterWarrants" xlink:href="jfbr-20221231.xsd#jfbr_UnderwriterWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jfbr_TotalDilutedWeightedAverageSharesOutstanding" xlink:to="jfbr_UnderwriterWarrants" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="jfbr_OtherWarrants" xlink:href="jfbr-20221231.xsd#jfbr_OtherWarrants"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="jfbr_TotalDilutedWeightedAverageSharesOutstanding" xlink:to="jfbr_OtherWarrants" order="3" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LaborAndRelatedExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_LaborAndRelatedExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseDirectorsFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseDirectorsFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_NoninterestExpenseDirectorsFees" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_ProfessionalFees" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders" xlink:href="jfbr-20221231.xsd#jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdvancesToSuppliers" xlink:href="jfbr-20221231.xsd#jfbr_AdvancesToSuppliers"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherAssets" xlink:to="jfbr_AdvancesToSuppliers" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansFromShareholders" xlink:href="jfbr-20221231.xsd#jfbr_LoansFromShareholders"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="jfbr_LoansFromShareholders" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_DueToOtherRelatedPartiesNoncurrent" order="3" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>jfbr-20221231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 10 08:08:28 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedBalanceSheet" roleURI="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedIncomeStatement" roleURI="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareholdersEquityType2or3" roleURI="http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedCashFlow" roleURI="http://www.jeffsbrands.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_GeneralInformation" roleURI="http://www.jeffsbrands.com/role/GeneralInformation"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_Otherreceivables" roleURI="http://www.jeffsbrands.com/role/Otherreceivables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_Inventory" roleURI="http://www.jeffsbrands.com/role/Inventory"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_IntangibleAssets" roleURI="http://www.jeffsbrands.com/role/IntangibleAssets"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_Leases" roleURI="http://www.jeffsbrands.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_OtherPayables" roleURI="http://www.jeffsbrands.com/role/OtherPayables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShortTermLoans" roleURI="http://www.jeffsbrands.com/role/ShortTermLoans"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_DerivativeLiabilities" roleURI="http://www.jeffsbrands.com/role/DerivativeLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_LoansfromShareholders" roleURI="http://www.jeffsbrands.com/role/LoansfromShareholders"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_TaxesonIncome" roleURI="http://www.jeffsbrands.com/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareCapital" roleURI="http://www.jeffsbrands.com/role/ShareCapital"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareIncentivePlan" roleURI="http://www.jeffsbrands.com/role/ShareIncentivePlan"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_FinanceIncomeExpenseNet" roleURI="http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_NetIncomeLossPerShareAttributabletoOrdinaryShareholders" roleURI="http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholders"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_RelatedParties" roleURI="http://www.jeffsbrands.com/role/RelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_SubsequentEvents" roleURI="http://www.jeffsbrands.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_AccountingPoliciesByPolicy" roleURI="http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_OtherreceivablesTables" roleURI="http://www.jeffsbrands.com/role/OtherreceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_InventoryTables" roleURI="http://www.jeffsbrands.com/role/InventoryTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_IntangibleAssetsTables" roleURI="http://www.jeffsbrands.com/role/IntangibleAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_LeasesTables" roleURI="http://www.jeffsbrands.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_OtherPayablesTables" roleURI="http://www.jeffsbrands.com/role/OtherPayablesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShortTermLoansTables" roleURI="http://www.jeffsbrands.com/role/ShortTermLoansTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_DerivativeLiabilitiesTables" roleURI="http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_LoansfromShareholdersTables" roleURI="http://www.jeffsbrands.com/role/LoansfromShareholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_TaxesonIncomeTables" roleURI="http://www.jeffsbrands.com/role/TaxesonIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareCapitalTables" roleURI="http://www.jeffsbrands.com/role/ShareCapitalTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_FinanceIncomeExpenseNetTables" roleURI="http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables" roleURI="http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_RelatedPartiesTables" roleURI="http://www.jeffsbrands.com/role/RelatedPartiesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofotherreceivablesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofinventoryTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofinventoryTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoftotalintangibleassetsTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoffutureleasepaymentsunderoperatingleasesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofotherpayablesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofshorttermloansTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoffairvalueofthederivativewarrantliabilityTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofloansfromshareholdersconsistsTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofincomelossbeforetaxesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofincometaxexpensebenefitTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofdeferredtaxesassetsandliabilitiesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofsharecapitalcomposedofordinarysharesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofsharecapitalcomposedofordinarysharesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoffinanceincomeexpensesnetTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals" roleURI="http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofdilutedweightedaveragesharesoutstandingTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoftransactionswithinterestedandrelatedpartiesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofbalanceswithinterestedandrelatedpartiesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_GeneralInformationDetails" roleURI="http://www.jeffsbrands.com/role/GeneralInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_OtherreceivablesDetails" roleURI="http://www.jeffsbrands.com/role/OtherreceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_IntangibleAssetsDetails" roleURI="http://www.jeffsbrands.com/role/IntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_LeasesDetails" roleURI="http://www.jeffsbrands.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShortTermLoansDetails" roleURI="http://www.jeffsbrands.com/role/ShortTermLoansDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_DerivativeLiabilitiesDetails" roleURI="http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_LoansfromShareholdersDetails" roleURI="http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_TaxesonIncomeDetails" roleURI="http://www.jeffsbrands.com/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareCapitalDetails" roleURI="http://www.jeffsbrands.com/role/ShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareIncentivePlanDetails" roleURI="http://www.jeffsbrands.com/role/ShareIncentivePlanDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_RelatedPartiesDetails" roleURI="http://www.jeffsbrands.com/role/RelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_SubsequentEventsDetails" roleURI="http://www.jeffsbrands.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#DocumentAndEntityInformation" roleURI="http://www.jeffsbrands.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_NonCurrentAssetsAbstract" xlink:href="jfbr-20221231.xsd#jfbr_NonCurrentAssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="jfbr_NonCurrentAssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentAssetsAbstract" xlink:to="us-gaap_DeferredCosts" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentAssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentAssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentAssetsAbstract" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentAssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentAssetsAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLoansPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLoansPayableCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ShortTermBankLoansAndNotesPayable" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_NonCurrentLiabilitiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_NonCurrentLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="jfbr_NonCurrentLiabilitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLoansPayableLongTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLoansPayableLongTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_OtherLoansPayableLongTerm" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockNoParValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinancialincomeExpensesNet" xlink:href="jfbr-20221231.xsd#jfbr_FinancialincomeExpensesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="jfbr_FinancialincomeExpensesNet" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossAttributableToParent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" xlink:href="jfbr-20221231.xsd#jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares" xlink:href="jfbr-20221231.xsd#jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherDepreciationAndAmortization" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" xlink:href="jfbr-20221231.xsd#jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShortTermLeasePayments" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceCostsOnDerivativeLiabilities" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceCostsOnDerivativeLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="jfbr_IssuanceCostsOnDerivativeLiabilities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromOtherShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherShortTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromOtherShortTermDebt" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfOtherShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherShortTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfOtherShortTermDebt" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromBankDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromBankDebt" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfBankDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfBankDebt" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_InterestPaidNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_DeferredOfferingCostsIncludedInOtherPayables" xlink:href="jfbr-20221231.xsd#jfbr_DeferredOfferingCostsIncludedInOtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="jfbr_DeferredOfferingCostsIncludedInOtherPayables" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts" xlink:href="jfbr-20221231.xsd#jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity" xlink:href="jfbr-20221231.xsd#jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:href="jfbr-20221231.xsd#jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/GeneralInformation">
    <loc xlink:type="locator" xlink:label="jfbr_GeneralInformationAbstract" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="jfbr_GeneralInformationTextBlock" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationAbstract" xlink:to="jfbr_GeneralInformationTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/Otherreceivables">
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/Inventory">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/IntangibleAssets">
    <loc xlink:type="locator" xlink:label="jfbr_IntangibleAssetsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_IntangibleAssetsTable" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_IntangibleAssetsLineItems" xlink:to="jfbr_IntangibleAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_IntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/Leases">
    <loc xlink:type="locator" xlink:label="jfbr_LeasesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LeasesLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_LeasesTable" xlink:href="jfbr-20221231.xsd#jfbr_LeasesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_LeasesLineItems" xlink:to="jfbr_LeasesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LeasesLineItems" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/OtherPayables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShortTermLoans">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ShortTermDebtTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/DerivativeLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/LoansfromShareholders">
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersTable" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_LoansfromShareholdersLineItems" xlink:to="jfbr_LoansfromShareholdersTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersLineItems" xlink:to="us-gaap_DebtDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/TaxesonIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareCapital">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareIncentivePlan">
    <loc xlink:type="locator" xlink:label="jfbr_ShareIncentivePlanLineItems" xlink:href="jfbr-20221231.xsd#jfbr_ShareIncentivePlanLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShareIncentivePlanTable" xlink:href="jfbr-20221231.xsd#jfbr_ShareIncentivePlanTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_ShareIncentivePlanLineItems" xlink:to="jfbr_ShareIncentivePlanTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareIncentivePlanLineItems" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet">
    <loc xlink:type="locator" xlink:label="jfbr_FinanceIncomeExpenseNetLineItems" xlink:href="jfbr-20221231.xsd#jfbr_FinanceIncomeExpenseNetLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceIncomeExpenseNetTable" xlink:href="jfbr-20221231.xsd#jfbr_FinanceIncomeExpenseNetTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_FinanceIncomeExpenseNetLineItems" xlink:to="jfbr_FinanceIncomeExpenseNetTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceIncomeExpenseNetLineItems" xlink:to="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholders">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/RelatedParties">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionCustomerAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionCustomerAcquisitions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionCustomerAcquisitions" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PolicyLoansReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyLoansReceivablePolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PolicyLoansReceivablePolicy" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/OtherreceivablesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/InventoryTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/IntangibleAssetsTables">
    <loc xlink:type="locator" xlink:label="jfbr_IntangibleAssetsTablesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_IntangibleAssetsTablesTable" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_IntangibleAssetsTablesLineItems" xlink:to="jfbr_IntangibleAssetsTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_IntangibleAssetsTablesLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/OtherPayablesTables">
    <loc xlink:type="locator" xlink:label="jfbr_OtherPayablesTablesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_OtherPayablesTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_OtherPayablesTablesTable" xlink:href="jfbr-20221231.xsd#jfbr_OtherPayablesTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_OtherPayablesTablesLineItems" xlink:to="jfbr_OtherPayablesTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_OtherPayablesTablesLineItems" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShortTermLoansTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/LoansfromShareholdersTables">
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersTablesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersTablesTable" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_LoansfromShareholdersTablesLineItems" xlink:to="jfbr_LoansfromShareholdersTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersTablesLineItems" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/TaxesonIncomeTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareCapitalTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_BankingAndThriftInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankingAndThriftInterestAbstract"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BankingAndThriftInterestAbstract" xlink:to="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/RelatedPartiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ComputersEquipmentMember" xlink:href="jfbr-20221231.xsd#jfbr_ComputersEquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jfbr_ComputersEquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfOtherReceivablesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Supplies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Supplies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfOtherReceivablesAbstract" xlink:to="us-gaap_Supplies" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentContractReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfOtherReceivablesAbstract" xlink:to="us-gaap_GovernmentContractReceivable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfOtherReceivablesAbstract" xlink:to="us-gaap_OtherReceivables" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PremiumsAndOtherReceivablesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfOtherReceivablesAbstract" xlink:to="us-gaap_PremiumsAndOtherReceivablesNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofinventoryTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfInventoryAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfInventoryAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInventoryInTransit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventoryInTransit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfInventoryAbstract" xlink:to="us-gaap_OtherInventoryInTransit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfInventoryAbstract" xlink:to="us-gaap_InventoryFinishedGoods" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfInventoryAbstract" xlink:to="us-gaap_InventoryGross" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_BrandsMember" xlink:href="jfbr-20221231.xsd#jfbr_BrandsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="jfbr_BrandsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_FutureOperatingLeasePayments" xlink:href="jfbr-20221231.xsd#jfbr_FutureOperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="jfbr_FutureOperatingLeasePayments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivableWithImputedInterestDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableWithImputedInterestDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_ReceivableWithImputedInterestDiscount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_PresentValueOfLeaseLiability" xlink:href="jfbr-20221231.xsd#jfbr_PresentValueOfLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="jfbr_PresentValueOfLeaseLiability" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfOtherPayablesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfOtherPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfOtherPayablesAbstract" xlink:to="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfOtherPayablesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfOtherPayablesAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfOtherPayablesAbstract" xlink:to="us-gaap_InterestPayableCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AccruedExpensesAndOtherPayables" xlink:href="jfbr-20221231.xsd#jfbr_AccruedExpensesAndOtherPayables"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfOtherPayablesAbstract" xlink:to="jfbr_AccruedExpensesAndOtherPayables" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfOtherPayablesAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfShortTermLoansAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfShortTermLoansAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfShortTermLoansAbstract" xlink:to="us-gaap_LoansPayable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansAndLeasesReceivableRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedParties"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfShortTermLoansAbstract" xlink:to="us-gaap_LoansAndLeasesReceivableRelatedParties" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ThirdPartyLoan" xlink:href="jfbr-20221231.xsd#jfbr_ThirdPartyLoan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfShortTermLoansAbstract" xlink:to="jfbr_ThirdPartyLoan" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfShortTermLoansAbstract" xlink:to="us-gaap_ShortTermBorrowings" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract"/>
    <loc xlink:type="locator" xlink:label="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:href="jfbr-20221231.xsd#jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty" xlink:href="jfbr-20221231.xsd#jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ChangeInFairValue" xlink:href="jfbr-20221231.xsd#jfbr_ChangeInFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="jfbr_ChangeInFairValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable">
    <loc xlink:type="locator" xlink:label="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_SharePrice" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfWeightedAverageCostInventory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract" xlink:to="us-gaap_LoansPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable">
    <loc xlink:type="locator" xlink:label="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable" xlink:href="jfbr-20221231.xsd#jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems" xlink:to="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="country_IL" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="jfbr_CurrentStateAndLocalTaxExpensesBenefit" xlink:href="jfbr-20221231.xsd#jfbr_CurrentStateAndLocalTaxExpensesBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="jfbr_CurrentStateAndLocalTaxExpensesBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_DeferredAbstract" xlink:href="jfbr-20221231.xsd#jfbr_DeferredAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="jfbr_DeferredAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit" xlink:href="jfbr-20221231.xsd#jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DeferredAbstract" xlink:to="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DeferredAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZqAlP1yOSc1A/ANEzuo53ddr/LMBLom9FlRSK3NKkyEbonVWG5HPDY+G1lW3BvjVh1hGR4TsEWxikRSd2CzczjxOi38/JBT4C/OcGQ5Ko7wX9cWbP+EcSCjzoKw5UOEXtltIx6qGM8m+WHjAhoKAqHXg9v/7inBQezt5KwYVPvHGi+aa1see5Nnq1daHt5a30T4G8t30Po9pmFPw83br61] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="jfbr_DeferredTaxAssetAbstract" xlink:href="jfbr-20221231.xsd#jfbr_DeferredTaxAssetAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="jfbr_DeferredTaxAssetAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DeferredTaxAssetAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DeferredTaxAssetAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DeferredTaxAssetAbstract" xlink:to="us-gaap_OperatingLossCarryforwards" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans" xlink:href="jfbr-20221231.xsd#jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesOther" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofsharecapitalcomposedofordinarysharesTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceIncomeAbstract" xlink:href="jfbr-20221231.xsd#jfbr_FinanceIncomeAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract" xlink:to="jfbr_FinanceIncomeAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceIncomeAbstract" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceIncomeAbstract" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceIncomeAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceExpenseAbstract" xlink:href="jfbr-20221231.xsd#jfbr_FinanceExpenseAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract" xlink:to="jfbr_FinanceExpenseAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceExpensesInRespectOfThirdpartyLoan" xlink:href="jfbr-20221231.xsd#jfbr_FinanceExpensesInRespectOfThirdpartyLoan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceExpenseAbstract" xlink:to="jfbr_FinanceExpensesInRespectOfThirdpartyLoan" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceExpenseAbstract" xlink:to="us-gaap_IncreaseDecreaseInDerivativeLiabilities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceExpenseAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceExpenseAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceExpenseAbstract" xlink:to="us-gaap_InterestExpenseRelatedParty" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingExpense" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceExpenseAbstract" xlink:to="us-gaap_OtherTaxExpenseBenefit" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceExpenseNet" xlink:href="jfbr-20221231.xsd#jfbr_FinanceExpenseNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_FinanceExpenseAbstract" xlink:to="jfbr_FinanceExpenseNet" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="us-gaap_WeightedAverageBasicSharesOutstandingProForma" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedProFormaAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedProFormaAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="us-gaap_EarningsPerShareDilutedProFormaAdjustment" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedProFormaAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedProFormaAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="us-gaap_EarningsPerShareDilutedProFormaAdjustment" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="jfbr_IPOAndAdditionalWarrants" xlink:href="jfbr-20221231.xsd#jfbr_IPOAndAdditionalWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:to="jfbr_IPOAndAdditionalWarrants" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnderwriterWarrants" xlink:href="jfbr-20221231.xsd#jfbr_UnderwriterWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:to="jfbr_UnderwriterWarrants" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_OtherWarrants" xlink:href="jfbr-20221231.xsd#jfbr_OtherWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:to="jfbr_OtherWarrants" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_TotalDilutedWeightedAverageSharesOutstanding" xlink:href="jfbr-20221231.xsd#jfbr_TotalDilutedWeightedAverageSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:to="jfbr_TotalDilutedWeightedAverageSharesOutstanding" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LaborAndRelatedExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_LaborAndRelatedExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseDirectorsFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseDirectorsFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_NoninterestExpenseDirectorsFees" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_ProfessionalFees" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders" xlink:href="jfbr-20221231.xsd#jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable">
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="jfbr_AssetsAbstract0" xlink:href="jfbr-20221231.xsd#jfbr_AssetsAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:to="jfbr_AssetsAbstract0" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdvancesToSuppliers" xlink:href="jfbr-20221231.xsd#jfbr_AdvancesToSuppliers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_AssetsAbstract0" xlink:to="jfbr_AdvancesToSuppliers" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_OtherAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansFromShareholders" xlink:href="jfbr-20221231.xsd#jfbr_LoansFromShareholders"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="jfbr_LoansFromShareholders" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_DueToOtherRelatedPartiesNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_OtherLiabilities" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/GeneralInformationDetails">
    <loc xlink:type="locator" xlink:label="jfbr_GeneralInformationDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_GeneralInformationDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="jfbr_GeneralInformationDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_GeneralInformationDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_GeneralInformationDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_GeneralInformationDetailsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_GeneralInformationDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_SmartProMember" xlink:href="jfbr-20221231.xsd#jfbr_SmartProMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="jfbr_SmartProMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_PurexCorpMember" xlink:href="jfbr-20221231.xsd#jfbr_PurexCorpMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="jfbr_PurexCorpMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_JeffsBrandsMember" xlink:href="jfbr-20221231.xsd#jfbr_JeffsBrandsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="jfbr_JeffsBrandsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_MrHakmonMember" xlink:href="jfbr-20221231.xsd#jfbr_MrHakmonMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="jfbr_MrHakmonMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_IPOWarrantMember" xlink:href="jfbr-20221231.xsd#jfbr_IPOWarrantMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="jfbr_IPOWarrantMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnderwritersWarrantsMember" xlink:href="jfbr-20221231.xsd#jfbr_UnderwritersWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="jfbr_UnderwritersWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ExercisePriceAdjustment" xlink:href="jfbr-20221231.xsd#jfbr_ExercisePriceAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="jfbr_ExercisePriceAdjustment" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ClassOfAdditionalWarrantOrRightOutstanding" xlink:href="jfbr-20221231.xsd#jfbr_ClassOfAdditionalWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="jfbr_ClassOfAdditionalWarrantOrRightOutstanding" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_NetProceedsOfWarrants" xlink:href="jfbr-20221231.xsd#jfbr_NetProceedsOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="jfbr_NetProceedsOfWarrants" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights" xlink:href="jfbr-20221231.xsd#jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_BonusSharesAndReverseShareSplitDescription" xlink:href="jfbr-20221231.xsd#jfbr_BonusSharesAndReverseShareSplitDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="jfbr_BonusSharesAndReverseShareSplitDescription" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaturityOfTimeDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturityOfTimeDeposits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MaturityOfTimeDeposits" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredOfferingCosts" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingAndMarketingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OtherSellingAndMarketingExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/OtherreceivablesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAdditionalCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAdditionalCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_OtherAdditionalCapital" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/IntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_AdjustmentForAmortization" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_FiniteLivedIntangibleAssetAmortizationMethod" xlink:href="jfbr-20221231.xsd#jfbr_FiniteLivedIntangibleAssetAmortizationMethod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="jfbr_FiniteLivedIntangibleAssetAmortizationMethod" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/LeasesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_OperatingLeaseAssets" xlink:href="jfbr-20221231.xsd#jfbr_OperatingLeaseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="jfbr_OperatingLeaseAssets" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_WeightedAverageBorrowingRate" xlink:href="jfbr-20221231.xsd#jfbr_WeightedAverageBorrowingRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="jfbr_WeightedAverageBorrowingRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShortTermLoansDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="jfbr_AggregatesAmount" xlink:href="jfbr-20221231.xsd#jfbr_AggregatesAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="jfbr_AggregatesAmount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForPreviousAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPreviousAcquisition"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_PaymentsForPreviousAcquisition" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtPercentageBearingFixedInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LoansPayable" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AggregateAmount" xlink:href="jfbr-20221231.xsd#jfbr_AggregateAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="jfbr_AggregateAmount" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_PrincipalLoanAmount" xlink:href="jfbr-20221231.xsd#jfbr_PrincipalLoanAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="jfbr_PrincipalLoanAmount" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ShorttermDebtFairValue" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtCurrent" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_OtherExpenses" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtPercentageBearingVariableInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShortTermLineOfCredits" xlink:href="jfbr-20221231.xsd#jfbr_ShortTermLineOfCredits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="jfbr_ShortTermLineOfCredits" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LinesOfCreditCurrent" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_DerivativeLiabilitiesDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="jfbr_DerivativeLiabilitiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_DerivativeLiabilitiesDetailsTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeContractTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_DerivativeLiabilitiesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_DerivativeLiabilitiesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceDateMember" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceDateMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="jfbr_IssuanceDateMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnderwritersWarrantsMember" xlink:href="jfbr-20221231.xsd#jfbr_UnderwritersWarrantsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="jfbr_UnderwritersWarrantsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ThirdPartyLoan" xlink:href="jfbr-20221231.xsd#jfbr_ThirdPartyLoan"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="jfbr_ThirdPartyLoan" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_DerivativeLiability" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="jfbr_DerivativeLiability" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_PublicOfferingPricePerShare" xlink:href="jfbr-20221231.xsd#jfbr_PublicOfferingPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="jfbr_PublicOfferingPricePerShare" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_ExcessStockSharesIssued" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceDecrease" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdditionalWarrants" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="jfbr_AdditionalWarrants" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAsset" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeCostOfHedgeNetOfCashReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCostOfHedgeNetOfCashReceived"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_DerivativeCostOfHedgeNetOfCashReceived" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_RevenuesPercentage" xlink:href="jfbr-20221231.xsd#jfbr_RevenuesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="jfbr_RevenuesPercentage" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_RelatedPartyFairValue" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartyFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="jfbr_RelatedPartyFairValue" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet" order="18" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/LoansfromShareholdersDetails">
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="jfbr_LoansfromShareholdersDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_LoansfromShareholdersDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_LoansfromShareholdersDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_LoansfromShareholdersDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_LoansfromShareholdersDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AmazoncomMember" xlink:href="jfbr-20221231.xsd#jfbr_AmazoncomMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="jfbr_AmazoncomMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_MedigusMember" xlink:href="jfbr-20221231.xsd#jfbr_MedigusMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="jfbr_MedigusMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_MrHakmonAndLIAMember" xlink:href="jfbr-20221231.xsd#jfbr_MrHakmonAndLIAMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="jfbr_MrHakmonAndLIAMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_PureCapitalLtdMember" xlink:href="jfbr-20221231.xsd#jfbr_PureCapitalLtdMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="jfbr_PureCapitalLtdMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_LineOfCredit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_LongTermDebt" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlanFundedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DefinedBenefitPlanFundedPercentage" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_InvestmentInterestRate" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedTrademarksGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedTrademarksGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_FiniteLivedTrademarksGross" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_InventoryNoncurrent" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherMinorityInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherMinorityInterests"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_OtherMinorityInterests" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseOtherShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseOtherShortTermBorrowings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_InterestExpenseOtherShortTermBorrowings" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipalAmountOutstandingOnLoansSecuritized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DividendsCommonStock" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_StockholdersEquityPeriodIncreaseDecrease" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest" order="19" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/TaxesonIncomeDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareCapitalDetails">
    <loc xlink:type="locator" xlink:label="jfbr_ShareCapitalDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_ShareCapitalDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShareCapitalDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_ShareCapitalDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_ShareCapitalDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_ShareCapitalDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_ShareCapitalDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_ShareCapitalDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_ShareCapitalDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_ShareCapitalDetailsTable" xlink:to="srt_RangeAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_ShareCapitalDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_OverAllotmentOptionMember" order="1" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MajorityShareholderMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MajorityShareholderMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_MajorityShareholderMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AgreementDescription" xlink:href="jfbr-20221231.xsd#jfbr_AgreementDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_AgreementDescription" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuedAndOutstandingShareCapitalPercentage" xlink:href="jfbr-20221231.xsd#jfbr_IssuedAndOutstandingShareCapitalPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_IssuedAndOutstandingShareCapitalPercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_InvestAmount" xlink:href="jfbr-20221231.xsd#jfbr_InvestAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_InvestAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_SharesIssued" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_MinorityShareholderAmount" xlink:href="jfbr-20221231.xsd#jfbr_MinorityShareholderAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_MinorityShareholderAmount" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_PaymentsOfDividendsCommonStock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceOfPeriodTerm" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceOfPeriodTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_IssuanceOfPeriodTerm" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceOfBonusShares" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceOfBonusShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_IssuanceOfBonusShares" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AggregateIssuanceShares" xlink:href="jfbr-20221231.xsd#jfbr_AggregateIssuanceShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_AggregateIssuanceShares" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_GrossProceeds" xlink:href="jfbr-20221231.xsd#jfbr_GrossProceeds"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_GrossProceeds" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_InitialExercisePriceExpire" xlink:href="jfbr-20221231.xsd#jfbr_InitialExercisePriceExpire"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_InitialExercisePriceExpire" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionExercisePriceDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_StockOptionExercisePriceDecrease" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionExercisePriceIncrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_StockOptionExercisePriceIncrease" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdditionalWarrantTerm" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalWarrantTerm"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_AdditionalWarrantTerm" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_RevenuesPercentage" xlink:href="jfbr-20221231.xsd#jfbr_RevenuesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_RevenuesPercentage" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdditionalWarrantsDescription" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalWarrantsDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_AdditionalWarrantsDescription" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ConsideredAsIssuanceCosts" xlink:href="jfbr-20221231.xsd#jfbr_ConsideredAsIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_ConsideredAsIssuanceCosts" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="29" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareIncentivePlanDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/RelatedPartiesDetails">
    <loc xlink:type="locator" xlink:label="jfbr_RelatedPartiesDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartiesDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_RelatedPartiesDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartiesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="jfbr_RelatedPartiesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_RelatedPartiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_RelatedPartiesDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_MinorityShareholderMember" xlink:href="jfbr-20221231.xsd#jfbr_MinorityShareholderMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="jfbr_MinorityShareholderMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="us-gaap_SharesIssued" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_RelatedPartyFairValue" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartyFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="jfbr_RelatedPartyFairValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="us-gaap_AccruedPayrollTaxesCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalariesWagesAndOfficersCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesWagesAndOfficersCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="us-gaap_SalariesWagesAndOfficersCompensation" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_Bonus" xlink:href="jfbr-20221231.xsd#jfbr_Bonus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="jfbr_Bonus" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ConsultancyServicesFees" xlink:href="jfbr-20221231.xsd#jfbr_ConsultancyServicesFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="jfbr_ConsultancyServicesFees" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_PercentageOfGrossProceed" xlink:href="jfbr-20221231.xsd#jfbr_PercentageOfGrossProceed"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="jfbr_PercentageOfGrossProceed" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_PercentageOfTotalConsiderationPaid" xlink:href="jfbr-20221231.xsd#jfbr_PercentageOfTotalConsiderationPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="jfbr_PercentageOfTotalConsiderationPaid" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_UndefinedPeriodOfTime" xlink:href="jfbr-20221231.xsd#jfbr_UndefinedPeriodOfTime"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="jfbr_UndefinedPeriodOfTime" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToSuppliers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="us-gaap_PaymentsToSuppliers" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_PercentageLeaseAndMaintenanceExpensesRelated" xlink:href="jfbr-20221231.xsd#jfbr_PercentageLeaseAndMaintenanceExpensesRelated"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="jfbr_PercentageLeaseAndMaintenanceExpensesRelated" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLaborRelatedExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLaborRelatedExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="us-gaap_OtherLaborRelatedExpenses" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_OutstandingPayable" xlink:href="jfbr-20221231.xsd#jfbr_OutstandingPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="jfbr_OutstandingPayable" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="us-gaap_RelatedPartyCosts" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeRelatedParty"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="us-gaap_InterestIncomeRelatedParty" order="16" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="jfbr_SubsequentEventsDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_SubsequentEventsDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="jfbr_SubsequentEventsDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_SubsequentEventsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="jfbr_SubsequentEventsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_SubsequentEventsDetailsTable" xlink:to="srt_OwnershipAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain_0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="jfbr_SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_OwnershipMember" xlink:href="jfbr-20221231.xsd#jfbr_OwnershipMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="jfbr_OwnershipMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockOtherSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_CommonStockOtherSharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage" xlink:href="jfbr-20221231.xsd#jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage" xlink:href="jfbr-20221231.xsd#jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdditionalDividendsPayableSharesValue" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalDividendsPayableSharesValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="jfbr_AdditionalDividendsPayableSharesValue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MembersCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MembersCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_MembersCapital" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFeeAmount" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalAccountReturnOfCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountReturnOfCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="us-gaap_PartnersCapitalAccountReturnOfCapital" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain_0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="39" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="40" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>jfbr-20221231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 10 08:08:28 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total non-current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total non-current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">TOTAL SHAREHOLDERS&#8217; EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossAttributableToParent_lbl" xml:lang="en-US">Profit (loss) before taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossAttributableToParent" xlink:to="us-gaap_IncomeLossAttributableToParent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Profit (loss) for the year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US">Net profit (loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_NetIncomeLoss_lbl2" xml:lang="en-US">Net loss (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl2"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash from (used in) operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net cash provided by (Used in) operating activities (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash from financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">NET INCREASE IN CASH AND CASH EQUIVALENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">CASH AND CASH EQUIVALENTS AT END OF THE YEAR</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PremiumsAndOtherReceivablesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PremiumsAndOtherReceivablesNet_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PremiumsAndOtherReceivablesNet" xlink:to="us-gaap_PremiumsAndOtherReceivablesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Disclosure Of Intangible Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockAbstract_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_DisclosureTextBlockAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Schedule of Other Payables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Short-Term Loans [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:href="jfbr-20221231.xsd#jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Balance at beginning</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:to="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl0" xml:lang="en-US">Balance at ending</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:to="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total current income tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xml:lang="en-US">Total deferred tax income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total tax (benefit) expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Tax (benefit) expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share Incentive Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BankingAndThriftInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankingAndThriftInterestAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BankingAndThriftInterestAbstract_lbl" xml:lang="en-US">Finance (Income) Expenses, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BankingAndThriftInterestAbstract" xlink:to="us-gaap_BankingAndThriftInterestAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_TotalDilutedWeightedAverageSharesOutstanding" xlink:href="jfbr-20221231.xsd#jfbr_TotalDilutedWeightedAverageSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="jfbr_TotalDilutedWeightedAverageSharesOutstanding_lbl" xml:lang="en-US">Total diluted weighted average shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_TotalDilutedWeightedAverageSharesOutstanding" xlink:to="jfbr_TotalDilutedWeightedAverageSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl" xml:lang="en-US">Total transactions with interested and related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_ContactPersonnelEmailAddress_lbl" xml:lang="en-US">Contact Personnel Email Address</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_NonCurrentAssetsAbstract" xlink:href="jfbr-20221231.xsd#jfbr_NonCurrentAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_NonCurrentAssetsAbstract_lbl" xml:lang="en-US">NON-CURRENT ASSETS:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_NonCurrentAssetsAbstract" xlink:to="jfbr_NonCurrentAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredCosts_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCosts" xlink:to="us-gaap_DeferredCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US">Deferred taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract" xlink:to="jfbr_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_LiabilitiesAndEquityAbstract" xlink:href="jfbr-20221231.xsd#jfbr_LiabilitiesAndEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_LiabilitiesAndEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND EQUITY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LiabilitiesAndEquityAbstract" xlink:to="jfbr_LiabilitiesAndEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract0" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract0" xlink:to="jfbr_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Trade payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLoansPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLoansPayableCurrent_lbl" xml:lang="en-US">Other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLoansPayableCurrent" xlink:to="us-gaap_OtherLoansPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl" xml:lang="en-US">Related party payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable_lbl" xml:lang="en-US">Short-term loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:to="us-gaap_ShortTermBankLoansAndNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_NonCurrentLiabilitiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_NonCurrentLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_NonCurrentLiabilitiesAbstract_lbl" xml:lang="en-US">NON-CURRENT LIABILITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_NonCurrentLiabilitiesAbstract" xlink:to="jfbr_NonCurrentLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLoansPayableLongTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLoansPayableLongTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLoansPayableLongTerm_lbl" xml:lang="en-US">Loans from shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLoansPayableLongTerm" xlink:to="us-gaap_OtherLoansPayableLongTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl" xml:lang="en-US">Derivative liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl0" xml:lang="en-US">Financial liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xml:lang="en-US">Deferred taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract1" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract1_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract1" xlink:to="jfbr_UnlabeledAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS&#8217; EQUITY:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Ordinary shares of no par value per share - Authorized: 43,567,567 and 4,356,757 shares as of December 31, 2022, and December 31, 2021, respectively; Issued and outstanding: 8,074,217 shares as of December 31, 2022; 2,893,125 shares as of December 31, 2021</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockNoParValue_lbl" xml:lang="en-US">Ordinary shares, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Ordinary shares, Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Ordinary shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Common Stock, Shares, Issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares, outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in-capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Accumulated deficit	(in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract2" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract2_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract2" xlink:to="jfbr_UnlabeledAbstract2_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract3" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract3_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract3" xlink:to="jfbr_UnlabeledAbstract3_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract4" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract4"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract4_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract4" xlink:to="jfbr_UnlabeledAbstract4_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Other expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract5" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract5"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract5_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract5" xlink:to="jfbr_UnlabeledAbstract5_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract6" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract6"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract6_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract6" xlink:to="jfbr_UnlabeledAbstract6_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract7" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract7"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract7_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract7" xlink:to="jfbr_UnlabeledAbstract7_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract8" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract8"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract8_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract8" xlink:to="jfbr_UnlabeledAbstract8_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract9" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract9"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract9_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract9" xlink:to="jfbr_UnlabeledAbstract9_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract10" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract10"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract10_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract10" xlink:to="jfbr_UnlabeledAbstract10_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic and diluted net profit (loss) attributable to shareholders per ordinary share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted net profit (loss) attributable to shareholders per ordinary share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract11" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract11"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract11_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract11" xlink:to="jfbr_UnlabeledAbstract11_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted-average ordinary shares used in computing net profit (loss) per share, basic and diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted-average ordinary shares used in computing net profit (loss) per share, diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Transactions with shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Share-based compensation to service provider</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Share-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium_lbl" xml:lang="en-US">Debt extinguishment of shareholders&#8217; loans (Note 10d)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" xlink:to="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" xlink:href="jfbr-20221231.xsd#jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts_lbl" xml:lang="en-US">Issuance of ordinary shares upon initial public offering, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" xlink:to="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares" xlink:href="jfbr-20221231.xsd#jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares_lbl" xml:lang="en-US">Issuance of ordinary shares upon initial public offering, net of issuance costs (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares" xlink:to="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Issuance of warrants to third party upon initial public offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xml:lang="en-US">Conversion of shareholder loans (Note 12i)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Conversion of shareholder loans (Note 12i) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US">Reclassification of derivative warrant liabilities to equity (Note 9c)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net profit (loss) to net cash from (used in) operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Depreciation and amortization of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xml:lang="en-US">Impairment of intangible asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Accrued interest and amortization of discount on third party loans (Note 8)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Change in fair value of derivative liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl0" xml:lang="en-US">Fair value warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" xlink:href="jfbr-20221231.xsd#jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans_lbl" xml:lang="en-US">Accrued interest and amortization of discount on related party and shareholders&#8217; loans (Note 8)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" xlink:to="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Benefit for deferred taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xml:lang="en-US">Operating lease right-of-use assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceCostsOnDerivativeLiabilities" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceCostsOnDerivativeLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_IssuanceCostsOnDerivativeLiabilities_lbl" xml:lang="en-US">Issuance costs on derivative liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceCostsOnDerivativeLiabilities" xlink:to="jfbr_IssuanceCostsOnDerivativeLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl" xml:lang="en-US">Decrease (increase) related party balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent_lbl" xml:lang="en-US">Increase (decrease) related party liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Increase (decrease) accounts payable and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Decrease in operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract12" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract12"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract12_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract12" xlink:to="jfbr_UnlabeledAbstract12_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS USED IN INVESTING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract13" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract13"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract13_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract13" xlink:to="jfbr_UnlabeledAbstract13_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromOtherShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherShortTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromOtherShortTermDebt_lbl" xml:lang="en-US">Short-term loan received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromOtherShortTermDebt" xlink:to="us-gaap_ProceedsFromOtherShortTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xml:lang="en-US">Proceeds from initial public offering, net of issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0" xml:lang="en-US">Net proceeds of IPO (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromBankDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromBankDebt_lbl" xml:lang="en-US">Loan received from shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromBankDebt" xlink:to="us-gaap_ProceedsFromBankDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Loan received (repaid) from related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Issuance of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract14" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract14"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract14_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract14" xlink:to="jfbr_UnlabeledAbstract14_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract15" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract15"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract15_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract15" xlink:to="jfbr_UnlabeledAbstract15_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract16" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract16"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract16_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract16" xlink:to="jfbr_UnlabeledAbstract16_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Taxes paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Supplemental disclosure of noncash investing and financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DeferredOfferingCostsIncludedInOtherPayables" xlink:href="jfbr-20221231.xsd#jfbr_DeferredOfferingCostsIncludedInOtherPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_DeferredOfferingCostsIncludedInOtherPayables_lbl" xml:lang="en-US">Deferred offering costs included in other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DeferredOfferingCostsIncludedInOtherPayables" xlink:to="jfbr_DeferredOfferingCostsIncludedInOtherPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts" xlink:href="jfbr-20221231.xsd#jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts_lbl" xml:lang="en-US">Share-based compensation included in deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts" xlink:to="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans_lbl" xml:lang="en-US">Issuance of ordinary shares upon conversion of shareholders&#8217; loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans" xlink:to="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity" xlink:href="jfbr-20221231.xsd#jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity_lbl" xml:lang="en-US">Substantial modification of shareholders&#8217; loans recorded in equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity" xlink:to="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:href="jfbr-20221231.xsd#jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_lbl" xml:lang="en-US">Right of use assets obtained in exchange for lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:to="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinancialincomeExpensesNet" xlink:href="jfbr-20221231.xsd#jfbr_FinancialincomeExpensesNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="jfbr_FinancialincomeExpensesNet_lbl" xml:lang="en-US">Financial (income) expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinancialincomeExpensesNet" xlink:to="jfbr_FinancialincomeExpensesNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain from debt extinguishment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShortTermLeasePayments_lbl" xml:lang="en-US">Interest expense on short-term loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeasePayments" xlink:to="us-gaap_ShortTermLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Decrease (increase) in trade receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US">Decrease (increase) in other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Decrease (increase) in inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Purchase of intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfOtherShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherShortTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfOtherShortTermDebt_lbl" xml:lang="en-US">Short-term loan repaid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherShortTermDebt" xlink:to="us-gaap_RepaymentsOfOtherShortTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfBankDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfBankDebt_lbl" xml:lang="en-US">Loan repaid to shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfBankDebt" xlink:to="us-gaap_RepaymentsOfBankDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Ordinary Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Ordinary Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Ordinary Share [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional paid-in-capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained earnings (Accumulated deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_GeneralInformationTextBlock" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_GeneralInformationTextBlock_lbl" xml:lang="en-US">GENERAL INFORMATION</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_GeneralInformationTextBlock" xlink:to="jfbr_GeneralInformationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl" xml:lang="en-US">Property and equipment percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xml:lang="en-US">Property and equipment term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER RECEIVABLES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Supplies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Supplies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Supplies_lbl" xml:lang="en-US">Advances to suppliers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Supplies" xlink:to="us-gaap_Supplies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentContractReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GovernmentContractReceivable_lbl" xml:lang="en-US">Government institutions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GovernmentContractReceivable" xlink:to="us-gaap_GovernmentContractReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherReceivables_lbl" xml:lang="en-US">Other receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">schedule of inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInventoryInTransit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventoryInTransit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherInventoryInTransit_lbl" xml:lang="en-US">Goods in transit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventoryInTransit" xlink:to="us-gaap_OtherInventoryInTransit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryGross_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">INTANGIBLE ASSETS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of total intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Net Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">LEASES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of future lease payments under operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2023</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2024-2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FutureOperatingLeasePayments" xlink:href="jfbr-20221231.xsd#jfbr_FutureOperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_FutureOperatingLeasePayments_lbl" xml:lang="en-US">Total future operating lease payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FutureOperatingLeasePayments" xlink:to="jfbr_FutureOperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_PresentValueOfLeaseLiability" xlink:href="jfbr-20221231.xsd#jfbr_PresentValueOfLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_PresentValueOfLeaseLiability_lbl" xml:lang="en-US">Present value of lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PresentValueOfLeaseLiability" xlink:to="jfbr_PresentValueOfLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">OTHER PAYABLES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_lbl" xml:lang="en-US">Government institutions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" xlink:to="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employees and related benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Accrued Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AccruedExpensesAndOtherPayables" xlink:href="jfbr-20221231.xsd#jfbr_AccruedExpensesAndOtherPayables"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AccruedExpensesAndOtherPayables_lbl" xml:lang="en-US">Accrued expenses and other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AccruedExpensesAndOtherPayables" xlink:to="jfbr_AccruedExpensesAndOtherPayables_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract17" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract17"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract17_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract17" xlink:to="jfbr_UnlabeledAbstract17_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Total other payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermDebtTextBlock_lbl" xml:lang="en-US">SHORT-TERM LOANS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTextBlock" xlink:to="us-gaap_ShortTermDebtTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl" xml:lang="en-US">Schedule of short term loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansPayable_lbl" xml:lang="en-US">Loans with Amazon</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LoansPayable_lbl0" xml:lang="en-US">Outstanding loan amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansAndLeasesReceivableRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedParties"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansAndLeasesReceivableRelatedParties_lbl" xml:lang="en-US">Related party loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansAndLeasesReceivableRelatedParties" xlink:to="us-gaap_LoansAndLeasesReceivableRelatedParties_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ThirdPartyLoan" xlink:href="jfbr-20221231.xsd#jfbr_ThirdPartyLoan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ThirdPartyLoan_lbl" xml:lang="en-US">Third party loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ThirdPartyLoan" xlink:to="jfbr_ThirdPartyLoan_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jfbr_ThirdPartyLoan_lbl0" xml:lang="en-US">Loan from third parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ThirdPartyLoan" xlink:to="jfbr_ThirdPartyLoan_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Short term loans total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">DERIVATIVE LIABILITIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of fair value of the derivative warrant liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty" xlink:href="jfbr-20221231.xsd#jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty_lbl" xml:lang="en-US">Fair value of warrant liability to be issued to third-party upon IPO (note 9a)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty" xlink:to="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ChangeInFairValue" xlink:href="jfbr-20221231.xsd#jfbr_ChangeInFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ChangeInFairValue_lbl" xml:lang="en-US">Change in fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ChangeInFairValue" xlink:to="jfbr_ChangeInFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Issuance of warrants in connection with the IPO</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0" xml:lang="en-US">(in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1" xml:lang="en-US">Warrants issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Classification to additional paid in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of fair value of the IPO warrants and additional warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfWeightedAverageCostInventory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory_lbl" xml:lang="en-US">WACC</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">LOANS FROM SHAREHOLDERS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of loans from shareholders consists</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansPayableCurrent_lbl" xml:lang="en-US">Loan amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">TAXES ON INCOME</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Schedule of income (loss) before taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xml:lang="en-US">Income loss before taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract18" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract18"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract18_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract18" xlink:to="jfbr_UnlabeledAbstract18_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of income tax expense (benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_CurrentStateAndLocalTaxExpensesBenefit" xlink:href="jfbr-20221231.xsd#jfbr_CurrentStateAndLocalTaxExpensesBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_CurrentStateAndLocalTaxExpensesBenefit_lbl" xml:lang="en-US">Israel</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_CurrentStateAndLocalTaxExpensesBenefit" xlink:to="jfbr_CurrentStateAndLocalTaxExpensesBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DeferredAbstract" xlink:href="jfbr-20221231.xsd#jfbr_DeferredAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_DeferredAbstract_lbl" xml:lang="en-US">Deferred:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DeferredAbstract" xlink:to="jfbr_DeferredAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit" xlink:href="jfbr-20221231.xsd#jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit_lbl" xml:lang="en-US">Israel</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit" xlink:to="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of statutory income tax rate to effective income tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Income (loss) before taxes on income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Statutory tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl" xml:lang="en-US">Tax (tax benefit) computed at the statutory tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IncreaseDecreaseInTaxesOnIncomeResultingFromTheFollowingAbstract" xlink:href="jfbr-20221231.xsd#jfbr_IncreaseDecreaseInTaxesOnIncomeResultingFromTheFollowingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_IncreaseDecreaseInTaxesOnIncomeResultingFromTheFollowingAbstract_lbl" xml:lang="en-US">Increase (decrease) in taxes on income resulting from the following:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IncreaseDecreaseInTaxesOnIncomeResultingFromTheFollowingAbstract" xlink:to="jfbr_IncreaseDecreaseInTaxesOnIncomeResultingFromTheFollowingAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Tax rate differences applicable to subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_lbl" xml:lang="en-US">Tax losses and timing differences for which deferred taxes were not recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Taxes on income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of deferred taxes assets and liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DeferredTaxAssetAbstract" xlink:href="jfbr-20221231.xsd#jfbr_DeferredTaxAssetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_DeferredTaxAssetAbstract_lbl" xml:lang="en-US">Deferred tax asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DeferredTaxAssetAbstract" xlink:to="jfbr_DeferredTaxAssetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Operating lease right of use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Total deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets after valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract19" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract19"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract19_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract19" xlink:to="jfbr_UnlabeledAbstract19_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract20" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract20"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract20_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract20" xlink:to="jfbr_UnlabeledAbstract20_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating lease liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">Total deferred tax liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract21" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract21"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract21_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract21" xlink:to="jfbr_UnlabeledAbstract21_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl" xml:lang="en-US">Net deferred tax assets (liabilities)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">SHARE CAPITAL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl" xml:lang="en-US">Schedule of share capital composed of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">SHARE INCENTIVE PLAN</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock_lbl" xml:lang="en-US">FINANCE (INCOME) EXPENSE, NET</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock" xlink:to="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock_lbl" xml:lang="en-US">Schedule of finance (income) expenses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock" xlink:to="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceIncomeAbstract" xlink:href="jfbr-20221231.xsd#jfbr_FinanceIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_FinanceIncomeAbstract_lbl" xml:lang="en-US">Finance income:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceIncomeAbstract" xlink:to="jfbr_FinanceIncomeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl" xml:lang="en-US">Change in fair value of derivative liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl" xml:lang="en-US">Gain from debt extinguishment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceExpenseAbstract" xlink:href="jfbr-20221231.xsd#jfbr_FinanceExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_FinanceExpenseAbstract_lbl" xml:lang="en-US">Finance expense:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceExpenseAbstract" xlink:to="jfbr_FinanceExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceExpensesInRespectOfThirdpartyLoan" xlink:href="jfbr-20221231.xsd#jfbr_FinanceExpensesInRespectOfThirdpartyLoan"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_FinanceExpensesInRespectOfThirdpartyLoan_lbl" xml:lang="en-US">Finance expenses in respect of third-party loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceExpensesInRespectOfThirdpartyLoan" xlink:to="jfbr_FinanceExpensesInRespectOfThirdpartyLoan_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl" xml:lang="en-US">Change in fair value of derivative liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization of loan discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Exchange rate changes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpenseRelatedParty_lbl" xml:lang="en-US">Interest expense on loans from shareholders and related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseRelatedParty" xlink:to="us-gaap_InterestExpenseRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Other finance expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherTaxExpenseBenefit_lbl" xml:lang="en-US">Total finance expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherTaxExpenseBenefit" xlink:to="us-gaap_OtherTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceExpenseNet" xlink:href="jfbr-20221231.xsd#jfbr_FinanceExpenseNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_FinanceExpenseNet_lbl" xml:lang="en-US">Finance (income) expense, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceExpenseNet" xlink:to="jfbr_FinanceExpenseNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_NumeratorAbstract" xlink:href="jfbr-20221231.xsd#jfbr_NumeratorAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_NumeratorAbstract_lbl" xml:lang="en-US">Numerator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_NumeratorAbstract" xlink:to="jfbr_NumeratorAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net income (loss) applicable to shareholders of ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnlabeledAbstract22" xlink:href="jfbr-20221231.xsd#jfbr_UnlabeledAbstract22"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnlabeledAbstract22_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract22" xlink:to="jfbr_UnlabeledAbstract22_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DenominatorAbstract" xlink:href="jfbr-20221231.xsd#jfbr_DenominatorAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_DenominatorAbstract_lbl" xml:lang="en-US">Denominator:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DenominatorAbstract" xlink:to="jfbr_DenominatorAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xml:lang="en-US">Shares of ordinary share used in computing basic and diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Shares of ordinary share used in computing diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedProFormaAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedProFormaAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDilutedProFormaAdjustment_lbl" xml:lang="en-US">Net loss per share of ordinary share, basic and diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedProFormaAdjustment" xlink:to="us-gaap_EarningsPerShareDilutedProFormaAdjustment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDilutedProFormaAdjustment_lbl0" xml:lang="en-US">Net loss per share of ordinary share, diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedProFormaAdjustment" xlink:to="us-gaap_EarningsPerShareDilutedProFormaAdjustment_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xml:lang="en-US">Schedule of diluted weighted average shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IPOAndAdditionalWarrants" xlink:href="jfbr-20221231.xsd#jfbr_IPOAndAdditionalWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_IPOAndAdditionalWarrants_lbl" xml:lang="en-US">IPO Warrants and Additional Warrants (Note 12h)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IPOAndAdditionalWarrants" xlink:to="jfbr_IPOAndAdditionalWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnderwriterWarrants" xlink:href="jfbr-20221231.xsd#jfbr_UnderwriterWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnderwriterWarrants_lbl" xml:lang="en-US">Underwriter warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnderwriterWarrants" xlink:to="jfbr_UnderwriterWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_OtherWarrants" xlink:href="jfbr-20221231.xsd#jfbr_OtherWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_OtherWarrants_lbl" xml:lang="en-US">Other warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OtherWarrants" xlink:to="jfbr_OtherWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">RELATED PARTIES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Schedule of transactions with interested and related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LaborAndRelatedExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Labor cost and related expenses (c1)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseDirectorsFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseDirectorsFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NoninterestExpenseDirectorsFees_lbl" xml:lang="en-US">Directors&#8217; fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseDirectorsFees" xlink:to="us-gaap_NoninterestExpenseDirectorsFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Consulting fees (c2)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders" xlink:href="jfbr-20221231.xsd#jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders_lbl" xml:lang="en-US">Interest expenses on loans from related parties and shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders" xlink:to="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock_lbl" xml:lang="en-US">Schedule of balances with interested and related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock" xlink:to="jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AssetsAbstract0" xlink:href="jfbr-20221231.xsd#jfbr_AssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AssetsAbstract0_lbl" xml:lang="en-US">Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AssetsAbstract0" xlink:to="jfbr_AssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdvancesToSuppliers" xlink:href="jfbr-20221231.xsd#jfbr_AdvancesToSuppliers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AdvancesToSuppliers_lbl" xml:lang="en-US">Advances to suppliers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdvancesToSuppliers" xlink:to="jfbr_AdvancesToSuppliers_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansFromShareholders" xlink:href="jfbr-20221231.xsd#jfbr_LoansFromShareholders"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_LoansFromShareholders_lbl" xml:lang="en-US">Loans from shareholders (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LoansFromShareholders" xlink:to="jfbr_LoansFromShareholders_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DueToOtherRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Loan from related parties (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOtherRelatedPartiesNoncurrent" xlink:to="us-gaap_DueToOtherRelatedPartiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivableWithImputedInterestDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableWithImputedInterestDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ReceivableWithImputedInterestDiscount_lbl" xml:lang="en-US">Less: imputed interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivableWithImputedInterestDiscount" xlink:to="us-gaap_ReceivableWithImputedInterestDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Loan discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans" xlink:href="jfbr-20221231.xsd#jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans_lbl" xml:lang="en-US">Differences between tax basis and carrying value of loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans" xlink:to="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US">Total finance income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ComputersEquipmentMember" xlink:href="jfbr-20221231.xsd#jfbr_ComputersEquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ComputersEquipmentMember_lbl" xml:lang="en-US">Computers equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ComputersEquipmentMember" xlink:to="jfbr_ComputersEquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold improvements [Member[</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_BrandsMember" xlink:href="jfbr-20221231.xsd#jfbr_BrandsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_BrandsMember_lbl" xml:lang="en-US">Brands [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_BrandsMember" xlink:to="jfbr_BrandsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IL_lbl" xml:lang="en-US">Israel [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Shares acquired percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl" xml:lang="en-US">Percentage of shares ownership after Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0" xml:lang="en-US">Sale of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Price per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ExercisePriceAdjustment" xlink:href="jfbr-20221231.xsd#jfbr_ExercisePriceAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ExercisePriceAdjustment_lbl" xml:lang="en-US">Exercise price adjustment (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ExercisePriceAdjustment" xlink:to="jfbr_ExercisePriceAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0" xml:lang="en-US">Warrants purchase shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrants term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ClassOfAdditionalWarrantOrRightOutstanding" xlink:href="jfbr-20221231.xsd#jfbr_ClassOfAdditionalWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ClassOfAdditionalWarrantOrRightOutstanding_lbl" xml:lang="en-US">Additional warrants outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ClassOfAdditionalWarrantOrRightOutstanding" xlink:to="jfbr_ClassOfAdditionalWarrantOrRightOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Additional warrant total consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl" xml:lang="en-US">Net proceeds (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_NetProceedsOfWarrants" xlink:href="jfbr-20221231.xsd#jfbr_NetProceedsOfWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_NetProceedsOfWarrants_lbl" xml:lang="en-US">Net proceeds of warrants (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_NetProceedsOfWarrants" xlink:to="jfbr_NetProceedsOfWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights" xlink:href="jfbr-20221231.xsd#jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights_lbl" xml:lang="en-US">Exercise price adjustment (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights" xlink:to="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xml:lang="en-US">Revenue percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Converted into ordinary shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl0" xml:lang="en-US">Converted into an aggregate of ordinary shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_BonusSharesAndReverseShareSplitDescription" xlink:href="jfbr-20221231.xsd#jfbr_BonusSharesAndReverseShareSplitDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_BonusSharesAndReverseShareSplitDescription_lbl" xml:lang="en-US">Bonus shares and reverse share split, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_BonusSharesAndReverseShareSplitDescription" xlink:to="jfbr_BonusSharesAndReverseShareSplitDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse Share Split, description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaturityOfTimeDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturityOfTimeDeposits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MaturityOfTimeDeposits_lbl" xml:lang="en-US">Short-term bank deposits maturities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaturityOfTimeDeposits" xlink:to="us-gaap_MaturityOfTimeDeposits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xml:lang="en-US">Leases term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Estimated useful lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_lbl" xml:lang="en-US">Tax benefit percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for returns</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingAndMarketingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherSellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingAndMarketingExpense" xlink:to="us-gaap_OtherSellingAndMarketingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xml:lang="en-US">Monthly contribution percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAdditionalCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAdditionalCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAdditionalCapital_lbl" xml:lang="en-US">Pure capital amoun</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAdditionalCapital" xlink:to="us-gaap_OtherAdditionalCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FiniteLivedIntangibleAssetAmortizationMethod" xlink:href="jfbr-20221231.xsd#jfbr_FiniteLivedIntangibleAssetAmortizationMethod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_FiniteLivedIntangibleAssetAmortizationMethod_lbl" xml:lang="en-US">Estimated annual amortization expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FiniteLivedIntangibleAssetAmortizationMethod" xlink:to="jfbr_FiniteLivedIntangibleAssetAmortizationMethod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_lbl" xml:lang="en-US">Write off the intangible asset balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Remaining useful life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_OperatingLeaseAssets" xlink:href="jfbr-20221231.xsd#jfbr_OperatingLeaseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_OperatingLeaseAssets_lbl" xml:lang="en-US">Operating lease assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OperatingLeaseAssets" xlink:to="jfbr_OperatingLeaseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl" xml:lang="en-US">Lease term period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_WeightedAverageBorrowingRate" xlink:href="jfbr-20221231.xsd#jfbr_WeightedAverageBorrowingRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_WeightedAverageBorrowingRate_lbl" xml:lang="en-US">Weighted average borrowing rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_WeightedAverageBorrowingRate" xlink:to="jfbr_WeightedAverageBorrowingRate_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AggregatesAmount" xlink:href="jfbr-20221231.xsd#jfbr_AggregatesAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AggregatesAmount_lbl" xml:lang="en-US">Aggregate amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AggregatesAmount" xlink:to="jfbr_AggregatesAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForPreviousAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPreviousAcquisition"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsForPreviousAcquisition_lbl" xml:lang="en-US">Amazon loan balance.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForPreviousAcquisition" xlink:to="us-gaap_PaymentsForPreviousAcquisition_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtPercentageBearingFixedInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate_lbl" xml:lang="en-US">Bears annual interest percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:to="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Additional interest rate percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AggregateAmount" xlink:href="jfbr-20221231.xsd#jfbr_AggregateAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AggregateAmount_lbl" xml:lang="en-US">Aggregate amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AggregateAmount" xlink:to="jfbr_AggregateAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_PrincipalLoanAmount" xlink:href="jfbr-20221231.xsd#jfbr_PrincipalLoanAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_PrincipalLoanAmount_lbl" xml:lang="en-US">Principal loan amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PrincipalLoanAmount" xlink:to="jfbr_PrincipalLoanAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShorttermDebtFairValue_lbl" xml:lang="en-US">Fair value amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShorttermDebtFairValue" xlink:to="us-gaap_ShorttermDebtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtCurrent_lbl" xml:lang="en-US">Derivate liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtCurrent" xlink:to="us-gaap_DebtCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Finance expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtPercentageBearingVariableInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate_lbl" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" xlink:to="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShortTermLineOfCredits" xlink:href="jfbr-20221231.xsd#jfbr_ShortTermLineOfCredits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ShortTermLineOfCredits_lbl" xml:lang="en-US">Short term line of credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShortTermLineOfCredits" xlink:to="jfbr_ShortTermLineOfCredits_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xml:lang="en-US">Under line credit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_lbl" xml:lang="en-US">Fair value issuance amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DerivativeLiability" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_DerivativeLiability_lbl" xml:lang="en-US">Derivative liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DerivativeLiability" xlink:to="jfbr_DerivativeLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl" xml:lang="en-US">Warrants issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl" xml:lang="en-US">Exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_PublicOfferingPricePerShare" xlink:href="jfbr-20221231.xsd#jfbr_PublicOfferingPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_PublicOfferingPricePerShare_lbl" xml:lang="en-US">Public offering price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PublicOfferingPricePerShare" xlink:to="jfbr_PublicOfferingPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExcessStockSharesIssued_lbl" xml:lang="en-US">Number of shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesIssued" xlink:to="us-gaap_ExcessStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WarrantExercisePriceDecrease_lbl" xml:lang="en-US">Initial exercise price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceDecrease" xlink:to="us-gaap_WarrantExercisePriceDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xml:lang="en-US">Purchase of share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdditionalWarrants" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalWarrants"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AdditionalWarrants_lbl" xml:lang="en-US">Additional warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalWarrants" xlink:to="jfbr_AdditionalWarrants_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl" xml:lang="en-US">Consideration amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeCostOfHedgeNetOfCashReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCostOfHedgeNetOfCashReceived"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeCostOfHedgeNetOfCashReceived_lbl" xml:lang="en-US">Derivative, Cost of Hedge Net of Cash Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeCostOfHedgeNetOfCashReceived" xlink:to="us-gaap_DerivativeCostOfHedgeNetOfCashReceived_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl" xml:lang="en-US">Issuance of costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Weighted average stock price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_RevenuesPercentage" xlink:href="jfbr-20221231.xsd#jfbr_RevenuesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_RevenuesPercentage_lbl" xml:lang="en-US">Revenues percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RevenuesPercentage" xlink:to="jfbr_RevenuesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_RelatedPartyFairValue" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartyFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_RelatedPartyFairValue_lbl" xml:lang="en-US">Fair value amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RelatedPartyFairValue" xlink:to="jfbr_RelatedPartyFairValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="jfbr_RelatedPartyFairValue_lbl0" xml:lang="en-US">Related party fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RelatedPartyFairValue" xlink:to="jfbr_RelatedPartyFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_lbl" xml:lang="en-US">Fair value amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_lbl" xml:lang="en-US">Finance the acquisition percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Line of credit amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Loan amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Annual interest percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlanFundedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedBenefitPlanFundedPercentage_lbl" xml:lang="en-US">Benefit percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanFundedPercentage" xlink:to="us-gaap_DefinedBenefitPlanFundedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentInterestRate_lbl" xml:lang="en-US">Interest rate percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedTrademarksGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedTrademarksGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedTrademarksGross_lbl" xml:lang="en-US">Total trademarks</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedTrademarksGross" xlink:to="us-gaap_FiniteLivedTrademarksGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryNoncurrent_lbl" xml:lang="en-US">Inventory total amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNoncurrent" xlink:to="us-gaap_InventoryNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl" xml:lang="en-US">Transferred to smart pro amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherMinorityInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherMinorityInterests"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherMinorityInterests_lbl" xml:lang="en-US">Minority shareholders transferred amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherMinorityInterests" xlink:to="us-gaap_OtherMinorityInterests_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseOtherShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseOtherShortTermBorrowings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpenseOtherShortTermBorrowings_lbl" xml:lang="en-US">Capital reserve from the transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOtherShortTermBorrowings" xlink:to="us-gaap_InterestExpenseOtherShortTermBorrowings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod_lbl" xml:lang="en-US">Loans was determined percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod" xlink:to="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipalAmountOutstandingOnLoansSecuritized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized_lbl" xml:lang="en-US">Outstanding loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized" xlink:to="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DividendsCommonStock_lbl" xml:lang="en-US">Ordinary Share price divided</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStock" xlink:to="us-gaap_DividendsCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl" xml:lang="en-US">Financial instrument</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityPeriodIncreaseDecrease_lbl" xml:lang="en-US">Increase in equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="us-gaap_StockholdersEquityPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Accrued interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl" xml:lang="en-US">tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Corporate tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_lbl" xml:lang="en-US">Carry forward tax losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AgreementDescription" xlink:href="jfbr-20221231.xsd#jfbr_AgreementDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AgreementDescription_lbl" xml:lang="en-US">Agreement description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AgreementDescription" xlink:to="jfbr_AgreementDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuedAndOutstandingShareCapitalPercentage" xlink:href="jfbr-20221231.xsd#jfbr_IssuedAndOutstandingShareCapitalPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_IssuedAndOutstandingShareCapitalPercentage_lbl" xml:lang="en-US">Issued and outstanding share capital percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuedAndOutstandingShareCapitalPercentage" xlink:to="jfbr_IssuedAndOutstandingShareCapitalPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_InvestAmount" xlink:href="jfbr-20221231.xsd#jfbr_InvestAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_InvestAmount_lbl" xml:lang="en-US">Invest amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_InvestAmount" xlink:to="jfbr_InvestAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssued_lbl0" xml:lang="en-US">Issued to the minority Shareholder (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_MinorityShareholderAmount" xlink:href="jfbr-20221231.xsd#jfbr_MinorityShareholderAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_MinorityShareholderAmount_lbl" xml:lang="en-US">Minority shareholder amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MinorityShareholderAmount" xlink:to="jfbr_MinorityShareholderAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_lbl" xml:lang="en-US">Additional payroll expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xml:lang="en-US">Divided ordinary shares amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceOfPeriodTerm" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceOfPeriodTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_IssuanceOfPeriodTerm_lbl" xml:lang="en-US">Issuance of period term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceOfPeriodTerm" xlink:to="jfbr_IssuanceOfPeriodTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Ordinary shares exercisable (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Ordinary shares exercisable term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Ordinary shares exercisable per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceOfBonusShares" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceOfBonusShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_IssuanceOfBonusShares_lbl" xml:lang="en-US">Issuance of bonus shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceOfBonusShares" xlink:to="jfbr_IssuanceOfBonusShares_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AggregateIssuanceShares" xlink:href="jfbr-20221231.xsd#jfbr_AggregateIssuanceShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AggregateIssuanceShares_lbl" xml:lang="en-US">Aggregate issuance shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AggregateIssuanceShares" xlink:to="jfbr_AggregateIssuanceShares_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_GrossProceeds" xlink:href="jfbr-20221231.xsd#jfbr_GrossProceeds"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_GrossProceeds_lbl" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_GrossProceeds" xlink:to="jfbr_GrossProceeds_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_InitialExercisePriceExpire" xlink:href="jfbr-20221231.xsd#jfbr_InitialExercisePriceExpire"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_InitialExercisePriceExpire_lbl" xml:lang="en-US">Initial exercise price expire</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_InitialExercisePriceExpire" xlink:to="jfbr_InitialExercisePriceExpire_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionExercisePriceDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockOptionExercisePriceDecrease_lbl" xml:lang="en-US">Exercise price less (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionExercisePriceDecrease" xlink:to="us-gaap_StockOptionExercisePriceDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionExercisePriceIncrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockOptionExercisePriceIncrease_lbl" xml:lang="en-US">Exercise price (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionExercisePriceIncrease" xlink:to="us-gaap_StockOptionExercisePriceIncrease_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdditionalWarrantTerm" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalWarrantTerm"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AdditionalWarrantTerm_lbl" xml:lang="en-US">Additional warrant term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalWarrantTerm" xlink:to="jfbr_AdditionalWarrantTerm_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdditionalWarrantsDescription" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalWarrantsDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AdditionalWarrantsDescription_lbl" xml:lang="en-US">Additional warrants description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalWarrantsDescription" xlink:to="jfbr_AdditionalWarrantsDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Warrants issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xml:lang="en-US">Total consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ConsideredAsIssuanceCosts" xlink:href="jfbr-20221231.xsd#jfbr_ConsideredAsIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ConsideredAsIssuanceCosts_lbl" xml:lang="en-US">Considered as issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ConsideredAsIssuanceCosts" xlink:to="jfbr_ConsideredAsIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares_lbl" xml:lang="en-US">Ordinary Shares were reserved</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl" xml:lang="en-US">Additional payroll expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalariesWagesAndOfficersCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesWagesAndOfficersCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SalariesWagesAndOfficersCompensation_lbl" xml:lang="en-US">Salary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesWagesAndOfficersCompensation" xlink:to="us-gaap_SalariesWagesAndOfficersCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_Bonus" xlink:href="jfbr-20221231.xsd#jfbr_Bonus"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_Bonus_lbl" xml:lang="en-US">Bonus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_Bonus" xlink:to="jfbr_Bonus_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ConsultancyServicesFees" xlink:href="jfbr-20221231.xsd#jfbr_ConsultancyServicesFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ConsultancyServicesFees_lbl" xml:lang="en-US">Consultancy services fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ConsultancyServicesFees" xlink:to="jfbr_ConsultancyServicesFees_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_PercentageOfGrossProceed" xlink:href="jfbr-20221231.xsd#jfbr_PercentageOfGrossProceed"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_PercentageOfGrossProceed_lbl" xml:lang="en-US">Percentage of gross proceed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PercentageOfGrossProceed" xlink:to="jfbr_PercentageOfGrossProceed_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_PercentageOfTotalConsiderationPaid" xlink:href="jfbr-20221231.xsd#jfbr_PercentageOfTotalConsiderationPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_PercentageOfTotalConsiderationPaid_lbl" xml:lang="en-US">Percentage of total consideration paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PercentageOfTotalConsiderationPaid" xlink:to="jfbr_PercentageOfTotalConsiderationPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UndefinedPeriodOfTime" xlink:href="jfbr-20221231.xsd#jfbr_UndefinedPeriodOfTime"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UndefinedPeriodOfTime_lbl" xml:lang="en-US">Undefined period of time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UndefinedPeriodOfTime" xlink:to="jfbr_UndefinedPeriodOfTime_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToSuppliers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliers"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToSuppliers_lbl" xml:lang="en-US">Advances to suppliers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToSuppliers" xlink:to="us-gaap_PaymentsToSuppliers_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_PercentageLeaseAndMaintenanceExpensesRelated" xlink:href="jfbr-20221231.xsd#jfbr_PercentageLeaseAndMaintenanceExpensesRelated"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_PercentageLeaseAndMaintenanceExpensesRelated_lbl" xml:lang="en-US">Percentage lease and maintenance expenses related</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PercentageLeaseAndMaintenanceExpensesRelated" xlink:to="jfbr_PercentageLeaseAndMaintenanceExpensesRelated_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLaborRelatedExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLaborRelatedExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLaborRelatedExpenses_lbl" xml:lang="en-US">Lease and maintenance expenses related</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLaborRelatedExpenses" xlink:to="us-gaap_OtherLaborRelatedExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_OutstandingPayable" xlink:href="jfbr-20221231.xsd#jfbr_OutstandingPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_OutstandingPayable_lbl" xml:lang="en-US">outstanding payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OutstandingPayable" xlink:to="jfbr_OutstandingPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyCosts_lbl" xml:lang="en-US">Related party balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyCosts" xlink:to="us-gaap_RelatedPartyCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl" xml:lang="en-US">Another related party balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeRelatedParty"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestIncomeRelatedParty_lbl" xml:lang="en-US">Accrued interest related party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeRelatedParty" xlink:to="us-gaap_InterestIncomeRelatedParty_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription_lbl" xml:lang="en-US">Stock purchase agreement description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockOtherSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockOtherSharesOutstanding_lbl" xml:lang="en-US">Ordinary shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockOtherSharesOutstanding" xlink:to="us-gaap_CommonStockOtherSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage" xlink:href="jfbr-20221231.xsd#jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage_lbl" xml:lang="en-US">Shares issued percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage" xlink:to="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage" xlink:href="jfbr-20221231.xsd#jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage_lbl" xml:lang="en-US">Shares outstanding percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage" xlink:to="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Shares acquired value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AdditionalDividendsPayableSharesValue" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalDividendsPayableSharesValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AdditionalDividendsPayableSharesValue_lbl" xml:lang="en-US">Adjusted shares value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalDividendsPayableSharesValue" xlink:to="jfbr_AdditionalDividendsPayableSharesValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Ownership limitation percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MembersCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MembersCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MembersCapital_lbl" xml:lang="en-US">Issued and outstanding share capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MembersCapital" xlink:to="us-gaap_MembersCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFeeAmount_lbl" xml:lang="en-US">Monthly fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFeeAmount" xlink:to="us-gaap_DebtInstrumentFeeAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalAccountReturnOfCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountReturnOfCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PartnersCapitalAccountReturnOfCapital_lbl" xml:lang="en-US">Pure capital amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalAccountReturnOfCapital" xlink:to="us-gaap_PartnersCapitalAccountReturnOfCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of preparation of the financial statements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Functional and presentation currency</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventories</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZqAlP1yOSc1A/ANEzuo53ddr/LMBLom9FlRSK3NKkyEbonVWG5HPDY+G1lW3BvjVh1hGR4TsEWxikRSd2CzczjxOi38/JBT4C/OcGQ5Ko7wX9cWbP+EcSCjzoKw5UOEXtltIx6qGM8m+WHjAhoKAqHXg9v/7inBQezt5KwYVPvHGi+aa1see5NZ2dwkmaERHPeNz2kzAI9LgkpCDah5uIW] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xml:lang="en-US">Deferred offering costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionCustomerAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionCustomerAcquisitions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionCustomerAcquisitions_lbl" xml:lang="en-US">Asset acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionCustomerAcquisitions" xlink:to="us-gaap_RevenueRecognitionCustomerAcquisitions_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of long-lived assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PolicyLoansReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyLoansReceivablePolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PolicyLoansReceivablePolicy_lbl" xml:lang="en-US">Loans from shareholders and related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PolicyLoansReceivablePolicy" xlink:to="us-gaap_PolicyLoansReceivablePolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_lbl" xml:lang="en-US">Employee benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair value measurement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Legal and other contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and diluted net loss per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently adopted and recently issued accounting pronouncements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_SmartProMember" xlink:href="jfbr-20221231.xsd#jfbr_SmartProMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_SmartProMember_lbl" xml:lang="en-US">Smart Pro [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_SmartProMember" xlink:to="jfbr_SmartProMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_PurexCorpMember" xlink:href="jfbr-20221231.xsd#jfbr_PurexCorpMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_PurexCorpMember_lbl" xml:lang="en-US">Purex Corp [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PurexCorpMember" xlink:to="jfbr_PurexCorpMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_JeffsBrandsMember" xlink:href="jfbr-20221231.xsd#jfbr_JeffsBrandsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_JeffsBrandsMember_lbl" xml:lang="en-US">Jeffs&#8217; Brands [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_JeffsBrandsMember" xlink:to="jfbr_JeffsBrandsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_MrHakmonMember" xlink:href="jfbr-20221231.xsd#jfbr_MrHakmonMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_MrHakmonMember_lbl" xml:lang="en-US">Mr. Hakmon [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MrHakmonMember" xlink:to="jfbr_MrHakmonMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IPOMember_lbl" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IPOMember_lbl0" xml:lang="en-US">IPO Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_IPOWarrantMember" xlink:href="jfbr-20221231.xsd#jfbr_IPOWarrantMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_IPOWarrantMember_lbl" xml:lang="en-US">IPO Warrant [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IPOWarrantMember" xlink:to="jfbr_IPOWarrantMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_UnderwritersWarrantsMember" xlink:href="jfbr-20221231.xsd#jfbr_UnderwritersWarrantsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_UnderwritersWarrantsMember_lbl" xml:lang="en-US">Underwriter&#8217;s Warrants [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnderwritersWarrantsMember" xlink:to="jfbr_UnderwritersWarrantsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IssuanceDateMember" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceDateMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_IssuanceDateMember_lbl" xml:lang="en-US">Issuance Date [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceDateMember" xlink:to="jfbr_IssuanceDateMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xml:lang="en-US">Business Combination [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_AmazoncomMember" xlink:href="jfbr-20221231.xsd#jfbr_AmazoncomMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_AmazoncomMember_lbl" xml:lang="en-US">Amazon.com [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AmazoncomMember" xlink:to="jfbr_AmazoncomMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_MedigusMember" xlink:href="jfbr-20221231.xsd#jfbr_MedigusMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_MedigusMember_lbl" xml:lang="en-US">Medigus [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MedigusMember" xlink:to="jfbr_MedigusMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_MrHakmonAndLIAMember" xlink:href="jfbr-20221231.xsd#jfbr_MrHakmonAndLIAMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_MrHakmonAndLIAMember_lbl" xml:lang="en-US">Mr. Hakmon and L.I.A [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MrHakmonAndLIAMember" xlink:to="jfbr_MrHakmonAndLIAMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_PureCapitalLtdMember" xlink:href="jfbr-20221231.xsd#jfbr_PureCapitalLtdMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_PureCapitalLtdMember_lbl" xml:lang="en-US">Pure Capital Ltd. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PureCapitalLtdMember" xlink:to="jfbr_PureCapitalLtdMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MajorityShareholderMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MajorityShareholderMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MajorityShareholderMember_lbl" xml:lang="en-US">Majority Shareholder [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorityShareholderMember" xlink:to="us-gaap_MajorityShareholderMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_MinorityShareholderMember" xlink:href="jfbr-20221231.xsd#jfbr_MinorityShareholderMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_MinorityShareholderMember_lbl" xml:lang="en-US">Minority Shareholder [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MinorityShareholderMember" xlink:to="jfbr_MinorityShareholderMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_OwnershipMember" xlink:href="jfbr-20221231.xsd#jfbr_OwnershipMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_OwnershipMember_lbl" xml:lang="en-US">Ownership [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OwnershipMember" xlink:to="jfbr_OwnershipMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IntangibleAssetsTable" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IntangibleAssetsTable_lbl" xml:lang="en-US">Intangible Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IntangibleAssetsTable" xlink:to="jfbr_IntangibleAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IntangibleAssetsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_IntangibleAssetsLineItems_lbl" xml:lang="en-US">Disclosure Of Intangible Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IntangibleAssetsLineItems" xlink:to="jfbr_IntangibleAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_LeasesTable" xlink:href="jfbr-20221231.xsd#jfbr_LeasesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_LeasesTable_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LeasesTable" xlink:to="jfbr_LeasesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_LeasesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LeasesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_LeasesLineItems_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LeasesLineItems" xlink:to="jfbr_LeasesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersTable" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_LoansfromShareholdersTable_lbl" xml:lang="en-US">Loans from Shareholders [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LoansfromShareholdersTable" xlink:to="jfbr_LoansfromShareholdersTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_LoansfromShareholdersLineItems_lbl" xml:lang="en-US">Loans from Shareholders [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LoansfromShareholdersLineItems" xlink:to="jfbr_LoansfromShareholdersLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShareIncentivePlanTable" xlink:href="jfbr-20221231.xsd#jfbr_ShareIncentivePlanTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ShareIncentivePlanTable_lbl" xml:lang="en-US">Share Incentive Plan [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareIncentivePlanTable" xlink:to="jfbr_ShareIncentivePlanTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShareIncentivePlanLineItems" xlink:href="jfbr-20221231.xsd#jfbr_ShareIncentivePlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_ShareIncentivePlanLineItems_lbl" xml:lang="en-US">Share Incentive Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareIncentivePlanLineItems" xlink:to="jfbr_ShareIncentivePlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceIncomeExpenseNetTable" xlink:href="jfbr-20221231.xsd#jfbr_FinanceIncomeExpenseNetTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_FinanceIncomeExpenseNetTable_lbl" xml:lang="en-US">Finance (Income) Expenses, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceIncomeExpenseNetTable" xlink:to="jfbr_FinanceIncomeExpenseNetTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_FinanceIncomeExpenseNetLineItems" xlink:href="jfbr-20221231.xsd#jfbr_FinanceIncomeExpenseNetLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_FinanceIncomeExpenseNetLineItems_lbl" xml:lang="en-US">Finance (Income) Expenses, Net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceIncomeExpenseNetLineItems" xlink:to="jfbr_FinanceIncomeExpenseNetLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IntangibleAssetsTablesTable" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IntangibleAssetsTablesTable_lbl" xml:lang="en-US">Intangible Assets (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IntangibleAssetsTablesTable" xlink:to="jfbr_IntangibleAssetsTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_IntangibleAssetsTablesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IntangibleAssetsTablesLineItems_lbl" xml:lang="en-US">Disclosure Of Intangible Assets Text Block [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IntangibleAssetsTablesLineItems" xlink:to="jfbr_IntangibleAssetsTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_OtherPayablesTablesTable" xlink:href="jfbr-20221231.xsd#jfbr_OtherPayablesTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_OtherPayablesTablesTable_lbl" xml:lang="en-US">Schedule of Other Payables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OtherPayablesTablesTable" xlink:to="jfbr_OtherPayablesTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_OtherPayablesTablesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_OtherPayablesTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_OtherPayablesTablesLineItems_lbl" xml:lang="en-US">Schedule of Other Payables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OtherPayablesTablesLineItems" xlink:to="jfbr_OtherPayablesTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersTablesTable" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_LoansfromShareholdersTablesTable_lbl" xml:lang="en-US">Loans from Shareholders (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LoansfromShareholdersTablesTable" xlink:to="jfbr_LoansfromShareholdersTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersTablesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="jfbr_LoansfromShareholdersTablesLineItems_lbl" xml:lang="en-US">Loans from Shareholders [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LoansfromShareholdersTablesLineItems" xlink:to="jfbr_LoansfromShareholdersTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable_lbl" xml:lang="en-US">Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" xlink:to="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems_lbl" xml:lang="en-US">Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US">Income Tax Authority [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable" xlink:href="jfbr-20221231.xsd#jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable_lbl" xml:lang="en-US">Taxes on Income (Details) - Schedule of income (loss) before taxes [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable" xlink:to="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems_lbl" xml:lang="en-US">Taxes on Income (Details) - Schedule of income (loss) before taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems" xlink:to="jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US">Sale of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US">Investment, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_GeneralInformationDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_GeneralInformationDetailsTable_lbl" xml:lang="en-US">General Information (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_GeneralInformationDetailsTable" xlink:to="jfbr_GeneralInformationDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_GeneralInformationDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_GeneralInformationDetailsLineItems_lbl" xml:lang="en-US">General Information (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_GeneralInformationDetailsLineItems" xlink:to="jfbr_GeneralInformationDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeContractTypeDomain_lbl" xml:lang="en-US">Derivative Contract [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_DerivativeContractTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DerivativeLiabilitiesDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DerivativeLiabilitiesDetailsTable_lbl" xml:lang="en-US">Derivative Liabilities (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DerivativeLiabilitiesDetailsTable" xlink:to="jfbr_DerivativeLiabilitiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DerivativeLiabilitiesDetailsLineItems_lbl" xml:lang="en-US">Derivative Liabilities (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DerivativeLiabilitiesDetailsLineItems" xlink:to="jfbr_DerivativeLiabilitiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_LoansfromShareholdersDetailsTable_lbl" xml:lang="en-US">Loans from Shareholders (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LoansfromShareholdersDetailsTable" xlink:to="jfbr_LoansfromShareholdersDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_LoansfromShareholdersDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_LoansfromShareholdersDetailsLineItems_lbl" xml:lang="en-US">Loans from Shareholders (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LoansfromShareholdersDetailsLineItems" xlink:to="jfbr_LoansfromShareholdersDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShareCapitalDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_ShareCapitalDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ShareCapitalDetailsTable_lbl" xml:lang="en-US">Share Capital (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareCapitalDetailsTable" xlink:to="jfbr_ShareCapitalDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_ShareCapitalDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_ShareCapitalDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ShareCapitalDetailsLineItems_lbl" xml:lang="en-US">Share Capital (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareCapitalDetailsLineItems" xlink:to="jfbr_ShareCapitalDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_RelatedPartiesDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartiesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_RelatedPartiesDetailsTable_lbl" xml:lang="en-US">Related Parties (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RelatedPartiesDetailsTable" xlink:to="jfbr_RelatedPartiesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_RelatedPartiesDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartiesDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_RelatedPartiesDetailsLineItems_lbl" xml:lang="en-US">Related Parties (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RelatedPartiesDetailsLineItems" xlink:to="jfbr_RelatedPartiesDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US">Subsequent Event Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipDomain_lbl" xml:lang="en-US">Ownership [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_SubsequentEventsDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_SubsequentEventsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_SubsequentEventsDetailsTable_lbl" xml:lang="en-US">Subsequent Events (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_SubsequentEventsDetailsTable" xlink:to="jfbr_SubsequentEventsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="jfbr_SubsequentEventsDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_SubsequentEventsDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_SubsequentEventsDetailsLineItems_lbl" xml:lang="en-US">Subsequent Events (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_SubsequentEventsDetailsLineItems" xlink:to="jfbr_SubsequentEventsDetailsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_AccruedExpensesAndOtherPayables_lbl0" xml:lang="en-US">The amount of accrued expenses and other payables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AccruedExpensesAndOtherPayables" xlink:to="jfbr_AccruedExpensesAndOtherPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans_lbl0" xml:lang="en-US">The amount is accrued interest and amortization of discount on related party and shareholders&#8217; loans.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" xlink:to="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_AdditionalDividendsPayableSharesValue_lbl0" xml:lang="en-US">The aomunt of additional dividends payable shares value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalDividendsPayableSharesValue" xlink:to="jfbr_AdditionalDividendsPayableSharesValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_AdditionalWarrantTerm_lbl0" xml:lang="en-US">Additional warrant term.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalWarrantTerm" xlink:to="jfbr_AdditionalWarrantTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_AdditionalWarrants_lbl0" xml:lang="en-US">Number of additional warrants are options issued by a company that trade on an exchange and give investors the right (but not obligation) to purchase company stock at a specific price within a specified time period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalWarrants" xlink:to="jfbr_AdditionalWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_AdditionalWarrantsDescription_lbl0" xml:lang="en-US">Additional warrants description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalWarrantsDescription" xlink:to="jfbr_AdditionalWarrantsDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_AdvancesToSuppliers_lbl0" xml:lang="en-US">The amount is advances to suppliers.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdvancesToSuppliers" xlink:to="jfbr_AdvancesToSuppliers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_AggregateAmount_lbl0" xml:lang="en-US">The value of aggregate amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AggregateAmount" xlink:to="jfbr_AggregateAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_AggregateIssuanceShares_lbl0" xml:lang="en-US">Aggregate issuance shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AggregateIssuanceShares" xlink:to="jfbr_AggregateIssuanceShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_AgreementDescription_lbl0" xml:lang="en-US">Agreement description.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AgreementDescription" xlink:to="jfbr_AgreementDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_Bonus_lbl0" xml:lang="en-US">The amount is bonus.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_Bonus" xlink:to="jfbr_Bonus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_BonusSharesAndReverseShareSplitDescription_lbl0" xml:lang="en-US">Description of bonus shares and reverse share split.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_BonusSharesAndReverseShareSplitDescription" xlink:to="jfbr_BonusSharesAndReverseShareSplitDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ChangeInFairValue_lbl0" xml:lang="en-US">Change in fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ChangeInFairValue" xlink:to="jfbr_ChangeInFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ClassOfAdditionalWarrantOrRightOutstanding_lbl0" xml:lang="en-US">Number of additional warrants or rights outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ClassOfAdditionalWarrantOrRightOutstanding" xlink:to="jfbr_ClassOfAdditionalWarrantOrRightOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights_lbl0" xml:lang="en-US">Adjustment exercise price per share or per unit of warrants or rights outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights" xlink:to="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ConsideredAsIssuanceCosts_lbl0" xml:lang="en-US">Considered as issuance costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ConsideredAsIssuanceCosts" xlink:to="jfbr_ConsideredAsIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ConsultancyServicesFees_lbl0" xml:lang="en-US">The amount is consultancy services fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ConsultancyServicesFees" xlink:to="jfbr_ConsultancyServicesFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_CurrentStateAndLocalTaxExpensesBenefit_lbl0" xml:lang="en-US">The amount of current state and local tax expense (benefit).</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_CurrentStateAndLocalTaxExpensesBenefit" xlink:to="jfbr_CurrentStateAndLocalTaxExpensesBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_DeferredOfferingCostsIncludedInOtherPayables_lbl0" xml:lang="en-US">The amount is deferred offering costs included in other payables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DeferredOfferingCostsIncludedInOtherPayables" xlink:to="jfbr_DeferredOfferingCostsIncludedInOtherPayables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit_lbl0" xml:lang="en-US">Teh amount of deferred state and local income tax expenses benefit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit" xlink:to="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_DerivativeLiability_lbl0" xml:lang="en-US">Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DerivativeLiability" xlink:to="jfbr_DerivativeLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans_lbl0" xml:lang="en-US">The amount of differences between tax basis and carrying value of loans.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans" xlink:to="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ExercisePriceAdjustment_lbl0" xml:lang="en-US">Exercise price per share adjustment.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ExercisePriceAdjustment" xlink:to="jfbr_ExercisePriceAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl1" xml:lang="en-US">Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity&apos;s own assumption about the assumptions market participants would use in pricing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:to="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty_lbl0" xml:lang="en-US">Amount of expense (income) related to adjustment to fair value of warrant liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty" xlink:to="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_FinanceExpenseNet_lbl0" xml:lang="en-US">This element represents interest incurred for borrowed money which was used to produce goods or render services.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceExpenseNet" xlink:to="jfbr_FinanceExpenseNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_FinanceExpensesInRespectOfThirdpartyLoan_lbl0" xml:lang="en-US">Amount of expense classified as finance expenses in respect of third-party loan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceExpensesInRespectOfThirdpartyLoan" xlink:to="jfbr_FinanceExpensesInRespectOfThirdpartyLoan_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_FinancialincomeExpensesNet_lbl0" xml:lang="en-US">Amount of financial (income) expenses, net.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinancialincomeExpensesNet" xlink:to="jfbr_FinancialincomeExpensesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_FiniteLivedIntangibleAssetAmortizationMethod_lbl0" xml:lang="en-US">The amortization method of a major finite-lived intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar either by their nature or by their use in the operations of a company. The straight-line method is the preferred amortization method, unless another method better reflects the pattern in which the asset is consumed.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FiniteLivedIntangibleAssetAmortizationMethod" xlink:to="jfbr_FiniteLivedIntangibleAssetAmortizationMethod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_FutureOperatingLeasePayments_lbl0" xml:lang="en-US">Amount of lessee&apos;s undiscounted obligation for lease payment for operating lease.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FutureOperatingLeasePayments" xlink:to="jfbr_FutureOperatingLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_GrossProceeds_lbl0" xml:lang="en-US">Amount of gross proceeds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_GrossProceeds" xlink:to="jfbr_GrossProceeds_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_IPOAndAdditionalWarrants_lbl0" xml:lang="en-US">Number of shares is IPO and additional warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IPOAndAdditionalWarrants" xlink:to="jfbr_IPOAndAdditionalWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_InitialExercisePriceExpire_lbl0" xml:lang="en-US">Initial exercise price expire.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_InitialExercisePriceExpire" xlink:to="jfbr_InitialExercisePriceExpire_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders_lbl0" xml:lang="en-US">Interest expenses on loans from related parties and shareholders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders" xlink:to="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_InvestAmount_lbl0" xml:lang="en-US">Invest amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_InvestAmount" xlink:to="jfbr_InvestAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_IssuanceCostsOnDerivativeLiabilities_lbl0" xml:lang="en-US">The amount is issuance costs on derivative liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceCostsOnDerivativeLiabilities" xlink:to="jfbr_IssuanceCostsOnDerivativeLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_IssuanceOfBonusShares_lbl0" xml:lang="en-US">Issuance of bonus shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceOfBonusShares" xlink:to="jfbr_IssuanceOfBonusShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans_lbl0" xml:lang="en-US">The amount is issuance of ordinary shares upon conversion of shareholders&#8217; loans.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans" xlink:to="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_IssuanceOfPeriodTerm_lbl0" xml:lang="en-US">Issuance of period term.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceOfPeriodTerm" xlink:to="jfbr_IssuanceOfPeriodTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_IssuedAndOutstandingShareCapitalPercentage_lbl0" xml:lang="en-US">Issued and outstanding share capital percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuedAndOutstandingShareCapitalPercentage" xlink:to="jfbr_IssuedAndOutstandingShareCapitalPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_LoansFromShareholders_lbl0" xml:lang="en-US">The amount is loans from shareholders.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LoansFromShareholders" xlink:to="jfbr_LoansFromShareholders_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_MinorityShareholderAmount_lbl0" xml:lang="en-US">Minority shareholder amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MinorityShareholderAmount" xlink:to="jfbr_MinorityShareholderAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_NetProceedsOfWarrants_lbl0" xml:lang="en-US">Amount of net proceeds of warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_NetProceedsOfWarrants" xlink:to="jfbr_NetProceedsOfWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_OperatingLeaseAssets_lbl0" xml:lang="en-US">Amount of lessee&apos;s right to use underlying asset under operating lease.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OperatingLeaseAssets" xlink:to="jfbr_OperatingLeaseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_OtherWarrants_lbl0" xml:lang="en-US">Number of shares is other warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OtherWarrants" xlink:to="jfbr_OtherWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_OutstandingPayable_lbl0" xml:lang="en-US">The amount is outstanding payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OutstandingPayable" xlink:to="jfbr_OutstandingPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_PercentageLeaseAndMaintenanceExpensesRelated_lbl0" xml:lang="en-US">Percentage lease and maintenance expenses related.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PercentageLeaseAndMaintenanceExpensesRelated" xlink:to="jfbr_PercentageLeaseAndMaintenanceExpensesRelated_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_PercentageOfGrossProceed_lbl0" xml:lang="en-US">Percentage of gross proceed.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PercentageOfGrossProceed" xlink:to="jfbr_PercentageOfGrossProceed_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_PercentageOfTotalConsiderationPaid_lbl0" xml:lang="en-US">Percentage of total consideration paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PercentageOfTotalConsiderationPaid" xlink:to="jfbr_PercentageOfTotalConsiderationPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_PresentValueOfLeaseLiability_lbl0" xml:lang="en-US">The amount is present value of lease liability.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PresentValueOfLeaseLiability" xlink:to="jfbr_PresentValueOfLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_PrincipalLoanAmount_lbl0" xml:lang="en-US">The amountof principal loan amount.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PrincipalLoanAmount" xlink:to="jfbr_PrincipalLoanAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_PublicOfferingPricePerShare_lbl0" xml:lang="en-US">Per share amount received public offering price per share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PublicOfferingPricePerShare" xlink:to="jfbr_PublicOfferingPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_RelatedPartyFairValue_lbl1" xml:lang="en-US">The amount of related party fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RelatedPartyFairValue" xlink:to="jfbr_RelatedPartyFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_RevenuesPercentage_lbl0" xml:lang="en-US">Revenues percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RevenuesPercentage" xlink:to="jfbr_RevenuesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_lbl0" xml:lang="en-US">The amount is right of use assets obtained in exchange for lease liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:to="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock_lbl0" xml:lang="en-US">The entire disclosure for financing income expenses net.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock" xlink:to="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage_lbl0" xml:lang="en-US">Percentage of issued shares of award under share-based payment arrangement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage" xlink:to="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage_lbl0" xml:lang="en-US">Percentage of outstanding shares of award under share-based payment arrangement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage" xlink:to="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts_lbl0" xml:lang="en-US">The amount is share-based compensation included in deferred offering costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts" xlink:to="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ShortTermLineOfCredits_lbl0" xml:lang="en-US">The amount of short term line of credits.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShortTermLineOfCredits" xlink:to="jfbr_ShortTermLineOfCredits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts_lbl0" xml:lang="en-US">The amount is issuance of ordinary shares upon initial public offering, net of issuance costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" xlink:to="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares_lbl0" xml:lang="en-US">Number of shares is issuance of ordinary shares upon initial public offering, net of issuance costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares" xlink:to="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity_lbl0" xml:lang="en-US">The amount is substantial modification of shareholders&#8217; loans recorded in equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity" xlink:to="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_ThirdPartyLoan_lbl1" xml:lang="en-US">The amount of third party loans.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ThirdPartyLoan" xlink:to="jfbr_ThirdPartyLoan_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_TotalDilutedWeightedAverageSharesOutstanding_lbl0" xml:lang="en-US">Total diluted weighted average shares outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_TotalDilutedWeightedAverageSharesOutstanding" xlink:to="jfbr_TotalDilutedWeightedAverageSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_UndefinedPeriodOfTime_lbl0" xml:lang="en-US">Undefined period of time.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UndefinedPeriodOfTime" xlink:to="jfbr_UndefinedPeriodOfTime_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_UnderwriterWarrants_lbl0" xml:lang="en-US">Number of shares is underwriter warrants.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnderwriterWarrants" xlink:to="jfbr_UnderwriterWarrants_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="jfbr_WeightedAverageBorrowingRate_lbl0" xml:lang="en-US">Weighted average interest rate of borrowings.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_WeightedAverageBorrowingRate" xlink:to="jfbr_WeightedAverageBorrowingRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AddressTypeDomain_lbl" xml:lang="en-US">Address Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity_lbl1" xml:lang="en-US">Substantial Modification Of Shareholders Loans Recorded In Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity" xlink:to="jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl0" xml:lang="en-US">Proceeds from (Repayments of) Related Party Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_PercentageOfTotalConsiderationPaid_lbl1" xml:lang="en-US">Percentage Of Total Consideration Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PercentageOfTotalConsiderationPaid" xlink:to="jfbr_PercentageOfTotalConsiderationPaid_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IssuedAndOutstandingShareCapitalPercentage_lbl1" xml:lang="en-US">Issued And Outstanding Share Capital Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuedAndOutstandingShareCapitalPercentage" xlink:to="jfbr_IssuedAndOutstandingShareCapitalPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayable_lbl1" xml:lang="en-US">Loans Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl0" xml:lang="en-US">Extinguishment of Debt, Gain (Loss), Net of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl0" xml:lang="en-US">Entity File Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl0" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl0" xml:lang="en-US">Auditor Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl0" xml:lang="en-US">Document Accounting Standard</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AdditionalWarrants_lbl1" xml:lang="en-US">Additional Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalWarrants" xlink:to="jfbr_AdditionalWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl0" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl0" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl0" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl0" xml:lang="en-US">Shares Issued, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_NetProceedsOfWarrants_lbl1" xml:lang="en-US">Net Proceeds Of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_NetProceedsOfWarrants" xlink:to="jfbr_NetProceedsOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnderwritersWarrantsMember_lbl0" xml:lang="en-US">Underwriters Warrants Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnderwritersWarrantsMember" xlink:to="jfbr_UnderwritersWarrantsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ShortTermLineOfCredits_lbl1" xml:lang="en-US">Short Term Line Of Credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShortTermLineOfCredits" xlink:to="jfbr_ShortTermLineOfCredits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstanding_lbl0" xml:lang="en-US">Warrants and Rights Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstanding" xlink:to="us-gaap_WarrantsAndRightsOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl0" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract_lbl" xml:lang="en-US">Schedule Of Loans From Shareholders Consists Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract" xlink:to="jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl0" xml:lang="en-US">Accounts Payable, Trade, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0" xml:lang="en-US">Stockholders&apos; Equity Note Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_NonCurrentLiabilitiesAbstract_lbl0" xml:lang="en-US">Non Current Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_NonCurrentLiabilitiesAbstract" xlink:to="jfbr_NonCurrentLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts_lbl1" xml:lang="en-US">Stock Issued During Period Issuance Of Ordinary Shares Upon Initial Public Offering Net Of Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" xlink:to="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate_lbl0" xml:lang="en-US">Short-Term Debt, Percentage Bearing Variable Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" xlink:to="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl0" xml:lang="en-US">Financial Instruments, Owned, at Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromOtherShortTermDebt_lbl0" xml:lang="en-US">Proceeds from Other Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromOtherShortTermDebt" xlink:to="us-gaap_ProceedsFromOtherShortTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US">Schedule Of Deferred Taxes Assets And Liabilities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl0" xml:lang="en-US">Local Phone Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Income Tax Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_lbl0" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseOtherShortTermBorrowings_lbl0" xml:lang="en-US">Interest Expense, Other Short-Term Borrowings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOtherShortTermBorrowings" xlink:to="us-gaap_InterestExpenseOtherShortTermBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod_lbl0" xml:lang="en-US">Loans Receivable, Basis Spread on Variable Rate, During Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod" xlink:to="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_PrincipalLoanAmount_lbl1" xml:lang="en-US">Principal Loan Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PrincipalLoanAmount" xlink:to="jfbr_PrincipalLoanAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl0" xml:lang="en-US">Document Registration Statement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl0" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl0" xml:lang="en-US">Debt Instrument, Unamortized Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AggregatesAmount_lbl0" xml:lang="en-US">Aggregates Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AggregatesAmount" xlink:to="jfbr_AggregatesAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl0" xml:lang="en-US">Due to Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl0" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl0" xml:lang="en-US">Related Party Transaction, Due from (to) Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GovernmentContractReceivable_lbl0" xml:lang="en-US">Government Contract Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GovernmentContractReceivable" xlink:to="us-gaap_GovernmentContractReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl0" xml:lang="en-US">Board of Directors Chairman [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract18_lbl0" xml:lang="en-US">Unlabeled Abstract18</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract18" xlink:to="jfbr_UnlabeledAbstract18_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract19_lbl0" xml:lang="en-US">Unlabeled Abstract19</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract19" xlink:to="jfbr_UnlabeledAbstract19_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract16_lbl0" xml:lang="en-US">Unlabeled Abstract16</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract16" xlink:to="jfbr_UnlabeledAbstract16_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract17_lbl0" xml:lang="en-US">Unlabeled Abstract17</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract17" xlink:to="jfbr_UnlabeledAbstract17_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MajorityShareholderMember_lbl0" xml:lang="en-US">Majority Shareholder [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorityShareholderMember" xlink:to="us-gaap_MajorityShareholderMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DenominatorAbstract_lbl0" xml:lang="en-US">Denominator Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DenominatorAbstract" xlink:to="jfbr_DenominatorAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AmazoncomMember_lbl0" xml:lang="en-US">Amazoncom Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AmazoncomMember" xlink:to="jfbr_AmazoncomMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_InvestAmount_lbl1" xml:lang="en-US">Invest Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_InvestAmount" xlink:to="jfbr_InvestAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory_lbl0" xml:lang="en-US">Percentage of Weighted Average Cost Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Award Ordinaty Shares Issued Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage" xlink:to="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl0" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FinanceIncomeExpenseNetTable_lbl0" xml:lang="en-US">Finance Income Expense Net Table</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceIncomeExpenseNetTable" xlink:to="jfbr_FinanceIncomeExpenseNetTable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoninterestExpenseDirectorsFees_lbl0" xml:lang="en-US">Noninterest Expense Directors Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoninterestExpenseDirectorsFees" xlink:to="us-gaap_NoninterestExpenseDirectorsFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract21_lbl0" xml:lang="en-US">Unlabeled Abstract21</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract21" xlink:to="jfbr_UnlabeledAbstract21_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherTaxExpenseBenefit_lbl0" xml:lang="en-US">Other Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherTaxExpenseBenefit" xlink:to="us-gaap_OtherTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract22_lbl0" xml:lang="en-US">Unlabeled Abstract22</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract22" xlink:to="jfbr_UnlabeledAbstract22_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract20_lbl0" xml:lang="en-US">Unlabeled Abstract20</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract20" xlink:to="jfbr_UnlabeledAbstract20_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FinanceIncomeExpenseNetLineItems_lbl0" xml:lang="en-US">Finance Income Expense Net Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceIncomeExpenseNetLineItems" xlink:to="jfbr_FinanceIncomeExpenseNetLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl0" xml:lang="en-US">Security Exchange Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate_lbl0" xml:lang="en-US">Short-Term Debt, Percentage Bearing Fixed Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:to="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl0" xml:lang="en-US">Entity Address, Address Line Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl0" xml:lang="en-US">Entity Address, Address Line One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_BonusSharesAndReverseShareSplitDescription_lbl1" xml:lang="en-US">Bonus Shares And Reverse Share Split Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_BonusSharesAndReverseShareSplitDescription" xlink:to="jfbr_BonusSharesAndReverseShareSplitDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl0" xml:lang="en-US">Dividends Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_BrandsMember_lbl0" xml:lang="en-US">Brands Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_BrandsMember" xlink:to="jfbr_BrandsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DeferredOfferingCostsIncludedInOtherPayables_lbl1" xml:lang="en-US">Deferred Offering Costs Included In Other Payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DeferredOfferingCostsIncludedInOtherPayables" xlink:to="jfbr_DeferredOfferingCostsIncludedInOtherPayables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl0" xml:lang="en-US">Inventory, Finished Goods, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl0" xml:lang="en-US">Title of 12(b) Security</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IssuanceOfPeriodTerm_lbl1" xml:lang="en-US">Issuance Of Period Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceOfPeriodTerm" xlink:to="jfbr_IssuanceOfPeriodTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IntangibleAssetsLineItems_lbl0" xml:lang="en-US">Intangible Assets Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IntangibleAssetsLineItems" xlink:to="jfbr_IntangibleAssetsLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl0" xml:lang="en-US">Contact Personnel Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_lbl0" xml:lang="en-US">Accrued Payroll Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionCustomerAcquisitions_lbl0" xml:lang="en-US">Revenue Recognition, Customer Acquisitions [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionCustomerAcquisitions" xlink:to="us-gaap_RevenueRecognitionCustomerAcquisitions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares_lbl0" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Number of Allocated Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl0" xml:lang="en-US">Debt Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0" xml:lang="en-US">Accounts Receivable [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl1" xml:lang="en-US">Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl0" xml:lang="en-US">Document Shell Company Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherMinorityInterests_lbl0" xml:lang="en-US">Other Noncontrolling Interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherMinorityInterests" xlink:to="us-gaap_OtherMinorityInterests_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl0" xml:lang="en-US">Other Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl0" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract10_lbl0" xml:lang="en-US">Unlabeled Abstract10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract10" xlink:to="jfbr_UnlabeledAbstract10_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_OwnershipMember_lbl0" xml:lang="en-US">Ownership Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OwnershipMember" xlink:to="jfbr_OwnershipMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract11_lbl0" xml:lang="en-US">Unlabeled Abstract11</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract11" xlink:to="jfbr_UnlabeledAbstract11_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_RelatedPartyFairValue_lbl2" xml:lang="en-US">Related Party Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RelatedPartyFairValue" xlink:to="jfbr_RelatedPartyFairValue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract14_lbl0" xml:lang="en-US">Unlabeled Abstract14</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract14" xlink:to="jfbr_UnlabeledAbstract14_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract15_lbl0" xml:lang="en-US">Unlabeled Abstract15</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract15" xlink:to="jfbr_UnlabeledAbstract15_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract12_lbl0" xml:lang="en-US">Unlabeled Abstract12</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract12" xlink:to="jfbr_UnlabeledAbstract12_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl0" xml:lang="en-US">Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract13_lbl0" xml:lang="en-US">Unlabeled Abstract13</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract13" xlink:to="jfbr_UnlabeledAbstract13_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl0" xml:lang="en-US">Debt Conversion, Converted Instrument, Warrants or Options Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl0" xml:lang="en-US">Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl0" xml:lang="en-US">Furniture and Fixtures [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShorttermDebtFairValue_lbl0" xml:lang="en-US">Short-Term Debt, Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShorttermDebtFairValue" xlink:to="us-gaap_ShorttermDebtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl0" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromBankDebt_lbl0" xml:lang="en-US">Proceeds from Bank Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromBankDebt" xlink:to="us-gaap_ProceedsFromBankDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossAttributableToParent_lbl0" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossAttributableToParent" xlink:to="us-gaap_IncomeLossAttributableToParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl0" xml:lang="en-US">Temporary Equity, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl0" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl0" xml:lang="en-US">Other Depreciation and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceIncrease_lbl0" xml:lang="en-US">Warrant, Exercise Price, Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceIncrease" xlink:to="us-gaap_WarrantExercisePriceIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedPayrollTaxesCurrent_lbl0" xml:lang="en-US">Accrued Payroll Taxes, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedPayrollTaxesCurrent" xlink:to="us-gaap_AccruedPayrollTaxesCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl0" xml:lang="en-US">Long-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_PurexCorpMember_lbl0" xml:lang="en-US">Purex Corp Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PurexCorpMember" xlink:to="jfbr_PurexCorpMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLoansPayableCurrent_lbl0" xml:lang="en-US">Other Loans Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLoansPayableCurrent" xlink:to="us-gaap_OtherLoansPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseRelatedParty_lbl0" xml:lang="en-US">Interest Expense, Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseRelatedParty" xlink:to="us-gaap_InterestExpenseRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract2_lbl0" xml:lang="en-US">Unlabeled Abstract2</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract2" xlink:to="jfbr_UnlabeledAbstract2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract1_lbl0" xml:lang="en-US">Unlabeled Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract1" xlink:to="jfbr_UnlabeledAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract4_lbl0" xml:lang="en-US">Unlabeled Abstract4</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract4" xlink:to="jfbr_UnlabeledAbstract4_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract3_lbl0" xml:lang="en-US">Unlabeled Abstract3</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract3" xlink:to="jfbr_UnlabeledAbstract3_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl0" xml:lang="en-US">Deferred Income Taxes and Tax Credits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl0" xml:lang="en-US">Schedule of Short-Term Debt [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract0" xlink:to="jfbr_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_LeasesTable_lbl0" xml:lang="en-US">Leases Table</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LeasesTable" xlink:to="jfbr_LeasesTable_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract_lbl" xml:lang="en-US">Schedule Of Diluted Weighted Average Shares Outstanding Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:to="jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract9_lbl0" xml:lang="en-US">Unlabeled Abstract9</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract9" xlink:to="jfbr_UnlabeledAbstract9_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IPOWarrantMember_lbl0" xml:lang="en-US">IPOWarrant Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IPOWarrantMember" xlink:to="jfbr_IPOWarrantMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract6_lbl0" xml:lang="en-US">Unlabeled Abstract6</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract6" xlink:to="jfbr_UnlabeledAbstract6_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_OtherWarrants_lbl1" xml:lang="en-US">Other Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OtherWarrants" xlink:to="jfbr_OtherWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract5_lbl0" xml:lang="en-US">Unlabeled Abstract5</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract5" xlink:to="jfbr_UnlabeledAbstract5_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract8_lbl0" xml:lang="en-US">Unlabeled Abstract8</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract8" xlink:to="jfbr_UnlabeledAbstract8_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract7_lbl0" xml:lang="en-US">Unlabeled Abstract7</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract7" xlink:to="jfbr_UnlabeledAbstract7_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_LiabilitiesAndEquityAbstract_lbl0" xml:lang="en-US">Liabilities And Equity Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LiabilitiesAndEquityAbstract" xlink:to="jfbr_LiabilitiesAndEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl0" xml:lang="en-US">Deferred Income Tax Liabilities, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Purchase of Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OverAllotmentOptionMember_lbl0" xml:lang="en-US">Over-Allotment Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Of The Derivative Warrant Liability Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable_lbl0" xml:lang="en-US">Short-Term Bank Loans and Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:to="us-gaap_ShortTermBankLoansAndNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl0" xml:lang="en-US">Inventory Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AggregateIssuanceShares_lbl1" xml:lang="en-US">Aggregate Issuance Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AggregateIssuanceShares" xlink:to="jfbr_AggregateIssuanceShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLoansPayableLongTerm_lbl0" xml:lang="en-US">Other Loans Payable, Long-Term, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLoansPayableLongTerm" xlink:to="us-gaap_OtherLoansPayableLongTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription_lbl0" xml:lang="en-US">Securities Sold under Agreements to Repurchase, Setoff Rights, Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_lbl0" xml:lang="en-US">Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UndefinedPeriodOfTime_lbl1" xml:lang="en-US">Undefined Period Of Time</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UndefinedPeriodOfTime" xlink:to="jfbr_UndefinedPeriodOfTime_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares_lbl1" xml:lang="en-US">Stock Issued During Period Issuance Of Ordinary Shares Upon Initial Public Offering Net Of Issuance Costsin Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares" xlink:to="jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl0" xml:lang="en-US">Business Contact [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl0" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DeferredAbstract_lbl0" xml:lang="en-US">Deferred Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DeferredAbstract" xlink:to="jfbr_DeferredAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl1" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl2" xml:lang="en-US">Fair Value Measurement With Unobservable Input Reconciliations Recurring Basis Liability Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:to="jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AgreementDescription_lbl1" xml:lang="en-US">Agreement Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AgreementDescription" xlink:to="jfbr_AgreementDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ConsultancyServicesFees_lbl1" xml:lang="en-US">Consultancy Services Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ConsultancyServicesFees" xlink:to="jfbr_ConsultancyServicesFees_lbl1"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfShortTermLoansAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfShortTermLoansAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfShortTermLoansAbstract_lbl" xml:lang="en-US">Schedule Of Short Term Loans Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfShortTermLoansAbstract" xlink:to="jfbr_ScheduleOfShortTermLoansAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl0" xml:lang="en-US">Current Fiscal Year End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnlabeledAbstract" xlink:to="jfbr_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LinesOfCreditCurrent_lbl0" xml:lang="en-US">Line of Credit, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Other Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl0" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_UnderwriterWarrants_lbl1" xml:lang="en-US">Underwriter Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_UnderwriterWarrants" xlink:to="jfbr_UnderwriterWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_PublicOfferingPricePerShare_lbl1" xml:lang="en-US">Public Offering Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PublicOfferingPricePerShare" xlink:to="jfbr_PublicOfferingPricePerShare_lbl1"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfInventoryAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfInventoryAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfInventoryAbstract_lbl" xml:lang="en-US">Schedule Of Inventory Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfInventoryAbstract" xlink:to="jfbr_ScheduleOfInventoryAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_CurrentStateAndLocalTaxExpensesBenefit_lbl1" xml:lang="en-US">Current State And Local Tax Expenses Benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_CurrentStateAndLocalTaxExpensesBenefit" xlink:to="jfbr_CurrentStateAndLocalTaxExpensesBenefit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage_lbl1" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Award Ordinaty Shares Outstanding Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage" xlink:to="jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ClassOfAdditionalWarrantOrRightOutstanding_lbl1" xml:lang="en-US">Class Of Additional Warrant Or Right Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ClassOfAdditionalWarrantOrRightOutstanding" xlink:to="jfbr_ClassOfAdditionalWarrantOrRightOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_MinorityShareholderMember_lbl0" xml:lang="en-US">Minority Shareholder Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MinorityShareholderMember" xlink:to="jfbr_MinorityShareholderMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl0" xml:lang="en-US">Other Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Stockholders&apos; Equity Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalariesWagesAndOfficersCompensation_lbl0" xml:lang="en-US">Salary and Wage, Excluding Cost of Good and Service Sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesWagesAndOfficersCompensation" xlink:to="us-gaap_SalariesWagesAndOfficersCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_PercentageOfGrossProceed_lbl1" xml:lang="en-US">Percentage Of Gross Proceed</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PercentageOfGrossProceed" xlink:to="jfbr_PercentageOfGrossProceed_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl0" xml:lang="en-US">Other Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtCurrent_lbl0" xml:lang="en-US">Debt, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtCurrent" xlink:to="us-gaap_DebtCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_InitialExercisePriceExpire_lbl1" xml:lang="en-US">Initial Exercise Price Expire</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_InitialExercisePriceExpire" xlink:to="jfbr_InitialExercisePriceExpire_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0" xml:lang="en-US">Increase (Decrease) in Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_OtherPayablesTablesLineItems_lbl0" xml:lang="en-US">Other Payables Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OtherPayablesTablesLineItems" xlink:to="jfbr_OtherPayablesTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_LoansFromShareholders_lbl1" xml:lang="en-US">Loans From Shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LoansFromShareholders" xlink:to="jfbr_LoansFromShareholders_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ChangeInFairValue_lbl1" xml:lang="en-US">Change In Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ChangeInFairValue" xlink:to="jfbr_ChangeInFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl0" xml:lang="en-US">Schedule of Debt [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl0" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl0" xml:lang="en-US">Inventory, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_PresentValueOfLeaseLiability_lbl1" xml:lang="en-US">Present Value Of Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PresentValueOfLeaseLiability" xlink:to="jfbr_PresentValueOfLeaseLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeCostOfHedgeNetOfCashReceived_lbl0" xml:lang="en-US">Derivative, Cost of Hedge Net of Cash Received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeCostOfHedgeNetOfCashReceived" xlink:to="us-gaap_DerivativeCostOfHedgeNetOfCashReceived_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock_lbl0" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock" xlink:to="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_GrossProceeds_lbl1" xml:lang="en-US">Gross Proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_GrossProceeds" xlink:to="jfbr_GrossProceeds_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl0" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl0" xml:lang="en-US">Entity Address, Postal Zip Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_GeneralInformationAbstract" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_GeneralInformationAbstract_lbl" xml:lang="en-US">General Information Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_GeneralInformationAbstract" xlink:to="jfbr_GeneralInformationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl0" xml:lang="en-US">Document Fiscal Period Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl0" xml:lang="en-US">Entity Interactive Data Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedTrademarksGross_lbl0" xml:lang="en-US">Finite-Lived Trademarks, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedTrademarksGross" xlink:to="us-gaap_FiniteLivedTrademarksGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl0" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0" xml:lang="en-US">Proceeds from Issuance of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRate_lbl0" xml:lang="en-US">Investment Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRate" xlink:to="us-gaap_InvestmentInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockNoParValue_lbl0" xml:lang="en-US">Common Stock, No Par Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNoParValue" xlink:to="us-gaap_CommonStockNoParValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Supplies_lbl0" xml:lang="en-US">Prepaid Supplies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Supplies" xlink:to="us-gaap_Supplies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_MrHakmonMember_lbl0" xml:lang="en-US">Mr Hakmon Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MrHakmonMember" xlink:to="jfbr_MrHakmonMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl0" xml:lang="en-US">Trading Symbol</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_NumeratorAbstract_lbl0" xml:lang="en-US">Numerator Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_NumeratorAbstract" xlink:to="jfbr_NumeratorAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfIncomeLossBeforeTaxesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfIncomeLossBeforeTaxesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfIncomeLossBeforeTaxesAbstract_lbl" xml:lang="en-US">Schedule Of Income Loss Before Taxes Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfIncomeLossBeforeTaxesAbstract" xlink:to="jfbr_ScheduleOfIncomeLossBeforeTaxesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl0" xml:lang="en-US">Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FinanceExpenseNet_lbl1" xml:lang="en-US">Finance Expense Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceExpenseNet" xlink:to="jfbr_FinanceExpenseNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl0" xml:lang="en-US">Convertible Debt [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl0" xml:lang="en-US">Document Period End Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl0" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract_lbl" xml:lang="en-US">Schedule Of Finance Income Expenses Net Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract" xlink:to="jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_GeneralInformationTextBlock_lbl0" xml:lang="en-US">General Information Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_GeneralInformationTextBlock" xlink:to="jfbr_GeneralInformationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl0" xml:lang="en-US">Operating Lease, Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ConsideredAsIssuanceCosts_lbl1" xml:lang="en-US">Considered As Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ConsideredAsIssuanceCosts" xlink:to="jfbr_ConsideredAsIssuanceCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeasePayments_lbl0" xml:lang="en-US">Short-Term Lease Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeasePayments" xlink:to="us-gaap_ShortTermLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent_lbl0" xml:lang="en-US">Increase (Decrease) in Notes Payable, Related Parties, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty_lbl1" xml:lang="en-US">Fair Value Of Warrant Liability To Be Issued To Thirdparty</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty" xlink:to="jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeRelatedParty_lbl0" xml:lang="en-US">Interest Income, Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeRelatedParty" xlink:to="us-gaap_InterestIncomeRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AdditionalWarrantsDescription_lbl1" xml:lang="en-US">Additional Warrants Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalWarrantsDescription" xlink:to="jfbr_AdditionalWarrantsDescription_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl0" xml:lang="en-US">Lessee, Finance Lease, Renewal Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryGross_lbl0" xml:lang="en-US">Inventory, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryGross" xlink:to="us-gaap_InventoryGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl0" xml:lang="en-US">Current Federal Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US">Stockholders&apos; Equity Note [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl0" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AccruedExpensesAndOtherPayables_lbl1" xml:lang="en-US">Accrued Expenses And Other Payables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AccruedExpensesAndOtherPayables" xlink:to="jfbr_AccruedExpensesAndOtherPayables_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl0" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans_lbl1" xml:lang="en-US">Differences Between Tax Basis And Carrying Value Of Loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans" xlink:to="jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl0" xml:lang="en-US">Document Annual Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl0" xml:lang="en-US">Entity Address, City or Town</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfOtherShortTermDebt_lbl0" xml:lang="en-US">Repayments of Other Short-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherShortTermDebt" xlink:to="us-gaap_RepaymentsOfOtherShortTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl2" xml:lang="en-US">Proceeds from Issuance of Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl0" xml:lang="en-US">Amortization of Debt Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl0" xml:lang="en-US">Entity Voluntary Filers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl0" xml:lang="en-US">Notes Payable, Related Parties, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PartnersCapitalAccountReturnOfCapital_lbl0" xml:lang="en-US">Partners&apos; Capital Account, Return of Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PartnersCapitalAccountReturnOfCapital" xlink:to="us-gaap_PartnersCapitalAccountReturnOfCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantExercisePriceDecrease_lbl0" xml:lang="en-US">Warrant, Exercise Price, Decrease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantExercisePriceDecrease" xlink:to="us-gaap_WarrantExercisePriceDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_TotalDilutedWeightedAverageSharesOutstanding_lbl1" xml:lang="en-US">Total Diluted Weighted Average Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_TotalDilutedWeightedAverageSharesOutstanding" xlink:to="jfbr_TotalDilutedWeightedAverageSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingExpense_lbl0" xml:lang="en-US">Other Nonoperating Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFeeAmount_lbl0" xml:lang="en-US">Debt Instrument, Fee Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFeeAmount" xlink:to="us-gaap_DebtInstrumentFeeAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl0" xml:lang="en-US">Liabilities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_MrHakmonAndLIAMember_lbl0" xml:lang="en-US">Mr Hakmon And LIAMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MrHakmonAndLIAMember" xlink:to="jfbr_MrHakmonAndLIAMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IPOMember_lbl1" xml:lang="en-US">IPO [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl0" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl0" xml:lang="en-US">Cost of Goods and Services Sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTextBlock_lbl0" xml:lang="en-US">Short-Term Debt [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTextBlock" xlink:to="us-gaap_ShortTermDebtTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl0" xml:lang="en-US">Amortization of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl0" xml:lang="en-US">Income Taxes Paid, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl0" xml:lang="en-US">Weighted Average Basic Shares Outstanding, Pro Forma</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivables_lbl0" xml:lang="en-US">Other Receivables</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DerivativeLiability_lbl1" xml:lang="en-US">Derivative Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DerivativeLiability" xlink:to="jfbr_DerivativeLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl0" xml:lang="en-US">Document Transition Report</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract_lbl" xml:lang="en-US">Schedule Of Income Tax Expense Benefit Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaturityOfTimeDeposits_lbl0" xml:lang="en-US">Maturity of Time Deposits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaturityOfTimeDeposits" xlink:to="us-gaap_MaturityOfTimeDeposits_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract_lbl" xml:lang="en-US">Schedule Of Statutory Income Tax Rate To Effective Income Tax Rate Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AggregateAmount_lbl1" xml:lang="en-US">Aggregate Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AggregateAmount" xlink:to="jfbr_AggregateAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl0" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract_lbl" xml:lang="en-US">Schedule Of Share Capital Composed Of Ordinary Shares Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract" xlink:to="jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PolicyLoansReceivablePolicy_lbl0" xml:lang="en-US">Policy Loans Receivable, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PolicyLoansReceivablePolicy" xlink:to="us-gaap_PolicyLoansReceivablePolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_lbl0" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AdditionalWarrantTerm_lbl1" xml:lang="en-US">Additional Warrant Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalWarrantTerm" xlink:to="jfbr_AdditionalWarrantTerm_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionExercisePriceIncrease_lbl0" xml:lang="en-US">Stock Option, Exercise Price, Increase</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionExercisePriceIncrease" xlink:to="us-gaap_StockOptionExercisePriceIncrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_lbl0" xml:lang="en-US">Asset Acquisition, Consideration Transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IssuanceDateMember_lbl0" xml:lang="en-US">Issuance Date Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceDateMember" xlink:to="jfbr_IssuanceDateMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl0" xml:lang="en-US">Property, Plant and Equipment, Estimated Useful Lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl0" xml:lang="en-US">Entity Shell Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract_lbl" xml:lang="en-US">Schedule Of Fair Value Of The Ipo Warrants And Additional Warrants Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract" xlink:to="jfbr_ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl2" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Derivative Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:to="us-gaap_IncreaseDecreaseInDerivativeLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl0" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_LoansfromShareholdersTablesLineItems_lbl0" xml:lang="en-US">Loansfrom Shareholders Tables Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LoansfromShareholdersTablesLineItems" xlink:to="jfbr_LoansfromShareholdersTablesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FutureOperatingLeasePayments_lbl1" xml:lang="en-US">Future Operating Lease Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FutureOperatingLeasePayments" xlink:to="jfbr_FutureOperatingLeasePayments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FinanceExpenseAbstract_lbl0" xml:lang="en-US">Finance Expense Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceExpenseAbstract" xlink:to="jfbr_FinanceExpenseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl0" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders_lbl1" xml:lang="en-US">Interest Expenses On Loans From Related Parties And Shareholders</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders" xlink:to="jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans_lbl1" xml:lang="en-US">Accrued Interest And Amortization Of Discount On Related Party And Shareholders Loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" xlink:to="jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AdvancesToSuppliers_lbl1" xml:lang="en-US">Advances To Suppliers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdvancesToSuppliers" xlink:to="jfbr_AdvancesToSuppliers_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_LeasesLineItems_lbl0" xml:lang="en-US">Leases Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_LeasesLineItems" xlink:to="jfbr_LeasesLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl0" xml:lang="en-US">Inventory, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0" xml:lang="en-US">Additional Paid in Capital, Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl1" xml:lang="en-US">Conversion of Stock, Shares Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl0" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl0" xml:lang="en-US">Interest Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockOtherSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Other Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockOtherSharesOutstanding" xlink:to="us-gaap_CommonStockOtherSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl0" xml:lang="en-US">Professional Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans_lbl1" xml:lang="en-US">Issuance Of Ordinary Shares Upon Conversion Of Shareholders Loans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans" xlink:to="jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl0" xml:lang="en-US">Income (Loss) from Equity Method Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_OtherPayablesTablesTable_lbl0" xml:lang="en-US">Other Payables Tables Table</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OtherPayablesTablesTable" xlink:to="jfbr_OtherPayablesTablesTable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl0" xml:lang="en-US">Auditor Location</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl0" xml:lang="en-US">Selling and Marketing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfOtherPayablesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfOtherPayablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfOtherPayablesAbstract_lbl" xml:lang="en-US">Schedule Of Other Payables Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfOtherPayablesAbstract" xlink:to="jfbr_ScheduleOfOtherPayablesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_lbl0" xml:lang="en-US">US Government Agencies Securities, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" xlink:to="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_OutstandingPayable_lbl1" xml:lang="en-US">Outstanding Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OutstandingPayable" xlink:to="jfbr_OutstandingPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_lbl0" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl0" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingAndMarketingExpense_lbl0" xml:lang="en-US">Other Selling and Marketing Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingAndMarketingExpense" xlink:to="us-gaap_OtherSellingAndMarketingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ThirdPartyLoan_lbl2" xml:lang="en-US">Third Party Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ThirdPartyLoan" xlink:to="jfbr_ThirdPartyLoan_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_NonCurrentAssetsAbstract_lbl0" xml:lang="en-US">Non Current Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_NonCurrentAssetsAbstract" xlink:to="jfbr_NonCurrentAssetsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl0" xml:lang="en-US">Business Combination, Contingent Consideration, Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit_lbl1" xml:lang="en-US">Deferred State And Local Income Tax Expenses Benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit" xlink:to="jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_SmartProMember_lbl0" xml:lang="en-US">Smart Pro Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_SmartProMember" xlink:to="jfbr_SmartProMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl0" xml:lang="en-US">Sale of Stock, Price Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_DeferredTaxAssetAbstract_lbl0" xml:lang="en-US">Deferred Tax Asset Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_DeferredTaxAssetAbstract" xlink:to="jfbr_DeferredTaxAssetAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl0" xml:lang="en-US">Subsequent Event [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">Other Selling, General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAdditionalCapital_lbl0" xml:lang="en-US">Other Additional Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAdditionalCapital" xlink:to="us-gaap_OtherAdditionalCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl0" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl0" xml:lang="en-US">City Area Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_OperatingLeaseAssets_lbl1" xml:lang="en-US">Operating Lease Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_OperatingLeaseAssets" xlink:to="jfbr_OperatingLeaseAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IssuanceCostsOnDerivativeLiabilities_lbl1" xml:lang="en-US">Issuance Costs On Derivative Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceCostsOnDerivativeLiabilities" xlink:to="jfbr_IssuanceCostsOnDerivativeLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl0" xml:lang="en-US">Increase (Decrease) in Inventories</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl0" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl0" xml:lang="en-US">Long-Term Debt, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl0" xml:lang="en-US">Leasehold Improvements [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl0" xml:lang="en-US">Entity Address, Country</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0" xml:lang="en-US">Equity Method Investment, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl0" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivableWithImputedInterestDiscount_lbl0" xml:lang="en-US">Receivable with Imputed Interest, Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivableWithImputedInterestDiscount" xlink:to="us-gaap_ReceivableWithImputedInterestDiscount_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfTotalIntangibleAssetsAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfTotalIntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfTotalIntangibleAssetsAbstract_lbl" xml:lang="en-US">Schedule Of Total Intangible Assets Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfTotalIntangibleAssetsAbstract" xlink:to="jfbr_ScheduleOfTotalIntangibleAssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl0" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCosts_lbl0" xml:lang="en-US">Deferred Costs, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCosts" xlink:to="us-gaap_DeferredCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl0" xml:lang="en-US">Other Receivables, Net, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNoncurrent_lbl0" xml:lang="en-US">Inventory, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNoncurrent" xlink:to="us-gaap_InventoryNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IPOAndAdditionalWarrants_lbl1" xml:lang="en-US">IPOAnd Additional Warrants</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IPOAndAdditionalWarrants" xlink:to="jfbr_IPOAndAdditionalWarrants_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl0" xml:lang="en-US">Labor and Related Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanFundedPercentage_lbl0" xml:lang="en-US">Defined Benefit Plan, Funded Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanFundedPercentage" xlink:to="us-gaap_DefinedBenefitPlanFundedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FinanceIncomeAbstract_lbl0" xml:lang="en-US">Finance Income Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceIncomeAbstract" xlink:to="jfbr_FinanceIncomeAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AdditionalDividendsPayableSharesValue_lbl1" xml:lang="en-US">Additional Dividends Payable Shares Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AdditionalDividendsPayableSharesValue" xlink:to="jfbr_AdditionalDividendsPayableSharesValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl0" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ShareIncentivePlanLineItems_lbl0" xml:lang="en-US">Share Incentive Plan Line Items</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ShareIncentivePlanLineItems" xlink:to="jfbr_ShareIncentivePlanLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToSuppliers_lbl0" xml:lang="en-US">Payments to Suppliers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToSuppliers" xlink:to="us-gaap_PaymentsToSuppliers_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToOtherRelatedPartiesNoncurrent_lbl0" xml:lang="en-US">Due to Other Related Parties, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToOtherRelatedPartiesNoncurrent" xlink:to="us-gaap_DueToOtherRelatedPartiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ExercisePriceAdjustment_lbl1" xml:lang="en-US">Exercise Price Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ExercisePriceAdjustment" xlink:to="jfbr_ExercisePriceAdjustment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForPreviousAcquisition_lbl0" xml:lang="en-US">Payments for Previous Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForPreviousAcquisition" xlink:to="us-gaap_PaymentsForPreviousAcquisition_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ComputersEquipmentMember_lbl0" xml:lang="en-US">Computers Equipment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ComputersEquipmentMember" xlink:to="jfbr_ComputersEquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl0" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Units</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_lbl0" xml:lang="en-US">Indefinite-Lived Intangible Assets, Written off Related to Sale of Business Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsCommonStock_lbl0" xml:lang="en-US">Dividends, Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStock" xlink:to="us-gaap_DividendsCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl0" xml:lang="en-US">Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_MinorityShareholderAmount_lbl1" xml:lang="en-US">Minority Shareholder Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MinorityShareholderAmount" xlink:to="jfbr_MinorityShareholderAmount_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_MedigusMember_lbl0" xml:lang="en-US">Medigus Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_MedigusMember" xlink:to="jfbr_MedigusMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FinancialincomeExpensesNet_lbl1" xml:lang="en-US">Financialincome Expenses Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinancialincomeExpensesNet" xlink:to="jfbr_FinancialincomeExpensesNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_AssetsAbstract0_lbl0" xml:lang="en-US">Assets Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_AssetsAbstract0" xlink:to="jfbr_AssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLaborRelatedExpenses_lbl0" xml:lang="en-US">Other Labor-related Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLaborRelatedExpenses" xlink:to="us-gaap_OtherLaborRelatedExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl0" xml:lang="en-US">Advertising Cost [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl0" xml:lang="en-US">ICFR Auditor Attestation Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionExercisePriceDecrease_lbl0" xml:lang="en-US">Stock Option, Exercise Price, Decrease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionExercisePriceDecrease" xlink:to="us-gaap_StockOptionExercisePriceDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent_lbl1" xml:lang="en-US">Derivative Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl0" xml:lang="en-US">Long-Term Line of Credit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl0" xml:lang="en-US">Other Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IncreaseDecreaseInTaxesOnIncomeResultingFromTheFollowingAbstract_lbl0" xml:lang="en-US">Increase Decrease In Taxes On Income Resulting From The Following Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IncreaseDecreaseInTaxesOnIncomeResultingFromTheFollowingAbstract" xlink:to="jfbr_IncreaseDecreaseInTaxesOnIncomeResultingFromTheFollowingAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl0" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_PureCapitalLtdMember_lbl0" xml:lang="en-US">Pure Capital Ltd Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PureCapitalLtdMember" xlink:to="jfbr_PureCapitalLtdMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract_lbl" xml:lang="en-US">Schedule Of Balances With Interested And Related Parties Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:to="jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelEmailAddress_lbl0" xml:lang="en-US">Contact Personnel Email Address</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl0" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_lbl0" xml:lang="en-US">Gross Profit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts_lbl1" xml:lang="en-US">Sharebased Compensation Included In Deferred Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts" xlink:to="jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_lbl1" xml:lang="en-US">Right Of Use Assets Obtained In Exchange For Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:to="jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_RevenuesPercentage_lbl1" xml:lang="en-US">Revenues Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_RevenuesPercentage" xlink:to="jfbr_RevenuesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FinanceExpensesInRespectOfThirdpartyLoan_lbl1" xml:lang="en-US">Finance Expenses In Respect Of Thirdparty Loan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FinanceExpensesInRespectOfThirdpartyLoan" xlink:to="jfbr_FinanceExpensesInRespectOfThirdpartyLoan_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl0" xml:lang="en-US">General and Administrative Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfBankDebt_lbl0" xml:lang="en-US">Repayments of Bank Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfBankDebt" xlink:to="us-gaap_RepaymentsOfBankDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_JeffsBrandsMember_lbl0" xml:lang="en-US">Jeffs Brands Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_JeffsBrandsMember" xlink:to="jfbr_JeffsBrandsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl0" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl0" xml:lang="en-US">Increase (Decrease) in Due to Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_WeightedAverageBorrowingRate_lbl1" xml:lang="en-US">Weighted Average Borrowing Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_WeightedAverageBorrowingRate" xlink:to="jfbr_WeightedAverageBorrowingRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_FiniteLivedIntangibleAssetAmortizationMethod_lbl1" xml:lang="en-US">Finite Lived Intangible Asset Amortization Method</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_FiniteLivedIntangibleAssetAmortizationMethod" xlink:to="jfbr_FiniteLivedIntangibleAssetAmortizationMethod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Interested And Related Parties Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock" xlink:to="jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl0" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl0" xml:lang="en-US">Document Fiscal Year Focus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PremiumsAndOtherReceivablesNet_lbl0" xml:lang="en-US">Premiums and Other Receivables, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PremiumsAndOtherReceivablesNet" xlink:to="us-gaap_PremiumsAndOtherReceivablesNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_PercentageLeaseAndMaintenanceExpensesRelated_lbl1" xml:lang="en-US">Percentage Lease And Maintenance Expenses Related</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_PercentageLeaseAndMaintenanceExpensesRelated" xlink:to="jfbr_PercentageLeaseAndMaintenanceExpensesRelated_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet_lbl0" xml:lang="en-US">Derivative, Fair Value, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract_lbl" xml:lang="en-US">Schedule Of Assets Are Depreciated Using The Straight Line Method To Allocate Their Cost Over Their Estimated Useful Lives Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract" xlink:to="jfbr_ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl0" xml:lang="en-US">Entity Current Reporting Status</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl0" xml:lang="en-US">Fair Value, Option, Changes in Fair Value, Gain (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_lbl0" xml:lang="en-US">Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_IssuanceOfBonusShares_lbl1" xml:lang="en-US">Issuance Of Bonus Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_IssuanceOfBonusShares" xlink:to="jfbr_IssuanceOfBonusShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl0" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl0" xml:lang="en-US">Additional Paid in Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl0" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl0" xml:lang="en-US">Auditor Firm ID</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl0" xml:lang="en-US">Property, Plant and Equipment, Salvage Value, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyCosts_lbl0" xml:lang="en-US">Related Party Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyCosts" xlink:to="us-gaap_RelatedPartyCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl3" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Current Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOfferingCosts_lbl0" xml:lang="en-US">Deferred Offering Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized_lbl0" xml:lang="en-US">Principal Amount Outstanding on Loans Securitized or Asset-Backed Financing Arrangement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized" xlink:to="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_Bonus_lbl1" xml:lang="en-US">Bonus</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_Bonus" xlink:to="jfbr_Bonus_lbl1"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract_lbl" xml:lang="en-US">Schedule Of Transactions With Interested And Related Parties Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl0" xml:lang="en-US">Foreign Tax Authority [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansAndLeasesReceivableRelatedParties_lbl0" xml:lang="en-US">Loans and Leases Receivable, Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansAndLeasesReceivableRelatedParties" xlink:to="us-gaap_LoansAndLeasesReceivableRelatedParties_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventoryInTransit_lbl0" xml:lang="en-US">Other Inventory, in Transit, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventoryInTransit" xlink:to="us-gaap_OtherInventoryInTransit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl0" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Stockholders&apos; Equity, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:to="us-gaap_StockholdersEquityPeriodIncreaseDecrease_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium_lbl0" xml:lang="en-US">Adjustment to Additional Paid-in Capital, Convertible Debt Instrument Issued at Substantial Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" xlink:to="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl0" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_lbl0" xml:lang="en-US">Interest and Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDilutedProFormaAdjustment_lbl1" xml:lang="en-US">Earnings Per Share, Diluted, Pro Forma Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedProFormaAdjustment" xlink:to="us-gaap_EarningsPerShareDilutedProFormaAdjustment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExcessStockSharesIssued_lbl0" xml:lang="en-US">Excess Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessStockSharesIssued" xlink:to="us-gaap_ExcessStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl0" xml:lang="en-US">Stockholders&apos; Equity, Reverse Stock Split</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MembersCapital_lbl0" xml:lang="en-US">Members&apos; Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MembersCapital" xlink:to="us-gaap_MembersCapital_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract_lbl" xml:lang="en-US">Schedule Of Basic And Diluted Net Income Loss Per Share Attributable To Ordinary Shareholders Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IL_lbl0" xml:lang="en-US">ISRAEL</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract_lbl" xml:lang="en-US">Schedule Of Future Lease Payments Under Operating Leases Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:to="jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl0" xml:lang="en-US">Temporary Equity, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights_lbl1" xml:lang="en-US">Class Of Warrant Or Right Adjusted Exercise Price Of Warrants Or Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights" xlink:to="jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0" xml:lang="en-US">Payments to Acquire Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="jfbr_ScheduleOfOtherReceivablesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfOtherReceivablesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfOtherReceivablesAbstract_lbl" xml:lang="en-US">Schedule Of Other Receivables Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfOtherReceivablesAbstract" xlink:to="jfbr_ScheduleOfOtherReceivablesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableCurrent_lbl0" xml:lang="en-US">Loans Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Finance Income Expenses Net Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock" xlink:to="jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>jfbr-20221231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Apr 10 08:08:28 UTC 2023 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedBalanceSheet" roleURI="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedIncomeStatement" roleURI="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedIncomeStatement_Parentheticals" roleURI="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareholdersEquityType2or3" roleURI="http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ConsolidatedCashFlow" roleURI="http://www.jeffsbrands.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_GeneralInformation" roleURI="http://www.jeffsbrands.com/role/GeneralInformation"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_SummaryofSignificantAccountingPolicies" roleURI="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_Otherreceivables" roleURI="http://www.jeffsbrands.com/role/Otherreceivables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_Inventory" roleURI="http://www.jeffsbrands.com/role/Inventory"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_IntangibleAssets" roleURI="http://www.jeffsbrands.com/role/IntangibleAssets"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_Leases" roleURI="http://www.jeffsbrands.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_OtherPayables" roleURI="http://www.jeffsbrands.com/role/OtherPayables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShortTermLoans" roleURI="http://www.jeffsbrands.com/role/ShortTermLoans"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_DerivativeLiabilities" roleURI="http://www.jeffsbrands.com/role/DerivativeLiabilities"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_LoansfromShareholders" roleURI="http://www.jeffsbrands.com/role/LoansfromShareholders"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_TaxesonIncome" roleURI="http://www.jeffsbrands.com/role/TaxesonIncome"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareCapital" roleURI="http://www.jeffsbrands.com/role/ShareCapital"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareIncentivePlan" roleURI="http://www.jeffsbrands.com/role/ShareIncentivePlan"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_FinanceIncomeExpenseNet" roleURI="http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_NetIncomeLossPerShareAttributabletoOrdinaryShareholders" roleURI="http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholders"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_RelatedParties" roleURI="http://www.jeffsbrands.com/role/RelatedParties"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_SubsequentEvents" roleURI="http://www.jeffsbrands.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_AccountingPoliciesByPolicy" roleURI="http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_OtherreceivablesTables" roleURI="http://www.jeffsbrands.com/role/OtherreceivablesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_InventoryTables" roleURI="http://www.jeffsbrands.com/role/InventoryTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_IntangibleAssetsTables" roleURI="http://www.jeffsbrands.com/role/IntangibleAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_LeasesTables" roleURI="http://www.jeffsbrands.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_OtherPayablesTables" roleURI="http://www.jeffsbrands.com/role/OtherPayablesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShortTermLoansTables" roleURI="http://www.jeffsbrands.com/role/ShortTermLoansTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_DerivativeLiabilitiesTables" roleURI="http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_LoansfromShareholdersTables" roleURI="http://www.jeffsbrands.com/role/LoansfromShareholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_TaxesonIncomeTables" roleURI="http://www.jeffsbrands.com/role/TaxesonIncomeTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareCapitalTables" roleURI="http://www.jeffsbrands.com/role/ShareCapitalTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_FinanceIncomeExpenseNetTables" roleURI="http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables" roleURI="http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_RelatedPartiesTables" roleURI="http://www.jeffsbrands.com/role/RelatedPartiesTables"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofotherreceivablesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofinventoryTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofinventoryTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoftotalintangibleassetsTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoffutureleasepaymentsunderoperatingleasesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofotherpayablesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofshorttermloansTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoffairvalueofthederivativewarrantliabilityTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofloansfromshareholdersconsistsTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofincomelossbeforetaxesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofincometaxexpensebenefitTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofdeferredtaxesassetsandliabilitiesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofsharecapitalcomposedofordinarysharesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofsharecapitalcomposedofordinarysharesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoffinanceincomeexpensesnetTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals" roleURI="http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofdilutedweightedaveragesharesoutstandingTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleoftransactionswithinterestedandrelatedpartiesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ScheduleofbalanceswithinterestedandrelatedpartiesTable" roleURI="http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_GeneralInformationDetails" roleURI="http://www.jeffsbrands.com/role/GeneralInformationDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_OtherreceivablesDetails" roleURI="http://www.jeffsbrands.com/role/OtherreceivablesDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_IntangibleAssetsDetails" roleURI="http://www.jeffsbrands.com/role/IntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_LeasesDetails" roleURI="http://www.jeffsbrands.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShortTermLoansDetails" roleURI="http://www.jeffsbrands.com/role/ShortTermLoansDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_DerivativeLiabilitiesDetails" roleURI="http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_LoansfromShareholdersDetails" roleURI="http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_TaxesonIncomeDetails" roleURI="http://www.jeffsbrands.com/role/TaxesonIncomeDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareCapitalDetails" roleURI="http://www.jeffsbrands.com/role/ShareCapitalDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_ShareIncentivePlanDetails" roleURI="http://www.jeffsbrands.com/role/ShareIncentivePlanDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_RelatedPartiesDetails" roleURI="http://www.jeffsbrands.com/role/RelatedPartiesDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#jfbr_r_SubsequentEventsDetails" roleURI="http://www.jeffsbrands.com/role/SubsequentEventsDetails"/>
  <roleRef xlink:type="simple" xlink:href="jfbr-20221231.xsd#DocumentAndEntityInformation" roleURI="http://www.jeffsbrands.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_InventoryNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentAssetsAbstract" xlink:href="jfbr-20221231.xsd#jfbr_NonCurrentAssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentAssetsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_DeferredCosts" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentAssetsAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLoansPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLoansPayableCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ShortTermBankLoansAndNotesPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="NonCurrentLiabilitiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_NonCurrentLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="NonCurrentLiabilitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLoansPayableLongTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLoansPayableLongTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_OtherLoansPayableLongTerm" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonCurrentLiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockNoParValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSold" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_GrossProfit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_SellingAndMarketingExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingGeneralAndAdministrativeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OtherSellingGeneralAndAdministrativeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialincomeExpensesNet" xlink:href="jfbr-20221231.xsd#jfbr_FinancialincomeExpensesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="FinancialincomeExpensesNet" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossAttributableToParent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="3.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" xlink:href="jfbr-20221231.xsd#jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares" xlink:href="jfbr-20221231.xsd#jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_0" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_0" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherDepreciationAndAmortization" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" xlink:href="jfbr-20221231.xsd#jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShortTermLeasePayments" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceCostsOnDerivativeLiabilities" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceCostsOnDerivativeLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IssuanceCostsOnDerivativeLiabilities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueToRelatedParties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInInventories" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromOtherShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromOtherShortTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromOtherShortTermDebt" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfOtherShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherShortTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfOtherShortTermDebt" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromBankDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromBankDebt" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RepaymentsOfBankDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfBankDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfBankDebt" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_InterestPaidNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredOfferingCostsIncludedInOtherPayables" xlink:href="jfbr-20221231.xsd#jfbr_DeferredOfferingCostsIncludedInOtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="DeferredOfferingCostsIncludedInOtherPayables" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharebasedCompensationIncludedInDeferredOfferingCosts" xlink:href="jfbr-20221231.xsd#jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="SharebasedCompensationIncludedInDeferredOfferingCosts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubstantialModificationOfShareholdersLoansRecordedInEquity" xlink:href="jfbr-20221231.xsd#jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="SubstantialModificationOfShareholdersLoansRecordedInEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" xlink:href="jfbr-20221231.xsd#jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/GeneralInformation">
    <loc xlink:type="locator" xlink:label="GeneralInformationAbstract" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralInformationTextBlock" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationAbstract" xlink:to="GeneralInformationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/Otherreceivables">
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/Inventory">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/IntangibleAssets">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsTable" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsTable"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="IntangibleAssetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsTable" xlink:to="IntangibleAssetsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsLineItems" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/Leases">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="LeasesTable" xlink:href="jfbr-20221231.xsd#jfbr_LeasesTable"/>
    <loc xlink:type="locator" xlink:label="LeasesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LeasesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="LeasesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesTable" xlink:to="LeasesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesLineItems" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/OtherPayables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShortTermLoans">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ShortTermDebtTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/DerivativeLiabilities">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/LoansfromShareholders">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="LoansfromShareholdersTable" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersTable"/>
    <loc xlink:type="locator" xlink:label="LoansfromShareholdersLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="LoansfromShareholdersTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersTable" xlink:to="LoansfromShareholdersLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersLineItems" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/TaxesonIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareCapital">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareIncentivePlan">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareIncentivePlanTable" xlink:href="jfbr-20221231.xsd#jfbr_ShareIncentivePlanTable"/>
    <loc xlink:type="locator" xlink:label="ShareIncentivePlanLineItems" xlink:href="jfbr-20221231.xsd#jfbr_ShareIncentivePlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ShareIncentivePlanTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareIncentivePlanTable" xlink:to="ShareIncentivePlanLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareIncentivePlanLineItems" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet">
    <loc xlink:type="locator" xlink:label="us-gaap_BankingAndThriftInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankingAndThriftInterestAbstract"/>
    <loc xlink:type="locator" xlink:label="FinanceIncomeExpenseNetTable" xlink:href="jfbr-20221231.xsd#jfbr_FinanceIncomeExpenseNetTable"/>
    <loc xlink:type="locator" xlink:label="FinanceIncomeExpenseNetLineItems" xlink:href="jfbr-20221231.xsd#jfbr_FinanceIncomeExpenseNetLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BankingAndThriftInterestAbstract" xlink:to="FinanceIncomeExpenseNetTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceIncomeExpenseNetTable" xlink:to="FinanceIncomeExpenseNetLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceIncomeExpenseNetLineItems" xlink:to="us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholders">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/RelatedParties">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InventoryPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredChargesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionCustomerAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionCustomerAcquisitions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionCustomerAcquisitions" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PolicyLoansReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyLoansReceivablePolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PolicyLoansReceivablePolicy" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CostOfSalesPolicyTextBlock" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPPolicy" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/OtherreceivablesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/InventoryTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/IntangibleAssetsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsTablesTable" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsTablesTable"/>
    <loc xlink:type="locator" xlink:label="IntangibleAssetsTablesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_IntangibleAssetsTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="IntangibleAssetsTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsTablesTable" xlink:to="IntangibleAssetsTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IntangibleAssetsTablesLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/OtherPayablesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <loc xlink:type="locator" xlink:label="OtherPayablesTablesTable" xlink:href="jfbr-20221231.xsd#jfbr_OtherPayablesTablesTable"/>
    <loc xlink:type="locator" xlink:label="OtherPayablesTablesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_OtherPayablesTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="OtherPayablesTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherPayablesTablesTable" xlink:to="OtherPayablesTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherPayablesTablesLineItems" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShortTermLoansTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShortTermDebtTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/LoansfromShareholdersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="LoansfromShareholdersTablesTable" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersTablesTable"/>
    <loc xlink:type="locator" xlink:label="LoansfromShareholdersTablesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="LoansfromShareholdersTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersTablesTable" xlink:to="LoansfromShareholdersTablesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersTablesLineItems" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/TaxesonIncomeTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareCapitalTables">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_BankingAndThriftInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BankingAndThriftInterestAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfFinanceIncomeExpensesNetTableTextBlock" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BankingAndThriftInterestAbstract" xlink:to="ScheduleOfFinanceIncomeExpensesNetTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/RelatedPartiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfInterestedAndRelatedPartiesTableTextBlock" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="ScheduleOfInterestedAndRelatedPartiesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ComputersEquipmentMember" xlink:href="jfbr-20221231.xsd#jfbr_ComputersEquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ComputersEquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherReceivablesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfOtherReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Supplies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Supplies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherReceivablesAbstract" xlink:to="us-gaap_Supplies" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GovernmentContractReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherReceivablesAbstract" xlink:to="us-gaap_GovernmentContractReceivable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherReceivablesAbstract" xlink:to="us-gaap_OtherReceivables" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PremiumsAndOtherReceivablesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsAndOtherReceivablesNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherReceivablesAbstract" xlink:to="us-gaap_PremiumsAndOtherReceivablesNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofinventoryTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfInventoryAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfInventoryAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInventoryInTransit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventoryInTransit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoryAbstract" xlink:to="us-gaap_OtherInventoryInTransit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoryAbstract" xlink:to="us-gaap_InventoryFinishedGoods" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInventoryAbstract" xlink:to="us-gaap_InventoryGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTotalIntangibleAssetsAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfTotalIntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTotalIntangibleAssetsAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BrandsMember" xlink:href="jfbr-20221231.xsd#jfbr_BrandsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="BrandsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FutureOperatingLeasePayments" xlink:href="jfbr-20221231.xsd#jfbr_FutureOperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="FutureOperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivableWithImputedInterestDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableWithImputedInterestDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_ReceivableWithImputedInterestDiscount" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PresentValueOfLeaseLiability" xlink:href="jfbr-20221231.xsd#jfbr_PresentValueOfLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="PresentValueOfLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfOtherPayablesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfOtherPayablesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherPayablesAbstract" xlink:to="us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherPayablesAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherPayablesAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherPayablesAbstract" xlink:to="us-gaap_InterestPayableCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AccruedExpensesAndOtherPayables" xlink:href="jfbr-20221231.xsd#jfbr_AccruedExpensesAndOtherPayables"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherPayablesAbstract" xlink:to="AccruedExpensesAndOtherPayables" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfOtherPayablesAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShortTermLoansAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfShortTermLoansAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShortTermLoansAbstract" xlink:to="us-gaap_LoansPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansAndLeasesReceivableRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansAndLeasesReceivableRelatedParties"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShortTermLoansAbstract" xlink:to="us-gaap_LoansAndLeasesReceivableRelatedParties" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThirdPartyLoan" xlink:href="jfbr-20221231.xsd#jfbr_ThirdPartyLoan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShortTermLoansAbstract" xlink:to="ThirdPartyLoan" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShortTermLoansAbstract" xlink:to="us-gaap_ShortTermBorrowings" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" xlink:href="jfbr-20221231.xsd#jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueOfWarrantLiabilityToBeIssuedToThirdparty" xlink:href="jfbr-20221231.xsd#jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="FairValueOfWarrantLiabilityToBeIssuedToThirdparty" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInFairValue" xlink:href="jfbr-20221231.xsd#jfbr_ChangeInFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="ChangeInFairValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_0" xlink:href="jfbr-20221231.xsd#jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue_0" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract"/>
    <loc xlink:type="locator" xlink:label="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"/>
    <loc xlink:type="locator" xlink:label="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract" xlink:to="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable" xlink:to="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_SharePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfWeightedAverageCostInventory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfLoansFromShareholdersConsistsAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLoansFromShareholdersConsistsAbstract" xlink:to="us-gaap_LoansPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLoansFromShareholdersConsistsAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfLoansFromShareholdersConsistsAbstract" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIncomeLossBeforeTaxesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfIncomeLossBeforeTaxesAbstract"/>
    <loc xlink:type="locator" xlink:label="TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable" xlink:href="jfbr-20221231.xsd#jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable"/>
    <loc xlink:type="locator" xlink:label="TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems" xlink:href="jfbr-20221231.xsd#jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeLossBeforeTaxesAbstract" xlink:to="TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_IL" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="country_IL" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_ForeignCountryMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrZqAlP1yOSc1A/ANEzuo53ddr/LMBLom9FlRSK3NKkyEbonVWG5HPDY+G1lW3BvjVh1hGR4TsEWxikRSd2CzczjxOi38/JBT4C/OcGQ5Ko7wX9cWbP+EcSCjzoKw5UOEXtltIx6qGM8m+WHjAhoKAqHXg9v/7inBQezt5KwYVPvHGi+aa1see5Nnq1daHt5a31TWM/ud+c/Ztt5Y5WGKdMC] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable" xlink:to="TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract"/>
    <loc xlink:type="locator" xlink:label="CurrentStateAndLocalTaxExpensesBenefit" xlink:href="jfbr-20221231.xsd#jfbr_CurrentStateAndLocalTaxExpensesBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="CurrentStateAndLocalTaxExpensesBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredAbstract" xlink:href="jfbr-20221231.xsd#jfbr_DeferredAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="DeferredAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredStateAndLocalIncomeTaxExpensesBenefit" xlink:href="jfbr-20221231.xsd#jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredAbstract" xlink:to="DeferredStateAndLocalIncomeTaxExpensesBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxExpenseBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherReconcilingItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetAbstract" xlink:href="jfbr-20221231.xsd#jfbr_DeferredTaxAssetAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxAssetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetAbstract" xlink:to="us-gaap_OperatingLossCarryforwards" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DifferencesBetweenTaxBasisAndCarryingValueOfLoans" xlink:href="jfbr-20221231.xsd#jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="DifferencesBetweenTaxBasisAndCarryingValueOfLoans" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesOther" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofsharecapitalcomposedofordinarysharesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinanceIncomeExpensesNetAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract"/>
    <loc xlink:type="locator" xlink:label="FinanceIncomeAbstract" xlink:href="jfbr-20221231.xsd#jfbr_FinanceIncomeAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinanceIncomeExpensesNetAbstract" xlink:to="FinanceIncomeAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceIncomeAbstract" xlink:to="us-gaap_FairValueOptionChangesInFairValueGainLoss1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceIncomeAbstract" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceIncomeAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="FinanceExpenseAbstract" xlink:href="jfbr-20221231.xsd#jfbr_FinanceExpenseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinanceIncomeExpensesNetAbstract" xlink:to="FinanceExpenseAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinanceExpensesInRespectOfThirdpartyLoan" xlink:href="jfbr-20221231.xsd#jfbr_FinanceExpensesInRespectOfThirdpartyLoan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceExpenseAbstract" xlink:to="FinanceExpensesInRespectOfThirdpartyLoan" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInDerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDerivativeLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceExpenseAbstract" xlink:to="us-gaap_IncreaseDecreaseInDerivativeLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceExpenseAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceExpenseAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceExpenseAbstract" xlink:to="us-gaap_InterestExpenseRelatedParty" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceExpenseAbstract" xlink:to="us-gaap_OtherTaxExpenseBenefit" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinanceExpenseNet" xlink:href="jfbr-20221231.xsd#jfbr_FinanceExpenseNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceExpenseAbstract" xlink:to="FinanceExpenseNet" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="us-gaap_WeightedAverageBasicSharesOutstandingProForma" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedProFormaAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedProFormaAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="us-gaap_EarningsPerShareDilutedProFormaAdjustment" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals">
    <loc xlink:type="locator" xlink:label="ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedProFormaAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDilutedProFormaAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract" xlink:to="us-gaap_EarningsPerShareDilutedProFormaAdjustment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract"/>
    <loc xlink:type="locator" xlink:label="IPOAndAdditionalWarrants" xlink:href="jfbr-20221231.xsd#jfbr_IPOAndAdditionalWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:to="IPOAndAdditionalWarrants" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwriterWarrants" xlink:href="jfbr-20221231.xsd#jfbr_UnderwriterWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:to="UnderwriterWarrants" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherWarrants" xlink:href="jfbr-20221231.xsd#jfbr_OtherWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:to="OtherWarrants" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TotalDilutedWeightedAverageSharesOutstanding" xlink:href="jfbr-20221231.xsd#jfbr_TotalDilutedWeightedAverageSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract" xlink:to="TotalDilutedWeightedAverageSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LaborAndRelatedExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_LaborAndRelatedExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NoninterestExpenseDirectorsFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoninterestExpenseDirectorsFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_NoninterestExpenseDirectorsFees" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_ProfessionalFees" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestExpensesOnLoansFromRelatedPartiesAndShareholders" xlink:href="jfbr-20221231.xsd#jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="InterestExpensesOnLoansFromRelatedPartiesAndShareholders" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:href="jfbr-20221231.xsd#jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="AssetsAbstract0" xlink:href="jfbr-20221231.xsd#jfbr_AssetsAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:to="AssetsAbstract0" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdvancesToSuppliers" xlink:href="jfbr-20221231.xsd#jfbr_AdvancesToSuppliers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract0" xlink:to="AdvancesToSuppliers" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_OtherAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LoansFromShareholders" xlink:href="jfbr-20221231.xsd#jfbr_LoansFromShareholders"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="LoansFromShareholders" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DueToOtherRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DueToOtherRelatedPartiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_DueToOtherRelatedPartiesNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract" xlink:to="us-gaap_OtherLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/GeneralInformationDetails">
    <loc xlink:type="locator" xlink:label="GeneralInformationAbstract" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="GeneralInformationDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationDetailsTable"/>
    <loc xlink:type="locator" xlink:label="GeneralInformationDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_GeneralInformationDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationAbstract" xlink:to="GeneralInformationDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="IPOWarrantMember" xlink:href="jfbr-20221231.xsd#jfbr_IPOWarrantMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="IPOWarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritersWarrantsMember" xlink:href="jfbr-20221231.xsd#jfbr_UnderwritersWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="UnderwritersWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SmartProMember" xlink:href="jfbr-20221231.xsd#jfbr_SmartProMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="SmartProMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurexCorpMember" xlink:href="jfbr-20221231.xsd#jfbr_PurexCorpMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="PurexCorpMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="JeffsBrandsMember" xlink:href="jfbr-20221231.xsd#jfbr_JeffsBrandsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="JeffsBrandsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MrHakmonMember" xlink:href="jfbr-20221231.xsd#jfbr_MrHakmonMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="MrHakmonMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsTable" xlink:to="GeneralInformationDetailsLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePriceAdjustment" xlink:href="jfbr-20221231.xsd#jfbr_ExercisePriceAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="ExercisePriceAdjustment" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfAdditionalWarrantOrRightOutstanding" xlink:href="jfbr-20221231.xsd#jfbr_ClassOfAdditionalWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="ClassOfAdditionalWarrantOrRightOutstanding" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstanding" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetProceedsOfWarrants" xlink:href="jfbr-20221231.xsd#jfbr_NetProceedsOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="NetProceedsOfWarrants" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights" xlink:href="jfbr-20221231.xsd#jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BonusSharesAndReverseShareSplitDescription" xlink:href="jfbr-20221231.xsd#jfbr_BonusSharesAndReverseShareSplitDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="BonusSharesAndReverseShareSplitDescription" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityReverseStockSplit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_NetIncomeLoss" order="18.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GeneralInformationDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MaturityOfTimeDeposits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaturityOfTimeDeposits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MaturityOfTimeDeposits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredOfferingCosts" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherSellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSellingAndMarketingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OtherSellingAndMarketingExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/OtherreceivablesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAdditionalCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAdditionalCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_OtherAdditionalCapital" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/IntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_AdjustmentForAmortization" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FiniteLivedIntangibleAssetAmortizationMethod" xlink:href="jfbr-20221231.xsd#jfbr_FiniteLivedIntangibleAssetAmortizationMethod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="FiniteLivedIntangibleAssetAmortizationMethod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/LeasesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureTextBlockAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperatingLeaseAssets" xlink:href="jfbr-20221231.xsd#jfbr_OperatingLeaseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="OperatingLeaseAssets" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeFinanceLeaseRenewalTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeaseRenewalTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="us-gaap_LesseeFinanceLeaseRenewalTerm1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageBorrowingRate" xlink:href="jfbr-20221231.xsd#jfbr_WeightedAverageBorrowingRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockAbstract" xlink:to="WeightedAverageBorrowingRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShortTermLoansDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="AggregatesAmount" xlink:href="jfbr-20221231.xsd#jfbr_AggregatesAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="AggregatesAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForPreviousAcquisition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPreviousAcquisition"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_PaymentsForPreviousAcquisition" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtPercentageBearingFixedInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ShortTermDebtPercentageBearingFixedInterestRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LoansPayable" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateAmount" xlink:href="jfbr-20221231.xsd#jfbr_AggregateAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="AggregateAmount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrincipalLoanAmount" xlink:href="jfbr-20221231.xsd#jfbr_PrincipalLoanAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="PrincipalLoanAmount" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShorttermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ShorttermDebtFairValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtCurrent" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_OtherExpenses" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtPercentageBearingVariableInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ShortTermDebtPercentageBearingVariableInterestRate" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShortTermLineOfCredits" xlink:href="jfbr-20221231.xsd#jfbr_ShortTermLineOfCredits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="ShortTermLineOfCredits" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LinesOfCreditCurrent" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="DerivativeLiabilitiesDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="DerivativeLiabilitiesDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiabilitiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="DerivativeLiabilitiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="IssuanceDateMember" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceDateMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="IssuanceDateMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnderwritersWarrantsMember" xlink:href="jfbr-20221231.xsd#jfbr_UnderwritersWarrantsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="UnderwritersWarrantsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsTable" xlink:to="DerivativeLiabilitiesDetailsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ThirdPartyLoan" xlink:href="jfbr-20221231.xsd#jfbr_ThirdPartyLoan"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="ThirdPartyLoan" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DerivativeLiability" xlink:href="jfbr-20221231.xsd#jfbr_DerivativeLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="DerivativeLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceIncrease" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PublicOfferingPricePerShare" xlink:href="jfbr-20221231.xsd#jfbr_PublicOfferingPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="PublicOfferingPricePerShare" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExcessStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_ExcessStockSharesIssued" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WarrantExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantExercisePriceDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_WarrantExercisePriceDecrease" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalWarrants" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="AdditionalWarrants" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAsset" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeCostOfHedgeNetOfCashReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeCostOfHedgeNetOfCashReceived"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_DerivativeCostOfHedgeNetOfCashReceived" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_ProceedsFromDebtNetOfIssuanceCosts" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevenuesPercentage" xlink:href="jfbr-20221231.xsd#jfbr_RevenuesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="RevenuesPercentage" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyFairValue" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartyFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="RelatedPartyFairValue" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DerivativeLiabilitiesDetailsLineItems" xlink:to="us-gaap_DerivativeFairValueOfDerivativeNet" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/LoansfromShareholdersDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="LoansfromShareholdersDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersDetailsTable"/>
    <loc xlink:type="locator" xlink:label="LoansfromShareholdersDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_LoansfromShareholdersDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="LoansfromShareholdersDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AmazoncomMember" xlink:href="jfbr-20221231.xsd#jfbr_AmazoncomMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="AmazoncomMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MedigusMember" xlink:href="jfbr-20221231.xsd#jfbr_MedigusMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="MedigusMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MrHakmonAndLIAMember" xlink:href="jfbr-20221231.xsd#jfbr_MrHakmonAndLIAMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="MrHakmonAndLIAMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PureCapitalLtdMember" xlink:href="jfbr-20221231.xsd#jfbr_PureCapitalLtdMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="PureCapitalLtdMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsTable" xlink:to="LoansfromShareholdersDetailsLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_LineOfCredit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_LongTermDebt" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedBenefitPlanFundedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DefinedBenefitPlanFundedPercentage" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_InvestmentInterestRate" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedTrademarksGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedTrademarksGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_FiniteLivedTrademarksGross" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InventoryNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_InventoryNoncurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherMinorityInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherMinorityInterests"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_OtherMinorityInterests" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseOtherShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseOtherShortTermBorrowings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_InterestExpenseOtherShortTermBorrowings" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrincipalAmountOutstandingOnLoansSecuritized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_PrincipalAmountOutstandingOnLoansSecuritized" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DividendsCommonStock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DerivativeLiabilitiesNoncurrent" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_StockholdersEquityPeriodIncreaseDecrease" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LoansfromShareholdersDetailsLineItems" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/TaxesonIncomeDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareCapitalDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_ShareCapitalDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ShareCapitalDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_ShareCapitalDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="ShareCapitalDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MajorityShareholderMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MajorityShareholderMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_MajorityShareholderMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_IPOMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OverAllotmentOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_OverAllotmentOptionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_CommonStockMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsTable" xlink:to="srt_RangeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember_1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember_1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsTable" xlink:to="ShareCapitalDetailsLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="AgreementDescription" xlink:href="jfbr-20221231.xsd#jfbr_AgreementDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="AgreementDescription" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuedAndOutstandingShareCapitalPercentage" xlink:href="jfbr-20221231.xsd#jfbr_IssuedAndOutstandingShareCapitalPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="IssuedAndOutstandingShareCapitalPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InvestAmount" xlink:href="jfbr-20221231.xsd#jfbr_InvestAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="InvestAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_SharesIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MinorityShareholderAmount" xlink:href="jfbr-20221231.xsd#jfbr_MinorityShareholderAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="MinorityShareholderAmount" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_PaymentsOfDividendsCommonStock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfPeriodTerm" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceOfPeriodTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="IssuanceOfPeriodTerm" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="IssuanceOfBonusShares" xlink:href="jfbr-20221231.xsd#jfbr_IssuanceOfBonusShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="IssuanceOfBonusShares" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateIssuanceShares" xlink:href="jfbr-20221231.xsd#jfbr_AggregateIssuanceShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="AggregateIssuanceShares" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GrossProceeds" xlink:href="jfbr-20221231.xsd#jfbr_GrossProceeds"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="GrossProceeds" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InitialExercisePriceExpire" xlink:href="jfbr-20221231.xsd#jfbr_InitialExercisePriceExpire"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="InitialExercisePriceExpire" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionExercisePriceDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionExercisePriceDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_StockOptionExercisePriceDecrease" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionExercisePriceIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockOptionExercisePriceIncrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_StockOptionExercisePriceIncrease" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalWarrantTerm" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalWarrantTerm"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="AdditionalWarrantTerm" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RevenuesPercentage" xlink:href="jfbr-20221231.xsd#jfbr_RevenuesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="RevenuesPercentage" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_FairValueAdjustmentOfWarrants" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalWarrantsDescription" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalWarrantsDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="AdditionalWarrantsDescription" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsideredAsIssuanceCosts" xlink:href="jfbr-20221231.xsd#jfbr_ConsideredAsIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="ConsideredAsIssuanceCosts" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareCapitalDetailsLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/ShareIncentivePlanDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/RelatedPartiesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartiesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartiesDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="RelatedPartiesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="MinorityShareholderMember" xlink:href="jfbr-20221231.xsd#jfbr_MinorityShareholderMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="MinorityShareholderMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_BoardOfDirectorsChairmanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsTable" xlink:to="RelatedPartiesDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="us-gaap_SharesIssued" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyFairValue" xlink:href="jfbr-20221231.xsd#jfbr_RelatedPartyFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="RelatedPartyFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="us-gaap_AccruedPayrollTaxesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SalariesWagesAndOfficersCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalariesWagesAndOfficersCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="us-gaap_SalariesWagesAndOfficersCompensation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Bonus" xlink:href="jfbr-20221231.xsd#jfbr_Bonus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="Bonus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConsultancyServicesFees" xlink:href="jfbr-20221231.xsd#jfbr_ConsultancyServicesFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="ConsultancyServicesFees" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfGrossProceed" xlink:href="jfbr-20221231.xsd#jfbr_PercentageOfGrossProceed"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="PercentageOfGrossProceed" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfTotalConsiderationPaid" xlink:href="jfbr-20221231.xsd#jfbr_PercentageOfTotalConsiderationPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="PercentageOfTotalConsiderationPaid" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UndefinedPeriodOfTime" xlink:href="jfbr-20221231.xsd#jfbr_UndefinedPeriodOfTime"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="UndefinedPeriodOfTime" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToSuppliers" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToSuppliers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="us-gaap_PaymentsToSuppliers" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageLeaseAndMaintenanceExpensesRelated" xlink:href="jfbr-20221231.xsd#jfbr_PercentageLeaseAndMaintenanceExpensesRelated"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="PercentageLeaseAndMaintenanceExpensesRelated" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLaborRelatedExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLaborRelatedExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="us-gaap_OtherLaborRelatedExpenses" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OutstandingPayable" xlink:href="jfbr-20221231.xsd#jfbr_OutstandingPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="OutstandingPayable" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="us-gaap_RelatedPartyCosts" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionDueFromToRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="us-gaap_RelatedPartyTransactionDueFromToRelatedParty" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestIncomeRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeRelatedParty"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesDetailsLineItems" xlink:to="us-gaap_InterestIncomeRelatedParty" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/SubsequentEventsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsTable" xlink:href="jfbr-20221231.xsd#jfbr_SubsequentEventsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SubsequentEventsDetailsLineItems" xlink:href="jfbr-20221231.xsd#jfbr_SubsequentEventsDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="SubsequentEventsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="srt_OwnershipAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="OwnershipMember" xlink:href="jfbr-20221231.xsd#jfbr_OwnershipMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="OwnershipMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsTable" xlink:to="SubsequentEventsDetailsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockOtherSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockOtherSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_CommonStockOtherSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage" xlink:href="jfbr-20221231.xsd#jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage" xlink:href="jfbr-20221231.xsd#jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_DividendsPayableCurrentAndNoncurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdditionalDividendsPayableSharesValue" xlink:href="jfbr-20221231.xsd#jfbr_AdditionalDividendsPayableSharesValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="AdditionalDividendsPayableSharesValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MembersCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MembersCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_MembersCapital" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_DebtInstrumentFeeAmount" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PartnersCapitalAccountReturnOfCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PartnersCapitalAccountReturnOfCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsDetailsLineItems" xlink:to="us-gaap_PartnersCapitalAccountReturnOfCapital" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.jeffsbrands.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="jfbr-20221231.xsd#jfbr_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AddressTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_BusinessContactMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_BusinessContactMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="2.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentRegistrationStatement" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentShellCompanyReport" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCountry" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelName" order="29.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="30.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="31.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ContactPersonnelEmailAddress"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_ContactPersonnelEmailAddress" order="32.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="33.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="34.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="35.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAccountingStandard" order="36.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="37.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="38.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="39.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "9 6 # 2(  A$! Q$!_\0
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MMZ@\]#7??"S_ ) 5Y_U\_P#LHKGQ<E*@VC6@FJEF=W1117B'HA1110 4444
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MT_5[O396E@*M(0 &D&XKCIBJYO+HJZ_:9@KL690Y )/4XKT/_A5 _P"@N?\
MOQ_]>C_A5 _Z"Y_[\?\ UZ/K6'O>_P" _8U3SJ6XGN-OG3R2[1A=[EL?G7J?
MPL_Y 5Y_U\_^RBJ/_"J!_P!!<_\ ?G_Z]=7X6\.?\(U8S6WVHW'F2^9NV;<<
M 8_2N?%8BE.ERQ9K1I3C.\C>HHHKR3M"BBB@ HHHH **** "O$/'?_(Y7W_
M?_017M]<-KWP^76=:FOSJ?DF;&(_+ST&/6NS!U(TYMR?0PKP<HV1Y0DCQYV.
MR[A@[21D>AI1-*$V"5PN,;=QQCKC\Z]&_P"%4#_H+G_OQ_\ 7H_X50/^@N?^
M_'_UZ]/ZW0[_ (''["IV/.9)I9?]9*[\Y^9B>:/.ER3YLF2 "=QY Z"O1O\
MA5 _Z"Y_[\__ %Z/^%4#_H+G_OQ_]>CZW0[_ (!["IV//6O;MI%D:[G+IRK&
M0Y7Z<\4UKFX9BS3RECGDN<\]?SKT3_A5 _Z"Y_[\?_7H_P"%4#_H+G_OQ_\
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M81&0[DVMWQW3L*U5N+P>#YH%-YYV]VC.U_,^S>?@<]<^7_P*NQHH \^O=_\
M84XA>_WI=.=.&9][1 +P,=3NW!=_'X5<OX=9TV^GGBDDGCE997&7(5=_&[&<
M=>0H^ZI]:[6B@#EFQJ^HZ6+R!X?M=C<+/!N(R 8\>_<D=^:D\_4?#)VW1EU#
M2!TN -TUN/\ ;'\:^XY]:WS:VYNA=&"/[0%V"7:-P7TSUQ4V*J,K:/835R*W
MN8;NW2XMY4EA<95T.014M<]<Z+<Z;</?: R1LYW36+G$,WN/[C>XX]:O:5K=
MMJF^,!X+N+B:UF&)(S].X]QQ3<=+K82?1FG1114%!1137=8U+NP55&2Q. *
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M!RMG#E8$^HZO^/Y5XI]KN?\ GYG_ ._C?XT?:[G_ )^9_P#OXW^--8&2VE^
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MJ*.>7<.5=C%_X1+0O^?!?^^V_P :/^$2T+_GP7_OMO\ &MJBCGEW#E78Q?\
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MQN"W*Y4\_2D9'3 =&4D9&X8R*[^UU>SN]8M(A??;'EU'SX2T946\>T_)S^'
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1+BO@.>HHHKVCSPHHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  > " # 2(  A$! Q$!_\0
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6Y2+/\1/=JZ/%+6O)?XG<PY[?"K'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ? "<# 2(  A$! Q$!_\0
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HX"MNB%)+5BP.4PI>_5U?;HO\W^ R.)(D"1(J(. JC %%/HK<]T__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  D "0# 2(  A$! Q$!_\0
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1BG2;]FPFO>1V]%%%<AL?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $V ?,# 2(  A$! Q$!_\0
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M?F-_<_6CS&_N?K0!)14?F-_<_6EW/_<_6@!]%,W/_<_6C<_]S]: 'T4S<_\
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M?_6IU% #<O\ W5_[Z_\ K49?^ZO_ 'U_]:G44 -R_P#=7_OK_P"M1E_[J_\
M?7_UJ=10!&Q?'W1_WU_]:F9?^Z/SJ5_NTR@!N7_NC\Z,O_='YTZB@!N7_NC\
MZ,O_ '1^=.HH 12^X?*/^^O_ *U29?\ NK_WU_\ 6IJ_>%24 -R_]U?^^O\
MZU&7_NK_ -]?_6IU% #<O_=7_OK_ .M1E_[J_P#?7_UJ=10 PE\'Y5_[Z_\
MK5'E_P"Z/SJ8]#4= #<O_='YT9?^Z/SIU% #<O\ W1^=&7_NC\Z=10 W+Y^Z
M/SJ7+_W5_P"^O_K4SO4M #<O_=7_ +Z_^M1E_P"ZO_?7_P!:G44 -R_]U?\
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ME5F__P"0E=_]=G_]"-5Z_/I_&_5_FSA>XFU?0?E1M7T'Y4M%2!J>&@!XCLL
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M&N;1^]M.G_/G%_\ $TO_  G&N?\ /6T_\ X__B:]*'ACP]@?\2.R_P"^6_\
MBJ/^$8\/?] .R_[Y;_XJO.^I>GW?\ ^C_M#+O^?/X1/-?^$XUS_GK:?^ <?_
M ,31_P )QKG_ #UM/_ ./_XFO2O^$8\/?] .R_[Y;_XJC_A&/#W_ $ [+_OE
MO_BJ/J7I]W_ #^T,N_Y\_A$I_"/Q%J6K^*+N"\>%HULRX\N!$.=ZCJ /6O8F
MZGZ5Q?@W1]+T_5II;'3K>VD,!4O$#DC<..2?05VC=3]*[*-/V<.4\;&5:56K
MS48\J[:?H?%,G^ND_P!\_P Z;7:/X4T8R.?M^I?>/_+&/U_WJ3_A$]&_Y_\
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M_LF';\6>C[/*NTS*_P"$I\/?]!&3_P !7H_X2GP]_P!!&3_P%>M7_A!_#/\
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M44 =7\.3CQE#G_GA)_*O9T9<?>'YUXQ\.>?&4/\ UPD_E7LZ*,=!^5?*YO\
M[PO1?J>]EW\'YGSSJ_\ R&]0_P"OF7_T,U3JYJ__ "&]0_Z^9?\ T,U3KZ>'
MPKT7Y(\.7Q,****LDZ#P1QXSTS_KHW_H#5[D2#T(->&^"/\ D<],_P"NC?\
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M_P#KLG_H-=UJ?_(&O/\ KW?_ -!-<+\*?^0?J?\ UV3_ -!KNM3_ .0->?\
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MAIXMY'S=!S7;A\.Z]14T<]6O["/M$[>G](YC_A+OAW_SXP?^"D4?\)=\._\
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M45]:?/!1110!Z?\ "G_D'ZG_ -=D_P#0:[K4_P#D#7G_ %[O_P"@FN%^%/\
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MZ]W_ /037"_"G_D'ZG_UV3_T&NZU/_D#7G_7N_\ Z":^/QW^^2]5^A]%A?\
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M$,;(1)>+DY.>PKTJBN*E6G2G[2&YU5*4:D>26QXC_P *Z\5?\^-I_P"!8_\
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M## ]A[5UU%<3K3=7VKWO<ZE2BH>S6VQXC_PKKQ5_SXVG_@6/_B:/^%=>*O\
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MO^%=>*O^?&T_\"Q_\31_PKKQ5_SXVG_@6/\ XFO7/[:@ @=HI5BF5B)"!A2
M201G/&T\XQ4]C?I?*Y$<D3(1E),9P1D'@GJ#1_:F*[K[D'U"AV_$\]\'^&_$
MGAO59KN?2X9EDA,86.[7(.X'/(]J[,ZAK)/_ " #_P"!B5M45Q5JTZT^>>YU
M4J4:4>6.QXDWP[\5%F/V&TY)/_'V/_B:3_A77BK_ )\;3_P+'_Q->W5GW.K1
M6EP\4T,HPF]6&"'Y P.<CD@<XKM_M7$]U]R.7ZA0[?B>0_\ "NO%7_/C:?\
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M5+>+.Q,XW').3DU/10 4444 %9BZ+"L!B%Q<G]X95<N-R,<YP<=\D<YK3HH
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M[N-N>O:J\UYXFEMO+<RM=*C/'-%;E,%K8MC;G!P_'/?WK@N=?6QW]%<$-?\
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B1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %S DT# 2(  A$! Q$!_\0
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M +Y-'FKZ-_WR: )**9YH/9O^^31Y@_NO_P!\F@!]%,\P?W7_ .^31Y@_NO\
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M_ODT>8/[K_\ ?)H ?13/,']U_P#ODT>:/[K?]\F@!]%1^:OHW_?)H\U?1O\
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M0HRL.H(/(J5NM,18HHHI#"BBHY)X8F59)41G.%#, 6^E $E%1_:(?WG[V/\
M=_?^8?+]?2GHZR('1@RD9!!R#0 M%%% !1110!&WWJ2E;[U)0 4Y?O4VG+]Z
M@!]%%% !4;?>-25&WWC0 E%%% #DZT^F)UI] !1110!%1110 4].AIE/3H:
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MPZ)='S!MA^3./F_U_P"\W_-QQQQWZUKZ9;26MH4D"JS2,^Q#D)DYVCZ5<HH
M#R",XIFP_P#/1OTI]% #-A_YZ-^E&P_\]'_3_"GT4 0LAS_K&_2DV'_GHWZ4
M]OO4E #=A_OM^E*J'=_K&_2EIR_>H -A_P">C?I1L/\ ST?]/\*?10 S8?\
MGH_Z?X4QD.3^\;]*FJ-OO&@!FP_WV_2C8?[[?I3J* $1#G_6-^E/V'_GH_Z?
MX4)UI] #-A_YZ/\ I_A1L/\ ST;]/\*?10!!L/\ ?;]*-A_OM^E.HH ;L/\
M?;]*<B''^L;]**>G0T )L/\ ST;]/\*-A_YZ-^E/HH 84.#^\;]*CV'^^WZ5
M,>AJ.@!NP_WV_2C8?[[?I3J* !$./]8WZ4[8?^>C?I2ITIU #-A_YZ-^E(R'
M!_>-^E24C?=- $.P_P!]OTHV'^^WZ4ZB@!NP_P#/1OTIZH=O^L;]*2I%^Z*
M&[#_ ,]&_2C8?^>C?I3Z* (V0X_UC?I3-A_OM^E2OTIE #=A_P">C?I1L/\
MST;]*=10 X(<#]XWZ4;#_P ]&_3_  IPZ"EH 9L/_/1OTIKH<#]XWZ5+37Z"
M@"+8?^>C?I1L/_/1OTIU% #=A_OM^E2;#_ST;]/\*;4M #-A_P">C?I1L/\
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M2M]ZDH *<OWJ;3E^]0 ^BBB@ J-OO&I*C;[QH 2BBB@!R=:?3$ZT^@ HHHH
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MBQ_Q_P"E_P#7*3^:UYY7V67?[K#^NK/F\9_'E_70U_"O_(VZ3_U])7M/B/\
MY%S5/^O23_T$UXMX5_Y&W2?^OI*]I\1_\BYJG_7I)_Z":\W-/]XI_P!=4=N
M_@S_ *Z'S^.E% Z45]">.>V_#_\ Y$S3_P#MI_Z&U>>?$7_D=;K_ *Y1_P#H
M->A_#_\ Y$S3_P#MI_Z&U>>?$7_D=;K_ *Y1_P#H-?/8+_?ZGS_,]C%?[I#Y
M?D<K78_#/_D;O^W:3^:UQU=A\,_^1N_[=I/YK7K8W_=Y^AY^&_C1]3V)JB;K
M4IJ,]:^*/IB>JM]'"\.^>XD@C3DNLQC'XD&K54-9.-,D(8HP9"K<#:=PP22"
M /4TADUB+86J_9)!)$23O#[]QSR2>YJS5+29WN+!7DD$CAF4N,8;!Z@@ $>]
M7: "BBB@ HHHH **** (V^]24K?>I* "G+]ZFTY?O4 /HHHH *C;[QJ2HV^\
M: $HHHH <G6GTQ.M/H **** (J*** "GIT-,IZ=#0 ZBBB@!#T-1U(>AJ.@
MHHHH >G2G4U.E.H *1ONFEI&^Z: (Z*** "I%^Z*CJ1?NB@!:*** &OTIE/?
MI3* "BBB@"0=!2T@Z"EH *:_04ZFOT% #**** "I:BJ6@ HHHH 8_6FTY^M-
MH *5?O"DI5^\* /,?BQ_Q_Z7_P!<I/YK7GE>A_%C_C_TO_KE)_-:\\K[++O]
MUA_75GS>,_CR_KH:_A7_ )&W2?\ KZ2O:?$?_(N:I_UZ2?\ H)KQ;PK_ ,C;
MI/\ U])7M/B/_D7-4_Z])/\ T$UYN:?[Q3_KJCMP'\&?]=#Y_'2B@=**^A/'
M/;?A_P#\B9I__;3_ -#:O//B+_R.MU_URC_]!KT/X?\ _(F:?_VT_P#0VKSS
MXB_\CK=?]<H__0:^>P7^_P!3Y_F>QBO]TA\OR.5KL/AG_P C=_V[2?S6N/KL
M?AG_ ,C=_P!NTG\UKUL;_N\_0\_#?QH^I[":C;K4C5$QYKXH^F+%96L-*2D:
MJQ1E.[$<K?K'_6M6LS698E@"-$9)&P%_<NX )&3\OYXR.E2QD^EJ4L$4@C!/
M!#COZ/S4EQ>0VKQK,6'F,%!"$@$\#)'3GUJ#2/\ D'J!&$ 9@,(R!AGKM;D9
MIU]IYO98&\T((G#?<R>O8YX_6GU 3^U[(>=F4_NNOR'YN<?+Q\W/''>K-O<1
M74(EB;*G(Y!!!'4$'H:S#H.=W^E'Y<^1\G^K^??SS\W('IQ6A96OV2 H9/,=
MG9W;&,L3D\=J +%%!&013/+']Y_^^C0 ^BF>6/[S_P#?1H\L?WG_ .^C0 C?
M>I*1HQN^\_\ WT:3RQ_>?_OHT .IR_>J/8/[S_\ ?1I5C&[[S_\ ?1H FHIG
MEC^\_P#WT:/+']Y_^^C0 ^HV^\:7RQ_>?_OHTQHQD_,__?1H 6BF[!_>?_OH
MT;!_>;_OHT 2)UI]0I&,_>?_ +Z-/\L?WG_[Z- #Z*9Y8_O/_P!]&CRQ_>?_
M +Z- #:*;L']Y_\ OHT;!_>;_OHT .IZ=#46P?WF_P"^C3DC&/O/_P!]&@"6
MBF>6/[S_ /?1H\L?WG_[Z- #CT-1TXQC!^9_^^C4>P?WF_[Z- #J*;L']YO^
M^C1L']Y_^^C0!*G2G5$D8Q]Y_P#OHT[RQ_>?_OHT /I&^Z:;Y8_O/_WT:1HQ
M@_,__?1H 2BF[!_>;_OHT;!_>?\ [Z- #JD7[HJ'RQ_>?_OHT]8QM^\__?1H
M DHIGEC^\_\ WT:/+']YO^^C0 K]*92M&,?>?_OHTS8/[S?]]&@!U%-\L?WG
M_P"^C1Y8_O/_ -]&@"8=!2U&(QC[S_\ ?1I?+']YO^^C0 ^FOT%)Y8_O/_WT
M::T8 'S/_P!]&@ HIOEC^\__ 'T:/+']Y_\ OHT .J6H-@_O/_WT:D\L?WF_
M[Z- #Z*9Y8_O-_WT:/+']Y_^^C0!4_M2P?4&L5NXOM2 DQ9YXZU NNZ2]M+<
MKJ%N882%D?=PI/3\ZSIK/5;GQ!+)/9I]FAC=+*0S JI9<%G7J23Q["L;3/#F
MKV$22F#>UO-%*D$MPK,Y565@K8P%^;*@].:$!V,NHV4%A]ODNHEM-H;SMWRX
M/3FH?[=TI!;.U_"JW'^J). _./Y\5E0Z5=1>'3IMS9-. OF 0W(0[RY;:#QC
M;QS4-Q8Z_/8Z=97=N+R#[UZ1<*K,0V44DCD 8R1UQ0!SGQ8_X_\ 2_\ KE)_
M-:\\KT+XKKB_TSKS%)U/NM>>U]EEW^ZP_KJSYO&?QY?UT-?PK_R-ND_]?25[
M3XC_ .1<U3_KTD_]!->+>%AGQ9I(_P"GE/YU[/XB0#PYJARW_'I)U;_9->9F
MG^\4_P"OM([<!_!G_70\!'2B@=**^B/'/;?A_P#\B9I__;3_ -#:O//B+_R.
MMU_URC_]!KT'P @/@W3SEO\ EIT/^VU>>_$0;?&ET,D_NX^I_P!FOGL%_O\
M4^?YGL8K_=(?+\CEJ['X9_\ (W?]NTG\UKCJ[#X:#=XNQDC_ $:3H<=UKUL;
M_N\_0\_#?QH^I[$:B;K4A&!CG\:C8<U\4?3%BJ.K736MB[I)L?(Y !.,C. >
M#P:O57OKB*UM'GF0NB#D  D_GQ28QFFSBXL4E$SS9)^=U"D\^@XJW5:QN8+N
MU6:W&(B3CC%6: "BBB@ HHHH **** (V^]24K?>I* "G+]ZFTY?O4 /HHHH
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M^:UYY7H?Q8_X_P#2_P#KE)_-:\\KTLN_W6']=6<6,_CR_KH:_A7_ )&W2?\
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M_7%__037SFGW%^E>GDOPS^7ZG%F?Q1^8M>Q?#/\ Y%)?^OF3^E>.U[%\,_\
MD4E_Z^9/Z5T9O_N_S7ZF.7_QODS ^+'_ !_Z7_URD_FM>>5Z'\6/^/\ TO\
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M#%?73^!^C_)GST?B1[_J'_'A<_\ 7%__ $$U\YI]Q?I7T3J#/]@N?D_Y8O\
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MOTIE/?I3* "BBB@"0=!2T@Z4N: "J\]K!-/!/)&&E@),;'JI(P<?A5BFMVH
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M5OK%_P"S5+\6?^/72O\ KI)_(5%\*.FK?6+_ -FJ7XL_\>NE?]=)/Y"O"?\
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M_P C>/\ KVD_I7NXW_=Y^C/*PW\:/J=O\1E4>#)R% _>Q=!_M"O&:]G^(_\
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M';WKZ23I6&.P2PO+:5[_ *&V%Q+KWNK6/)M7^(.OV>M7UK#);"*&X>-,PY.
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M])/_ $ UZ;XY_P"1(U+_ *YK_P"ABO,O '_(ZV/TD_\ 0#7IOCG_ )$C4O\
MKFO_ *&*\K'_ .^T_E^9Z&$_W6?S_(\-HHHKZ$\<][\+_P#(HZ3_ ->L?\J\
MN^(O_(YW'_7*+_T&O4?"_P#R*.D_]>L?\J\N^(O_ ".=Q_URB_\ 0:^:R[_?
M)_/\SVL9_NT?E^1RM=?\-?\ D;Q_U[2?TKD*Z_X:_P#(WC_KVD_I7MXW_=Y^
MC/,PW\:/J=Q\1_\ D2Y_^NL7_H0KQBO9_B/_ ,B7/_UUB_\ 0A7C%<64?[O\
MW^ATYC_&^0C?</TKZ(TK_D"Z?_U[Q_\ H(KYW;[A^E?1&E?\@73_ /KWC_\
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M.=>I.:G*5VBXTH1BXQ6C/+?^%177_0Q1_P#@!_\ ;*/^%177_0Q1_P#@!_\
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M%:&[MV,;VKR;HY!UP#ZX/!_.ME260$J5)&2#VK/L-/"3?;I]YNI47>I;Y4;
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MK+ S%1(A4D=1GO3;.T2RMEA1G?'+.YRS'N34]% !1110!2&FQ_VHU\9)"Q4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  > " # 2(  A$! Q$!_\0
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4$3W)[M71XI:UY+_$[F//;96/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ? "<# 2(  A$! Q$!_\0
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HX"MNB%)+5BP.4PI>_5U?;HO\W^ R.)(D"1(J(. JC %%/HK<]T__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  D "0# 2(  A$! Q$!_\0
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,*?QH[RBBBN,Z#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "C )@# 2(  A$! Q$!_\0
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M3Q6U9^,M4TC?IMC;6QB@<J)G5OG]3C-<U)1=VWH?1XJ=6-E2C=OH^QZ!\/\
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=4N!112 4 4M%%,!11110 GK1110 #K1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image_011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "> )0# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W\T9I#10
MN:,UR'BOX@Z7X1OHK.\@N99I8_,7RE&,9(ZD^U<Q)\<M)BE0'2;PQL<%E=21
M^'_UZ /52:3%>3:A\:(RJ#2]*;>V26NFP,?05A7?QA\2"&22*"Q38"V-A/3Z
MF@#W:DP:\!G^,/B74+-!%':V99@"T*DG]:R;OQWXK,3S+KETKH-R@$8S],4
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MEF4$?P+R:@7Q7X;C@+M<W-U./^7:WCQS[N>!7G<5I=:E)M/F7!)^X@POX_\
MUZZ*P\+.%4W4@C4?\LX_\:ES4=9,VC1=32FK^9+JOB>[UR(V,6GVMK:N<")(
MQ+(WU9AU^@K1\._#6^>$$V\.G6[<G(^<_@/ZU9M[.UL5_=(J?[7?\ZD_M6>!
M@(+B1&[?.:S^M*^QUK+96UEJ>GV5JME86]JK%EAC"!CWP,59'2LW0)I;G1+6
M:=R\K+EF/?DUIUV)W5SSI1Y6T)12T4R1:*** .<\;:'<^(/#[V5IY?F^8KXD
M. 0.U>#Z[\/KFQ+&]T5XQ_SUB7(_,5]':CJ4&FV;7,^[RP0.!SDUR]UXMEG!
M6TC1$/=OF/Y5E.I&&[-J>'J5?A1X[X1U33_",H8:#9WCYYFD)$H'MU'Z"N\;
MQ]X/NK<O/8WMG/\ W%7(_,<5%J.E6>J2-)=0(TK=74;3^E<[>>"5.6L[H@]E
MD&?UK)8B#WT-Y8"M'5:FO!XILII&,:L8L\%6!./>KQU^P5-X=F./NA>:\ZO/
M#FHV;;GM68#^.(Y_ES61>WE_%&L,<\_S'&WJW^--7>S,I*"=IQ:.^U3QJMN"
M Z0>@^\Y_#M7'7OBBYNY"8LC_II*=S?@.@I-*\$ZOJ1$LZ_98FY+S?>/X=:[
MC2O!NE:9AVC-S,/XY>0/H.E1*<([NYT4Z-:?P+E1QNF:1J.KR"589'_Z:RG
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7%%>@<(4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image_012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "! (8# 2(  A$! Q$!_\0
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CC?>HHI%(1_X:>O2BBGT$+2-]TT44@$'2E-%% "4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image_013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "3 ) # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WVBD)IA.*
M ),BDW"F$X'-4K[4[33XA)<2@%N%0?>;Z"HE.,5S2=D5&+D[(T"P]12<&N2C
M\8Q&["R6<BP-_P M-V2/J*Z6.2&]MP8I=R..&0UE1Q-*M\#N:5:%2E\:L/F8
M*I9F4*HR2QP *Y6[^)&@V5V;9_/D"'#S1QY0'V/?\*\[\7^,+W5]8O-,:X*:
M;;2&( +CS2/XCZ\]JY?(1 FWOG<>M:.=]B%'N?2-E>VVIVR7=E/'- _*NAR/
M_K5FWWC+0-/O?L5UJ,23#[W4A?J1P*\2LM=O=,L;C3[*X,$5WAI2I(/ /0]L
MUG>83&$=BS$YR3FARZ(.4^F(Y4FA66)U>-AE64Y!'M3P<UYE\)[B4+J=IYK&
MWC6-UC)R%8YSCTZ"O2HSFK6I+T)***7K3$)111VH 6BBD% #:C<$@A20?45)
MQWJ*>X@MHC)-*L:#J6.*EM)78TK['+>*/$UYI7EV5NB&X==S2+R43H#M]<UR
MEO*9G:6YE:>8MC>V3GZ&H_$\QU+7KJ_A+%414B(8C* ?XYI-.F<C:T;* H)8
M\9)[8]O6OD<RQ#JR;B[I'T^#H*E25U[S-%56*',FT!>I'2M/P_J+6&F:Q>L2
M4MX&EP!W /;\*SDDCD4I(N0>QKH/"5JGV6]BF59(W 1P1PP(.1^M3E<N:O&W
M]:,SQU_8N_\ 6I\X0-(R-=.6<32L[2R9 !.21^M:6E_:9<B5U%OC@R>O^R>X
MKN/'O@FW\(VCZEIMTBZ;*PB^PW!)56)R OMZ=Q7(17<4R1ID;@3@EN,^@KZO
M5-H\%M-7(M0MBS(82S&/A@&X/TJM!J)1-EPI= /O?Q)]1W'O6HLA$Q,N=QYR
M>]6--\-V6G^((8/&IN-,M+@![6Z@QY,V[D!G['!]*N*)DSM/@QJ%O>W6LI#,
MC/LCP.^!GG]:]<5"HKR_5/A)86[V^M>![YM(U.W7=&RN7AG_ -[Z_E[5H^'/
MB2TE^-!\66G]CZZIVJ).(KCW1NG-6C,] S3JB4L3G%.SBF ^C%&:6@ HHI*
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M,/F0^C+VK[+#TO8THT[WL?*5JGM)N?<J:-KU\MA;?\)!!!#<R("TMJ2T)/\
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+8YD8=6^M%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>image_014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "5 *T# 2(  A$! Q$!_\0
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ML$($K$*"2QW'')Z5R,G7FM73D_XI75I<=+JW3/X.: +GB/QUXG\1NRWVK3+
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M\I+(P*D^O(- '&Q:%/?>%=1UI'0P6<:>=[.YPJCWQ7U?X-3R_ NA*.UC#_Z
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?&:])B@CMK:*WA79%$@1%'8 8 HHH <!BG@444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>image_015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %K A(# 2(  A$! Q$!_\0
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MJ>S\1P2OY5XC6TO3YAQ51QU/FY:B<7Y_U83PTK<T7S+R-S)]:,GWIBNK*"K
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M4R:9((7ED.U$&232DTE=C2=[(BNKN*PMC-.^ /S-8"IJ'B.7.3;V /&/XO\
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M:2K>:87&999.T8]034.L?$?6=$U2"*TDC,H8--8A08X(S]V(8YWXY)I >W@
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M&BM?:@DSC=MBCA3+.WI[5Z%.?LY<UCEG'F5CB!K5W&<21J?JI%3)KP/WX/\
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MIK)DL;VTDQ<1.@'=AQ^=>G@ _6AD#+M<!E/8C-;3P=.3NM&*&+J15MSS53(
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M.111ZU%-*$*H.78\#TH F&,YJM?7]OI]N9KAPJ]AU)^E)J%[#IUF;B4Y"C
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MK(R$@< &ND50HP*<%&.E=[5U9G+&7*TT>4V7A;Q*GB:SO;NT9[>$Y $H.WV
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M4C^$')KDQ%'#RUK)>NWXF]*I5B[4VS(&BZO#_J-3) [,31_9_B%N#J"X^O\
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M8<!B, ?046VD:YKDR7%RWV2T'.QOO-_]:KESK/A7PK<I;WM_!]N89".<M_\
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M?$K[(>T2GC\?6LS':EI.3STKADW+=GJQA&*M%"]JAFF2(9;KV%07=]';KC>
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MGW*-SF,_RK&\*MOT4#/W)"!7G_!CE;[4?R.OXL-K]E_F;=5=1LDU"S%O([(
MZN"H!.0<CK5FF2E]A,84MV#'BO1;Y=3C,&/PI;0Q.B:A<A)4:)E*K@JQR1C'
M R31;^$K>U,)AO[I&@V^7@+QM&T=O2DU#4;DR)')$(3&VXC/6M2RNKB[ D:W
M$<6.&+<G\*\^AF\:U65&-[KR^^^FEMCIGAY1@ILRO^$1A:>>5M5OC]H?S)%+
M#:S#'..F>!3KWPNFH7*W,VK7[2K&8PRL%RA/(X'(JWJ%[=6R.IMUV,,+(&Z5
M7TN]NFB6WCB$NSDN6P!2GG$(XA4+N_I_P 6&E[/V@V7PM#/]F634+EEM@!"
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MM#*GO533&-YKM_=]5!*@_C6NT2MG(KBR[6G*71RD_P 3HQ;M-1[)&)KCEM-
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G^E+FK!C3^[2>6G]V@9"#FD/6I_+3'2E\M,_=H K458\M/2B@9__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>image_016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "4 =P# 2(  A$! Q$!_\0
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M?^?6\_\  V3_ !KT"B@#S_\ X4SX-_Y];S_P-D_QH_X4SX-_Y];S_P #9/\
M&O0** //_P#A3/@W_GUO/_ V3_&O!O'5BGAWQKJ>EZ9<3Q6<#J(T:9F(RBD\
MY]2:^N:^3_BQ_P E/UO_ 'X__124 >W_  9_Y)W;_P#7U<?^C#7H->??!G_D
MG=O_ -?5Q_Z,->@T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %4-;YT'40.?]&D_]!-7Z3KP: .+\(K>I\(M.6S4K?#3,0@C!#[3M_7%
M<=I4.DW+>&8-(CE?67)76%._>8RC><)\_P"UC&><]*]D  & ,#L!4$36[22F
M$QEP<2%,9!]Z /$].?2K;PCX;T[[):HIEN#/+?.ZVT4H.-LBC[SD$;0?<U<\
M*^>TGA^-MS)#K]T(]L;HB1^62-H;D+SQGUKV$P1$%6B0@G<05&"?7ZU!<ZA8
M6<<TMS<0Q+#AI2S#Y,\ GTH YKQ@KMXI\'%49@NHN6('3]T]<?:1W^H>'8/#
MMA&$N+_6KN:5IU;RUACE+'=CG#':/?FO8OE8!N".H- 55.0H!]A0!P?A@:KH
MOC/4=,U;[,5U-/MUN;56$8=<+(.>Y^4_G7&^,/[.BTWQ:=92X'B!K@FR<!\^
M3\NS81QM SN[=<U[2TL*S+$SIYK LJDC)'?%<S?^"K74;VXDEU'4A9W4@DN+
M$3?N9&&/49 .!D @&@#F8+6W75_&6K7%C/=SVEO!]G$;,' -N-WEGL3ZBN8L
MG6/5K4Z:;%8I=+NTE73ED89\K<HE=OO/D'WZU[NJ*@ 50 ..!4:11QC:D:@9
M)P  ,GK0!Y5INAVMF?!#06KJ]_:2Q7[$L3,IASA^>>>GIVK#LK338_!'AE/M
M-M:F![A98+Z)S:O+G!64@_*^,;3]:]LU#4++2;)[R_GCM[:(?-)(<!:(#:7M
MHDT*QR6\P$@.T8;/(- '/^"[HW?@BUD%D]FJQNB1,[/P"0"I;DJ>HSVQ7FR:
M9):?#_PU=PQQPP74Y.JSW*.X8 ML\T Y*9P/0<=J]T  &!TJ,HI0H54J1@KC
MC'TH \;M+=UL(3;WL-Y9G7[5HDL[=T@C/.[RRQ.03@GL#FLS5+N.2\^VVD5M
M:7PUA24/FR7RCS0"7;[J)CMR,$"O=UC15"*BA5Z # 'TJM;7%G>/.UM)#*R2
M&*8I@D,O\)]Q0!Y)9V=M93WT%I 8;D>+8S(B @^5U4D?W3DX[4Y=*AB\,MK2
MP2_VHGB$A)SN+HAN,$#T7:3QTYKTVYU[0[.VN+RXO[6.*&7R)I68?+(/X3[\
M]*=I7B#1M:+IINH6UT4Y98V!(]R* /)?$_\ 9T6DZ]_:J3KXG.H[HI,/GRO,
M785/3R]F/;/7FO;H?]2G^Z*Y:X\%6EW?RR3:EJ+V4LXGDL&F_<LX(/<9VY .
MT'%=;0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R?\6/^2GZ
MW_OQ_P#HI*^L*^3_ (L?\E/UO_?C_P#124 >W_!G_DG=O_U]7'_HPUZ#7GWP
M9_Y)W;_]?5Q_Z,->@T %%%%  >E>(W>I3-\.+.6_U*[B@?Q&\-Q,D[*XA\U@
M1N'. !^E>W'I7G4/@&^3P[8Z:US;L]OK1U%S@E60R%MOUP: ,S1)["+QII,'
M@_5K^_M)!+_:233/-$D>WY6RW1MV/KFNZU?6SI.IZ1!);[K;4)S;F<''E2$$
MID>^"/KBMF.*.,$1HJ \X48S6+XIT9_$&@7-C#*(;H%9;:8C/E2J0R-^8H S
M)O%EY(-6.F:0;O[%>"S1S,$1GQEV9C]U5/'?FN9UWQE>WWACQ/ITJ06NHV5H
MLZ3V%WYJ,&;'##!4@@\5J7G@6];PAI>FPW-O<W=M.;J[CN-PAO9&R7W[><9;
M(^@K./PZU6>'6]S:39G4;!;6.&SA*1PL&W<_WL^M '7V'B$S:GJFGM;_ /(.
MM89C*6YD+(6QCMC%8#?$5YK'1S:6EJE]J-K]K*7ET(HX8\XY8]23T ]ZMWOA
MO7[?7+R\T>[L1%J5I';W'VE6)A9%*AEQ][(/0UE?\*\O;.UT26WCTN_O-/LO
ML4\%_$6BE7=N#*<':P)/;H: .L\+^)(_$UA/*(TBN;:8P7$:2"1588/RL.&!
M!!!KHZYWPMI-SH^G/'=BQ6:60NR6, CCC'0* .3CU-=%0 5DZ[<7UGH]Q<Z9
M;+<W,0\P0,<>8 <L![XSCWK6K'UZVO[[1Y[/3;I;:XFQ'Y[9S&A.&(_VL9Q[
MT 9_AKQ+_P )/<W-W8Q+_9**J0SMG=++C+C'HN<?7-=17,>'O#9\-WMS;V,B
MC1955XK<Y+12CAB#Z-@'ZY]:Z>@ HHHH **Q[[Q!8Z=<_9[CS]^T-\D+.,'W
M J#_ (3#2?\ IZ_\!7_PH WZ\<L)]0T?^VX[75YU?4?$WV%[B4*?LX(!+CC&
MX\*,\=*]$_X3#2O^GK_P%?\ PK$DE\(3OJ#2V$SC4-K72FVDQ(5Z-C'#>XYZ
M4 3>'+N]M?%>J>'Y]1EU&VMK>*XCN)L&2,L2"C$  ],CCH:XGQ/9RIJ7Q&F-
M],_^C6@$3XV MRO Y^7''UYKMM'U#PSH,,D6FVUS LAS(?L\C,Y' R3DG'2H
M[NX\)WM]/>7-C-)-<0B&9C;R8D0'(##H<8XH Q=1UC6?"-W?1KJ5QJBG16OD
M6X5?W<JL%R, ?+SG!]*M>%[WQ%%KUA'=->S65W SSF^GA8A@ 5:((<XZ@CGM
M6U+K/AV:[%U+:SO,(#;[FM'.8SR5Z<@XJCI(\':)<&YL-/GAF*E0_P!GE8HI
MZJN<[1["@"EX@AFC^*=G>1WTZ&+1KF58AC;\I''KSG/_  $51@U'4D\(Z)/<
M^(-4FU#6"LGE6T*&5P%)9(\@!!T))S72WNI>&-2OK6]N[>>2YM@RQ2?9Y 5#
M###@=#Z&J]]+X2U#3;;3KBRG:UM<?9U6WD4Q8X^4C!''% ',VGB/7Y; V U*
MZMYDU^*Q$T_ER3+"RY*MM^4D>HJY=WOB"R.NZ+::Q)<26MW;"&6X=$N'CD&Y
MXT8C;NX.W(K9MI/!]F@2VTZ2,+.MQQ:R?ZU1@/TY.*DO;GPGJ*W8N["67[64
M:<FUDW,4X4YQD$=B,4 <9K4\VM>'K6RFU?54N;37;:*6*[B19H@Y!4,0"K$=
M0?IFKEQK?BB[NM5N[%KT'3KQ[:!?-A2V(C('[T,0V6Y.1CJ,5T=O)X0M;)+*
M'3YO)69;C#6TC$RK@AR3R2,#K4=XG@S4-4_M&ZTV66Y)!9C;2;7(Z%E'#$8[
MB@#/N]2UIW\8:A_:\\(TN(?9K5 I1&,(8YXR<,>*J7E_K]O=Z-HT=_JEXU]9
MF_FFMWB29FX&Q"W 49)QR:ZEM5\,/'?(UI,4O_\ CZ'V63][QCGCT&*@U.Y\
M*ZQ:06M]9W$D< _<D6\B-&,8^5A@@8XZT 8UKJGB+49=%T2_OY-/:XDN#)>0
MO&TLBQ$;4+#*A^?F ]#6K\-E=+;7EDNA=.NKSJTX 'F8P,G'&?7WHF_X0^?2
M8=+?3919P-NBC2UD4HW]X,.<\\G/.>:O:7J_AK1;9K;3;6:UA9S(R1VLF"QZ
MGIWQ0!PFI&0:;JIMX8I9O^$Q3;'(0%<_+P3VSZUVEAHNKW?BFVUO4[.PT]+2
M!XDBM7WO,7(SN; X&,@>IIQOO";*X-C+B2Z%XW^BR<S#&'Z=>!6I_P )AI7_
M $]?^ K_ .% &_16!_PF&D_]/7_@*_\ A1_PF&E?]/7_ ("O_A0!OT5FZ=J]
MKJB2-;^;A" WF1LG7ZUI4 %4+S5;#3F1+R]@MVD^X)9 N[Z9J_5&YTVQOF1K
MRRM[AH_N&:)7*_3(XH YGXCS30^$1Y%S-;M+>6\1DA?:VUI #@CIP35&^L6\
M&:AI%Y8:C?RVUU>):7%M=3F56#@X89Y!!'\ZZ/Q3H'_"2:(=/%P;5Q+'*DP0
M-M9&##CN.*I6WAF]FU2UO=<UE]1%HQ:"W6 11JY!&\@$[C@G'IF@#!A^*=M+
MJ$;".T.GRW0M5"W&;D$MM#F/&-N??..:L-X^U%%U"^;1%&E:=>M9W,PN!YAP
MX7>JXY R,_I5JR\$3:=>1Q6NK"/2X[@SK +1#*.=VSS?[N3Z9[9K&TCP=JNH
M1ZS;W][/::9=:O--)9&$9E4/E=KYX5L"@#5G\<SP-KEW-IJII6CR-#+,9OGD
M?"E0JXXSN R3Q5;3OB7 \MRFH1VG[NT>\5K"<S#:N,HW P_(]C6S_P (5:2:
M=KUC<7,DD.KW!N&P #$=J@8^A4&JUIX,GEAN8M8U1;JWEMFMO*AM4@!!ZNQ'
M);CVQ0!1U?Q)K4?AN^N]8T%H+)K7SHWM;PAUY'R,0/E;GJ,BI/$/CBZ\/F5_
ML=F+2VA20FYO LLX*Y/EJ 22.G.,FG77@C4]1TZ73]2\1SSVPMS;P*D 3&2/
MF<9^=@!QT%1ZE\/GN[K41%J:Q6^I)MF+6BR3*0@7".>@XSCZXH RM1\5ZDVI
M>(GGB=]%ATVVN(8XKCRY!O.00<9!/?Z5N7GBW4 ][-I>CK=V.E*!>223[78[
M S",8Y*@C.<9Z4V\^'_VE;N)=4=(;S3XK*8>4"<Q?==?3OD5->>"[J22^CL-
M9DL['4@!>P>2&+':%9D;/REE&#U]: *TWCK4+BYOUT?28[F"RM(KUY9I_+WQ
MNI; &#\V ?:NNTG48M7T>SU&%66*ZA650>H##/-8MMX.MK2;5S!/(D6H6<=F
M(]N?)5$* @]^N:V-$TP:-HECIBR&5;6%8@Y&"V!C..U &G7R?\6/^2GZW_OQ
M_P#HI*^L*^3_ (L?\E/UO_?C_P#124 >W_!G_DG=O_U]7'_HPUZ#7GWP9_Y)
MW;_]?5Q_Z,->@T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ,8E5) +$#.!U-<2?'\ZZHNG?\(MK7VMHC,(MB9* X+=?4@5W-<=,C_P#"
MW+1]C;!HT@W8XSYJ\9H Z>.Z1EB$A$,DB@B*1@&^F*JVVM6-WK%YI<,X:\LU
M1IT_NALD?RKR_7/[-$WBE=<69O$1G/\ 9) ?>4VCR?)QQ][.??.:9*D>E:IX
MLGU"PDFU.;2[0R)&61Y<C$K!AV!P3CG% 'J6HZS::?I%[J3.)8;2)I)!"P8X
M R1]:=+J6-$&I6]O-/NB$JPQXWL",X&>,\UXN@47&N16)LVM9?#T^Y=-AD$+
M.,8!+???&>E>@>*UE/P?N!$LGF?V='@(#NSA>F.: .R^U0JJ>9(D;-@!78 Y
M]/K4^]?F^8?+UYZ5Y#?Z+;7Y\>W=U:RRW%O;0M:L2WR,+8$%/?(ZBH]7;4[6
M2#3X%NG/BRQM8S+@XAE7:LI)_AS&?S% 'KK7$*,BM,@9_N L,M]/6E>>*-U1
MY45V^ZK, 3]*\3\16<D6OZW::C>6EIL6..P-Q;2RRB$( A@*\;@V>!SGK4OB
MB..TU1KB[G6_OELK?=:7\,D<DK*/O6SKT8G.1Z]: /6K?6K"ZU6]TV*=3=60
M0SK_ '=PR/Y5;^U6X7?]HBV[MN[>,9]/K7C/B&SMQ=^-&6TEMKZ\M["2-%#"
M4H67S,$=>>#BM6\\+Z8/$GB>U&GM]DCT=)X8OGV"7#Y=?]O@<]: /4Y9X8 #
M+*D88X!=@,FB2>&$9EE1!_M,!7A]V;NXETR36[JTBM7T6#[.^I022*7P?,V[
M>DG3KSZ5N:'H46J:]IL&L^?J4*:!P]S&\8?]Z=NY>QVXZ\T >CSZW8V^LVFD
MR3@7EW&\D*?WE7&?YU)/>M#?6UO]GE99@Y:88V1[1GYOK7E'AZVA&M^!;S4(
M6\S[)=6Z32AL[E?]VF3WP3C-=+X^69M>TDQB4J+*_P E 2,^4,9Q0!W23PR.
M425&=1DJK D"J=YK5C8:G8Z=<3A;F^+B!/[VT9->=Z-I$&DW/@.ZLK>2*XN8
M'2[E^8F0&('#D^XXSTK7\86=E_PGW@^]NX5PLLZ><RG ;9E 2.AW=* .IT/7
M[/7=/BO+9B@E+!8Y" _RL5/'U!K1\^+SO)\U/-QG9N&['TKQW2]&ALO"WA[5
MK>UDCU1M;VO/\V_8TKA@1_=QVZ=ZH+!=2ZE*E[J=M:ZY_:9;Y;25[SB3Y0IZ
M%"N/;% 'L&MZY;Z#8QW=TLC1R3QVX$8R=SL%!^F36+<>.-NKW^GVF@ZK?&QD
M$<\MN@*ABH;'7T-,^(\;OX;LPJ,[#4K0D*,_\M5R:Q]*T?5M0\6>+GL];N=+
MA-\@*QVZMO\ W2\AF_I0!W.DZK:ZUID&H6;EX)AE21@CU!'8YXK3K+T32;;0
MM(@TZTW^5$#\SG+,2<EC[DDFM2@ HHHH **** "BBB@ HHHH **** "BBB@
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MV*U_Y]H?^_8H^Q6O_/M#_P!^Q0!A?\+ \*?]!NW_ ";_  H_X6!X4_Z#=O\
MDW^%;OV*U_Y]H?\ OV*/L5K_ ,^T/_?L4 96F^*]!U6Y^S6&J6\\VTML!()
MZGGK5:3Q[X6C9E;6[7*G!P21GZ@5SWQ8A;3O"*ZOIR)#>V<ZA'C7:0LG[MAQ
MV^8'\*[#2M(M-/TFTLUMX2(8E0?NQS@?3\: */\ PL#PI_T&[?\ )O\ "C_A
M8'A3_H-V_P"3?X5N_8K7_GVA_P"_8H^Q6O\ S[0_]^Q0!A?\+ \*?]!NW_)O
M\*/^%@>%/^@W;_DW^%;OV*U_Y]H?^_8H^Q6O_/M#_P!^Q0!A?\+ \*?]!NW_
M ";_  H_X6!X4_Z#=O\ DW^%;OV*U_Y]H?\ OV*/L5K_ ,^T/_?L4 87_"P/
M"G_0;M_R;_"C_A8'A3_H-V_Y-_A6[]BM?^?:'_OV*/L5K_S[0_\ ?L4 87_"
MP/"G_0;M_P F_P */^%@>%/^@W;_ )-_A6[]BM?^?:'_ +]BC[%:_P#/M#_W
M[% &%_PL#PI_T&[?\F_PH_X6!X4_Z#=O^3?X5N_8K7_GVA_[]BC[%:_\^T/_
M '[% &%_PL#PI_T&[?\ )O\ "C_A8'A3_H-V_P"3?X5N_8K7_GVA_P"_8H^Q
M6O\ S[0_]^Q0!A?\+ \*?]!NW_)O\*/^%@>%/^@W;_DW^%;OV*U_Y]H?^_8H
M^Q6O_/M#_P!^Q0!A?\+ \*?]!NW_ ";_  H_X6!X4_Z#=O\ DW^%;OV*U_Y]
MH?\ OV*/L5K_ ,^T/_?L4 87_"P/"G_0;M_R;_"LRTU*U\2^.[>ZTZ7[18Z;
M9/NE4';YLC# &1R=JG\Z[#[%:_\ /M#_ -^Q2QPQQ(5CC1 >RJ ,_A0!/111
M0 4444 %%%% !1110 4444 %%%% !1110 5\G_%C_DI^M_[\?_HI*^L*^3_B
MQ_R4_6_]^/\ ]%)0![?\&?\ DG=O_P!?5Q_Z,->@UY]\&?\ DG=O_P!?5Q_Z
M,->@T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
M+?$'39]5\&W=G:P/-,\D)5%&2<2*3^@-=.O"@>U.HH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KY/^+'_)3];_WX_P#T4E?6%?)_Q8_Y*?K?^_'_ .BDH ]O
M^#/_ "3NW_Z^KC_T8:]!KS[X,_\ ).[?_KZN/_1AKT&@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH ,T5@^+IYK;P;K,\$K12QV<K)(IP5(4X(KSC1=2
M%O<^&I+*Y\0V]Q=21+=RZHSFVE4K\P!8D;B?NX[T >RYHKSS5O'USHNIE+JS
MLX[-;I;?8UZ#=."P D$8_AYZ$YP*LQ^-KFX\6S:/!I]OY<%P('26Y$=PPXS*
MD;##(,]CDT =UFBO.[3Q9,EQ<Z?I=A-=:E<:I<P1I<W)V*(\%G)P=JCC"CUK
MKM&O;Z\L-^HZ>UE<HY1X]X=3C^)3W![4 :U%>>_\+ N;?7+.TO+&SBAN[H6J
M1)>J]S&22 SH. #CIGC(IB>/]4>.UNX]#1K.ZOGT^+_2?G,H9E!QC&SY?K0!
MZ+FC-<$GCB[CM[FVN=)3^VXK];!+2*;,<CLH<-O(X7:<GCM1+XYNM-ANX-3T
MQ$U*SGMHY(HI<QNDS[5=6(SZ\'TH [VBN(\1^.3H-UK$ TXSG3[.&Y&'QYGF
M2%-O3BLCQ'XRU^RTK7+(Z=%9:G#IWVZVD2?>!&6VMGCAE].E 'IU%9NC37-Q
MHME->HJ73PJTBJVX!B/6M*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "OD_XL?\E/UO\ WX__ $4E
M?6%?)_Q8_P"2GZW_ +\?_HI* /;_ (,_\D[M_P#KZN/_ $8:]!KS[X,\?#NW
MSQ_I5Q_Z,->@T %%%% !1110 4444 %%%% !1110 4444 %%%% &;K6FKK&B
M7VFM(T:W4#0EP.5# C/ZUS%OX*U.6"PL]7\0&]TZR>-TMTM5CWF/&S<V22 0
M#^%=S10!YQ<?#66X%U;C5U6TGNOM6?LBM,6WA]K2'DKD>W&*OZKX&N=7U027
M6KF2R%RERL;VZF:,J0=J2]57(Z8[UW%% '$'P-)!<->V&J-!J*WT]U%,T0=5
M67&Z-E[C@=Q6[HVDW.GZ?-%?:E/?7,[M)+._RX)[(H^ZH["MJB@#SFS^&LML
M;%&U9#;V%XMU$$M%620@DXD?JW!QGCUK4A\#I#INFV0O7(LM4.HA]@^8EV;;
M_P"/?I7944 <9>^"4N+K4+N'4)(;R>]2^MY5C!\B1$"XQ_$",Y'O4$_@274+
M+4FU'5GFU2]:%_M2PA5B,3;HPJ>F<YYYKNJ* . N/A_<ZF-4EU+6FFN=0MX8
M'=( BQB-]PVK[UI:YX,BUR^O+F2[DB^TZ4VFE54':"V[=_\ 6KK:* *&F6L]
MGIMM:W,ZSS11JC2JFT-@8SC)Q5^BB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OD_P"+'_)3];_W
MX_\ T4E?6%?*'Q9!_P"%GZW_ +\?_HI* ,G3OB5XL\.6DFG:3JOV>SBF<I%Y
M$;8RQSR5)_6K/_"Z?B!_T'C_ . L/_Q%%% !_P +I^('_0>/_@+#_P#$4?\
M"Z?B!_T'C_X"P_\ Q%%% !_PNGX@?]!X_P#@+#_\11_PNGX@?]!X_P#@+#_\
M1110 ?\ "Z?B!_T'C_X"P_\ Q%'_  NGX@?]!X_^ L/_ ,1110 ?\+I^('_0
M>/\ X"P__$4?\+I^('_0>/\ X"P__$444 '_  NGX@?]!X_^ L/_ ,11_P +
MI^('_0>/_@+#_P#$444 '_"Z?B!_T'C_ . L/_Q%'_"Z?B!_T'C_ . L/_Q%
M%% !_P +I^('_0>/_@+#_P#$4?\ "Z?B!_T'C_X"P_\ Q%%% !_PNGX@?]!X
M_P#@+#_\11_PNGX@?]!X_P#@+#_\1110 ?\ "Z?B!_T'C_X"P_\ Q%'_  NG
MX@?]!X_^ L/_ ,1110 ?\+I^('_0>/\ X"P__$4?\+I^('_0>/\ X"P__$44
M4 '_  NGX@?]!X_^ L/_ ,11_P +I^('_0>/_@+#_P#$444 '_"Z?B!_T'C_
M . L/_Q%'_"Z?B!_T'C_ . L/_Q%%% !_P +I^('_0>/_@+#_P#$4?\ "Z?B
M!_T'C_X"P_\ Q%%% !_PNGX@?]!X_P#@+#_\11_PNGX@?]!X_P#@+#_\1110
M ?\ "Z?B!_T'C_X"P_\ Q%'_  NGX@?]!X_^ L/_ ,1110 ?\+I^('_0>/\
MX"P__$4?\+I^('_0>/\ X"P__$444 '_  NGX@?]!X_^ L/_ ,11_P +I^('
M_0>/_@+#_P#$444 '_"Z?B!_T'C_ . L/_Q%'_"Z?B!_T'C_ . L/_Q%%% !
M_P +I^('_0>/_@+#_P#$4?\ "Z?B!_T'C_X"P_\ Q%%% !_PNGX@?]!X_P#@
M+#_\11_PNGX@?]!X_P#@+#_\1110 ?\ "Z?B!_T'C_X"P_\ Q%'_  NGX@?]
M!X_^ L/_ ,1110 ?\+I^('_0>/\ X"P__$4?\+I^('_0>/\ X"P__$444 '_
M  NGX@?]!X_^ L/_ ,11_P +I^('_0>/_@+#_P#$444 '_"Z?B!_T'C_ . L
M/_Q%'_"Z?B!_T'C_ . L/_Q%%% !_P +I^('_0>/_@+#_P#$4?\ "Z?B!_T'
MC_X"P_\ Q%%% !_PNGX@?]!X_P#@+#_\11_PNGX@?]!X_P#@+#_\1110 ?\
M"Z?B!_T'C_X"P_\ Q%'_  NGX@?]!X_^ L/_ ,1110 ?\+I^('_0>/\ X"P_
M_$4?\+I^('_0>/\ X"P__$444 '_  NGX@?]!X_^ L/_ ,16)=:E>>);V?5=
45G,]Y,PWR;57.  . ,=!110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130113690528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Jeffs&#8217; Brands Ltd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JFBR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">8,074,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001885408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7 Mezada Street.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Bnei Brak<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Israel<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">5126112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Viki Hakmon<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, no par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Brightman Almagor Zohar&#160;& Co.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel Aviv, Israel<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7 Mezada Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Bnei Brak<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Israel<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">5126112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Viki Hakmon<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3-7713520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">victor@jeffsbrands.com<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130113784864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 8,137<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables</a></td>
<td class="nump">327<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">779<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">1,791<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">11,034<span></span>
</td>
<td class="nump">2,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_NonCurrentAssetsAbstract', window );"><strong>NON-CURRENT ASSETS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">4,452<span></span>
</td>
<td class="nump">5,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred taxes</a></td>
<td class="nump">110<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">138<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="nump">4,741<span></span>
</td>
<td class="nump">5,390<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">15,775<span></span>
</td>
<td class="nump">7,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Trade payables</a></td>
<td class="nump">131<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLoansPayableCurrent', window );">Other payables</a></td>
<td class="nump">391<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Related party payables</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBankLoansAndNotesPayable', window );">Short-term loans</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">927<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">640<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_NonCurrentLiabilitiesAbstract', window );"><strong>NON-CURRENT LIABILITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLoansPayableLongTerm', window );">Loans from shareholders</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative liabilities</a></td>
<td class="nump">2,216<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">98<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="nump">2,314<span></span>
</td>
<td class="nump">4,085<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">2,954<span></span>
</td>
<td class="nump">6,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS&#8217; EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares of no par value per share - Authorized: 43,567,567 and 4,356,757 shares as of December 31, 2022, and December 31, 2021, respectively; Issued and outstanding: 8,074,217 shares as of December 31, 2022; 2,893,125 shares as of December 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">16,499<span></span>
</td>
<td class="nump">2,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(3,678)<span></span>
</td>
<td class="num">(1,477)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">TOTAL SHAREHOLDERS&#8217; EQUITY</a></td>
<td class="nump">12,821<span></span>
</td>
<td class="nump">1,253<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND EQUITY</a></td>
<td class="nump">$ 15,775<span></span>
</td>
<td class="nump">$ 7,412<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_NonCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_NonCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_NonCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_NonCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term loans classified as other, payable within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLoansPayableLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term loans classified as other, payable after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLoansPayableLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBankLoansAndNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBankLoansAndNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112951968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Ordinary shares, par value (in Dollars per share)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, Authorized</a></td>
<td class="nump">43,567,567<span></span>
</td>
<td class="nump">4,356,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, Issued</a></td>
<td class="nump">8,074,217<span></span>
</td>
<td class="nump">2,893,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, outstanding</a></td>
<td class="nump">8,074,217<span></span>
</td>
<td class="nump">2,893,125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112675552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 5,859<span></span>
</td>
<td class="nump">$ 6,509<span></span>
</td>
<td class="nump">$ 2,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">5,060<span></span>
</td>
<td class="nump">4,560<span></span>
</td>
<td class="nump">1,165<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">799<span></span>
</td>
<td class="nump">1,949<span></span>
</td>
<td class="nump">1,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">1,198<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">4,113<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense', window );">Other expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit (loss)</a></td>
<td class="num">(4,512)<span></span>
</td>
<td class="num">(932)<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FinancialincomeExpensesNet', window );">Financial (income) expenses, net</a></td>
<td class="num">(2,305)<span></span>
</td>
<td class="nump">629<span></span>
</td>
<td class="nump">232<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Profit (loss) before taxes</a></td>
<td class="num">(2,207)<span></span>
</td>
<td class="num">(1,561)<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax (benefit) expense</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="num">$ (2,201)<span></span>
</td>
<td class="num">$ (1,540)<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic and diluted net profit (loss) attributable to shareholders per ordinary share (in Dollars per share)</a></td>
<td class="num">$ (0.47)<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average ordinary shares used in computing net profit (loss) per share, basic and diluted (in Shares)</a></td>
<td class="nump">4,643,879<span></span>
</td>
<td class="nump">2,892,347<span></span>
</td>
<td class="nump">2,888,768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_FinancialincomeExpensesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of financial (income) expenses, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_FinancialincomeExpensesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130113740304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net profit (loss) attributable to shareholders per ordinary share</a></td>
<td class="num">$ (0.47)<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average ordinary shares used in computing net profit (loss) per share, diluted</a></td>
<td class="nump">4,643,879<span></span>
</td>
<td class="nump">2,892,347<span></span>
</td>
<td class="nump">2,888,768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130108126304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders&#8217; Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Ordinary Shares</div></th>
<th class="th"><div>Additional paid-in-capital</div></th>
<th class="th"><div>Retained earnings (Accumulated deficit)</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 232<span></span>
</td>
<td class="num">$ (49)<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2019</a></td>
<td class="nump">2,893,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Profit (loss) for the year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Transactions with shareholders</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2020</a></td>
<td class="nump">2,893,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Profit (loss) for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,540)<span></span>
</td>
<td class="num">(1,540)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Share-based compensation to service provider</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Transactions with shareholders</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,058<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,058<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,730<span></span>
</td>
<td class="num">(1,477)<span></span>
</td>
<td class="nump">1,253<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="nump">2,893,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Profit (loss) for the year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,201)<span></span>
</td>
<td class="num">(2,201)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium', window );">Debt extinguishment of shareholders&#8217; loans (Note 10d)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts', window );">Issuance of ordinary shares upon initial public offering, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,194<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">6,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares', window );">Issuance of ordinary shares upon initial public offering, net of issuance costs (in Shares)</a></td>
<td class="nump">3,717,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of warrants to third party upon initial public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of shareholder loans (Note 12i)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,461<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of shareholder loans (Note 12i) (in Shares)</a></td>
<td class="nump">1,463,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Reclassification of derivative warrant liabilities to equity (Note 9c)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,319<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,319<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,499<span></span>
</td>
<td class="num">$ (3,678)<span></span>
</td>
<td class="nump">$ 12,821<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2022</a></td>
<td class="nump">8,074,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is issuance of ordinary shares upon initial public offering, net of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares is issuance of ordinary shares upon initial public offering, net of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid-in capital (APIC) from recognition of substantial premium at which convertible debt instrument is issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130108222640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="num">$ (2,201)<span></span>
</td>
<td class="num">$ (1,540)<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net profit (loss) to net cash from (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">570<span></span>
</td>
<td class="nump">524<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible asset</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Accrued interest and amortization of discount on third party loans (Note 8)</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain from debt extinguishment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative liabilities</a></td>
<td class="num">(2,822)<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans', window );">Accrued interest and amortization of discount on related party and shareholders&#8217; loans (Note 8)</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">324<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeasePayments', window );">Interest expense on short-term loan</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Benefit for deferred taxes</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Operating lease right-of-use assets</a></td>
<td class="nump">14<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_IssuanceCostsOnDerivativeLiabilities', window );">Issuance costs on derivative liabilities</a></td>
<td class="nump">1,416<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Decrease (increase) in trade receivables</a></td>
<td class="nump">39<span></span>
</td>
<td class="num">(282)<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedParties', window );">Decrease (increase) related party balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Decrease (increase) in other receivables</a></td>
<td class="num">(743)<span></span>
</td>
<td class="num">(290)<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Decrease (increase) in inventory</a></td>
<td class="num">(564)<span></span>
</td>
<td class="num">(449)<span></span>
</td>
<td class="num">(638)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent', window );">Increase (decrease) related party liabilities</a></td>
<td class="num">(213)<span></span>
</td>
<td class="nump">241<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities', window );">Increase (decrease) accounts payable and other payables</a></td>
<td class="num">(579)<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Decrease in operating lease liabilities</a></td>
<td class="num">(15)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash from (used in) operating activities</a></td>
<td class="num">(4,840)<span></span>
</td>
<td class="num">(863)<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS USED IN INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(4,728)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(4,730)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherShortTermDebt', window );">Short-term loan received</a></td>
<td class="nump">752<span></span>
</td>
<td class="nump">981<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherShortTermDebt', window );">Short-term loan repaid</a></td>
<td class="num">(1,518)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="num">(196)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering, net of issuance costs</a></td>
<td class="nump">13,391<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromBankDebt', window );">Loan received from shareholders</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,800<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfBankDebt', window );">Loan repaid to shareholders</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Loan received (repaid) from related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,102)<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of ordinary shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash from financing activities</a></td>
<td class="nump">12,625<span></span>
</td>
<td class="nump">5,695<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">7,744<span></span>
</td>
<td class="nump">102<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR</a></td>
<td class="nump">393<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS AT END OF THE YEAR</a></td>
<td class="nump">8,137<span></span>
</td>
<td class="nump">393<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Taxes paid</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">477<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DeferredOfferingCostsIncludedInOtherPayables', window );">Deferred offering costs included in other payables</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts', window );">Share-based compensation included in deferred offering costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans', window );">Issuance of ordinary shares upon conversion of shareholders&#8217; loans</a></td>
<td class="nump">2,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity', window );">Substantial modification of shareholders&#8217; loans recorded in equity</a></td>
<td class="nump">982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities', window );">Right of use assets obtained in exchange for lease liabilities</a></td>
<td class="nump">$ 152<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Amount less than $1 thousand</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is accrued interest and amortization of discount on related party and shareholders&#8217; loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_DeferredOfferingCostsIncludedInOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is deferred offering costs included in other payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_DeferredOfferingCostsIncludedInOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_IssuanceCostsOnDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is issuance costs on derivative liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_IssuanceCostsOnDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is issuance of ordinary shares upon conversion of shareholders&#8217; loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is right of use assets obtained in exchange for lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is share-based compensation included in deferred offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is substantial modification of shareholders&#8217; loans recorded in equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the current portion (due within one year or one business cycle, whichever is longer) of the amount owed by the reporting entity in the form of loans and obligations (generally evidenced by promissory notes) made by the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromBankDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from bank borrowing during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromBankDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from short-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfBankDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle a bank borrowing during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfBankDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term lease payment excluded from lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130113649696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationAbstract', window );"><strong>General Information Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationTextBlock', window );">GENERAL INFORMATION</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 1 &#8212; GENERAL INFORMATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify"><b>General</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Jeffs&#8217; Brands Ltd (the &#8220;Company&#8221; or &#8220;Jeffs&#8217;
Brands&#8221;) was incorporated in Israel on March 7, 2021. As of the date of issuance of these financial statements the Company has five
wholly owned subsidiaries &#8212; Smart Repair Pro (&#8220;Smart Pro&#8221;), purex Corp. (&#8220;Purex&#8221;), Top Rank Ltd. (&#8220;Top
Rank&#8221;), Jeffs&#8217; Brands Holdings Inc. (&#8220;Jeffs&#8217; Brands Holdings&#8221;) and Fort Products Ltd. (&#8220;Fort&#8221;),
and together with Smart Pro, Purex, Top Rank and Jeffs&#8217; Brands Holdings, the &#8220;Subsidiaries&#8221;. The Company and the Subsidiaries
(&#8220;Group&#8221;) are engaged in the acquisition, improvement and operation of virtual stores (the &#8220;Brands&#8221;) mainly on
the Amazon.com (&#8220;Amazon&#8221;) website. Prior to consummation of the Stock Exchange and Plan of Restructuring Agreement (the &#8220;SEA&#8221;)
with Medigus Ltd., a publicly traded company incorporated under the laws of the State of Israel (&#8220;Medigus&#8221;), as described
below, all of the Company&#8217;s operations were carried under Smart Pro and Purex. References to the Company hereinafter, unless the
context otherwise provides, include Jeffs&#8217; Brands and the Subsidiaries on a consolidated basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Smart Pro, a private corporation founded
in the State of California, was established on December&#160;20, 2017, and commenced its operations in June&#160;2019. As of December&#160;31,
2022, Smart Pro operated four brands on the Amazon website.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Purex, a private corporation incorporated
in the State of California on April&#160;1, 2020, commenced its operations on that date. Purex was established for the purpose of purchasing
an online store. During 2022 Purex ceased its operation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In April&#160;2021, Top Rank Ltd.,
an Israeli company, was established as a wholly owned subsidiary of Jeffs&#8217; Brands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In February 23, 2023, Jeffs&#8217;
Brands Holdings Inc., was established and registered in Delaware as a wholly owned subsidiary of Jeffs&#8217; Brands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On March 9, 2023, the Company purchased
all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales. For additional information
see note 17.b.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On January&#160;4, 2021, Medigus Ltd.,
acquired 50.01% of Smart Pro and 50.03% of Purex pursuant to a share purchase agreement entered into in October&#160;2020. On May&#160;10,
2021, pursuant to the SEA, Medigus and Viki&#160;Hakmon, the shareholders of Smart Pro and Purex immediately prior to closing of the
SEA (the &#8220;Previous Shareholders&#8221;), contributed all of their equity interests in Smart Pro and Purex to Jeffs&#8217; Brands
in exchange for ordinary shares of Jeffs&#8217; Brands (the &#8220;Contribution Transactions&#8221;). As a result of the Contribution
Transactions, Jeffs&#8217; Brands held all of the outstanding shares of Smart Pro and Purex. Additionally, immediately after the transaction,
Medigus held 50.03% of the outstanding ordinary shares of Jeffs&#8217; Brands and Mr.&#160;Hakmon held the remaining 49.97% of the outstanding
ordinary shares, resulting in Jeffs&#8217; Brands being wholly owned by the Previous Shareholders, at the same interest proportion as
held by the Previous Shareholders in Smart Pro and Purex prior to the Contribution Transactions. Mr.&#160;Hakmon&#8217;s affiliates,
who were minority shareholders of Smart Pro and Purex, transferred all their holdings in Smart Pro and Purex to Mr.&#160;Hakmon, effective
immediately prior to the Contribution Transactions pursuant to a Share Transfer Deed dated May&#160;10, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As Smart Pro and Purex were owned solely by the Previous Shareholders
immediately prior to consummation of the Contribution Transactions and Jeffs&#8217; Brands was owned solely by the Previous Shareholders
immediately thereafter, the Contribution Transactions was accounted for in a manner similar to a transaction between entities under common
control. Accordingly, the Contribution Transactions were retrospectively applied to the prior periods, such that the combined financial
information of Smart Pro and Purex is presented in these financial statements for periods prior to the SEA, with share and per share data
in these financial statements being retrospectively adjusted based on the equivalent number of ordinary shares of Jeffs&#8217; Brands,
for the year ended December 31, 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify"><b>Initial public
                                            offering</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On August&#160;30, 2022, the Company
completed its initial public offering (&#8220;IPO&#8221;), In connection with the IPO, the Company sold 3,717,473 units at a public offering
price of $4.16 per unit, with each unit consisting of one of ordinary share, no par value per share (&#8220;Ordinary Share&#8221;), and
one warrant (&#8220;IPO Warrant&#8221;), to purchase one Ordinary Share, at an exercise price of $4.04 per Ordinary Share (and an exercise
price of $2.02 following the Exercise Price Adjustment, as defined below). Pursuant to the terms of the IPO Warrant, investors that purchased
and held at least 120,192 IPO Warrants on the 90th calendar day immediately following the issuance date of the IPO Warrants (each, a
&#8220;Qualified Buyer&#8221;), were entitled to additional warrants (&#8220;Additional Warrants&#8221;). Each Additional Warrant has
substantially the same terms as the As-Adjusted IPO Warrant (as defined below); provided, however, that the term of each Additional Warrant
is five (5) years from the issuance date and such Additional Warrant is not listed on any securities exchange. In addition, as long as
the Additional Warrants are outstanding, each holder of at least 120,192 IPO Warrants (each, a &#8220;Qualified Holder&#8221;) will receive
semi-annual payments based on the Group&#8217;s revenues, dependent on the amount of the Additional Warrants outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Additionally, the Company issued warrants
to the underwriter to purchase up to 185,873 ordinary shares at an exercise price of $5.20 per Ordinary Share (&#8220;Underwriter&#8217;s
Warrants&#8221;). The underwriter partially exercised its right to purchase an additional 425,912 warrants for total consideration of
$4 thousands. The Company received total net proceeds of $13.4&#160;million after deducting issuance costs of $2.1&#160;million.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On September 7, 2022, the Company&#8217;s
volume weighted average stock price was less than the exercise floor of $4.04 for the IPO Warrants. Accordingly, and based on the contractual
terms of the IPO Warrants, effective after the closing of trading on November 28, 2022 (the 90th calendar day immediately following the
issuance date of the IPO Warrants), the IPO Warrants were adjusted (&#8220;As-Adjusted IPO Warrants&#8221;) pursuant to their terms,
including, but not limited to, to adjust the exercise price of the IPO Warrants to $2.02 (the &#8220;Exercise Price Adjustment&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, in connection with the
Exercise Price Adjustment, Additional Warrants were issued to each Qualified Buyer who continued to hold at least 120,192 IPO Warrants
as of November 28, 2022. Accordingly, the Company issued Additional Warrants to purchase up to 2,824,525 Ordinary Shares.As of December
31, 2022, the revenue payment to Qualified Holders was equal to approximately 2.3% of the Group&#8217;s revenues for the period ended
December 31,2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In connection with the IPO, all loans
from shareholders then outstanding as of August 30, 2022 were converted into 1,463,619 ordinary shares. Additionally, all outstanding
loans from third-parties were repaid.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Ordinary Shares and IPO Warrants
trade on the Nasdaq under the symbol &#8220;JFBR&#8221; and &#8220;JFBRW&#8221;, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify"><b>Bonus Shares
                                            and Reverse Share Split</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On February&#160;17, 2022, the Company&#8217;s
Board of Directors approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments
for subsequent reverse share split) ordinary shares of the Company for each Ordinary Share issued and outstanding as of the close of
business on February&#160;17, 2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an
aggregate issuance by the Company as of such date of 6,630,547 (prior to adjustments for subsequent reverse share splits) Ordinary Shares.
Additionally, the Board approved an increase in the authorized share capital of the Company to 100,000,000 (43,567,567 after giving effect
to the two subsequent reverse share splits) ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On May&#160;3, 2022, the Company&#8217;s
Board of Directors approved a 0.806-for-1&#160;reverse split of its issued and outstanding Ordinary Shares, effective as of May&#160;3,
2022, pursuant to which holders of the Company&#8217;s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On June&#160;16, 2022, the Company&#8217;s
Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June&#160;16, 2022,
pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85&#160;Ordinary Shares held as of such date.
The reverse stock split proportionally reduced the number of the Company&#8217;s authorized share capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All issued and outstanding Ordinary
Shares contained in these financial statements have been retroactively adjusted to reflect the bonus share issuance and the reverse share
splits for all periods presented, unless explicitly stated otherwise. (See note 12g).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -25.5pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>d.</b></td><td style="text-align: justify"><b>Concentration
                                            risk</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group&#8217;s activities are mainly
conducted through Amazon&#8217;s commercial platform. Any material change, whether temporary or permanent, including changes in Amazon&#8217;s
terms of use and/or its policies, may affect sales performance, and may have a material effect on the Group&#8217;s financial position
and the results of its operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, the Group is engaged with
a small number of suppliers as part of the production process of its brands . Any material changes in the supply process, whether temporary
or permanent, may affect sales performance, and may have a material effect on the Group&#8217;s financial position and the results of
its operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>e.</b></td><td style="text-align: justify"><b>Liquidity</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the year ended December 31,
2022, the Group incurred a net loss of $&#160;2,201 thousands and cash flows used in operating activities were $&#160;4,840 thousand.
As of December 31, 2022, the Group had an accumulated deficit of approximately $3,678 thousand.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group has funded its operations
to date through the sale of its products, through equity financings, loans from shareholders and other third parties, and sale of its
Ordinary Shares and warrants. The Company intends to continue to finance its operating activities through the sale of products via its
Brands and through raising additional capital, as needed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As detailed above, the Company completed
its IPO for total net proceeds of approximately $13.4 million in August 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">After the balance sheet date, the Company purchased Fort &#160;and
SciSparc Nutraceuticals Inc. (&#8220;SciSparc U.S.&#8221;) with proceeds from the IPO. Based on historical sales of Fort and SciSparc
Ltd. (&#8220;SciSparc&#8221;) brands and the ongoing revenues generated from previously purchased brands, management believes that expected
cash flows are sufficient to support the Group&#8217;s current operations for more than 12&#160;months from the issuance date of these
consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_GeneralInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_GeneralInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_GeneralInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_GeneralInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115629824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 2 &#8212; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify"><b>Basis of preparation of the financial statements</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group&#8217;s consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) and include the accounts of Jeffs&#8217; Brands Ltd and its wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to 2022, the&#160;Group prepared
its financial statements in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting
Standards Board (IASB), as permitted in the United States based on the Company&#8217;s qualification as a &#8220;foreign private issuer&#8221;
under the rules and regulations of the U.S Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify"><b>Use of estimates</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements
in conformity with U.S.&#160;GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the
reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances,
fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent
liabilities, among others.&#160;Such estimates are based on&#160;historical experience and on various other assumptions that are believed
to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group&#8217;s assets and
liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify"><b>Functional and presentation currency</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The functional and reporting currency
of the Group is the United States dollar (&#8220;U.S dollar&#8221;) as the U.S. dollar is the currency of the primary economic environment
in which the Group has operated and expects to continue to operate in the foreseeable future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group transactions and balances denominated in U.S. dollars are
presented at their original amounts. Non-U.S. dollar transactions and balances have been remeasured to U.S. dollars in accordance with
Accounting Standards Codification (&#8220;ASC&#8221;) 830, &#8220;Foreign Currency Transaction&#8221;. All transaction gains and losses
from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected in the statement of operations
as financial income or expenses foreign currency gain/loss, as appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>d.</b></td><td style="text-align: justify"><b>Cash and cash equivalents</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cash and cash equivalents include cash
in banks and short-term bank deposits (with original maturities of <span style="-sec-ix-hidden: hidden-fact-79">three</span>&#160;months or less) that are not restricted as to withdrawal
or use and are therefore considered to be cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>e.</b></td><td style="text-align: justify"><b>Accounts receivable</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivables are stated at realizable value, net of an allowance
for credit losses. The Group evaluates its outstanding accounts receivable and establishes an allowance for credit losses based on information
available on their credit condition, current aging, historical experience and future economic and market conditions. These allowances
are reevaluated and adjusted periodically as additional information is available. Payments are made by customers immediately at the point
of sale, therefore, no provision for credit losses has been recorded as of December 31, 2022 and 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>f.</b></td><td style="text-align: justify"><b>Inventories</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories are stated at the lower
of cost and or market based on net realizable value. Inventories are adjusted for estimated excess and obsolescence and written down
to net realizable value based upon estimates of future demand, technology developments, and market conditions. Cost is determined in
accordance with first-in, first-out Method (&#8220;FIFO&#8221;) and the cost of inventory includes shipment and freight costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>g.</b></td><td style="text-align: justify"><b>Property and equipment</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment are stated at
historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition
of the items. Repairs and maintenance are charged to the statement of operations during the period in which they are incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assets are depreciated using the
straight-line method to allocate their cost over their estimated useful lives, as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; text-indent: -10pt; padding-left: 10pt">Computers equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 44%; text-align: center">33</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt">Furniture</td><td>&#160;</td>
    <td style="text-align: center">7</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center">Shorter of remaining lease term or estimated useful life</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>h.</b></td><td style="text-align: justify"><b>Deferred offering costs</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company capitalized certain legal
and other third-party fees that were directly related to the Company&#8217;s IPO. As of December 31, 2021, there were $366 thousands
of deferred offering costs included in other non-current assets on the balance sheet.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The total gross consideration from
the IPO was initially allocated to the derivative warrant liability based on its fair value and the remaining amount was allocated to
the Ordinary Shares issued and recognized as a component of equity. (refer to Note 12h below). Accordingly, issuance costs were allocated
between the warrant liability and Ordinary Shares based on their relative fair values.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>i.</b></td><td style="text-align: justify"><b>Leases</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with ASC 842, the Group
determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves
the use of a distinct identified asset, (2) whether the Group obtains the right to substantially all the economic benefits from the use
of the asset throughout the period, and (3) whether the Group has a right to direct the use of the asset. The Group elected the practical
expedient to not recognize a lease liability and a right-of-use (&#8220;ROU&#8221;) asset for leases with a term of twelve months or
less. The Group also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent
the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments
arising from the lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ROU assets are initially measured at
amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred.
The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments
over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Group uses its Incremental
Borrowing Rate (&#8220;IBR&#8221;) based on the information available at commencement date in determining the present value of lease
payments. The Group&#8217;s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments
and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">An option to extend the lease is considered
in connection with determining the ROU asset and lease liability when it is reasonably certain that the Group will exercise that option.
An option to terminate is considered unless it is reasonably certain that the Group will not exercise the option.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Operating lease expense is recognized
on a straight-line basis over the lease term.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>j.</b></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Asset acquisition</b></p></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Group accounts for a transaction
as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable
asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs
are capitalized as part of the asset or assets acquired.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>k.</b></td><td style="text-align: justify"><b>Intangible assets</b></td>
</tr></table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Group&#8217;s intangible assets consist of its Brands. Intangible assets that are not considered to have an indefinite useful life are
amortized over their estimated useful lives. Each period the Group evaluates the estimated remaining useful lives of its intangible assets
and whether events or changes in circumstances warrant a revision to the remaining period of amortization.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The estimated useful lives of the Group&#8217;s
intangible assets (Brands) are 10 years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>l.</b></td><td style="text-align: justify"><b>Impairment of long-lived assets</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group&#8217;s long-lived&#160;assets
(assets group) to be held or used, including property and equipment, right of use assets and intangible assets subject to amortization
are reviewed for impairment in accordance with ASC 360, &#8220;Accounting for the Impairment or Disposal of Long-Lived Assets&#8221;,
whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The recoverability of
these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate.
If property and equipment, intangible assets or right of use assets are considered to be impaired, the impairment to be recognized equals
the amount by which the carrying value of the asset exceeds its fair market value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining the fair values of long-lived
assets for the purpose of measuring impairment, the Group&#8217;s assumptions include those that market participants will consider in
valuations of similar assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>m.</b></td><td style="text-align: justify"><b>Loans from shareholders and related parties:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">On the borrowing date of loans received from shareholders or related
parties, the Group estimates the value of the benefit granted to it as the difference between the interest rate that the Group is required
to pay to investors for the loans provided by them and secured by such lien and the interest rate required to pay for similar unsecured
loans to non-related parties. The Group assesses changes to the term of loans with shareholders and related parties in accordance with
ASC 470, &#8220;Debt&#8221; (&#8220;ASC 470&#8221;), Subtopic 50&#8212; &#8220;Modifications and Extinguishments&#8221; (&#8220;ASC 470-50&#8221;).
For transactions accounted for as debt extinguishment, the difference between the reacquisition price of the debt and the net carrying
amount of the extinguished debt is recorded as an in-essence capital transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>n.</b></td><td style="text-align: justify"><b>Income taxes</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for income taxes
in accordance with ASC 740, &#8220;Income Taxes&#8221;. ASC 740 prescribes the use of the liability method whereby deferred tax assets
and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities
and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Valuation
allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than
not to be realized. As of December 31, 2022 and 2021 a partial valuation allowance was recorded on the Group&#8217;s deferred tax assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group implements a two-step approach
to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax
return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical
merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second
step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate
settlement. As of December 31, 2022 and 2021, no liability for unrecognized tax positions has been recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>o.</b></td><td style="text-align: justify"><b>Revenue recognition</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">The Group sells products
directly to customers mainly through its online Amazon stores.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under the Group&#8217;s standard contract
terms, customers have a right of return within 30 until 90 days. For contracts with rights of return, the Group recognizes revenue based
on the amount of the consideration which the Group expects to receive for products which are not expected to be returned and recognizes
a refund liability for the amount not expected to be received. At the end of each reporting period, the Group updates its estimates of
expected product returns and adjusts the refund liabilities with a corresponding adjustment in revenues. The Group recorded an allowance
for returns in the amounts of $35 thousand and $35 thousand as of December 31, 2022, and 2021, respectively. The allowance for returns
is recorded as decrease in revenues against other payables.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group evaluates the criteria outlined
in ASC 606-10-55, &#8220;Principal versus Agent Considerations&#8221;, in determining whether it is appropriate to record the gross amount
of product sales and related costs or the net amount earned as commissions. The Group evaluates whether it is appropriate to recognize
revenue on a gross or net basis based upon its evaluation of whether the Company obtains control of the specified goods by considering
if it is primarily responsible for fulfillment of the promise, has inventory risk, and has the latitude in establishing pricing and selecting
suppliers, among other factors. Based on its evaluation of these factors, management has determined that it is the principal in these
arrangements; therefore, sales are recorded on a gross basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>p.</b></td><td style="text-align: justify"><b>Cost of sales</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with Amazon&#8217;s terms
of use, the Group is obligated to pay to Amazon incremental costs, such as sales fulfillment commissions which are contingent on making
binding sales. Sales commissions would not have been incurred if the contract had not been obtained.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cost of sales primarily consists of
expenses related to Amazon&#8217;s commissions, storage costs and freight.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>q.</b></td><td style="text-align: justify"><b>Advertising expenses</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt">The Group expenses
advertising costs as incurred. Advertising expenses, included within sales and marketing expenses, were $1,163 thousands, $1,211 thousands,
and $371 thousands for the years ended December 31, 2022, 2021 and 2020, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>r.</b></td><td style="text-align: justify"><b>Employee benefits</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt">Pension
and severance pay obligations</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Groups employees are employed by Jeffs&#8217;
Brands and subject to Israeli labor laws. Israeli labor law generally requires payment of severance pay upon dismissal of an employee
or upon termination of employment in certain other circumstances. Pursuant to Section&#160;14 of the Severance Compensation Act, 1963
(&#8220;Section&#160;14&#8221;), all of the Group&#8217;s employees in Israel are entitled to a monthly contribution, at a rate of 8.33%
of their monthly salary, made in their name with insurance companies. Contributions under Section&#160;14 relieve the Group from any future
severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Group&#8217;s
balance sheet, and there is no liability recorded as the Group does not have a future obligation to make any additional payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>s.</b></td><td style="text-align: justify"><b>Fair value measurement</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group applies ASC 820, &#8220;Fair
Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;). Under this standard, fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability (i.e., the &#8220;exit price&#8221;) in an orderly transaction between market
participants at the measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining fair value, the Group
uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable
inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs
are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent
from the Group. Unobservable inputs are inputs that reflect the Group&#8217;s assumptions about the assumptions market participants would
use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken
down into three levels based on the inputs as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 1 - Valuations based on quoted
prices in active markets for identical assets that the Group has the ability to access. Valuation adjustments and block discounts are
not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active
market, valuation of these products does not entail a significant degree of judgment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 2 - Valuations based on one or
more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 3 - Valuations based on inputs
that are unobservable and significant to the overall fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amounts of cash and cash equivalents, trade receivables,
other receivable, trade payables, other accounts payable and accrued expenses and payables to related parties approximate their fair value
due to the short-term maturity of such instruments. The Group&#8217;s derivative liabilities in respect of Additional Warrants are classified
within Level 3 of the fair value hierarchy because their fair values are estimated by utilizing valuation models and significant unobservable
inputs. For more details, see Note 9.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>t.</b></td><td style="text-align: justify"><b>Warrants</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for warrants as either
equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific terms and applicable authoritative
guidance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assessment considers whether the
warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, &#8220;Distinguishing Liabilities and
Equity&#8221;, are indexed to the Group&#8217;s own stock and whether the warrants are eligible for equity classification under ASC 815
(&#8220;ASC 815&#8221;), &#8220;Derivatives and Hedging&#8221;, Subtopic 40 &#8220;Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC
815-40&#8221;). This assessment is conducted at the time of warrant issuance and as of each subsequent reporting period end date while
the warrants are outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Warrants that meet all the criteria for
equity classification, are recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity
classification, are recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value through earnings
at each balance sheet date thereafter.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>u.</b></td><td style="text-align: justify"><b>Legal and other contingencies</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for its contingent
liabilities in accordance with ASC 450, &#8220;Contingencies&#8221;. A provision is recorded when it is both probable that a liability
has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, the Group reviews the status
of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable
and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Legal costs incurred in connection with
loss contingencies are expensed as incurred. As of December 31, 2022, and 2021, the Group is not a party to any litigation that could
have a material adverse effect on the Group&#8217;s business, financial position, results of operations or cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>v.</b></td><td style="text-align: justify"><b>Basic and diluted net loss per share.</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group calculates basic net profit
(loss) per share by dividing the net profit (loss) by the weighted-average number of Ordinary Shares outstanding during the period. Diluted
net loss per share is computed by giving effect to all potentially dilutive Ordinary Share equivalents outstanding for the period. All
outstanding share options and warrants for the years ended December 31, 2022 and 2021 have been excluded from the calculation of the diluted
net loss per share since all such securities were anti-dilutive. For the year ended December 31, 2020 there were no Ordinary Share equivalents
outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>w.</b></td><td style="text-align: justify"><b>Recently adopted and recently issued accounting pronouncements.</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In May 2021, the FASB issued ASU No.
2021-04 to ASC 260, ASC 470-50, ASC 718 &#8220;Compensation&#8212;Stock Compensation&#8221;, and ASC 815: &#8220;Issuer&#8217;s counting
for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#8221;. The amendments in ASU No. 2021-
modification or exchange. The amendments in this ASU No. 2021-04 were effective for after the Company beginning on January 1, 2022. The
adoption of the standard did not have material effect on Group&#8217;s results.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115826464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">OTHER RECEIVABLES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 3 &#8212; OTHER RECEIVABLES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Advances to suppliers</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">641</td><td style="width: 1%; text-align: left">(*)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Government institutions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">779</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(*) Includes $228 thousand to Pure Capital. See
Note 16 for additional information.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115593680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORY</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 4 &#8212; INVENTORY</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Goods in transit</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">161</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,783</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,066</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,791</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,227</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115635312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_IntangibleAssetsLineItems', window );"><strong>Disclosure Of Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 5 &#8212; INTANGIBLE ASSETS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Total intangible assets consisted of
the following as of December&#160;31, 2022 and 2021:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, 2022</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Gross Amount</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Accumulated Amortization</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Net Balance</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center"><b>U.S.&#160;dollars in thousands</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; width: 64%; text-align: left">Brands</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">5,783</td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(1,331</td><td style="padding-bottom: 4pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">4,452</td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, 2021</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Gross Amount</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Accumulated Amortization</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Net Balance</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center"><b>U.S.&#160;dollars in thousands</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; width: 64%; text-align: left">Brands</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">5,783</td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(762</td><td style="padding-bottom: 4pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-size: 10pt">5,021</span></td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Amortization expense was $570 thousand,
$524 thousand, and $104 thousand, for the years ended December 31, 2022, 2021, and 2020, respectively. Estimated annual amortization expense
for each of the next five years is expected to be $570 thousand.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In March&#160;2021, Purex received
an update from Amazon regarding a new Environmental Protection Agency (&#8220;EPA&#8221;) regulation. Following the new EPA regulation,
Amazon categorized Purex&#8217;s product as a pesticide product. Amazon requires that pesticide products be filed with evidence of an
EPA registration number and/or EPA Establishment number or certification that the product is exempt from EPA regulation, otherwise the
existing listing (of the product) may be subject to removal. The Group examined the related costs following the requirement to comply
with such regulations and decided to write off the intangible asset balance in a total amount of $87 thousands during 2021 following the
EPA regulation update.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_IntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_IntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115680544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LeasesLineItems', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 6 &#8212; LEASES:</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company leases office space with
a remaining useful life of less than 3 years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of December 31, 2022, the Company&#8217;s
operating lease assets and lease liabilities (both the current and non-current portion) for operating leases totaled $138 thousands and
$141 thousands, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company uses its incremental borrowing
rate as the discount rate for its leases, as the implicit rate in the lease is not readily determinable. As of December 31, 2022, the
Company&#8217;s operating leases had a weighted average remaining lease term of 3 years and a weighted average borrowing rate of approximately
10%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Future lease payments under operating
leases as of December 31, 2022, were as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">58</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">2024-2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">103</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total future operating lease payments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">161</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Less: imputed interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(20</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Present value of lease liability</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">141</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_LeasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_LeasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115635312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Payables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Schedule of Other Payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">OTHER PAYABLES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 7 &#8212;&#160;OTHER PAYABLES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Government institutions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">36</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Employees and related benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Accrued Interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">294</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses and other payables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">266</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">271</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">391</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">715</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115687904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Loans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Short-Term Loans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">SHORT-TERM LOANS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 8 &#8212;&#160;SHORT-TERM LOANS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December&#160;31,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Loans with Amazon (8a)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">86</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">101</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Related party loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Third party loans (8b)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">715</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">86</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">927</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September&#160;22, 2021, Smart Pro entered into a loan agreement with Amazon. Pursuant to the loan agreement, Smart Pro received an aggregate amount of $153 thousands from Amazon, of which $14 was repayment of a previous Amazon loan balance. The loan matures within nine&#160;months and bears annual interest at a rate of 9.99% per year. In order to secure the loan, Smart Pro pledged its financial balances on its Amazon account on Amazon and its inventories held in Amazon&#8217;s warehouses, in favor of Amazon. On May&#160;9, 2022, the loan was fully repaid. As of December 31, 2022, the remaining loan balance to Amazon was $86 thousand.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On May&#160;9, 2022, Smart Pro entered
into a new loan agreement with Amazon. Pursuant to the loan agreement, Smart Pro received an aggregate amount of $152 thousands from Amazon.
The loan matures within 12&#160;months and bears annual interest at a rate of 9.99% per year. In order to secure the loan, Smart Pro pledged
its financial balances on its account on Amazon and its inventories held in Amazon&#8217;s warehouses, in favor of Amazon.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July&#160;2021, Smart Pro entered into a loan agreement with two third parties. The loans bore annual interest rate of 10% and were payable in January&#160; 2022. Smart Pro was entitled to extend the loans by an additional sixty&#160;days, with additional interest of 1% per month. In addition, pursuant to the loan agreement, in the event of an IPO of the Company, the lenders would be entitled to Ordinary Shares of the Company at an aggregate value of $250 thousands with a conversion price at the IPO price. In July&#160;2021, the loan principal of $750 thousands was received. The proceeds from the lenders were first allocated to the liability (see note 9.a) to issue a variable number of shares based on its fair value at the date of issuance in an amount of $62 thousands, with a corresponding discount recorded on the third-party loan. The derivate liability was revalued at each period-end and amounted to $137 thousands as of December 31, 2021.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On November&#160;23, 2021, the loan
agreement was amended to extend the maturity date of the loans to the earlier of (i)&#160;March&#160;31, 2023, or (ii)&#160;the closing
of an IPO of the Company. Based on management&#8217;s assessment, the amendment resulted in a substantial modification to the loan in
accordance with ASC 470-50. As a result of the debt extinguishment, the Group recorded , a gain in the amount of $14 thousand within finance
expenses, net for the year ended December 31, 2021 as the difference between the net carrying value of the original loans and the fair
value of the loan bearing the modified terms.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Following the IPO in 2022, the Group
repaid the third-party loan.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify">On February&#160;22, 2022, the Company entered into a loan
agreement with Bank Leumi Le-Israel&#160;(&#8220;Bank Leumi&#8221;) to provide for a line of credit in an aggregate amount of up to $1,000
thousands, which the Company may draw in two tranches at its request, but in no event after July&#160;21, 2022. Pursuant to the loan
agreement, amounts drawn bear interest at a rate of Secured Overnight Financing Rate (&#8220;SOFR&#8221;) plus 3.25% annually. On March
3, 2022, the Company drew $400 thousands under the line of credit. On June 2, 2022, the Company drew another $200 thousands million under
the line of credit. Following an agreement with Bank Leumi, the loan was extended until October 31, 2022. All amounts outstanding under
the line of credit were fully repaid on September 6, 2022.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115660944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">DERIVATIVE LIABILITIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 9 &#8212;&#160;DERIVATIVE LIABILITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The following table presents changes in the fair value of
the derivative warrant liability during the year (in thousands)</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Balance as of January 1, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Fair value of warrant liability to be issued to third-party upon IPO (note 9a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">75</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Balance as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of warrants in connection with the IPO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,220</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,822</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Classification to additional paid in capital</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,319</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">Balance as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,216</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As detailed in Note 8b , the Group received two loans of $375 thousands each from third parties. As part of the loan agreements, the lenders were entitled to receive warrants in the event of an initial public offering at a conversion price equal to the IPO issuance price.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Management determined that the obligation to issue a variable number
of shares represents a derivative liability. The proceeds from the lender were first allocated to the derivate liability based on its
fair value at the date of issuance in an amount of $62 thousands, with a corresponding discount recorded on the third-party loan. The
derivate liability was revalued at each period-end and amounted to $137 thousand as of December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Effective
as of August 30, 2022, the closing date of the IPO, and pursuant to the loan agreements (the &#8220;Issuance Date&#8221;), the Company
issued warrants to the lenders to purchase up to 60,096 </span>&#160;&#160;<span style="font-family: Times New Roman, Times, Serif">Ordinary
Shares, exercisable at an exercise price of $4.04 per share, exercisable for three years following the IPO. The warrants have cashless
exercise mechanism.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On the issuance date of the warrants, all conditions for equity classification
under U.S. GAAP were met, and as such, the fair value of the warrants as of the issuance date were reclassified to equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><b>b</b></span><b>.</b></td><td style="text-align: justify">In connection with the IPO (including the partial exercise
of over-allotment option), the Company sold 3,717,473 units at a public offering price of $4.16 per unit, with each unit consisting of
one of ordinary share, no par value per share (&#8220;Ordinary Share&#8221;), and one warrant (&#8220;IPO Warrant&#8221;), to purchase
one Ordinary Share, at an initial exercise price of $4.04 per Ordinary Share. Additionally, the Company issued and sold 3,717,473 ordinary
shares, no par value per share (&#8220;Ordinary Shares&#8221;), warrants to purchase up to 4,143,385 Ordinary Shares (&#8220;IPO Warrants&#8221;)
and warrants issued to the underwriter in the offering to purchase up to 185,873 Ordinary Shares at an exercise price of $5.20 per Ordinary
Share (&#8220;Underwriter&#8217;s Warrants&#8221;). The underwriter partially exercised its right to purchase an additional 425,912 warrants
for total consideration of $4 thousands. The Company received net proceeds of $13.4 million after deducting issuance costs of $2.1 million.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On September 7, 2022, the Company&#8217;s
volume weighted average stock price was less than the exercise floor of $4.04 for the Warrants. Accordingly, effective after the closing
of trading on November 28, 2022 (the 90th calendar day immediately following the issuance date of the IPO Warrants), the IPO Warrants
were adjusted (&#8220;As-Adjusted IPO Warrants&#8221;) pursuant to their terms, including, but not limited to, the reduction of the exercise
price of the IPO Warrants to $2.02. Additionally, Additional Warrants were issued to each qualified buyer who continued to hold at least
120,192 IPO Warrants as of November 28, 2022. Accordingly, the Company issued Additional Warrants to purchase 2,824,525 Ordinary Shares.
Each Additional Warrant has substantially the same terms as the As-Adjusted IPO Warrant; provided, however, that the term of each Additional
Warrant will be five (5) years from the issuance date and such Additional Warrant will not be listed on any securities exchange. Each
Additional Warrant holder will receive semi-annual payments based on revenues during the period. The total annual payment depends on
the amount of the Additional Warrants outstanding. As of December 31, 2022, the payment will be equal to approximately 2.3% of the Company&#8217;s
revenues for the period November 28, 2022 until December 31,2022. The Company determined that the Additional Warrants preclude equity
classification. The derivative liability is recorded at fair value and amounted to $2,216 thousands as of December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Given their contractual terms, from
the issuance date and up until the 90th day immediately following issuance, the IPO warrants did not meet the U.S. GAAP definition for
equity classification. As such, they were classified as a liability up until November 28, 2022.Upon issuance, the IPO Warrants (which
included the right to issue Additional Warrants) were accounted for as derivative instrument which was classified as a liability and measured
at fair value through profit or loss. The fair value was $8,245 thousands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On November 28, 2022, following the adjustment to the exercise price
and issuance of the Additional Warrants, the Company determined that all conditions for equity classification under U.S. GAAP were met
for the IPO Warrants, and as such, the fair value of the IPO warrants as of November 28, 2022 at the amount of $3,319 thousands, was recorded
as a component of Company&#8217;s shareholder&#8217;s equity. The value of the IPO Warrants upon issuance and the Additional Warrants
upon issuance and at year-end was calculated based on the binomial option pricing model.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During 2022, an amount of $2,710 thousands was recorded as finance
income to account for the change in the value of the IPO Warrants and Additional Warrants value during the period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The following table lists the significant
unobservable inputs used for calculation of fair value of the IPO Warrants and Additional Warrants during the year:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; text-align: left">Expected volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: center"><span style="font-size: 10pt">77.57%-78.89%</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">$2.02-4.04</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Share price</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">$1.53-1.865</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">3.27%-4.04%</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-85">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">3-4.74</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>WACC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">21.5%-23.3%</span></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Additionally, the revenue forecast over
the life of the Additional Warrants is a significant input in determining the price of the Additional Warrants as of December 31, 2022.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130114613168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans from Shareholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LoansfromShareholdersLineItems', window );"><strong>Loans from Shareholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">LOANS FROM SHAREHOLDERS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 10 &#8212;&#160;LOANS FROM SHAREHOLDERS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify">Loans from shareholders consists of the following:</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December&#160;31,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Loan amount</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,950</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">Loan discount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,316</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,634</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.25in">&#160;</td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October&#160;8, 2020, Smart Pro, together with its shareholders (the &#8220;Shareholders&#8221;), entered into a share purchase agreement (the &#8220;Purchase Agreement&#8221;) (see Note&#160;1a) with Medigus. As part of the Purchase Agreement, Medigus and the shareholders committed to transfer funds, as loans to Smart Pro, in order to finance Smart Pro&#8217;s&#160;day-to-day operations in exchange for Smart Pro shares. In accordance with the Purchase Agreement, the Shareholders agreed that all loans transferred to Smart Pro in order to finance the acquisition of additional online Amazon.com stores will be funded 20% by the shareholders and funded 80% by Medigus.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Additionally, as a part of the Purchase Agreement, the Shareholders
&#160;agreed to provide a line of credit to the Smart Pro in the amount of $1,000 thousands to finance ongoing capital requirements as
needed from time to time.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During October and November&#160;2020,
an amount of $250 thousands was transferred to Smart Pro on account of the loan. During 2021, Smart Pro received additional loans under
the same agreement. According to the loan agreement, the loans bear annual interest rate of 4%. Smart Pro will repay the loans and all
accrued interest five&#160;years from October 8, 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On October 8, 2020, the Group estimated
the value of the benefit granted to it by its shareholders as the difference between the interest rate that Smart Pro is required to pay
to the Shareholders for the loans provided by them and secured by such lien and the interest rate Smart Pro is required to pay for similar
unsecured loans to non-related parties. The value of the said benefit is estimated by the Group based on the weighted interest rate that
Smart Pro would have been required to pay if the loans had been granted to it by the bank and by Amazon, and which the Group management
estimates is the best estimate of Smart Pro&#8217;s interest rate close to receiving loans from investors. Accordingly, the value of the
benefit was estimated by the Group at approximately 8%, and as a result the effective interest rate for these loans is about 12%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">During the first half of 2021, the loan
from the Shareholders was partially repaid.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c.</b></span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 2, 2021, Smart Pro entered into a purchase agreement of a virtual store &#8220;Whoobli&#8221; from a third party. As part of the agreement, Smart Pro purchased a seller account which operates on the Amazon website under the name &#8220;Whoobli&#8221;, which markets a private label of basketball shooting baskets, children&#8217;s punching bags and decoration for children&#8217;s birthday parties, including the intellectual property attributed to it and including trademarks attributed to products sold on the account&#8217;s sales page, for a total of $4,000 thousands. In addition, in accordance with the agreement, Smart Pro purchased from the seller the remaining inventory for a total amount of approximately $350 thousands, which is the cost of the inventory purchased by the seller. Additionally, purchased two additional Amazon stores &#8220;Wellted&#8221; and &#8220;PetEvo&#8221; (See Note&#160;5).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to finance the purchase of the store, Smart Pro received loan
from its shareholders in a ratio of 20:80, as described in section b above. Medigus transferred to Smart Pro an amount of approximately
$3,760 thousands and the minority shareholders transferred an amount of approximately $940 thousands. This Shareholders loans bore an
annual interest at a rate of 4% and will be repaid after five&#160;years.</p></td></tr> <tr style="vertical-align: top"> <td style="font-size: 10pt">&#160;</td> <td style="font-size: 10pt">&#160;</td> <td style="text-align: justify; font-size: 10pt">&#160;</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On the borrowing date of the loans,
Smart Pro estimated the value of the benefit granted to it by Medigus and the minority shareholders as the difference between the interest
rate that Smart Pro is required to pay to Medigus and the minority shareholders for the loans and the interest rate required to pay for
similar unsecured loans to non-related parties, the capital reserve from the transaction on the borrowing date was $1,026 thousands. The
value of the said benefit was estimated by the Group based on the interest rate that Smart Pro is required to pay for the loan received
from Amazon and which the Company&#8217;s management considers to be the best estimate of Smart Pro&#8217;s interest rate close to the
date of receiving loans from investors. Accordingly, the value of the benefit was estimated by the Group at approximately 8% and as a
result the effective interest rate for these loans was determined at 11.79%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px">&#160;</td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>d.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of May&#160;3, 2022, Smart Pro had outstanding loans to Medigus, Mr.&#160;Hakmon and L.I.A.&#160;Pure Capital Ltd. (&#8220;Pure Capital&#8221;) of $4,010 thousands, $940 thousands and $109 thousands, respectively. On May&#160;3, 2022, the Company entered into Assignments to Loan Agreements with Smart Pro, Medigus, Mr.&#160;Hakmon and Pure Capital, pursuant to which the Company assumed Smart Pro&#8217;s obligations under the outstanding loans and agreed that unless earlier repaid pursuant to the terms of the respective loan agreements with such parties, effective immediately upon the consummation of IPO, all outstanding principal due to each such party will be automatically converted into a number of Ordinary Shares equal to the quotient obtained by dividing the outstanding principal amount due to such party, by the per Ordinary Share price obtained by dividing $10,000 thousands by the fully diluted issued and outstanding Ordinary Shares as of immediately prior to the closing of the IPO.&#160;Any accrued and unpaid interest due to such party as of such date will be paid in cash.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Based on management&#8217;s assessment,
the modified loan terms including an equity conversion feature upon IPO represented a substantial modification in accordance with ASC
470-50 and is accounted for as an extinguishment of the original financial liability in the amount of $3,821 thousands and the recognition
of a new financial instrument in the amount of $2,839 thousands. The difference between the fair value of the instrument bearing the modified
terms and the carrying values of the original loans immediately prior to the modification, was recorded as an increase in equity in the
amount of $982 thousands.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As the convertible note was not issued
with a substantial premium or with an embedded conversion feature required to be bifurcated under ASC 815, the convertible note was accounted
for as a liability in its entirety.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with such assignment agreements,
on August&#160;30, 2022, the outstanding amounts due to Medigus, Mr.&#160;Hakmon and Pure Capital at a total amount of $5,059 thousands
were converted into an aggregate of 1,463,619&#160;Ordinary Shares. In addition, accrued interest of $393 thousands was paid.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_LoansfromShareholdersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_LoansfromShareholdersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130209090192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">TAXES ON INCOME</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 11 &#8212; TAXES ON INCOME:</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Jeffs&#8217; Brands and Top Rank are
taxed according to Israeli tax laws. The corporate tax rate in Israel is 23%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Smart Pro and Purex are taxed according
to US federal and California state laws. The blended corporate tax rate is 28%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Capital gains are subject to capital
gain tax according to the corporate tax rate for the year during which the assets are sold.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For financial reporting
purposes, income (loss) before taxes includes the following components:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 0.5in">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Israel</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,081</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,096</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(126</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(465</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">188</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,207</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,561</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">188</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Income tax expense
(benefit) was as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended December&#160;31</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current:</span></td>
    <td>&#160;</td>
    <td colspan="10" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.&#160;dollars in thousands</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-90; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-91; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current income tax expense</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 20pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-95; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 20pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(115</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax income</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(115</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total tax (benefit) expense</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td>
    <td>&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;<b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A reconciliation of the Group&#8217;s
statutory income tax rate to effective income tax rate is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="border: Black 1pt solid"><b>December 31,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>U.S.&#160;dollars in thousands</b></p></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Income (loss) before taxes on income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(2,201</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(1,561</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">188</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Statutory tax rate</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax (tax benefit) computed at the statutory tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(506</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(359</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Increase (decrease) in taxes on income resulting from the following:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax rate differences applicable to subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(110</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(78</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Tax losses and timing differences for which deferred taxes were not recognized</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">610</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">416</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Taxes on income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Deferred taxes are comprised of the following components:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 76%; text-align: left">Intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">110</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">56</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease right of use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Operating loss carryforward</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">890</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">172</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">228</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(890</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(172</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total deferred tax assets after valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">142</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">56</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Differences between tax basis and carrying value of loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">370</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Operating lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total deferred tax liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">370</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Net deferred tax assets (liabilities)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">110</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(314</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Deferred tax assets on losses for tax
purposes carried forward to subsequent years are recognized if utilization of the related tax benefit against a future taxable income
is expected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Carry forward tax losses of Jeffs&#8217;
Brands were $3,870 thousands and $747 thousands as of December 31, 2022 and 2021, respectively. Jeffs&#8217;&#160;Brands did not record
deferred tax assets in respect of these losses, as the utilization thereof is not expected to occur in the foreseeable future. There is
no expiration on net operating loss carryforwards in Israel.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Smart Pro and Purex did not have any
net operating loss carryforwards as of December 31, 2022, and 2021. net deferred tax asset is with respect to Smart Pro.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Deferred tax is the tax expected to be
payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding
tax bases used in the computation of taxable profit and is accounted for using the liability method. Deferred tax liabilities are generally
recognized for all taxable temporary differences and deferred tax assets are recognized to the extent that it is probable that taxable
profits will be available against which deductible temporary differences can be utilized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Such assets and liabilities are not recognized
if the temporary difference arises from the initial recognition (other than in a business combination) of other assets and liabilities
in a transaction that affects neither the taxable profit nor the accounting profit.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130114510480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHARE CAPITAL</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 12 &#8212; SHARE CAPITAL:</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify">The share capital composed of ordinary shares as follows:</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of ordinary shares<br/>
 December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 4pt">Issued (*)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">8,074,217</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">2,893,125</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Authorized</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">43,567,567</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,356,757</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">Retroactively adjusted. See Note&#160;1b</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Ordinary Shares confer upon their
holders the following rights: (i)&#160;the right to vote in any general meeting of the Company, (ii)&#160;the right to receive dividends,
if and when declared by the Board of Directors and (iii)&#160;the right to receive upon liquidation of the Company a sum equal to the
nominal value of the share, and if a surplus remains, to receive such surplus, subject to the rights conferred on any class of shares
which may be issued in the future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify">On October&#160;8, 2020, Smart Pro entered into a definitive
agreement with Medigus. According to the agreement, Medigus will hold 50.01% of the issued and outstanding share capital of Smart Pro,
acquired through a combination of a cash investment in Smart Pro and an acquisition of additional shares from Smart Pro&#8217;s&#8217;
previous shareholders in consideration for restricted American Depository Shares (&#8220;ADS&#8221;) of Medigus and a cash component.
Medigus invested $1,100 thousands in Smart Pro in exchange of issuing 5,572 ordinary shares, pay $150 thousands in cash consideration
to the current shareholders and shall issue $500 thousands worth of restricted ADS of Medigus to the current shareholders of such company,
with the value of restricted ADS to be subject to downward adjustment based on Smart Pro&#8217;s 2020 results. In addition, Smart Pro&#8217;s
current shareholders shall be entitled to additional milestone allotments of up to an aggregate $750 thousands in restricted ADS subject
to Smart Pro &#8217;s achievement of certain milestones throughout 2021. The closing of the transactions contemplated in the definitive
agreements are subject to customary closing conditions, which did not stand as of December&#160;31, 2020, and as such no shares were
issued and no cash or restricted ADS were received during the reporting period.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On January&#160;4, 2021, the terms and
conditions to the agreement with Medigus Ltd were completed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify">On October&#160;8, 2020, Purex signed on a definitive agreement
with Medigus. According to the agreement, Medigus will hold 50.01% of the issued and outstanding share capital of Purex, acquired through
a combination of a cash investment in Purex and asn acquisition of additional shares from the Purex&#8217;s previous shareholders in
consideration for restricted ADS of Medigus and a cash component. Medigus shall invest $150 thousands in Purex in exchange of issuing
557 ordinary shares. The closing of the transactions contemplated in the definitive agreements are subject to customary closing conditions,
which did not stand as of December&#160;31, 2020, and as such no shares were issued and no cash or restricted ADS were received during
the reporting period.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>d.</b></td><td style="text-align: justify">On May&#160;10, 2021, pursuant to the SEA, Medigus and the minority shareholders (see Note 1a)
                                                                                         contributed all of the equity interests they owned in Smart Pro and Purex to Jeffs&#8217; Brands. As of result of the Contribution
                                                                                         Transactions pursuant to the SEA, Jeffs&#8217; Brands holds all of the outstanding shares of Smart Pro and Purex</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>e.</b></td><td style="text-align: justify">On July 23, 2021, Medigus issued to the minority shareholder
33,202 ADS as a bonus for his services provided to the Group for the year-ended December 31, 2021 in the amount of $60 thousands. Accordingly,
the Group recognized an amount of $60 thousands as additional payroll expenses and respectively a capital reserve as a benefit from Medigus
(the controlling shareholder).</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>f.</b></td><td style="text-align: justify">The Company engaged an advisor during 2021 in connection
with the IPO process. This advisor was entitled to receive a warrant upon the completion of the IPO to purchase up to a number of Ordinary
Shares equal to $75 thousands divided by the IPO price per Unit (as defined below), sold in the IPO, exercisable immediately upon issuance
for a period of two years, at an exercise price equal to the IPO price per unit. On August 30, 2022, following the closing of the IPO,
the Company issued to the Advisor warrants to purchase up to 18,564 Ordinary Shares exercisable 5 years from the date of issuance at
an exercise price of $4.04 per Ordinary Share (the exercise price was adjusted to $2.02 per share on November 28, 2022 based on the terms
of the warrant). These warrants were treated as issuance costs, which amounted to $12 thousand based on a third-party valuation using
the Black &amp;Scholes Model and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>g.</b></td><td style="text-align: justify">On February&#160;17, 2022, the Company&#8217;s Board of Directors
approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments for subsequent reverse
share split) Ordinary Shares of the Company for each Ordinary Share issued and outstanding as of the close of business on February&#160;17,
2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an aggregate issuance by the Company
as of such date of 6,630,547 (prior to adjustments for subsequent reverse share split) Ordinary Shares. (See also note 1c).</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>h.</b></td><td style="text-align: justify">On August&#160;30, 2022, the Company closed its IPO, and
the simultaneous partial exercise of the underwriter&#8217;s over-allotment&#160;option, for aggregate gross proceeds of approximately
$15.5&#160;million, before deducting underwriting discounts and estimated offering expenses. The Company issued 3,717,473 Ordinary Shares,
(&#8220;Ordinary Shares&#8221;) and IPO&#160;warrants to purchase up to 3,717,473&#160;Ordinary Shares. The Ordinary Shares and IPO Warrants
were sold together in the IPO as units (&#8220;Units&#8221;) at an initial public offering price of $4.16 per Unit.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The IPO Warrants had an initial exercise
price of $4.04, and expire five years from the issuance day. The IPO Warrants became exercisable immediately after the completion of the
IPO (and until August 30, 2027). On the 90th day after completion of the IPO, the exercise price of the IPO Warrants was adjusted to be
equal to the lowest quoted share price during the 90 days. The daily quoted price used in the determination of such minimum was calculated
as the weighted average price of each day. The exercise price however may not be reduced to less than $2.02.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The IPO Warrants contain a down round
protection, so that for a period of two years from the date of issuance of the IPO Warrant, the exercise price is adjusted to the price
in subsequent fundings of the Company, if shares in these fundings are sold at a price per share below the warrant exercise price at the
time of such future fundings (or if other instruments with an exercise / conversion price at a price below the warrant exercise price
are sold). The exercise price however may not be reduced to less than $2.02. On November 28, 2022, the IPO Warrant&#8217;s exercise price
was adjusted to $2.02.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In addition, On November 28, 2022,
the Company issued Additional Warrants to purchase 2,824,525 Ordinary Shares. Each Additional Warrant has substantially the same
terms as the As-Adjusted IPO Warrant; provided, however, that the term of each Additional Warrant will be five (5) years from the
issuance date and such Additional Warrant will not be listed on any securities exchange. Each Additional Warrants holder will
receive semi-annual payments. The total annual payment depends on the amount of the Additional Warrants outstanding. As of December
31, 2022, the payment will be equal to approximately 2.3% of the Group &#8217;s revenues for the period from November 28, 2022 until
December 31,2022. The Additional Warrants may be redeemed by the Company at any time at a price equal to three times the Initial
Exercise Price, or $6.06.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As the IPO Warrants and the Additional
Warrants are not separable at the issuance date, the IPO Warrants and the Additional Warrants are accounted for as derivative instruments
which are classified as a liability and measured at fair value through profit or loss. The fair value of the warrants and the Additional
Warrants was calculated by an independent valuation expert and as of the issuance date the fair value was $4,651 thousands and $3,594
thousands, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On November 28, 2022, following the issuance of the Additional warrants,
the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair
value of the IPO Warrants as of November 28, 2022 at the amount of $3,319 thousands which was calculated based on a third-party appraiser
valuation, was recorded as a component of Group&#8217;s shareholder&#8217;s equity. (Refer also to Note 9c). The total gross consideration
was 15.5&#160;million (including the exercise of the underwriter&#8217;s option at the amount of $4 thousands). $8,245 thousand was initially
attributed to the warrants based on their fair value and the remaining amount was attributed to the ordinary shares issued and recognized
as an equity component. Applicable issuance costs, amounting to $2,193 thousand, have been allocated in the same proportion as the allocation
of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and has been recorded in
profit or loss as finance expense, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand have been
recorded in equity as a reduction of the paid in capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On November 28, 2022, following the issuance of the Additional Warrants,
the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair
value of the IPO Warrants as of November 28, 2022 at the amount of $3,319 thousands, was recorded as a component of Group&#8217;s shareholder&#8217;s
equity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As part of the IPO (see above), on August
30, 2022, the Company issued to the underwriter Warrants to purchase up to 185,873 Ordinary Shares (&#8220;Underwriters Warrants&#8221;)
exercisable at an exercise price of $5.20, and are exercisable beginning on February&#160;21, 2023 and will expire on August&#160;25,
2027. The Underwriter&#8217;s Warrants have a cashless exercise mechanism. The Underwriters Warrants were treated as issuance costs, which
amounted to $109 thousand based on third party valuation, and have been allocated in the same proportion as the allocation of the gross
proceeds from the IPO. An amount of $58 thousand was considered as issuance costs allocated to the warrants and has been recorded in profit
or loss as finance expense, while costs allocated as issuance costs of ordinary shares in the amount of $51 thousand have been recorded
in equity as a reduction of the additional paid in capital.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>i.</b></td><td style="text-align: justify">On August 30, 2022, the underwriter (see Note 12h), partially
exercised its overallotment right to purchase additional IPO Warrants to purchase up to 425,912 Ordinary Shares for a total consideration
of $4 thousands. These additional IPO Warrants were treated as issuance costs, which amounted to $1 thousand based on third party valuation,
and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO. An amount of $0.5 thousand was considered
as issuance costs allocated to the additional IPO Warrants and has been recorded in profit or loss as finance expense, while costs allocated
as issuance costs of Ordinary Shares in the amount of $0.5 thousand have been recorded in equity as a reduction of the paid in capital.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>j.</b></td><td style="text-align: justify">In accordance with an assignment agreement (see also Note
10d) and in connection with the IPO (see above), on August&#160;30, 2022, the Company converted outstanding amounts due to Medigus, Mr.&#160;Hakmon
and Pure Capital into 1,463,619&#160;Ordinary Shares.</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130116445856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Incentive Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareIncentivePlanLineItems', window );"><strong>Share Incentive Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE INCENTIVE PLAN</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 13 &#8212; SHARE INCENTIVE PLAN</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On January&#160;19, 2022, the Company&#8217;s
Board of Directors adopted the 2022 Incentive Option Plan (&#8220;Plan&#8221;). A total of 1,307,027&#160;Ordinary Shares were reserved
and subject to the Plan. The Plan is intended as an incentive to retain directors, officers, employees, consultants and advisers of the
Company. As of December 31, 2022, the Company had not granted awards under the Plan.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ShareIncentivePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ShareIncentivePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115809776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance (Income) Expense, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FinanceIncomeExpenseNetLineItems', window );"><strong>Finance (Income) Expenses, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock', window );">FINANCE (INCOME) EXPENSE, NET</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 14 &#8212;&#160;FINANCE (INCOME) EXPENSE, NET</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Finance income:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Change in fair value of derivative liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,822</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Gain from debt extinguishment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(14</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-99">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total finance income</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,822</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(14</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-100">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Finance expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Finance expenses in respect of third-party loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-101">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value of derivative liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization of loan discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exchange rate changes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">156</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense on loans from shareholders and related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">203</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">381</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">221</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Other finance expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">38</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total finance expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">517</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">643</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">232</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Finance (income) expense, net</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,305</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">629</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">232</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_FinanceIncomeExpenseNetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_FinanceIncomeExpenseNetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for interest income and interest expense for enterprises that derive a significant portion of their revenue from interest collected on investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-12)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115769920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share Attributable to Ordinary Shareholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 15 &#8212;&#160;NET INCOME (LOSS) PER
SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0pt">The following
table sets forth the computation of basic and diluted net income (loss) per share attributable to ordinary shareholders:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands (*)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Net income (loss) applicable
    to shareholders of ordinary shares</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(2,201</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(1,540</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">112</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-hidden: hidden-fact-108; -sec-ix-hidden: hidden-fact-107; -sec-ix-hidden: hidden-fact-106; font-size: 10pt">Shares of ordinary share used in computing basic and diluted net loss per share</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,643,879</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,892,347</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,888,768</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><div style="-sec-ix-hidden: hidden-fact-111; -sec-ix-hidden: hidden-fact-110; -sec-ix-hidden: hidden-fact-109">Net loss per share of ordinary share, basic and diluted</div></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.47</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.53</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.04</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0pt">The following potentially dilutive securities outstanding have been
excluded from the computation of diluted weighted average shares outstanding, because such securities had an antidilutive impact:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands (*)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">IPO Warrants and Additional Warrants (Note 12h)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,541,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Underwriter warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">611,785</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other warrants </td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">78,661</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,232,444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left">(*)</td><td style="text-align: justify">except share and per share data</td>
</tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115883136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 16 &#8212;&#160;RELATED PARTIES&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify"><b>Transactions with interested and related parties:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Labor cost and related expenses (c1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">358</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">192</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Directors&#8217; fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">172</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consulting fees (c2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest expenses on loans from related parties and shareholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">203</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">381</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">951</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">573</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify"><b>Balances with interested and related parties:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="text-decoration:underline">Assets:</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Advances to suppliers (c2)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">228</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">228</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="text-decoration:underline">Liabilities:</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Related parties (c3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loans from shareholders (Note 10),(c3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,634</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loan from related parties (Note 9)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">111</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">32</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,010</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify"><b>Additional information:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">1.</td><td style="text-align: justify">On July&#160;23, 2021, Medigus issued to the minority Shareholder
and amount of 33,202 ADS as a bonus for his services provided to the Group for the six&#160;months ended June&#160;30, 2021 in a value
of $60 thousand. Accordingly, the Group recognized an amount of $60 thousand as additional payroll expenses and respectively a capital
reserve as a benefit from Medigus (the Group&#8217;s controlling shareholder).</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">On August 3, 2022, the Company&#8217;s
Board of Directors approved the increase to Mr. Hakmon&#8217;s monthly salary to NIS 55 thousand (approximately $23 thousands) plus applicable
value added taxes (&#8220;VAT&#8221;), retroactively from February 1, 2022. Effective on September 1, 2022, the Company&#8217;s Board
of Directors approved an increase to Mr. Hakmon&#8217;s monthly salary to NIS 80 thousands (approximately $23 thousands) plus VAT and
a one-time bonus of NIS 480 thousands (approximately $140 thousands).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">2.</td><td style="text-align: justify">On October 26, 2022, the Group and Pure Capital entered into
a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousands
(approximately $16.5 thousands) the Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousands (approximately
$121 thousands) for their services to the Group from the day of the Company&#8217;s inception until the closing of the IPO. Pure Capital is
also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid
to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration
paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved
by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined
period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. Additionally
On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse
lease agreement located in the USA. As of December 31, 2022 the advances to suppliers comprised of $228 thousands to Pure NJ Logistics
LLC.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">3.</td><td style="text-align: justify">On May 21, 2022, the Company has entered into a short-term
lease agreement for its offices from Medigus and participated in 50% of the lease and maintenance expenses related. The Company paid
$86 thousand plus VAT on December 30, 2022. The outstanding payable to Medigus as of December 31, 2022, was $32 thousands plus VAT.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">During September 2022, the Group repaid:
(i) a related party balance to Medigus, in the amount of $150 thousands and (ii) another related party balance in the amount of $175 thousands
and (iii) $393 thousand in accrued interest with respect to certain related party loans upon the conversion of such loans at the closing
of the IPO.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115932016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE 17 &#8212; SUBSEQUENT EVENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td> <td style="text-align: justify; font-size: 10pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">On February 23, 2023, the Company and Jeffs&#8217; Brands Holdings entered into a stock purchase agreement with SciSparc (the &#8220;Wellution Agreement&#8221;), as amended on March 22, 2023 by Addendum No. 1 to the Wellution Agreement (the &#8220;Addendum&#8221;), pursuant which, on March 22, 2023, Jeffs&#8217; Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S., a wholly-owned subsidiary of SciSparc that owns and operates Wellution, a top-selling Amazon food supplements and cosmetics brand, subject to the holdback by SciSparc of 11 shares as described below, representing approximately 49% of the issued and outstanding common stock of SciSparc U.S., for approximately $3 million in cash (including the Price Adjustment, as defined below), of which approximately $2.5 million was paid at the closing (the &#8220;Wellution Transaction&#8221;). The Addendum provided for the payment by us to SciSparc of an additional amount of $489,330 in cash for the purchase price adjustments (the &#8220;Price Adjustment,&#8221;) related to inventory and working capital, payable in five equal installments of $97,866 on the tenth day of each consecutive calendar month, beginning in May 2023. As collateral for the payment in full of the Price Adjustment, SciSparc held back 11 shares of common stock of SciSparc U.S, which will be released to Jeffs&#8217; Brands Holdings once the final payment is made. Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Transaction, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S. (the &#8220;SciSparc Consulting Agreement&#8221;), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousands and the Company will receive a one-time signing bonus in the amount of $51 thousands. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice.</span></p></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Also pursuant to the Wellution Agreement,
in connection with the closing of the Wellution Transaction, effective as of March 22, 2023, the Company issued 247,415 of its Ordinary
Shares to SciSparc and on March 29, 2023 SciSparc issued 360,297 of its Ordinary Shares to the Company in a mutual share exchange (collectively,
the &#8220;Exchange Shares&#8221;), representing 2.97% and 4.99%, respectively, of the Company&#8217;s and SciSparc&#8217;s issued and
outstanding ordinary shares. The number of Exchange Shares acquired by each company was calculated by dividing $288,238, which was adjusted
from $300,000, pursuant to the 4.99% ownership limitation included in the Wellution Agreement, by the average closing price of the relevant
company&#8217;s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior
to the closing date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 2.5pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">b.</td><td style="text-align: justify">On March 2, 2023, the Company entered into a share purchase
agreement (the &#8220;Fort SPA&#8221;), with the holders (the &#8220;Sellers&#8221;), of all of the issued and outstanding share capital
of Fort, a company incorporated under the laws of England and Wales and engaged in the sale of pest control products primarily through
Amazon.uk, pursuant to which on March 9, 2023, the Company acquired all of the issued and outstanding share capital of Fort, for approximately
&#163;2,000,000 (approximately $2,400 thousands) in cash (the &#8220;Fort Acquisition&#8221;). The Fort SPA provides that for a period
of three years from closing, the Sellers will not compete with Fort&#8217;s business.</td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Also in connection with the Fort Acquisition,
on March 9, 2023, the Company and Fort entered into settlement agreements with all of Fort&#8217;s employees, including the Sellers, providing
that such employees&#8217; employment with Fort will terminate three months following March 9, 2023 and certain other customary conditions.
During this three-month period, the Company intends to carry out operational changes in Fort&#8217;s business that will allow Fort to
wind down the activities conducted in its leased warehouse and to move all such operations to warehouses operated by Amazon. In connection
with the closing of the acquisition, on March 9, 2023, the Company and the Sellers entered into a consulting agreement, pursuant to which
the Sellers will provide us with consultancy services for a period of three months, in consideration for a monthly fee of &#163;2,500
(approximately $3,000).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The Fort acquisition was accounted for as an asset acquisition, as
substantially all of the fair value of the assets being acquired under the arrangement was concentrated in the brand name.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px">&#160;</td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023 the Company paid to Pure Capital $352 thousands in accordance with the consultant agreement in relation to the two purchases as described in note 17.a and note 17.b. For additional information see note 16.c.2.</span></td></tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112902096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of preparation of the financial statements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>a.</b></td><td style="text-align: justify"><b>Basis of preparation of the financial statements</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group&#8217;s consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S.
GAAP&#8221;) and include the accounts of Jeffs&#8217; Brands Ltd and its wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated in consolidation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Prior to 2022, the&#160;Group prepared
its financial statements in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting
Standards Board (IASB), as permitted in the United States based on the Company&#8217;s qualification as a &#8220;foreign private issuer&#8221;
under the rules and regulations of the U.S Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of estimates</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>b.</b></td><td style="text-align: justify"><b>Use of estimates</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements
in conformity with U.S.&#160;GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the
reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances,
fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent
liabilities, among others.&#160;Such estimates are based on&#160;historical experience and on various other assumptions that are believed
to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group&#8217;s assets and
liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional and presentation currency</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>c.</b></td><td style="text-align: justify"><b>Functional and presentation currency</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The functional and reporting currency
of the Group is the United States dollar (&#8220;U.S dollar&#8221;) as the U.S. dollar is the currency of the primary economic environment
in which the Group has operated and expects to continue to operate in the foreseeable future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group transactions and balances denominated in U.S. dollars are
presented at their original amounts. Non-U.S. dollar transactions and balances have been remeasured to U.S. dollars in accordance with
Accounting Standards Codification (&#8220;ASC&#8221;) 830, &#8220;Foreign Currency Transaction&#8221;. All transaction gains and losses
from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected in the statement of operations
as financial income or expenses foreign currency gain/loss, as appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and cash equivalents</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>d.</b></td><td style="text-align: justify"><b>Cash and cash equivalents</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cash and cash equivalents include cash
in banks and short-term bank deposits (with original maturities of <span style="-sec-ix-hidden: hidden-fact-79">three</span>&#160;months or less) that are not restricted as to withdrawal
or use and are therefore considered to be cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts receivable</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>e.</b></td><td style="text-align: justify"><b>Accounts receivable</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Accounts receivables are stated at realizable value, net of an allowance
for credit losses. The Group evaluates its outstanding accounts receivable and establishes an allowance for credit losses based on information
available on their credit condition, current aging, historical experience and future economic and market conditions. These allowances
are reevaluated and adjusted periodically as additional information is available. Payments are made by customers immediately at the point
of sale, therefore, no provision for credit losses has been recorded as of December 31, 2022 and 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>f.</b></td><td style="text-align: justify"><b>Inventories</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Inventories are stated at the lower
of cost and or market based on net realizable value. Inventories are adjusted for estimated excess and obsolescence and written down
to net realizable value based upon estimates of future demand, technology developments, and market conditions. Cost is determined in
accordance with first-in, first-out Method (&#8220;FIFO&#8221;) and the cost of inventory includes shipment and freight costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and equipment</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>g.</b></td><td style="text-align: justify"><b>Property and equipment</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Property and equipment are stated at
historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition
of the items. Repairs and maintenance are charged to the statement of operations during the period in which they are incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assets are depreciated using the
straight-line method to allocate their cost over their estimated useful lives, as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; text-indent: -10pt; padding-left: 10pt">Computers equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 44%; text-align: center">33</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt">Furniture</td><td>&#160;</td>
    <td style="text-align: center">7</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center">Shorter of remaining lease term or estimated useful life</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred offering costs</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>h.</b></td><td style="text-align: justify"><b>Deferred offering costs</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company capitalized certain legal
and other third-party fees that were directly related to the Company&#8217;s IPO. As of December 31, 2021, there were $366 thousands
of deferred offering costs included in other non-current assets on the balance sheet.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The total gross consideration from
the IPO was initially allocated to the derivative warrant liability based on its fair value and the remaining amount was allocated to
the Ordinary Shares issued and recognized as a component of equity. (refer to Note 12h below). Accordingly, issuance costs were allocated
between the warrant liability and Ordinary Shares based on their relative fair values.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>i.</b></td><td style="text-align: justify"><b>Leases</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with ASC 842, the Group
determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves
the use of a distinct identified asset, (2) whether the Group obtains the right to substantially all the economic benefits from the use
of the asset throughout the period, and (3) whether the Group has a right to direct the use of the asset. The Group elected the practical
expedient to not recognize a lease liability and a right-of-use (&#8220;ROU&#8221;) asset for leases with a term of twelve months or
less. The Group also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent
the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments
arising from the lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">ROU assets are initially measured at
amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred.
The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments
over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Group uses its Incremental
Borrowing Rate (&#8220;IBR&#8221;) based on the information available at commencement date in determining the present value of lease
payments. The Group&#8217;s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments
and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">An option to extend the lease is considered
in connection with determining the ROU asset and lease liability when it is reasonably certain that the Group will exercise that option.
An option to terminate is considered unless it is reasonably certain that the Group will not exercise the option.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Operating lease expense is recognized
on a straight-line basis over the lease term.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionCustomerAcquisitions', window );">Asset acquisition</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>j.</b></td><td style="text-align: justify"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><b>Asset acquisition</b></p></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The Group accounts for a transaction
as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable
asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs
are capitalized as part of the asset or assets acquired.</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>k.</b></td><td style="text-align: justify"><b>Intangible assets</b></td>
</tr></table><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The
Group&#8217;s intangible assets consist of its Brands. Intangible assets that are not considered to have an indefinite useful life are
amortized over their estimated useful lives. Each period the Group evaluates the estimated remaining useful lives of its intangible assets
and whether events or changes in circumstances warrant a revision to the remaining period of amortization.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The estimated useful lives of the Group&#8217;s
intangible assets (Brands) are 10 years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of long-lived assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>l.</b></td><td style="text-align: justify"><b>Impairment of long-lived assets</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group&#8217;s long-lived&#160;assets
(assets group) to be held or used, including property and equipment, right of use assets and intangible assets subject to amortization
are reviewed for impairment in accordance with ASC 360, &#8220;Accounting for the Impairment or Disposal of Long-Lived Assets&#8221;,
whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The recoverability of
these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate.
If property and equipment, intangible assets or right of use assets are considered to be impaired, the impairment to be recognized equals
the amount by which the carrying value of the asset exceeds its fair market value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining the fair values of long-lived
assets for the purpose of measuring impairment, the Group&#8217;s assumptions include those that market participants will consider in
valuations of similar assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyLoansReceivablePolicy', window );">Loans from shareholders and related parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>m.</b></td><td style="text-align: justify"><b>Loans from shareholders and related parties:</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">On the borrowing date of loans received from shareholders or related
parties, the Group estimates the value of the benefit granted to it as the difference between the interest rate that the Group is required
to pay to investors for the loans provided by them and secured by such lien and the interest rate required to pay for similar unsecured
loans to non-related parties. The Group assesses changes to the term of loans with shareholders and related parties in accordance with
ASC 470, &#8220;Debt&#8221; (&#8220;ASC 470&#8221;), Subtopic 50&#8212; &#8220;Modifications and Extinguishments&#8221; (&#8220;ASC 470-50&#8221;).
For transactions accounted for as debt extinguishment, the difference between the reacquisition price of the debt and the net carrying
amount of the extinguished debt is recorded as an in-essence capital transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>n.</b></td><td style="text-align: justify"><b>Income taxes</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for income taxes
in accordance with ASC 740, &#8220;Income Taxes&#8221;. ASC 740 prescribes the use of the liability method whereby deferred tax assets
and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities
and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Valuation
allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than
not to be realized. As of December 31, 2022 and 2021 a partial valuation allowance was recorded on the Group&#8217;s deferred tax assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group implements a two-step approach
to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax
return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical
merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second
step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate
settlement. As of December 31, 2022 and 2021, no liability for unrecognized tax positions has been recognized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue recognition</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>o.</b></td><td style="text-align: justify"><b>Revenue recognition</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">The Group sells products
directly to customers mainly through its online Amazon stores.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under the Group&#8217;s standard contract
terms, customers have a right of return within 30 until 90 days. For contracts with rights of return, the Group recognizes revenue based
on the amount of the consideration which the Group expects to receive for products which are not expected to be returned and recognizes
a refund liability for the amount not expected to be received. At the end of each reporting period, the Group updates its estimates of
expected product returns and adjusts the refund liabilities with a corresponding adjustment in revenues. The Group recorded an allowance
for returns in the amounts of $35 thousand and $35 thousand as of December 31, 2022, and 2021, respectively. The allowance for returns
is recorded as decrease in revenues against other payables.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group evaluates the criteria outlined
in ASC 606-10-55, &#8220;Principal versus Agent Considerations&#8221;, in determining whether it is appropriate to record the gross amount
of product sales and related costs or the net amount earned as commissions. The Group evaluates whether it is appropriate to recognize
revenue on a gross or net basis based upon its evaluation of whether the Company obtains control of the specified goods by considering
if it is primarily responsible for fulfillment of the promise, has inventory risk, and has the latitude in establishing pricing and selecting
suppliers, among other factors. Based on its evaluation of these factors, management has determined that it is the principal in these
arrangements; therefore, sales are recorded on a gross basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of sales</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>p.</b></td><td style="text-align: justify"><b>Cost of sales</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In accordance with Amazon&#8217;s terms
of use, the Group is obligated to pay to Amazon incremental costs, such as sales fulfillment commissions which are contingent on making
binding sales. Sales commissions would not have been incurred if the contract had not been obtained.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cost of sales primarily consists of
expenses related to Amazon&#8217;s commissions, storage costs and freight.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising expenses</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>q.</b></td><td style="text-align: justify"><b>Advertising expenses</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt">The Group expenses
advertising costs as incurred. Advertising expenses, included within sales and marketing expenses, were $1,163 thousands, $1,211 thousands,
and $371 thousands for the years ended December 31, 2022, 2021 and 2020, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPPolicy', window );">Employee benefits</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>r.</b></td><td style="text-align: justify"><b>Employee benefits</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt">Pension
and severance pay obligations</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Groups employees are employed by Jeffs&#8217;
Brands and subject to Israeli labor laws. Israeli labor law generally requires payment of severance pay upon dismissal of an employee
or upon termination of employment in certain other circumstances. Pursuant to Section&#160;14 of the Severance Compensation Act, 1963
(&#8220;Section&#160;14&#8221;), all of the Group&#8217;s employees in Israel are entitled to a monthly contribution, at a rate of 8.33%
of their monthly salary, made in their name with insurance companies. Contributions under Section&#160;14 relieve the Group from any future
severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Group&#8217;s
balance sheet, and there is no liability recorded as the Group does not have a future obligation to make any additional payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair value measurement</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>s.</b></td><td style="text-align: justify"><b>Fair value measurement</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group applies ASC 820, &#8220;Fair
Value Measurements and Disclosures&#8221; (&#8220;ASC 820&#8221;). Under this standard, fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability (i.e., the &#8220;exit price&#8221;) in an orderly transaction between market
participants at the measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In determining fair value, the Group
uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable
inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs
are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent
from the Group. Unobservable inputs are inputs that reflect the Group&#8217;s assumptions about the assumptions market participants would
use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken
down into three levels based on the inputs as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 1 - Valuations based on quoted
prices in active markets for identical assets that the Group has the ability to access. Valuation adjustments and block discounts are
not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active
market, valuation of these products does not entail a significant degree of judgment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 2 - Valuations based on one or
more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">Level 3 - Valuations based on inputs
that are unobservable and significant to the overall fair value measurement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The carrying amounts of cash and cash equivalents, trade receivables,
other receivable, trade payables, other accounts payable and accrued expenses and payables to related parties approximate their fair value
due to the short-term maturity of such instruments. The Group&#8217;s derivative liabilities in respect of Additional Warrants are classified
within Level 3 of the fair value hierarchy because their fair values are estimated by utilizing valuation models and significant unobservable
inputs. For more details, see Note 9.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>t.</b></td><td style="text-align: justify"><b>Warrants</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for warrants as either
equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific terms and applicable authoritative
guidance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The assessment considers whether the
warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, &#8220;Distinguishing Liabilities and
Equity&#8221;, are indexed to the Group&#8217;s own stock and whether the warrants are eligible for equity classification under ASC 815
(&#8220;ASC 815&#8221;), &#8220;Derivatives and Hedging&#8221;, Subtopic 40 &#8220;Contracts in Entity&#8217;s Own Equity&#8221; (&#8220;ASC
815-40&#8221;). This assessment is conducted at the time of warrant issuance and as of each subsequent reporting period end date while
the warrants are outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Warrants that meet all the criteria for
equity classification, are recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity
classification, are recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value through earnings
at each balance sheet date thereafter.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Legal and other contingencies</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>u.</b></td><td style="text-align: justify"><b>Legal and other contingencies</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group accounts for its contingent
liabilities in accordance with ASC 450, &#8220;Contingencies&#8221;. A provision is recorded when it is both probable that a liability
has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, the Group reviews the status
of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable
and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Legal costs incurred in connection with
loss contingencies are expensed as incurred. As of December 31, 2022, and 2021, the Group is not a party to any litigation that could
have a material adverse effect on the Group&#8217;s business, financial position, results of operations or cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and diluted net loss per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>v.</b></td><td style="text-align: justify"><b>Basic and diluted net loss per share.</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Group calculates basic net profit
(loss) per share by dividing the net profit (loss) by the weighted-average number of Ordinary Shares outstanding during the period. Diluted
net loss per share is computed by giving effect to all potentially dilutive Ordinary Share equivalents outstanding for the period. All
outstanding share options and warrants for the years ended December 31, 2022 and 2021 have been excluded from the calculation of the diluted
net loss per share since all such securities were anti-dilutive. For the year ended December 31, 2020 there were no Ordinary Share equivalents
outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently adopted and recently issued accounting pronouncements</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><b>w.</b></td><td style="text-align: justify"><b>Recently adopted and recently issued accounting pronouncements.</b></td>
</tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In May 2021, the FASB issued ASU No.
2021-04 to ASC 260, ASC 470-50, ASC 718 &#8220;Compensation&#8212;Stock Compensation&#8221;, and ASC 815: &#8220;Issuer&#8217;s counting
for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#8221;. The amendments in ASU No. 2021-
modification or exchange. The amendments in this ASU No. 2021-04 were effective for after the Company beginning on January 1, 2022. The
adoption of the standard did not have material effect on Group&#8217;s results.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI https://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for ESOP transactions, including the method of measuring compensation, the classification of dividends on ESOP shares, and the treatment of ESOP shares for EPS computations. If the employer has both old ESOP shares for which it does not adopt new guidance and new ESOP shares for which new guidance is required, these disclosures are required for both blocks of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155638-234783<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 920<br> -SubTopic 350<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=120155617&amp;loc=SL120155628-234783<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyLoansReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for policy loans receivable, including the basis for determining the amount reported for loans made to policyholders against and secured by future policy benefits. May also disclose the range of interest rates charged to policyholders on such loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyLoansReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionCustomerAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for incremental direct costs incurred related to the acquisition or origination of a customer contract in a transaction that results in revenue deferral (that is, whether such costs are expensed as incurred or deferred and charged to expense in proportion to the revenue recognized.) Also describes the entity's policy for determining which costs are capitalized as contract acquisition or origination costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionCustomerAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115987472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; text-align: left; text-indent: -10pt; padding-left: 10pt">Computers equipment</td><td style="width: 1%">&#160;</td>
    <td style="width: 44%; text-align: center">33</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt">Furniture</td><td>&#160;</td>
    <td style="text-align: center">7</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt">Leasehold improvements</td><td>&#160;</td>
    <td style="text-align: center">Shorter of remaining lease term or estimated useful life</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115830736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of other receivables</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Advances to suppliers</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">641</td><td style="width: 1%; text-align: left">(*)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-80">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Government institutions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">130</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">35</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other receivables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">8</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">779</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">36</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(*) Includes $228 thousand to Pure Capital. See
Note 16 for additional information.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115634512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">schedule of inventory</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Goods in transit</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">161</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Finished goods</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,783</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,066</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,791</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,227</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115897744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_IntangibleAssetsTablesLineItems', window );"><strong>Disclosure Of Intangible Assets Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of total intangible assets</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, 2022</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Gross Amount</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Accumulated Amortization</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Net Balance</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center"><b>U.S.&#160;dollars in thousands</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; width: 64%; text-align: left">Brands</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">5,783</td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(1,331</td><td style="padding-bottom: 4pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">4,452</td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"><b>December&#160;31, 2021</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Gross Amount</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Accumulated Amortization</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><b>Net Balance</b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td colspan="10" style="text-align: center"><b>U.S.&#160;dollars in thousands</b></td><td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt; width: 64%; text-align: left">Brands</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">5,783</td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right">(762</td><td style="padding-bottom: 4pt; width: 1%; text-align: left">)</td><td style="padding-bottom: 4pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 4pt double; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-size: 10pt">5,021</span></td><td style="padding-bottom: 4pt; width: 1%; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_IntangibleAssetsTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_IntangibleAssetsTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115832864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of future lease payments under operating leases</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">58</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">2024-2025</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">103</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total future operating lease payments</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">161</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Less: imputed interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(20</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">Present value of lease liability</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">141</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115856400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Payables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_OtherPayablesTablesLineItems', window );"><strong>Schedule of Other Payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of other payables</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Government institutions</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">36</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Employees and related benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">49</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Lease liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-81">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Accrued Interest</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-82">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">294</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued expenses and other payables</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">266</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">271</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">391</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">715</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_OtherPayablesTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_OtherPayablesTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130117759312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Loans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Short-Term Loans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of short term loans</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December&#160;31,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Loans with Amazon (8a)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">86</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">101</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Related party loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-83">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">111</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Third party loans (8b)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-84">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">715</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">86</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">927</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130111375472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of fair value of the derivative warrant liability</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%">Balance as of January 1, 2020</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Fair value of warrant liability to be issued to third-party upon IPO (note 9a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Change in fair value</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">75</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Balance as of December 31, 2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">137</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of warrants in connection with the IPO</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,220</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,822</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Classification to additional paid in capital</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(3,319</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">Balance as of December 31, 2022</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,216</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of fair value of the IPO warrants and additional warrants</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt"><b>&#160;</b></td><td style="padding-bottom: 1.5pt"><b>&#160;</b></td>
    <td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td><td style="border-bottom: Black 1.5pt solid; text-align: center"><b>2022</b></td><td style="padding-bottom: 1.5pt; text-align: left"><b>&#160;</b></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 82%; text-align: left">Expected volatility</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 15%; text-align: center"><span style="font-size: 10pt">77.57%-78.89%</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>Exercise price</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">$2.02-4.04</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Share price</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">$1.53-1.865</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">3.27%-4.04%</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Dividend yield</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="-sec-ix-hidden: hidden-fact-85">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Expected life</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">3-4.74</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>WACC</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-size: 10pt">21.5%-23.3%</span></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130110413712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans from Shareholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LoansfromShareholdersTablesLineItems', window );"><strong>Loans from Shareholders [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of loans from shareholders consists</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">December&#160;31,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&#160;</td>
    <td colspan="6" style="text-align: center; font-weight: bold">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Loan amount</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-86">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">4,950</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt; text-align: left">Loan discount</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-87">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,316</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-88">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">3,634</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_LoansfromShareholdersTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_LoansfromShareholdersTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115967152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of income (loss) before taxes</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Israel</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,081</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(1,096</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-89">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">Foreign</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(126</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(465</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">188</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,207</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(1,561</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">188</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of income tax expense (benefit)</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended December&#160;31</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current:</span></td>
    <td>&#160;</td>
    <td colspan="10" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.&#160;dollars in thousands</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-90; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-91; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 64%; padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid">&#160;</td>
    <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total current income tax expense</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred:</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 20pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-95; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 20pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(115</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total deferred tax income</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(115</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(50</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total tax (benefit) expense</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 4.5pt double">&#160;</td>
    <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td>
    <td>&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;<b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of statutory income tax rate to effective income tax rate</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="border: Black 1pt solid"><b>December 31,</b></span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="10" style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>U.S.&#160;dollars in thousands</b></p></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt">Income (loss) before taxes on income</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(2,201</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(1,561</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">188</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Statutory tax rate</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax (tax benefit) computed at the statutory tax rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(506</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(359</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Increase (decrease) in taxes on income resulting from the following:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Tax rate differences applicable to subsidiaries</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(110</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(78</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Tax losses and timing differences for which deferred taxes were not recognized</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">610</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">416</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">23</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Taxes on income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(21</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">76</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred taxes assets and liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="width: 76%; text-align: left">Intangible assets</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">110</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">56</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating lease right of use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Operating loss carryforward</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">890</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">172</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total deferred tax assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,032</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">228</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(890</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(172</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total deferred tax assets after valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">142</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">56</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Deferred tax liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Differences between tax basis and carrying value of loans</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">370</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Operating lease liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total deferred tax liability</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">32</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">370</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Net deferred tax assets (liabilities)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">110</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(314</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115809776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of share capital composed of ordinary shares</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of ordinary shares<br/>
 December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 4pt">Issued (*)</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">8,074,217</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 4pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 4pt double; text-align: right">2,893,125</td><td style="width: 1%; padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Authorized</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">43,567,567</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,356,757</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130108240016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance (Income) Expense, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BankingAndThriftInterestAbstract', window );"><strong>Finance (Income) Expenses, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock', window );">Schedule of finance (income) expenses, net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Finance income:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Change in fair value of derivative liabilities</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">(2,822</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-96">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-97">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Gain from debt extinguishment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-98">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(14</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-99">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 4pt">Total finance income</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,822</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(14</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-100">-</div></td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Finance expense:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Finance expenses in respect of third-party loan</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">77</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-101">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Change in fair value of derivative liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-102">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-103">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Amortization of loan discount</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">37</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-104">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Exchange rate changes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">156</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-105">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Interest expense on loans from shareholders and related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">203</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">381</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">221</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Other finance expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">38</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">15</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Total finance expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">517</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">643</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">232</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 4pt">Finance (income) expense, net</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">(2,305</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">629</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">232</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financing income expenses net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BankingAndThriftInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BankingAndThriftInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130116332832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands (*)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>Numerator:</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Net income (loss) applicable
    to shareholders of ordinary shares</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(2,201</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">(1,540</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">112</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt"><span style="-sec-ix-hidden: hidden-fact-108; -sec-ix-hidden: hidden-fact-107; -sec-ix-hidden: hidden-fact-106; font-size: 10pt">Shares of ordinary share used in computing basic and diluted net loss per share</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,643,879</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,892,347</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,888,768</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><div style="-sec-ix-hidden: hidden-fact-111; -sec-ix-hidden: hidden-fact-110; -sec-ix-hidden: hidden-fact-109">Net loss per share of ordinary share, basic and diluted</div></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.47</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.53</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.04</td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt">&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of diluted weighted average shares outstanding</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December&#160;31</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="10" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands (*)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">IPO Warrants and Additional Warrants (Note 12h)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,541,998</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-112">-</div></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-113">-</div></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Underwriter warrants</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">611,785</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-114">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-115">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other warrants </td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">78,661</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7,232,444</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130116377104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of transactions with interested and related parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">Labor cost and related expenses (c1)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">358</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">192</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Directors&#8217; fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">172</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Consulting fees (c2)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">218</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Interest expenses on loans from related parties and shareholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">203</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">381</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">951</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">573</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock', window );">Schedule of balances with interested and related parties</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended December&#160;31,</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="font-weight: bold; text-align: center">U.S.&#160;dollars in thousands</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="text-decoration:underline">Assets:</span></td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Advances to suppliers (c2)</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">228</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">&#8212;</div></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">228</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">&#8212;</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="text-decoration:underline">Liabilities:</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left">Related parties (c3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">32</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">265</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loans from shareholders (Note 10),(c3)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">-</div></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,634</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt">Loan from related parties (Note 9)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">111</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 4pt">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">32</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td><td style="padding-bottom: 4pt">&#160;</td>
    <td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right">4,010</td><td style="padding-bottom: 4pt; text-align: left">&#160;</td></tr>
  </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><b>&#160;</b></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130106292192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 03, 2022</div></th>
<th class="th"><div>May 10, 2021</div></th>
<th class="th"><div>Aug. 30, 2022</div></th>
<th class="th"><div>Jun. 16, 2022</div></th>
<th class="th"><div>Feb. 17, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 28, 2022</div></th>
<th class="th"><div>Sep. 07, 2022</div></th>
<th class="th"><div>Jan. 04, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,717,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">(in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Converted into ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,463,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_BonusSharesAndReverseShareSplitDescription', window );">Bonus shares and reverse share split, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company&#8217;s
Board of Directors approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments
for subsequent reverse share split) ordinary shares of the Company for each Ordinary Share issued and outstanding as of the close of
business on February&#160;17, 2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an
aggregate issuance by the Company as of such date of 6,630,547 (prior to adjustments for subsequent reverse share splits) Ordinary Shares.
Additionally, the Board approved an increase in the authorized share capital of the Company to 100,000,000 (43,567,567 after giving effect
to the two subsequent reverse share splits) ordinary shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse Share Split, description</a></td>
<td class="text">the Company&#8217;s
Board of Directors approved a 0.806-for-1&#160;reverse split of its issued and outstanding Ordinary Shares, effective as of May&#160;3,
2022, pursuant to which holders of the Company&#8217;s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company&#8217;s
Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June&#160;16, 2022,
pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85&#160;Ordinary Shares held as of such date.
The reverse stock split proportionally reduced the number of the Company&#8217;s authorized share capital.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,201)<span></span>
</td>
<td class="num">$ (1,540)<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (Used in) operating activities (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,840)<span></span>
</td>
<td class="num">(863)<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,678)<span></span>
</td>
<td class="num">(1,477)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds of IPO (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,391<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,717,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ClassOfAdditionalWarrantOrRightOutstanding', window );">Additional warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,824,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Converted into ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,463,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_SmartProMember', window );">Smart Pro [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Shares acquired percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.01%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_PurexCorpMember', window );">Purex Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Shares acquired percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.03%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_JeffsBrandsMember', window );">Jeffs&#8217; Brands [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Percentage of shares ownership after Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_MrHakmonMember', window );">Mr. Hakmon [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Percentage of shares ownership after Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,717,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,717,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">(in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=jfbr_IPOWarrantMember', window );">IPO Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ExercisePriceAdjustment', window );">Exercise price adjustment (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ClassOfAdditionalWarrantOrRightOutstanding', window );">Additional warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights', window );">Exercise price adjustment (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=jfbr_UnderwritersWarrantsMember', window );">Underwriter&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GeneralInformationDetailsLineItems', window );"><strong>General Information (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ClassOfAdditionalWarrantOrRightOutstanding', window );">Additional warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Additional warrant total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Net proceeds (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_NetProceedsOfWarrants', window );">Net proceeds of warrants (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">(in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_BonusSharesAndReverseShareSplitDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of bonus shares and reverse share split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_BonusSharesAndReverseShareSplitDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ClassOfAdditionalWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ClassOfAdditionalWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ExercisePriceAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ExercisePriceAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_GeneralInformationDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_GeneralInformationDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_NetProceedsOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net proceeds of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_NetProceedsOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_SmartProMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_SmartProMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_PurexCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_PurexCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_JeffsBrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_JeffsBrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_MrHakmonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jfbr_MrHakmonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=jfbr_IPOWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=jfbr_IPOWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=jfbr_UnderwritersWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=jfbr_UnderwritersWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112185072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MaturityOfTimeDeposits', window );">Short-term bank deposits maturities</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="nump">$ 366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Leases term</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Tax benefit percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for returns</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSellingAndMarketingExpense', window );">Sales and marketing expenses</a></td>
<td class="nump">$ 1,163<span></span>
</td>
<td class="nump">$ 1,211<span></span>
</td>
<td class="nump">$ 371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Monthly contribution percentage</a></td>
<td class="nump">8.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturityOfTimeDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of customer deposits, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher SEC<br> -Name Industry Guide<br> -Number 3<br> -Section V<br> -Paragraph D-E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturityOfTimeDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of selling and marketing expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130106164560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - Schedule of assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jfbr_ComputersEquipmentMember', window );">Computers equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment percentage</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage', window );">Property and equipment percentage</a></td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member[</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment term</a></td>
<td class="text">Shorter of remaining lease term or estimated useful life<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905813&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jfbr_ComputersEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jfbr_ComputersEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130108093104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other receivables (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAdditionalCapital', window );">Pure capital amoun</a></td>
<td class="nump">$ 228<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAdditionalCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of additional paid-in capital (APIC) classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 5.T)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868742-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAdditionalCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130114611152">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Other receivables (Details) - Schedule of other receivables - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfOtherReceivablesAbstract', window );"><strong>Schedule Of Other Receivables Abstract</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Supplies', window );">Advances to suppliers</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 641<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GovernmentContractReceivable', window );">Government institutions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">130<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsAndOtherReceivablesNet', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 779<span></span>
</td>
<td class="nump">$ 36<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes $228 thousand to Pure Capital. See
Note 16 for additional information.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GovernmentContractReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of receivables that are derived from government contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55295-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GovernmentContractReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsAndOtherReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsAndOtherReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Supplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Supplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112172752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory (Details) - Schedule of inventory - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfInventoryAbstract', window );"><strong>Schedule Of Inventory Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryInTransit', window );">Goods in transit</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">1,783<span></span>
</td>
<td class="nump">1,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Total</a></td>
<td class="nump">$ 1,791<span></span>
</td>
<td class="nump">$ 1,227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfInventoryAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfInventoryAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryInTransit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryInTransit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130116293024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Disclosure Of Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 570<span></span>
</td>
<td class="nump">$ 524<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FiniteLivedIntangibleAssetAmortizationMethod', window );">Estimated annual amortization expense</a></td>
<td class="nump">$ 570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit', window );">Write off the intangible asset balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_FiniteLivedIntangibleAssetAmortizationMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amortization method of a major finite-lived intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar either by their nature or by their use in the operations of a company. The straight-line method is the preferred amortization method, unless another method better reflects the pattern in which the asset is consumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_FiniteLivedIntangibleAssetAmortizationMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset lacking physical substance and having a projected indefinite period of benefit to fair value. Excludes financial assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112169328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets (Details) - Schedule of total intangible assets - Brands [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">$ 5,783<span></span>
</td>
<td class="nump">$ 5,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,331)<span></span>
</td>
<td class="num">(762)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Balance</a></td>
<td class="nump">$ 4,452<span></span>
</td>
<td class="nump">$ 5,021<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jfbr_BrandsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jfbr_BrandsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130111390816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Remaining useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_OperatingLeaseAssets', window );">Operating lease assets</a></td>
<td class="nump">$ 138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRenewalTerm1', window );">Lease term period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_WeightedAverageBorrowingRate', window );">Weighted average borrowing rate</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_OperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_OperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_WeightedAverageBorrowingRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_WeightedAverageBorrowingRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130113657936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - Schedule of future lease payments under operating leases<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract', window );"><strong>Schedule Of Future Lease Payments Under Operating Leases Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024-2025</a></td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FutureOperatingLeasePayments', window );">Total future operating lease payments</a></td>
<td class="nump">161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivableWithImputedInterestDiscount', window );">Less: imputed interest</a></td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_PresentValueOfLeaseLiability', window );">Present value of lease liability</a></td>
<td class="nump">$ 141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_FutureOperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_FutureOperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_PresentValueOfLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is present value of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_PresentValueOfLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivableWithImputedInterestDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the unamortized amount of the discount on the note or receivable which is deducted from the face amount of the receivable or loan. The discount or premium is the difference between the present value and the face amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivableWithImputedInterestDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112884096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Payables (Details) - Schedule of other payables - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfOtherPayablesAbstract', window );"><strong>Schedule Of Other Payables Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue', window );">Government institutions</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employees and related benefits</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Lease liabilities</a></td>
<td class="nump">40<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued Interest</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AccruedExpensesAndOtherPayables', window );">Accrued expenses and other payables</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Total other payables</a></td>
<td class="nump">$ 391<span></span>
</td>
<td class="nump">$ 715<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AccruedExpensesAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accrued expenses and other payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AccruedExpensesAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfOtherPayablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfOtherPayablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt securities issued by a United States government agency such as Government National Mortgage Association (Ginnie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac), and Federal National Mortgage Association (Fannie Mae), which are short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130111549824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Loans (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 22, 2023</div></th>
<th class="th"><div>Sep. 22, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 02, 2022</div></th>
<th class="th"><div>May 09, 2022</div></th>
<th class="th"><div>Mar. 03, 2022</div></th>
<th class="th"><div>Feb. 22, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Short-Term Loans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AggregatesAmount', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForPreviousAcquisition', window );">Amazon loan balance.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtPercentageBearingFixedInterestRate', window );">Bears annual interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Outstanding loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Additional interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AggregateAmount', window );">Aggregate amount</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_PrincipalLoanAmount', window );">Principal loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtFairValue', window );">Fair value amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Derivate liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Finance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtPercentageBearingVariableInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShortTermLineOfCredits', window );">Short term line of credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Under line credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of aggregate amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AggregatesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AggregatesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_PrincipalLoanAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amountof principal loan amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_PrincipalLoanAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ShortTermLineOfCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short term line of credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ShortTermLineOfCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4,6)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPreviousAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow representing an adjustment to the purchase price of a previous acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPreviousAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtPercentageBearingVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date, which accrues interest at a rate subject to change from time to time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtPercentageBearingVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130108169184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Loans (Details) - Schedule of short term loans - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfShortTermLoansAbstract', window );"><strong>Schedule Of Short Term Loans Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loans with Amazon</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">$ 101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansAndLeasesReceivableRelatedParties', window );">Related party loan</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ThirdPartyLoan', window );">Third party loans</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short term loans total</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">$ 927<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfShortTermLoansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfShortTermLoansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ThirdPartyLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of third party loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ThirdPartyLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansAndLeasesReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, reflects the carrying amount of unpaid loan amounts due from related parties at the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.7(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansAndLeasesReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130111811168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 28, 2022</div></th>
<th class="th"><div>Aug. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DerivativeLiabilitiesDetailsLineItems', window );"><strong>Derivative Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ThirdPartyLoan', window );">Loan from third parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 715,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues', window );">Fair value issuance amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DerivativeLiability', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,717,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_PublicOfferingPricePerShare', window );">Public offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesIssued', window );">Number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AdditionalWarrants', window );">Additional warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Consideration amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeCostOfHedgeNetOfCashReceived', window );">Derivative, Cost of Hedge Net of Cash Received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Issuance of costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Weighted average stock price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_RevenuesPercentage', window );">Revenues percentage</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_RelatedPartyFairValue', window );">Fair value amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="nump">$ 2,216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value amount</a></td>
<td class="nump">$ 3,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Share [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DerivativeLiabilitiesDetailsLineItems', window );"><strong>Derivative Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,717,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesIssued', window );">Number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceDecrease', window );">Initial exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Purchase of share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,143,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DerivativeLiabilitiesDetailsLineItems', window );"><strong>Derivative Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ThirdPartyLoan', window );">Loan from third parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,717,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessStockSharesIssued', window );">Number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AdditionalWarrants', window );">Additional warrants</a></td>
<td class="nump">120,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Fair value amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=jfbr_IssuanceDateMember', window );">Issuance Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DerivativeLiabilitiesDetailsLineItems', window );"><strong>Derivative Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=jfbr_UnderwritersWarrantsMember', window );">Underwriter&#8217;s Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DerivativeLiabilitiesDetailsLineItems', window );"><strong>Derivative Liabilities (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantExercisePriceIncrease', window );">Exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Purchase of share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AdditionalWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional warrants are options issued by a company that trade on an exchange and give investors the right (but not obligation) to purchase company stock at a specific price within a specified time period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AdditionalWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_DerivativeLiabilitiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_DerivativeLiabilitiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_DerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_DerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_PublicOfferingPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received public offering price per share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_PublicOfferingPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_RelatedPartyFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of related party fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_RelatedPartyFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_RevenuesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenues percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_RevenuesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ThirdPartyLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of third party loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ThirdPartyLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeCostOfHedgeNetOfCashReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The premium (cost) of a hedge, net of any cash received on settlement during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeCostOfHedgeNetOfCashReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of excess stock shares of an entity that have been sold or granted to shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=jfbr_IssuanceDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=jfbr_IssuanceDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=jfbr_UnderwritersWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=jfbr_UnderwritersWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130111356528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities (Details) - Schedule of fair value of the derivative warrant liability - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract', window );"><strong>Schedule Of Fair Value Of The Derivative Warrant Liability Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue', window );">Balance at beginning</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty', window );">Fair value of warrant liability to be issued to third-party upon IPO (note 9a)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ChangeInFairValue', window );">Change in fair value</a></td>
<td class="num">(2,822)<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Classification to additional paid in capital</a></td>
<td class="num">(3,319)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue', window );">Balance at ending</a></td>
<td class="num">(2,216)<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Issuance of warrants in connection with the IPO</a></td>
<td class="nump">$ 8,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ChangeInFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ChangeInFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130111402512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems', window );"><strong>Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems', window );"><strong>Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">77.57%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (in Dollars per share)</a></td>
<td class="nump">$ 2,020.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in Dollars per share)</a></td>
<td class="nump">$ 1,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">3.27%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PercentageOfWeightedAverageCostInventory', window );">WACC</a></td>
<td class="nump">21.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems', window );"><strong>Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">78.89%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice', window );">Exercise price (in Dollars per share)</a></td>
<td class="nump">$ 4,040.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in Dollars per share)</a></td>
<td class="nump">$ 1,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.04%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">4 years 8 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PercentageOfWeightedAverageCostInventory', window );">WACC</a></td>
<td class="nump">23.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfWeightedAverageCostInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of weighted average cost inventory present at the reporting date when inventory is valued using different valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfWeightedAverageCostInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112408912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans from Shareholders (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 03, 2022</div></th>
<th class="th"><div>Feb. 02, 2021</div></th>
<th class="th"><div>Aug. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 08, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LoansfromShareholdersDetailsLineItems', window );"><strong>Loans from Shareholders (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Loan amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedPercentage', window );">Benefit percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRate', window );">Interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedTrademarksGross', window );">Total trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Inventory total amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseOtherShortTermBorrowings', window );">Capital reserve from the transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod', window );">Loans was determined percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.79%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Ordinary Share price divided</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Financial liability</a></td>
<td class="nump">3,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,216<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Financial instrument</a></td>
<td class="nump">2,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease', window );">Increase in equity</a></td>
<td class="nump">982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Converted into an aggregate of ordinary shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,463,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=jfbr_PureCapitalLtdMember', window );">Pure Capital Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LoansfromShareholdersDetailsLineItems', window );"><strong>Loans from Shareholders (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipalAmountOutstandingOnLoansSecuritized', window );">Outstanding loans</a></td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=jfbr_MrHakmonAndLIAMember', window );">Mr. Hakmon and L.I.A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LoansfromShareholdersDetailsLineItems', window );"><strong>Loans from Shareholders (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipalAmountOutstandingOnLoansSecuritized', window );">Outstanding loans</a></td>
<td class="nump">940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jfbr_MedigusMember', window );">Medigus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LoansfromShareholdersDetailsLineItems', window );"><strong>Loans from Shareholders (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction', window );">Transferred to smart pro amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherMinorityInterests', window );">Minority shareholders transferred amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipalAmountOutstandingOnLoansSecuritized', window );">Outstanding loans</a></td>
<td class="nump">$ 4,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jfbr_MedigusMember', window );">Medigus [Member] | Mr. Hakmon and L.I.A [Member] | Pure Capital Ltd. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LoansfromShareholdersDetailsLineItems', window );"><strong>Loans from Shareholders (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrincipalAmountOutstandingOnLoansSecuritized', window );">Outstanding loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Business Combination [Member] | Amazon.com [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LoansfromShareholdersDetailsLineItems', window );"><strong>Loans from Shareholders (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Finance the acquisition percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Business Combination [Member] | Medigus [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LoansfromShareholdersDetailsLineItems', window );"><strong>Loans from Shareholders (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Finance the acquisition percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_LoansfromShareholdersDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_LoansfromShareholdersDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of plan assets to benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42546-110969<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedTrademarksGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedTrademarksGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOtherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expense incurred during the reporting period on other short-term borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOtherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate or index during the adjustment period to compute the variable [fully indexed] rate on the loans receivable realized during the reporting period. This may be an effective margin for the period depending on the specific terms of the underlying loan agreement (for example, an annual disclosure for a loan with a quarterly adjustment period).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherMinorityInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of equity interests owned by noncontrolling shareholders, partners, or other equity holders in one or more of the entities consolidated into the reporting entity's financial statements other than joint ventures, limited partnerships, operating partnerships or interests held by preferred unit holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherMinorityInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipalAmountOutstandingOnLoansSecuritized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is the principal amount outstanding for securitized loans only (across all types of loans).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=d3e107314-111719<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipalAmountOutstandingOnLoansSecuritized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in stockholders' equity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=jfbr_PureCapitalLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=jfbr_PureCapitalLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=jfbr_MrHakmonAndLIAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=jfbr_MrHakmonAndLIAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jfbr_MedigusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jfbr_MedigusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jfbr_AmazoncomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jfbr_AmazoncomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112303344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Loans from Shareholders (Details) - Schedule of loans from shareholders consists - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract', window );"><strong>Schedule Of Loans From Shareholders Consists Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loan amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 4,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Loan discount</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,316)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3,634<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130106215232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate', window );">tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Corporate tax rate</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses', window );">Carry forward tax losses</a></td>
<td class="nump">$ 3,870<span></span>
</td>
<td class="nump">$ 747<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated impairment losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130108131936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - Schedule of income (loss) before taxes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems', window );"><strong>Taxes on Income (Details) - Schedule of income (loss) before taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Income loss before taxes</a></td>
<td class="num">$ (2,207)<span></span>
</td>
<td class="num">$ (1,561)<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=country_IL', window );">Israel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems', window );"><strong>Taxes on Income (Details) - Schedule of income (loss) before taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Income loss before taxes</a></td>
<td class="num">(2,081)<span></span>
</td>
<td class="num">(1,096)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems', window );"><strong>Taxes on Income (Details) - Schedule of income (loss) before taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Income loss before taxes</a></td>
<td class="num">$ (126)<span></span>
</td>
<td class="num">$ (465)<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130111787632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - Schedule of income tax expense (benefit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract', window );"><strong>Schedule Of Income Tax Expense Benefit Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_CurrentStateAndLocalTaxExpensesBenefit', window );">Israel</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DeferredAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit', window );">Israel</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Total deferred tax income</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total tax (benefit) expense</a></td>
<td class="num">$ (6)<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_CurrentStateAndLocalTaxExpensesBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current state and local tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_CurrentStateAndLocalTaxExpensesBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_DeferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_DeferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Teh amount of deferred state and local income tax expenses benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130111540048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - Schedule of statutory income tax rate to effective income tax rate - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract', window );"><strong>Schedule Of Statutory Income Tax Rate To Effective Income Tax Rate Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Income (loss) before taxes on income</a></td>
<td class="num">$ (2,201)<span></span>
</td>
<td class="num">$ (1,561)<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Tax (tax benefit) computed at the statutory tax rate</a></td>
<td class="num">$ (506)<span></span>
</td>
<td class="num">$ (359)<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Tax rate differences applicable to subsidiaries</a></td>
<td class="num">(110)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Tax losses and timing differences for which deferred taxes were not recognized</a></td>
<td class="nump">610<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Taxes on income</a></td>
<td class="num">$ (6)<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126970579&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130107595232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Taxes on Income (Details) - Schedule of deferred taxes assets and liabilities - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DeferredTaxAssetAbstract', window );"><strong>Deferred tax asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Operating lease right of use asset</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforward</a></td>
<td class="nump">890<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">1,032<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(890)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets after valuation allowance</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans', window );">Differences between tax basis and carrying value of loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease liability</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Total deferred tax liability</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Net deferred tax assets (liabilities)</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="num">$ (314)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_DeferredTaxAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_DeferredTaxAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of differences between tax basis and carrying value of loans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130106392048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Capital (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 28, 2022</div></th>
<th class="th"><div>Oct. 08, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Nov. 28, 2022</div></th>
<th class="th"><div>Aug. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 17, 2022</div></th>
<th class="th"><div>Jul. 23, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AgreementDescription', window );">Agreement description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Smart Pro entered into a definitive
agreement with Medigus. According to the agreement, Medigus will hold 50.01% of the issued and outstanding share capital of Smart Pro,
acquired through a combination of a cash investment in Smart Pro and an acquisition of additional shares from Smart Pro&#8217;s&#8217;
previous shareholders in consideration for restricted American Depository Shares (&#8220;ADS&#8221;) of Medigus and a cash component.
Medigus invested $1,100 thousands in Smart Pro in exchange of issuing 5,572 ordinary shares, pay $150 thousands in cash consideration
to the current shareholders and shall issue $500 thousands worth of restricted ADS of Medigus to the current shareholders of such company,
with the value of restricted ADS to be subject to downward adjustment based on Smart Pro&#8217;s 2020 results. In addition, Smart Pro&#8217;s
current shareholders shall be entitled to additional milestone allotments of up to an aggregate $750 thousands in restricted ADS subject
to Smart Pro &#8217;s achievement of certain milestones throughout 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_IssuedAndOutstandingShareCapitalPercentage', window );">Issued and outstanding share capital percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_InvestAmount', window );">Invest amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent', window );">Additional payroll expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Warrants issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_IssuanceOfBonusShares', window );">Issuance of bonus shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">664.0547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AggregateIssuanceShares', window );">Aggregate issuance shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,630,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GrossProceeds', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants purchase shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="nump">$ 6.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_InitialExercisePriceExpire', window );">Initial exercise price expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionExercisePriceDecrease', window );">Exercise price less (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionExercisePriceIncrease', window );">Exercise price (in Dollars per share)</a></td>
<td class="nump">$ 2.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AdditionalWarrantTerm', window );">Additional warrant term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_RevenuesPercentage', window );">Revenues percentage</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,822,000)<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AdditionalWarrantsDescription', window );">Additional warrants description</a></td>
<td class="text">On November 28, 2022, following the issuance of the Additional warrants,
the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair
value of the IPO Warrants as of November 28, 2022 at the amount of $3,319 thousands which was calculated based on a third-party appraiser
valuation, was recorded as a component of Group&#8217;s shareholder&#8217;s equity. (Refer also to Note 9c). The total gross consideration
was 15.5&#160;million (including the exercise of the underwriter&#8217;s option at the amount of $4 thousands). $8,245 thousand was initially
attributed to the warrants based on their fair value and the remaining amount was attributed to the ordinary shares issued and recognized
as an equity component. Applicable issuance costs, amounting to $2,193 thousand, have been allocated in the same proportion as the allocation
of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and has been recorded in
profit or loss as finance expense, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand have been
recorded in equity as a reduction of the paid in capital.&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Warrants issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,074,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,074,217<span></span>
</td>
<td class="nump">2,893,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Warrants issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ConsideredAsIssuanceCosts', window );">Considered as issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,463,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,651,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,594,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,717,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Divided ordinary shares amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_IssuanceOfPeriodTerm', window );">Issuance of period term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Ordinary shares exercisable (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Ordinary shares exercisable term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Ordinary shares exercisable per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in Dollars per share)</a></td>
<td class="nump">$ 2.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.02<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Warrants issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants purchase shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,717,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,319,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Warrants issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ConsideredAsIssuanceCosts', window );">Considered as issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_GrossProceeds', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants purchase shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants purchase shares (in Shares)</a></td>
<td class="nump">2,824,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,824,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_MajorityShareholderMember', window );">Majority Shareholder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareCapitalDetailsLineItems', window );"><strong>Share Capital (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares issued (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_MinorityShareholderAmount', window );">Minority shareholder amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AdditionalWarrantTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional warrant term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AdditionalWarrantTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AdditionalWarrantsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional warrants description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AdditionalWarrantsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AggregateIssuanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate issuance shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AggregateIssuanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AgreementDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AgreementDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ConsideredAsIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Considered as issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ConsideredAsIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_GrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_GrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_InitialExercisePriceExpire">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial exercise price expire.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_InitialExercisePriceExpire</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_InvestAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Invest amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_InvestAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_IssuanceOfBonusShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of bonus shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_IssuanceOfBonusShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_IssuanceOfPeriodTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of period term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_IssuanceOfPeriodTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_IssuedAndOutstandingShareCapitalPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issued and outstanding share capital percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_IssuedAndOutstandingShareCapitalPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_MinorityShareholderAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minority shareholder amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_MinorityShareholderAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_RevenuesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenues percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_RevenuesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ShareCapitalDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ShareCapitalDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 55<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6829253&amp;loc=SL6831962-166255<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionExercisePriceDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share decrease in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionExercisePriceDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_MajorityShareholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_MajorityShareholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115605216">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Share Capital (Details) - Schedule of share capital composed of ordinary shares - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract', window );"><strong>Schedule Of Share Capital Composed Of Ordinary Shares Abstract</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">8,074,217<span></span>
</td>
<td class="nump">2,893,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">43,567,567<span></span>
</td>
<td class="nump">4,356,757<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Retroactively adjusted. See Note 1b</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130115818720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share Incentive Plan (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share Incentive Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares', window );">Ordinary Shares were reserved</a></td>
<td class="nump">1,307,027<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The shares or units in an ESOP trust that have been assigned to individual participant accounts based on a known formula. IRS rules require allocations to be nondiscriminatory generally based on compensation, length of service, or a combination of both. For any particular participant such shares or units may be vested, unvested, or partially vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=109244661&amp;loc=d3e17540-113929<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112099040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance (Income) Expense, Net (Details) - Schedule of finance (income) expenses, net - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FinanceIncomeAbstract', window );"><strong>Finance income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Change in fair value of derivative liabilities</a></td>
<td class="num">$ (2,822)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Gain from debt extinguishment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Total finance income</a></td>
<td class="num">(2,822)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FinanceExpenseAbstract', window );"><strong>Finance expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FinanceExpensesInRespectOfThirdpartyLoan', window );">Finance expenses in respect of third-party loan</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities', window );">Change in fair value of derivative liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of loan discount</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Exchange rate changes</a></td>
<td class="nump">156<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseRelatedParty', window );">Interest expense on loans from shareholders and related parties</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="nump">221<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other finance expenses</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Total finance expenses</a></td>
<td class="nump">517<span></span>
</td>
<td class="nump">643<span></span>
</td>
<td class="nump">232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_FinanceExpenseNet', window );">Finance (income) expense, net</a></td>
<td class="num">$ (2,305)<span></span>
</td>
<td class="nump">$ 629<span></span>
</td>
<td class="nump">$ 232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_FinanceExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_FinanceExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_FinanceExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents interest incurred for borrowed money which was used to produce goods or render services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_FinanceExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_FinanceExpensesInRespectOfThirdpartyLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as finance expenses in respect of third-party loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_FinanceExpensesInRespectOfThirdpartyLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_FinanceIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_FinanceIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense incurred on a debt or other obligation to related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130113657776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract', window );"><strong>Schedule Of Basic And Diluted Net Income Loss Per Share Attributable To Ordinary Shareholders Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) applicable to shareholders of ordinary shares</a></td>
<td class="num">$ (2,201)<span></span>
</td>
<td class="num">$ (1,540)<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Shares of ordinary share used in computing basic and diluted net loss per share</a></td>
<td class="nump">4,643,879<span></span>
</td>
<td class="nump">2,892,347<span></span>
</td>
<td class="nump">2,888,768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedProFormaAdjustment', window );">Net loss per share of ordinary share, basic and diluted</a></td>
<td class="num">$ (0.47)<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedProFormaAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pro forma diluted earnings per share adjustment to reconcile between net income and pro forma amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedProFormaAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageBasicSharesOutstandingProForma</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130108109712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract', window );"><strong>Schedule Of Basic And Diluted Net Income Loss Per Share Attributable To Ordinary Shareholders Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Shares of ordinary share used in computing diluted net loss per share</a></td>
<td class="nump">4,643,879<span></span>
</td>
<td class="nump">2,892,347<span></span>
</td>
<td class="nump">2,888,768<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedProFormaAdjustment', window );">Net loss per share of ordinary share, diluted</a></td>
<td class="num">$ (0.47)<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedProFormaAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pro forma diluted earnings per share adjustment to reconcile between net income and pro forma amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedProFormaAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130110462800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of diluted weighted average shares outstanding - shares<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract', window );"><strong>Schedule Of Diluted Weighted Average Shares Outstanding Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_IPOAndAdditionalWarrants', window );">IPO Warrants and Additional Warrants (Note 12h)</a></td>
<td class="nump">6,541,998<span></span>
</td>
<td colspan="2" class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_UnderwriterWarrants', window );">Underwriter warrants</a></td>
<td class="nump">611,785<span></span>
</td>
<td colspan="2" class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_OtherWarrants', window );">Other warrants</a></td>
<td class="nump">78,661<span></span>
</td>
<td colspan="2" class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_TotalDilutedWeightedAverageSharesOutstanding', window );">Total diluted weighted average shares outstanding</a></td>
<td class="nump">7,232,444<span></span>
</td>
<td colspan="2" class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">except share and per share data</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_IPOAndAdditionalWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares is IPO and additional warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_IPOAndAdditionalWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_OtherWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares is other warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_OtherWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_TotalDilutedWeightedAverageSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total diluted weighted average shares outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_TotalDilutedWeightedAverageSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_UnderwriterWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares is underwriter warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_UnderwriterWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130112740752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details)<br></strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 01, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Aug. 03, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 03, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th"><div>May 21, 2022</div></th>
<th class="th">
<div>Oct. 26, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 26, 2022 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 23, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_RelatedPartiesDetailsLineItems', window );"><strong>Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_RelatedPartyFairValue', window );">Related party fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="nump">$ 2,216,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Additional payroll expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_Bonus', window );">Bonus</a></td>
<td class="nump">$ 140,000<span></span>
</td>
<td class="nump">&#8362; 480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121,000<span></span>
</td>
<td class="nump">&#8362; 425,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ConsultancyServicesFees', window );">Consultancy services fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="nump">&#8362; 57,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_PercentageOfGrossProceed', window );">Percentage of gross proceed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_PercentageOfTotalConsiderationPaid', window );">Percentage of total consideration paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_UndefinedPeriodOfTime', window );">Undefined period of time</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliers', window );">Advances to suppliers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_PercentageLeaseAndMaintenanceExpensesRelated', window );">Percentage lease and maintenance expenses related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLaborRelatedExpenses', window );">Lease and maintenance expenses related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_OutstandingPayable', window );">outstanding payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyCosts', window );">Related party balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionDueFromToRelatedParty', window );">Another related party balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeRelatedParty', window );">Accrued interest related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 393,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_RelatedPartiesDetailsLineItems', window );"><strong>Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalariesWagesAndOfficersCompensation', window );">Salary</a></td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="nump">&#8362; 80,000<span></span>
</td>
<td class="nump">$ 23,000<span></span>
</td>
<td class="nump">&#8362; 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jfbr_MinorityShareholderMember', window );">Minority Shareholder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_RelatedPartiesDetailsLineItems', window );"><strong>Related Parties (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Issued to the minority Shareholder (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,202<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_Bonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is bonus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_Bonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ConsultancyServicesFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is consultancy services fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ConsultancyServicesFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_OutstandingPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is outstanding payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_OutstandingPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_PercentageLeaseAndMaintenanceExpensesRelated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage lease and maintenance expenses related.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_PercentageLeaseAndMaintenanceExpensesRelated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_PercentageOfGrossProceed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of gross proceed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_PercentageOfGrossProceed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_PercentageOfTotalConsiderationPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of total consideration paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_PercentageOfTotalConsiderationPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_RelatedPartiesDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_RelatedPartiesDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_RelatedPartyFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of related party fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_RelatedPartyFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_UndefinedPeriodOfTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undefined period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_UndefinedPeriodOfTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest-bearing assets owed to the entity by related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLaborRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of labor-related expenses classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLaborRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments of cash to suppliers for goods and services during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionDueFromToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionDueFromToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesWagesAndOfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesWagesAndOfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jfbr_MinorityShareholderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=jfbr_MinorityShareholderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130209113392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details) - Schedule of transactions with interested and related parties - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract', window );"><strong>Schedule Of Transactions With Interested And Related Parties Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Labor cost and related expenses (c1)</a></td>
<td class="nump">$ 358<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoninterestExpenseDirectorsFees', window );">Directors&#8217; fees</a></td>
<td class="nump">172<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Consulting fees (c2)</a></td>
<td class="nump">218<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders', window );">Interest expenses on loans from related parties and shareholders</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Total transactions with interested and related parties</a></td>
<td class="nump">$ 951<span></span>
</td>
<td class="nump">$ 573<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expenses on loans from related parties and shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoninterestExpenseDirectorsFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoninterestExpenseDirectorsFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130106239648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Parties (Details) - Schedule of balances with interested and related parties - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AssetsAbstract0', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AdvancesToSuppliers', window );">Advances to suppliers</a></td>
<td class="nump">$ 228<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Assets</a></td>
<td class="nump">228<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Related parties</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_LoansFromShareholders', window );">Loans from shareholders (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DueToOtherRelatedPartiesNoncurrent', window );">Loan from related parties (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Liabilities</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 4,010<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AdvancesToSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is advances to suppliers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AdvancesToSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AssetsAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AssetsAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_LoansFromShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount is loans from shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_LoansFromShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToOtherRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount payable from related parties classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToOtherRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140130111578928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 29, 2023 </div>
<div>shares</div>
</th>
<th class="th"><div>Feb. 23, 2023</div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 22, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 09, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 09, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Shares acquired value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 288,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_AdditionalDividendsPayableSharesValue', window );">Adjusted shares value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription', window );">Stock purchase agreement description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">On February 23, 2023, the Company and Jeffs&#8217; Brands Holdings entered into a stock purchase agreement with SciSparc (the &#8220;Wellution Agreement&#8221;), as amended on March 22, 2023 by Addendum No. 1 to the Wellution Agreement (the &#8220;Addendum&#8221;), pursuant which, on March 22, 2023, Jeffs&#8217; Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S., a wholly-owned subsidiary of SciSparc that owns and operates Wellution, a top-selling Amazon food supplements and cosmetics brand, subject to the holdback by SciSparc of 11 shares as described below, representing approximately 49% of the issued and outstanding common stock of SciSparc U.S., for approximately $3 million in cash (including the Price Adjustment, as defined below), of which approximately $2.5 million was paid at the closing (the &#8220;Wellution Transaction&#8221;). The Addendum provided for the payment by us to SciSparc of an additional amount of $489,330 in cash for the purchase price adjustments (the &#8220;Price Adjustment,&#8221;) related to inventory and working capital, payable in five equal installments of $97,866 on the tenth day of each consecutive calendar month, beginning in May 2023. As collateral for the payment in full of the Price Adjustment, SciSparc held back 11 shares of common stock of SciSparc U.S, which will be released to Jeffs&#8217; Brands Holdings once the final payment is made. Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Transaction, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S. (the &#8220;SciSparc Consulting Agreement&#8221;), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousands and the Company will receive a one-time signing bonus in the amount of $51 thousands. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockOtherSharesOutstanding', window );">Ordinary shares issued (in Shares) | shares</a></td>
<td class="nump">360,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage', window );">Shares issued percentage</a></td>
<td class="nump">2.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage', window );">Shares outstanding percentage</a></td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MembersCapital', window );">Issued and outstanding share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">&#8364; 2,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Monthly fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">&#8364; 2,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PartnersCapitalAccountReturnOfCapital', window );">Pure capital amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 352<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=jfbr_OwnershipMember', window );">Ownership [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_jfbr_SubsequentEventsDetailsLineItems', window );"><strong>Subsequent Events (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership limitation percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_AdditionalDividendsPayableSharesValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aomunt of additional dividends payable shares value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_AdditionalDividendsPayableSharesValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of issued shares of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding shares of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jfbr_SubsequentEventsDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jfbr_SubsequentEventsDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jfbr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockOtherSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockOtherSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MembersCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of member capital in limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MembersCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PartnersCapitalAccountReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total change in each class of partners' capital accounts during the year due to the return of partner's capital. That is, excess distributions over earnings to partners. All partners include general, limited and preferred partners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187171-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PartnersCapitalAccountReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of rights of setoff associated with the entity's recognized securities sold under agreements to repurchase subject to an enforceable master netting arrangement or similar agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225880-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=jfbr_OwnershipMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=jfbr_OwnershipMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>f20f2022_jeffsbrands_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:jfbr="http://www.jeffsbrands.com/20221231"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="jfbr-20221231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jfbr:SmartProMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-04</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jfbr:PurexCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-04</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jfbr:JeffsBrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-10</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jfbr:MrHakmonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-10</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:IPOWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:IPOWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:UnderwritersWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:UnderwritersWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:IPOWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-07</instant>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:IPOWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">jfbr:IPOWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-28</instant>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-17</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-16</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jfbr:ComputersEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jfbr:BrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jfbr:BrandsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-09-22</instant>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-09-02</startDate>
            <endDate>2022-09-22</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-05-09</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-31</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2023-04-12</startDate>
            <endDate>2023-04-22</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-02-22</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-03-03</instant>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-06-02</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">jfbr:IssuanceDateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-30</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-08-30</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">jfbr:UnderwritersWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-28</startDate>
            <endDate>2022-11-28</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-11-29</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-11-28</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:AmazoncomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-08</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MedigusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-08</instant>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2020-10-08</instant>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2021-02-02</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MedigusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-02</endDate>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MedigusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-02</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-02</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MedigusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-03</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jfbr:MrHakmonAndLIAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-03</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">jfbr:PureCapitalLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-03</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-05-03</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">jfbr:PureCapitalLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">jfbr:MrHakmonAndLIAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MedigusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-30</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-08</endDate>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-08</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:MajorityShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:MajorityShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-28</instant>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-11-28</startDate>
            <endDate>2022-11-28</endDate>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-28</instant>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-28</endDate>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-30</instant>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">jfbr:MinorityShareholderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-03</endDate>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-25</startDate>
            <endDate>2022-09-01</endDate>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-08-25</startDate>
            <endDate>2022-09-01</endDate>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-10-10</startDate>
            <endDate>2022-10-26</endDate>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-05-10</startDate>
            <endDate>2022-05-21</endDate>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <startDate>2022-09-02</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-23</startDate>
            <endDate>2023-02-23</endDate>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-22</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-29</instant>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-28</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">jfbr:OwnershipMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-09</instant>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001885408</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <dei:DocumentType contextRef="c0">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c0">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c0">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c0">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c0">001-41482</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0">Jeffs&#x2019; Brands Ltd</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c0">7 Mezada Street.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0">Bnei Brak</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0">Israel</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c0">5126112</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c0">IL</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="c1">Viki Hakmon</dei:ContactPersonnelName>
    <dei:ContactPersonnelName contextRef="c0">Viki Hakmon</dei:ContactPersonnelName>
    <dei:CityAreaCode contextRef="c1">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c1">3-7713520</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress contextRef="c1">victor@jeffsbrands.com</dei:ContactPersonnelEmailAddress>
    <dei:EntityAddressAddressLine1 contextRef="c1">7 Mezada Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c1">Bnei Brak</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c1">Israel</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c1">IL</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="c1">5126112</dei:EntityAddressPostalZipCode>
    <dei:Security12bTitle contextRef="c0">Ordinary Shares, no par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0">JFBR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">8074217</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c0">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c0">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentAccountingStandard contextRef="c0">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="c0">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="c0">1197</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c0">Brightman Almagor Zohar&#160;&amp; Co.</dei:AuditorName>
    <dei:AuditorLocation contextRef="c0">Tel Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c2" decimals="-3" unitRef="usd">8137000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c3" decimals="-3" unitRef="usd">393000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c2" decimals="-3" unitRef="usd">327000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c3" decimals="-3" unitRef="usd">366000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c2" decimals="-3" unitRef="usd">779000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent contextRef="c3" decimals="-3" unitRef="usd">36000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:InventoryNet contextRef="c2" decimals="-3" unitRef="usd">1791000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c3" decimals="-3" unitRef="usd">1227000</us-gaap:InventoryNet>
    <us-gaap:AssetsCurrent contextRef="c2" decimals="-3" unitRef="usd">11034000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c3" decimals="-3" unitRef="usd">2022000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredCosts contextRef="c3" decimals="-3" unitRef="usd">366000</us-gaap:DeferredCosts>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c2" decimals="-3" unitRef="usd">41000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c3" decimals="-3" unitRef="usd">3000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c2" decimals="-3" unitRef="usd">4452000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c3" decimals="-3" unitRef="usd">5021000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c2" decimals="-3" unitRef="usd">110000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c2" decimals="-3" unitRef="usd">138000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent contextRef="c2" decimals="-3" unitRef="usd">4741000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="c3" decimals="-3" unitRef="usd">5390000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets contextRef="c2" decimals="-3" unitRef="usd">15775000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c3" decimals="-3" unitRef="usd">7412000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c2" decimals="-3" unitRef="usd">131000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c3" decimals="-3" unitRef="usd">167000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:OtherLoansPayableCurrent contextRef="c2" decimals="-3" unitRef="usd">391000</us-gaap:OtherLoansPayableCurrent>
    <us-gaap:OtherLoansPayableCurrent contextRef="c3" decimals="-3" unitRef="usd">715000</us-gaap:OtherLoansPayableCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="c2" decimals="-3" unitRef="usd">32000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="c3" decimals="-3" unitRef="usd">265000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:ShortTermBankLoansAndNotesPayable contextRef="c2" decimals="-3" unitRef="usd">86000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ShortTermBankLoansAndNotesPayable contextRef="c3" decimals="-3" unitRef="usd">927000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:LiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">640000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">2074000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLoansPayableLongTerm contextRef="c3" decimals="-3" unitRef="usd">3634000</us-gaap:OtherLoansPayableLongTerm>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c2" decimals="-3" unitRef="usd">2216000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c3" decimals="-3" unitRef="usd">137000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c2" decimals="-3" unitRef="usd">98000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c3" decimals="-3" unitRef="usd">314000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LiabilitiesNoncurrent contextRef="c2" decimals="-3" unitRef="usd">2314000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="c3" decimals="-3" unitRef="usd">4085000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c2" decimals="-3" unitRef="usd">2954000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c3" decimals="-3" unitRef="usd">6159000</us-gaap:Liabilities>
    <us-gaap:CommonStockSharesAuthorized contextRef="c2" decimals="INF" unitRef="shares">43567567</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">4356757</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c2" decimals="INF" unitRef="shares">8074217</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c2" decimals="INF" unitRef="shares">8074217</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c3" decimals="INF" unitRef="shares">2893125</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c3" decimals="INF" unitRef="shares">2893125</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital contextRef="c2" decimals="-3" unitRef="usd">16499000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c3" decimals="-3" unitRef="usd">2730000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="-3" unitRef="usd">-3678000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c3" decimals="-3" unitRef="usd">-1477000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" unitRef="usd">12821000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-3" unitRef="usd">1253000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c2" decimals="-3" unitRef="usd">15775000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c3" decimals="-3" unitRef="usd">7412000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c0" decimals="-3" unitRef="usd">5859000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c4" decimals="-3" unitRef="usd">6509000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c5" decimals="-3" unitRef="usd">2289000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c0" decimals="-3" unitRef="usd">5060000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c4" decimals="-3" unitRef="usd">4560000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c5" decimals="-3" unitRef="usd">1165000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c0" decimals="-3" unitRef="usd">799000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c4" decimals="-3" unitRef="usd">1949000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c5" decimals="-3" unitRef="usd">1124000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense contextRef="c0" decimals="-3" unitRef="usd">1198000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c4" decimals="-3" unitRef="usd">1314000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c5" decimals="-3" unitRef="usd">376000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c0" decimals="-3" unitRef="usd">4113000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c4" decimals="-3" unitRef="usd">1480000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c5" decimals="-3" unitRef="usd">328000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense contextRef="c4" decimals="-3" unitRef="usd">87000</us-gaap:OtherSellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-4512000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c4" decimals="-3" unitRef="usd">-932000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c5" decimals="-3" unitRef="usd">420000</us-gaap:OperatingIncomeLoss>
    <jfbr:FinancialincomeExpensesNet contextRef="c0" decimals="-3" unitRef="usd">2305000</jfbr:FinancialincomeExpensesNet>
    <jfbr:FinancialincomeExpensesNet contextRef="c4" decimals="-3" unitRef="usd">-629000</jfbr:FinancialincomeExpensesNet>
    <jfbr:FinancialincomeExpensesNet contextRef="c5" decimals="-3" unitRef="usd">-232000</jfbr:FinancialincomeExpensesNet>
    <us-gaap:IncomeLossAttributableToParent contextRef="c0" decimals="-3" unitRef="usd">-2207000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent contextRef="c4" decimals="-3" unitRef="usd">-1561000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent contextRef="c5" decimals="-3" unitRef="usd">188000</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-3" unitRef="usd">-6000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c4" decimals="-3" unitRef="usd">-21000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c5" decimals="-3" unitRef="usd">76000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-2201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c4" decimals="-3" unitRef="usd">-1540000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="-3" unitRef="usd">112000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic contextRef="c0" decimals="2" unitRef="usdPershares">-0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c4" decimals="2" unitRef="usdPershares">-0.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="c5" decimals="2" unitRef="usdPershares">0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c0" decimals="INF" unitRef="shares">4643879</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c4" decimals="INF" unitRef="shares">2892347</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c5" decimals="INF" unitRef="shares">2888768</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:SharesOutstanding contextRef="c6" decimals="INF" unitRef="shares">2893125</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c7" decimals="-3" unitRef="usd">232000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c8" decimals="-3" unitRef="usd">-49000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c9" decimals="-3" unitRef="usd">183000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c10" decimals="-3" unitRef="usd">112000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="-3" unitRef="usd">112000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c12" decimals="-3" unitRef="usd">55000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c5" decimals="-3" unitRef="usd">55000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:SharesOutstanding contextRef="c13" decimals="INF" unitRef="shares">2893125</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c14" decimals="-3" unitRef="usd">287000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c15" decimals="-3" unitRef="usd">63000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c16" decimals="-3" unitRef="usd">350000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c19" decimals="-3" unitRef="usd">-1540000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c4" decimals="-3" unitRef="usd">-1540000</us-gaap:NetIncomeLoss>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c18" decimals="-3" unitRef="usd">75000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c4" decimals="-3" unitRef="usd">75000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c18" decimals="-3" unitRef="usd">1250000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c4" decimals="-3" unitRef="usd">1250000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c18" decimals="-3" unitRef="usd">60000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c4" decimals="-3" unitRef="usd">60000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c18" decimals="-3" unitRef="usd">1058000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c4" decimals="-3" unitRef="usd">1058000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:SharesOutstanding contextRef="c20" decimals="INF" unitRef="shares">2893125</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c21" decimals="-3" unitRef="usd">2730000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="-3" unitRef="usd">-1477000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c3" decimals="-3" unitRef="usd">1253000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c25" decimals="-3" unitRef="usd">-2201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-2201000</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium contextRef="c24" decimals="-3" unitRef="usd">769000</us-gaap:AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium contextRef="c0" decimals="-3" unitRef="usd">769000</us-gaap:AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium>
    <jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares contextRef="c23" decimals="INF" unitRef="shares">3717473</jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares>
    <jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts contextRef="c24" decimals="-3" unitRef="usd">6194000</jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts>
    <jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts contextRef="c0" decimals="-3" unitRef="usd">6194000</jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c24" decimals="-3" unitRef="usd">26000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c0" decimals="-3" unitRef="usd">26000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c23" decimals="INF" unitRef="shares">1463619</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c24" decimals="-3" unitRef="usd">3461000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits contextRef="c0" decimals="-3" unitRef="usd">3461000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="c24" decimals="-3" unitRef="usd">3319000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="c0" decimals="-3" unitRef="usd">3319000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:SharesOutstanding contextRef="c26" decimals="INF" unitRef="shares">8074217</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c27" decimals="-3" unitRef="usd">16499000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c28" decimals="-3" unitRef="usd">-3678000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c2" decimals="-3" unitRef="usd">12821000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-2201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c4" decimals="-3" unitRef="usd">-1540000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="-3" unitRef="usd">112000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation contextRef="c4" decimals="-3" unitRef="usd">60000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c0" decimals="-3" unitRef="usd">570000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c4" decimals="-3" unitRef="usd">524000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c5" decimals="-3" unitRef="usd">104000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c4" decimals="-3" unitRef="usd">87000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:OtherDepreciationAndAmortization contextRef="c0" decimals="-3" unitRef="usd">95000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization contextRef="c4" decimals="-3" unitRef="usd">222000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c4" decimals="-3" unitRef="usd">14000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c0" decimals="-3" unitRef="usd">-2822000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c4" decimals="-3" unitRef="usd">75000</us-gaap:FairValueAdjustmentOfWarrants>
    <jfbr:AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans contextRef="c0" decimals="-3" unitRef="usd">203000</jfbr:AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans>
    <jfbr:AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans contextRef="c4" decimals="-3" unitRef="usd">324000</jfbr:AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans>
    <jfbr:AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans contextRef="c5" decimals="-3" unitRef="usd">162000</jfbr:AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans>
    <us-gaap:ShortTermLeasePayments contextRef="c0" decimals="-3" unitRef="usd">25000</us-gaap:ShortTermLeasePayments>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c0" decimals="-3" unitRef="usd">-15000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c4" decimals="-3" unitRef="usd">-115000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c5" decimals="-3" unitRef="usd">-50000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c0" decimals="-3" unitRef="usd">14000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <jfbr:IssuanceCostsOnDerivativeLiabilities contextRef="c0" decimals="-3" unitRef="usd">1416000</jfbr:IssuanceCostsOnDerivativeLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c0" decimals="-3" unitRef="usd">-39000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c4" decimals="-3" unitRef="usd">282000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c5" decimals="-3" unitRef="usd">-43000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties contextRef="c4" decimals="-3" unitRef="usd">40000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties contextRef="c5" decimals="-3" unitRef="usd">-40000</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c0" decimals="-3" unitRef="usd">743000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c4" decimals="-3" unitRef="usd">290000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="c5" decimals="-3" unitRef="usd">-96000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c0" decimals="-3" unitRef="usd">564000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c4" decimals="-3" unitRef="usd">449000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c5" decimals="-3" unitRef="usd">638000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent contextRef="c0" decimals="-3" unitRef="usd">-213000</us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent contextRef="c4" decimals="-3" unitRef="usd">241000</us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent contextRef="c5" decimals="-3" unitRef="usd">14000</us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c0" decimals="-3" unitRef="usd">-579000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c4" decimals="-3" unitRef="usd">254000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities contextRef="c5" decimals="-3" unitRef="usd">323000</us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c0" decimals="-3" unitRef="usd">-15000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" unitRef="usd">-4840000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c4" decimals="-3" unitRef="usd">-863000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c5" decimals="-3" unitRef="usd">126000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" unitRef="usd">41000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c4" decimals="-3" unitRef="usd">2000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c5" decimals="-3" unitRef="usd">1000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c4" decimals="-3" unitRef="usd">4728000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="c5" decimals="-3" unitRef="usd">100000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" unitRef="usd">-41000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c4" decimals="-3" unitRef="usd">-4730000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c5" decimals="-3" unitRef="usd">-101000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromOtherShortTermDebt contextRef="c0" decimals="-3" unitRef="usd">752000</us-gaap:ProceedsFromOtherShortTermDebt>
    <us-gaap:ProceedsFromOtherShortTermDebt contextRef="c4" decimals="-3" unitRef="usd">981000</us-gaap:ProceedsFromOtherShortTermDebt>
    <us-gaap:RepaymentsOfOtherShortTermDebt contextRef="c0" decimals="-3" unitRef="usd">1518000</us-gaap:RepaymentsOfOtherShortTermDebt>
    <us-gaap:RepaymentsOfOtherShortTermDebt contextRef="c4" decimals="-3" unitRef="usd">134000</us-gaap:RepaymentsOfOtherShortTermDebt>
    <us-gaap:RepaymentsOfOtherShortTermDebt contextRef="c5" decimals="-3" unitRef="usd">196000</us-gaap:RepaymentsOfOtherShortTermDebt>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c0" decimals="-3" unitRef="usd">13391000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromBankDebt contextRef="c4" decimals="-3" unitRef="usd">4800000</us-gaap:ProceedsFromBankDebt>
    <us-gaap:ProceedsFromBankDebt contextRef="c5" decimals="-3" unitRef="usd">250000</us-gaap:ProceedsFromBankDebt>
    <us-gaap:RepaymentsOfBankDebt contextRef="c4" decimals="-3" unitRef="usd">100000</us-gaap:RepaymentsOfBankDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="c4" decimals="-3" unitRef="usd">-1102000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="c5" decimals="-3" unitRef="usd">105000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c4" decimals="-3" unitRef="usd">1250000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" unitRef="usd">12625000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c4" decimals="-3" unitRef="usd">5695000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c5" decimals="-3" unitRef="usd">159000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="-3" unitRef="usd">7744000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c4" decimals="-3" unitRef="usd">102000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c5" decimals="-3" unitRef="usd">184000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" decimals="-3" unitRef="usd">393000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c16" decimals="-3" unitRef="usd">291000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c9" decimals="-3" unitRef="usd">107000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c2" decimals="-3" unitRef="usd">8137000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c3" decimals="-3" unitRef="usd">393000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c16" decimals="-3" unitRef="usd">291000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet contextRef="c0" decimals="-3" unitRef="usd">73000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c4" decimals="-3" unitRef="usd">116000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c5" decimals="-3" unitRef="usd">3000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet contextRef="c0" decimals="-3" unitRef="usd">477000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c4" decimals="-3" unitRef="usd">4000</us-gaap:InterestPaidNet>
    <jfbr:DeferredOfferingCostsIncludedInOtherPayables contextRef="c4" decimals="-3" unitRef="usd">86000</jfbr:DeferredOfferingCostsIncludedInOtherPayables>
    <jfbr:SharebasedCompensationIncludedInDeferredOfferingCosts contextRef="c4" decimals="-3" unitRef="usd">75000</jfbr:SharebasedCompensationIncludedInDeferredOfferingCosts>
    <jfbr:IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans contextRef="c0" decimals="-3" unitRef="usd">2839000</jfbr:IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans>
    <jfbr:SubstantialModificationOfShareholdersLoansRecordedInEquity contextRef="c0" decimals="-3" unitRef="usd">982000</jfbr:SubstantialModificationOfShareholdersLoansRecordedInEquity>
    <jfbr:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities contextRef="c0" decimals="-3" unitRef="usd">152000</jfbr:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities>
    <jfbr:GeneralInformationTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 1 &#x2014; GENERAL INFORMATION&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;General&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Jeffs&#x2019; Brands Ltd (the &#x201c;Company&#x201d; or &#x201c;Jeffs&#x2019;
Brands&#x201d;) was incorporated in Israel on March 7, 2021. As of the date of issuance of these financial statements the Company has five
wholly owned subsidiaries &#x2014; Smart Repair Pro (&#x201c;Smart Pro&#x201d;), purex Corp. (&#x201c;Purex&#x201d;), Top Rank Ltd. (&#x201c;Top
Rank&#x201d;), Jeffs&#x2019; Brands Holdings Inc. (&#x201c;Jeffs&#x2019; Brands Holdings&#x201d;) and Fort Products Ltd. (&#x201c;Fort&#x201d;),
and together with Smart Pro, Purex, Top Rank and Jeffs&#x2019; Brands Holdings, the &#x201c;Subsidiaries&#x201d;. The Company and the Subsidiaries
(&#x201c;Group&#x201d;) are engaged in the acquisition, improvement and operation of virtual stores (the &#x201c;Brands&#x201d;) mainly on
the Amazon.com (&#x201c;Amazon&#x201d;) website. Prior to consummation of the Stock Exchange and Plan of Restructuring Agreement (the &#x201c;SEA&#x201d;)
with Medigus Ltd., a publicly traded company incorporated under the laws of the State of Israel (&#x201c;Medigus&#x201d;), as described
below, all of the Company&#x2019;s operations were carried under Smart Pro and Purex. References to the Company hereinafter, unless the
context otherwise provides, include Jeffs&#x2019; Brands and the Subsidiaries on a consolidated basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Smart Pro, a private corporation founded
in the State of California, was established on December&#160;20, 2017, and commenced its operations in June&#160;2019. As of December&#160;31,
2022, Smart Pro operated four brands on the Amazon website.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Purex, a private corporation incorporated
in the State of California on April&#160;1, 2020, commenced its operations on that date. Purex was established for the purpose of purchasing
an online store. During 2022 Purex ceased its operation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In April&#160;2021, Top Rank Ltd.,
an Israeli company, was established as a wholly owned subsidiary of Jeffs&#x2019; Brands.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In February 23, 2023, Jeffs&#x2019;
Brands Holdings Inc., was established and registered in Delaware as a wholly owned subsidiary of Jeffs&#x2019; Brands.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On March 9, 2023, the Company purchased
all of the issued and outstanding share capital of Fort, a company incorporated under the laws of England and Wales. For additional information
see note 17.b.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On January&#160;4, 2021, Medigus Ltd.,
acquired 50.01% of Smart Pro and 50.03% of Purex pursuant to a share purchase agreement entered into in October&#160;2020. On May&#160;10,
2021, pursuant to the SEA, Medigus and Viki&#160;Hakmon, the shareholders of Smart Pro and Purex immediately prior to closing of the
SEA (the &#x201c;Previous Shareholders&#x201d;), contributed all of their equity interests in Smart Pro and Purex to Jeffs&#x2019; Brands
in exchange for ordinary shares of Jeffs&#x2019; Brands (the &#x201c;Contribution Transactions&#x201d;). As a result of the Contribution
Transactions, Jeffs&#x2019; Brands held all of the outstanding shares of Smart Pro and Purex. Additionally, immediately after the transaction,
Medigus held 50.03% of the outstanding ordinary shares of Jeffs&#x2019; Brands and Mr.&#160;Hakmon held the remaining 49.97% of the outstanding
ordinary shares, resulting in Jeffs&#x2019; Brands being wholly owned by the Previous Shareholders, at the same interest proportion as
held by the Previous Shareholders in Smart Pro and Purex prior to the Contribution Transactions. Mr.&#160;Hakmon&#x2019;s affiliates,
who were minority shareholders of Smart Pro and Purex, transferred all their holdings in Smart Pro and Purex to Mr.&#160;Hakmon, effective
immediately prior to the Contribution Transactions pursuant to a Share Transfer Deed dated May&#160;10, 2021.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As Smart Pro and Purex were owned solely by the Previous Shareholders
immediately prior to consummation of the Contribution Transactions and Jeffs&#x2019; Brands was owned solely by the Previous Shareholders
immediately thereafter, the Contribution Transactions was accounted for in a manner similar to a transaction between entities under common
control. Accordingly, the Contribution Transactions were retrospectively applied to the prior periods, such that the combined financial
information of Smart Pro and Purex is presented in these financial statements for periods prior to the SEA, with share and per share data
in these financial statements being retrospectively adjusted based on the equivalent number of ordinary shares of Jeffs&#x2019; Brands,
for the year ended December 31, 2020.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Initial public
                                            offering&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On August&#160;30, 2022, the Company
completed its initial public offering (&#x201c;IPO&#x201d;), In connection with the IPO, the Company sold 3,717,473 units at a public offering
price of $4.16 per unit, with each unit consisting of one of ordinary share, no par value per share (&#x201c;Ordinary Share&#x201d;), and
one warrant (&#x201c;IPO Warrant&#x201d;), to purchase one Ordinary Share, at an exercise price of $4.04 per Ordinary Share (and an exercise
price of $2.02 following the Exercise Price Adjustment, as defined below). Pursuant to the terms of the IPO Warrant, investors that purchased
and held at least 120,192 IPO Warrants on the 90th calendar day immediately following the issuance date of the IPO Warrants (each, a
&#x201c;Qualified Buyer&#x201d;), were entitled to additional warrants (&#x201c;Additional Warrants&#x201d;). Each Additional Warrant has
substantially the same terms as the As-Adjusted IPO Warrant (as defined below); provided, however, that the term of each Additional Warrant
is five (5) years from the issuance date and such Additional Warrant is not listed on any securities exchange. In addition, as long as
the Additional Warrants are outstanding, each holder of at least 120,192 IPO Warrants (each, a &#x201c;Qualified Holder&#x201d;) will receive
semi-annual payments based on the Group&#x2019;s revenues, dependent on the amount of the Additional Warrants outstanding.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Additionally, the Company issued warrants
to the underwriter to purchase up to 185,873 ordinary shares at an exercise price of $5.20 per Ordinary Share (&#x201c;Underwriter&#x2019;s
Warrants&#x201d;). The underwriter partially exercised its right to purchase an additional 425,912 warrants for total consideration of
$4 thousands. The Company received total net proceeds of $13.4&#160;million after deducting issuance costs of $2.1&#160;million.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On September 7, 2022, the Company&#x2019;s
volume weighted average stock price was less than the exercise floor of $4.04 for the IPO Warrants. Accordingly, and based on the contractual
terms of the IPO Warrants, effective after the closing of trading on November 28, 2022 (the 90th calendar day immediately following the
issuance date of the IPO Warrants), the IPO Warrants were adjusted (&#x201c;As-Adjusted IPO Warrants&#x201d;) pursuant to their terms,
including, but not limited to, to adjust the exercise price of the IPO Warrants to $2.02 (the &#x201c;Exercise Price Adjustment&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In addition, in connection with the
Exercise Price Adjustment, Additional Warrants were issued to each Qualified Buyer who continued to hold at least 120,192 IPO Warrants
as of November 28, 2022. Accordingly, the Company issued Additional Warrants to purchase up to 2,824,525 Ordinary Shares.As of December
31, 2022, the revenue payment to Qualified Holders was equal to approximately 2.3% of the Group&#x2019;s revenues for the period ended
December 31,2022.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In connection with the IPO, all loans
from shareholders then outstanding as of August 30, 2022 were converted into 1,463,619 ordinary shares. Additionally, all outstanding
loans from third-parties were repaid.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Ordinary Shares and IPO Warrants
trade on the Nasdaq under the symbol &#x201c;JFBR&#x201d; and &#x201c;JFBRW&#x201d;, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Bonus Shares
                                            and Reverse Share Split&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On February&#160;17, 2022, the Company&#x2019;s
Board of Directors approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments
for subsequent reverse share split) ordinary shares of the Company for each Ordinary Share issued and outstanding as of the close of
business on February&#160;17, 2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an
aggregate issuance by the Company as of such date of 6,630,547 (prior to adjustments for subsequent reverse share splits) Ordinary Shares.
Additionally, the Board approved an increase in the authorized share capital of the Company to 100,000,000 (43,567,567 after giving effect
to the two subsequent reverse share splits) ordinary shares.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On May&#160;3, 2022, the Company&#x2019;s
Board of Directors approved a 0.806-for-1&#160;reverse split of its issued and outstanding Ordinary Shares, effective as of May&#160;3,
2022, pursuant to which holders of the Company&#x2019;s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On June&#160;16, 2022, the Company&#x2019;s
Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June&#160;16, 2022,
pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85&#160;Ordinary Shares held as of such date.
The reverse stock split proportionally reduced the number of the Company&#x2019;s authorized share capital.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;All issued and outstanding Ordinary
Shares contained in these financial statements have been retroactively adjusted to reflect the bonus share issuance and the reverse share
splits for all periods presented, unless explicitly stated otherwise. (See note 12g).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -25.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Concentration
                                            risk&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group&#x2019;s activities are mainly
conducted through Amazon&#x2019;s commercial platform. Any material change, whether temporary or permanent, including changes in Amazon&#x2019;s
terms of use and/or its policies, may affect sales performance, and may have a material effect on the Group&#x2019;s financial position
and the results of its operations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In addition, the Group is engaged with
a small number of suppliers as part of the production process of its brands . Any material changes in the supply process, whether temporary
or permanent, may affect sales performance, and may have a material effect on the Group&#x2019;s financial position and the results of
its operations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Liquidity&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During the year ended December 31,
2022, the Group incurred a net loss of $&#160;2,201 thousands and cash flows used in operating activities were $&#160;4,840 thousand.
As of December 31, 2022, the Group had an accumulated deficit of approximately $3,678 thousand.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group has funded its operations
to date through the sale of its products, through equity financings, loans from shareholders and other third parties, and sale of its
Ordinary Shares and warrants. The Company intends to continue to finance its operating activities through the sale of products via its
Brands and through raising additional capital, as needed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As detailed above, the Company completed
its IPO for total net proceeds of approximately $13.4 million in August 2022.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;After the balance sheet date, the Company purchased Fort &#160;and
SciSparc Nutraceuticals Inc. (&#x201c;SciSparc U.S.&#x201d;) with proceeds from the IPO. Based on historical sales of Fort and SciSparc
Ltd. (&#x201c;SciSparc&#x201d;) brands and the ongoing revenues generated from previously purchased brands, management believes that expected
cash flows are sufficient to support the Group&#x2019;s current operations for more than 12&#160;months from the issuance date of these
consolidated financial statements.&lt;/p&gt;</jfbr:GeneralInformationTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c29" decimals="4" unitRef="pure">0.5001</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c30" decimals="4" unitRef="pure">0.5003</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction contextRef="c31" decimals="4" unitRef="pure">0.5003</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction contextRef="c32" decimals="4" unitRef="pure">0.4997</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c33" decimals="0" unitRef="shares">3717473</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="c34" decimals="2" unitRef="usdPershares">4.16</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c35" decimals="2" unitRef="usdPershares">4.04</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <jfbr:ExercisePriceAdjustment contextRef="c35" decimals="2" unitRef="usdPershares">2.02</jfbr:ExercisePriceAdjustment>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c35" decimals="0" unitRef="shares">120192</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c35">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <jfbr:ClassOfAdditionalWarrantOrRightOutstanding contextRef="c36" decimals="0" unitRef="shares">120192</jfbr:ClassOfAdditionalWarrantOrRightOutstanding>
    <jfbr:ClassOfAdditionalWarrantOrRightOutstanding contextRef="c37" decimals="0" unitRef="shares">185873</jfbr:ClassOfAdditionalWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c38" decimals="2" unitRef="usdPershares">5.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="c38" decimals="0" unitRef="shares">425912</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c38" decimals="-3" unitRef="usd">4000</us-gaap:WarrantsAndRightsOutstanding>
    <jfbr:NetProceedsOfWarrants contextRef="c37" decimals="-5" unitRef="usd">13400000</jfbr:NetProceedsOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c37" decimals="-5" unitRef="usd">2100000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c39" decimals="2" unitRef="usdPershares">4.04</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <jfbr:ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights contextRef="c40" decimals="2" unitRef="usdPershares">2.02</jfbr:ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c41" decimals="0" unitRef="shares">120192</us-gaap:ClassOfWarrantOrRightOutstanding>
    <jfbr:ClassOfAdditionalWarrantOrRightOutstanding contextRef="c23" decimals="0" unitRef="shares">2824525</jfbr:ClassOfAdditionalWarrantOrRightOutstanding>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="c2" decimals="3" unitRef="pure">0.023</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ConversionOfStockSharesConverted1 contextRef="c42" decimals="0" unitRef="shares">1463619</us-gaap:ConversionOfStockSharesConverted1>
    <jfbr:BonusSharesAndReverseShareSplitDescription contextRef="c43">the Company&#x2019;s
Board of Directors approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments
for subsequent reverse share split) ordinary shares of the Company for each Ordinary Share issued and outstanding as of the close of
business on February&#160;17, 2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an
aggregate issuance by the Company as of such date of 6,630,547 (prior to adjustments for subsequent reverse share splits) Ordinary Shares.
Additionally, the Board approved an increase in the authorized share capital of the Company to 100,000,000 (43,567,567 after giving effect
to the two subsequent reverse share splits) ordinary shares.</jfbr:BonusSharesAndReverseShareSplitDescription>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c44">the Company&#x2019;s
Board of Directors approved a 0.806-for-1&#160;reverse split of its issued and outstanding Ordinary Shares, effective as of May&#160;3,
2022, pursuant to which holders of the Company&#x2019;s Ordinary Shares received 0.806 of an Ordinary Share for every one Ordinary share.</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="c45">the Company&#x2019;s
Board of Directors approved a 1-for-1.85 reverse split of our issued and outstanding Ordinary Shares, effective as of June&#160;16, 2022,
pursuant to which holders of our Ordinary Shares received one Ordinary Share for every 1.85&#160;Ordinary Shares held as of such date.
The reverse stock split proportionally reduced the number of the Company&#x2019;s authorized share capital.</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" unitRef="usd">-2201000</us-gaap:NetIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" unitRef="usd">-4840000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c2" decimals="-3" unitRef="usd">-3678000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c0" decimals="-5" unitRef="usd">13400000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 2 &#x2014; SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basis of preparation of the financial statements&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group&#x2019;s consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S.
GAAP&#x201d;) and include the accounts of Jeffs&#x2019; Brands Ltd and its wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated in consolidation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Prior to 2022, the&#160;Group prepared
its financial statements in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting
Standards Board (IASB), as permitted in the United States based on the Company&#x2019;s qualification as a &#x201c;foreign private issuer&#x201d;
under the rules and regulations of the U.S Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Use of estimates&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The preparation of financial statements
in conformity with U.S.&#160;GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the
reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances,
fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent
liabilities, among others.&#160;Such estimates are based on&#160;historical experience and on various other assumptions that are believed
to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group&#x2019;s assets and
liabilities.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Functional and presentation currency&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The functional and reporting currency
of the Group is the United States dollar (&#x201c;U.S dollar&#x201d;) as the U.S. dollar is the currency of the primary economic environment
in which the Group has operated and expects to continue to operate in the foreseeable future.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group transactions and balances denominated in U.S. dollars are
presented at their original amounts. Non-U.S. dollar transactions and balances have been remeasured to U.S. dollars in accordance with
Accounting Standards Codification (&#x201c;ASC&#x201d;) 830, &#x201c;Foreign Currency Transaction&#x201d;. All transaction gains and losses
from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected in the statement of operations
as financial income or expenses foreign currency gain/loss, as appropriate.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Cash and cash equivalents&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Cash and cash equivalents include cash
in banks and short-term bank deposits (with original maturities of &lt;span style="-sec-ix-hidden: hidden-fact-79"&gt;three&lt;/span&gt;&#160;months or less) that are not restricted as to withdrawal
or use and are therefore considered to be cash equivalents.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Accounts receivable&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Accounts receivables are stated at realizable value, net of an allowance
for credit losses. The Group evaluates its outstanding accounts receivable and establishes an allowance for credit losses based on information
available on their credit condition, current aging, historical experience and future economic and market conditions. These allowances
are reevaluated and adjusted periodically as additional information is available. Payments are made by customers immediately at the point
of sale, therefore, no provision for credit losses has been recorded as of December 31, 2022 and 2021.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;f.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Inventories&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inventories are stated at the lower
of cost and or market based on net realizable value. Inventories are adjusted for estimated excess and obsolescence and written down
to net realizable value based upon estimates of future demand, technology developments, and market conditions. Cost is determined in
accordance with first-in, first-out Method (&#x201c;FIFO&#x201d;) and the cost of inventory includes shipment and freight costs.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;g.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Property and equipment&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property and equipment are stated at
historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition
of the items. Repairs and maintenance are charged to the statement of operations during the period in which they are incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The assets are depreciated using the
straight-line method to allocate their cost over their estimated useful lives, as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Computers equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 44%; text-align: center"&gt;33&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;Furniture&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Shorter of remaining lease term or estimated useful life&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;h.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Deferred offering costs&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company capitalized certain legal
and other third-party fees that were directly related to the Company&#x2019;s IPO. As of December 31, 2021, there were $366 thousands
of deferred offering costs included in other non-current assets on the balance sheet.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The total gross consideration from
the IPO was initially allocated to the derivative warrant liability based on its fair value and the remaining amount was allocated to
the Ordinary Shares issued and recognized as a component of equity. (refer to Note 12h below). Accordingly, issuance costs were allocated
between the warrant liability and Ordinary Shares based on their relative fair values.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;i.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In accordance with ASC 842, the Group
determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves
the use of a distinct identified asset, (2) whether the Group obtains the right to substantially all the economic benefits from the use
of the asset throughout the period, and (3) whether the Group has a right to direct the use of the asset. The Group elected the practical
expedient to not recognize a lease liability and a right-of-use (&#x201c;ROU&#x201d;) asset for leases with a term of twelve months or
less. The Group also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent
the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments
arising from the lease.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;ROU assets are initially measured at
amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred.
The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments
over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Group uses its Incremental
Borrowing Rate (&#x201c;IBR&#x201d;) based on the information available at commencement date in determining the present value of lease
payments. The Group&#x2019;s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments
and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;An option to extend the lease is considered
in connection with determining the ROU asset and lease liability when it is reasonably certain that the Group will exercise that option.
An option to terminate is considered unless it is reasonably certain that the Group will not exercise the option.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Operating lease expense is recognized
on a straight-line basis over the lease term.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;j.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Asset acquisition&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;The Group accounts for a transaction
as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable
asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs
are capitalized as part of the asset or assets acquired.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;k.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Intangible assets&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Group&#x2019;s intangible assets consist of its Brands. Intangible assets that are not considered to have an indefinite useful life are
amortized over their estimated useful lives. Each period the Group evaluates the estimated remaining useful lives of its intangible assets
and whether events or changes in circumstances warrant a revision to the remaining period of amortization.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The estimated useful lives of the Group&#x2019;s
intangible assets (Brands) are 10 years.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;l.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Impairment of long-lived assets&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group&#x2019;s long-lived&#160;assets
(assets group) to be held or used, including property and equipment, right of use assets and intangible assets subject to amortization
are reviewed for impairment in accordance with ASC 360, &#x201c;Accounting for the Impairment or Disposal of Long-Lived Assets&#x201d;,
whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The recoverability of
these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate.
If property and equipment, intangible assets or right of use assets are considered to be impaired, the impairment to be recognized equals
the amount by which the carrying value of the asset exceeds its fair market value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In determining the fair values of long-lived
assets for the purpose of measuring impairment, the Group&#x2019;s assumptions include those that market participants will consider in
valuations of similar assets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;m.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Loans from shareholders and related parties:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;On the borrowing date of loans received from shareholders or related
parties, the Group estimates the value of the benefit granted to it as the difference between the interest rate that the Group is required
to pay to investors for the loans provided by them and secured by such lien and the interest rate required to pay for similar unsecured
loans to non-related parties. The Group assesses changes to the term of loans with shareholders and related parties in accordance with
ASC 470, &#x201c;Debt&#x201d; (&#x201c;ASC 470&#x201d;), Subtopic 50&#x2014; &#x201c;Modifications and Extinguishments&#x201d; (&#x201c;ASC 470-50&#x201d;).
For transactions accounted for as debt extinguishment, the difference between the reacquisition price of the debt and the net carrying
amount of the extinguished debt is recorded as an in-essence capital transaction.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;n.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Income taxes&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group accounts for income taxes
in accordance with ASC 740, &#x201c;Income Taxes&#x201d;. ASC 740 prescribes the use of the liability method whereby deferred tax assets
and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities
and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Valuation
allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than
not to be realized. As of December 31, 2022 and 2021 a partial valuation allowance was recorded on the Group&#x2019;s deferred tax assets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group implements a two-step approach
to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax
return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical
merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second
step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate
settlement. As of December 31, 2022 and 2021, no liability for unrecognized tax positions has been recognized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;o.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Revenue recognition&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"&gt;The Group sells products
directly to customers mainly through its online Amazon stores.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Under the Group&#x2019;s standard contract
terms, customers have a right of return within 30 until 90 days. For contracts with rights of return, the Group recognizes revenue based
on the amount of the consideration which the Group expects to receive for products which are not expected to be returned and recognizes
a refund liability for the amount not expected to be received. At the end of each reporting period, the Group updates its estimates of
expected product returns and adjusts the refund liabilities with a corresponding adjustment in revenues. The Group recorded an allowance
for returns in the amounts of $35 thousand and $35 thousand as of December 31, 2022, and 2021, respectively. The allowance for returns
is recorded as decrease in revenues against other payables.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group evaluates the criteria outlined
in ASC 606-10-55, &#x201c;Principal versus Agent Considerations&#x201d;, in determining whether it is appropriate to record the gross amount
of product sales and related costs or the net amount earned as commissions. The Group evaluates whether it is appropriate to recognize
revenue on a gross or net basis based upon its evaluation of whether the Company obtains control of the specified goods by considering
if it is primarily responsible for fulfillment of the promise, has inventory risk, and has the latitude in establishing pricing and selecting
suppliers, among other factors. Based on its evaluation of these factors, management has determined that it is the principal in these
arrangements; therefore, sales are recorded on a gross basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;p.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Cost of sales&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In accordance with Amazon&#x2019;s terms
of use, the Group is obligated to pay to Amazon incremental costs, such as sales fulfillment commissions which are contingent on making
binding sales. Sales commissions would not have been incurred if the contract had not been obtained.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Cost of sales primarily consists of
expenses related to Amazon&#x2019;s commissions, storage costs and freight.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;q.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Advertising expenses&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt"&gt;The Group expenses
advertising costs as incurred. Advertising expenses, included within sales and marketing expenses, were $1,163 thousands, $1,211 thousands,
and $371 thousands for the years ended December 31, 2022, 2021 and 2020, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;r.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Employee benefits&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt"&gt;Pension
and severance pay obligations&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Groups employees are employed by Jeffs&#x2019;
Brands and subject to Israeli labor laws. Israeli labor law generally requires payment of severance pay upon dismissal of an employee
or upon termination of employment in certain other circumstances. Pursuant to Section&#160;14 of the Severance Compensation Act, 1963
(&#x201c;Section&#160;14&#x201d;), all of the Group&#x2019;s employees in Israel are entitled to a monthly contribution, at a rate of 8.33%
of their monthly salary, made in their name with insurance companies. Contributions under Section&#160;14 relieve the Group from any future
severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Group&#x2019;s
balance sheet, and there is no liability recorded as the Group does not have a future obligation to make any additional payments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;s.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Fair value measurement&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group applies ASC 820, &#x201c;Fair
Value Measurements and Disclosures&#x201d; (&#x201c;ASC 820&#x201d;). Under this standard, fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability (i.e., the &#x201c;exit price&#x201d;) in an orderly transaction between market
participants at the measurement date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In determining fair value, the Group
uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable
inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs
are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent
from the Group. Unobservable inputs are inputs that reflect the Group&#x2019;s assumptions about the assumptions market participants would
use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken
down into three levels based on the inputs as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Level 1 - Valuations based on quoted
prices in active markets for identical assets that the Group has the ability to access. Valuation adjustments and block discounts are
not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active
market, valuation of these products does not entail a significant degree of judgment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Level 2 - Valuations based on one or
more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Level 3 - Valuations based on inputs
that are unobservable and significant to the overall fair value measurement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The carrying amounts of cash and cash equivalents, trade receivables,
other receivable, trade payables, other accounts payable and accrued expenses and payables to related parties approximate their fair value
due to the short-term maturity of such instruments. The Group&#x2019;s derivative liabilities in respect of Additional Warrants are classified
within Level 3 of the fair value hierarchy because their fair values are estimated by utilizing valuation models and significant unobservable
inputs. For more details, see Note 9.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;t.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group accounts for warrants as either
equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s specific terms and applicable authoritative
guidance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The assessment considers whether the
warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, &#x201c;Distinguishing Liabilities and
Equity&#x201d;, are indexed to the Group&#x2019;s own stock and whether the warrants are eligible for equity classification under ASC 815
(&#x201c;ASC 815&#x201d;), &#x201c;Derivatives and Hedging&#x201d;, Subtopic 40 &#x201c;Contracts in Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASC
815-40&#x201d;). This assessment is conducted at the time of warrant issuance and as of each subsequent reporting period end date while
the warrants are outstanding.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Warrants that meet all the criteria for
equity classification, are recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity
classification, are recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value through earnings
at each balance sheet date thereafter.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;u.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Legal and other contingencies&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group accounts for its contingent
liabilities in accordance with ASC 450, &#x201c;Contingencies&#x201d;. A provision is recorded when it is both probable that a liability
has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, the Group reviews the status
of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable
and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Legal costs incurred in connection with
loss contingencies are expensed as incurred. As of December 31, 2022, and 2021, the Group is not a party to any litigation that could
have a material adverse effect on the Group&#x2019;s business, financial position, results of operations or cash flows.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;v.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basic and diluted net loss per share.&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group calculates basic net profit
(loss) per share by dividing the net profit (loss) by the weighted-average number of Ordinary Shares outstanding during the period. Diluted
net loss per share is computed by giving effect to all potentially dilutive Ordinary Share equivalents outstanding for the period. All
outstanding share options and warrants for the years ended December 31, 2022 and 2021 have been excluded from the calculation of the diluted
net loss per share since all such securities were anti-dilutive. For the year ended December 31, 2020 there were no Ordinary Share equivalents
outstanding.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;w.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Recently adopted and recently issued accounting pronouncements.&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In May 2021, the FASB issued ASU No.
2021-04 to ASC 260, ASC 470-50, ASC 718 &#x201c;Compensation&#x2014;Stock Compensation&#x201d;, and ASC 815: &#x201c;Issuer&#x2019;s counting
for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#x201d;. The amendments in ASU No. 2021-
modification or exchange. The amendments in this ASU No. 2021-04 were effective for after the Company beginning on January 1, 2022. The
adoption of the standard did not have material effect on Group&#x2019;s results.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basis of preparation of the financial statements&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group&#x2019;s consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S.
GAAP&#x201d;) and include the accounts of Jeffs&#x2019; Brands Ltd and its wholly owned subsidiaries. All intercompany balances and transactions
have been eliminated in consolidation.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Prior to 2022, the&#160;Group prepared
its financial statements in accordance with International Financial Reporting Standards (IFRS), as issued by the International Accounting
Standards Board (IASB), as permitted in the United States based on the Company&#x2019;s qualification as a &#x201c;foreign private issuer&#x201d;
under the rules and regulations of the U.S Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Use of estimates&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The preparation of financial statements
in conformity with U.S.&#160;GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of
assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the
reporting periods and accompanying notes. The Group evaluates on an ongoing basis its assumptions including those related to sales allowances,
fair value of intangible assets, useful lives of intangible assets, realizability of deferred tax assets, derivative liability and contingent
liabilities, among others.&#160;Such estimates are based on&#160;historical experience and on various other assumptions that are believed
to be reasonable, the results of which form the basis for making judgments about the carrying values of the Group&#x2019;s assets and
liabilities.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Functional and presentation currency&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The functional and reporting currency
of the Group is the United States dollar (&#x201c;U.S dollar&#x201d;) as the U.S. dollar is the currency of the primary economic environment
in which the Group has operated and expects to continue to operate in the foreseeable future.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group transactions and balances denominated in U.S. dollars are
presented at their original amounts. Non-U.S. dollar transactions and balances have been remeasured to U.S. dollars in accordance with
Accounting Standards Codification (&#x201c;ASC&#x201d;) 830, &#x201c;Foreign Currency Transaction&#x201d;. All transaction gains and losses
from remeasurement of monetary balance sheet items denominated in non-U.S. dollar currencies are reflected in the statement of operations
as financial income or expenses foreign currency gain/loss, as appropriate.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Cash and cash equivalents&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Cash and cash equivalents include cash
in banks and short-term bank deposits (with original maturities of &lt;span style="-sec-ix-hidden: hidden-fact-79"&gt;three&lt;/span&gt;&#160;months or less) that are not restricted as to withdrawal
or use and are therefore considered to be cash equivalents.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Accounts receivable&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Accounts receivables are stated at realizable value, net of an allowance
for credit losses. The Group evaluates its outstanding accounts receivable and establishes an allowance for credit losses based on information
available on their credit condition, current aging, historical experience and future economic and market conditions. These allowances
are reevaluated and adjusted periodically as additional information is available. Payments are made by customers immediately at the point
of sale, therefore, no provision for credit losses has been recorded as of December 31, 2022 and 2021.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;f.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Inventories&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Inventories are stated at the lower
of cost and or market based on net realizable value. Inventories are adjusted for estimated excess and obsolescence and written down
to net realizable value based upon estimates of future demand, technology developments, and market conditions. Cost is determined in
accordance with first-in, first-out Method (&#x201c;FIFO&#x201d;) and the cost of inventory includes shipment and freight costs.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;g.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Property and equipment&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Property and equipment are stated at
historical cost less accumulated depreciation. Historical cost includes expenditures that are directly attributable to the acquisition
of the items. Repairs and maintenance are charged to the statement of operations during the period in which they are incurred.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The assets are depreciated using the
straight-line method to allocate their cost over their estimated useful lives, as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Computers equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 44%; text-align: center"&gt;33&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;Furniture&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Shorter of remaining lease term or estimated useful life&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 55%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Computers equipment&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 44%; text-align: center"&gt;33&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;Furniture&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;7&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="vertical-align: top; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Leasehold improvements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;Shorter of remaining lease term or estimated useful life&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c46" decimals="2" unitRef="pure">0.33</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage contextRef="c47" decimals="2" unitRef="pure">0.07</us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives contextRef="c48">Shorter of remaining lease term or estimated useful life</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;h.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Deferred offering costs&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company capitalized certain legal
and other third-party fees that were directly related to the Company&#x2019;s IPO. As of December 31, 2021, there were $366 thousands
of deferred offering costs included in other non-current assets on the balance sheet.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The total gross consideration from
the IPO was initially allocated to the derivative warrant liability based on its fair value and the remaining amount was allocated to
the Ordinary Shares issued and recognized as a component of equity. (refer to Note 12h below). Accordingly, issuance costs were allocated
between the warrant liability and Ordinary Shares based on their relative fair values.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts contextRef="c2" decimals="-3" unitRef="usd">366000</us-gaap:DeferredOfferingCosts>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;i.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In accordance with ASC 842, the Group
determines if an arrangement is a lease and the classification of that lease at inception based on: (1) whether the contract involves
the use of a distinct identified asset, (2) whether the Group obtains the right to substantially all the economic benefits from the use
of the asset throughout the period, and (3) whether the Group has a right to direct the use of the asset. The Group elected the practical
expedient to not recognize a lease liability and a right-of-use (&#x201c;ROU&#x201d;) asset for leases with a term of twelve months or
less. The Group also elected the practical expedient to not separate lease and non-lease components for its leases. ROU assets represent
the right to use an underlying asset for the lease term and lease liabilities represent the obligation to make minimum lease payments
arising from the lease.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;ROU assets are initially measured at
amounts, which represents the discounted present value of the lease payments over the lease, plus any initial direct costs incurred.
The lease liability is initially measured at lease commencement date based on the discounted present value of minimum lease payments
over the lease term. The implicit rate within the operating leases is generally not determinable, therefore the Group uses its Incremental
Borrowing Rate (&#x201c;IBR&#x201d;) based on the information available at commencement date in determining the present value of lease
payments. The Group&#x2019;s IBR is estimated to approximate the interest rate for collateralized borrowing with similar terms and payments
and in economic environments where the leased asset is located. Certain leases include options to extend or terminate the lease.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;An option to extend the lease is considered
in connection with determining the ROU asset and lease liability when it is reasonably certain that the Group will exercise that option.
An option to terminate is considered unless it is reasonably certain that the Group will not exercise the option.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Operating lease expense is recognized
on a straight-line basis over the lease term.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c2">P12M</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:RevenueRecognitionCustomerAcquisitions contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;j.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Asset acquisition&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;The Group accounts for a transaction
as an asset acquisition when substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable
asset or group of similar identifiable assets, or otherwise does not meet the definition of a business. Asset acquisition-related costs
are capitalized as part of the asset or assets acquired.&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:RevenueRecognitionCustomerAcquisitions>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;k.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Intangible assets&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
Group&#x2019;s intangible assets consist of its Brands. Intangible assets that are not considered to have an indefinite useful life are
amortized over their estimated useful lives. Each period the Group evaluates the estimated remaining useful lives of its intangible assets
and whether events or changes in circumstances warrant a revision to the remaining period of amortization.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The estimated useful lives of the Group&#x2019;s
intangible assets (Brands) are 10 years.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c0">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;l.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Impairment of long-lived assets&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group&#x2019;s long-lived&#160;assets
(assets group) to be held or used, including property and equipment, right of use assets and intangible assets subject to amortization
are reviewed for impairment in accordance with ASC 360, &#x201c;Accounting for the Impairment or Disposal of Long-Lived Assets&#x201d;,
whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. The recoverability of
these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate.
If property and equipment, intangible assets or right of use assets are considered to be impaired, the impairment to be recognized equals
the amount by which the carrying value of the asset exceeds its fair market value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In determining the fair values of long-lived
assets for the purpose of measuring impairment, the Group&#x2019;s assumptions include those that market participants will consider in
valuations of similar assets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PolicyLoansReceivablePolicy contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;m.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Loans from shareholders and related parties:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;On the borrowing date of loans received from shareholders or related
parties, the Group estimates the value of the benefit granted to it as the difference between the interest rate that the Group is required
to pay to investors for the loans provided by them and secured by such lien and the interest rate required to pay for similar unsecured
loans to non-related parties. The Group assesses changes to the term of loans with shareholders and related parties in accordance with
ASC 470, &#x201c;Debt&#x201d; (&#x201c;ASC 470&#x201d;), Subtopic 50&#x2014; &#x201c;Modifications and Extinguishments&#x201d; (&#x201c;ASC 470-50&#x201d;).
For transactions accounted for as debt extinguishment, the difference between the reacquisition price of the debt and the net carrying
amount of the extinguished debt is recorded as an in-essence capital transaction.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:PolicyLoansReceivablePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;n.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Income taxes&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group accounts for income taxes
in accordance with ASC 740, &#x201c;Income Taxes&#x201d;. ASC 740 prescribes the use of the liability method whereby deferred tax assets
and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities
and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Valuation
allowances in respect of deferred tax assets are provided for, if necessary, to reduce deferred tax assets to amounts more likely than
not to be realized. As of December 31, 2022 and 2021 a partial valuation allowance was recorded on the Group&#x2019;s deferred tax assets.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group implements a two-step approach
to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax
return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical
merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second
step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate
settlement. As of December 31, 2022 and 2021, no liability for unrecognized tax positions has been recognized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent contextRef="c0" decimals="2" unitRef="pure">0.50</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;o.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Revenue recognition&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"&gt;The Group sells products
directly to customers mainly through its online Amazon stores.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Under the Group&#x2019;s standard contract
terms, customers have a right of return within 30 until 90 days. For contracts with rights of return, the Group recognizes revenue based
on the amount of the consideration which the Group expects to receive for products which are not expected to be returned and recognizes
a refund liability for the amount not expected to be received. At the end of each reporting period, the Group updates its estimates of
expected product returns and adjusts the refund liabilities with a corresponding adjustment in revenues. The Group recorded an allowance
for returns in the amounts of $35 thousand and $35 thousand as of December 31, 2022, and 2021, respectively. The allowance for returns
is recorded as decrease in revenues against other payables.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group evaluates the criteria outlined
in ASC 606-10-55, &#x201c;Principal versus Agent Considerations&#x201d;, in determining whether it is appropriate to record the gross amount
of product sales and related costs or the net amount earned as commissions. The Group evaluates whether it is appropriate to recognize
revenue on a gross or net basis based upon its evaluation of whether the Company obtains control of the specified goods by considering
if it is primarily responsible for fulfillment of the promise, has inventory risk, and has the latitude in establishing pricing and selecting
suppliers, among other factors. Based on its evaluation of these factors, management has determined that it is the principal in these
arrangements; therefore, sales are recorded on a gross basis.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c2" decimals="-3" unitRef="usd">35000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c3" decimals="-3" unitRef="usd">35000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;p.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Cost of sales&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In accordance with Amazon&#x2019;s terms
of use, the Group is obligated to pay to Amazon incremental costs, such as sales fulfillment commissions which are contingent on making
binding sales. Sales commissions would not have been incurred if the contract had not been obtained.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Cost of sales primarily consists of
expenses related to Amazon&#x2019;s commissions, storage costs and freight.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;q.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Advertising expenses&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt"&gt;The Group expenses
advertising costs as incurred. Advertising expenses, included within sales and marketing expenses, were $1,163 thousands, $1,211 thousands,
and $371 thousands for the years ended December 31, 2022, 2021 and 2020, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:OtherSellingAndMarketingExpense contextRef="c0" decimals="-3" unitRef="usd">1163000</us-gaap:OtherSellingAndMarketingExpense>
    <us-gaap:OtherSellingAndMarketingExpense contextRef="c4" decimals="-3" unitRef="usd">1211000</us-gaap:OtherSellingAndMarketingExpense>
    <us-gaap:OtherSellingAndMarketingExpense contextRef="c5" decimals="-3" unitRef="usd">371000</us-gaap:OtherSellingAndMarketingExpense>
    <us-gaap:EmployeeStockOwnershipPlanESOPPolicy contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;r.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Employee benefits&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0pt"&gt;Pension
and severance pay obligations&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Groups employees are employed by Jeffs&#x2019;
Brands and subject to Israeli labor laws. Israeli labor law generally requires payment of severance pay upon dismissal of an employee
or upon termination of employment in certain other circumstances. Pursuant to Section&#160;14 of the Severance Compensation Act, 1963
(&#x201c;Section&#160;14&#x201d;), all of the Group&#x2019;s employees in Israel are entitled to a monthly contribution, at a rate of 8.33%
of their monthly salary, made in their name with insurance companies. Contributions under Section&#160;14 relieve the Group from any future
severance payment obligation with respect to those employees. The aforementioned contributions are not recorded as an asset on the Group&#x2019;s
balance sheet, and there is no liability recorded as the Group does not have a future obligation to make any additional payments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:EmployeeStockOwnershipPlanESOPPolicy>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch contextRef="c0" decimals="4" unitRef="pure">0.0833</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;s.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Fair value measurement&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group applies ASC 820, &#x201c;Fair
Value Measurements and Disclosures&#x201d; (&#x201c;ASC 820&#x201d;). Under this standard, fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability (i.e., the &#x201c;exit price&#x201d;) in an orderly transaction between market
participants at the measurement date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In determining fair value, the Group
uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable
inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs
are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent
from the Group. Unobservable inputs are inputs that reflect the Group&#x2019;s assumptions about the assumptions market participants would
use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken
down into three levels based on the inputs as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Level 1 - Valuations based on quoted
prices in active markets for identical assets that the Group has the ability to access. Valuation adjustments and block discounts are
not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active
market, valuation of these products does not entail a significant degree of judgment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Level 2 - Valuations based on one or
more quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Level 3 - Valuations based on inputs
that are unobservable and significant to the overall fair value measurement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The carrying amounts of cash and cash equivalents, trade receivables,
other receivable, trade payables, other accounts payable and accrued expenses and payables to related parties approximate their fair value
due to the short-term maturity of such instruments. The Group&#x2019;s derivative liabilities in respect of Additional Warrants are classified
within Level 3 of the fair value hierarchy because their fair values are estimated by utilizing valuation models and significant unobservable
inputs. For more details, see Note 9.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;t.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group accounts for warrants as either
equity-classified or liability-classified instruments based on an assessment of the warrant&#x2019;s specific terms and applicable authoritative
guidance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The assessment considers whether the
warrants are freestanding financial instruments, meet the definition of a liability under ASC 480, &#x201c;Distinguishing Liabilities and
Equity&#x201d;, are indexed to the Group&#x2019;s own stock and whether the warrants are eligible for equity classification under ASC 815
(&#x201c;ASC 815&#x201d;), &#x201c;Derivatives and Hedging&#x201d;, Subtopic 40 &#x201c;Contracts in Entity&#x2019;s Own Equity&#x201d; (&#x201c;ASC
815-40&#x201d;). This assessment is conducted at the time of warrant issuance and as of each subsequent reporting period end date while
the warrants are outstanding.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Warrants that meet all the criteria for
equity classification, are recorded as a component of additional paid-in capital. Warrants that do not meet all the criteria for equity
classification, are recorded as liabilities at their initial fair value on the date of issuance and remeasured to fair value through earnings
at each balance sheet date thereafter.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;u.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Legal and other contingencies&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group accounts for its contingent
liabilities in accordance with ASC 450, &#x201c;Contingencies&#x201d;. A provision is recorded when it is both probable that a liability
has been incurred and the amount of the loss can be reasonably estimated. With respect to legal matters, the Group reviews the status
of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable
and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Legal costs incurred in connection with
loss contingencies are expensed as incurred. As of December 31, 2022, and 2021, the Group is not a party to any litigation that could
have a material adverse effect on the Group&#x2019;s business, financial position, results of operations or cash flows.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;v.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Basic and diluted net loss per share.&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Group calculates basic net profit
(loss) per share by dividing the net profit (loss) by the weighted-average number of Ordinary Shares outstanding during the period. Diluted
net loss per share is computed by giving effect to all potentially dilutive Ordinary Share equivalents outstanding for the period. All
outstanding share options and warrants for the years ended December 31, 2022 and 2021 have been excluded from the calculation of the diluted
net loss per share since all such securities were anti-dilutive. For the year ended December 31, 2020 there were no Ordinary Share equivalents
outstanding.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;w.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Recently adopted and recently issued accounting pronouncements.&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In May 2021, the FASB issued ASU No.
2021-04 to ASC 260, ASC 470-50, ASC 718 &#x201c;Compensation&#x2014;Stock Compensation&#x201d;, and ASC 815: &#x201c;Issuer&#x2019;s counting
for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options&#x201d;. The amendments in ASU No. 2021-
modification or exchange. The amendments in this ASU No. 2021-04 were effective for after the Company beginning on January 1, 2022. The
adoption of the standard did not have material effect on Group&#x2019;s results.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 3 &#x2014; OTHER RECEIVABLES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Advances to suppliers&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;641&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-80"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Government institutions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other receivables&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;779&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;36&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(*) Includes $228 thousand to Pure Capital. See
Note 16 for additional information.&lt;/p&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Advances to suppliers&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;641&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-80"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Government institutions&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;130&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;35&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other receivables&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;8&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;779&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;36&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(*) Includes $228 thousand to Pure Capital. See
Note 16 for additional information.&lt;/p&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:Supplies contextRef="c2" decimals="-3" id="ix_0_fact" unitRef="usd">641000</us-gaap:Supplies>
    <us-gaap:GovernmentContractReceivable contextRef="c2" decimals="-3" unitRef="usd">130000</us-gaap:GovernmentContractReceivable>
    <us-gaap:GovernmentContractReceivable contextRef="c3" decimals="-3" unitRef="usd">35000</us-gaap:GovernmentContractReceivable>
    <us-gaap:OtherReceivables contextRef="c2" decimals="-3" unitRef="usd">8000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables contextRef="c3" decimals="-3" unitRef="usd">1000</us-gaap:OtherReceivables>
    <us-gaap:PremiumsAndOtherReceivablesNet contextRef="c2" decimals="-3" unitRef="usd">779000</us-gaap:PremiumsAndOtherReceivablesNet>
    <us-gaap:PremiumsAndOtherReceivablesNet contextRef="c3" decimals="-3" unitRef="usd">36000</us-gaap:PremiumsAndOtherReceivablesNet>
    <us-gaap:OtherAdditionalCapital contextRef="c2" decimals="-3" unitRef="usd">228000</us-gaap:OtherAdditionalCapital>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 4 &#x2014; INVENTORY&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Goods in transit&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;161&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,783&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,066&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,791&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,227&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;Goods in transit&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;8&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;161&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"&gt;Finished goods&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,783&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,066&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,791&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,227&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventoryInTransit contextRef="c2" decimals="-3" unitRef="usd">8000</us-gaap:OtherInventoryInTransit>
    <us-gaap:OtherInventoryInTransit contextRef="c3" decimals="-3" unitRef="usd">161000</us-gaap:OtherInventoryInTransit>
    <us-gaap:InventoryFinishedGoods contextRef="c2" decimals="-3" unitRef="usd">1783000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="c3" decimals="-3" unitRef="usd">1066000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryGross contextRef="c2" decimals="-3" unitRef="usd">1791000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross contextRef="c3" decimals="-3" unitRef="usd">1227000</us-gaap:InventoryGross>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 5 &#x2014; INTANGIBLE ASSETS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Total intangible assets consisted of
the following as of December&#160;31, 2022 and 2021:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31, 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Gross Amount&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Accumulated Amortization&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Net Balance&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;&lt;b&gt;U.S.&#160;dollars in thousands&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; width: 64%; text-align: left"&gt;Brands&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;5,783&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(1,331&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;4,452&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31, 2021&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Gross Amount&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Accumulated Amortization&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Net Balance&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;&lt;b&gt;U.S.&#160;dollars in thousands&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; width: 64%; text-align: left"&gt;Brands&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;5,783&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(762&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Amortization expense was $570 thousand,
$524 thousand, and $104 thousand, for the years ended December 31, 2022, 2021, and 2020, respectively. Estimated annual amortization expense
for each of the next five years is expected to be $570 thousand.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In March&#160;2021, Purex received
an update from Amazon regarding a new Environmental Protection Agency (&#x201c;EPA&#x201d;) regulation. Following the new EPA regulation,
Amazon categorized Purex&#x2019;s product as a pesticide product. Amazon requires that pesticide products be filed with evidence of an
EPA registration number and/or EPA Establishment number or certification that the product is exempt from EPA regulation, otherwise the
existing listing (of the product) may be subject to removal. The Group examined the related costs following the requirement to comply
with such regulations and decided to write off the intangible asset balance in a total amount of $87 thousands during 2021 following the
EPA regulation update.&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31, 2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Gross Amount&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Accumulated Amortization&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Net Balance&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;&lt;b&gt;U.S.&#160;dollars in thousands&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; width: 64%; text-align: left"&gt;Brands&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;5,783&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(1,331&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;4,452&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;December&#160;31, 2021&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Gross Amount&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Accumulated Amortization&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;&lt;b&gt;Net Balance&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;&lt;b&gt;U.S.&#160;dollars in thousands&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt; width: 64%; text-align: left"&gt;Brands&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;5,783&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;(762&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; width: 9%; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;5,021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c49" decimals="-3" unitRef="usd">5783000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c49" decimals="-3" unitRef="usd">-1331000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c49" decimals="-3" unitRef="usd">4452000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c50" decimals="-3" unitRef="usd">5783000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c50" decimals="-3" unitRef="usd">-762000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c50" decimals="-3" unitRef="usd">5021000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AdjustmentForAmortization contextRef="c0" decimals="-3" unitRef="usd">570000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c4" decimals="-3" unitRef="usd">524000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c5" decimals="-3" unitRef="usd">104000</us-gaap:AdjustmentForAmortization>
    <jfbr:FiniteLivedIntangibleAssetAmortizationMethod contextRef="c0" decimals="-3" unitRef="usd">570000</jfbr:FiniteLivedIntangibleAssetAmortizationMethod>
    <us-gaap:IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit contextRef="c4" decimals="-3" unitRef="usd">87000</us-gaap:IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 6 &#x2014; LEASES:&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company leases office space with
a remaining useful life of less than 3 years.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As of December 31, 2022, the Company&#x2019;s
operating lease assets and lease liabilities (both the current and non-current portion) for operating leases totaled $138 thousands and
$141 thousands, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Company uses its incremental borrowing
rate as the discount rate for its leases, as the implicit rate in the lease is not readily determinable. As of December 31, 2022, the
Company&#x2019;s operating leases had a weighted average remaining lease term of 3 years and a weighted average borrowing rate of approximately
10%.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Future lease payments under operating
leases as of December 31, 2022, were as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;58&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;2024-2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;103&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total future operating lease payments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;161&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Less: imputed interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(20&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Present value of lease liability&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;141&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c0">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <jfbr:OperatingLeaseAssets contextRef="c0" decimals="-3" unitRef="usd">138000</jfbr:OperatingLeaseAssets>
    <us-gaap:OperatingLeaseLiability contextRef="c2" decimals="-3" unitRef="usd">141000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeFinanceLeaseRenewalTerm1 contextRef="c2">P3Y</us-gaap:LesseeFinanceLeaseRenewalTerm1>
    <jfbr:WeightedAverageBorrowingRate contextRef="c2" decimals="2" unitRef="pure">0.10</jfbr:WeightedAverageBorrowingRate>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%; text-align: left"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;58&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;2024-2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;103&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total future operating lease payments&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;161&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Less: imputed interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(20&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Present value of lease liability&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;141&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c2" decimals="-3" unitRef="usd">58000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c2" decimals="-3" unitRef="usd">103000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <jfbr:FutureOperatingLeasePayments contextRef="c2" decimals="-3" unitRef="usd">161000</jfbr:FutureOperatingLeasePayments>
    <us-gaap:ReceivableWithImputedInterestDiscount contextRef="c2" decimals="-3" unitRef="usd">20000</us-gaap:ReceivableWithImputedInterestDiscount>
    <jfbr:PresentValueOfLeaseLiability contextRef="c2" decimals="-3" unitRef="usd">141000</jfbr:PresentValueOfLeaseLiability>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 7 &#x2014;&#160;OTHER PAYABLES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Government institutions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Employees and related benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Accrued Interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;294&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued expenses and other payables&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;266&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;271&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;391&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;715&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Government institutions&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;36&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Employees and related benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;49&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;40&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-81"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Accrued Interest&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-82"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;294&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued expenses and other payables&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;266&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;271&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;391&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;715&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue contextRef="c2" decimals="-3" unitRef="usd">36000</us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue>
    <us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue contextRef="c3" decimals="-3" unitRef="usd">100000</us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">49000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c3" decimals="-3" unitRef="usd">50000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c2" decimals="-3" unitRef="usd">40000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:InterestPayableCurrent contextRef="c3" decimals="-3" unitRef="usd">294000</us-gaap:InterestPayableCurrent>
    <jfbr:AccruedExpensesAndOtherPayables contextRef="c2" decimals="-3" unitRef="usd">266000</jfbr:AccruedExpensesAndOtherPayables>
    <jfbr:AccruedExpensesAndOtherPayables contextRef="c3" decimals="-3" unitRef="usd">271000</jfbr:AccruedExpensesAndOtherPayables>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="c2" decimals="-3" unitRef="usd">391000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="c3" decimals="-3" unitRef="usd">715000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ShortTermDebtTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 8 &#x2014;&#160;SHORT-TERM LOANS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-weight: bold"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Loans with Amazon (8a)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;86&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;101&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Related party loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-83"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Third party loans (8b)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-84"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;715&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;86&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;927&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On September&#160;22, 2021, Smart Pro entered into a loan agreement with Amazon. Pursuant to the loan agreement, Smart Pro received an aggregate amount of $153 thousands from Amazon, of which $14 was repayment of a previous Amazon loan balance. The loan matures within nine&#160;months and bears annual interest at a rate of 9.99% per year. In order to secure the loan, Smart Pro pledged its financial balances on its Amazon account on Amazon and its inventories held in Amazon&#x2019;s warehouses, in favor of Amazon. On May&#160;9, 2022, the loan was fully repaid. As of December 31, 2022, the remaining loan balance to Amazon was $86 thousand.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On May&#160;9, 2022, Smart Pro entered
into a new loan agreement with Amazon. Pursuant to the loan agreement, Smart Pro received an aggregate amount of $152 thousands from Amazon.
The loan matures within 12&#160;months and bears annual interest at a rate of 9.99% per year. In order to secure the loan, Smart Pro pledged
its financial balances on its account on Amazon and its inventories held in Amazon&#x2019;s warehouses, in favor of Amazon.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In July&#160;2021, Smart Pro entered into a loan agreement with two third parties. The loans bore annual interest rate of 10% and were payable in January&#160; 2022. Smart Pro was entitled to extend the loans by an additional sixty&#160;days, with additional interest of 1% per month. In addition, pursuant to the loan agreement, in the event of an IPO of the Company, the lenders would be entitled to Ordinary Shares of the Company at an aggregate value of $250 thousands with a conversion price at the IPO price. In July&#160;2021, the loan principal of $750 thousands was received. The proceeds from the lenders were first allocated to the liability (see note 9.a) to issue a variable number of shares based on its fair value at the date of issuance in an amount of $62 thousands, with a corresponding discount recorded on the third-party loan. The derivate liability was revalued at each period-end and amounted to $137 thousands as of December 31, 2021.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On November&#160;23, 2021, the loan
agreement was amended to extend the maturity date of the loans to the earlier of (i)&#160;March&#160;31, 2023, or (ii)&#160;the closing
of an IPO of the Company. Based on management&#x2019;s assessment, the amendment resulted in a substantial modification to the loan in
accordance with ASC 470-50. As a result of the debt extinguishment, the Group recorded , a gain in the amount of $14 thousand within finance
expenses, net for the year ended December 31, 2021 as the difference between the net carrying value of the original loans and the fair
value of the loan bearing the modified terms.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Following the IPO in 2022, the Group
repaid the third-party loan.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: -0.25in"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On February&#160;22, 2022, the Company entered into a loan
agreement with Bank Leumi Le-Israel&#160;(&#x201c;Bank Leumi&#x201d;) to provide for a line of credit in an aggregate amount of up to $1,000
thousands, which the Company may draw in two tranches at its request, but in no event after July&#160;21, 2022. Pursuant to the loan
agreement, amounts drawn bear interest at a rate of Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) plus 3.25% annually. On March
3, 2022, the Company drew $400 thousands under the line of credit. On June 2, 2022, the Company drew another $200 thousands million under
the line of credit. Following an agreement with Bank Leumi, the loan was extended until October 31, 2022. All amounts outstanding under
the line of credit were fully repaid on September 6, 2022.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:ScheduleOfShortTermDebtTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-weight: bold"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Loans with Amazon (8a)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;86&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;101&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Related party loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-83"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Third party loans (8b)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-84"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;715&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;86&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;927&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:LoansPayable contextRef="c2" decimals="-3" unitRef="usd">86000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable contextRef="c3" decimals="-3" unitRef="usd">101000</us-gaap:LoansPayable>
    <us-gaap:LoansAndLeasesReceivableRelatedParties contextRef="c3" decimals="-3" unitRef="usd">111000</us-gaap:LoansAndLeasesReceivableRelatedParties>
    <jfbr:ThirdPartyLoan contextRef="c3" decimals="-3" unitRef="usd">715000</jfbr:ThirdPartyLoan>
    <us-gaap:ShortTermBorrowings contextRef="c2" decimals="-3" unitRef="usd">86000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="c3" decimals="-3" unitRef="usd">927000</us-gaap:ShortTermBorrowings>
    <jfbr:AggregatesAmount contextRef="c51" decimals="-3" unitRef="usd">153000</jfbr:AggregatesAmount>
    <us-gaap:PaymentsForPreviousAcquisition contextRef="c52" decimals="-3" unitRef="usd">14000</us-gaap:PaymentsForPreviousAcquisition>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate contextRef="c51" decimals="4" unitRef="pure">0.0999</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LoansPayable contextRef="c2" decimals="-3" unitRef="usd">86000</us-gaap:LoansPayable>
    <jfbr:AggregatesAmount contextRef="c53" decimals="-3" unitRef="usd">152000</jfbr:AggregatesAmount>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate contextRef="c53" decimals="4" unitRef="pure">0.0999</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:ShortTermDebtPercentageBearingFixedInterestRate contextRef="c54" decimals="2" unitRef="pure">0.10</us-gaap:ShortTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c54" decimals="2" unitRef="pure">0.01</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <jfbr:AggregateAmount contextRef="c55" decimals="-3" unitRef="usd">250000</jfbr:AggregateAmount>
    <jfbr:PrincipalLoanAmount contextRef="c55" decimals="-3" unitRef="usd">750000</jfbr:PrincipalLoanAmount>
    <us-gaap:ShorttermDebtFairValue contextRef="c54" decimals="-3" unitRef="usd">62000</us-gaap:ShorttermDebtFairValue>
    <us-gaap:DebtCurrent contextRef="c3" decimals="-3" unitRef="usd">137000</us-gaap:DebtCurrent>
    <us-gaap:OtherExpenses contextRef="c4" decimals="-3" unitRef="usd">14000</us-gaap:OtherExpenses>
    <jfbr:AggregateAmount contextRef="c56" decimals="-3" unitRef="usd">1000000</jfbr:AggregateAmount>
    <us-gaap:ShortTermDebtPercentageBearingVariableInterestRate contextRef="c57" decimals="4" unitRef="pure">0.0325</us-gaap:ShortTermDebtPercentageBearingVariableInterestRate>
    <jfbr:ShortTermLineOfCredits contextRef="c58" decimals="-3" unitRef="usd">400000</jfbr:ShortTermLineOfCredits>
    <us-gaap:LinesOfCreditCurrent contextRef="c59" decimals="-3" unitRef="usd">200000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 9 &#x2014;&#160;DERIVATIVE LIABILITIES&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;The following table presents changes in the fair value of
the derivative warrant liability during the year (in thousands)&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;Balance as of January 1, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Fair value of warrant liability to be issued to third-party upon IPO (note 9a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;75&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Balance as of December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of warrants in connection with the IPO&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,822&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Classification to additional paid in capital&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,319&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Balance as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,216&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As detailed in Note 8b , the Group received two loans of $375 thousands each from third parties. As part of the loan agreements, the lenders were entitled to receive warrants in the event of an initial public offering at a conversion price equal to the IPO issuance price.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Management determined that the obligation to issue a variable number
of shares represents a derivative liability. The proceeds from the lender were first allocated to the derivate liability based on its
fair value at the date of issuance in an amount of $62 thousands, with a corresponding discount recorded on the third-party loan. The
derivate liability was revalued at each period-end and amounted to $137 thousand as of December 31, 2021.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Effective
as of August 30, 2022, the closing date of the IPO, and pursuant to the loan agreements (the &#x201c;Issuance Date&#x201d;), the Company
issued warrants to the lenders to purchase up to 60,096 &lt;/span&gt;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ordinary
Shares, exercisable at an exercise price of $4.04 per share, exercisable for three years following the IPO. The warrants have cashless
exercise mechanism.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On the issuance date of the warrants, all conditions for equity classification
under U.S. GAAP were met, and as such, the fair value of the warrants as of the issuance date were reclassified to equity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;b&lt;/b&gt;&lt;/span&gt;&lt;b&gt;.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;In connection with the IPO (including the partial exercise
of over-allotment option), the Company sold 3,717,473 units at a public offering price of $4.16 per unit, with each unit consisting of
one of ordinary share, no par value per share (&#x201c;Ordinary Share&#x201d;), and one warrant (&#x201c;IPO Warrant&#x201d;), to purchase
one Ordinary Share, at an initial exercise price of $4.04 per Ordinary Share. Additionally, the Company issued and sold 3,717,473 ordinary
shares, no par value per share (&#x201c;Ordinary Shares&#x201d;), warrants to purchase up to 4,143,385 Ordinary Shares (&#x201c;IPO Warrants&#x201d;)
and warrants issued to the underwriter in the offering to purchase up to 185,873 Ordinary Shares at an exercise price of $5.20 per Ordinary
Share (&#x201c;Underwriter&#x2019;s Warrants&#x201d;). The underwriter partially exercised its right to purchase an additional 425,912 warrants
for total consideration of $4 thousands. The Company received net proceeds of $13.4 million after deducting issuance costs of $2.1 million.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On September 7, 2022, the Company&#x2019;s
volume weighted average stock price was less than the exercise floor of $4.04 for the Warrants. Accordingly, effective after the closing
of trading on November 28, 2022 (the 90th calendar day immediately following the issuance date of the IPO Warrants), the IPO Warrants
were adjusted (&#x201c;As-Adjusted IPO Warrants&#x201d;) pursuant to their terms, including, but not limited to, the reduction of the exercise
price of the IPO Warrants to $2.02. Additionally, Additional Warrants were issued to each qualified buyer who continued to hold at least
120,192 IPO Warrants as of November 28, 2022. Accordingly, the Company issued Additional Warrants to purchase 2,824,525 Ordinary Shares.
Each Additional Warrant has substantially the same terms as the As-Adjusted IPO Warrant; provided, however, that the term of each Additional
Warrant will be five (5) years from the issuance date and such Additional Warrant will not be listed on any securities exchange. Each
Additional Warrant holder will receive semi-annual payments based on revenues during the period. The total annual payment depends on
the amount of the Additional Warrants outstanding. As of December 31, 2022, the payment will be equal to approximately 2.3% of the Company&#x2019;s
revenues for the period November 28, 2022 until December 31,2022. The Company determined that the Additional Warrants preclude equity
classification. The derivative liability is recorded at fair value and amounted to $2,216 thousands as of December 31, 2022.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Given their contractual terms, from
the issuance date and up until the 90th day immediately following issuance, the IPO warrants did not meet the U.S. GAAP definition for
equity classification. As such, they were classified as a liability up until November 28, 2022.Upon issuance, the IPO Warrants (which
included the right to issue Additional Warrants) were accounted for as derivative instrument which was classified as a liability and measured
at fair value through profit or loss. The fair value was $8,245 thousands.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On November 28, 2022, following the adjustment to the exercise price
and issuance of the Additional Warrants, the Company determined that all conditions for equity classification under U.S. GAAP were met
for the IPO Warrants, and as such, the fair value of the IPO warrants as of November 28, 2022 at the amount of $3,319 thousands, was recorded
as a component of Company&#x2019;s shareholder&#x2019;s equity. The value of the IPO Warrants upon issuance and the Additional Warrants
upon issuance and at year-end was calculated based on the binomial option pricing model.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During 2022, an amount of $2,710 thousands was recorded as finance
income to account for the change in the value of the IPO Warrants and Additional Warrants value during the period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The following table lists the significant
unobservable inputs used for calculation of fair value of the IPO Warrants and Additional Warrants during the year:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;77.57%-78.89%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$2.02-4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$1.53-1.865&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;3.27%-4.04%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-85"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;3-4.74&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;WACC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;21.5%-23.3%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Additionally, the revenue forecast over
the life of the Additional Warrants is a significant input in determining the price of the Additional Warrants as of December 31, 2022.&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 88%"&gt;Balance as of January 1, 2020&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Fair value of warrant liability to be issued to third-party upon IPO (note 9a)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;75&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Balance as of December 31, 2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;137&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Issuance of warrants in connection with the IPO&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,220&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Change in fair value&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,822&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Classification to additional paid in capital&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(3,319&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt"&gt;Balance as of December 31, 2022&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,216&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right"&gt;&#160;&lt;/p&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue contextRef="c16" decimals="-3" unitRef="usd">0</jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue>
    <jfbr:FairValueOfWarrantLiabilityToBeIssuedToThirdparty contextRef="c4" decimals="-3" unitRef="usd">62000</jfbr:FairValueOfWarrantLiabilityToBeIssuedToThirdparty>
    <jfbr:ChangeInFairValue contextRef="c4" decimals="-3" unitRef="usd">75000</jfbr:ChangeInFairValue>
    <jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue contextRef="c3" decimals="-3" unitRef="usd">137000</jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c0" decimals="-3" unitRef="usd">8220000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <jfbr:ChangeInFairValue contextRef="c0" decimals="-3" unitRef="usd">-2822000</jfbr:ChangeInFairValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c2" decimals="-3" unitRef="usd">-3319000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue contextRef="c2" decimals="-3" unitRef="usd">-2216000</jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue>
    <jfbr:ThirdPartyLoan contextRef="c60" decimals="-3" unitRef="usd">375000</jfbr:ThirdPartyLoan>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues contextRef="c0" decimals="-3" unitRef="usd">62000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues>
    <jfbr:DerivativeLiability contextRef="c3" decimals="-3" unitRef="usd">137000</jfbr:DerivativeLiability>
    <us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 contextRef="c61" decimals="0" unitRef="shares">60096</us-gaap:DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1>
    <us-gaap:WarrantExercisePriceIncrease contextRef="c62" decimals="2" unitRef="usdPershares">4.04</us-gaap:WarrantExercisePriceIncrease>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c0" decimals="0" unitRef="shares">3717473</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <jfbr:PublicOfferingPricePerShare contextRef="c0" decimals="2" unitRef="usdPershares">4.16</jfbr:PublicOfferingPricePerShare>
    <us-gaap:ExcessStockSharesIssued contextRef="c26" decimals="0" unitRef="shares">1</us-gaap:ExcessStockSharesIssued>
    <us-gaap:ExcessStockSharesIssued contextRef="c60" decimals="0" unitRef="shares">1</us-gaap:ExcessStockSharesIssued>
    <us-gaap:ExcessStockSharesIssued contextRef="c2" decimals="0" unitRef="shares">1</us-gaap:ExcessStockSharesIssued>
    <us-gaap:WarrantExercisePriceDecrease contextRef="c23" decimals="2" unitRef="usdPershares">4.04</us-gaap:WarrantExercisePriceDecrease>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c23" decimals="0" unitRef="shares">3717473</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets contextRef="c23" decimals="0" unitRef="shares">4143385</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets contextRef="c63" decimals="0" unitRef="shares">185873</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <us-gaap:WarrantExercisePriceIncrease contextRef="c63" decimals="2" unitRef="usdPershares">5.2</us-gaap:WarrantExercisePriceIncrease>
    <jfbr:AdditionalWarrants contextRef="c0" decimals="0" unitRef="shares">425912</jfbr:AdditionalWarrants>
    <us-gaap:BusinessCombinationContingentConsiderationAsset contextRef="c2" decimals="-3" unitRef="usd">4000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:DerivativeCostOfHedgeNetOfCashReceived contextRef="c0" decimals="-5" unitRef="usd">13400000</us-gaap:DerivativeCostOfHedgeNetOfCashReceived>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts contextRef="c0" decimals="-5" unitRef="usd">2100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="c2" decimals="2" unitRef="usdPershares">4.04</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:WarrantExercisePriceIncrease contextRef="c64" decimals="2" unitRef="usdPershares">2.02</us-gaap:WarrantExercisePriceIncrease>
    <jfbr:AdditionalWarrants contextRef="c65" decimals="0" unitRef="shares">120192</jfbr:AdditionalWarrants>
    <jfbr:RevenuesPercentage contextRef="c66" decimals="3" unitRef="pure">0.023</jfbr:RevenuesPercentage>
    <jfbr:RelatedPartyFairValue contextRef="c0" decimals="-3" unitRef="usd">2216000</jfbr:RelatedPartyFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c2" decimals="-3" unitRef="usd">8245000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c67" decimals="0" unitRef="usd">3319</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet contextRef="c60" decimals="0" unitRef="usd">2710</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: center"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 82%; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 15%; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;77.57%-78.89%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;Exercise price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$2.02-4.04&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share price&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$1.53-1.865&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;3.27%-4.04%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-85"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Expected life&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;3-4.74&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;WACC&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;21.5%-23.3%&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c68" decimals="4" unitRef="pure">0.7757</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c69" decimals="4" unitRef="pure">0.7889</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="c70" decimals="-1" unitRef="usdPershares">2020.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice contextRef="c71" decimals="-1" unitRef="usdPershares">4040.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:SharePrice contextRef="c70" decimals="-1" unitRef="usdPershares">1530</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="c71" decimals="0" unitRef="usdPershares">1865</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c68" decimals="4" unitRef="pure">0.0327</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c69" decimals="4" unitRef="pure">0.0404</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c68">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c69">P4Y8M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:PercentageOfWeightedAverageCostInventory contextRef="c70" decimals="3" unitRef="pure">0.215</us-gaap:PercentageOfWeightedAverageCostInventory>
    <us-gaap:PercentageOfWeightedAverageCostInventory contextRef="c71" decimals="3" unitRef="pure">0.233</us-gaap:PercentageOfWeightedAverageCostInventory>
    <us-gaap:DebtDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 10 &#x2014;&#160;LOANS FROM SHAREHOLDERS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Loans from shareholders consists of the following:&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-weight: bold"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Loan amount&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-86"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,950&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Loan discount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-87"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,316&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-88"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,634&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On October&#160;8, 2020, Smart Pro, together with its shareholders (the &#x201c;Shareholders&#x201d;), entered into a share purchase agreement (the &#x201c;Purchase Agreement&#x201d;) (see Note&#160;1a) with Medigus. As part of the Purchase Agreement, Medigus and the shareholders committed to transfer funds, as loans to Smart Pro, in order to finance Smart Pro&#x2019;s&#160;day-to-day operations in exchange for Smart Pro shares. In accordance with the Purchase Agreement, the Shareholders agreed that all loans transferred to Smart Pro in order to finance the acquisition of additional online Amazon.com stores will be funded 20% by the shareholders and funded 80% by Medigus.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Additionally, as a part of the Purchase Agreement, the Shareholders
&#160;agreed to provide a line of credit to the Smart Pro in the amount of $1,000 thousands to finance ongoing capital requirements as
needed from time to time.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During October and November&#160;2020,
an amount of $250 thousands was transferred to Smart Pro on account of the loan. During 2021, Smart Pro received additional loans under
the same agreement. According to the loan agreement, the loans bear annual interest rate of 4%. Smart Pro will repay the loans and all
accrued interest five&#160;years from October 8, 2020.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On October 8, 2020, the Group estimated
the value of the benefit granted to it by its shareholders as the difference between the interest rate that Smart Pro is required to pay
to the Shareholders for the loans provided by them and secured by such lien and the interest rate Smart Pro is required to pay for similar
unsecured loans to non-related parties. The value of the said benefit is estimated by the Group based on the weighted interest rate that
Smart Pro would have been required to pay if the loans had been granted to it by the bank and by Amazon, and which the Group management
estimates is the best estimate of Smart Pro&#x2019;s interest rate close to receiving loans from investors. Accordingly, the value of the
benefit was estimated by the Group at approximately 8%, and as a result the effective interest rate for these loans is about 12%.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;During the first half of 2021, the loan
from the Shareholders was partially repaid.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt; &lt;td style="width: 24px; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 2, 2021, Smart Pro entered into a purchase agreement of a virtual store &#x201c;Whoobli&#x201d; from a third party. As part of the agreement, Smart Pro purchased a seller account which operates on the Amazon website under the name &#x201c;Whoobli&#x201d;, which markets a private label of basketball shooting baskets, children&#x2019;s punching bags and decoration for children&#x2019;s birthday parties, including the intellectual property attributed to it and including trademarks attributed to products sold on the account&#x2019;s sales page, for a total of $4,000 thousands. In addition, in accordance with the agreement, Smart Pro purchased from the seller the remaining inventory for a total amount of approximately $350 thousands, which is the cost of the inventory purchased by the seller. Additionally, purchased two additional Amazon stores &#x201c;Wellted&#x201d; and &#x201c;PetEvo&#x201d; (See Note&#160;5).&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In order to finance the purchase of the store, Smart Pro received loan
from its shareholders in a ratio of 20:80, as described in section b above. Medigus transferred to Smart Pro an amount of approximately
$3,760 thousands and the minority shareholders transferred an amount of approximately $940 thousands. This Shareholders loans bore an
annual interest at a rate of 4% and will be repaid after five&#160;years.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: justify; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On the borrowing date of the loans,
Smart Pro estimated the value of the benefit granted to it by Medigus and the minority shareholders as the difference between the interest
rate that Smart Pro is required to pay to Medigus and the minority shareholders for the loans and the interest rate required to pay for
similar unsecured loans to non-related parties, the capital reserve from the transaction on the borrowing date was $1,026 thousands. The
value of the said benefit was estimated by the Group based on the interest rate that Smart Pro is required to pay for the loan received
from Amazon and which the Company&#x2019;s management considers to be the best estimate of Smart Pro&#x2019;s interest rate close to the
date of receiving loans from investors. Accordingly, the value of the benefit was estimated by the Group at approximately 8% and as a
result the effective interest rate for these loans was determined at 11.79%.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 24px"&gt;&#160;&lt;/td&gt; &lt;td style="width: 24px; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As of May&#160;3, 2022, Smart Pro had outstanding loans to Medigus, Mr.&#160;Hakmon and L.I.A.&#160;Pure Capital Ltd. (&#x201c;Pure Capital&#x201d;) of $4,010 thousands, $940 thousands and $109 thousands, respectively. On May&#160;3, 2022, the Company entered into Assignments to Loan Agreements with Smart Pro, Medigus, Mr.&#160;Hakmon and Pure Capital, pursuant to which the Company assumed Smart Pro&#x2019;s obligations under the outstanding loans and agreed that unless earlier repaid pursuant to the terms of the respective loan agreements with such parties, effective immediately upon the consummation of IPO, all outstanding principal due to each such party will be automatically converted into a number of Ordinary Shares equal to the quotient obtained by dividing the outstanding principal amount due to such party, by the per Ordinary Share price obtained by dividing $10,000 thousands by the fully diluted issued and outstanding Ordinary Shares as of immediately prior to the closing of the IPO.&#160;Any accrued and unpaid interest due to such party as of such date will be paid in cash.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Based on management&#x2019;s assessment,
the modified loan terms including an equity conversion feature upon IPO represented a substantial modification in accordance with ASC
470-50 and is accounted for as an extinguishment of the original financial liability in the amount of $3,821 thousands and the recognition
of a new financial instrument in the amount of $2,839 thousands. The difference between the fair value of the instrument bearing the modified
terms and the carrying values of the original loans immediately prior to the modification, was recorded as an increase in equity in the
amount of $982 thousands.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As the convertible note was not issued
with a substantial premium or with an embedded conversion feature required to be bifurcated under ASC 815, the convertible note was accounted
for as a liability in its entirety.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In accordance with such assignment agreements,
on August&#160;30, 2022, the outstanding amounts due to Medigus, Mr.&#160;Hakmon and Pure Capital at a total amount of $5,059 thousands
were converted into an aggregate of 1,463,619&#160;Ordinary Shares. In addition, accrued interest of $393 thousands was paid.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="text-align: center; font-weight: bold"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Loan amount&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-86"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;4,950&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Loan discount&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-87"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,316&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-88"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;3,634&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LoansPayableCurrent contextRef="c3" decimals="-3" unitRef="usd">4950000</us-gaap:LoansPayableCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c3" decimals="-3" unitRef="usd">1316000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c3" decimals="-3" unitRef="usd">3634000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage contextRef="c72" decimals="2" unitRef="pure">0.20</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage contextRef="c73" decimals="2" unitRef="pure">0.80</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:LineOfCredit contextRef="c74" decimals="-3" unitRef="usd">1000000</us-gaap:LineOfCredit>
    <us-gaap:LongTermDebt contextRef="c75" decimals="-3" unitRef="usd">250000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c76" decimals="-3" unitRef="usd">250000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c74" decimals="2" unitRef="pure">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DefinedBenefitPlanFundedPercentage contextRef="c74" decimals="2" unitRef="pure">0.08</us-gaap:DefinedBenefitPlanFundedPercentage>
    <us-gaap:InvestmentInterestRate contextRef="c74" decimals="2" unitRef="pure">0.12</us-gaap:InvestmentInterestRate>
    <us-gaap:FiniteLivedTrademarksGross contextRef="c77" decimals="-3" unitRef="usd">4000000</us-gaap:FiniteLivedTrademarksGross>
    <us-gaap:InventoryNoncurrent contextRef="c77" decimals="-3" unitRef="usd">350000</us-gaap:InventoryNoncurrent>
    <us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction contextRef="c78" decimals="-3" unitRef="usd">3760000</us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction>
    <us-gaap:OtherMinorityInterests contextRef="c79" decimals="-3" unitRef="usd">940000</us-gaap:OtherMinorityInterests>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c77" decimals="2" unitRef="pure">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseOtherShortTermBorrowings contextRef="c80" decimals="-3" unitRef="usd">1026000</us-gaap:InterestExpenseOtherShortTermBorrowings>
    <us-gaap:InvestmentInterestRate contextRef="c77" decimals="2" unitRef="pure">0.08</us-gaap:InvestmentInterestRate>
    <us-gaap:LoansReceivableBasisSpreadOnVariableRateDuringPeriod contextRef="c80" decimals="4" unitRef="pure">0.1179</us-gaap:LoansReceivableBasisSpreadOnVariableRateDuringPeriod>
    <us-gaap:PrincipalAmountOutstandingOnLoansSecuritized contextRef="c81" decimals="-3" unitRef="usd">4010000</us-gaap:PrincipalAmountOutstandingOnLoansSecuritized>
    <us-gaap:PrincipalAmountOutstandingOnLoansSecuritized contextRef="c82" decimals="-3" unitRef="usd">940000</us-gaap:PrincipalAmountOutstandingOnLoansSecuritized>
    <us-gaap:PrincipalAmountOutstandingOnLoansSecuritized contextRef="c83" decimals="-3" unitRef="usd">109000</us-gaap:PrincipalAmountOutstandingOnLoansSecuritized>
    <us-gaap:DividendsCommonStock contextRef="c44" decimals="-3" unitRef="usd">10000000</us-gaap:DividendsCommonStock>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c84" decimals="-3" unitRef="usd">3821000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="c84" decimals="-3" unitRef="usd">2839000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:StockholdersEquityPeriodIncreaseDecrease contextRef="c44" decimals="-3" unitRef="usd">982000</us-gaap:StockholdersEquityPeriodIncreaseDecrease>
    <us-gaap:PrincipalAmountOutstandingOnLoansSecuritized contextRef="c85" decimals="-3" unitRef="usd">5059000</us-gaap:PrincipalAmountOutstandingOnLoansSecuritized>
    <us-gaap:ConversionOfStockSharesConverted1 contextRef="c86" decimals="0" unitRef="shares">1463619</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest contextRef="c86" decimals="-3" unitRef="usd">393000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 11 &#x2014; TAXES ON INCOME:&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Jeffs&#x2019; Brands and Top Rank are
taxed according to Israeli tax laws. The corporate tax rate in Israel is 23%.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Smart Pro and Purex are taxed according
to US federal and California state laws. The blended corporate tax rate is 28%.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Capital gains are subject to capital
gain tax according to the corporate tax rate for the year during which the assets are sold.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;For financial reporting
purposes, income (loss) before taxes includes the following components:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 13.5pt; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Israel&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,081&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,096&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-89"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(126&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(465&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;188&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,207&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1,561&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;188&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Income tax expense
(benefit) was as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year ended December&#160;31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.&#160;dollars in thousands&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Israel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-90; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-91; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 64%; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;94&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;126&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;94&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;126&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 20pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Israel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-95; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 20pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(18&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(115&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(50&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total deferred tax income&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(18&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(115&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(50&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total tax (benefit) expense&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;76&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;A reconciliation of the Group&#x2019;s
statutory income tax rate to effective income tax rate is as follows:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="border: Black 1pt solid"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;U.S.&#160;dollars in thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Income (loss) before taxes on income&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,201&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,561&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;188&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Statutory tax rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax (tax benefit) computed at the statutory tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(506&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(359&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Increase (decrease) in taxes on income resulting from the following:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax rate differences applicable to subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(110&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(78&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Tax losses and timing differences for which deferred taxes were not recognized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;610&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;416&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Taxes on income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;Deferred taxes are comprised of the following components:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Intangible assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;110&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;56&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating lease right of use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Operating loss carryforward&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;890&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;172&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(890&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(172&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total deferred tax assets after valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;142&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;56&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Differences between tax basis and carrying value of loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;370&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total deferred tax liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;370&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Net deferred tax assets (liabilities)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;110&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(314&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Deferred tax assets on losses for tax
purposes carried forward to subsequent years are recognized if utilization of the related tax benefit against a future taxable income
is expected.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Carry forward tax losses of Jeffs&#x2019;
Brands were $3,870 thousands and $747 thousands as of December 31, 2022 and 2021, respectively. Jeffs&#x2019;&#160;Brands did not record
deferred tax assets in respect of these losses, as the utilization thereof is not expected to occur in the foreseeable future. There is
no expiration on net operating loss carryforwards in Israel.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Smart Pro and Purex did not have any
net operating loss carryforwards as of December 31, 2022, and 2021. net deferred tax asset is with respect to Smart Pro.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Deferred tax is the tax expected to be
payable or recoverable on differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding
tax bases used in the computation of taxable profit and is accounted for using the liability method. Deferred tax liabilities are generally
recognized for all taxable temporary differences and deferred tax assets are recognized to the extent that it is probable that taxable
profits will be available against which deductible temporary differences can be utilized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;Such assets and liabilities are not recognized
if the temporary difference arises from the initial recognition (other than in a business combination) of other assets and liabilities
in a transaction that affects neither the taxable profit nor the accounting profit.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate contextRef="c0" decimals="2" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c0" decimals="2" unitRef="pure">0.28</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Israel&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,081&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(1,096&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-89"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Foreign&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(126&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(465&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;188&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,207&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(1,561&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;188&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c87" decimals="-3" unitRef="usd">-2081000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c88" decimals="-3" unitRef="usd">-1096000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c90" decimals="-3" unitRef="usd">-126000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c91" decimals="-3" unitRef="usd">-465000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c92" decimals="-3" unitRef="usd">188000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c0" decimals="-3" unitRef="usd">-2207000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c4" decimals="-3" unitRef="usd">-1561000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c5" decimals="-3" unitRef="usd">188000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year ended December&#160;31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;U.S.&#160;dollars in thousands&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Israel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-90; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-91; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-92; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 64%; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;94&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;126&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;94&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;126&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-left: 20pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Israel&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-93; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-94; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-95; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 20pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(18&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(115&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(50&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total deferred tax income&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(18&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(115&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(50&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total tax (benefit) expense&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(6&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(21&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 4.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;76&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c0" decimals="-3" unitRef="usd">12000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c4" decimals="-3" unitRef="usd">94000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c5" decimals="-3" unitRef="usd">126000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c0" decimals="-3" unitRef="usd">12000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c4" decimals="-3" unitRef="usd">94000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c5" decimals="-3" unitRef="usd">126000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c0" decimals="-3" unitRef="usd">-18000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c4" decimals="-3" unitRef="usd">-115000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c5" decimals="-3" unitRef="usd">-50000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c0" decimals="-3" unitRef="usd">-18000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c4" decimals="-3" unitRef="usd">-115000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c5" decimals="-3" unitRef="usd">-50000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-3" unitRef="usd">-6000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c4" decimals="-3" unitRef="usd">-21000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c5" decimals="-3" unitRef="usd">76000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="border: Black 1pt solid"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;b&gt;U.S.&#160;dollars in thousands&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt"&gt;Income (loss) before taxes on income&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,201&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,561&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;188&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Statutory tax rate&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax (tax benefit) computed at the statutory tax rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(506&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(359&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;43&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Increase (decrease) in taxes on income resulting from the following:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Tax rate differences applicable to subsidiaries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(110&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(78&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Tax losses and timing differences for which deferred taxes were not recognized&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;610&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;416&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;23&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Taxes on income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(21&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;76&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c0" decimals="-3" unitRef="usd">-2201000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c4" decimals="-3" unitRef="usd">-1561000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c5" decimals="-3" unitRef="usd">188000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="2" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c4" decimals="2" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c5" decimals="2" unitRef="pure">0.23</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c0" decimals="-3" unitRef="usd">-506000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c4" decimals="-3" unitRef="usd">-359000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount contextRef="c5" decimals="-3" unitRef="usd">43000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c0" decimals="-3" unitRef="usd">-110000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c4" decimals="-3" unitRef="usd">-78000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c5" decimals="-3" unitRef="usd">10000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c0" decimals="-3" unitRef="usd">610000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c4" decimals="-3" unitRef="usd">416000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems contextRef="c5" decimals="-3" unitRef="usd">23000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" unitRef="usd">-6000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c4" decimals="-3" unitRef="usd">-21000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c5" decimals="-3" unitRef="usd">76000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Deferred tax asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Intangible assets&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;110&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;56&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Operating lease right of use asset&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Operating loss carryforward&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;890&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;172&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Total deferred tax assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,032&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;228&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(890&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(172&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total deferred tax assets after valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;142&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;56&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Differences between tax basis and carrying value of loans&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;370&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Operating lease liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"&gt;Total deferred tax liability&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;32&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;370&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Net deferred tax assets (liabilities)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;110&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(314&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c2" decimals="-3" unitRef="usd">110000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c3" decimals="-3" unitRef="usd">56000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c0" decimals="-3" unitRef="usd">32000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLossCarryforwards contextRef="c2" decimals="-3" unitRef="usd">890000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c3" decimals="-3" unitRef="usd">172000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsGross contextRef="c2" decimals="-3" unitRef="usd">1032000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c3" decimals="-3" unitRef="usd">228000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c2" decimals="-3" unitRef="usd">890000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c3" decimals="-3" unitRef="usd">172000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c2" decimals="-3" unitRef="usd">142000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c3" decimals="-3" unitRef="usd">56000</us-gaap:DeferredTaxAssetsNet>
    <jfbr:DifferencesBetweenTaxBasisAndCarryingValueOfLoans contextRef="c3" decimals="-3" unitRef="usd">-370000</jfbr:DifferencesBetweenTaxBasisAndCarryingValueOfLoans>
    <us-gaap:OperatingLeasePayments contextRef="c0" decimals="-3" unitRef="usd">32000</us-gaap:OperatingLeasePayments>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c2" decimals="-3" unitRef="usd">32000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c3" decimals="-3" unitRef="usd">370000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c0" decimals="-3" unitRef="usd">110000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes contextRef="c4" decimals="-3" unitRef="usd">-314000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses contextRef="c2" decimals="-3" unitRef="usd">3870000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses contextRef="c3" decimals="-3" unitRef="usd">747000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 12 &#x2014; SHARE CAPITAL:&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The share capital composed of ordinary shares as follows:&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of ordinary shares&lt;br/&gt;
 December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 4pt"&gt;Issued (*)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;8,074,217&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;2,893,125&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;43,567,567&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,356,757&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Retroactively adjusted. See Note&#160;1b&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The Ordinary Shares confer upon their
holders the following rights: (i)&#160;the right to vote in any general meeting of the Company, (ii)&#160;the right to receive dividends,
if and when declared by the Board of Directors and (iii)&#160;the right to receive upon liquidation of the Company a sum equal to the
nominal value of the share, and if a surplus remains, to receive such surplus, subject to the rights conferred on any class of shares
which may be issued in the future.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On October&#160;8, 2020, Smart Pro entered into a definitive
agreement with Medigus. According to the agreement, Medigus will hold 50.01% of the issued and outstanding share capital of Smart Pro,
acquired through a combination of a cash investment in Smart Pro and an acquisition of additional shares from Smart Pro&#x2019;s&#x2019;
previous shareholders in consideration for restricted American Depository Shares (&#x201c;ADS&#x201d;) of Medigus and a cash component.
Medigus invested $1,100 thousands in Smart Pro in exchange of issuing 5,572 ordinary shares, pay $150 thousands in cash consideration
to the current shareholders and shall issue $500 thousands worth of restricted ADS of Medigus to the current shareholders of such company,
with the value of restricted ADS to be subject to downward adjustment based on Smart Pro&#x2019;s 2020 results. In addition, Smart Pro&#x2019;s
current shareholders shall be entitled to additional milestone allotments of up to an aggregate $750 thousands in restricted ADS subject
to Smart Pro &#x2019;s achievement of certain milestones throughout 2021. The closing of the transactions contemplated in the definitive
agreements are subject to customary closing conditions, which did not stand as of December&#160;31, 2020, and as such no shares were
issued and no cash or restricted ADS were received during the reporting period.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On January&#160;4, 2021, the terms and
conditions to the agreement with Medigus Ltd were completed.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On October&#160;8, 2020, Purex signed on a definitive agreement
with Medigus. According to the agreement, Medigus will hold 50.01% of the issued and outstanding share capital of Purex, acquired through
a combination of a cash investment in Purex and asn acquisition of additional shares from the Purex&#x2019;s previous shareholders in
consideration for restricted ADS of Medigus and a cash component. Medigus shall invest $150 thousands in Purex in exchange of issuing
557 ordinary shares. The closing of the transactions contemplated in the definitive agreements are subject to customary closing conditions,
which did not stand as of December&#160;31, 2020, and as such no shares were issued and no cash or restricted ADS were received during
the reporting period.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;d.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On May&#160;10, 2021, pursuant to the SEA, Medigus and the minority shareholders (see Note 1a)
                                                                                         contributed all of the equity interests they owned in Smart Pro and Purex to Jeffs&#x2019; Brands. As of result of the Contribution
                                                                                         Transactions pursuant to the SEA, Jeffs&#x2019; Brands holds all of the outstanding shares of Smart Pro and Purex&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;e.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On July 23, 2021, Medigus issued to the minority shareholder
33,202 ADS as a bonus for his services provided to the Group for the year-ended December 31, 2021 in the amount of $60 thousands. Accordingly,
the Group recognized an amount of $60 thousands as additional payroll expenses and respectively a capital reserve as a benefit from Medigus
(the controlling shareholder).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;f.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company engaged an advisor during 2021 in connection
with the IPO process. This advisor was entitled to receive a warrant upon the completion of the IPO to purchase up to a number of Ordinary
Shares equal to $75 thousands divided by the IPO price per Unit (as defined below), sold in the IPO, exercisable immediately upon issuance
for a period of two years, at an exercise price equal to the IPO price per unit. On August 30, 2022, following the closing of the IPO,
the Company issued to the Advisor warrants to purchase up to 18,564 Ordinary Shares exercisable 5 years from the date of issuance at
an exercise price of $4.04 per Ordinary Share (the exercise price was adjusted to $2.02 per share on November 28, 2022 based on the terms
of the warrant). These warrants were treated as issuance costs, which amounted to $12 thousand based on a third-party valuation using
the Black &amp;amp;Scholes Model and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;g.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On February&#160;17, 2022, the Company&#x2019;s Board of Directors
approved the issuance of bonus shares (equivalent to a stock dividend) on a basis of 664.0547 (prior to adjustments for subsequent reverse
share split) Ordinary Shares of the Company for each Ordinary Share issued and outstanding as of the close of business on February&#160;17,
2022 (provided that any fractional shares be rounded down to the nearest whole number), resulting in an aggregate issuance by the Company
as of such date of 6,630,547 (prior to adjustments for subsequent reverse share split) Ordinary Shares. (See also note 1c).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;h.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On August&#160;30, 2022, the Company closed its IPO, and
the simultaneous partial exercise of the underwriter&#x2019;s over-allotment&#160;option, for aggregate gross proceeds of approximately
$15.5&#160;million, before deducting underwriting discounts and estimated offering expenses. The Company issued 3,717,473 Ordinary Shares,
(&#x201c;Ordinary Shares&#x201d;) and IPO&#160;warrants to purchase up to 3,717,473&#160;Ordinary Shares. The Ordinary Shares and IPO Warrants
were sold together in the IPO as units (&#x201c;Units&#x201d;) at an initial public offering price of $4.16 per Unit.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The IPO Warrants had an initial exercise
price of $4.04, and expire five years from the issuance day. The IPO Warrants became exercisable immediately after the completion of the
IPO (and until August 30, 2027). On the 90th day after completion of the IPO, the exercise price of the IPO Warrants was adjusted to be
equal to the lowest quoted share price during the 90 days. The daily quoted price used in the determination of such minimum was calculated
as the weighted average price of each day. The exercise price however may not be reduced to less than $2.02.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;The IPO Warrants contain a down round
protection, so that for a period of two years from the date of issuance of the IPO Warrant, the exercise price is adjusted to the price
in subsequent fundings of the Company, if shares in these fundings are sold at a price per share below the warrant exercise price at the
time of such future fundings (or if other instruments with an exercise / conversion price at a price below the warrant exercise price
are sold). The exercise price however may not be reduced to less than $2.02. On November 28, 2022, the IPO Warrant&#x2019;s exercise price
was adjusted to $2.02.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;In addition, On November 28, 2022,
the Company issued Additional Warrants to purchase 2,824,525 Ordinary Shares. Each Additional Warrant has substantially the same
terms as the As-Adjusted IPO Warrant; provided, however, that the term of each Additional Warrant will be five (5) years from the
issuance date and such Additional Warrant will not be listed on any securities exchange. Each Additional Warrants holder will
receive semi-annual payments. The total annual payment depends on the amount of the Additional Warrants outstanding. As of December
31, 2022, the payment will be equal to approximately 2.3% of the Group &#x2019;s revenues for the period from November 28, 2022 until
December 31,2022. The Additional Warrants may be redeemed by the Company at any time at a price equal to three times the Initial
Exercise Price, or $6.06.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As the IPO Warrants and the Additional
Warrants are not separable at the issuance date, the IPO Warrants and the Additional Warrants are accounted for as derivative instruments
which are classified as a liability and measured at fair value through profit or loss. The fair value of the warrants and the Additional
Warrants was calculated by an independent valuation expert and as of the issuance date the fair value was $4,651 thousands and $3,594
thousands, respectively.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On November 28, 2022, following the issuance of the Additional warrants,
the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair
value of the IPO Warrants as of November 28, 2022 at the amount of $3,319 thousands which was calculated based on a third-party appraiser
valuation, was recorded as a component of Group&#x2019;s shareholder&#x2019;s equity. (Refer also to Note 9c). The total gross consideration
was 15.5&#160;million (including the exercise of the underwriter&#x2019;s option at the amount of $4 thousands). $8,245 thousand was initially
attributed to the warrants based on their fair value and the remaining amount was attributed to the ordinary shares issued and recognized
as an equity component. Applicable issuance costs, amounting to $2,193 thousand, have been allocated in the same proportion as the allocation
of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and has been recorded in
profit or loss as finance expense, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand have been
recorded in equity as a reduction of the paid in capital.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On November 28, 2022, following the issuance of the Additional Warrants,
the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair
value of the IPO Warrants as of November 28, 2022 at the amount of $3,319 thousands, was recorded as a component of Group&#x2019;s shareholder&#x2019;s
equity.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;As part of the IPO (see above), on August
30, 2022, the Company issued to the underwriter Warrants to purchase up to 185,873 Ordinary Shares (&#x201c;Underwriters Warrants&#x201d;)
exercisable at an exercise price of $5.20, and are exercisable beginning on February&#160;21, 2023 and will expire on August&#160;25,
2027. The Underwriter&#x2019;s Warrants have a cashless exercise mechanism. The Underwriters Warrants were treated as issuance costs, which
amounted to $109 thousand based on third party valuation, and have been allocated in the same proportion as the allocation of the gross
proceeds from the IPO. An amount of $58 thousand was considered as issuance costs allocated to the warrants and has been recorded in profit
or loss as finance expense, while costs allocated as issuance costs of ordinary shares in the amount of $51 thousand have been recorded
in equity as a reduction of the additional paid in capital.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;i.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;On August 30, 2022, the underwriter (see Note 12h), partially
exercised its overallotment right to purchase additional IPO Warrants to purchase up to 425,912 Ordinary Shares for a total consideration
of $4 thousands. These additional IPO Warrants were treated as issuance costs, which amounted to $1 thousand based on third party valuation,
and have been allocated in the same proportion as the allocation of the gross proceeds from the IPO. An amount of $0.5 thousand was considered
as issuance costs allocated to the additional IPO Warrants and has been recorded in profit or loss as finance expense, while costs allocated
as issuance costs of Ordinary Shares in the amount of $0.5 thousand have been recorded in equity as a reduction of the paid in capital.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -21.3pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;j.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;In accordance with an assignment agreement (see also Note
10d) and in connection with the IPO (see above), on August&#160;30, 2022, the Company converted outstanding amounts due to Medigus, Mr.&#160;Hakmon
and Pure Capital into 1,463,619&#160;Ordinary Shares.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Number of ordinary shares&lt;br/&gt;
 December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 4pt"&gt;Issued (*)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;8,074,217&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 4pt double; text-align: right"&gt;2,893,125&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Authorized&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;43,567,567&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,356,757&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c2"
      decimals="INF"
      id="ix_1_fact"
      unitRef="shares">8074217</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c3"
      decimals="INF"
      id="ix_2_fact"
      unitRef="shares">2893125</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="c2" decimals="INF" unitRef="shares">43567567</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized contextRef="c3" decimals="INF" unitRef="shares">4356757</us-gaap:TemporaryEquitySharesAuthorized>
    <jfbr:AgreementDescription contextRef="c93">Smart Pro entered into a definitive
agreement with Medigus. According to the agreement, Medigus will hold 50.01% of the issued and outstanding share capital of Smart Pro,
acquired through a combination of a cash investment in Smart Pro and an acquisition of additional shares from Smart Pro&#x2019;s&#x2019;
previous shareholders in consideration for restricted American Depository Shares (&#x201c;ADS&#x201d;) of Medigus and a cash component.
Medigus invested $1,100 thousands in Smart Pro in exchange of issuing 5,572 ordinary shares, pay $150 thousands in cash consideration
to the current shareholders and shall issue $500 thousands worth of restricted ADS of Medigus to the current shareholders of such company,
with the value of restricted ADS to be subject to downward adjustment based on Smart Pro&#x2019;s 2020 results. In addition, Smart Pro&#x2019;s
current shareholders shall be entitled to additional milestone allotments of up to an aggregate $750 thousands in restricted ADS subject
to Smart Pro &#x2019;s achievement of certain milestones throughout 2021.</jfbr:AgreementDescription>
    <jfbr:IssuedAndOutstandingShareCapitalPercentage contextRef="c93" decimals="4" unitRef="pure">0.5001</jfbr:IssuedAndOutstandingShareCapitalPercentage>
    <jfbr:InvestAmount contextRef="c93" decimals="-3" unitRef="usd">150000</jfbr:InvestAmount>
    <us-gaap:SharesIssued contextRef="c94" decimals="0" unitRef="shares">557</us-gaap:SharesIssued>
    <us-gaap:SharesIssued contextRef="c95" decimals="0" unitRef="shares">33202</us-gaap:SharesIssued>
    <jfbr:MinorityShareholderAmount contextRef="c96" decimals="-3" unitRef="usd">60000</jfbr:MinorityShareholderAmount>
    <us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent contextRef="c3" decimals="-3" unitRef="usd">60000</us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c97" decimals="-3" unitRef="usd">75000</us-gaap:PaymentsOfDividendsCommonStock>
    <jfbr:IssuanceOfPeriodTerm contextRef="c97">P2Y</jfbr:IssuanceOfPeriodTerm>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c34" decimals="0" unitRef="shares">18564</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c33">P5Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharesIssuedPricePerShare contextRef="c34" decimals="2" unitRef="usdPershares">4.04</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c98" decimals="2" unitRef="usdPershares">2.02</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c97" decimals="-3" unitRef="usd">12000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <jfbr:IssuanceOfBonusShares contextRef="c99" decimals="4" unitRef="shares">664.0547</jfbr:IssuanceOfBonusShares>
    <jfbr:AggregateIssuanceShares contextRef="c99" decimals="0" unitRef="shares">6630547</jfbr:AggregateIssuanceShares>
    <jfbr:GrossProceeds contextRef="c100" decimals="-5" unitRef="usd">15500000</jfbr:GrossProceeds>
    <us-gaap:SharesIssued contextRef="c101" decimals="0" unitRef="shares">3717473</us-gaap:SharesIssued>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c34" decimals="0" unitRef="shares">3717473</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SaleOfStockPricePerShare contextRef="c34" decimals="2" unitRef="usdPershares">4.16</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="c102" decimals="2" unitRef="usdPershares">4.04</us-gaap:SaleOfStockPricePerShare>
    <jfbr:InitialExercisePriceExpire contextRef="c102">P5Y</jfbr:InitialExercisePriceExpire>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c102" decimals="2" unitRef="usdPershares">2.02</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockOptionExercisePriceDecrease contextRef="c86" decimals="2" unitRef="usdPershares">2.02</us-gaap:StockOptionExercisePriceDecrease>
    <us-gaap:StockOptionExercisePriceIncrease contextRef="c103" decimals="2" unitRef="usdPershares">2.02</us-gaap:StockOptionExercisePriceIncrease>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c104" decimals="0" unitRef="shares">2824525</us-gaap:ClassOfWarrantOrRightOutstanding>
    <jfbr:AdditionalWarrantTerm contextRef="c103">P5Y</jfbr:AdditionalWarrantTerm>
    <jfbr:RevenuesPercentage contextRef="c103" decimals="3" unitRef="pure">0.023</jfbr:RevenuesPercentage>
    <us-gaap:SaleOfStockPricePerShare contextRef="c2" decimals="2" unitRef="usdPershares">6.06</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c69" decimals="-3" unitRef="usd">4651000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c68" decimals="-3" unitRef="usd">3594000</us-gaap:FairValueAdjustmentOfWarrants>
    <jfbr:AdditionalWarrantsDescription contextRef="c103">On November 28, 2022, following the issuance of the Additional warrants,
the Company determined that all conditions for equity classification under U.S. GAAP were met for the IPO Warrants, and as such, the fair
value of the IPO Warrants as of November 28, 2022 at the amount of $3,319 thousands which was calculated based on a third-party appraiser
valuation, was recorded as a component of Group&#x2019;s shareholder&#x2019;s equity. (Refer also to Note 9c). The total gross consideration
was 15.5&#160;million (including the exercise of the underwriter&#x2019;s option at the amount of $4 thousands). $8,245 thousand was initially
attributed to the warrants based on their fair value and the remaining amount was attributed to the ordinary shares issued and recognized
as an equity component. Applicable issuance costs, amounting to $2,193 thousand, have been allocated in the same proportion as the allocation
of the gross proceeds. An amount of $1,169 thousand was considered as issuance costs allocated to the warrants and has been recorded in
profit or loss as finance expense, while costs allocated as issuance costs of ordinary shares in the amount of $1,024 thousand have been
recorded in equity as a reduction of the paid in capital.&#160;</jfbr:AdditionalWarrantsDescription>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c105" decimals="-3" unitRef="usd">3319000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c102" decimals="0" unitRef="shares">185873</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="c34" decimals="2" unitRef="usdPershares">5.2</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c33" decimals="-3" unitRef="usd">109000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <jfbr:GrossProceeds contextRef="c102" decimals="-3" unitRef="usd">58000</jfbr:GrossProceeds>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c42" decimals="-3" unitRef="usd">51000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c100" decimals="0" unitRef="shares">425912</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c86" decimals="-3" unitRef="usd">4000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c86" decimals="-3" unitRef="usd">1000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <jfbr:ConsideredAsIssuanceCosts contextRef="c33" decimals="-2" unitRef="usd">500</jfbr:ConsideredAsIssuanceCosts>
    <jfbr:ConsideredAsIssuanceCosts contextRef="c42" decimals="-2" unitRef="usd">500</jfbr:ConsideredAsIssuanceCosts>
    <us-gaap:CommonStockSharesIssued contextRef="c106" decimals="0" unitRef="shares">1463619</us-gaap:CommonStockSharesIssued>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 13 &#x2014; SHARE INCENTIVE PLAN&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;On January&#160;19, 2022, the Company&#x2019;s
Board of Directors adopted the 2022 Incentive Option Plan (&#x201c;Plan&#x201d;). A total of 1,307,027&#160;Ordinary Shares were reserved
and subject to the Plan. The Plan is intended as an incentive to retain directors, officers, employees, consultants and advisers of the
Company. As of December 31, 2022, the Company had not granted awards under the Plan.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares contextRef="c2" decimals="0" unitRef="shares">1307027</us-gaap:EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;NOTE 14 &#x2014;&#160;FINANCE (INCOME) EXPENSE, NET&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Finance income:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Change in fair value of derivative liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,822&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-96"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-97"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Gain from debt extinguishment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-98"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-99"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total finance income&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,822&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(14&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-100"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Finance expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Finance expenses in respect of third-party loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-101"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Change in fair value of derivative liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-102"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-103"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Amortization of loan discount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;85&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-104"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Exchange rate changes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;156&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-105"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Interest expense on loans from shareholders and related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;203&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;381&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;221&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other finance expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;38&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total finance expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;517&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;643&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;232&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Finance (income) expense, net&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,305&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;629&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;232&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock>
    <jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Finance income:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Change in fair value of derivative liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;(2,822&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-96"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-97"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Gain from debt extinguishment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-98"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(14&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-99"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Total finance income&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,822&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(14&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-100"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Finance expense:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Finance expenses in respect of third-party loan&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;83&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;77&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-101"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Change in fair value of derivative liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-102"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;75&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-103"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Amortization of loan discount&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;85&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-104"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Exchange rate changes&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;156&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-105"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Interest expense on loans from shareholders and related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;203&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;381&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;221&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other finance expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;38&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total finance expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;517&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;643&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;232&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 4pt"&gt;Finance (income) expense, net&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(2,305&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;629&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;232&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1 contextRef="c0" decimals="-3" unitRef="usd">-2822000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax contextRef="c4" decimals="-3" unitRef="usd">-14000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:InterestAndOtherIncome contextRef="c0" decimals="-3" unitRef="usd">2822000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome contextRef="c4" decimals="-3" unitRef="usd">14000</us-gaap:InterestAndOtherIncome>
    <jfbr:FinanceExpensesInRespectOfThirdpartyLoan contextRef="c0" decimals="-3" unitRef="usd">83000</jfbr:FinanceExpensesInRespectOfThirdpartyLoan>
    <jfbr:FinanceExpensesInRespectOfThirdpartyLoan contextRef="c4" decimals="-3" unitRef="usd">77000</jfbr:FinanceExpensesInRespectOfThirdpartyLoan>
    <us-gaap:IncreaseDecreaseInDerivativeLiabilities contextRef="c4" decimals="-3" unitRef="usd">75000</us-gaap:IncreaseDecreaseInDerivativeLiabilities>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c0" decimals="-3" unitRef="usd">37000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c4" decimals="-3" unitRef="usd">85000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c0" decimals="-3" unitRef="usd">156000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c4" decimals="-3" unitRef="usd">10000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestExpenseRelatedParty contextRef="c0" decimals="-3" unitRef="usd">203000</us-gaap:InterestExpenseRelatedParty>
    <us-gaap:InterestExpenseRelatedParty contextRef="c4" decimals="-3" unitRef="usd">381000</us-gaap:InterestExpenseRelatedParty>
    <us-gaap:InterestExpenseRelatedParty contextRef="c5" decimals="-3" unitRef="usd">221000</us-gaap:InterestExpenseRelatedParty>
    <us-gaap:OtherNonoperatingExpense contextRef="c0" decimals="-3" unitRef="usd">38000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c4" decimals="-3" unitRef="usd">15000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c5" decimals="-3" unitRef="usd">11000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherTaxExpenseBenefit contextRef="c0" decimals="-3" unitRef="usd">517000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit contextRef="c4" decimals="-3" unitRef="usd">643000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit contextRef="c5" decimals="-3" unitRef="usd">232000</us-gaap:OtherTaxExpenseBenefit>
    <jfbr:FinanceExpenseNet contextRef="c0" decimals="-3" unitRef="usd">-2305000</jfbr:FinanceExpenseNet>
    <jfbr:FinanceExpenseNet contextRef="c4" decimals="-3" unitRef="usd">629000</jfbr:FinanceExpenseNet>
    <jfbr:FinanceExpenseNet contextRef="c5" decimals="-3" unitRef="usd">232000</jfbr:FinanceExpenseNet>
    <us-gaap:EarningsPerShareTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 15 &#x2014;&#160;NET INCOME (LOSS) PER
SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0pt"&gt;The following
table sets forth the computation of basic and diluted net income (loss) per share attributable to ordinary shareholders:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands (*)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"&gt;Net income (loss) applicable
    to shareholders of ordinary shares&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,201&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,540&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;112&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-108; -sec-ix-hidden: hidden-fact-107; -sec-ix-hidden: hidden-fact-106; font-size: 10pt"&gt;Shares of ordinary share used in computing basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,643,879&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,892,347&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,888,768&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-111; -sec-ix-hidden: hidden-fact-110; -sec-ix-hidden: hidden-fact-109"&gt;Net loss per share of ordinary share, basic and diluted&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.47&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.53&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.04&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0pt"&gt;The following potentially dilutive securities outstanding have been
excluded from the computation of diluted weighted average shares outstanding, because such securities had an antidilutive impact:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands (*)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;IPO Warrants and Additional Warrants (Note 12h)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,541,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-112"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-113"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Underwriter warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;611,785&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-114"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-115"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other warrants &lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;78,661&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-116"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-117"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,232,444&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-118"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-119"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;(*)&lt;/td&gt;&lt;td style="text-align: justify"&gt;except share and per share data&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands (*)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"&gt;Net income (loss) applicable
    to shareholders of ordinary shares&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(2,201&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;(1,540&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;112&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-108; -sec-ix-hidden: hidden-fact-107; -sec-ix-hidden: hidden-fact-106; font-size: 10pt"&gt;Shares of ordinary share used in computing basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;4,643,879&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,892,347&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;2,888,768&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-111; -sec-ix-hidden: hidden-fact-110; -sec-ix-hidden: hidden-fact-109"&gt;Net loss per share of ordinary share, basic and diluted&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.47&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.53&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.04&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c0" decimals="-3" unitRef="usd">-2201000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c4" decimals="-3" unitRef="usd">-1540000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c5" decimals="-3" unitRef="usd">112000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="c0" decimals="INF" unitRef="shares">4643879</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="c4" decimals="INF" unitRef="shares">2892347</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="c5" decimals="INF" unitRef="shares">2888768</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:EarningsPerShareDilutedProFormaAdjustment contextRef="c0" decimals="2" unitRef="usdPershares">-0.47</us-gaap:EarningsPerShareDilutedProFormaAdjustment>
    <us-gaap:EarningsPerShareDilutedProFormaAdjustment contextRef="c4" decimals="2" unitRef="usdPershares">-0.53</us-gaap:EarningsPerShareDilutedProFormaAdjustment>
    <us-gaap:EarningsPerShareDilutedProFormaAdjustment contextRef="c5" decimals="2" unitRef="usdPershares">0.04</us-gaap:EarningsPerShareDilutedProFormaAdjustment>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Year ended December&#160;31&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;2020&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands (*)&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;IPO Warrants and Additional Warrants (Note 12h)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;6,541,998&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-112"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-113"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Underwriter warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;611,785&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-114"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-115"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other warrants &lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;78,661&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-116"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-117"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7,232,444&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-118"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-119"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-indent: -20.7pt"&gt;&#160;&lt;/p&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <jfbr:IPOAndAdditionalWarrants contextRef="c0" decimals="INF" unitRef="shares">6541998</jfbr:IPOAndAdditionalWarrants>
    <jfbr:UnderwriterWarrants contextRef="c0" decimals="INF" unitRef="shares">611785</jfbr:UnderwriterWarrants>
    <jfbr:OtherWarrants contextRef="c0" decimals="INF" unitRef="shares">78661</jfbr:OtherWarrants>
    <jfbr:TotalDilutedWeightedAverageSharesOutstanding contextRef="c0" decimals="INF" unitRef="shares">7232444</jfbr:TotalDilutedWeightedAverageSharesOutstanding>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 16 &#x2014;&#160;RELATED PARTIES&#160;&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;a.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Transactions with interested and related parties:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Labor cost and related expenses (c1)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;358&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Directors&#x2019; fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;172&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-120"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Consulting fees (c2)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;218&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-121"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Interest expenses on loans from related parties and shareholders&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;203&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;381&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;951&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;573&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;b.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Balances with interested and related parties:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Advances to suppliers (c2)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;228&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-122"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;228&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-123"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Related parties (c3)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loans from shareholders (Note 10),(c3)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-124"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loan from related parties (Note 9)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-125"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;111&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;32&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,010&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.25in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;c.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Additional information:&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;1.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On July&#160;23, 2021, Medigus issued to the minority Shareholder
and amount of 33,202 ADS as a bonus for his services provided to the Group for the six&#160;months ended June&#160;30, 2021 in a value
of $60 thousand. Accordingly, the Group recognized an amount of $60 thousand as additional payroll expenses and respectively a capital
reserve as a benefit from Medigus (the Group&#x2019;s controlling shareholder).&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;On August 3, 2022, the Company&#x2019;s
Board of Directors approved the increase to Mr. Hakmon&#x2019;s monthly salary to NIS 55 thousand (approximately $23 thousands) plus applicable
value added taxes (&#x201c;VAT&#x201d;), retroactively from February 1, 2022. Effective on September 1, 2022, the Company&#x2019;s Board
of Directors approved an increase to Mr. Hakmon&#x2019;s monthly salary to NIS 80 thousands (approximately $23 thousands) plus VAT and
a one-time bonus of NIS 480 thousands (approximately $140 thousands).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;2.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On October 26, 2022, the Group and Pure Capital entered into
a consultant agreement, pursuant to which Pure Capital will provide consultancy services to the Group for a monthly fee of NIS 57.5 thousands
(approximately $16.5 thousands) the Group paid Pure Capital a one-time signing bonus in the amount of NIS 425 thousands (approximately
$121 thousands) for their services to the Group from the day of the Company&#x2019;s inception until the closing of the IPO. Pure Capital is
also entitled during the term of the consulting agreement to the following payment: (i) an amount equal to 7% of the gross proceeds paid
to the Company in connection with any exercise of warrants, whether or not currently outstanding; and (ii) 8% of the total consideration
paid in connection with any purchase of a new brand, businesses, or similar events initiated or assisted by Pure Capital and approved
by the Chief Executive Officer and Chairman of the Board based on agreement with Pure Capital. The consulting agreement is for an undefined
period of time and may be terminated after 3 years from October 26, 2022 by either party upon 30 days of advance notice. Additionally
On October 26, 2022 the Group and Pure NJ Logistics LLC, owned by Pure Capital and a director of the Company, entered into a warehouse
lease agreement located in the USA. As of December 31, 2022 the advances to suppliers comprised of $228 thousands to Pure NJ Logistics
LLC.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;3.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On May 21, 2022, the Company has entered into a short-term
lease agreement for its offices from Medigus and participated in 50% of the lease and maintenance expenses related. The Company paid
$86 thousand plus VAT on December 30, 2022. The outstanding payable to Medigus as of December 31, 2022, was $32 thousands plus VAT.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;During September 2022, the Group repaid:
(i) a related party balance to Medigus, in the amount of $150 thousands and (ii) another related party balance in the amount of $175 thousands
and (iii) $393 thousand in accrued interest with respect to certain related party loans upon the conversion of such loans at the closing
of the IPO.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left"&gt;Labor cost and related expenses (c1)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;358&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;192&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Directors&#x2019; fees&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;172&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-120"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Consulting fees (c2)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;218&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-121"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Interest expenses on loans from related parties and shareholders&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;203&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;381&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;951&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;573&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:LaborAndRelatedExpense contextRef="c0" decimals="-3" unitRef="usd">358000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c4" decimals="-3" unitRef="usd">192000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:NoninterestExpenseDirectorsFees contextRef="c0" decimals="-3" unitRef="usd">172000</us-gaap:NoninterestExpenseDirectorsFees>
    <us-gaap:ProfessionalFees contextRef="c0" decimals="-3" unitRef="usd">218000</us-gaap:ProfessionalFees>
    <jfbr:InterestExpensesOnLoansFromRelatedPartiesAndShareholders contextRef="c0" decimals="-3" unitRef="usd">203000</jfbr:InterestExpensesOnLoansFromRelatedPartiesAndShareholders>
    <jfbr:InterestExpensesOnLoansFromRelatedPartiesAndShareholders contextRef="c4" decimals="-3" unitRef="usd">381000</jfbr:InterestExpensesOnLoansFromRelatedPartiesAndShareholders>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="c0" decimals="-3" unitRef="usd">951000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty contextRef="c4" decimals="-3" unitRef="usd">573000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <jfbr:ScheduleOfInterestedAndRelatedPartiesTableTextBlock contextRef="c0">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Year ended December&#160;31,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2022&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2021&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="font-weight: bold; text-align: center"&gt;U.S.&#160;dollars in thousands&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="text-decoration:underline"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 76%; text-align: left; padding-bottom: 1.5pt"&gt;Advances to suppliers (c2)&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;228&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-122"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;228&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-123"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="text-decoration:underline"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Related parties (c3)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;32&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;265&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loans from shareholders (Note 10),(c3)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-124"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,634&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loan from related parties (Note 9)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;div style="-sec-ix-hidden: hidden-fact-125"&gt;-&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;111&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;32&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,010&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;</jfbr:ScheduleOfInterestedAndRelatedPartiesTableTextBlock>
    <jfbr:AdvancesToSuppliers contextRef="c2" decimals="-3" unitRef="usd">228000</jfbr:AdvancesToSuppliers>
    <us-gaap:OtherAssets contextRef="c2" decimals="-3" unitRef="usd">228000</us-gaap:OtherAssets>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="c2" decimals="-3" unitRef="usd">32000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="c3" decimals="-3" unitRef="usd">265000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <jfbr:LoansFromShareholders contextRef="c3" decimals="-3" unitRef="usd">3634000</jfbr:LoansFromShareholders>
    <us-gaap:DueToOtherRelatedPartiesNoncurrent contextRef="c3" decimals="-3" unitRef="usd">111000</us-gaap:DueToOtherRelatedPartiesNoncurrent>
    <us-gaap:OtherLiabilities contextRef="c2" decimals="-3" unitRef="usd">32000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="c3" decimals="-3" unitRef="usd">4010000</us-gaap:OtherLiabilities>
    <us-gaap:SharesIssued contextRef="c107" decimals="0" unitRef="shares">33202</us-gaap:SharesIssued>
    <jfbr:RelatedPartyFairValue contextRef="c108" decimals="-3" unitRef="usd">60000</jfbr:RelatedPartyFairValue>
    <us-gaap:AccruedPayrollTaxesCurrent contextRef="c109" decimals="-3" unitRef="usd">60000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="c110" decimals="-3" unitRef="ils">55000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="c110" decimals="-3" unitRef="usd">23000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="c111" decimals="-3" unitRef="ils">80000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="c111" decimals="-3" unitRef="usd">23000</us-gaap:SalariesWagesAndOfficersCompensation>
    <jfbr:Bonus contextRef="c112" decimals="-3" unitRef="ils">480000</jfbr:Bonus>
    <jfbr:Bonus contextRef="c112" decimals="-3" unitRef="usd">140000</jfbr:Bonus>
    <jfbr:ConsultancyServicesFees contextRef="c113" decimals="-2" unitRef="ils">57500</jfbr:ConsultancyServicesFees>
    <jfbr:ConsultancyServicesFees contextRef="c113" decimals="-2" unitRef="usd">16500</jfbr:ConsultancyServicesFees>
    <jfbr:Bonus contextRef="c113" decimals="-3" unitRef="ils">425000</jfbr:Bonus>
    <jfbr:Bonus contextRef="c113" decimals="-3" unitRef="usd">121000</jfbr:Bonus>
    <jfbr:PercentageOfGrossProceed contextRef="c113" decimals="2" unitRef="pure">0.07</jfbr:PercentageOfGrossProceed>
    <jfbr:PercentageOfTotalConsiderationPaid contextRef="c113" decimals="2" unitRef="pure">0.08</jfbr:PercentageOfTotalConsiderationPaid>
    <jfbr:UndefinedPeriodOfTime contextRef="c113">P3Y</jfbr:UndefinedPeriodOfTime>
    <us-gaap:PaymentsToSuppliers contextRef="c0" decimals="-3" unitRef="usd">228000</us-gaap:PaymentsToSuppliers>
    <jfbr:PercentageLeaseAndMaintenanceExpensesRelated contextRef="c114" decimals="2" unitRef="pure">0.50</jfbr:PercentageLeaseAndMaintenanceExpensesRelated>
    <us-gaap:OtherLaborRelatedExpenses contextRef="c0" decimals="-3" unitRef="usd">86000</us-gaap:OtherLaborRelatedExpenses>
    <jfbr:OutstandingPayable contextRef="c0" decimals="-3" unitRef="usd">32000</jfbr:OutstandingPayable>
    <us-gaap:RelatedPartyCosts contextRef="c115" decimals="0" unitRef="usd">150</us-gaap:RelatedPartyCosts>
    <us-gaap:RelatedPartyTransactionDueFromToRelatedParty contextRef="c116" decimals="0" unitRef="usd">175</us-gaap:RelatedPartyTransactionDueFromToRelatedParty>
    <us-gaap:InterestIncomeRelatedParty contextRef="c115" decimals="-3" unitRef="usd">393000</us-gaap:InterestIncomeRelatedParty>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;NOTE 17 &#x2014; SUBSEQUENT EVENTS&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 24px; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;a.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;On February 23, 2023, the Company and Jeffs&#x2019; Brands Holdings entered into a stock purchase agreement with SciSparc (the &#x201c;Wellution Agreement&#x201d;), as amended on March 22, 2023 by Addendum No. 1 to the Wellution Agreement (the &#x201c;Addendum&#x201d;), pursuant which, on March 22, 2023, Jeffs&#x2019; Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S., a wholly-owned subsidiary of SciSparc that owns and operates Wellution, a top-selling Amazon food supplements and cosmetics brand, subject to the holdback by SciSparc of 11 shares as described below, representing approximately 49% of the issued and outstanding common stock of SciSparc U.S., for approximately $3 million in cash (including the Price Adjustment, as defined below), of which approximately $2.5 million was paid at the closing (the &#x201c;Wellution Transaction&#x201d;). The Addendum provided for the payment by us to SciSparc of an additional amount of $489,330 in cash for the purchase price adjustments (the &#x201c;Price Adjustment,&#x201d;) related to inventory and working capital, payable in five equal installments of $97,866 on the tenth day of each consecutive calendar month, beginning in May 2023. As collateral for the payment in full of the Price Adjustment, SciSparc held back 11 shares of common stock of SciSparc U.S, which will be released to Jeffs&#x2019; Brands Holdings once the final payment is made. Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Transaction, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S. (the &#x201c;SciSparc Consulting Agreement&#x201d;), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousands and the Company will receive a one-time signing bonus in the amount of $51 thousands. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Also pursuant to the Wellution Agreement,
in connection with the closing of the Wellution Transaction, effective as of March 22, 2023, the Company issued 247,415 of its Ordinary
Shares to SciSparc and on March 29, 2023 SciSparc issued 360,297 of its Ordinary Shares to the Company in a mutual share exchange (collectively,
the &#x201c;Exchange Shares&#x201d;), representing 2.97% and 4.99%, respectively, of the Company&#x2019;s and SciSparc&#x2019;s issued and
outstanding ordinary shares. The number of Exchange Shares acquired by each company was calculated by dividing $288,238, which was adjusted
from $300,000, pursuant to the 4.99% ownership limitation included in the Wellution Agreement, by the average closing price of the relevant
company&#x2019;s shares on the Nasdaq Capital Market for the 30 consecutive trading days ending on the third trading day immediately prior
to the closing date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 2.5pt"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.25in; text-align: left"&gt;b.&lt;/td&gt;&lt;td style="text-align: justify"&gt;On March 2, 2023, the Company entered into a share purchase
agreement (the &#x201c;Fort SPA&#x201d;), with the holders (the &#x201c;Sellers&#x201d;), of all of the issued and outstanding share capital
of Fort, a company incorporated under the laws of England and Wales and engaged in the sale of pest control products primarily through
Amazon.uk, pursuant to which on March 9, 2023, the Company acquired all of the issued and outstanding share capital of Fort, for approximately
&#xa3;2,000,000 (approximately $2,400 thousands) in cash (the &#x201c;Fort Acquisition&#x201d;). The Fort SPA provides that for a period
of three years from closing, the Sellers will not compete with Fort&#x2019;s business.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;Also in connection with the Fort Acquisition,
on March 9, 2023, the Company and Fort entered into settlement agreements with all of Fort&#x2019;s employees, including the Sellers, providing
that such employees&#x2019; employment with Fort will terminate three months following March 9, 2023 and certain other customary conditions.
During this three-month period, the Company intends to carry out operational changes in Fort&#x2019;s business that will allow Fort to
wind down the activities conducted in its leased warehouse and to move all such operations to warehouses operated by Amazon. In connection
with the closing of the acquisition, on March 9, 2023, the Company and the Sellers entered into a consulting agreement, pursuant to which
the Sellers will provide us with consultancy services for a period of three months, in consideration for a monthly fee of &#xa3;2,500
(approximately $3,000).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"&gt;The Fort acquisition was accounted for as an asset acquisition, as
substantially all of the fair value of the assets being acquired under the arrangement was concentrated in the brand name.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 48px"&gt;&#160;&lt;/td&gt; &lt;td style="width: 24px; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;c.&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In March 2023 the Company paid to Pure Capital $352 thousands in accordance with the consultant agreement in relation to the two purchases as described in note 17.a and note 17.b. For additional information see note 16.c.2.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription contextRef="c117">On February 23, 2023, the Company and Jeffs&#x2019; Brands Holdings entered into a stock purchase agreement with SciSparc (the &#x201c;Wellution Agreement&#x201d;), as amended on March 22, 2023 by Addendum No. 1 to the Wellution Agreement (the &#x201c;Addendum&#x201d;), pursuant which, on March 22, 2023, Jeffs&#x2019; Brands Holdings acquired from SciSparc 57 shares of common stock of SciSparc U.S., a wholly-owned subsidiary of SciSparc that owns and operates Wellution, a top-selling Amazon food supplements and cosmetics brand, subject to the holdback by SciSparc of 11 shares as described below, representing approximately 49% of the issued and outstanding common stock of SciSparc U.S., for approximately $3 million in cash (including the Price Adjustment, as defined below), of which approximately $2.5 million was paid at the closing (the &#x201c;Wellution Transaction&#x201d;). The Addendum provided for the payment by us to SciSparc of an additional amount of $489,330 in cash for the purchase price adjustments (the &#x201c;Price Adjustment,&#x201d;) related to inventory and working capital, payable in five equal installments of $97,866 on the tenth day of each consecutive calendar month, beginning in May 2023. As collateral for the payment in full of the Price Adjustment, SciSparc held back 11 shares of common stock of SciSparc U.S, which will be released to Jeffs&#x2019; Brands Holdings once the final payment is made. Pursuant to the Wellution Agreement, in connection with the closing of the Wellution Transaction, on March 22, 2023, the Company entered into a consulting agreement with SciSparc U.S. (the &#x201c;SciSparc Consulting Agreement&#x201d;), pursuant to which the Company will provide management services to SciSparc U.S. for the Wellution brand for a monthly fee of $20 thousands and the Company will receive a one-time signing bonus in the amount of $51 thousands. The SciSparc Consulting Agreement is for an undefined period of time and may be terminated by either party with 30 days advance notice.</us-gaap:SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription>
    <us-gaap:CommonStockOtherSharesOutstanding contextRef="c118" decimals="0" unitRef="shares">247415</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:CommonStockOtherSharesOutstanding contextRef="c119" decimals="0" unitRef="shares">360297</us-gaap:CommonStockOtherSharesOutstanding>
    <jfbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage contextRef="c120" decimals="4" unitRef="pure">0.0297</jfbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage>
    <jfbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage contextRef="c120" decimals="4" unitRef="pure">0.0499</jfbr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c2" decimals="0" unitRef="usd">288238</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <jfbr:AdditionalDividendsPayableSharesValue contextRef="c0" decimals="0" unitRef="usd">300000</jfbr:AdditionalDividendsPayableSharesValue>
    <us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="c121" decimals="4" unitRef="pure">0.0499</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MembersCapital contextRef="c122" decimals="0" unitRef="usd">2000000</us-gaap:MembersCapital>
    <us-gaap:MembersCapital contextRef="c122" decimals="0" unitRef="eur">2400</us-gaap:MembersCapital>
    <us-gaap:DebtInstrumentFeeAmount contextRef="c122" decimals="0" unitRef="eur">2500</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentFeeAmount contextRef="c122" decimals="0" unitRef="usd">3000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:PartnersCapitalAccountReturnOfCapital contextRef="c123" decimals="0" unitRef="usd">352</us-gaap:PartnersCapitalAccountReturnOfCapital>
    <us-gaap:DeferredCosts
      contextRef="c2"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="c3"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c3"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherLoansPayableLongTerm
      contextRef="c2"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c3"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="c2"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c2"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="c3"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockNoParValue
      contextRef="c2"
      id="hidden-fact-8"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:CommonStockNoParValue
      contextRef="c3"
      id="hidden-fact-9"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="c0"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherSellingGeneralAndAdministrativeExpense
      contextRef="c5"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c5"
      decimals="2"
      id="hidden-fact-12"
      unitRef="usdPershares">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="hidden-fact-13"
      unitRef="usdPershares">-0.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c4"
      decimals="2"
      id="hidden-fact-14"
      unitRef="usdPershares">-0.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c5"
      decimals="INF"
      id="hidden-fact-15"
      unitRef="shares">2888768</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="hidden-fact-16"
      unitRef="shares">2892347</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="INF"
      id="hidden-fact-17"
      unitRef="shares">4643879</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="c6"
      id="hidden-fact-18"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c11"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c10"
      id="hidden-fact-20"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c13"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c17"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c18"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c17"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="c19"
      id="hidden-fact-25"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c17"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c19"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c17"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="c19"
      id="hidden-fact-29"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c17"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c19"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c20"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c23"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c24"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium
      contextRef="c23"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium
      contextRef="c25"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts
      contextRef="c23"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts
      contextRef="c25"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c23"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="c25"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c23"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="c25"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="c23"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="c25"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c0"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="c5"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="c0"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="c5"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="c5"
      id="hidden-fact-49"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c0"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c5"
      id="hidden-fact-51"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="c5"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShortTermLeasePayments
      contextRef="c4"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShortTermLeasePayments
      contextRef="c5"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="c4"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="c5"
      id="hidden-fact-56"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:IssuanceCostsOnDerivativeLiabilities
      contextRef="c4"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:IssuanceCostsOnDerivativeLiabilities
      contextRef="c5"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="c0"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="c4"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="c5"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="c0"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromOtherShortTermDebt
      contextRef="c5"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="c4"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="c5"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromBankDebt
      contextRef="c0"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="c0"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfBankDebt
      contextRef="c5"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="c0"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c0"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c5"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestPaidNet
      contextRef="c5"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:DeferredOfferingCostsIncludedInOtherPayables
      contextRef="c0"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:DeferredOfferingCostsIncludedInOtherPayables
      contextRef="c5"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:SharebasedCompensationIncludedInDeferredOfferingCosts
      contextRef="c0"
      id="hidden-fact-75"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:SharebasedCompensationIncludedInDeferredOfferingCosts
      contextRef="c5"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities
      contextRef="c4"
      id="hidden-fact-77"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:RightOfUseAssetsObtainedInExchangeForLeaseLiabilities
      contextRef="c5"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:MaturityOfTimeDeposits contextRef="c0" id="hidden-fact-79">P3M</us-gaap:MaturityOfTimeDeposits>
    <us-gaap:Supplies
      contextRef="c3"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="c3"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestPayableCurrent
      contextRef="c2"
      id="hidden-fact-82"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LoansAndLeasesReceivableRelatedParties
      contextRef="c2"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:ThirdPartyLoan
      contextRef="c2"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c0"
      id="hidden-fact-85"
      unitRef="pure"
      xsi:nil="true"/>
    <us-gaap:LoansPayableCurrent
      contextRef="c2"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="c2"
      id="hidden-fact-87"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="c2"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="c89"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:CurrentStateAndLocalTaxExpensesBenefit
      contextRef="c0"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:CurrentStateAndLocalTaxExpensesBenefit
      contextRef="c4"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:CurrentStateAndLocalTaxExpensesBenefit
      contextRef="c5"
      id="hidden-fact-92"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:DeferredStateAndLocalIncomeTaxExpensesBenefit
      contextRef="c0"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:DeferredStateAndLocalIncomeTaxExpensesBenefit
      contextRef="c4"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:DeferredStateAndLocalIncomeTaxExpensesBenefit
      contextRef="c5"
      id="hidden-fact-95"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="c4"
      id="hidden-fact-96"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="c5"
      id="hidden-fact-97"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="c0"
      id="hidden-fact-98"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax
      contextRef="c5"
      id="hidden-fact-99"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestAndOtherIncome
      contextRef="c5"
      id="hidden-fact-100"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:FinanceExpensesInRespectOfThirdpartyLoan
      contextRef="c5"
      id="hidden-fact-101"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDerivativeLiabilities
      contextRef="c0"
      id="hidden-fact-102"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDerivativeLiabilities
      contextRef="c5"
      id="hidden-fact-103"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="c5"
      id="hidden-fact-104"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c5"
      id="hidden-fact-105"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c5"
      decimals="INF"
      id="hidden-fact-106"
      unitRef="shares">2888768</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c4"
      decimals="INF"
      id="hidden-fact-107"
      unitRef="shares">2892347</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c0"
      decimals="INF"
      id="hidden-fact-108"
      unitRef="shares">4643879</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:EarningsPerShareDilutedProFormaAdjustment
      contextRef="c5"
      decimals="2"
      id="hidden-fact-109"
      unitRef="usdPershares">0.04</us-gaap:EarningsPerShareDilutedProFormaAdjustment>
    <us-gaap:EarningsPerShareDilutedProFormaAdjustment
      contextRef="c0"
      decimals="2"
      id="hidden-fact-110"
      unitRef="usdPershares">-0.47</us-gaap:EarningsPerShareDilutedProFormaAdjustment>
    <us-gaap:EarningsPerShareDilutedProFormaAdjustment
      contextRef="c4"
      decimals="2"
      id="hidden-fact-111"
      unitRef="usdPershares">-0.53</us-gaap:EarningsPerShareDilutedProFormaAdjustment>
    <jfbr:IPOAndAdditionalWarrants
      contextRef="c4"
      id="hidden-fact-112"
      unitRef="shares"
      xsi:nil="true"/>
    <jfbr:IPOAndAdditionalWarrants
      contextRef="c5"
      id="hidden-fact-113"
      unitRef="shares"
      xsi:nil="true"/>
    <jfbr:UnderwriterWarrants
      contextRef="c4"
      id="hidden-fact-114"
      unitRef="shares"
      xsi:nil="true"/>
    <jfbr:UnderwriterWarrants
      contextRef="c5"
      id="hidden-fact-115"
      unitRef="shares"
      xsi:nil="true"/>
    <jfbr:OtherWarrants
      contextRef="c4"
      id="hidden-fact-116"
      unitRef="shares"
      xsi:nil="true"/>
    <jfbr:OtherWarrants
      contextRef="c5"
      id="hidden-fact-117"
      unitRef="shares"
      xsi:nil="true"/>
    <jfbr:TotalDilutedWeightedAverageSharesOutstanding
      contextRef="c4"
      id="hidden-fact-118"
      unitRef="shares"
      xsi:nil="true"/>
    <jfbr:TotalDilutedWeightedAverageSharesOutstanding
      contextRef="c5"
      id="hidden-fact-119"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:NoninterestExpenseDirectorsFees
      contextRef="c4"
      id="hidden-fact-120"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProfessionalFees
      contextRef="c4"
      id="hidden-fact-121"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:AdvancesToSuppliers
      contextRef="c3"
      id="hidden-fact-122"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherAssets
      contextRef="c3"
      id="hidden-fact-123"
      unitRef="usd"
      xsi:nil="true"/>
    <jfbr:LoansFromShareholders
      contextRef="c2"
      id="hidden-fact-124"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DueToOtherRelatedPartiesNoncurrent
      contextRef="c2"
      id="hidden-fact-125"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0">0001885408</dei:EntityCentralIndexKey>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#hidden-fact-71"
          xlink:label="hidden-fact-71"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amount less than $1 thousand</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-71"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-80"
          xlink:label="hidden-fact-80"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes $228 thousand to Pure Capital. See
Note 16 for additional information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-80"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Retroactively adjusted. See Note 1b</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-118"
          xlink:label="hidden-fact-118"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-114"
          xlink:label="hidden-fact-114"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-116"
          xlink:label="hidden-fact-116"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-112"
          xlink:label="hidden-fact-112"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">except share and per share data</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-118"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-114"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-116"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-112"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>105
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MY;LW4[L;P=;YRYTG)@1+\LL5E4T@5P;R]R5CXNU&O2_:OQ\<_0M02P,$%
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M*53;Z-N)D8WKE7-IL/.Z885W(R@;@/L+*<WCQ+;?_K;-?P-02P,$%     @
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M=+5':O3I,G(E5V<>7<JQ&R:>BEZQ&5\AT^I+[*,?R[$'VO;S6%DZ0&=8+8<
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M'C(WZO15TJZHT#93H6[OQH]@:P'\PRX>JO9"8K9*1:!4$[K;>T??9@2\2UE
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M.J^K@H$&5;=*U'].57Y:9E^$^AWBU<1',& 15F$>$R/YF&V)2X8*J.BEY-X
MY": 14GT.:9 DB%AR,EU'C[(#(PP-7\[/RCO?;D"IT:5P)D=0S$S(EK4K&YI
M<D&'\E^,H@V6Y#F^DY!\MLW*5OL,3Q82TYJF\BG6EQ1C3([N>?LL$!X>IU"[
M#IJU[MVZY9",)8,SI&U,]D_U2'W82'68M$=H0SL/"'9=$%Y"%QYXAZE/MGVA
MHR X)Z9MJ@ $OVW!J7)XX3'FQ^R5<:$?@7T,+6'\"WTGF9@([D()OJ99N-2
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M4O6IJ@C0E(P!,#^ZB:P@C(GLJ-.2C!@ZJ!$B<VN%N970?*6[37OB.[/F5 (
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M:A[43H'.*Z7L?N,<#$_[\C]02P,$%     @ N4.*5K4*6N:G @  F@4  !D
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M^ 3<)GJV-EEGWT%].;,.%6' [B'UU.\]>V11KJ&7LO'0XMYB#0F>O*A"4>'
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M<=KZK2D5Q9I^48/"0$C:GYW<4_>CW<+^5M4<M[_X?>+%&I@=IN,57!T&L^G
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MEYO?W['IA/WZR\5L.GO)[A&<\#&+O&1B+^4*$M%8P]22V5*PI:H@H66S>I%
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M$(G2O/\J*CW#4#@AF>!H7M."6$F%P%@&\*<@G#X91YH0:+18\VVT'CT#&$C
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MHDF_=,=:M]\VZ.*G'@4W+*L,26\W,MWX46ZM</5&.L^&#+6#K:3B*I50PPC
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M^ =1<SAFH6[# 45)_"Q*HMM6[5:E9,)^>+I$5*G[--G21 %?.2H4SA-A7V*
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MJ>8K!Q;N]R#$TX2,V3$<2;M$YCK$0W3=\?12N*T0X:!!(RE#2'B#R#R"%T1
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M57FU6SRS0C+1]ILN&,^C<P"-WZM:?I]J1_P$!W BTR6695"T))!'ML,X%=J
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M"([B3@OP?*;P>E)?T &;KUSG_P502P,$%     @ N4.*5HR5.6I&"0  ^A<
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M"SQ+:EJ ^RL%L.$''="][K_^+U!+ P04    " "Y0XI6)7&DTA$?   ;8@
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MICUY9FAS2]7P3S?,NR!6OW=Y999PGFSB@9=*SA4<%EAD%";S /,PG58..>O
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M6FZP8#@ZT;!XK;#0,;3 J:][0I<E5H=X5)%P%$6WZ3B3 A<$&FBDIO+3P?#
M17+Q<)@=YK8AV2@AU2U:L@:M-8NN)3D"R>+"$=#DZ/Q]^$O!R11K*I"J.1$5
MK K5) (X9;'.[8KCLY%(),E"Q=*I-*S=TU1 /)K@DGV%STI(AF7/*.C.9[-8
M]T3A.,=S41N6.B #+6Z!4:\8>A*U!ZZ?F%3UTO22XIUE@\;:O<S^D6'EIFO1
MB,:3NKS,;CM;$U/5\^P=Q'=ZW52PE0U:3DG0[S%F@-4H'T=N(;T5CE442#2#
M)"Q' X994A^?C0KW&Y_^-DOX@U(:5)U!Z1Z=:5BZUU-U8@4Z,ZEW022U-2W:
M*1A6@,P#%X %J[S*R,Y1-MRNC2W/MSEJQ%)[*05SFXAI4CX8*J?=?7@/<<R@
M&YJ);^,)_WYY=845B<YA"31+RP0'NQ %(O%D.C$6#Z$!RZ14]WJ!/ MMV\"V
MU<J"SZ1:CBE% Q0F!1G5'#^\5SNL1((@&?;V(K!AGTFY8@<)? XKQ[)%#'"P
M6AI+*+$PY(6.4R]:+%V"J'AO(>#";.0>]%>'NBAGPT6SJNGLJ$*)U2'(75BE
M41O:_52=660@$OR?!E1M-E]C):/9/>; $F=?5?L)S4M,8O;2:01BLH5N=QA3
M($7'.T5B#NE,RZNP=1(0Y%-DQ%?<Q#QJTGQ4DTB]AQ5G],%AQ3%3Q1-"7'!4
MRX9T5+UXFM;$L^!VX6@XMD;N2($2@T Q*<&A5B";,=$E^YVW?A Y!DVEI\#!
ME^IL]AA,L!9MI.(CM9+0*S<5&$62E([KKCEH)9BM&G^&;+6%M4A 0"$FZFS>
MGXGC_&;14FI,4DEN',N W0+#_2CZ]'.(I1>ZUDN2;$RB97WOCF@U3*^:;K7V
M)2YV)QS'G%T.T;$F,0X4L'51R=["W+TL15)LKL]@K@]>-D._6AJI$M=-&[4E
M'$E?@&7A\V9YCJOYJ.CC^T])G0BWA6%AQ2+"K2-Q%T#>3L-I8 $!NY.-S3 H
M2$G-*]<,TZN.Z'5<,->)_*"%XT]!U;FPB.? )$$,\/Z3-W]62\$GZYUL1],I
MZE545'2,&Z-8.OI *I;TF(51<IB7AC>0\*U8FGU!'O3!;+J-/+J5Y ?R*D-!
M01 9^KU',H<7WN"&HA($7%*?FD@P$FA@L069IXQ4AVIB+%C'/7E*0IC!WT_4
MMNHP:MK[M;WL!5_#\4[V2Y@J"H]QPQ2K<%0;3!3((% +H==Y&B/\!!O[Q--!
ML9!!>(/=9I!U7 :%4\I.$M_Y^ :]2-+;1&GS9BP4M#G;3)2S<U('N*L++I:!
MEKUN+-AKG/@C+NF5YN[UQZ TO=VF&7+,]?-V@$M NB<J!*2'#*+=9)XQTX'^
M,%""FXV!',:=6"W[0I^%*%@&1C#;**/&:EZ+["'ON@B[)(5W9F.H, K$<:P=
M)9QZO(/E86SB:N$HT2U&&<D3-PO)7(C!^)BDX-7X9@18CR\0U%-V*P?6ZE25
MKFL9G(R-HF)BL(-=7.JWU8)CH:T=<CQHYH EV..&,+K!:4,[9!_B2/)K47YV
MID(KIVUA4&CQ1Z9TFO6(CMOJ40OFBE*LO[0<2G:RI&?D5+WO*X0OM/+4/JK*
M4$A5/WOA9LZ@!HX%,Q$Y,AN%>KRZ9F;'#&\PKOD&N,AO&( ?S)UZ)E_00_'/
MT[(YUJ8QK#EZF$[_.$KP^(U>SQ"_X6#;V_F"VKFE''*A,:*10CGP'(-2'>(7
M-!+<FT6Y7W',L@QZF X+G4082&G!#H^^;$"94!@V6DLO%X*7VO@0+%<+3%?)
M6Q]QZ=PG-^0,J#B8IDV(-(#<J!>>X.H'&QV7CXC5F8V#=>X..ZN#\O$-<)S/
M6 @[F!OE(^O;TZ/.+JNH%(G@(X-7AB8+Q0T\B$2Q0>>ID91C*5C.1?<2;FQ=
M@?NW+3'\JR6"J7J;0X0@Y8MH$F(YFR+9\&Q,Q([ZV.W CLG(^^ 5&_D83UC%
M\ WJ=Q7&%MT&]0*[9#Y?RK'MSU5;21_CPD(KBB+O4\I&O_0(/23OJ$.<'1_/
M&1_(8^+\[$+M=6Z_DGE%",EL'$-RM\%RDR\B54V].D?:RC'1_ 9,2072-+[2
M@.,_&I.=R5BR'X\5M_'7NB)G"JR%U"2B(K:#-<")!-%  P71$2YRS'BPC+]1
M^M+TSE2:"P]&[Z3$;.+>!N!3F')>7L7.9]([]?%ZRARKWABW;5Q.AO@=,N$=
M,8',FI.H;)*A\=8/?TZ 02N-U.GR(;2";RJ1Y=OD'% 21*) 7>4.R"_KY L/
M L&\)/(17$$(G[$]@D6D4(P,2WH8C>B05,\AF8F!-#4.EU@AC":94PMNO[/1
MX0"XU=/L;GGRO(_/%3@U* 16'QBUA9:C1<EJUSH]:(\A"04<C8@SSN.E&K38
M)VB"8X9'7X.-"5VZ6&:2)D%H;QQ%=4D-IJ].'@#E)6O;V6W#J3>?#,X0MS$Y
MMD #(",M$".2'J$-/29D*MN<XF(,U3SOL'G!=MH#YKR;9]K&35>$N\S&\2[O
M&@AP.!%U6+#"\K"V'K#'_IZ(/%%9^@;<"X2(?V'5E^J]%"]#\N'Q9Q7-PIU7
MM"%'TS76SY;);"F*,S:?\+N>0$E1!TQD7HN6F-;#8TJ#%5CJ>:7EP'[V=!"%
M4SS- 1#VQ2!/HCEK<&!M8Z.@\9:HK5D&U">7'QSB)/D[A_"NRN@Z5-/ZB_NE
ME"R%LWOIZ6J9*..UJ,H28SOA4Z]8@^U4S,*\812+XZL]/ ]GA%\YS$$0#!CV
MI\^C87^C%ZV8YQ3^@F-\+CU1]]VB;;:06#ZC+V?S[_WC/R?P&8\H12\!4>R:
MTL\3<Y\_"]-/L]OF$.Y3>)M*>0%V&1=H<=*9)V/2 8E:DC)LK2F"L-%4_B"Q
M8^J-G)1Z_+BX&G75%JW/TGQSFP+'<SPKJE]S;)[N8]QF1%#,;!P5<\>XG#;_
M<L(H? ,2ID8#':<]E9&99$QV(DIX_C0*D\SY"XZ/>"@>1&64PIJ%6("DMAI3
M>^G24<EBL1\":V8I2G;OR4W0Y]0/##WI4 :*@N*"I$3L4T3XD63 :@NJA&"(
M,0C.)3((5>%#A]!X5+K.V=G#-)81H?APOO,]+'0\"RHU:08&4T[;%^?CP '1
MNQ:++;]Z/Y5%\ A.!OS%T2=0KC1?,'5PNA/L'-0:X06YW4]XB;(K].#3'$^2
M9&RP0E>9SP@;@0W5&09> 9Y*Z>FIMEM$?T!>0E8*F!_\;@+<P:944#:IXO4]
M_@"1J1G%HJ2'1*MVUYR[5F^Y!@=96D:;#95Y[%OS.8+!#I4=F)?@7 &NPR &
M13,9+HM);L<6.GD /GR&,Q4PG3_"A9;OJ=P XS.K(8ZL%<EZC)8,Z\5.^X@O
M%BTUGA]RR(?'(E1<H#H\&HJ)\?>)P+-U9+8H'P$_J'>!5TE:\=F]O7B!=9U#
MSO")Y)"QM&GN N+75%VH;=2Q/0M<![F@  &U1ZKV<!*%CM@OA]7+,DN8ZX_$
MT^/#! D,*@06(.J&S39S05A >W]V\0]U)L@([ %2$>UQ8$]/8!D@TU4<HV0@
M32V+S]<EF:!1T2*AW>SJ),;NR5$?)\4CQOU$! /.QM& 'P7=+Q.?K.)] QRP
M08S'T>R)MCE=511(@?T &QT:](@W#G SK#J07%)_CL%]M+ZZWN1_P'P8G*$X
M? K76?HJ[P2U&SJ1&=7")\D:7-*)J9+HES0E+B\4)K&5^NX"PMH]+'5+97>>
M3:(J>M;%A],@-AR:"Y<IR,-D8J+Z(42_PW\(TDXPV1)4D^QX)LIX7[DZ,"-,
MVF%''MP2@G^[GHOTP:[0-C@9Q_0@ZZUX,"H*Z9P[7KU+(2D[NFT9<)HIN"P+
M"\ANA%Z78!JE[]NGUL3N)MA^=&B-(#_I&5^M$-[W#'X,S0Z!IGYMDYX1'?#?
M+Y\%V >1UO]B6/$GB>:+RP7F57N!)?6PI[)T=A ZEKJPW!F)>U$Y <5;@95
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MX #X?=F =90/N$#X]R!>_1]02P,$%     @ N4.*5JAYE3R1 @  I 4  !D
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M2_2T2E&LZ.T"&P+(OT+T.R5<T+^&^1]02P,$%     @ N4.*5AZN(KJ% @
MR 4  !D   !X;"]W;W)K<VAE971S+W-H965T,CDN>&ULM51-;]LP#+WG5Q >
M,+1 $'\D:8LN,1"WV]I#MZ)IM\.P@V+3L5!9RB2ZZ?;K)\F)FVUI;KM8(D4^
MOB>9G*R5?C05(L%S+:29!A71ZCP,35YAS<Q K5#:DU+IFI$U]3(T*XVL\$FU
M"),H.@EKQF603KSO5J<3U9#@$F\UF*:NF?Z9H5#K:1 '6\<=7U;D'&$Z6;$E
MSI$>5K?:6F&'4O :I>%*@L9R&LSB\VSDXGW %XYKL[,'IV2AU*,SKHMI$#E"
M*# GA\#L\H07*(0#LC1^;#"#KJ1+W-UOT3]X[5;+@AF\4.(K+ZB:!F<!%%BR
M1M"=6E_A1L_8X>5*&/^%=1L['@60-X94O4FV#&HNVY4];^YA)^$L>B4AV20D
MGG=;R+.\9,32B59KT"[:HKF-E^JS+3DNW:/,2=M3;O,HO9;$Y)(O!,+,&"0#
M1_?,6N9X$I+%=U%AOL'*6JSD%:PX@1LEJ3+P7A98_ D06F(=NV3++DL.(EYB
M/H!AW(<D2I(#>,-.[=#C#5_#XR87RC0:X7,)_VJ_QV>"3*C\$;[-%H:T_6F^
M[[N(MLQH?QG72.=FQ7*<!K93#.HG#-*W;^*3Z-T!$:-.Q.@0>CJWC5DTEK0J
M@10Q ?Q%"/-"]E$^"+J?LKU^K!>HNR?H?=3*&)C5JI$$LSQOZD8PPL*Y-/%?
MS+?:)SM,,B:8S+'W,)@/H%!",&TL4:!*-8;)PO0R[188]T_/AG 4]X?#&(YA
MU!^-D][?E>/_6/GT)+%UQWU;!?8]3[C3737JI9\A!G+'I&VTSMN-J5G;G2_A
M[8R[87K)I0&!I4V-!J?C '0[-UJ#U,KWZD*1[7R_K>RH1>T"['FI%&T-5Z ;
MWNEO4$L#!!0    ( +E#BE:J:]+$9@(  $@%   9    >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;'U436_;, R]YU<0WC"TP%9_)&F++#'0M"LVH 6"MML.
MPPZ*3<="9<F3Z*;]]Z/LQ,V&-!=+%,G']V12T[6QCZY$)'BNE':SH"2J)V'H
MLA(KX4Y,C9H]A;&5(#;M*G2U19&W294*DR@Z#2LA=9!.V[.%3:>F(24U+BRX
MIJJ$?9FC,NM9$ ?;@SNY*LD?A.FT%BN\1_I>+RQ;88^2RPJUDT:#Q6(67,23
M^<C'MP$_)*[=SAZ\DJ4QC][XEL^"R!-"A1EY!,'+$UZB4AZ(:?S98 9]29^X
MN]^B7[?:6<M2.+PTZJ?,J9P%YP'D6(A&T9U9?\6-GK''RXQR[1?67>SX+("L
M<62J33(SJ*3N5O&\N8>=A//HC81DDY"TO+M"+<LK02*=6K,&ZZ,9S6]:J6TV
MDY/:_Y1[LNR5G$?I#;(D!T</8JG0'4]#8E#O"K,-P+P#2-X B!.X-9I*!U]T
MCOF_ "&SZ2DE6TKSY"#B%68G,(P_0A(ER0&\82]QV.(-#TO\=;%T9+D+?N\3
MV4&,]D/XR9BX6F0X"[CU'=HG#-(/[^+3Z/,!@J.>X.@0>GK/DY8W"L$44#34
M6 3E.4,M7KC_R4'#5VN!)]$*DGK5N=T^'0<K[=?!USR$]S ^'_!N](D_8S;C
M:#AX,"34EM)_U5_)<>QI/+A!YR8@J[HAS$%J0BY [#Q*(C@>+'PY3? D5-,*
M[4"4%$NI)+UXE%$,^VXSW.GN"NVJG6$'F6DT=8W>G_;/Q$4W':_AW1MS*^Q*
M:L?%"TZ-3L[& =AN;CN#3-W.RM(03UZ[+?FI0^L#V%\80UO#%^@?S_0O4$L#
M!!0    ( +E#BE8P8=C?D@(  )$%   9    >&PO=V]R:W-H965T<R]S:&5E
M=#,Q+GAM;'U4RV[;,!"\^RL6*E"T0&,]_,BCM@$[2=L #6K$37LH>J"DM46$
M(E62BI._[Y*25:=P?#')Y>QP=JW9R5;I!U,@6G@JA333H+"VN@A#DQ58,M-7
M%4JZ62M=,DM'O0E-I9'E/JD481)%X[!D7 :SB8\M]6RB:BNXQ*4&4Y<ET\\+
M%&H[#>)@%[CCF\*Z0#B;5&R#*[3WU5+3*>Q8<EZB-%Q)T+B>!O/X8C%T> _X
MP7%K]O;@*DF5>G"'FWP:1$X0"LRL8V"T/.(E"N&(2,:?EC/HGG2)^_L=^R=?
M.]62,H.72OSDN2VFP5D .:Y9+>R=VG[!MIZ1X\N4,/X7M@UV0."L-E:5;3(I
M*+EL5O;4]F$OX2QZ)2%I$Q*ONWG(J[QBELTF6FU!.S2QN8TOU6>3."[=G[*R
MFFXYY=G9-UN@AB5[9JE  ^^^^_7])+1$[B!AUA(M&J+D%:(X@5LE;6'@6N:8
MOR0(254G+=E)6R1'&:\PZ\,@_@!)E"1'^ 9=J0//-WB%;T4?=%X+!+6&_\K^
M-4^-U?2%_#Y4>$,[/$SK7'-A*I;A-"!;&-2/&,S>OHG'T<<CHH>=Z.$Q]A>B
ME1==M:(/*3W*=5@I=1G+E'BITSW7:=?NN'??7_4A5T(P;8!+L(6J#9.YZ7U6
MCZ@E^=)2W%AN:V<O X,QQ%'4NRXKH9Z1FDIHLJU@%G-(4>*:6P/#<QA%O:](
M1@+!6<H%MYS PPA.>O,LTS6A;Z1%$FCA!)+S81?&)QI%IF5^V0Q(QF-(3N/>
MX#R&TW@$AUH?[MFD1+WQP\! IFII&\=TT6[>S!N;_8,WP^J6Z0U5#P+7E!KU
M3T<!Z&8 - >K*F^Z5%FRL-\6-#-1.P#=KY6RNX-[H)O"L[]02P,$%     @
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M ^T"\+Q2RNX-5V!X+/._4$L#!!0    ( +E#BE;@R=_OD 0  'H,   9
M>&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;*5746_C-@Q^]Z\0/&Q(@%YC.XF3
M9DF MMFP/MQ67'LW#,,>%)M.A).MG"0W[7[]2-EQW<[)6@P!;%DB/Y/?1\K*
M?*_T5[,%L.PQEX59^%MK=[/!P"1;R+DY5SLH<"53.N<6'_5F8'8:>.J<<CF(
M@B >Y%P4_G+NYF[U<JY**T4!MYJ9,L^Y?KH"J?8+/_0/$Y_$9FMI8K"<[_@&
M[L!^WMUJ?!HT**G(H3!"%4Q#MO OP]G5A.R=P1<!>],:,\IDK=17>KA)%WY
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M\:SJAEO\<P":#' ]4\H>'N@%S=^-Y3]02P,$%     @ N4.*5AM),#YL @
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MK,_\L+87&RB78-<WTAZ//G ;#%=E\1=02P,$%     @ N4.*5K)=O5Y  P
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MA&]0" =$:?RSQPR.(9WCZ?B _KOG3ES6S. ;)3[RPI:S8!) @1O6"/M>[?[
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M[QZKC\*L)2E0N*+4='!.'IGN >@F3K>AZ>;:40L/PXK>3#0^@/97FGCO)KY
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MXYGM2VGSQRJ077F\EB_6W@=II&;#5[FZ6=V#B4GV5G:VSG]X90?KE-8'K+J
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M#ZKY4"V :B%4BU":&-NFG%'=U&V]S1=/56BY(U2SH)H-U1RHYD(U#ZKY4"V
M:B%4BU":&.2F0E*5ET@>_1:JO'WOK$+K(Z&:#=4<J.;6VO'OHD*[]:%: -5"
MJ!:A-/%6)$VII"8OE6RJ.,A3_?6<W8\5NX(I%_L&$ZI94,V&:@Y4<[7]JE!M
MHAFF9K:"">W6AVH!5 NA6H32Q& VM9*:O!ZO?PVS'.R=2VAA9*T=KV&&=NM
M-1>J>5#-AVH!5 NA6H32Q%PV96&:O*#GU1_MRYW><8260$$U&ZHY4,W]$:WK
M4JJ'@GSH_ 50+81J$4H3D]H4X6CR(IS;99R7Y";/I-=VY4COF$(K<*":#=4<
MJ.9"-0^J^5 M@&HA5(M0FAC8IO!',][PVJX&+?&!:A94LZ&: ]5<J.9!-1^J
M!5 MA&H12A.#W)06:?+2HOHCU7CZ]SK)V1FL_&OP<JQW<*%%15#-AFH.5'.A
MF@?5?*@60+40JD6U)MZ2P%1V2I'%2#;%1YJ\^.AFG=/OY#K+5_+1,+3>"*I9
M4,V&:@Y4<Z&:!]5\J!9 M1"J12A-3&Q3H*2-WW(T#"U9@FH65+.AF@/57*CF
M034?J@50+81J$4H3@]R4+&GR6[#U' U#2Y2@F@75;*CF0#47JGE0S8=J 50+
MH5I4:WNC8?W :+@I/M+DQ4<!O;\OZF\+D\\Y?[*,?%@,K46":A94LZ&: ]5<
MJ.9!-1^J!5 MA&H12A.?.],4+.G*&PZ+=6CM$E2SH)H-U1RHYD(U#ZKY4"V
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M4X+?X\FP%8IIA5M)UY)I]'7(3#=I3"H;NT/..9&G.G<FLIYSEYUSETZ1"RA
M2LCQA,"""<1,*#WH5D.46")SWSRD<9),_8=]7YR#G>K+F<AZOB2=+XG3E[\
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M!I 68/970NC'B>T^W<\F^P-02P,$%     @ N4.*5O\%Z"61 @  M@8  !D
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M30"^CX70VXGI2<TG2/ /4$L#!!0    ( +E#BE:Q%T^IDP4  (0O   9
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M4=[6#Y2$:_M!#AMF,#D;W,^-@1C2]U5[0P:T(6$.),R%A'EM]]6LWU<?,F
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M&N6=G6M[LFG638"BLOUN*5!W3SO,]?T&TB3H]4P(W :FA78W9OP'4$L#!!0
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MR!%])(PB80$2%B)A# 1K*&E;]?%*ZY4MX9/>] GY@ZA2S_-[(6905S<KVNA
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MNJ.I;J9H1G 3*%[:*;;F2L]$N\STK07").CW&\[5(3 %NGLP_@U02P,$%
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M\PMF3M:4:!*/I=@@::,-FKUQWKALHX9R^S<^:&G>4I.GXT?R! H9/^]X(C)
M9U/0A#)UCB[0@UDS:<X B;EU!J2$%&F70)0";2X\18R2&6544S-\@;X_3-'9
MVW/T%E&.'I<B5R9&C7UMN-H9_:3D=5/P"EMXX1!]%EPO%?K$4T@/ 7PCLE(:
M;I7>A)V(4T@N483?HS (PP9"MZ>GXPXZ465\Y/"B5KR=H86=3285&+UF#+O%
MK]6*)##QS!Y6(-?@Q>_>X$'PH4G@/P([D-NKY/:ZT.,[K@E?T)E93<7::5);
M0 P<A#U_UC'&P=A?[XNHQ_0'5<@!M7Y%K=])[>L*)-&4+Q #<R @:7>^7?.Y
M@O9_IL#L[_&(PB.JG=.^TN]!)6IPJBBA%$J(E,_FT-\0F3:I&=34C*Z.G:_'
MX&'8;/VP8CGL9/DH-&$'9TO'ZAC6YP]JGM>#PG#43')4D1QUDOQ!6$Z*FL-,
MU2,\@29ZH]K,%W4/&X):3;RJ^%V]SD1$YAHD6I_&_ZIN;^_8W7I,V^;#P:X
M!9WTIW1NF(-AI= ,] : .PVF.-.BPKC%:Y>R5>*J$1.$-Q>5SKE>>F"6: >;
M?!BT"-ZKN/A%Y\VV@#XW"L)_/V>ZYWOE08/#G9[PI>NO6U)X@J2&F%;G=R47
M=Y:X^(MIBYOVR=E>#W/>2#DZH3(U!%U$N'=$VM_KU3*0"]?"F@-:Y%P7S4PU
M6K7)'UUS>#1^8]MGUP/N8(K>^S.1"\J565YS QE<#HV-LFAGBP<M5JXCG EM
M^DMWNS2? "!M@'D_%T)O'^P$U4=%_ =02P,$%     @ N4.*5G+)YC&>$@
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MG5V+-;N_UE7;$C/<RL=Q7?/D:Y:@S.ZA=4;)!0O]&+%HF1+SG+!3'EE=)M7
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M-GAWP88$7-\9XT]!Z*?I;U#^!5!+ P04    " "Y0XI6!^J$)SX$  "A$0
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M-,)^TN9J,0K:7)T!_037:,LU<G)]I!(I2+FI D#-LIYB47U010$Y*AA1:T(
MU1VK D&4*#G0=>' JJA'W"4<!>VR8#&*AV%;%@M2M#7:I[SM1D-GSY9^E@7B
MS:=Q4_VL3&)+D&TB79NPD\H6FT,TMKUAZ&X.][_P3AJ]SO#]L+,DNT9)+VX3
MZ1I%<72 R;9]"]W]V\.!C9K9IUD)]2UM;1STVY2Z9DETW:;4->I2\G?VKB7B
M<W,&(("I@=6NKGG:G#/<FMUUZ_F=/G\P>^(M3'5X\1'R.5;+CJ"9@@RN!BHN
M7IT'5#>2+<P.^85)M=\VEP6":F%J _5^QIC<W.@!FE.9]%]02P,$%     @
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MK4F+!&Q#LTA_$=L5*SHT-#Q?1,K^)=N\[6#0(GZFM(@+8X@@YDG^/_U1).+
MP'5.&+B%@7MD,.F=,.@7!OUC#^X)@T%A,'BKP; P&+ZU#Z/"8/16#^/"8/Q6
M@TEA,+&CFP^''<LYU71V*<662-,::.:%%82UAB'DB='N@Y;P*0<[/7O(UHI]
MSUBBB?<$?Q5Y/V>:\DA]N.QJ<&":=?T"-L]A[@F80^Y$HD-%O"1@08V]]XJ]
MVP#H0L_*[KF[[MVXC<0[*CO$G;:)VW/[1(54,E43UVTS9<'60.GGE+JTO"&(
MOE,$\?5A3MZ_J\NNUXR9,[_$N V8Q5M2XKZ6DN4;*+WIJWU:G8/QOGXA[W_^
M:=(?#2X^-(Q^OQ1WW]+[YXN;_/5O:$P^:Q:K_]3$?9.3!_5D<T?YI%+JLZL6
MW#(4DT^L-?OY)V?4NZB3%R9LC@GS,&$+3-@2$[9"@E54."A5.&BBSQ[L%(.[
M]/>,2Q:0)QIEK$YRC9AS)8<)FV/"O!PVLC"SM'J:N9.)VY]<=I\.Q83I<XD)
M6R'!*F(:EF(:-HKI.O@;%@6@HKQPGQ93(^9<,6'"YI@P;_A"3/V>^7<D)DR?
M2TS8"@E6$=.H%-.HN3(=W1_)7W<L7C-9>T-L1)TK*$S8'!/F8<(6F+ E)FR%
M!*O(;ES*;OR/+<O&F"K$A,TQ81XF;($)6V+"5DBPB@HGI0HGS<5/"_\;23/I
MAU0Q0A\E8['19,"4+WEJME;J%-A(/5>!S2'^EA!X])09E<_EXV>;Z)"16Q&G
M-'DF- G(+VRS4?#4Y#KC"W(CX9(B*Q$%/'E4!#K$S**3)UH02M2I3F^Y#LF#
MSQ]2*GWRWO@P2+=W\2>+HLSN,UWO6MM/G(L/;4)A70M7X&&=0 -XFO/#_;/E
M^IE<!P%\FL7D5]$A#H$8#+D&67&YL]K[@8A51DV<(??#]DMG[>8TE(OOC13Q
MOI_#\6X=)3;$%W$,W#Q%\+YL];7ST(&N@F\11<\?Q38QZR\H8CS@9F@.V^J0
M:@(ME!T:D3))->#+'AN.%NE'!1<@,G(=T_^"TXT0!IFFD<U&;NT+%3/-?476
MICMMX_-OYNM=&B&<8$TA6$AT&0 $XSB[7L'PY&I>0\1KLU'9)I)982;:N*=I
M*L4/'D.0T3,93/]E[ V;*Y6!C>U$II6&%Z;]*SG:"'F$?-<G,8>N@A%/B$]5
M2-[SQ(\RBS.>[B7W&<G7M:;O[3SJ#4]V,</X@RL[\L=TMS,L^5NP2RF'H+4%
M^Y%0QDF]F'^'E"IJ-U!W,NN0WT.VERPX>N)&V:97AI'29RM52'>FS" <)ITF
MA 8!-SP:P:00&;2$Z^\&DVF[W^^5W2]INTF8V@30,@&J$O&+].RBA8&,J'D2
M@$!X8NZC0N8%P>P6V\&B*=<T:IO Z3IB)H0-?V($;KX0(T]@6*,H=VDBG8[;
MD]'(S"WC7\/UD 34ZIM1R+TO$L7\S&PV SN"+%%)8K-AUX:!>N1)8KQR,S6?
M[:3LD&L%5I&)4X+'XT2:>+(HVFGNI1+*!(<L C$8K>_%_<J4;1>*V8(\(#R3
M+@;IMOEJK!4B@2A,/"!!"+H,5I&8!JQ#[G>UZ'0U:]O1%DE2[-#;ZGJHR:+'
MM7*LK6Z'1?^HIIMAR:)\.I^HYV9V5E15?G*[-ZXI[^E!5_-L'L9A,UO,$LA-
M0A]SW^:N!R-9G2(VA)T ]OVVE2VO&[F48%9O&+-Z='O06&3*#H]I]L*Y9#XS
M:J20,O91\Y@1Q1^M#-<B@4G*<RT?3,>ALX?F$[XQ%V;8;70)R9)=58*JSJ%>
MFT$T+DUH,4A^;2:-C$$U9EI"E6 P"$R"@J1^SD<$Z@#,*.A-\$2-S!(!]9UU
MZM:3F.L,#Q.VP(0M,6$K)%AE/3DMUY/3YL6:A/)AE@-%>2KNH'"W(_D.X ?R
MO]/;[3<Y?'BXD3'JN=-Q=2/CMC&&<Q]9,&$>)FSQ,AON8#QPAM5L+#%]KI!@
M%?$XO?TY7.\MN\2%:J#"^%!]H*+6::5 30[2T^O4B*79Y;EJ0:5YJ+0%*FV)
M2EMAT:K".CC@==XBK,-5_"OJ<NK4-9A.C]75Z/=L=6'2/%3: I6V1*6ML&A5
M=;E[=;F-ZOI<_YQH[W.[!Y!:D35BS]U&0:7-46D>*FV!2EL6M,I97*_F_&15
M-'3ZE3OR0;.J?/8']$[CR>OL;K_DKU4)ZBD\*FV.2O-0:0M4VK*@'1^R'4ND
M7R.1X4F)[$_/G>;C<WC<+BM)\2!7*Q74TW-4VMQY>>3='[K5_'FH+A>HM"4J
M;85%JPIJ?X+N-!^A_[9-F%0A3QN/.YLA9^L)]00=E>:ATA:HM"4J;85%JPIO
M?]KNC/ZQ<T\']?@=E39'I7FHM 4J;8E*6V'1JG+<G\([C<>K!W4PXC'<7>U^
M["N/AJC'[ZBT.2K-*VBO/00O4+TN46DK+%JNK^[!E\QC)A_M#P[,\0XLR/(O
M9)=7RQ\U7-NO\A]=7YH?.]@OK^\Q^2\E[JA\Y(DB$=L LM<90[V6^8\/\C=:
MI/:K[&NAM8CMRY#1@$G3 #[?"*%W;XR#\B<@L_\#4$L#!!0    ( +E#BE8T
M:??97@,  "85   -    >&PO<W1Y;&5S+GAM;-U8T4[;,!3]E2B,":2)- VD
MS6@K;960)FT3$CSL#;F-TUIRG,QQ6;O'?<[$5^U+YFNG25M\$? PZ%*5V/?X
MGGM\?9V8#BJUXO1J3JGRECD7U="?*U6^#X)J.J<YJ4Z*D@J-9(7,B=)=.0NJ
M4E*25N"4\Z#;Z<1!3ICP1P.QR"]R57G38B'4T.\W)L_>/J5#/XQ/?<_2C8N4
M#OV;H[??%X4Z?^/9^\&[@X/.S?'YKOW( ,=^X"0]>P3I20?GU1A&'6]3KX<?
M:J[&]Q!S[CU*UP.R,.*^0U4K"=63N"=C,G/4]A#W7L<]G3^_?B.KUR(/KE\O
MQ(CO4.*[^\1!78&C05:(MA CWQIT9))3[Y;PH3\FG$TD Z^,Y(ROK+D+AFG!
M"^DIO0.TE! LU4\+A[8'FZ/FR9DHI(EM(]B_DWKX#K#N@4#&>2.PZUO#:% 2
MI:@4%[IC!AOC/<BKV]>K4BN<2;(*NV=^ZV!N.LBDD"F539C07YM& TXSD"/9
M; YW590!@$H5N6ZDC,P*08R&M4?=T+13ROD5/#F^95O<RVQC34VIB*:I!=5-
M2V,[P+_)9KDW:4^?Q>N5[+90'Q=Z.L+TH5+HI:096YK^,FL$8.PASD[*DJ\^
M<#83.;63?W3 T8"L_;QY(=E/'0U*9:H-5/K>+96*33<M/R0IK^E2K<MIF>&:
MNWNH^=_F>48%E81OBM:U_YJS_&S%4>^E))NGRJY@I\;Z./#:19[M@\AX'T3N
M14WV]T%DL@<B>R_VU'R*R/!5B@SJH]#&>6OKM-58/3C5#OVO<'[F;5!OLF!<
M,5'WYBQ-J;AWZ-+TBDST/X%;_'I\2C.RX.JZ 8=^V_Y"4[;(DV;4)22B'M6V
M/\/TPK@Y4NM83*1T2=-QW96SB6EZNJ&CUA<X["(7YG(CF(_%W A@6!Q, >9C
MO; X_]-\^NA\+(9IZSN1/NK31WVLEPL9FP\6Q^V3Z,L]TR2)HCC&,CH>.Q6,
ML;S%,7S=;)@V\,#B0*2GY1I?;;Q"'JX#;$T?JA!LIG@E8C/%<PV(.V_@D23N
MU<;B@ >V"ECM0'QW'*@IMT\4P:IBVK =C"-)@B%0B^X:C6,D.S%\W.N#[9(H
M2A(W IA;011A".Q&',$4@ 8,B2+S'MQY'P7K]U30_C(Z^@M02P,$%     @
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M:[?O0;GBMMA_B+[_B/[R7U!+ P04    " "Y0XI6M\<#,$("  !"*P  &@
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M\[GE>OG+\GOGY%:YX%S?5@Q/?P%02P,$%     @ N4.*5OC# AT& @  3RH
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MZS]02P$"% ,4    " "Y0XI6!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( +E#BE9D?U6/[@   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( +E#BE:97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ N4.*5MK!]3OB!@   B$  !@
M         ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( +E#BE;:@0U9/08  "L<   8              " @24/  !X;"]W;W)K
M<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "Y0XI6(=UD7I<"  !Y!P
M&               @(&8%0  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!
M A0#%     @ N4.*5D-A=XK%!   )Q(  !@              ("!91@  'AL
M+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( +E#BE9F7'=>XP(
M -D'   8              " @6 =  !X;"]W;W)K<VAE971S+W-H965T-2YX
M;6Q02P$"% ,4    " "Y0XI6AN2:A@0&  #/(@  &               @(%Y
M(   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ N4.*5D=&
M?,1;"@  -S@  !@              ("!LR8  'AL+W=O<FMS:&5E=',O<VAE
M970W+GAM;%!+ 0(4 Q0    ( +E#BE8>"WXZO1    PQ   8
M  " @40Q  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "Y
M0XI6]T_'UX$=  !(5   &               @($W0@  >&PO=V]R:W-H965T
M<R]S:&5E=#DN>&UL4$L! A0#%     @ N4.*5L>:0VZE @  B 4  !D
M         ("![E\  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
M    " "Y0XI6V<7CH%T"   =!0  &0              @('*8@  >&PO=V]R
M:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( +E#BE:1KUF":P0  -$)
M   9              " @5YE  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL
M4$L! A0#%     @ N4.*5C]X(F"* P  Y@<  !D              ("! &H
M 'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "Y0XI6M0I:
MYJ<"  ":!0  &0              @('!;0  >&PO=V]R:W-H965T<R]S:&5E
M=#$T+GAM;%!+ 0(4 Q0    ( +E#BE9 _75A;@<  ,02   9
M  " @9]P  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @
MN4.*5CK3XTS)"@  UAP  !D              ("!1'@  'AL+W=O<FMS:&5E
M=',O<VAE970Q-BYX;6Q02P$"% ,4    " "Y0XI6'[(<HBD+  !4'P  &0
M            @(%$@P  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4
M Q0    ( +E#BE98D@HK=P<  , 2   9              " @:2.  !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ N4.*5M W[W(P$
MK3(  !D              ("!4I8  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX
M;6Q02P$"% ,4    " "Y0XI6>I6Q6>L"  !#!@  &0              @(&Y
MI@  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( +E#BE8@
MH%N[6P,  %$'   9              " @=NI  !X;"]W;W)K<VAE971S+W-H
M965T,C$N>&UL4$L! A0#%     @ N4.*5IYH'/8*!   Z @  !D
M     ("!;:T  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
M" "Y0XI6N)YR.<\'  #Q$@  &0              @(&NL0  >&PO=V]R:W-H
M965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( +E#BE:,E3EJ1@D  /H7   9
M              " @;2Y  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L!
M A0#%     @ N4.*5B5QI-(1'P  &V(  !D              ("!,<,  'AL
M+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "Y0XI6J'F5/)$"
M  "D!0  &0              @(%YX@  >&PO=V]R:W-H965T<R]S:&5E=#(V
M+GAM;%!+ 0(4 Q0    ( +E#BE8NWA 1D@(  'P%   9              "
M@4'E  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ N4.*
M5AJ;>P%4 @  &04  !D              ("!"N@  'AL+W=O<FMS:&5E=',O
M<VAE970R."YX;6Q02P$"% ,4    " "Y0XI6'JXBNH4"  #(!0  &0
M        @(&5Z@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0
M   ( +E#BE:J:]+$9@(  $@%   9              " @5'M  !X;"]W;W)K
M<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ N4.*5C!AV-^2 @  D04
M !D              ("![N\  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q0
M2P$"% ,4    " "Y0XI6Q0WELFL"  ! !0  &0              @(&W\@
M>&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( +E#BE:^(+O9
M>@,  .,'   9              " @5GU  !X;"]W;W)K<VAE971S+W-H965T
M,S,N>&UL4$L! A0#%     @ N4.*5GN":[M9 @  . 4  !D
M ("!"OD  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " "Y
M0XI6X,G?[Y $  !Z#   &0              @(&:^P  >&PO=V]R:W-H965T
M<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( +E#BE8;23 ^; (  #8%   9
M          " @6$  0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#
M%     @ N4.*5K)=O5Y  P  .0<  !D              ("!! ,! 'AL+W=O
M<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "Y0XI6N?N!/&X#   C
M"   &0              @(%[!@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM
M;%!+ 0(4 Q0    ( +E#BE9WMVK<)P,  )$'   9              " @2 *
M 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ N4.*5F+#
MMR1/$   <]0  !D              ("!?@T! 'AL+W=O<FMS:&5E=',O<VAE
M970T,"YX;6Q02P$"% ,4    " "Y0XI6#<(?TZ8#  !W#@  &0
M    @($$'@$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (
M +E#BE;';"7S)@,  !@*   9              " @>$A 0!X;"]W;W)K<VAE
M971S+W-H965T-#(N>&UL4$L! A0#%     @ N4.*5HM73XC] 0  #@0  !D
M             ("!/B4! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"
M% ,4    " "Y0XI6XX2/<P #  "'"   &0              @(%R)P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( +E#BE;&AQKM70(
M #(&   9              " @:DJ 0!X;"]W;W)K<VAE971S+W-H965T-#4N
M>&UL4$L! A0#%     @ N4.*5D/F*ZS& @  V0@  !D              ("!
M/2T! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "Y0XI6
MG[>((XH"  !X!@  &0              @($Z, $ >&PO=V]R:W-H965T<R]S
M:&5E=#0W+GAM;%!+ 0(4 Q0    ( +E#BE;_!>@ED0(  +8&   9
M      " @?LR 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%
M  @ N4.*5KM].*&/ @  6@8  !D              ("!PS4! 'AL+W=O<FMS
M:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " "Y0XI64Y4N3M8"  "."
M&0              @(&). $ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+
M 0(4 Q0    ( +E#BE:Q%T^IDP4  (0O   9              " @98[ 0!X
M;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ N4.*5NQ4+5B'
M @  /0<  !D              ("!8$$! 'AL+W=O<FMS:&5E=',O<VAE970U
M,BYX;6Q02P$"% ,4    " "Y0XI6OJ*MW(X(  "K7   &0
M@($>1 $ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( +E#
MBE:F4);R70,   H*   9              " @>-, 0!X;"]W;W)K<VAE971S
M+W-H965T-30N>&UL4$L! A0#%     @ N4.*5LH%PB>P P  [@X  !D
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M=#4Y+GAM;%!+ 0(4 Q0    ( +E#BE:HF$I\2P,  $$-   9
M  " @6)F 0!X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @
MN4.*5J+*YMZ0 P  1@L  !D              ("!Y&D! 'AL+W=O<FMS:&5E
M=',O<VAE970V,2YX;6Q02P$"% ,4    " "Y0XI6U^_RC(8#  !@#   &0
M            @(&K;0$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4
M Q0    ( +E#BE9RR>8QGA(  (;=   9              " @6AQ 0!X;"]W
M;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ N4.*5O(,B(FM @
M(@<  !D              ("!/80! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX
M;6Q02P$"% ,4    " "Y0XI6<9JD9/0!   9!   &0              @($A
MAP$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( +E#BE8'
MZH0G/@0  *$1   9              " @4R) 0!X;"]W;W)K<VAE971S+W-H
M965T-C8N>&UL4$L! A0#%     @ N4.*5@[:K.%) P  E D  !D
M     ("!P8T! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +E#BE8P4(T.X0(  +$)   9              "
M@8.C 0!X;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ N4.*
M5L[:F5%]"   #C(  !D              ("!FZ8! 'AL+W=O<FMS:&5E=',O
M<VAE970W,RYX;6Q02P$"% ,4    " "Y0XI6-&GWV5X#   F%0  #0
M        @ %/KP$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +E#BE:7BKL<
MP    !,"   +              "  =BR 0!?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( +E#BE9/E:\:*P4  ,@O   /              "  <&S 0!X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " "Y0XI6M\<#,$("  !"*P  &@
M    @ $9N0$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" "Y0XI6^,,"'08"  !/*@  $P              @ &3NP$ 6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     40!1 "X6  #*O0$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>124</ContextCount>
  <ElementCount>424</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>34</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>001 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>002 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>004 - Statement - Consolidated Statements of Operations (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals</Role>
      <ShortName>Consolidated Statements of Operations (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>005 - Statement - Consolidated Statements of Changes in Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>007 - Disclosure - General Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/GeneralInformation</Role>
      <ShortName>General Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>009 - Disclosure - Other receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/Otherreceivables</Role>
      <ShortName>Other receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>010 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>011 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>012 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>013 - Disclosure - Other Payables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/OtherPayables</Role>
      <ShortName>Other Payables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>014 - Disclosure - Short-Term Loans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ShortTermLoans</Role>
      <ShortName>Short-Term Loans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>015 - Disclosure - Derivative Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/DerivativeLiabilities</Role>
      <ShortName>Derivative Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>016 - Disclosure - Loans from Shareholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/LoansfromShareholders</Role>
      <ShortName>Loans from Shareholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>017 - Disclosure - Taxes on Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/TaxesonIncome</Role>
      <ShortName>Taxes on Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>018 - Disclosure - Share Capital</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ShareCapital</Role>
      <ShortName>Share Capital</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>019 - Disclosure - Share Incentive Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ShareIncentivePlan</Role>
      <ShortName>Share Incentive Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>020 - Disclosure - Finance (Income) Expense, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet</Role>
      <ShortName>Finance (Income) Expense, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>021 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholders</Role>
      <ShortName>Net Income (Loss) Per Share Attributable to Ordinary Shareholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>022 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>023 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>024 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>025 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>026 - Disclosure - Other receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/OtherreceivablesTables</Role>
      <ShortName>Other receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/Otherreceivables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>027 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/Inventory</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>028 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/IntangibleAssets</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>029 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/Leases</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>030 - Disclosure - Other Payables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/OtherPayablesTables</Role>
      <ShortName>Other Payables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/OtherPayables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>031 - Disclosure - Short-Term Loans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ShortTermLoansTables</Role>
      <ShortName>Short-Term Loans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/ShortTermLoans</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>032 - Disclosure - Derivative Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables</Role>
      <ShortName>Derivative Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/DerivativeLiabilities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>033 - Disclosure - Loans from Shareholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/LoansfromShareholdersTables</Role>
      <ShortName>Loans from Shareholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/LoansfromShareholders</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>034 - Disclosure - Taxes on Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/TaxesonIncomeTables</Role>
      <ShortName>Taxes on Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/TaxesonIncome</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>035 - Disclosure - Share Capital (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ShareCapitalTables</Role>
      <ShortName>Share Capital (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/ShareCapital</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>036 - Disclosure - Finance (Income) Expense, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables</Role>
      <ShortName>Finance (Income) Expense, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>037 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables</Role>
      <ShortName>Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholders</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>038 - Disclosure - Related Parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/RelatedPartiesTables</Role>
      <ShortName>Related Parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/RelatedParties</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>039 - Disclosure - General Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/GeneralInformationDetails</Role>
      <ShortName>General Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/GeneralInformation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>040 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>041 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable</Role>
      <ShortName>Summary of Significant Accounting Policies (Details) - Schedule of assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>042 - Disclosure - Other receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/OtherreceivablesDetails</Role>
      <ShortName>Other receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/OtherreceivablesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>043 - Disclosure - Other receivables (Details) - Schedule of other receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable</Role>
      <ShortName>Other receivables (Details) - Schedule of other receivables</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/OtherreceivablesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>044 - Disclosure - Inventory (Details) - Schedule of inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofinventoryTable</Role>
      <ShortName>Inventory (Details) - Schedule of inventory</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/InventoryTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>045 - Disclosure - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/IntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/IntangibleAssetsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>046 - Disclosure - Intangible Assets (Details) - Schedule of total intangible assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable</Role>
      <ShortName>Intangible Assets (Details) - Schedule of total intangible assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/IntangibleAssetsTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>047 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/LeasesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>048 - Disclosure - Leases (Details) - Schedule of future lease payments under operating leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable</Role>
      <ShortName>Leases (Details) - Schedule of future lease payments under operating leases</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/LeasesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>049 - Disclosure - Other Payables (Details) - Schedule of other payables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable</Role>
      <ShortName>Other Payables (Details) - Schedule of other payables</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/OtherPayablesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>050 - Disclosure - Short-Term Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ShortTermLoansDetails</Role>
      <ShortName>Short-Term Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/ShortTermLoansTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>051 - Disclosure - Short-Term Loans (Details) - Schedule of short term loans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable</Role>
      <ShortName>Short-Term Loans (Details) - Schedule of short term loans</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/ShortTermLoansTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>052 - Disclosure - Derivative Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails</Role>
      <ShortName>Derivative Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>053 - Disclosure - Derivative Liabilities (Details) - Schedule of fair value of the derivative warrant liability</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable</Role>
      <ShortName>Derivative Liabilities (Details) - Schedule of fair value of the derivative warrant liability</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>054 - Disclosure - Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable</Role>
      <ShortName>Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>055 - Disclosure - Loans from Shareholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/LoansfromShareholdersDetails</Role>
      <ShortName>Loans from Shareholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/LoansfromShareholdersTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>056 - Disclosure - Loans from Shareholders (Details) - Schedule of loans from shareholders consists</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable</Role>
      <ShortName>Loans from Shareholders (Details) - Schedule of loans from shareholders consists</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/LoansfromShareholdersTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>057 - Disclosure - Taxes on Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/TaxesonIncomeDetails</Role>
      <ShortName>Taxes on Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/TaxesonIncomeTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>058 - Disclosure - Taxes on Income (Details) - Schedule of income (loss) before taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable</Role>
      <ShortName>Taxes on Income (Details) - Schedule of income (loss) before taxes</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/TaxesonIncomeTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>059 - Disclosure - Taxes on Income (Details) - Schedule of income tax expense (benefit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable</Role>
      <ShortName>Taxes on Income (Details) - Schedule of income tax expense (benefit)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/TaxesonIncomeTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>060 - Disclosure - Taxes on Income (Details) - Schedule of statutory income tax rate to effective income tax rate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable</Role>
      <ShortName>Taxes on Income (Details) - Schedule of statutory income tax rate to effective income tax rate</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/TaxesonIncomeTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>061 - Disclosure - Taxes on Income (Details) - Schedule of deferred taxes assets and liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable</Role>
      <ShortName>Taxes on Income (Details) - Schedule of deferred taxes assets and liabilities</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/TaxesonIncomeTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>062 - Disclosure - Share Capital (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ShareCapitalDetails</Role>
      <ShortName>Share Capital (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/ShareCapitalTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>063 - Disclosure - Share Capital (Details) - Schedule of share capital composed of ordinary shares</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofsharecapitalcomposedofordinarysharesTable</Role>
      <ShortName>Share Capital (Details) - Schedule of share capital composed of ordinary shares</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/ShareCapitalTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>064 - Disclosure - Share Incentive Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ShareIncentivePlanDetails</Role>
      <ShortName>Share Incentive Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/ShareIncentivePlan</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>065 - Disclosure - Finance (Income) Expense, Net (Details) - Schedule of finance (income) expenses, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable</Role>
      <ShortName>Finance (Income) Expense, Net (Details) - Schedule of finance (income) expenses, net</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>066 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable</Role>
      <ShortName>Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>067 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals</Role>
      <ShortName>Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders (Parentheticals)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>068 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of diluted weighted average shares outstanding</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable</Role>
      <ShortName>Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of diluted weighted average shares outstanding</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>069 - Disclosure - Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/RelatedPartiesDetails</Role>
      <ShortName>Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/RelatedPartiesTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>070 - Disclosure - Related Parties (Details) - Schedule of transactions with interested and related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable</Role>
      <ShortName>Related Parties (Details) - Schedule of transactions with interested and related parties</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/RelatedPartiesTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>071 - Disclosure - Related Parties (Details) - Schedule of balances with interested and related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable</Role>
      <ShortName>Related Parties (Details) - Schedule of balances with interested and related parties</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/RelatedPartiesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="f20f2022_jeffsbrands.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>072 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jeffsbrands.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jeffsbrands.com/role/SubsequentEvents</ParentRole>
      <Position>73</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesClassifiedCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_jeffsbrands.htm 12898, 12899</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept PropertyPlantAndEquipmentEstimatedUsefulLives in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_jeffsbrands.htm 14126</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept InterestExpenseRelatedParty in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_jeffsbrands.htm 16085, 16086, 16087</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_jeffsbrands.htm 16277, 16278</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_jeffsbrands.htm 16339, 16340</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept DueToOtherRelatedPartiesNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_jeffsbrands.htm 16348, 16671</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyCosts in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_jeffsbrands.htm 16408</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept RelatedPartyTransactionDueFromToRelatedParty in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_jeffsbrands.htm 16408</Log>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept InterestIncomeRelatedParty in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f20f2022_jeffsbrands.htm 16409</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 13 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:EarningsPerShareDiluted, us-gaap:EarningsPerShareDilutedProFormaAdjustment, us-gaap:MaturityOfTimeDeposits, us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment, us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding -  f20f2022_jeffsbrands.htm 16556, 16557, 16558, 16559, 16560, 16561, 16623, 16651, 16652, 16653, 16654, 16655, 16656</Log>
  </Logs>
  <InputFiles>
    <File doctype="20-F" original="f20f2022_jeffsbrands.htm">f20f2022_jeffsbrands.htm</File>
    <File>f20f2022ex12-1_jeffsbrands.htm</File>
    <File>f20f2022ex12-2_jeffsbrands.htm</File>
    <File>f20f2022ex13-1_jeffsbrands.htm</File>
    <File>f20f2022ex13-2_jeffsbrands.htm</File>
    <File>f20f2022ex15-1_jeffsbrands.htm</File>
    <File>f20f2022ex2-5_jeffsbrands.htm</File>
    <File>f20f2022ex4-24_jeffsbrands.htm</File>
    <File>f20f2022ex8-1_jeffsbrands.htm</File>
    <File>jfbr-20221231.xsd</File>
    <File>jfbr-20221231_cal.xml</File>
    <File>jfbr-20221231_def.xml</File>
    <File>jfbr-20221231_lab.xml</File>
    <File>jfbr-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_002.jpg</File>
    <File>image_003.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>image_006.jpg</File>
    <File>image_007.jpg</File>
    <File>image_008.jpg</File>
    <File>image_009.jpg</File>
    <File>image_010.jpg</File>
    <File>image_011.jpg</File>
    <File>image_012.jpg</File>
    <File>image_013.jpg</File>
    <File>image_014.jpg</File>
    <File>image_015.jpg</File>
    <File>image_016.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="668">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="46">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>111
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f20f2022_jeffsbrands.htm": {
   "axisCustom": 0,
   "axisStandard": 16,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 668,
    "http://xbrl.sec.gov/dei/2022": 46
   },
   "contextCount": 124,
   "dts": {
    "calculationLink": {
     "local": [
      "jfbr-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "jfbr-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "f20f2022_jeffsbrands.htm"
     ]
    },
    "labelLink": {
     "local": [
      "jfbr-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "jfbr-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "jfbr-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd"
     ]
    }
   },
   "elementCount": 586,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 98,
    "http://www.jeffsbrands.com/20221231": 28,
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 129
   },
   "keyCustom": 71,
   "keyStandard": 353,
   "memberCustom": 15,
   "memberStandard": 16,
   "nsprefix": "jfbr",
   "nsuri": "http://www.jeffsbrands.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.jeffsbrands.com/role/DocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "009 - Disclosure - Other receivables",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.jeffsbrands.com/role/Otherreceivables",
     "shortName": "Other receivables",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "010 - Disclosure - Inventory",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.jeffsbrands.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "011 - Disclosure - Intangible Assets",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.jeffsbrands.com/role/IntangibleAssets",
     "shortName": "Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "012 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.jeffsbrands.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "013 - Disclosure - Other Payables",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.jeffsbrands.com/role/OtherPayables",
     "shortName": "Other Payables",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "014 - Disclosure - Short-Term Loans",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.jeffsbrands.com/role/ShortTermLoans",
     "shortName": "Short-Term Loans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "015 - Disclosure - Derivative Liabilities",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.jeffsbrands.com/role/DerivativeLiabilities",
     "shortName": "Derivative Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "016 - Disclosure - Loans from Shareholders",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.jeffsbrands.com/role/LoansfromShareholders",
     "shortName": "Loans from Shareholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "017 - Disclosure - Taxes on Income",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.jeffsbrands.com/role/TaxesonIncome",
     "shortName": "Taxes on Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "018 - Disclosure - Share Capital",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.jeffsbrands.com/role/ShareCapital",
     "shortName": "Share Capital",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "001 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "019 - Disclosure - Share Incentive Plan",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.jeffsbrands.com/role/ShareIncentivePlan",
     "shortName": "Share Incentive Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "020 - Disclosure - Finance (Income) Expense, Net",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet",
     "shortName": "Finance (Income) Expense, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeAndInterestExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "021 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholders",
     "shortName": "Net Income (Loss) Per Share Attributable to Ordinary Shareholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "022 - Disclosure - Related Parties",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.jeffsbrands.com/role/RelatedParties",
     "shortName": "Related Parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "023 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.jeffsbrands.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "024 - Disclosure - Accounting Policies, by Policy (Policies)",
     "menuCat": "Policies",
     "order": "25",
     "role": "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "025 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "026 - Disclosure - Other receivables (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.jeffsbrands.com/role/OtherreceivablesTables",
     "shortName": "Other receivables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "027 - Disclosure - Inventory (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.jeffsbrands.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "028 - Disclosure - Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.jeffsbrands.com/role/IntangibleAssetsTables",
     "shortName": "Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "029 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.jeffsbrands.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "030 - Disclosure - Other Payables (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.jeffsbrands.com/role/OtherPayablesTables",
     "shortName": "Other Payables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "031 - Disclosure - Short-Term Loans (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.jeffsbrands.com/role/ShortTermLoansTables",
     "shortName": "Short-Term Loans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "032 - Disclosure - Derivative Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables",
     "shortName": "Derivative Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertibleDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "033 - Disclosure - Loans from Shareholders (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.jeffsbrands.com/role/LoansfromShareholdersTables",
     "shortName": "Loans from Shareholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "034 - Disclosure - Taxes on Income (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.jeffsbrands.com/role/TaxesonIncomeTables",
     "shortName": "Taxes on Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "035 - Disclosure - Share Capital (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.jeffsbrands.com/role/ShareCapitalTables",
     "shortName": "Share Capital (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "036 - Disclosure - Finance (Income) Expense, Net (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables",
     "shortName": "Finance (Income) Expense, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "037 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables",
     "shortName": "Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "038 - Disclosure - Related Parties (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.jeffsbrands.com/role/RelatedPartiesTables",
     "shortName": "Related Parties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "003 - Statement - Consolidated Statements of Operations",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "039 - Disclosure - General Information (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.jeffsbrands.com/role/GeneralInformationDetails",
     "shortName": "General Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "3",
      "lang": null,
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredOfferingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "040 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredOfferingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c46",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "041 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable",
     "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c46",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentSalvageValuePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherAdditionalCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "042 - Disclosure - Other receivables (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.jeffsbrands.com/role/OtherreceivablesDetails",
     "shortName": "Other receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "p",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherAdditionalCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Supplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "043 - Disclosure - Other receivables (Details) - Schedule of other receivables",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable",
     "shortName": "Other receivables (Details) - Schedule of other receivables",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Supplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventoryInTransit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "044 - Disclosure - Inventory (Details) - Schedule of inventory",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.jeffsbrands.com/role/ScheduleofinventoryTable",
     "shortName": "Inventory (Details) - Schedule of inventory",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventoryInTransit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "045 - Disclosure - Intangible Assets (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.jeffsbrands.com/role/IntangibleAssetsDetails",
     "shortName": "Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c49",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "046 - Disclosure - Intangible Assets (Details) - Schedule of total intangible assets",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable",
     "shortName": "Intangible Assets (Details) - Schedule of total intangible assets",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c49",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "047 - Disclosure - Leases (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.jeffsbrands.com/role/LeasesDetails",
     "shortName": "Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "048 - Disclosure - Leases (Details) - Schedule of future lease payments under operating leases",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable",
     "shortName": "Leases (Details) - Schedule of future lease payments under operating leases",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "004 - Statement - Consolidated Statements of Operations (Parentheticals)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals",
     "shortName": "Consolidated Statements of Operations (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "049 - Disclosure - Other Payables (Details) - Schedule of other payables",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable",
     "shortName": "Other Payables (Details) - Schedule of other payables",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:USGovernmentAgenciesSecuritiesAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c51",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "jfbr:AggregatesAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "050 - Disclosure - Short-Term Loans (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.jeffsbrands.com/role/ShortTermLoansDetails",
     "shortName": "Short-Term Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c51",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "jfbr:AggregatesAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LoansPayable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "051 - Disclosure - Short-Term Loans (Details) - Schedule of short term loans",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable",
     "shortName": "Short-Term Loans (Details) - Schedule of short term loans",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LoansAndLeasesReceivableRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "jfbr:ThirdPartyLoan",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "052 - Disclosure - Derivative Liabilities (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
     "shortName": "Derivative Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "053 - Disclosure - Derivative Liabilities (Details) - Schedule of fair value of the derivative warrant liability",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable",
     "shortName": "Derivative Liabilities (Details) - Schedule of fair value of the derivative warrant liability",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c16",
      "decimals": "-3",
      "lang": null,
      "name": "jfbr:FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c68",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "054 - Disclosure - Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable",
     "shortName": "Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c68",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c74",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "055 - Disclosure - Loans from Shareholders (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails",
     "shortName": "Loans from Shareholders (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c74",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LoansPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "056 - Disclosure - Loans from Shareholders (Details) - Schedule of loans from shareholders consists",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable",
     "shortName": "Loans from Shareholders (Details) - Schedule of loans from shareholders consists",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c3",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LoansPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "057 - Disclosure - Taxes on Income (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.jeffsbrands.com/role/TaxesonIncomeDetails",
     "shortName": "Taxes on Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "pure",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "058 - Disclosure - Taxes on Income (Details) - Schedule of income (loss) before taxes",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable",
     "shortName": "Taxes on Income (Details) - Schedule of income (loss) before taxes",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c7",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "005 - Statement - Consolidated Statements of Changes in Shareholders\u2019 Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3",
     "shortName": "Consolidated Statements of Changes in Shareholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c7",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "059 - Disclosure - Taxes on Income (Details) - Schedule of income tax expense (benefit)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable",
     "shortName": "Taxes on Income (Details) - Schedule of income tax expense (benefit)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "060 - Disclosure - Taxes on Income (Details) - Schedule of statutory income tax rate to effective income tax rate",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable",
     "shortName": "Taxes on Income (Details) - Schedule of statutory income tax rate to effective income tax rate",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "061 - Disclosure - Taxes on Income (Details) - Schedule of deferred taxes assets and liabilities",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable",
     "shortName": "Taxes on Income (Details) - Schedule of deferred taxes assets and liabilities",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c93",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jfbr:AgreementDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "062 - Disclosure - Share Capital (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.jeffsbrands.com/role/ShareCapitalDetails",
     "shortName": "Share Capital (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c93",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jfbr:AgreementDescription",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "063 - Disclosure - Share Capital (Details) - Schedule of share capital composed of ordinary shares",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.jeffsbrands.com/role/ScheduleofsharecapitalcomposedofordinarysharesTable",
     "shortName": "Share Capital (Details) - Schedule of share capital composed of ordinary shares",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "064 - Disclosure - Share Incentive Plan (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.jeffsbrands.com/role/ShareIncentivePlanDetails",
     "shortName": "Share Incentive Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueOptionChangesInFairValueGainLoss1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "065 - Disclosure - Finance (Income) Expense, Net (Details) - Schedule of finance (income) expenses, net",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable",
     "shortName": "Finance (Income) Expense, Net (Details) - Schedule of finance (income) expenses, net",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "jfbr:ScheduleOfFinanceIncomeExpensesNetTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueOptionChangesInFairValueGainLoss1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "066 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable",
     "shortName": "Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EarningsPerShareDilutedProFormaAdjustment",
      "reportCount": 1,
      "unitRef": "usdPershares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "067 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders (Parentheticals)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals",
     "shortName": "Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "jfbr:IPOAndAdditionalWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "068 - Disclosure - Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of diluted weighted average shares outstanding",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable",
     "shortName": "Net Income (Loss) Per Share Attributable to Ordinary Shareholders (Details) - Schedule of diluted weighted average shares outstanding",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "jfbr:IPOAndAdditionalWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "006 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.jeffsbrands.com/role/ConsolidatedCashFlow",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c4",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c108",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "jfbr:RelatedPartyFairValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "069 - Disclosure - Related Parties (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.jeffsbrands.com/role/RelatedPartiesDetails",
     "shortName": "Related Parties (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c109",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AccruedPayrollTaxesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "070 - Disclosure - Related Parties (Details) - Schedule of transactions with interested and related parties",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable",
     "shortName": "Related Parties (Details) - Schedule of transactions with interested and related parties",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LaborAndRelatedExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "jfbr:ScheduleOfInterestedAndRelatedPartiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "jfbr:AdvancesToSuppliers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "071 - Disclosure - Related Parties (Details) - Schedule of balances with interested and related parties",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable",
     "shortName": "Related Parties (Details) - Schedule of balances with interested and related parties",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "jfbr:ScheduleOfInterestedAndRelatedPartiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "jfbr:AdvancesToSuppliers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DividendsPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "072 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.jeffsbrands.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c2",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:DividendsPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jfbr:GeneralInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "007 - Disclosure - General Information",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.jeffsbrands.com/role/GeneralInformation",
     "shortName": "General Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jfbr:GeneralInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "008 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "f20f2022_jeffsbrands.htm",
      "contextRef": "c0",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 34,
   "tag": {
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL",
        "terseLabel": "Israel [Member]"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]",
        "terseLabel": "Business Contact"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address",
        "terseLabel": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name",
        "terseLabel": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard",
        "terseLabel": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement",
        "terseLabel": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report",
        "terseLabel": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r504",
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "jfbr_AccruedExpensesAndOtherPayables": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of accrued expenses and other payables.",
        "label": "Accrued Expenses And Other Payables",
        "terseLabel": "Accrued expenses and other payables"
       }
      }
     },
     "localname": "AccruedExpensesAndOtherPayables",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is accrued interest and amortization of discount on related party and shareholders\u2019 loans.",
        "label": "Accrued Interest And Amortization Of Discount On Related Party And Shareholders Loans",
        "terseLabel": "Accrued interest and amortization of discount on related party and shareholders\u2019 loans (Note 8)"
       }
      }
     },
     "localname": "AccruedInterestAndAmortizationOfDiscountOnRelatedPartyAndShareholdersLoans",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_AdditionalDividendsPayableSharesValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aomunt of additional dividends payable shares value.",
        "label": "Additional Dividends Payable Shares Value",
        "terseLabel": "Adjusted shares value"
       }
      }
     },
     "localname": "AdditionalDividendsPayableSharesValue",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_AdditionalWarrantTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional warrant term.",
        "label": "Additional Warrant Term",
        "terseLabel": "Additional warrant term"
       }
      }
     },
     "localname": "AdditionalWarrantTerm",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "jfbr_AdditionalWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional warrants are options issued by a company that trade on an exchange and give investors the right (but not obligation) to purchase company stock at a specific price within a specified time period.",
        "label": "Additional Warrants",
        "terseLabel": "Additional warrants"
       }
      }
     },
     "localname": "AdditionalWarrants",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "jfbr_AdditionalWarrantsDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional warrants description.",
        "label": "Additional Warrants Description",
        "terseLabel": "Additional warrants description"
       }
      }
     },
     "localname": "AdditionalWarrantsDescription",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_AdvancesToSuppliers": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is advances to suppliers.",
        "label": "Advances To Suppliers",
        "terseLabel": "Advances to suppliers"
       }
      }
     },
     "localname": "AdvancesToSuppliers",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_AggregateAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of aggregate amount.",
        "label": "Aggregate Amount",
        "terseLabel": "Aggregate amount"
       }
      }
     },
     "localname": "AggregateAmount",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_AggregateIssuanceShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate issuance shares.",
        "label": "Aggregate Issuance Shares",
        "terseLabel": "Aggregate issuance shares (in Shares)"
       }
      }
     },
     "localname": "AggregateIssuanceShares",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "jfbr_AggregatesAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregates Amount",
        "terseLabel": "Aggregate amount"
       }
      }
     },
     "localname": "AggregatesAmount",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_AgreementDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement description.",
        "label": "Agreement Description",
        "terseLabel": "Agreement description"
       }
      }
     },
     "localname": "AgreementDescription",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_AmazoncomMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amazoncom Member",
        "terseLabel": "Amazon.com [Member]"
       }
      }
     },
     "localname": "AmazoncomMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_AssetsAbstract0": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Abstract0",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract0",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_Bonus": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is bonus.",
        "label": "Bonus",
        "terseLabel": "Bonus"
       }
      }
     },
     "localname": "Bonus",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_BonusSharesAndReverseShareSplitDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of bonus shares and reverse share split.",
        "label": "Bonus Shares And Reverse Share Split Description",
        "terseLabel": "Bonus shares and reverse share split, description"
       }
      }
     },
     "localname": "BonusSharesAndReverseShareSplitDescription",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_BrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Brands Member",
        "terseLabel": "Brands [Member]"
       }
      }
     },
     "localname": "BrandsMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_ChangeInFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in fair value.",
        "label": "Change In Fair Value",
        "terseLabel": "Change in fair value"
       }
      }
     },
     "localname": "ChangeInFairValue",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_ClassOfAdditionalWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional warrants or rights outstanding.",
        "label": "Class Of Additional Warrant Or Right Outstanding",
        "terseLabel": "Additional warrants outstanding"
       }
      }
     },
     "localname": "ClassOfAdditionalWarrantOrRightOutstanding",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "jfbr_ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class Of Warrant Or Right Adjusted Exercise Price Of Warrants Or Rights",
        "terseLabel": "Exercise price adjustment (in Dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAdjustedExercisePriceOfWarrantsOrRights",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "jfbr_ComputersEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computers Equipment Member",
        "terseLabel": "Computers equipment [Member]"
       }
      }
     },
     "localname": "ComputersEquipmentMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_ConsideredAsIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Considered as issuance costs.",
        "label": "Considered As Issuance Costs",
        "terseLabel": "Considered as issuance costs"
       }
      }
     },
     "localname": "ConsideredAsIssuanceCosts",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_ConsultancyServicesFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is consultancy services fees.",
        "label": "Consultancy Services Fees",
        "terseLabel": "Consultancy services fees"
       }
      }
     },
     "localname": "ConsultancyServicesFees",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_CurrentStateAndLocalTaxExpensesBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current state and local tax expense (benefit).",
        "label": "Current State And Local Tax Expenses Benefit",
        "terseLabel": "Israel"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpensesBenefit",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_DeferredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Abstract",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_DeferredOfferingCostsIncludedInOtherPayables": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is deferred offering costs included in other payables.",
        "label": "Deferred Offering Costs Included In Other Payables",
        "terseLabel": "Deferred offering costs included in other payables"
       }
      }
     },
     "localname": "DeferredOfferingCostsIncludedInOtherPayables",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_DeferredStateAndLocalIncomeTaxExpensesBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Teh amount of deferred state and local income tax expenses benefit.",
        "label": "Deferred State And Local Income Tax Expenses Benefit",
        "terseLabel": "Israel"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpensesBenefit",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_DeferredTaxAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Asset Abstract",
        "terseLabel": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_DerivativeLiabilitiesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liabilities (Details) [Line Items]"
       }
      }
     },
     "localname": "DerivativeLiabilitiesDetailsLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants [Line Items]"
       }
      }
     },
     "localname": "DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liabilities (Details) - Schedule of fair value of the IPO warrants and additional warrants [Table]"
       }
      }
     },
     "localname": "DerivativeLiabilitiesDetailsScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_DerivativeLiabilitiesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liabilities (Details) [Table]"
       }
      }
     },
     "localname": "DerivativeLiabilitiesDetailsTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_DerivativeLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liability"
       }
      }
     },
     "localname": "DerivativeLiability",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_DifferencesBetweenTaxBasisAndCarryingValueOfLoans": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of differences between tax basis and carrying value of loans.",
        "label": "Differences Between Tax Basis And Carrying Value Of Loans",
        "negatedLabel": "Differences between tax basis and carrying value of loans"
       }
      }
     },
     "localname": "DifferencesBetweenTaxBasisAndCarryingValueOfLoans",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ExercisePriceAdjustment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share adjustment.",
        "label": "Exercise Price Adjustment",
        "terseLabel": "Exercise price adjustment (in Dollars per share)"
       }
      }
     },
     "localname": "ExercisePriceAdjustment",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "jfbr_FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value Measurement With Unobservable Input Reconciliations Recurring Basis Liability Value",
        "periodEndLabel": "Balance at ending",
        "periodStartLabel": "Balance at beginning"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_FairValueOfWarrantLiabilityToBeIssuedToThirdparty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Of Warrant Liability To Be Issued To Thirdparty",
        "terseLabel": "Fair value of warrant liability to be issued to third-party upon IPO (note 9a)"
       }
      }
     },
     "localname": "FairValueOfWarrantLiabilityToBeIssuedToThirdparty",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_FinanceExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Expense Abstract",
        "terseLabel": "Finance expense:"
       }
      }
     },
     "localname": "FinanceExpenseAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_FinanceExpenseNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents interest incurred for borrowed money which was used to produce goods or render services.",
        "label": "Finance Expense Net",
        "terseLabel": "Finance (income) expense, net"
       }
      }
     },
     "localname": "FinanceExpenseNet",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_FinanceExpensesInRespectOfThirdpartyLoan": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense classified as finance expenses in respect of third-party loan.",
        "label": "Finance Expenses In Respect Of Thirdparty Loan",
        "terseLabel": "Finance expenses in respect of third-party loan"
       }
      }
     },
     "localname": "FinanceExpensesInRespectOfThirdpartyLoan",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_FinanceIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Income Abstract",
        "terseLabel": "Finance income:"
       }
      }
     },
     "localname": "FinanceIncomeAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_FinanceIncomeExpenseNetLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Income Expense Net Line Items",
        "terseLabel": "Finance (Income) Expenses, Net [Abstract]"
       }
      }
     },
     "localname": "FinanceIncomeExpenseNetLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_FinanceIncomeExpenseNetTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Income Expense Net Table",
        "terseLabel": "Finance (Income) Expenses, Net [Abstract]"
       }
      }
     },
     "localname": "FinanceIncomeExpenseNetTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_FinancialincomeExpensesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of financial (income) expenses, net.",
        "label": "Financialincome Expenses Net",
        "negatedLabel": "Financial (income) expenses, net"
       }
      }
     },
     "localname": "FinancialincomeExpensesNet",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_FiniteLivedIntangibleAssetAmortizationMethod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amortization method of a major finite-lived intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar either by their nature or by their use in the operations of a company. The straight-line method is the preferred amortization method, unless another method better reflects the pattern in which the asset is consumed.",
        "label": "Finite Lived Intangible Asset Amortization Method",
        "terseLabel": "Estimated annual amortization expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetAmortizationMethod",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_FutureOperatingLeasePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Future Operating Lease Payments",
        "terseLabel": "Total future operating lease payments"
       }
      }
     },
     "localname": "FutureOperatingLeasePayments",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_GeneralInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Information Abstract"
       }
      }
     },
     "localname": "GeneralInformationAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_GeneralInformationDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Information (Details) [Line Items]"
       }
      }
     },
     "localname": "GeneralInformationDetailsLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_GeneralInformationDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Information (Details) [Table]"
       }
      }
     },
     "localname": "GeneralInformationDetailsTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_GeneralInformationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Information Text Block",
        "terseLabel": "GENERAL INFORMATION"
       }
      }
     },
     "localname": "GeneralInformationTextBlock",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "jfbr_GrossProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gross proceeds.",
        "label": "Gross Proceeds",
        "terseLabel": "Gross proceeds"
       }
      }
     },
     "localname": "GrossProceeds",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_IPOAndAdditionalWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable": {
       "order": 1.0,
       "parentTag": "jfbr_TotalDilutedWeightedAverageSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares is IPO and additional warrants.",
        "label": "IPOAnd Additional Warrants",
        "terseLabel": "IPO Warrants and Additional Warrants (Note 12h)"
       }
      }
     },
     "localname": "IPOAndAdditionalWarrants",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "jfbr_IPOWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPOWarrant Member",
        "terseLabel": "IPO Warrant [Member]"
       }
      }
     },
     "localname": "IPOWarrantMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_InitialExercisePriceExpire": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial exercise price expire.",
        "label": "Initial Exercise Price Expire",
        "terseLabel": "Initial exercise price expire"
       }
      }
     },
     "localname": "InitialExercisePriceExpire",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "jfbr_IntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Line Items",
        "terseLabel": "Disclosure Of Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/IntangibleAssets"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_IntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets [Table]"
       }
      }
     },
     "localname": "IntangibleAssetsTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/IntangibleAssets"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_IntangibleAssetsTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Intangible Assets Text Block [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsTablesLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_IntangibleAssetsTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets (Tables) [Table]"
       }
      }
     },
     "localname": "IntangibleAssetsTablesTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_InterestExpensesOnLoansFromRelatedPartiesAndShareholders": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable": {
       "order": 4.0,
       "parentTag": "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expenses on loans from related parties and shareholders.",
        "label": "Interest Expenses On Loans From Related Parties And Shareholders",
        "terseLabel": "Interest expenses on loans from related parties and shareholders"
       }
      }
     },
     "localname": "InterestExpensesOnLoansFromRelatedPartiesAndShareholders",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_InvestAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Invest amount.",
        "label": "Invest Amount",
        "terseLabel": "Invest amount"
       }
      }
     },
     "localname": "InvestAmount",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_IssuanceCostsOnDerivativeLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is issuance costs on derivative liabilities.",
        "label": "Issuance Costs On Derivative Liabilities",
        "terseLabel": "Issuance costs on derivative liabilities"
       }
      }
     },
     "localname": "IssuanceCostsOnDerivativeLiabilities",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_IssuanceDateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Date Member",
        "terseLabel": "Issuance Date [Member]"
       }
      }
     },
     "localname": "IssuanceDateMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_IssuanceOfBonusShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of bonus shares.",
        "label": "Issuance Of Bonus Shares",
        "terseLabel": "Issuance of bonus shares (in Shares)"
       }
      }
     },
     "localname": "IssuanceOfBonusShares",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "jfbr_IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is issuance of ordinary shares upon conversion of shareholders\u2019 loans.",
        "label": "Issuance Of Ordinary Shares Upon Conversion Of Shareholders Loans",
        "terseLabel": "Issuance of ordinary shares upon conversion of shareholders\u2019 loans"
       }
      }
     },
     "localname": "IssuanceOfOrdinarySharesUponConversionOfShareholdersLoans",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_IssuanceOfPeriodTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of period term.",
        "label": "Issuance Of Period Term",
        "terseLabel": "Issuance of period term"
       }
      }
     },
     "localname": "IssuanceOfPeriodTerm",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "jfbr_IssuedAndOutstandingShareCapitalPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issued and outstanding share capital percentage.",
        "label": "Issued And Outstanding Share Capital Percentage",
        "terseLabel": "Issued and outstanding share capital percentage"
       }
      }
     },
     "localname": "IssuedAndOutstandingShareCapitalPercentage",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jfbr_JeffsBrandsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Jeffs Brands Member",
        "terseLabel": "Jeffs\u2019 Brands [Member]"
       }
      }
     },
     "localname": "JeffsBrandsMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_LeasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases Line Items",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/Leases"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_LeasesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases Table",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/Leases"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_LoansFromShareholders": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is loans from shareholders.",
        "label": "Loans From Shareholders",
        "terseLabel": "Loans from shareholders (Note 10)"
       }
      }
     },
     "localname": "LoansFromShareholders",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_LoansfromShareholdersDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans from Shareholders (Details) [Line Items]"
       }
      }
     },
     "localname": "LoansfromShareholdersDetailsLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_LoansfromShareholdersDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans from Shareholders (Details) [Table]"
       }
      }
     },
     "localname": "LoansfromShareholdersDetailsTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_LoansfromShareholdersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans from Shareholders [Abstract]"
       }
      }
     },
     "localname": "LoansfromShareholdersLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholders"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_LoansfromShareholdersTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans from Shareholders [Table]"
       }
      }
     },
     "localname": "LoansfromShareholdersTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholders"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_LoansfromShareholdersTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loansfrom Shareholders Tables Line Items",
        "terseLabel": "Loans from Shareholders [Abstract]"
       }
      }
     },
     "localname": "LoansfromShareholdersTablesLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersTables"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_LoansfromShareholdersTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans from Shareholders (Tables) [Table]"
       }
      }
     },
     "localname": "LoansfromShareholdersTablesTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersTables"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_MedigusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medigus Member",
        "terseLabel": "Medigus [Member]"
       }
      }
     },
     "localname": "MedigusMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_MinorityShareholderAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minority shareholder amount.",
        "label": "Minority Shareholder Amount",
        "terseLabel": "Minority shareholder amount"
       }
      }
     },
     "localname": "MinorityShareholderAmount",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_MinorityShareholderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minority Shareholder Member",
        "terseLabel": "Minority Shareholder [Member]"
       }
      }
     },
     "localname": "MinorityShareholderMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_MrHakmonAndLIAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr Hakmon And LIAMember",
        "terseLabel": "Mr. Hakmon and L.I.A [Member]"
       }
      }
     },
     "localname": "MrHakmonAndLIAMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_MrHakmonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mr Hakmon Member",
        "terseLabel": "Mr. Hakmon [Member]"
       }
      }
     },
     "localname": "MrHakmonMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_NetProceedsOfWarrants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net proceeds of warrants.",
        "label": "Net Proceeds Of Warrants",
        "terseLabel": "Net proceeds of warrants (in Dollars)"
       }
      }
     },
     "localname": "NetProceedsOfWarrants",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_NonCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Assets Abstract",
        "terseLabel": "NON-CURRENT ASSETS:"
       }
      }
     },
     "localname": "NonCurrentAssetsAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_NonCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Liabilities Abstract",
        "terseLabel": "NON-CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "NonCurrentLiabilitiesAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_OperatingLeaseAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease Assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseAssets",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_OtherPayablesTablesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Payables Tables Line Items",
        "terseLabel": "Schedule of Other Payables [Abstract]"
       }
      }
     },
     "localname": "OtherPayablesTablesLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/OtherPayablesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_OtherPayablesTablesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Payables Tables Table",
        "terseLabel": "Schedule of Other Payables [Abstract]"
       }
      }
     },
     "localname": "OtherPayablesTablesTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/OtherPayablesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_OtherWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable": {
       "order": 3.0,
       "parentTag": "jfbr_TotalDilutedWeightedAverageSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares is other warrants.",
        "label": "Other Warrants",
        "terseLabel": "Other warrants"
       }
      }
     },
     "localname": "OtherWarrants",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "jfbr_OutstandingPayable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is outstanding payable.",
        "label": "Outstanding Payable",
        "terseLabel": "outstanding payable"
       }
      }
     },
     "localname": "OutstandingPayable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_OwnershipMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership Member",
        "terseLabel": "Ownership [Member]"
       }
      }
     },
     "localname": "OwnershipMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_PercentageLeaseAndMaintenanceExpensesRelated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage lease and maintenance expenses related.",
        "label": "Percentage Lease And Maintenance Expenses Related",
        "terseLabel": "Percentage lease and maintenance expenses related"
       }
      }
     },
     "localname": "PercentageLeaseAndMaintenanceExpensesRelated",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jfbr_PercentageOfGrossProceed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of gross proceed.",
        "label": "Percentage Of Gross Proceed",
        "terseLabel": "Percentage of gross proceed"
       }
      }
     },
     "localname": "PercentageOfGrossProceed",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jfbr_PercentageOfTotalConsiderationPaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of total consideration paid.",
        "label": "Percentage Of Total Consideration Paid",
        "terseLabel": "Percentage of total consideration paid"
       }
      }
     },
     "localname": "PercentageOfTotalConsiderationPaid",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jfbr_PresentValueOfLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is present value of lease liability.",
        "label": "Present Value Of Lease Liability",
        "terseLabel": "Present value of lease liability"
       }
      }
     },
     "localname": "PresentValueOfLeaseLiability",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_PrincipalLoanAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amountof principal loan amount.",
        "label": "Principal Loan Amount",
        "terseLabel": "Principal loan amount"
       }
      }
     },
     "localname": "PrincipalLoanAmount",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_PublicOfferingPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received public offering price per share",
        "label": "Public Offering Price Per Share",
        "terseLabel": "Public offering price per share"
       }
      }
     },
     "localname": "PublicOfferingPricePerShare",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "jfbr_PureCapitalLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pure Capital Ltd Member",
        "terseLabel": "Pure Capital Ltd. [Member]"
       }
      }
     },
     "localname": "PureCapitalLtdMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_PurexCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purex Corp Member",
        "terseLabel": "Purex Corp [Member]"
       }
      }
     },
     "localname": "PurexCorpMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_RelatedPartiesDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) [Line Items]"
       }
      }
     },
     "localname": "RelatedPartiesDetailsLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_RelatedPartiesDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Parties (Details) [Table]"
       }
      }
     },
     "localname": "RelatedPartiesDetailsTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_RelatedPartyFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of related party fair value.",
        "label": "Related Party Fair Value",
        "terseLabel": "Fair value amount",
        "verboseLabel": "Related party fair value"
       }
      }
     },
     "localname": "RelatedPartyFairValue",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_RevenuesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues percentage.",
        "label": "Revenues Percentage",
        "terseLabel": "Revenues percentage"
       }
      }
     },
     "localname": "RevenuesPercentage",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jfbr_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is right of use assets obtained in exchange for lease liabilities.",
        "label": "Right Of Use Assets Obtained In Exchange For Lease Liabilities",
        "terseLabel": "Right of use assets obtained in exchange for lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetsObtainedInExchangeForLeaseLiabilities",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Assets Are Depreciated Using The Straight Line Method To Allocate Their Cost Over Their Estimated Useful Lives Abstract"
       }
      }
     },
     "localname": "ScheduleOfAssetsAreDepreciatedUsingTheStraightLineMethodToAllocateTheirCostOverTheirEstimatedUsefulLivesAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Balances With Interested And Related Parties Abstract"
       }
      }
     },
     "localname": "ScheduleOfBalancesWithInterestedAndRelatedPartiesAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Basic And Diluted Net Income Loss Per Share Attributable To Ordinary Shareholders Abstract"
       }
      }
     },
     "localname": "ScheduleOfBasicAndDilutedNetIncomeLossPerShareAttributableToOrdinaryShareholdersAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Deferred Taxes Assets And Liabilities Abstract"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxesAssetsAndLiabilitiesAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Diluted Weighted Average Shares Outstanding Abstract"
       }
      }
     },
     "localname": "ScheduleOfDilutedWeightedAverageSharesOutstandingAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Of The Derivative Warrant Liability Abstract"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfTheDerivativeWarrantLiabilityAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Fair Value Of The Ipo Warrants And Additional Warrants Abstract"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfTheIpoWarrantsAndAdditionalWarrantsAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfFinanceIncomeExpensesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Finance Income Expenses Net Abstract"
       }
      }
     },
     "localname": "ScheduleOfFinanceIncomeExpensesNetAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfFinanceIncomeExpensesNetTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financing income expenses net.",
        "label": "Schedule Of Finance Income Expenses Net Table Text Block",
        "terseLabel": "Schedule of finance (income) expenses, net"
       }
      }
     },
     "localname": "ScheduleOfFinanceIncomeExpensesNetTableTextBlock",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "jfbr_ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Future Lease Payments Under Operating Leases Abstract"
       }
      }
     },
     "localname": "ScheduleOfFutureLeasePaymentsUnderOperatingLeasesAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfIncomeLossBeforeTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Income Loss Before Taxes Abstract"
       }
      }
     },
     "localname": "ScheduleOfIncomeLossBeforeTaxesAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfIncomeTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Income Tax Expense Benefit Abstract"
       }
      }
     },
     "localname": "ScheduleOfIncomeTaxExpenseBenefitAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfInterestedAndRelatedPartiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Interested And Related Parties Table Text Block",
        "terseLabel": "Schedule of balances with interested and related parties"
       }
      }
     },
     "localname": "ScheduleOfInterestedAndRelatedPartiesTableTextBlock",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "jfbr_ScheduleOfInventoryAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Inventory Abstract"
       }
      }
     },
     "localname": "ScheduleOfInventoryAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfLoansFromShareholdersConsistsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Loans From Shareholders Consists Abstract"
       }
      }
     },
     "localname": "ScheduleOfLoansFromShareholdersConsistsAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfOtherPayablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Payables Abstract"
       }
      }
     },
     "localname": "ScheduleOfOtherPayablesAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfOtherReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Receivables Abstract"
       }
      }
     },
     "localname": "ScheduleOfOtherReceivablesAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Share Capital Composed Of Ordinary Shares Abstract"
       }
      }
     },
     "localname": "ScheduleOfShareCapitalComposedOfOrdinarySharesAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfShortTermLoansAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Short Term Loans Abstract"
       }
      }
     },
     "localname": "ScheduleOfShortTermLoansAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Statutory Income Tax Rate To Effective Income Tax Rate Abstract"
       }
      }
     },
     "localname": "ScheduleOfStatutoryIncomeTaxRateToEffectiveIncomeTaxRateAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfTotalIntangibleAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Total Intangible Assets Abstract"
       }
      }
     },
     "localname": "ScheduleOfTotalIntangibleAssetsAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Transactions With Interested And Related Parties Abstract"
       }
      }
     },
     "localname": "ScheduleOfTransactionsWithInterestedAndRelatedPartiesAbstract",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "xbrltype": "stringItemType"
    },
    "jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of issued shares of award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Ordinaty Shares Issued Percentage",
        "terseLabel": "Shares issued percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesIssuedPercentage",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jfbr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of outstanding shares of award under share-based payment arrangement.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Ordinaty Shares Outstanding Percentage",
        "terseLabel": "Shares outstanding percentage"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardOrdinatySharesOutstandingPercentage",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jfbr_ShareCapitalDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital (Details) [Line Items]"
       }
      }
     },
     "localname": "ShareCapitalDetailsLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_ShareCapitalDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital (Details) [Table]"
       }
      }
     },
     "localname": "ShareCapitalDetailsTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_ShareIncentivePlanLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Incentive Plan Line Items",
        "terseLabel": "Share Incentive Plan [Abstract]"
       }
      }
     },
     "localname": "ShareIncentivePlanLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareIncentivePlan"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_ShareIncentivePlanTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Incentive Plan [Table]"
       }
      }
     },
     "localname": "ShareIncentivePlanTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareIncentivePlan"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_SharebasedCompensationIncludedInDeferredOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is share-based compensation included in deferred offering costs.",
        "label": "Sharebased Compensation Included In Deferred Offering Costs",
        "terseLabel": "Share-based compensation included in deferred offering costs"
       }
      }
     },
     "localname": "SharebasedCompensationIncludedInDeferredOfferingCosts",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_ShortTermLineOfCredits": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of short term line of credits.",
        "label": "Short Term Line Of Credits",
        "terseLabel": "Short term line of credits"
       }
      }
     },
     "localname": "ShortTermLineOfCredits",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_SmartProMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Smart Pro Member",
        "terseLabel": "Smart Pro [Member]"
       }
      }
     },
     "localname": "SmartProMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is issuance of ordinary shares upon initial public offering, net of issuance costs.",
        "label": "Stock Issued During Period Issuance Of Ordinary Shares Upon Initial Public Offering Net Of Issuance Costs",
        "terseLabel": "Issuance of ordinary shares upon initial public offering, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCosts",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares is issuance of ordinary shares upon initial public offering, net of issuance costs.",
        "label": "Stock Issued During Period Issuance Of Ordinary Shares Upon Initial Public Offering Net Of Issuance Costsin Shares",
        "terseLabel": "Issuance of ordinary shares upon initial public offering, net of issuance costs (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodIssuanceOfOrdinarySharesUponInitialPublicOfferingNetOfIssuanceCostsinShares",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "jfbr_SubsequentEventsDetailsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_SubsequentEventsDetailsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events (Details) [Table]"
       }
      }
     },
     "localname": "SubsequentEventsDetailsTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_SubstantialModificationOfShareholdersLoansRecordedInEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount is substantial modification of shareholders\u2019 loans recorded in equity.",
        "label": "Substantial Modification Of Shareholders Loans Recorded In Equity",
        "terseLabel": "Substantial modification of shareholders\u2019 loans recorded in equity"
       }
      }
     },
     "localname": "SubstantialModificationOfShareholdersLoansRecordedInEquity",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income (Details) - Schedule of income (loss) before taxes [Line Items]"
       }
      }
     },
     "localname": "TaxesonIncomeDetailsScheduleofincomelossbeforetaxesLineItems",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Income (Details) - Schedule of income (loss) before taxes [Table]"
       }
      }
     },
     "localname": "TaxesonIncomeDetailsScheduleofincomelossbeforetaxesTable",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "jfbr_ThirdPartyLoan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of third party loans.",
        "label": "Third Party Loan",
        "terseLabel": "Third party loans",
        "verboseLabel": "Loan from third parties"
       }
      }
     },
     "localname": "ThirdPartyLoan",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jfbr_TotalDilutedWeightedAverageSharesOutstanding": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total diluted weighted average shares outstanding.",
        "label": "Total Diluted Weighted Average Shares Outstanding",
        "totalLabel": "Total diluted weighted average shares outstanding"
       }
      }
     },
     "localname": "TotalDilutedWeightedAverageSharesOutstanding",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "jfbr_UndefinedPeriodOfTime": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undefined period of time.",
        "label": "Undefined Period Of Time",
        "terseLabel": "Undefined period of time"
       }
      }
     },
     "localname": "UndefinedPeriodOfTime",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "jfbr_UnderwriterWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable": {
       "order": 2.0,
       "parentTag": "jfbr_TotalDilutedWeightedAverageSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares is underwriter warrants.",
        "label": "Underwriter Warrants",
        "terseLabel": "Underwriter warrants"
       }
      }
     },
     "localname": "UnderwriterWarrants",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdilutedweightedaveragesharesoutstandingTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "jfbr_UnderwritersWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Warrants Member",
        "terseLabel": "Underwriter\u2019s Warrants [Member]"
       }
      }
     },
     "localname": "UnderwritersWarrantsMember",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jfbr_WeightedAverageBorrowingRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of borrowings.",
        "label": "Weighted Average Borrowing Rate",
        "terseLabel": "Weighted average borrowing rate"
       }
      }
     },
     "localname": "WeightedAverageBorrowingRate",
     "nsuri": "http://www.jeffsbrands.com/20221231",
     "presentation": [
      "http://www.jeffsbrands.com/role/LeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board of Directors Chairman [Member]",
        "terseLabel": "Board of Directors [Member]"
       }
      }
     },
     "localname": "BoardOfDirectorsChairmanMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r302",
      "r350",
      "r439",
      "r465",
      "r474",
      "r475",
      "r491",
      "r494",
      "r499",
      "r543",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r302",
      "r350",
      "r439",
      "r465",
      "r474",
      "r475",
      "r491",
      "r494",
      "r499",
      "r543",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r302",
      "r348",
      "r350",
      "r354",
      "r355",
      "r356",
      "r438",
      "r439",
      "r465",
      "r474",
      "r475",
      "r491",
      "r494",
      "r499",
      "r540",
      "r543",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r302",
      "r348",
      "r350",
      "r354",
      "r355",
      "r356",
      "r438",
      "r439",
      "r465",
      "r474",
      "r475",
      "r491",
      "r494",
      "r499",
      "r540",
      "r543",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r532",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails",
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails",
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r151",
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities",
        "terseLabel": "Total other payables"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "OTHER PAYABLES"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/OtherPayables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r0",
      "r24"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Trade payables"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r282",
      "r283"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Payroll Taxes, Current",
        "terseLabel": "Additional payroll expenses"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent": {
     "auth_ref": [
      "r153",
      "r173"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs.",
        "label": "Accrued Payroll Taxes",
        "terseLabel": "Additional payroll expenses"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r14",
      "r498"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r14"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Classification to additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r527",
      "r528",
      "r529",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r58",
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium": {
     "auth_ref": [
      "r322"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in additional paid-in capital (APIC) from recognition of substantial premium at which convertible debt instrument is issued.",
        "label": "Adjustment to Additional Paid-in Capital, Convertible Debt Instrument Issued at Substantial Premium",
        "terseLabel": "Debt extinguishment of shareholders\u2019 loans (Note 10d)"
       }
      }
     },
     "localname": "AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "terseLabel": "Reclassification of derivative warrant liabilities to equity (Note 9c)"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r108",
      "r109",
      "r351"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r91",
      "r96",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Issuance of warrants to third party upon initial public offering"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net profit (loss) to net cash from (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising expenses"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r203",
      "r286",
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for returns"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r40",
      "r325",
      "r416",
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of loan discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r58",
      "r78",
      "r83"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "auth_ref": [
      "r496",
      "r556",
      "r557",
      "r558"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.",
        "label": "Asset Acquisition, Consideration Transferred",
        "terseLabel": "Total consideration"
       }
      }
     },
     "localname": "AssetAcquisitionConsiderationTransferred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r146",
      "r166",
      "r197",
      "r224",
      "r270",
      "r273",
      "r277",
      "r289",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r396",
      "r398",
      "r406",
      "r498",
      "r541",
      "r542",
      "r568"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r191",
      "r206",
      "r224",
      "r289",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r396",
      "r398",
      "r406",
      "r498",
      "r541",
      "r542",
      "r568"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r224",
      "r289",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r396",
      "r398",
      "r406",
      "r541",
      "r542",
      "r568"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BankingAndThriftInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance (Income) Expenses, Net [Abstract]"
       }
      }
     },
     "localname": "BankingAndThriftInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of preparation of the financial statements"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r394",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r119",
      "r120",
      "r394",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationAsset": {
     "auth_ref": [
      "r121",
      "r122",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Asset",
        "terseLabel": "Consideration amount"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Finance the acquisition percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r60",
      "r194",
      "r477"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r55",
      "r60",
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS AT END OF THE YEAR",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS AT BEGINNING OF THE YEAR"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r55",
      "r135"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET INCREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r224",
      "r246",
      "r247",
      "r250",
      "r252",
      "r260",
      "r261",
      "r289",
      "r303",
      "r306",
      "r307",
      "r308",
      "r312",
      "r313",
      "r332",
      "r333",
      "r335",
      "r339",
      "r345",
      "r406",
      "r476",
      "r511",
      "r522",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r101",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price (in Dollars per share)",
        "verboseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Additional warrant total consideration"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants",
        "verboseLabel": "Warrants purchase shares (in Shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r90",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Legal and other contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r527",
      "r528",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "netLabel": "Ordinary Share [Member]",
        "terseLabel": "Ordinary Shares",
        "verboseLabel": "Ordinary Shares [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails",
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Common Stock, No Par Value",
        "terseLabel": "Ordinary shares, par value (in Dollars per share)"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockOtherSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.",
        "label": "Common Stock, Other Shares, Outstanding",
        "terseLabel": "Ordinary shares issued (in Shares)"
       }
      }
     },
     "localname": "CommonStockOtherSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Ordinary shares, Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Ordinary shares, Issued",
        "verboseLabel": "Common Stock, Shares, Issued (in Shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r13",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Ordinary shares, outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r13",
      "r498"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Ordinary shares of no par value per share - Authorized: 43,567,567 and 4,356,757 shares as of December 31, 2022, and December 31, 2021, respectively; Issued and outstanding: 8,074,217 shares as of December 31, 2022; 2,893,125 shares as of December 31, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r63",
      "r64",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Converted into ordinary shares",
        "verboseLabel": "Converted into an aggregate of ordinary shares (in Shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.",
        "label": "Convertible Debt [Table Text Block]",
        "terseLabel": "Schedule of fair value of the derivative warrant liability"
       }
      }
     },
     "localname": "ConvertibleDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r42",
      "r445"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r525",
      "r552",
      "r555"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r118",
      "r378",
      "r386",
      "r525"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current income tax expense"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": {
     "auth_ref": [
      "r63",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Warrants or Options Issued",
        "terseLabel": "Warrants issued"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r198"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Derivate liability"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Loans [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r94",
      "r222",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r324",
      "r326",
      "r327",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "LOANS FROM SHAREHOLDERS"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r8",
      "r149",
      "r164",
      "r329"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "terseLabel": "Monthly fee"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r30",
      "r137",
      "r331",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Additional interest rate percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r30",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Annual interest percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r136",
      "r138",
      "r544"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Loan discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction": {
     "auth_ref": [
      "r63",
      "r64",
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of debt issuance costs that were incurred during a noncash or partial noncash transaction.",
        "label": "Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction",
        "terseLabel": "Transferred to smart pro amount"
       }
      }
     },
     "localname": "DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCosts": {
     "auth_ref": [
      "r145",
      "r165",
      "r512"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.",
        "label": "Deferred Costs, Noncurrent",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r118",
      "r525",
      "r553"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r367",
      "r368"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r58",
      "r118",
      "r379",
      "r385",
      "r386",
      "r525"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Benefit for deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r367",
      "r368"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "totalLabel": "Total deferred tax income"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r374"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "terseLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r550"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "terseLabel": "Total deferred tax assets after valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses": {
     "auth_ref": [
      "r116",
      "r551"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated impairment losses.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Impairment Losses",
        "terseLabel": "Carry forward tax losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r375"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r116",
      "r551"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "terseLabel": "Total deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of plan assets to benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Funded Percentage",
        "terseLabel": "Benefit percentage"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Monthly contribution percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeCostOfHedgeNetOfCashReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The premium (cost) of a hedge, net of any cash received on settlement during the period.",
        "label": "Derivative, Cost of Hedge Net of Cash Received",
        "terseLabel": "Derivative, Cost of Hedge Net of Cash Received"
       }
      }
     },
     "localname": "DerivativeCostOfHedgeNetOfCashReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r405"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "terseLabel": "Fair value amount"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r130",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r132",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "DERIVATIVE LIABILITIES"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r207"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Derivative liabilities",
        "verboseLabel": "Financial liability"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet",
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r126",
      "r131",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r352",
      "r357",
      "r358",
      "r359",
      "r363",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "SHARE INCENTIVE PLAN"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareIncentivePlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Incentive Plan [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureTextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "DisclosureTextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r98",
      "r162"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "terseLabel": "Ordinary Share price divided"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r7",
      "r10",
      "r148",
      "r167"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Shares acquired value"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToOtherRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r33",
      "r140",
      "r526"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount payable from related parties classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Due to Other Related Parties, Noncurrent",
        "terseLabel": "Loan from related parties (Note 9)"
       }
      }
     },
     "localname": "DueToOtherRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r152",
      "r176",
      "r305",
      "r306",
      "r307",
      "r311",
      "r312",
      "r313",
      "r432",
      "r526"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.",
        "label": "Due to Related Parties",
        "terseLabel": "Related parties"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r215",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r243",
      "r246",
      "r250",
      "r251",
      "r252",
      "r256",
      "r403",
      "r404",
      "r460",
      "r463",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic and diluted net profit (loss) attributable to shareholders per ordinary share (in Dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r215",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r246",
      "r250",
      "r251",
      "r252",
      "r256",
      "r403",
      "r404",
      "r460",
      "r463",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net profit (loss) attributable to shareholders per ordinary share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedProFormaAdjustment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pro forma diluted earnings per share adjustment to reconcile between net income and pro forma amounts.",
        "label": "Earnings Per Share, Diluted, Pro Forma Adjustment",
        "terseLabel": "Net loss per share of ordinary share, basic and diluted",
        "verboseLabel": "Net loss per share of ordinary share, diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedProFormaAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable",
      "http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r68",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Basic and diluted net loss per share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO ORDINARY SHAREHOLDERS"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Exchange rate changes"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Corporate tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r227",
      "r370",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r388",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent",
        "terseLabel": "tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/TaxesonIncomeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r547",
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount",
        "terseLabel": "Tax (tax benefit) computed at the statutory tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r547",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent",
        "terseLabel": "Tax benefit percentage"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employees and related benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The shares or units in an ESOP trust that have been assigned to individual participant accounts based on a known formula. IRS rules require allocations to be nondiscriminatory generally based on compensation, length of service, or a combination of both. For any particular participant such shares or units may be vested, unvested, or partially vested.",
        "label": "Employee Stock Ownership Plan (ESOP), Number of Allocated Shares",
        "terseLabel": "Ordinary Shares were reserved"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareIncentivePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPPolicy": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for ESOP transactions, including the method of measuring compensation, the classification of dividends on ESOP shares, and the treatment of ESOP shares for EPS computations. If the employer has both old ESOP shares for which it does not adopt new guidance and new ESOP shares for which new guidance is required, these disclosures are required for both blocks of shares.",
        "label": "Employee Stock Ownership Plan (ESOP), Policy [Policy Text Block]",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "EmployeeStockOwnershipPlanESOPPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r96",
      "r189",
      "r211",
      "r212",
      "r213",
      "r230",
      "r231",
      "r232",
      "r234",
      "r240",
      "r242",
      "r259",
      "r290",
      "r347",
      "r360",
      "r361",
      "r362",
      "r381",
      "r382",
      "r402",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r428",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails",
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Shares acquired percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ExcessStockSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of excess stock shares of an entity that have been sold or granted to shareholders.",
        "label": "Excess Stock, Shares Issued",
        "terseLabel": "Number of shares"
       }
      }
     },
     "localname": "ExcessStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ExtinguishmentOfDebtGainLossNetOfTax": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.",
        "label": "Extinguishment of Debt, Gain (Loss), Net of Tax",
        "terseLabel": "Gain from debt extinguishment"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r58",
      "r95"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "terseLabel": "Change in fair value of derivative liabilities",
        "verboseLabel": "Fair value warrants"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair value measurement"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues": {
     "auth_ref": [
      "r133"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances",
        "terseLabel": "Fair value issuance amount"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOptionChangesInFairValueGainLoss1": {
     "auth_ref": [
      "r134"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.",
        "label": "Fair Value, Option, Changes in Fair Value, Gain (Loss)",
        "terseLabel": "Change in fair value of derivative liabilities"
       }
      }
     },
     "localname": "FairValueOptionChangesInFairValueGainLoss1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r420",
      "r424",
      "r497"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentsOwnedAtFairValue": {
     "auth_ref": [
      "r144"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.",
        "label": "Financial Instruments, Owned, at Fair Value",
        "terseLabel": "Financial instrument"
       }
      }
     },
     "localname": "FinancialInstrumentsOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r195",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r82",
      "r447"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r82",
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Net Balance"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedTrademarksGross": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a specified period of time.",
        "label": "Finite-Lived Trademarks, Gross",
        "terseLabel": "Total trademarks"
       }
      }
     },
     "localname": "FiniteLivedTrademarksGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign [Member]"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Functional and presentation currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture [Member]"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r58",
      "r92",
      "r93"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Gain from debt extinguishment"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Intangible Assets [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GovernmentContractReceivable": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable": {
       "order": 2.0,
       "parentTag": "us-gaap_PremiumsAndOtherReceivablesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of receivables that are derived from government contracts.",
        "label": "Government Contract Receivable",
        "terseLabel": "Government institutions"
       }
      }
     },
     "localname": "GovernmentContractReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r41",
      "r224",
      "r270",
      "r272",
      "r276",
      "r278",
      "r289",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r406",
      "r487",
      "r541"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO [Member]",
        "verboseLabel": "IPO Warrants [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r521",
      "r539"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "terseLabel": "Impairment of intangible asset"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r84",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossAttributableToParent": {
     "auth_ref": [
      "r44",
      "r213"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss) Attributable to Parent, before Tax",
        "totalLabel": "Profit (loss) before taxes"
       }
      }
     },
     "localname": "IncomeLossAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r37",
      "r143",
      "r157",
      "r180",
      "r270",
      "r272",
      "r276",
      "r278",
      "r461",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Taxes on income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r226",
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Income loss before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r38",
      "r58",
      "r75",
      "r156",
      "r178",
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Income (loss) before taxes on income"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofincomelossbeforetaxesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r227",
      "r371",
      "r372",
      "r377",
      "r383",
      "r389",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "TAXES ON INCOME"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/TaxesonIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r228",
      "r241",
      "r242",
      "r269",
      "r369",
      "r384",
      "r390",
      "r464"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Tax (benefit) expense",
        "totalLabel": "Total tax (benefit) expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement",
      "http://www.jeffsbrands.com/role/ScheduleofincometaxexpensebenefitTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r210",
      "r365",
      "r366",
      "r372",
      "r373",
      "r376",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Tax rate differences applicable to subsidiaries"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Tax losses and timing differences for which deferred taxes were not recognized"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofstatutoryincometaxratetoeffectiveincometaxrateTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Decrease (increase) in trade receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "terseLabel": "Net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDerivativeLiabilities": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).",
        "label": "Increase (Decrease) in Derivative Liabilities",
        "terseLabel": "Change in fair value of derivative liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInDerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedParties": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Due to Related Parties",
        "terseLabel": "Decrease (increase) related party balance"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Decrease (increase) in inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInNotesPayableRelatedPartiesCurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the current portion (due within one year or one business cycle, whichever is longer) of the amount owed by the reporting entity in the form of loans and obligations (generally evidenced by promissory notes) made by the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Notes Payable, Related Parties, Current",
        "terseLabel": "Increase (decrease) related party liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInNotesPayableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r520",
      "r563"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Decrease in operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities",
        "terseLabel": "Increase (decrease) accounts payable and other payables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Decrease (increase) in other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r295",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable",
      "http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset lacking physical substance and having a projected indefinite period of benefit to fair value. Excludes financial assets and goodwill.",
        "label": "Indefinite-Lived Intangible Assets, Written off Related to Sale of Business Unit",
        "terseLabel": "Write off the intangible asset balance"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/IntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/IntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "auth_ref": [
      "r81",
      "r442",
      "r443",
      "r444",
      "r446",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r77",
      "r80"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "negatedLabel": "Total finance income"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseOtherShortTermBorrowings": {
     "auth_ref": [
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense incurred during the reporting period on other short-term borrowings.",
        "label": "Interest Expense, Other Short-Term Borrowings",
        "terseLabel": "Capital reserve from the transaction"
       }
      }
     },
     "localname": "InterestExpenseOtherShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense incurred on a debt or other obligation to related party.",
        "label": "Interest Expense, Related Party",
        "terseLabel": "Interest expense on loans from shareholders and related parties"
       }
      }
     },
     "localname": "InterestExpenseRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for interest income and interest expense for enterprises that derive a significant portion of their revenue from interest collected on investments, loans, and securities.",
        "label": "Interest Income and Interest Expense Disclosure [Text Block]",
        "terseLabel": "FINANCE (INCOME) EXPENSE, NET"
       }
      }
     },
     "localname": "InterestIncomeAndInterestExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/FinanceIncomeExpenseNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InterestIncomeRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income earned from interest-bearing assets owed to the entity by related party.",
        "label": "Interest Income, Related Party",
        "terseLabel": "Accrued interest related party"
       }
      }
     },
     "localname": "InterestIncomeRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r217",
      "r219",
      "r220"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued Interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORY"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r513"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofinventoryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventory, Gross",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofinventoryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r205",
      "r478",
      "r498"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNoncurrent": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.",
        "label": "Inventory, Noncurrent",
        "terseLabel": "Inventory total amount"
       }
      }
     },
     "localname": "InventoryNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r193",
      "r204",
      "r258",
      "r292",
      "r293",
      "r294",
      "r441",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentInterestRate": {
     "auth_ref": [
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of interest on investment.",
        "label": "Investment Interest Rate",
        "terseLabel": "Interest rate percentage"
       }
      }
     },
     "localname": "InvestmentInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "terseLabel": "Warrants issuance costs"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LaborAndRelatedExpense": {
     "auth_ref": [
      "r516"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.",
        "label": "Labor and Related Expense",
        "terseLabel": "Labor cost and related expenses (c1)"
       }
      }
     },
     "localname": "LaborAndRelatedExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements [Member["
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeFinanceLeaseRenewalTerm1": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's finance lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Renewal Term",
        "terseLabel": "Lease term period"
       }
      }
     },
     "localname": "LesseeFinanceLeaseRenewalTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of future lease payments under operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024-2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Leases term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r27",
      "r224",
      "r289",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r397",
      "r398",
      "r399",
      "r406",
      "r486",
      "r541",
      "r568",
      "r569"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "TOTAL LIABILITIES"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r18",
      "r150",
      "r171",
      "r498",
      "r524",
      "r536",
      "r561"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r29",
      "r192",
      "r224",
      "r289",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r397",
      "r398",
      "r399",
      "r406",
      "r498",
      "r541",
      "r568",
      "r569"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r8",
      "r9",
      "r224",
      "r289",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r397",
      "r398",
      "r399",
      "r406",
      "r541",
      "r568",
      "r569"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r8",
      "r149",
      "r164"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "terseLabel": "Line of credit amount"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r6",
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Under line credit"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansAndLeasesReceivableRelatedParties": {
     "auth_ref": [
      "r140",
      "r155"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, reflects the carrying amount of unpaid loan amounts due from related parties at the balance sheet date.",
        "label": "Loans and Leases Receivable, Related Parties",
        "terseLabel": "Related party loan"
       }
      }
     },
     "localname": "LoansAndLeasesReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "OTHER RECEIVABLES"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/Otherreceivables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LoansPayable": {
     "auth_ref": [
      "r8",
      "r149",
      "r163"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Loans Payable",
        "terseLabel": "Loans with Amazon",
        "verboseLabel": "Outstanding loan amount"
       }
      }
     },
     "localname": "LoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable",
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableCurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.",
        "label": "Loans Payable, Current",
        "terseLabel": "Loan amount"
       }
      }
     },
     "localname": "LoansPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofloansfromshareholdersconsistsTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansReceivableBasisSpreadOnVariableRateDuringPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate or index during the adjustment period to compute the variable [fully indexed] rate on the loans receivable realized during the reporting period. This may be an effective margin for the period depending on the specific terms of the underlying loan agreement (for example, an annual disclosure for a loan with a quarterly adjustment period).",
        "label": "Loans Receivable, Basis Spread on Variable Rate, During Period",
        "terseLabel": "Loans was determined percentage"
       }
      }
     },
     "localname": "LoansReceivableBasisSpreadOnVariableRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r8",
      "r149",
      "r169",
      "r323",
      "r330",
      "r489",
      "r490"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Loan amount"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MajorityShareholderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Owner that controls more than 50 percent of the voting interest in the entity through direct or indirect ownership.",
        "label": "Majority Shareholder [Member]",
        "terseLabel": "Majority Shareholder [Member]"
       }
      }
     },
     "localname": "MajorityShareholderMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaturityOfTimeDeposits": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of customer deposits, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maturity of Time Deposits",
        "terseLabel": "Short-term bank deposits maturities"
       }
      }
     },
     "localname": "MaturityOfTimeDeposits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MembersCapital": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of member capital in limited liability company (LLC).",
        "label": "Members' Capital",
        "terseLabel": "Issued and outstanding share capital"
       }
      }
     },
     "localname": "MembersCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Ownership limitation percentage"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS USED IN INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r55",
      "r56",
      "r59"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Net cash provided by (Used in) operating activities (in Dollars)",
        "totalLabel": "Net cash from (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM (USED IN) OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r39",
      "r59",
      "r158",
      "r179",
      "r190",
      "r208",
      "r209",
      "r213",
      "r224",
      "r233",
      "r235",
      "r236",
      "r237",
      "r238",
      "r241",
      "r242",
      "r248",
      "r270",
      "r272",
      "r276",
      "r278",
      "r289",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r404",
      "r406",
      "r487",
      "r541"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net loss (in Dollars)",
        "terseLabel": "Profit (loss) for the year",
        "totalLabel": "Net profit (loss)",
        "verboseLabel": "Net profit (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow",
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r235",
      "r236",
      "r237",
      "r238",
      "r243",
      "r244",
      "r249",
      "r252",
      "r270",
      "r272",
      "r276",
      "r278",
      "r487"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income (loss) applicable to shareholders of ordinary shares"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently adopted and recently issued accounting pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoninterestExpenseDirectorsFees": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable": {
       "order": 2.0,
       "parentTag": "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noninterest expense related to directors' fees which are fees paid by an Entity to its directors. Directors' fees may be paid in addition to salary and other benefits.",
        "label": "Noninterest Expense Directors Fees",
        "terseLabel": "Directors\u2019 fees"
       }
      }
     },
     "localname": "NoninterestExpenseDirectorsFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r23",
      "r141",
      "r526"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Notes Payable, Related Parties, Current",
        "terseLabel": "Related party payables"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r270",
      "r272",
      "r276",
      "r278",
      "r487"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating profit (loss)"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r421",
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Operating lease right of use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofdeferredtaxesassetsandliabilitiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAdditionalCapital": {
     "auth_ref": [
      "r35",
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of additional paid-in capital (APIC) classified as other.",
        "label": "Other Additional Capital",
        "terseLabel": "Pure capital amoun"
       }
      }
     },
     "localname": "OtherAdditionalCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/OtherreceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r145",
      "r165",
      "r196"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other Assets",
        "totalLabel": "Assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r45",
      "r58",
      "r86"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Other Depreciation and Amortization",
        "terseLabel": "Accrued interest and amortization of discount on third party loans (Note 8)"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpenses": {
     "auth_ref": [
      "r47",
      "r181"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense classified as other.",
        "label": "Other Expenses",
        "terseLabel": "Finance expenses"
       }
      }
     },
     "localname": "OtherExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInventoryInTransit": {
     "auth_ref": [
      "r514"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of merchandise or supplies to which the entity holds the title but does not hold physical possession because the goods are currently being transported.",
        "label": "Other Inventory, in Transit, Gross",
        "terseLabel": "Goods in transit"
       }
      }
     },
     "localname": "OtherInventoryInTransit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofinventoryTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLaborRelatedExpenses": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of labor-related expenses classified as other.",
        "label": "Other Labor-related Expenses",
        "terseLabel": "Lease and maintenance expenses related"
       }
      }
     },
     "localname": "OtherLaborRelatedExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other Liabilities",
        "totalLabel": "Liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbalanceswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r28",
      "r498"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLoansPayableCurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term loans classified as other, payable within one year or the operating cycle, if longer.",
        "label": "Other Loans Payable, Current",
        "terseLabel": "Other payables"
       }
      }
     },
     "localname": "OtherLoansPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLoansPayableLongTerm": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term loans classified as other, payable after one year or the operating cycle, if longer.",
        "label": "Other Loans Payable, Long-Term, Noncurrent",
        "terseLabel": "Loans from shareholders"
       }
      }
     },
     "localname": "OtherLoansPayableLongTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherMinorityInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of equity interests owned by noncontrolling shareholders, partners, or other equity holders in one or more of the entities consolidated into the reporting entity's financial statements other than joint ventures, limited partnerships, operating partnerships or interests held by preferred unit holders.",
        "label": "Other Noncontrolling Interests",
        "terseLabel": "Minority shareholders transferred amount"
       }
      }
     },
     "localname": "OtherMinorityInterests",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "terseLabel": "Other finance expenses"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r202"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable": {
       "order": 3.0,
       "parentTag": "us-gaap_PremiumsAndOtherReceivablesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSellingAndMarketingExpense": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling and marketing expense classified as other.",
        "label": "Other Selling and Marketing Expense",
        "terseLabel": "Sales and marketing expenses"
       }
      }
     },
     "localname": "OtherSellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expense classified as other.",
        "label": "Other Selling, General and Administrative Expense",
        "terseLabel": "Other expenses"
       }
      }
     },
     "localname": "OtherSellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "auth_ref": [
      "r225",
      "r548",
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other income tax expense (benefit).",
        "label": "Other Tax Expense (Benefit)",
        "terseLabel": "Total finance expenses"
       }
      }
     },
     "localname": "OtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffinanceincomeexpensesnetTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PartnersCapitalAccountReturnOfCapital": {
     "auth_ref": [
      "r98",
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total change in each class of partners' capital accounts during the year due to the return of partner's capital. That is, excess distributions over earnings to partners. All partners include general, limited and preferred partners.",
        "label": "Partners' Capital Account, Return of Capital",
        "terseLabel": "Pure capital amount"
       }
      }
     },
     "localname": "PartnersCapitalAccountReturnOfCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Payables [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForPreviousAcquisition": {
     "auth_ref": [
      "r517"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow representing an adjustment to the purchase price of a previous acquisition.",
        "label": "Payments for Previous Acquisition",
        "terseLabel": "Amazon loan balance."
       }
      }
     },
     "localname": "PaymentsForPreviousAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "terseLabel": "Divided ordinary shares amount"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Purchase of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliers": {
     "auth_ref": [
      "r518",
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments of cash to suppliers for goods and services during the current period.",
        "label": "Payments to Suppliers",
        "terseLabel": "Advances to suppliers"
       }
      }
     },
     "localname": "PaymentsToSuppliers",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PercentageOfWeightedAverageCostInventory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of weighted average cost inventory present at the reporting date when inventory is valued using different valuation methods.",
        "label": "Percentage of Weighted Average Cost Inventory",
        "terseLabel": "WACC"
       }
      }
     },
     "localname": "PercentageOfWeightedAverageCostInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PolicyLoansReceivablePolicy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for policy loans receivable, including the basis for determining the amount reported for loans made to policyholders against and secured by future policy benefits. May also disclose the range of interest rates charged to policyholders on such loans.",
        "label": "Policy Loans Receivable, Policy [Policy Text Block]",
        "terseLabel": "Loans from shareholders and related parties"
       }
      }
     },
     "localname": "PolicyLoansReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PremiumsAndOtherReceivablesNet": {
     "auth_ref": [
      "r177"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.",
        "label": "Premiums and Other Receivables, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PremiumsAndOtherReceivablesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrincipalAmountOutstandingOnLoansSecuritized": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is the principal amount outstanding for securitized loans only (across all types of loans).",
        "label": "Principal Amount Outstanding on Loans Securitized or Asset-Backed Financing Arrangement",
        "terseLabel": "Outstanding loans"
       }
      }
     },
     "localname": "PrincipalAmountOutstandingOnLoansSecuritized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromBankDebt": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from bank borrowing during the year.",
        "label": "Proceeds from Bank Debt",
        "terseLabel": "Loan received from shareholders"
       }
      }
     },
     "localname": "ProceedsFromBankDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Issuance of costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from initial public offering, net of issuance costs",
        "verboseLabel": "Net proceeds of IPO (in Dollars)"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Issuance of ordinary shares"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "netLabel": "Warrants issuance costs",
        "terseLabel": "Issuance of warrants in connection with the IPO",
        "verboseLabel": "(in Dollars)"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueofthederivativewarrantliabilityTable",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromOtherShortTermDebt": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from short-term debt classified as other.",
        "label": "Proceeds from Other Short-Term Debt",
        "terseLabel": "Short-term loan received"
       }
      }
     },
     "localname": "ProceedsFromOtherShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.",
        "label": "Proceeds from (Repayments of) Related Party Debt",
        "terseLabel": "Loan received (repaid) from related parties"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r182",
      "r183"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable": {
       "order": 3.0,
       "parentTag": "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees",
        "terseLabel": "Consulting fees (c2)"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property, Plant and Equipment, Estimated Useful Lives",
        "terseLabel": "Property and equipment term"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r88",
      "r172",
      "r462",
      "r498"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r88",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentSalvageValuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stated as a percentage, the estimated or actual value of the asset at the end of its useful life or when it is no longer serviceable (cannot be used for its original purpose) divided by its [historical] capitalized cost.",
        "label": "Property, Plant and Equipment, Salvage Value, Percentage",
        "terseLabel": "Property and equipment percentage"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentSalvageValuePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of assets are depreciated using the straight-line method to allocate their cost over their estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Remaining useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivableWithImputedInterestDiscount": {
     "auth_ref": [
      "r136"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the unamortized amount of the discount on the note or receivable which is deducted from the face amount of the receivable or loan. The discount or premium is the difference between the present value and the face amount.",
        "label": "Receivable with Imputed Interest, Discount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "ReceivableWithImputedInterestDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffutureleasepaymentsunderoperatingleasesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyCosts": {
     "auth_ref": [
      "r43",
      "r305",
      "r306",
      "r307",
      "r311",
      "r312",
      "r313",
      "r526"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.",
        "label": "Related Party Costs",
        "terseLabel": "Related party balance"
       }
      }
     },
     "localname": "RelatedPartyCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r349",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails",
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r188",
      "r431",
      "r432",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionDueFromToRelatedParty": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r311",
      "r312",
      "r313",
      "r526",
      "r565"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivables to be collected from (obligations owed to) related parties, net as of the balance sheet date where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.",
        "label": "Related Party Transaction, Due from (to) Related Party",
        "terseLabel": "Another related party balance"
       }
      }
     },
     "localname": "RelatedPartyTransactionDueFromToRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "totalLabel": "Total transactions with interested and related parties"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftransactionswithinterestedandrelatedpartiesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r349",
      "r431",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails",
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r429",
      "r430",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTIES"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfBankDebt": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to settle a bank borrowing during the year.",
        "label": "Repayments of Bank Debt",
        "negatedLabel": "Loan repaid to shareholders"
       }
      }
     },
     "localname": "RepaymentsOfBankDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherShortTermDebt": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing within one year or the operating cycle, if longer.",
        "label": "Repayments of Other Short-Term Debt",
        "negatedLabel": "Short-term loan repaid"
       }
      }
     },
     "localname": "RepaymentsOfOtherShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r15",
      "r98",
      "r170",
      "r469",
      "r470",
      "r498"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "verboseLabel": "Accumulated deficit\t(in Dollars)"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r189",
      "r230",
      "r231",
      "r232",
      "r234",
      "r240",
      "r242",
      "r290",
      "r360",
      "r361",
      "r362",
      "r381",
      "r382",
      "r402",
      "r466",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings (Accumulated deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionCustomerAcquisitions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for incremental direct costs incurred related to the acquisition or origination of a customer contract in a transaction that results in revenue deferral (that is, whether such costs are expensed as incurred or deferred and charged to expense in proportion to the revenue recognized.) Also describes the entity's policy for determining which costs are capitalized as contract acquisition or origination costs.",
        "label": "Revenue Recognition, Customer Acquisitions [Policy Text Block]",
        "terseLabel": "Asset acquisition"
       }
      }
     },
     "localname": "RevenueRecognitionCustomerAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Revenue percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r214",
      "r224",
      "r266",
      "r267",
      "r271",
      "r274",
      "r275",
      "r279",
      "r280",
      "r281",
      "r289",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r406",
      "r461",
      "r541"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalariesWagesAndOfficersCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
        "label": "Salary and Wage, Excluding Cost of Good and Service Sold",
        "terseLabel": "Salary"
       }
      }
     },
     "localname": "SalariesWagesAndOfficersCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock",
        "verboseLabel": "Sale of shares"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.",
        "label": "Sale of Stock, Percentage of Ownership after Transaction",
        "terseLabel": "Percentage of shares ownership after Transaction"
       }
      }
     },
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price per share (in Dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of other payables"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/OtherPayablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of income tax expense (benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/TaxesonIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of loans from shareholders consists"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred taxes assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/TaxesonIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of basic and diluted net income (loss) per share attributable to ordinary shareholders"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of statutory income tax rate to effective income tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/TaxesonIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r79",
      "r81",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoftotalintangibleassetsTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r79",
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of total intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/IntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of income (loss) before taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/TaxesonIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r19",
      "r20",
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "schedule of inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of other receivables"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/OtherreceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofassetsaredepreciatedusingthestraightlinemethodtoallocatetheircostovertheirestimatedusefullivesTable"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "terseLabel": "Schedule of transactions with interested and related parties"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of fair value of the IPO warrants and additional warrants"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of short term loans"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of share capital composed of ordinary shares"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "terseLabel": "Schedule of diluted weighted average shares outstanding"
       }
      }
     },
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/NetIncomeLossPerShareAttributabletoOrdinaryShareholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of rights of setoff associated with the entity's recognized securities sold under agreements to repurchase subject to an enforceable master netting arrangement or similar agreement.",
        "label": "Securities Sold under Agreements to Repurchase, Setoff Rights, Description",
        "terseLabel": "Stock purchase agreement description"
       }
      }
     },
     "localname": "SecuritiesSoldUnderAgreementsToRepurchaseSetoffRightsDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Business Combination [Member]"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price",
        "terseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Ordinary shares exercisable (in Shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in Dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleoffairvalueoftheIPOwarrantsandadditionalwarrantsTable"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average stock price"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Ordinary shares exercisable term"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "terseLabel": "Shares issued (in Shares)",
        "verboseLabel": "Issued to the minority Shareholder (in Shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/RelatedPartiesDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Ordinary shares exercisable per share (in Dollars per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance (in Shares)",
        "periodStartLabel": "Balance (in Shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBankLoansAndNotesPayable": {
     "auth_ref": [
      "r22",
      "r175"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.",
        "label": "Short-Term Bank Loans and Notes Payable",
        "terseLabel": "Short-term loans"
       }
      }
     },
     "localname": "ShortTermBankLoansAndNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r5",
      "r147",
      "r168",
      "r498"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short term loans total"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofshorttermloansTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date which accrues interest at a set, unchanging rate.",
        "label": "Short-Term Debt, Percentage Bearing Fixed Interest Rate",
        "terseLabel": "Bears annual interest percentage"
       }
      }
     },
     "localname": "ShortTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShortTermDebtPercentageBearingVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date, which accrues interest at a rate subject to change from time to time.",
        "label": "Short-Term Debt, Percentage Bearing Variable Interest Rate",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "ShortTermDebtPercentageBearingVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShortTermDebtTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for short-term debt.",
        "label": "Short-Term Debt [Text Block]",
        "terseLabel": "SHORT-TERM LOANS"
       }
      }
     },
     "localname": "ShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortTermLeasePayments": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term lease payment excluded from lease liability.",
        "label": "Short-Term Lease Payments",
        "negatedLabel": "Interest expense on short-term loan"
       }
      }
     },
     "localname": "ShortTermLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShorttermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents the amount of short-term debt existing as of the balance sheet date.",
        "label": "Short-Term Debt, Fair Value",
        "terseLabel": "Fair value amount"
       }
      }
     },
     "localname": "ShorttermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShortTermLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r67",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r224",
      "r246",
      "r247",
      "r250",
      "r252",
      "r260",
      "r261",
      "r289",
      "r303",
      "r306",
      "r307",
      "r308",
      "r312",
      "r313",
      "r332",
      "r333",
      "r335",
      "r339",
      "r345",
      "r406",
      "r476",
      "r511",
      "r522",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r34",
      "r96",
      "r189",
      "r211",
      "r212",
      "r213",
      "r230",
      "r231",
      "r232",
      "r234",
      "r240",
      "r242",
      "r259",
      "r290",
      "r347",
      "r360",
      "r361",
      "r362",
      "r381",
      "r382",
      "r402",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r428",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails",
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r230",
      "r231",
      "r232",
      "r259",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [
      "r12",
      "r13",
      "r96",
      "r97",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "terseLabel": "Conversion of shareholder loans (Note 12i) (in Shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.",
        "label": "Stock Issued During Period, Shares, Purchase of Assets",
        "terseLabel": "Purchase of share"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "auth_ref": [
      "r34",
      "r96",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "terseLabel": "Conversion of shareholder loans (Note 12i)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "terseLabel": "Share-based compensation to service provider"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r12",
      "r13",
      "r96",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of ordinary shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Transactions with shareholders"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionExercisePriceDecrease": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share decrease in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.",
        "label": "Stock Option, Exercise Price, Decrease",
        "terseLabel": "Exercise price less (in Dollars per share)"
       }
      }
     },
     "localname": "StockOptionExercisePriceDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_StockOptionExercisePriceIncrease": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share increase in exercise price of option. Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.",
        "label": "Stock Option, Exercise Price, Increase",
        "terseLabel": "Exercise price (in Dollars per share)"
       }
      }
     },
     "localname": "StockOptionExercisePriceIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r13",
      "r16",
      "r17",
      "r74",
      "r498",
      "r524",
      "r536",
      "r561"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "TOTAL SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet",
      "http://www.jeffsbrands.com/role/ShareholdersEquityType2or3"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "SHAREHOLDERS\u2019 EQUITY:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r102",
      "r223",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r347",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "SHARE CAPITAL"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ShareCapital"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r96",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in stockholders' equity during the period.",
        "label": "Stockholders' Equity, Period Increase (Decrease)",
        "terseLabel": "Increase in equity"
       }
      }
     },
     "localname": "StockholdersEquityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/LoansfromShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "auth_ref": [
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "terseLabel": "Reverse Share Split, description"
       }
      }
     },
     "localname": "StockholdersEquityReverseStockSplit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r414",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r414",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r414",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r435",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails",
      "http://www.jeffsbrands.com/role/GeneralInformationDetails",
      "http://www.jeffsbrands.com/role/ShareCapitalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedCashFlow"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Supplies": {
     "auth_ref": [
      "r479",
      "r488",
      "r537"
     ],
     "calculation": {
      "http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable": {
       "order": 1.0,
       "parentTag": "us-gaap_PremiumsAndOtherReceivablesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Supplies",
        "terseLabel": "Advances to suppliers"
       }
      }
     },
     "localname": "Supplies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofotherreceivablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofsharecapitalcomposedofordinarysharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofsharecapitalcomposedofordinarysharesTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r284",
      "r285",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_USGovernmentAgenciesSecuritiesAtCarryingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by a United States government agency such as Government National Mortgage Association (Ginnie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac), and Federal National Mortgage Association (Fannie Mae), which are short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.",
        "label": "US Government Agencies Securities, at Carrying Value",
        "terseLabel": "Government institutions"
       }
      }
     },
     "localname": "USGovernmentAgenciesSecuritiesAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofotherpayablesTable"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r262",
      "r263",
      "r264",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/AccountingPoliciesByPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantExercisePriceDecrease": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share decrease in exercise price of warrant. Excludes change due to standard antidilution provision.",
        "label": "Warrant, Exercise Price, Decrease",
        "terseLabel": "Initial exercise price"
       }
      }
     },
     "localname": "WarrantExercisePriceDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_WarrantExercisePriceIncrease": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share increase in exercise price of warrant. Excludes change due to standard antidilution provision.",
        "label": "Warrant, Exercise Price, Increase",
        "terseLabel": "Exercise price"
       }
      }
     },
     "localname": "WarrantExercisePriceIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/DerivativeLiabilitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Net proceeds (in Dollars)"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Warrants term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/GeneralInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageBasicSharesOutstandingProForma": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.",
        "label": "Weighted Average Basic Shares Outstanding, Pro Forma",
        "terseLabel": "Shares of ordinary share used in computing basic and diluted net loss per share"
       }
      }
     },
     "localname": "WeightedAverageBasicSharesOutstandingProForma",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Shares of ordinary share used in computing diluted net loss per share"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ScheduleofbasicanddilutednetincomelosspershareattributabletoordinaryshareholdersTable_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r245",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average ordinary shares used in computing net profit (loss) per share, diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement_Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r243",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average ordinary shares used in computing net profit (loss) per share, basic and diluted (in Shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.jeffsbrands.com/role/ConsolidatedIncomeStatement"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.F)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=109244661&loc=d3e17540-113929",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6411-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=35711157&loc=d3e42546-110969",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(3),(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.7(e))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1-12)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.14)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.7)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.7)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Industry Guide",
   "Number": "3",
   "Paragraph": "D-E",
   "Publisher": "SEC",
   "Section": "V",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225880-175312",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.20)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55295-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(b)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "350",
   "Subparagraph": "(a)",
   "Topic": "920",
   "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4,6)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(7)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.T)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868742-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6829253&loc=SL6831962-166255",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r501": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r502": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r503": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r504": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r505": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r506": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r507": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r508": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r509": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "https://asc.fasb.org/topic&trid=2122478",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.C)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>112
<FILENAME>0001213900-23-028401-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-028401-xbrl.zip
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MC9AT -3**89&VYU2ZO=VTUQ^^Z/,BV@T7]W!NG8)_20$X5HHV@!Q#6$[TK+
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MI4VN1V^,T_&P*D?Z;,B@5  2LH:KR3\Y=FN0>U4[M_KC:VS=C1Z@)9R0DGZ
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M3!959#&M/+FK CL %VN?P+^CBP0N@18LKC4\!FSH2%T2N0R0"L%5QYOGX&8
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M(..(%(ZLL@!/'GL=5EE$&.7 U4%2!& VTE#RP5R&AJM"6YGV?3M5 U4R$$Z
M,^8*J4U>8<.V=Q%$(%2RI*$T%O/%"56,5ZICG;%@8*=5>X>^G=39M9T<FI3O
MJA5CM382%^_/MHUL&D4VW+_ _5WPLS([%^ZV_ZF70?(,HA$.$N.1MJ@W0:N9
MR;%(BO"C,K<S;M&YBF/%(U3Q.EC(:C(@PZ&YI*.':3+BP>!P+^P(]1'SF46,
M]!)B<M.VS%+<4BIM%A3GRG9,I2JG,;VVT<0;7FP[<!DE[O1'CNAW>,YY9K/J
M/&LZDV;>,,4O_"3 E8PJIJ[N07:X8<4FLEK5EALJL8I_PPD;3KA1*R6KD9XK
MV*7L7; *M/,DQ2]7:F#\.N$-C):7.'U/*BX[?F +1%8SC0UTK@4?F*2YN+ +
M+01;J#OGKENW6/3Q93UCCEB0VM&.'P93;:8[P2*KKSB;IQL9G+2?S-6BJ>>K
M+*19''Q=Y7@O;?A5^@Q>;EH*%EH*]C8M!=\&H3<[J^\QA4FRX4R-2_@8XP<?
M AIMNG%9-\9!&]W<'!ZEG A0G)XY:4=D(/2\H3TP(- @D#P^SG2ER:V@(&E4
M]B89LB'26UBP*]&HTW-#A<AS3C^[@XZ 1$N=?A9BY7E(F=M_32 $SN4K-^2X
MMR;WC5(C5&920^%J0C=8-N1AQ:2C ?=8-A(B=:Q*+A[8\.2&)UM6'$%6T1H?
MM\]E5(35"0A2=PW#V/D7B#ZF+9[5F %'S@WG'=.&7G!KL73/V3B_X,/-"9=N
M(4GC2A6"8%NM8T J-&MJU-T&A4L9<NPW&$HK@ZM@N0J!9KGHH@(_72W>)=+&
MMF5LF'[#]&T'5<&Y3$*I0,!11\2TF.082L> KA%#II/8#2,GE@G5(2#V)% _
M,@*&98%38RXB6TWZ #N54T:7&*F0[%4P3(LL&F+NHLP*,X;G8Q+!&IG:"&0P
M]_,)8G@.%'VO/@]C4):7BN^Y:BD2;$(:EUQ:Q(B7PSB(IE@#$5'+ HW\H2<Y
M8(K=8;'AS@?#G7WIP0D=/VJU .XP Q)C--6D+#)=Z9R7LUDL\*3.6#DLQW85
M+_$?:KR!HEEU84J%0RNVQ>?IU,"M8L9$%;GT!"MJAT-^7K:X>JIQFA)L$C/L
MJHT1=9O"A%*U-1P))JRS "P_"HE0B"E1!U\*KFF&G%\F*]L>EU&*-HMM!H%G
MU'<>X^C&WJ"**+$XN ($KL<"*03XM%[*ZO@WNMV+8M0%,): ]<)#<!YY4D@O
M"0^8SV<I@R/4%OOZ8<:7F\-NN*\GUJ."G>WG6:#B3<CM^Q73?Z.L'TUY>+75
MW 8%AE ZC8;<8HXYJ8#01'/=SF7)COR+:#H#4V=)"JLB"5<SI4QWS"8%O2'Y
M6Y*\1@)?37$CG8[B$FN:6*X.5'&E5&)&R'-(;ZC;Q,A^-X&%PS2.@XR[KP2#
MX,N3P"K(L!?Y@2=7E^-LHZM4Y@Q??$H1!4^&(M/)G%R!/9%/HIFV"$\0UAWE
MUSD((3F^WX(L"\#ZVBC-C03YN^'&*!E2*9:M9(F,5R7%BM7)"+:RBK[@J!A%
M^H"&>4X#UV:C@[#:4IPAN=CMK2YQM(&+H((VN+:P*;;(DXBC!,P$DEL5=\U>
ML5K4$7VO-!FG^(XH)?6JR./9*/$'PX(G9:9;,6EH2I&EJZ64,%)=,0-Q$@A2
ME6YTGBI5N'-OD-##("-$.G@P8@-)[Y% >_I/=YZN6A]&(;(@&P2)RK=./L=J
MCF&RCDQ--QE #7Q0P64R#14+&T$O]\7VL-X(]*R'PS0+B8^)\ZIONF3U!K$/
M%[QB7EXF\>BPOD0,I%)/Y_>^6/QNY,.#D0]?3"-'A.7WY<A!U]F$)B08ED,.
MQ'-,L3K6J7:'5?/U3]+,/'!#\!N"O[G=9T78/!ESI=U72D>#+1CE>:DR&62E
MP[]@CTZC O1D1[+3A<(!,=B"#HXM]N/(+*]).EV-Z8"5$D2)M<,P./E,RFJ6
M8; ;)P9@9$D%(?&60>NSXR%QBA>M[#C(P^#/BC6Y8CZ<:J+1>+ 1?TK^.0EZ
MZBR.<E&K;$DSH"Z.,>.DF93TF!6N9DX@#A,<+KR[$T/@D]D(@XTPN%$87$Q6
M(S@DM2GEEX'!1)FE,[0@2_#[YAW]61[]Q=8K2HUAD!?N#P3KA<?X48YNY7@N
M>[KQ' ?R*6QI&I:< T.&Q)2\TN,>DP"',%+_ Z6++E6"Z2I'&</CI<%!"6[2
MBD5";*SGG*B7]U4:2;/6J<\6@091PTO\ +<+3BO(*'@(AP/K"\@7^399^/[/
M:GBUZ:%8Z*'8W_10;#3;]Z/95BWZLG%26'$P]2=!SO-[0)(C.G,6$3O0911P
MK45;OTU1O:')>^QZ@<5TJ(:*^E#W=SO^WL[>GLS7S,!XBF98@(0Q@TD:"R@0
M%L,@'!+U>8-CPP.3!RI16"7#0ZFODA6QB0C"X3/9??#[Y\^W=_?_H8,7:5E0
MH!19HBD4$N3<D "VT9PA+=$K(R4!RUIM&;JLZ#,02 W(P89!,:B(?6.8JV!7
M5)>ZN%M%?>_T7I?!-VIE;5CW'F?R,!:"\W*G*B-M(2[/T,DN!WX^!894F1."
ME^_M))Y0#:.<ZFX3&:R;K9;'LX7_:6)ZBB0&PW')T'D^BXU\&*=Y2<6+-CKB
M!E&0">7-O@3DD]^2J_^7;H*=<C\-/G%!4&YKBRG2 HQ.<9\52RO=(,QK?.7U
MLO\K] IN)0#V7M3,X W_?S.!DEL$^NO!>]U?<XDEMU&LMOT/?!/Y &OAX)(O
M@$BCR,0E.KQ<OR_T+RVMMUH;@TH+.LP?JQ8C,0JI[07:_CH%2>Q#4TF0YJJ[
M+T1R'MI8A/368!W#W0J, "&">,>SJ&VL#OHR)^TK%$]]U<JMW]2M9M-[7S*;
MWO^B>?/;:]Z)FEZXX^C;"DM8>C2>>S0\3PV,C\43HJ8-?08R19!_(\7\&M%5
M:2->!U*YN(DZ*KE$<@EQ>&@]Y'Z$H$#H'&&F!@LLD-]R=YB;>[[^[VF)-T1Q
MAXU<B,VSB&-C1B11Z@=QZ'2-A$'<MP\%EO:DA5(EE,M2V?9#IY^3Q5EZY"+R
MN#(/MQ7NK,CJ]<O9PO0RX.XICBKCAMMB@K6N/]Z3>/3&;&O1;&L"F%T9UX!:
MI:@)R2VFBN=WWQ.T(:"O34!VA$D\UXIFU8EY=D"A'1&#VJ'$X8%FZ#K054:3
M"JLC8.#WP7"R(;7OG]0DA;R1, _KV+$J'D/RW*6VZC!.W:XZ#899:GKFI%]V
M0S[?/_DXTD)2D2MW>QD4I VQ?.?$,B&49RRN'&>K@HHPJ G9,D408VP*X7C2
M&8XWX?Z'&,TC4]^<9N,@B?ZBL-V&MKY_V@HNTX@+=S/!4%XM:1U5>S=X,*Z+
M4F7F)((AGEXEV$;6\8?S 3: ,'Z5/R!CF?-#<3# +!'L$Y84;73A R!!T_&$
ML;0_RP"C/:L63B -.I2&@RF"O,BP+3M3DO7;$-)W3D@ZHHPMJB,5X-&O)LPP
MT9U,J,5@5"9#!OU!A+V'V4F_2HGM[LZFQG:AQO;IIL;VVZ!TG7EL&$KNQ*+9
MX_(JD\XXTCR<<-9+E[PL1<JU[4R8)0(!M4DNVN0BUMTRYII.(6)HQ:G\PZ2B
M#<8ZZ,!</V4B,GP1I@5'94;)(H(F\&=EEI?N6<+KZ0S\MG^.QVBF#!LL!FKT
M\*BJ2GU&<[4VM)B3@R"=L(RB4J>(-X],+9>M..XX2Y=!XJA7[3B2"GP1_';(
M%1I>8R-X8W.W5E^2.-6PTK+4)"$O,,M3^%?<L0^>9>E0A:6NYI3'5/+F00AB
M#+U0PIZF7B -S%:+:+CI5O>%"5I/IIW0L6"S?3JW"^(I+I>$@.F$U.-49G$^
M^$3J;ZHV<T:,9SJ^//<P+YTA&>-V48V=E  VD:XE'R$#0A67?R+LL)\#<6)U
MX A'M^'M\%D6J@2;OX"&AG#&9A@]LXJG@PK.Z6L,)%DK]8E%8\GBX\4(I#R<
MFQ5P%9*,^*D#A:$W*<" NN\KGIM;.VYHQ^.>+[Y;HVANQAVG%PIPPA8!D4E9
M@IVGL^UWW8J3JQMTB&?EB\,P#YZ@44;!W["M0-"J9) ((J68 @)4]>&)RL06
MVVB*@B=@Q-U2R.H*:\QC0M*("NKH&" 0%U:7_,$3 XLL&I1%FID:<<X3;ONB
M^ZF\Q2WB,' <FCIE#1Z!;P8S1M( 45]J7,J8")/019#,$Z5"$UP38<B-B5(<
MX]*:AA*&NY9*-PQBY(^'+L*S ZW*\!NO,JQ^0T9O^G#8X"TS_/A534AZ52&)
M9R(.HRZ%7G+636!+'0.LCF7)*@FI+T'P3O&\4L0K5Z12I5>]8XT_S^EEYP>;
M9B2W!GO;/[(8,4TI[<K4/[)" [-H%Z5E&?**5T->63)\P35(@#IY@ZLU4>LB
MO7OA*)"TV@)*F*ILJ"H<3%7T"'R%J#9>=QK\)3MU]+;+$LU.[N!O._+_B*RP
M^^)UKN?7&;3 ""-;V93.!/40RZG:I+6-&^%H$@,>3/,<TACI5(7I%(D8!0$<
MB7,R%&80S.0R'D4Q=ICC7-E,\5AVN;;$FNR_M/EC+S57T!QY..>./TU#%6_[
M(([HYMR58:4ZWTG5R(.-!WBW^N@&MQ5#RQ4F#I<LN#825Y?RO =#2.+9+/VI
M)X7HA%K/DPL-)'ZQ0)UIK*AG)%,L9KFMGXQ,(>T,#+@LU!N%0';X(([V\X?.
MXCHN5WA4(*HM2_KYH(0=),/5 9VCG8F*O(KG09S!MAH7H%<]1WJ]JOE+Y\2#
M(1&)3^N.(/88?B^J'" >BAZ.R-+5@>P$@R2XSI#<]H_39*O^#FZ3C7N8)%OE
MO#Q8OP,Z0@6G:HJ-;/2$A&>_8H.=H7M*PEC( W).)5(!XIK-3RIZ)AHFO6.D
MCHK(88:OW3=%/>(MU2-U!*^%N8\5'P!,YKB8I.68(!BXO0_NDV:U'8>%DNLH
M<( .I"#>/DG1RJ8E(X)\=7-)[9'QEZFA@A-B5$."A4 3"SQ@!"[/Z0'SM.3*
M9 2+T$,6P,;\%*%-B06J>'&*_H4^ #;D'I32^XU$S)R.FBBD,<F']$J$9EU)
M#>:\0"#D&#DCB[F2*D*&8F-$=\4Y2'G<R>)+91Y9X"3PS/,QCB+6$4D%CW&)
M= $ZF()A;FAZHT27QA>X)AM/.T]G6%R/S1(*0U#-I^X[I]YQ4W$N-908+L!6
M7#.4ETYQ-D/C6.;/:DG4\?'&^%P)4UAAU?&HMC=2Y-,EB@<?S-' GD[+)!JZ
M4<$0U'Y$83[MK==BAP3*0J/BEX4Q2&:P(% L242;IV6.?L64$6CP1^5LG 4"
M:*[?6N8V.0E)8@NL'.7F+%)W*.+,$&)3:+HE^:C049@ZM27;8O-4U$<$4CM6
M%5>&GD]KU#J93%2)HFC<KG'FQ#:7+_W!^YBK9<5V-UFQA:S8LTU6[!OG@89&
MGB#.4U$:N;?0N4-&;7>[OPW_QGS"HEQQ'8FE@A]S%P7J'[%-8TH2C/&-=,RM
MWGSF.8ZZ:']JU%*P'2&8HA<X+@N;VXD&L5U69G=A8Z!^'"= Q-D0Y\)UZ*Q5
M@J4'K#QRB@0:/;CM5=.+-IQ#;J,=MT>M[O9;!A5TS:,4D3_0 ,*11R31735,
MAJPVN=R<#%8:Y[DWQ;@F5O\Y^V)>LS+Z?8EWLR1W4.FG0X)SC3 RZSD/AZH.
M]3?&JL 0B].2-6W)79<\72VC8!E%ZI&L"!$@ OL<M"3FN]+*9K"KH'T[/<4I
MY).)TROXHIQM@4M$4#_&+B$/;]NKAPP;H_>.D6HF(YD,"64#R,-*G4R;\W6$
M232"A$7J6&8T>; =0%_#3VAC9^PV5\Z/PKY\,G'T256"@RN;Q7Z368S=YM<'
M#.N.WB9@N*KOI(=Z(IE3[ A<S2SD^#Z:;VB>Q2F'IUT'G+"IQ/=T*I.TP>:P
ML!L!L72!O[S*4N8Q;EW**EFUC1.TZ 25%(32YS,'"VM47($(\VA$ D9L8,LT
M]H.C7:ZXSYDED1%/( =23L<[BK$2UI?GY>9!6J/ZBQHU  *8_\6Q$ DH$G&Y
MBC17088U#<D8URFLVJF07YD$(U"O$4,45&@1T2S@)2*,>KU+TW',+@X'!+?]
M<YF=APOVB*RCW-Z:=#X77$B6CFZ^Q1M)ER- $PG]98')CF#F5JX.QID2B!K-
M/7)3HSPP.0??&8]2AG.RLJ=<H' .[;5>.A=:L'\Z@F<@@^"_P9M#%W**P+Y3
M[.1FJP%CF%*:@9DDO$E D,>4C8R!TSP*\5FKI^-7R(;II>-J3EUTP3V&N.:(
MS!Z>.RHQ;509=*Z*9Q5B=VN#+L=%PI(KTL*C%>8B'"8JGCGK86ECGD.*#RF8
MC T:E#BD:AA8:3D*Q(^=9!3'H]0J6@C.EV2F3$U]2(Z305)WK9X3G11+3+OS
M&%R YU]GJYAG2PQ53V<%_WLZ9=0!>+-10"XS'&/WM$\'XVR *$22N4$)M!+H
MF:>4)X3#G6 8VB#9:F=:KN4 -8>N\2($?Z'4X<C(V)B-!>+?8I+FS:_RX'WJ
MOAM5[5#,CP\A!U'KRB11AK+GF %HE"2N# 3C4<(>TX41G1V\$R-VC13W'Y#Y
MSTE]=&K&*"LF4\E,.,P[45SSQ?5<H$CA+U.( @(]$DE-F0^2PMI2(F9(R3::
MJC *P#H-&0=8WMM5^Y6XOR>& =%S96P0F.=1QF"6::>N*;"( FTWD*CH4.".
M:0G6M+ED<A/SS#)%M@$]CQ&Y* ;E&4DK:2&952X/(D;4,CW-'+1VJLA@WB2<
M#3!\8<DZSQ5ES@$NW01M'7E+WM+(]&W_E">IHU09@D^7.PDBC&W"_[/W />'
MI8C^T#$RKD8+>+^<H::H>D7.XV#3I6: G8546ZAKU$MGEG$JM,K*[>+! $^'
M^(\QB+N9G2%7#;%Z.B9/%KV> :O!3/#6E\ B:4F#=#M.IHO-0(Q%<A8H'FW9
M@;Z^'8ICH%LDF61OP!DZ%'%>B;D=(&)R[W0ZD,^02;0I+,"JT^!-V=HL<3KA
MWWBNS69OEH+4531D4MM,'8^?I:LX:H^S.I^,*%,S:JP%#@U(789SI!WW3.L5
M9/IAKG=<I]"Q2M@MSS#15#ZL]%&?1@9K(/1/2LU [LFL9:J<KOBJGA!/QRV;
MTJ$FG:ZN'8$*-ZZ++(%L3B;@X01E4RRC(;UJ]($VE>#=3-&U85M=9>UV5>7^
M7!6"M,\>BS:%0G9LEJ/[U#P8KSJV64?MZ.'UF!;9S1S3X'@@EW2;&BA,YUPE
M=0%1T5BY+OA;P*3R)!.IDS@B^BL6N9LNJ29(Y*V=25XZ]-(@ IORC0^;3BO!
M-XI0@+;*P>P(0H_#FVR.8]R,:QW1'8'_N4JS3S*>O$#U4,W[58@<"8'QHBK!
ML.K1Z-"N._ 0NQ$P=$5=9.B-I* GY[XN_*R,*>]80J. 7R5CYJ\F^]P2L4QA
M\-'-C'L2AUP*LK:RR'P0.FBEI-W>)FFWD+1[ODG:?1N4;BI4C2FZ-(;H#<HH
MUI:NKB(N*D%B-X#1'&5:UC4G]Z-:=^FI=22FO7$T0J!$*=/"9A-'!#OU$#:6
MAY,Y(ZKWTPDJJ<W6:M_, =,2-\9K0.*BEZ@=+/%<I>=,TA9>@P>N,R'QDHZ^
M&U(AC O&S69N\F-CJ.(2/M3*5)A2T%!MIA70UX@(CEJ2W&;=YJ<WN>Z&;?N_
MI%>8).[46O.H3RXU#5$SI&HJ$W1M/^ 0BO!9S] P4C5P@E,1HM  /TO;7"42
M+P5+3 \VP6TB*;Y.B1ZIL/>YXW\\/>_ *H$58J]2$6[ +VTP72&!(P#NV*3V
MTB3FD#_L;DRA6.3(>&ZB]V\5!T)((MB0.@]@1HO:O0&]* Y']]!E8#\VIO0V
MACZ(YX."K/V.D\DNDP5IP+6_7*H,S#&)9E+FM[P!2R9HQ6A,H?-<*>KUJ-(5
MI[6D9,7SO^S;7=G$FYO'L?MOP.<[E%35NT_!8=K5FIDG326.UX0O@1TD'OP@
MF.=.6HV7'U#1VV!.Q, ]'E<JP$,$ 8:%7!ABBG*<(8;'Q/@G!',?Y=../U%!
M#$>BP-I34UPQYC:B%.%:T@RNH"IS8T1[@\47U_U!**#&'+)A&D0NHC9!:J4B
M=K!8_)CY0.(WQ(6!3,GX$'T0&2YL# 8//=>G)&A<^ WI?VJ"T[\-@RG^'7)5
MN'G.8%Z)_U8YC6SIAL_],+5#G1G&R.-L_'7BGD5%%DCNFYJX,(B690KN2\3+
MBZQN\D)QG9%:E0H ]E6I6<QY1K6(A"H;7(UGD=IMJV2NW(]=;3M'\\;I/4-V
M+;,DK[L<<$Q3(!FOHNGMRU-\-Z)?<"&\^DPA[$MNR4YR[FFBR!D7:G=JJL_B
M,+M1[J8B *PQ&*CKM"K&$K#!U8;F,/;8T9%4B<D-T.FC=>GJ20P?6#_IIE/B
M-Y?6![Q5]4X6/5H00+%J_I(P^F^^:R7N09#&4C==S^#J-_064\A-X4@^2=07
M_B0:3S163B5G5Z%Z&3S"\8L8]@1\TAR=YV(RU^48HXBQ9FC*,<7=L /;]$>*
MVNK8F8D-UEY8S6,_^+A&]P8KUK-6++)>@QT+6J!D249UTAU'TAI)6?!:+:5@
M4!O.+XPU<1J$+9N"22UY>-*^7^G(!S(=@'K$B(:;HS(%VSJNQJN2Z(E%:^"^
M?44<1(77$YO/OHS45>Y$[NE]/-LJ@C+&;;)F9MKV#PPY$ZR&J0C+@Y$JYEN9
MS%<8PH9.W>XCPQ;4 J;3Q<N-&UN6IONYFH;^8C5>T\^Y*<=DC\1T93@TDMHF
MURW]6+J)!V_OB$/.>I#VJL! D%1EF4+2)JD\AQNG<KZI8G$1JV2,UMR(*$4N
M<:]B.8O[J7N.JAT>VN[TI)^H4ARB]XICQ LQN&I_%^>^C1TK!J)C)P"U!SKJ
M7 &CXV5CS0W*'*EW<(SLAQ+ LHVGTBF%"F3(M@25()).-Y*_XVFKVKF>2C P
MEFHX@UO?N-NN,N;>9"2MW%E2O.KZRC/*;&&FF0G?4<&>?916EO3 C2NL8^%D
M?XD=ZVI33ZPWW<!GC#>I-<:Y/?7CLBXS_DBL$BT!J\4LXD]R@9*H=VTW6ELQ
M\PR=V*/S3VEE^D[@K1K $<<8$CNCNJPE%A**-!VS%DJTJQ5*[M3SJC(7S#%[
M%HMGA1DJ]0*Z "$VI6-@*Z%AM54SK*H1,JW/O!Q$78[%3M18Y(I2/C$67V =
M9:C;:<M<E2*\9)8I3UD29AIC];80EZ2='*< LP)VH_3=JY4& ?4 XPN316XD
M1=.'= L<1@=[@G?"E%\YKRAN7QS$W&BDD6=_3U+;5%"1,"BMZ\)^"Z/(%-QI
MS)Z+G[K#JAHK8IRJ=&=[%E3EMH?U9#HSMT!+[&#7JUX:=]ZA&<V)C<$I6^3F
M1@QT?E%G*RND5 F$V-B+<S8F@.,PLDM$*Y9K>YMR[1;S1/N;/-%"GNC%)D_T
M;5!Z0U6.MB?1L+"B''3_TC(UBASIGV,4(.5Q7JB MZQFX^E>R_IKL$8%,9MT
M,"(2R-6-7:A[[;1)5,WD>:X-)$<76+AW>X++CZ2*4>(.NM%!A4&0*XM,$LQF
M*F!:H4I7>JBC]J\F*:LD'L>&B1IN:]!VIL27R"XRYH&N_* :1<5%-L;,N%*F
M59K-(W RZ$_;IT>%F.37ZVD\UCUESY.^X# \KP/<E!![QPP4#,;& EO3"$O_
MM 5/W)IB;#RKZ6%:L(F(Z*2/Z4CS=)!$1\]T]!G+E/3OR&(4Q$L3MR3SQTVT
M.KF6>LLAF^/;_H'3"D=[;_K-0H_;WQB"Q:GSY&X/&S84%]M)@PG@"0ZV,6:)
MOEY'E_$7-L<S3#.</T[&MHG<LL'E+8]K+A0K+UA08I_AQ$8JZ\2P155LZ4Q-
M/1RJP]J&/#WQKO1KNA$4A]"XO@V.E8*L/$<5ER[W7R[&&J3GXEYY2P4M,H_A
M";,L;"JE &+N!OH%&ZX6AF]>F*D[)7.=L!Q-.;-G_!,[-%X76(D1Z1BF3CB8
M'=!"U[)JAX%=1"U%[,J6&9AVA*0[HO/&!,%#5PJ_6:3#"@T15A#(7;@I'CCY
M77"4X58Z DE6(N*0<?D1,@<8"O4%4#T(&0G:-!6C@R^5D4EF58&@\W"_L1LQ
MLHN1ZK4XG;/.*.N(2B+.N/B#0Z<IY8=E0<0]]2 6>=WS)<\D1JM&4#IZ$&><
MLJ[)5<6Z686=J17*<J%FS)IL;N!,,*)L8EQR@*'(\3*K(56AW%&5R(>3A3/;
MMT3>'%$X*$#L$M""$1K?>SN[SS7,G(>PF-H!Q4 Q]US,0?K $5-'G9IS> 9D
MT5C1B!A@<HK=TW>:\$AA(/W T8 R(]@1&\$*\D_.MF$1CF)7E:-$E\KCFU)"
M@MMY GE.IY)HUL^6O:-%.:!K9-P,0?F$%E6+$I7R6B#_Y4)9M[P%Z$4<-J%R
MTO@HES$1@PL'+D$5.23BD]_24W.S%I,NK:K 2FI5OZ?^40=C[TO#.TY9]#(K
M?*%9)$W4IH2XWK^OJ1/ED@;8 Y+O""8:)4(8-[C#K2S26BUI"XE!AF!:S'$0
M>\F$:!E NF &RK:Z8JD$!JHHB09,7 \-82@*"-(^QM1 Y!74/F,:J62LX4#K
MQI<--]FV&AGX7HN;UG^P# '9@79H1G-X()&?!G^8S<%*1'@Q=]J >Z>QH9VB
MDHT[*TOXQ=U-!10::%O0([1\::"U:& ",6_!X1V+O_%H+"I]IAR<:%W0Y$"K
M@$!%2<]E@%JL>HXN/74Z K'V12^7G$5; Z(?*'H]MT;1XNK)0S.2XE.27L4J
M'"M39I(5$?FK7L4'LLUHE(C[)*C3U,]J2U7P%:6U&Q4(W2Y2A!YF%R#Q:/8#
MREEEF2Y&(X;/]>X-E2?NT/+=)I/!)(D$V-\&%*K3$G@.0Z.GI'TTR<A4TB.>
MX+UK2,@*$SI.Y-)XE<.1;MVA85@2MU;!9DVY$0V7BJ4**JQ"YFS04^X^Z]U$
M5 BMX2$YZ0S)8F.. TJHL28JXYK'I/^)BG5= O-2I=55'QP.*8C=@]*(@;I-
MAPL?=<QJ(6^^T0=.>-,<8RW.22-&T!6 WPD,1KV7NF$TMQW)#4Y"')0)MD".
M_2;JD)R=4UT]F#M5Y:Z+Z=G;(K'1[1;IY\&;XQ2MYIDZU"\J3=<8K<X_ 6_E
M50P4G<BL(>5P9 B$/8+:$(YQ]+D2%*Z<&VE;';U[\"?P_EJ*]RH[9PP6MS6B
MG#%66J44V78RN*7(E:J#QTDPY<*_,?@Y<:W,Y/3TP']\"J+P%(SG W#-/_W0
M638GE#',C-0UM@N%S#6V'18+@D%2K?IU 1"XOY+\*ZH60,R&09!E$0<D/)PW
MPL\RH.L8[JX ,KGQEH6HSK+>)Q-O-04B"*6@ Z4:FYNM E1J'KL:.4\,R95
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M$M+G]KN,9PE*BA['AS2A4U+H*QJ4.ASY1>[S]IV3Z[<59>;:@"A?K OP=%U
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M4:ZW=10,U2!-/]$2^@EX-3C$N^,--#!OQ .:PP$:4-Q 3FQ",&D)37_E('Q
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M/W8M0; <3S3 &O42\IP\Y'E:_+97P[6[[=A=E@IX2[N'!M:H2L&5 ZSP JB
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M>SE>@<2U*,)-I9,+L$;RD^"N\:RV#&I6]1P96TX@1CT=J9'&&^MBU(\4Q&[
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M-T6S0\6@I].8$IYVVQ\/P?2*R5^E'25\<*:&(B%1J:I#]M80/HE4,J?Y?M]
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MCPU?$+X=R3,%=^L=#D)!K4_$T-,>&.;TB_FJUE$I!+&^C95,AL]/7(%CKL7
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M,4UE"^EYZJ[R%3?+*8]4SF2,(0 ;0XW@IGY+CM%6^3?X=XL?B7WOT 2Q#NS
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MD_R  B&\:?@<5H00M0*4N0D5RZD%:N>.D0UD-G F+*?>"J'QM.<30%DX./Y
MIV R)?85/-YP4S _,BH'/VZ;"?)XN":U&\F=-)-F,N3$E&JZ9ZJ\$+CXA<$
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M#;UB;2J$D:E#\#4<'0?SVG1':C,207QUJV,,PC)!05\3JY!A/P4@$&[!I;?
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M)*FK"<!];;]A]-QMJC!<OVY!4@ +C[!A'F>&D/[B]04SQ:=N\)?WQN%'SVH
M/[\T@)<-X#]>&L"_:0M?&8ZE<_:-H4$1AKB7G$.@1/GU'8T]W=2'D\42_Z'O
MB[ZGL:ZG-E3[?24<_A:7N*#S\RF^J9!'G#"6G*E88]KV=8H]KX?D["LK9*:2
MM&&D!P>QD$ 8V2)I/A%F6/-V5PSV$RC(=RV/9X J*N$SO,3#AGLY?4NY*";Z
MF-B^>(CXY1C%)+BN1$6BM*$@*T00)))6ER+L&^;:5)EQG4'F+N&AE%"-P7,N
M)<?@2L6*<H#2*%J+LD0I4K;0%M?:5=\4_:9HJ^'9US\V5=1S)=3_%UU9/GOE
M_<!;[P]\-/1F]''QZ-T-4-'TJ9=*:F.9I7%C9OB%'FQ-AA5&CT-E9- Z,WX8
M>84O7]K15$2XRLH54/,8GJM:+7AP+ FH<CULFPZC> M9#!X81E].!H@06PFH
M04K%(J$;2<N?]K999T.U)L4MF4374V0P9^N_HH>'KR*]1*G<L#>>2DZXH[JD
MQG&S01_;SV\K"9V#CC+-8/2CT?5#M3- I^7F1:-5AU*T('S:?SO>T4,U<S0S
M.MU9R3YB5QE5/SN'@LMA/MG%#YL'9XH^QW5$5O]%:WCY#A=.(5&%^OB#C^]Q
M%")YG+SU.^("#%1)6>//HZKW@4=641&;;N*Z[^Y&4Z\O!BE?AHW_'U__^0UT
MS;+O9[+7-T1(90IZ,]<<C<PORFX7V*(4XN!F;P.=_!I1+8\7;V]:3+2:ZT;1
MU.!N  -N,U'5]9^>:%A/P<ZX:YD%/M <'W-G$QWZGMGB*\<@8F8 GHD%I5)"
M:3/^WE!#ZZ=CO==&!O=%AO'BO;ZGT9.FKFZEB2!\MK*$3I>0/-  D$K'F&P9
MF@5//M-Z 0L6:_]P#U+RCXBN, 4?:*>E=FE/:A:&SEA2NPQSX6#.XLT?-S<)
MGWK'!2*Y8;1WHE_3AN2NT+)8& V#7]6'2A%0(IHY0O)63FA03O_WY)<5!979
M0,NR C=3CP[ 2P%<\NX@BH#:N\VHB>J7MI Q&/DG7JSA;8VIH]!2<8JC>/)6
M/,/FQ!#'H;(7\2NBU<76W1R?[6I:T;+;3LK#^0C9,&^OVX+ZUF0V5$T#@BKH
MW.M^BMSG#H6FP(S"% G33 \X!G2;(]O!6 ?<;6C5]MS/K$7HV"CT"8'[EG!4
MNZE9/HI;G8%:U1*>SULI=XG"V@+(+- 01M+J^$QX4&:P[II;1J)0( (]OUSB
M +Y,T#SAB$9*X4)N&T>6F0V0+D:?W>=R\Q*L\*D=*''G<V9R3NE#WB\9=WJ2
M;#'^^AO??:M7^L?N*[D%$/#]W+YI4/1P(6@(%5]J65F:+1V@4JQ<'(.B@KMB
MH4<N0;<E&L6 -)+.N*1/$L1E)^,W%_+'75$W$\LO%ML;[.@DT(D9U>-OG>(C
M\%S%4/-1=W1"#/D!@I)8V$!C]1?VTPNC^-7/!;J)[WU,V0?T=\!A[X+/1T@X
M]<N7&#FF<7+[+3_LCO=E!GB%[Q7OWV=8?$C(!09NT7+/R+@I8#@":5/H7WE3
M:ZO8,GNTU2'NCHO@S"((]/7D&IPT9 G>D(.$VD.&<[8)7 *!L%M2L\C2+= <
MQ]*FJU</+-Z$75S[$(;^$DF7=F7I(B.03/\SO*%]*R/E([4W'0\0TFMF:=.M
M\'TQKBBDW$+-PAB(2.5B#H#?]Y9:^O6SFD4?79I%RV;1IY=FT3_/O/\5L<SW
MU4.EXT456@X $13[Z(/G<!SWUHAF1\$\5*4?)<F6G?5],1$P*8T3AR3G"/M'
M4SO4']!RO )(5H^>/J#M5X^=!T\:]QVWYN\B\T32U.&\S"!^39GY\8>/C/WP
MW6^*H69)2"Z(=6C_VU]%EL^<K3U-]O#WTJ/BO-,/[&$%OZ9%63 0F#A 7:(D
M:;P%GW5*)<H_Q^E!!W^X7557?A&]T;:!HKT+; (J\\B8&@81!5V*CZ!+\?RC
M*Y>.?'FS:RI:+F^_4J\[68$TBSI_E4KR(: -0BUA$C\\Q7PUW>F@F!59!*9!
M^_%085-F*GM&(%XNZ9GZHU_*/>BX-#J?%W$7;X:/;\>!8!CO8=*5W-JL874M
M0LQ(]BLQH^3"_JP#_=,YMJ,$1?7 ;&\R_R0MEZ;Q/XV0[;6,P;#@C'D5E;JD
MJ+E14BV5[B3<1<B"\Q@ ^5_AYPKSGH:F%!UPJ%@1[)8J7507@<X"R1?J**+4
M1,(ZH(]6>K,HMD<&43UZ&<(#^!=\& 262D-E+@G .7@<;+$Z)X)*%1CMF>NR
M8IQ;2GP+?2LI/DMM6.]<X':AN29X;']#Q ,;^XWRH5X%E=08=MVY 7AL8-C3
MY'%-!2?U_PHU5=[6OT00^!LY@5\0CD VO$Z9WITXE:NP 6M$^<:M6VT)GLZP
MHGQ6KL*8@;%N.(I8>SJ5U43&YBZ**-V3L$C->S'MEW:GD_ZA"3$HJJ <<_EP
MH+E"7P<;<K0.\2K[F[3F. LZE? Q0 _TKE(!WZ@6(2NSL7=/^,]GXX'AKG P
M:UFOK\ 8Q5U]J:U+\<)(CI!#D@ YR>P" YR+'7!ZW##Q.\QF5H>Q\YE"I8Q'
MC<!@T6[7 5'3!\!P:B!N)-HQ+1:#%2L\JG!&.J'$+$ LRWZ/AZ7!%$:9*W I
MP@4=AWGXQ<9NB 0>27=NU![HR^12RZ^Z4U^U3T8\N96JM( _.[Y&4TBZ\SF&
MTG2>5UL0*.Z#A%W"G]$0^A5+5U;;AD8S0F5&1N4!U0PCVT]JUO,5DS(-11/+
MURL@-*<@M$SU(JE/)L/+$*))%O,^&-L%^R2W\,; !>SZN_M6C]S=5\50%O^=
M&[]YQGL@E>]P,01RV!-7_O@'I3UQ4Y,RG-D31SN,8T$.,_JM!WXMUZ:XCWZI
MV5HCY6/:P$%-,+*12^606<.TZ\*/6[#]68?Y,Y[^-]Y#^=>05E,BI'@M'!E1
M1G.^?,+)8;@MPA"6C)_B'-SQ$)[WXA" 91X4@L.FE\M765]C5R&^5/>@:T&6
M(HV*LFYX]B]M4 2)V022#WF5:-NS:S^I@P#M;.%M4$8'Q4PB6^Z%JL%),'N@
M\<XQM&F!_"M!S<+EAT#2=P-B5K +'Q\ ]B7#*A3"W8%:.@99%(31K[$+=*G,
M7*0#-9UABC .$1'I3;;%#"M:8EI74$)Q%J@4A&1"<5+ZAR"1/S-&R*MR.<\L
MY:25_9Q9D>/UXAC1.XS]P9\<D\S=S^LH:COTOE=%WI$%R8<2N>A=.!Y3M*JW
M@1^/_&ISQ\/&/IQ\-J!,YO]QQW*?V^+ +)7X8/(SQF"38JR.HMLJ4AQ'5L%7
MS;*%[9)E>6=,9W%PV6)R9K#*4P6R**ZZ "=C4U()3N?C3,76K8;SD>J;-AR]
MI  .[H"$\ROF7R#%VD/":RF[)!*1WU&SRQX:G%*'(AMNVZW?MNWX)1-K;#YL
M.E+8].EG[Z_8',/#V6>0^WOA;<^_U#6YDI=ZQ^ZOQ5W.'__DTT\^>_;A9Y]]
M%D*7\*F,/A6;JIQ>AEHS:E1<8TW052'YNA7*)\*1-<?X(:(;J-J:XJ_ 5R/X
MQE(T'23)?<\[4<;G%*U6IZ^OJ73G?2L^\GXN(^<1?&T-Q[^X*$11R&$>K&E&
M3*@O5C;Q52;\],RT?<]V#U44;'OZZ07./NUK?!LV,__RJR^R]UX5=9]]$1[C
M?5C?U# Y^#UV_^0CO/-ZJ1]?>JG+7NJ?+KW4W_DF^$[X0^G(B&P3WLLRW;B3
MEF4H:,A9M^7ZV;#M#E4V@W0RLD2#2OA^#CZ)5XWU?,=ZI'8& !TAPGSR#HE2
MSD1L&EPH0@&?IAL:2]94%"CU/*4 A)/#AB;@%7<6]""DP1DS%K#YX*QE:44Y
M;9N*SUK"6?KS>*!! PDA'*09"JL-R57Y'\?9O4?1L+):L$]..+K_8VHK;=%+
M<Y3[;*I\P $=2W-U,JGSP(+L5D;RTYG_&%9V*1JUM]R*06V#12V ?@K$[01%
M1'NA\AFX&8Q(SNL$)5O<=G49RM/K.:0\ ^KAM@JO./1D%HD7D<_W-6Y-QYG!
ML!JI9*J W@:^43._$R#\3RK'_XZG]C#ZPLH>(B)^H(AY:M'UDJ++X$V#,:D=
M947#:+\@37MIR#^&0#%31D89 1,P?#8#P^-5H?7)C2#GMQI5 ]&"G:/!Y6:"
M0.:=Y$W$+L7]>9YXU"?P/\0W/L.I<VE1#9X^0NQ40[VO272"Q;T<[3H ?B_Y
MOMS"WU:,AZS&11.C-R:V$LWH%[ :'D,(>879Z&YJ)7\?CV%$-S+Y>J=DHX)X
MYT$:DR?'@D%F:HZS 6+1)=(LWT*BRF(L7)>HN"8+%%<FWEM?\4'G?_D'#3(8
M#,4SOH!-:"1B.,#Q8YP7\]D&RBS!93BM5&A_\*[:#/489]BEBN%?>D^'7L_'
M;FD5#?D5%!?51[J%KZI1-4?2,8TP]E+,29CT96.>1UHW1U/<X!*2QCBW7>-?
M=ZYCA.CG'CD<16HU,*AJ6_D</M=I!+8S_\O1]H$&V>@@L,RN^ACXMI+1:PY0
M^0TW11L)^NUI,79C06B@]*']_L88+BTA%4+H1F\FO\I1Y<#;VP8SI0%,MB<'
MW=(ML'!/SCQT-)[D,_B)LA9!/ 3^(S)L'\DT1W^X#W:N<P/Q;2'<HQDI\3BB
MRCCV?D&YU,5>A,#=PHJ)8&-?D30=OZM]5=#M[*9&QT6%H4K$:_C2P'0( 7[B
M/WP4N0VE2.LU[OH.."S@,-R =\S#U%2^H1*)3QBV]0&$YELEBHPC@!@8!N]G
MI4&=6LU8<9';OI=#U:M*F'Z+?RG^3$D"W,=H+\FT1\ EI"I\R9#:10CV06T[
MN-4,)0I7"(>(.'!O'-3!5'A'JH:6Q\'C6F!T"J&E8AXW70G $RR"XA:F,,>9
MC E2O@6!@'"K%MBRR$PFC(_ADO23MW1B7-/<( WT?]5Q>3M^)BK'7=<@QNIH
M:U9/_L6_JA7L*AI2#-4$N^G4B^^4V1<TE>15S=-&LA(UCHZ -&!U Q&__Q<Q
M%YTO7G'/*S\1HS"7QAKK(5-F0J;\GQ8OI<$7Q4/PZ(@GAAOE&S"SI@$]#HMC
M-I?08/$[XI;>5UV55]F7C\L)*)/EA "Y3;AWMQ*E/BHZ_1EI1&;3B*>]8;ZV
M:Z<:;3KZ2Z [Y4 .FK7TGM94RB.07VH4NDN>^A+/^X:18L,-4"0AAA0.C^J9
M!'3(O/;UCR*(,7-)_I5)]\H?&35#/WS>$2IQS\;N&17DZ$)26:._DO\D#U8/
MCK_*\,+ ]Y $S,K:P? @KA,Q DU;_-9U)1*3\DPV,$)FQ.A[NAG^KROW(KD(
M<(:Q6V>%!'?UCPIX,'0@X;P.R%4&F]++X>H<N2T=QIU!: 6(R^T_MQ.4S=0R
M>!O\X_Y^=@6(7>S#7'G7=$Q'AMG5(ES@5;//[J^<QNH64I6(+(?TA5UXPYS>
M%#_J3>5)U/B0:NJIL79F5@>\YZG4X<YJR'UR:<@M&W*?71IROP]35YJ%9,:P
M*O:@WE?.>G,DX6.6"2AP]5TJKE)QI3;624UK)XM[6ZVL;G9R=7,.GF1" ^G(
MC,LJXN-"F^88/@N5 "8<0[/,<7?M1X9M'3B1$(7<Y+J@DWEANVSS>53_.((M
MN;OIJ,BJ^45DG&$\4D7Q0BV\'+@  $60W^#3!@?9VM.?RH%,;RI"N+CL$49"
MC8!!!*$L-0)= +"-(G@F(U_#MI_\?Z,(8P%25.12+KZP]IKR418XETZ@J@+I
M[@ETRTS@VDKXG%</ &_"&IE%G]%'A0]2.V6W%-;(34!6!D*<NC<<?L5=<0S:
M.O/@T/(#*J55B$!MA/$ ;\Z"'^<4C=)3"3,4TNL7=3Z=^YPWFH^Z6JH$-BYM
M'9_0"-WX9(PV&7?@[R# 2>.1/R*']G_WQS]>??C1'X)<QS0&E9$UQ'8AL$E4
MO\EBW:AJGW9"C7#E8[(OD^&@* :T82@RJ-CFO.L(J45FYW*41/:R5=MPB6UD
MC[&-7(N7!G_XCUN+$PP^\L2Y"5"4&;4?.(WH I<V'1,+AR$'0LEP7QHHP*#"
MRD2!=F:"ZW7=SGLS'EL1-EM_>7\KA= (^)\.HP5"7QO@KT S1]FEF3Y3HCXO
M<S"I>L..]TBQ9>Z:ZXHV2AZ@)W:G; &6SU+6Y-NJ6= H%.!WY;WSD"S5C/.W
MX6YD@EW.HPI7D)(YK=T6KHU7E[Q7;6):W2R&BJA.@A$A2G38-#(H&G_<4&9+
M!JR@G#!=R!<092-[Q17IK*=T4 C]R&E:!GYO[=&5U9:5/*0C1-&"&27N6ITG
MCMA\)M1,B98,)#G!$Z4S%^LW0Q&5EAV$9./>@3DTQX14L^:R= RJ+L=!HB:^
MM !G+"#GHW0 D; TMRPGQ.8^$PHULNU-!XA\EXU0,%)/"L;P"-)$R$CE01\I
M.S/0?MI<+$;$>.#--+)(6*?C32?M*E<UVN#T_NV?_U;P?S_^$U49'GX]SQXP
MD1$/OZV:YD"5WO;Z__T?'_P/_'DX%%O]\\^\X7NK-Y_[?5Z.-W2]#_[@'<G8
MZ\]@[&];-/ID_BHGO(_[?\92OR57"\#UL?S?:__Z''P-]FI-M4,1YK,_?OK9
MY_/OK?XL@P:,-96HUCSV_ZG6V=G,,<*^>W+8_:R[6&-[X"ST\:3AO%S>EL:>
M5IQLZ6+L[YBQ8TQS&*0( AVLL^R,D6;>N%!X(*#P;4W=8&/;D?J4>:@XLZOW
M,E:$^:_P$?+9!!<^ZR92\0[OJ2^6^^Y;KH:.AEG[')NQ13)FM");71^Q#!S=
MZ <"/![QFPG+G0]QS[H+ @NP51!BX'.ZX,5TWWG3G<6QYX47*T.1E)3"!W=^
MA6HNE/C N1ZH/DW:(P!LGK#MT&GEU/8\[V]R=<H"KND2$$HIMC>3]\B'XBBC
M(*RP<4OQ.E5=\,6JO/K%K?UWEVA1$C1+?4AGAZ0F(I_X4!GJ36-.?,+.-5TH
M[[HWN3E*9L.X667?OR?=FPXZH"L$<,Q*A3DI4#\&A!7_PPX*]2WU # /)-^0
M42N#IGC]S=>8IG[^P?-/S2BVE=MQ.J%\NAXQ=!VXU6:< Z>_P*S14GGN &7+
M!/_*(R+*F(DW Y762^[W#GIFG1P,G:CS8HI[]H$B%2.L^W]^>/7\HT_XES;>
M_B30"/$$8#F72/9I&!VX0[V-L);/F3F8X>9I_,( 55LU /^7&(;J0^F*Z1A5
M(?I_?OK!!_PJ]V* 5&7SP<5HB9S.NIF;J@%8EV*18D?L&X1LO9CQ$S)C'68[
MRV[4/S+U<LZ>\)@9@7=E14X\Z <+_TF&9]C%SKJ)LMJ,QO _]Y'(Q7"?A.'^
M4P]]0?,6NU%1/XL F/\-TEQ;J&@N06V7Q.AG4]7\\8*,72!C/_K@@HS]G6^"
MI5AIO3,X%"2QNUHF,U;X.4\VO9F,.;9>=;[<I,"6((<4:VE"_V2G],J1$"#Y
MM0@._5DWIF ;S#'/[RFA[<F9TUOG+ I<RFE37Y ],OYU"MHSY[]54.;/X<Z5
M^Z!@Q=V"$[RY3$$F$T<1%$LBPBQ&]E +7M,8OPVX6?7/;D Y;4 MFTHHCB%&
M!<Q)A&%O::#/&\10-;<R:$F(M&"8C(Q(IH%.LJ1'$GXNM/6*74@YW\TWB'B*
M>48)!/V@P+R17,=8)FV$1ZR;"TR^*:1B"=A.FLL??O"I>@^5B=9!Y3B^26\2
MZPF,QH'ZWU%DC@@(P<(:H-J.LP!,25)Z4.^#SJF"SV@0J^[]\W2XT2>_Z3#_
M&N+-6!364L.]E=& RY%/)\6&84_R,+V!&*3EY*! *^S_1/O+5)@+; ]!O<-9
M YJ&.=CG%"CLO>K'!((8-MXJ<RR J(2SZ/J92M"JN,4C4!+O"^Y_WHW\IW08
MG5#)_7C,K!##OW=W1"BS3JVI7%I&5:3R=U++IE5"^&01R1&<>IM4 9I:G,QW
M5?@Z\6,(TP/XD/V>]O? %2=_L<"SI>Y)'@0L!:NNS(<TWN.)Q-%,D33R=P4J
M%,>2W*G'$F1R4PUKRNXV6,KN#Y;FI_F)N,3=J:8RQR95C8;,2GC"TLB/C(@>
M^O5B!@ON*Y>$/=D_'O8$F+Q$/2:<R?[5X<QO @3[W>/B0'<B#@QKE@DOEOP%
M3S8G,'1BAJB4J# 2[XB'>,S+0P?/I=HV40/[@FI5MLEJ>]-V37=]5&P^HCL?
MOOGM214K[V7BB%R)>79E1?*O)[Y!U>^AR45PG\2QIQD U@+:C06LJ50@^> -
M[)CH:;4XSP#XGY.AA#ZOF7&[@WN>3<D3_0C)(#DH%_ICFF2CLEW!HS^D9&3X
M,(;*4,N@/TUK<NS$IPB@,;]@:-_IDFI!!M2P)DB@E#H/P+I"U7"**& QWW=I
M-[W[)I;FQ(8)\=RVDW**DNN37)L3VUSG6JPFK/Q0549:,]'!M9#KBQ4^$2O4
M<A:Y.N(V/K=UE$RX*5_;Q7#>?<,Q+H4( ,ZSFSX5NTGGG*9 'W@QI"=@2/]X
MJ&5,D8S'\*-28:/0L4B5#JU&JIY=;.LIV%;;=D3WJ,V&\Y#JFE[3(WKC:KM;
M<5C:=0AD<2HK>;&QIVYCF_/ -ZM6,X^KP)C,[2._J"3Z,%;>*#&=+J00_N]_
MZ&HJROB[F/HS,8^D9UD<ZM&O<E_4S$E-%5@F[(':Y7Y?HXSW>S/I7^5FS@/[
M?'H!^RS!/A]>P#X77__;\_6EDO)2BY#Z?3_#V>Z4HG_HVK9J?F<.]6(W_UBR
M3 KHYYA+K,I=3S6WE+M^C4]/U,!2TO2TZFQD(2Y6]^Y;'6$Y)N9&\*8PG1T3
MSGOHH+!/B]:JED&&W38D>:+P ,2,))MTH3-X$L;FXZVM<I&>Z^/8COJ*AKI4
M-0JRQZG*\<6,WGTS,B=EQ$6=2Z8B&*J+O;S[]D*]AZF&\ F)^E3MF;7CKA>U
MO8($A@9"&UW,YMTWFQDZXSR3"6@-*[.FLQ:BB\0Q5Z3I4W95S!9'""6CJB)8
M_ERFMHNU/@5K97&8&2SN+%-1[E_;I[!\L!<K>@)69%(YDHL\QWX$P)FX30)T
MUYMIU,8]Z;2V Z$IVS% M^6+$76Z@NR\&-^[;WP1$\P6\0]A*>F<[2!(3!,8
MW?:MX(<MG;>9,< \0] !PY ---=^!DL)E#HN]OKNV^LO"F]298^+(3TI0SJW
M+"8]>>KXD_\CX5R5.!>]9AI.H^P#)RO(7T@N:#YB<3&S=]_,H*+(*I)Y=E.5
MU^>6S2(=H\\': Y3!O""4@5EK5US"VDHS1XNIO4$3(NGD@\U#PN<V^O&P)1@
M/!L?JCV;#C(E?#&>)V \PO!ZRP#,,UO?11!@BA/RQ';!83UT!VA&_J[H\9FZ
M5$Z)L>K[KJ^'/<=B//XWR'3,<%[RP?=^H;9^&O8Z5^4^^PR52=:HWWUA0DMO
MX=74DT^@2?R<IW,)3<@W1NQS0PYU2YO7RV"SG67V%R;NAVQ>5TAK!2!IP7=5
M>5T%)<-0LQE<MT/((-%81-+D6S!!'#5UN/ ?)[%CR;]NC=JDZELFM\?":[@_
MC%U/+>85:#:O)R:.0]^)6#=I9\MLWWK[ 90-Y!L-F0W_XJ;OBF"6C-4H_?OI
MC\F]Y"QXU#3TO_--D&>'CN;O_<9UJS8>\A)ZF4"<#'F0(.-)#,V#NJ .(Z.'
M?FU[_T[GMP,N(9+;\W%H<\QJ_U3):W+WSHJ;.?$GSY_SFFM>AV(8<V.>M#?<
M8E\],-3/S"!U+]LSFJ[5F8W;9=L4PN;1M9;!(?L^,'+XR[F12'_'P#TU'@_X
MI?@%O1=.>T'3I#]A/A1;N,(-(.6_&K=';% CSUZK^FS)FJZI,*_@Z(:%H"PB
M&2W=L$QCW\Z%7)N!Y)/Z?5+G^=<1C?P&S.T\\/N?+N#W)?C]^07\_KOQN?_R
MGXO"\P%&H-#?J!$K_O(ETYDINU)9-U/@.@G>]%<B)/I5V)#N/2%Y/0)C')B_
MG$+^B21A\B%67_]$((XID8.96J;]7D:,N4E69=GQ%E0RQ+PQ*]B*&6@?O;5C
M*MOJDNC9WJC^='$'IDBFN@FRY]7^T'3'2L"5DI0W0JK&HPA#:A9";TEW0LK)
MV6NH$E-1\&LP@KEO&GH!W>I'Z-^NLA=QZ>;QF2P7XQ'2WP6Q&5MJ9)#J>CV6
M4THI9ZS\*DOH.65QAJIZNZK]*RWKGC"G3*NW)[BA$N6]C$R ^%GS\KGTF9 #
MNBW09QQH=8@;_"\08=F.7UCRUCGD'1.AUF#^[ZJW@HBR)& ]> OI#^M"RB[P
MF?@@E9A6E;V/$ : %W1D&T4CB<0M^/RF?<Z&5)5(7WP&-?9$G.=CLSYH*V=_
M;VO_T[P.;T9,2O@WRGK37.O<-CYPNZT<KHFWZ&^XB^]/,\"FH)%+?]^5:/]F
MS/9+'^&8M^AYG#)RQ9K0%8RQ-GILZKT(:-I-+R;H?+" N)QX487IV%_OAZF$
M$GD6;Y8RQXD>"^#I:6#&5J-G/9,][]4AJ).8[206/^\K89>\IM9[JWR5@8[+
MOK)X"V%E?1HZ7=^,NMGQ_AGI+6]+7M)0C]99OJ0G]NOIC9#?V/_I^K=Y]N<.
MEZ,D_6]%ZW]Q+(2RBZE>*?.H]V;9(P.C_IY)4ZC#&Q@"B[)2\89U0[KPS\DM
M)!RCWO\KQ6@47B'&7/:,G#")W_O!__M E)9(KKS]+=\.5-U&YB_FS:O*[B@U
MI+LH"V+J+T"\Z>VG.>8^%4BH-W$YMV)RR&*3>R)U;CJ/H?&-'X0]44VEP[E/
M3^&_ADT0N DK^129SY[._$.37C<P<CM&*X/^V**F.B&8HY.RGQKE%BAK8AJH
M6O5DI$A/&M6\;?']4KB<9+.?$JA/_*I;^E62>Z)UY>?"1@VTQ,SH^$_WN2[Q
MN<:-,<GK+^-WJ3@&ENO4U6-Y,#"%*(3(5P.?-L/,U8W!0OR74'P\>@M0[TS^
M=_+_RV9?ZM#4ES]R 8R7 )X_H2D5;^R$\I7^+=P"1>[D?,N@S7Q7 $JLO %S
M@N"'G9VBE9G[EH_D@%AQH&3EI9O!J.@7Y^\J+)K??JT.M@*(X*,@OQ*'J??/
MCM>A1\U=30* 1&O0X_VUQU@MK)4BWV%QXHV'HV2V&'Z)I#0EM5VR9/YW(?JM
MKCMFU]6W*T]R8I<\^8KA&Q^'-$5//O3\LY\->Y.\]_!!H>B!2F)$P>,'2OVV
M?\E-=<V<>%O_]_""4FZ37W:P%N^(1W5ZLAF1%J"T5^VJ=M""90ID(!=+L4[<
MG]X5R"UF[]W=5%SIDYVN5<4"U?QC1GN#<%R]XTHHM1>%E#[JA>4VW.K\7V^K
M9>"E_!UYMJ_V&_Q'S-.(#^F:UOS]:/@T4JGM#]F#S=']<R*JR#A_I&HI!:*J
MD!GV>W)&*M>Y_JS[1P*YS 9RP?L7):+;POI_G,827G([P]PX_&*.,QXV!?=)
MN0*."G4MY,ES/2FZWMA9SD<,8D<$DGX5:A%_A5LC3EU;Z^8(/%T5O4N'A<CY
M0KCMTS\,SO\]]7LHY^[IC\A](036UA4SNTP5$YW3M>)WF4'W3NP71A.WK"-.
MWX'W<W2 DAJ(Z>J#2,H;#H?DDOPKX;K9"4^P^ET7OY9D"2?<\Y"5'=9<\B'L
M,8XJ3H<:4:E2-RH"^E[B WJE[HQTX,F? 8&BGT5RX5TEQG'@)V*3FH4 0_9>
M!&N80$$6>?%I,F=QRSE'6'FZ,8;[PCSW4)CW/@X<B9*-! N*I?VU__-/VH8L
MN^W$%$Y(/>3QXM$7R;&WY(XK'\NAD(JCRID;UC2T CXS(VHHY!$CM">(HUH.
M&/&3+"ZAP>1:,!SC%CD^3U5-U&W&FU[?I2#S+V3?W-&-^ML"F__]/T\'IW\2
M?O!_QHW(_%O=&HRT_^[4!H-K)!F7-QYKGI1,9J8X*UT]N8FJA(=SR!^0IG&'
M>AO$*O *DN0LK<40A49?P]\7):G>41=:P *VMY>OL3KG6N4B&EW:+H%K]^)8
M7AA-[$W5U-7M>MDMFMVF:JM=C;[N1JF..;+@ZBT'_4BAMZ%M+1:EA_*##C\W
M1R"5+OY:W,$5)?$*?9)%2X*]YOJ#U+7&1H@CR5W4$#]R(BD([M-;C&R;C[W"
M1HNQ*1V+@,G9IG<Q*P>&?CTJAD#,K10(F7SSJ&G1Z4JA!K)N63/4W4,/0,0C
M_D+4!PR+,0\X3%7%-NXU*=92$>+9KM]7IV_+Q?AZI93Y%+I:YS;=/[LTW9=-
M]X_>I:;[N]A$(@$B@\3K(Y!-*;!$O\A)^@ 6_ %>IRIZ.OXW),[&_D[_T1_>
M6W]1Z#Y3Y+$K;CO6K5M\+4\.?FU]ZN@AW=".73V7^D)]@-/VLIA+:3TD)AGB
MCEQK&*6(1#$)V&S&]H2@#X<S9;4E>J9+[T*U<VY.R4NY%=V9^$Y0E$7(NFLF
MKL4(SE,KO=%L$ )"!DUJ  ]8+QV=79^)BJ)3"UTWO]P8WPJ'+$+\KH6=0/1*
MRC7AQQZS1VJB[Z*F2?A7G.)%F^X31J-"-.VNO>ZI@;9BB'G(_0N^([O3[!:1
M6UB0XO;N[#V;+M@"XWL*/7HGW=BW%//KSD'.U!Z=K"#T*NE5;=&9FH:02&V!
M*,!?LS:@K.:.E#8A3DN5]KXYFL5G*_'/3J\9_1C< 35Y*3#<)(C,D' X@4=K
M[$7_/O6M2C<5JG7W\SP'W6MT&T\BBL*/OWK]U;<O>)3.KQBEC-N9VF (TMUJ
MD)[9('WB>MI T.J51;XX9..07X5,^K4ZQV^Y+=7U1_>"$3BC/PY?M]LKG+AX
M5SEJ,Q#2K53.D=\7UQN*40<-V,MPR\D"B:A$'.1+?()'Q?^W/J MJX(4)??^
M7[C71/EFUX*IY[KO)J(4H&.#\UC]->PY"U,:4-J"@^+2=A'%4JZR;_J:_K)+
M;Y 2I4G$"Z#-<O<,V[>TQ\C829#1=NTS2J'J<0JP>A%CR=.'&?AI]B1@&I^&
ME'7YH.JR;H.V=]UBN,!X9'HLO6RP]>B,J!- [FLL?LSTO\TJ="B:U[<)!LW\
MR%7V=U3Q9JV=*$:)%YOS*\<;]Q9$&3X=P=29I7>P<_H"N/I6L.B=/WDV85/B
M*'[,ZMH&;/("_06(JG!D0<RPTC@B>,",;S)Q&DOY84/%8_""B"#)P^ 5U2,?
ME@0!H$D2#E-F;]3:C@!@Y X=[C!6 ?16X9=6#^F8Q7,9 D&#]K9WBX;U8WR<
MBW*"/(O3:F@K@LYT\)G#&4L,N=73$Q[_0L3<;^!("N,26WJ=0;_X4 Q:1"(!
M76=VVUS(V"_I-Z]>O\Q/P&VHT^2O3%OW,/6';J@"+%,K,?[?8+@THZ5AJMQ0
MUP;(% U:('4>G?V"*DP&^5N)L?S.TB$?_#BZ]YQY#[-;]?]\*(XP.57S5AN4
MV'8!,MWY4,K1![L^1&=A#6DY+J>OW,*?44:5;1@EXLB*.A$NEWTHEH*).TMU
MAW; ,' T6FEZ0:-%7._;Z)KCM1)>F(ODZY\U[RB%!^>NT/HQ.WG27]] %MS_
MNL\)J&:C6IZ<:G/GLJS\L;*OVW##VH81F6G]L8$1@!TW'=J6YM8WQ5 /$9-3
M5@?O:)VLEEFC;+E&O"0\0336>U;H\_^+$2A-)D?!"@%L$];H4;O4R;Y+=F=H
MA8J>\WL?OL\7"@?7IY_\06_6QS'#H)?VCSGS+?P/XD=H([WW7"Y&2\0YC@O7
M_>2#/Z3&0%DQ"P*SIA?FT,R%47JFK5PU9>C[B_R7K&CZ!1\OI1?@+]6#DR4Q
M/H9;D=4,+^<_C#:=].5H"HPFQTLSLIAG?7?TAB8 ?NT*HDP==-GW7:D,[#9L
M< G6!/5KO'SHPG-_JQ(P&)X./7^-2ZX1'_4$C_*&\L"38]A,GU'@ZP/3=U2E
MVQPEO@L8F,H;*J"%-BK;^8TESSX;LB_J0=3,14\R"!X!'ZP;BKZA>ZE (!H-
M=]OU])/P'[4:-\77R62KD(S+;2XW#TWB%FC,A:M%$R> P%T; #?-46HK\J<\
M!FM%]OR3/[B ,WM/+?-]LOK1!UMT5<H$F'>8W<:(D0PT3<SS8H]RC!OC.F#;
MR5_@5PF9@M _1FZ8R7A+P#<N7C@C^LDO@DE]%@L@N(8>>F;5;=$*9(.N;MW:
M#+=-N]#>*5HS\%VA9M7Q!(4$7D&Y>^4TG6%K3SM?V/%=B!NH:]HS$(=.X1A2
MIR[>V?'.U[NY5UYQ<N74L^DQYF,9*" \&-:>1;IPRZ^XNQ5-:?43&K/>ZY>1
MI. ]Q-GO7 K#:_=8UB76@PVCS11MBVEO8(3)Q(88\_VW-[!Z1\;&'Z66GM_
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MLGH&M4H[SN?1F*XK)MRE9IA)M]YQ'[,=_-:"OSL_WJ/X"YU'4.5;B9LP471
M*6KW!IA WHZ/NH:3-/T]"" @R+#G"^4FFSLGF<3 H;75.(I*\-<=UTY)(>XP
M#<!%E,@:3:>M4]*GL&GCBWT%FV,D^%;C$"SQ!]\VGV^.44$<&\@%0BD%MU+1
M,C!@VL9UT_0+8Y7OBKUY79$54>:\I(PN=V^0?A*X0\U@@2JB']$:9N;EW 36
MYG0W*E.G^=@9X&U0?X?QI.=%;3_8Y1.UP"-BE9G#T4$.]Q.N9!8QA8QK#BI(
MBZ"&B^05N]VFK_@.OS *G53.K!@57009C4[)8 !+,R*K/$$E2@M F1:EY/Q=
MA!?)8O!-&'QB6495A=I4E=^=1C+G=AZ9+U+) MM_QC'(<6%<LXT;N^*<O[B,
M^47GFS^VWCJ&2-%R6N8"2ETI746$_X2;.\GXZ$[%HG#:N8JM$&7"@:X6U%;+
M0/#]]-]^?^!688IY:UV"56T*($;+9,I, )PSHW<"LJ<R]B&,O"!70_KXQFZ(
MR &&4="B<,\I-\H;O9#+;\$?T[:*.D!H4W@>;&F4G2CO)P,H=N,6O=2:T!C1
MS#Z+I"_6"ZPYA(B )SU> .%M,!HD*1OC,XVL)[Y=A#2::FF1(+M)T,:P,.EF
MX>,]WUMKDL[($ 2JHD5G6 E7^+R[##+N[2*C9/"M,HSA)!WR%$4%.7%78#P]
M\6Q=2G;#I ;(0)6!BR*2-.6U++7^*-S8VCH',*9L*98EWPDL8C,(M&@L][2-
M?0]B_(;G7?A$7E?U1>DF0BCE&YV<?U0L\6=QOCZ+T58L#C[0FLX!E6 XE]&J
M)U*E)'5 FAU:ZC89EB-Q5[ E6K395?0=2,-VU8XQN$8QCTKXX\R$3<1[9(6
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MYR>__G^I3%FZ-G,?#PV\,C_'@_GY"R""]SF''PI)<"6.X!(8 4WCR;Y,X3L
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MF:!T,$%1%TIKDB5&2?3@B>^'&HE[3IX;=QSJT+G*MLVPA]A:SZ<K^H#]'IJ
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M% _23O#2"D4:/6[9Y8I;5D)GGM4U-$:G]7V63(<2+'L@-_$7*:^Q$R0#S]7
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M2TMTRX7W:)1:1MD+OQ]PPX*VN*JKO?BSP9C##>Z#YX89 U/AQ;D_N%/CNKP
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M?(R@(8TB%KS8C2I,$A7+>B4,P_0WII& A[:L14?12:K((8X=H29RS,T:RAP
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MX^W;R.[#*=4U;#@.S<N^'1Q!LJ1TF9 2B^^8Z(RILU.HY=(6#>;CVI\QO\]
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M=^7^I,O%19WK>3"6WM/XK6L'\K"DQ,.CVBW>])S,1UKYP?UNT<=+QUS&";\
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MG-;8QPC;LNGYD6$36ET0_>YU[2!U<?_R%;F:UQF6<3R>9V6/Y\:Z[];CB5[
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M5?4DF'\5'"9<'8LI\\P^2;>&LA/K%V3&SSWGYS6*PYDHG>\X\[IT#_FZ&"K
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M;FGN^=*<(3/8P2DR+ ;Q*/4W%5M#%T1MZ6M+7\O3%^9Q8[(/4%%.R>/XATI
M2^AK@ANHH1)G*UC20'C].(S&;BOZ4H7?DJR5JP$9DFE+PEL27IQV4B3&2,HB
M!?XF*;*0VYR*:UI7[V($W/'D<#6LH7#L.JT+ G)LH]M7^5*30:UZFE.W&/B_
MWC2*N1@$7;Z@F (Q<,L*= 4E&![Y"5^\)?<MN2_Z/^/P.HF*Z4!IN3^G=3I:
MF$E.(*1/06 +=SYO/^?.Y^>+=3[_J')%?:M9%!NC(A!IS'(X!HZ54 Z/*OI/
M=.P;Z_!Y39$=+E)WVWMCL^G&O663+QS;:DN#0H0N#=W#.TK(L0%:T(UV,8=Y
M01$?SH0M!_%3RG;E@0-TUV.^;JZ4)[@-EX4:^X>MLY9ONV%]),\*QP8Z/SE?
M7,@5U]^4R.079RGZP0"[ @@F!#U4?:LG[Z( O?$7Z?')S9I%N8U5\Q++G0+\
M4M_OZJ?MQ2?KP61;,MM[:6=A+K \ <VCX HSZSQG9O;+8LSL4Z8(Y0.4)$XX
M^4XYU=J+F4P9NR=@CW[;"?Q-,"R2<1=$FT.:%R! 3/.G:HD"U='\>G;V0=#%
M"+U-QV4&$59(*,I [:GB5JG$_H#"0I>O/UXY'M;2+S1T##9@("8H::M:'7?^
M+#(5<ILIYT<SNKCI\R,?=NTPOW%\@_6@AYUN$T_KB:?=;>+I5_&TGIEP4^RQ
M(D6[SUF*PE9=M'B;%A"F\/1Y%M$T_#/+,B_@:P0YRLU CRQ?OPU1^H<RL%2<
MD@,_B8:P64GA.0)F ERHCZZ9<6K20;"8-"V4WT%A,T=FHFP#B:3B7!'@%5=7
MSH7BH0!P3\41*+T>IP".2O+/S,=B:A%ZJL:07F!B)*@U890@=6EUE!!#Z3$T
MIL)23"I0*8UGD+8%[,V8!C:4_+1%'5A\PWJ-R5PVL_?<W7"PZ@91CN6?TXQ[
MP\(:41%%@)JRRJ-CR+ET<QI+7'T<?E:^TO>+=17,#)\()#F>9TB:&-4Q9W3^
MF,NF\Y*&NBDFV^Q&=PF<J6E')E #I00V_D 7-+N8 $W$0/%U#T@U'2L^;K&P
M=%\@28R.T@$UQJ'YMK"-'Q4NR;'W"=4!%YU%E-O-VIQ&OD/#UNP*43B;QWA>
M$4&QT_1T[I=GB+.![A\G%'\_4:V.1[W U)M?%";L<VD4+;[4AKB,G<A!O3(6
MMG1U>_RY;0!G+O5QRI$.V)6 4/F41&V!6'1.F*G0X\QVHCMW$R.#.*V9)EQO
MU\%QW'K5 G[,O_A VUX"_B'/1/LGZ2Z&=^;*.1%;82(N"4J-),1CPOW7]>3E
M25M&@9^:PZ>?J40-H\*_Q@)NBX IJ&[&5-*VE5<'6C&R0[\MRGTW W82WEGH
M:$S&T7D_O(-N8TCX=,Q$:/NI4> "I%1B/&!E )OJJW#T/ )3-<Q P.B!3!U"
MDB9[E?/B$M_&7:&EH#5JX?T$1RRM[+J'N[X".;1B[O"'5.ZOZI*O+/?P*Y0Q
M79JJZ?#,YG?I[:#F*"+C[O;Z,8@^$A\@O_(BF[(\-U 1F$$,LC'/W08:@HE@
M@6 GJH]:GV][B(23"8@:!C:8@O "8<2^A.MIQ/X/ <EPVFT:.>5=H>(49B M
M7Z7P_\R+=EZ?7;W:=?5P^^1Y.B#-4Q+J@)]<G</.IA.8UP%"J JG^H7S *=1
M3E"[;QQQ3QSO@BZ!P?7E@=QQJ#^A^>BD?6B'-BX3WH3?U  .\EJ/Y9?&@A_R
M[73V%ZO$(DIG!U67@O[.=C-F_1"8I*GHL<J(>WBN0[PR][%2HM( #T@BK=.%
MEB+F_9JR"'EBGCLQ'M8!)"QE!R(M"F?1U,:G)#GQE;VTWJRF/2"]&^G^"[=J
MH<3)6U*_:ZUO&W[OV_9!J&R9Z#8E-=.<]5F:[KZ@&!8Q+47[]=&/Y_>CK#\=
MXTGT%17P139H*,4'5"^"F"@T"Z>KSLP=:?FO'(R6*#.Q=JK<P\L5S+[6F=(F
M%Q;98S0FIX!,S8UWMS(NM7D&*EXPK2(,*@KBC)WT(FJJ09HEUD-0]N$;C)_X
M73C["9RUOU-5@RC9-RTX_Z'98.Q+,UE6R^8:L+O$&;RF8V;<T3#&@A^R>IQ>
M(RRVHR0=X[O'Z0"F;"LS+-R-8T[]*(G2V+\5^P_M<;'F38JM;9%6 L\\$$=#
M%7"=)@88[B("Z$3++\H_[R%CJJA/;!7>J&1*A5^JCX$[&\:#X>8<P[H,WP<*
M\A6'PY;R*!_O;SW*=8_RP??O45[2#;L,^UPB)GM0\B8O$OEY3/?QBY_]RT\7
M;WWLMGSY\>+\TWN,B5U=O+M\_]%_>_;N[->+MQ?O/OEG[W[Q+]Y^>//^7Q<7
M5P\-67W5AC]D;P^?LZ?^;+%X]R_4ZP#-;P("5PE6_UOLQL6]\]]4K/)K-"('
M^8XHBIR?6 \[\IRT 1_+L5FWX HJC7N=,NXUS.6SNO,1F#V]4Z)T#^QA,+@"
MM3X7!.>NXWA\$LUSJ0LD0K"/,)>3'&2 _E?I'BQ.(2^0V<^Y-'S37HA(L$2_
M&F%<]V94 HB/,B9*93-BY3++$5CAB4OB[=R[59BKSNS+'B=>Y"4WIUGK:'C'
MV;5:R02;7G__I!O>\2'-(Y/-L[&S/$>#EJ>(''<1BH<WP<C7&9BN [QM:?:C
MGUWW=CK[!T&G>Q)T#@]WZ[="KF 7;V!5=%0SKMLDO/1&X1-,SR]^_F?T.?(9
M]V1&+G+[A[D;)T^=_-!$:"]^/CCZJF$/#AI6!YO<W(B ,_V$ 7_5>]N'/SPX
M3TK((H_^5'J7B2CXK9>7EW_-IY.?=PYW__H7_(<!#EV.9.H$\7 B^)@F*O'_
M;QB'=ZK0^[;<;7GQ\^'!LK]TS]*Z0>4LYPWV\[N_G*WCBCU\1]^%H(*]4MDU
M4,=#-[3;^9H-M4F\*]K0Q]RN]W_Z9X-X_ASG;M710[<JC$#9,]G&Y&VG(GBM
MQ<W=M8UF$.LE^(LXN@M'4_]?V/)V]& >,I?D?ZZR]G4>"I_)T>8P[3=1!B;*
M>9B-5?S@>W/R?>_W>N_ )_@5<(XD?# ?.VQOZGGP<1ROA/P7V-K'6]3;-)>:
MN(_J)NR/>&'MW9W.[DZW:7G+G^+!7&GTS9_B>B_5V3@JPCO_#Q7E<X7QO ,Y
MVO^N#V03KM6G=*PRFL9%\>==FD3E>[5S\$A7ZX$Z\<47+HFN68>-9^U\MHY[
ML=:#.LO#(<WBLO@3M-_/JSFGP[DW;I7GU.CA?KJ:\A?L*OW;BT5"!LW1@9E5
MXEQ';W;([L-JDO#IO_C.Y>KY5_S:N8'BC]-8[;F1Q*8H\'W!G@[Y@IP?NW?*
M"1;38 W.:;TQ-+EZH+,VQR?<NN\'>T%?GB5!%I@+ 3M<*/!VF3#H&Z:N:8:U
M%-P"I]$,.<^&$E7>A?D@_(\?"UA?!L21[]X;P=N>&Y];9[%S>ZLT1CSEWDP1
MJ/4\'8.F62BU>+BTM#WUS=E>L-D'U7W(06$2NDIRBLTN=<T6/]OM^?#Y'"QV
M/C5U#3G:4D=3YGX,HA[Y<7C[')F>J\XM?E:'BYU5V<5L\Q26.B[NS(A)Q)($
M(7#95%_(Z9P:,0ASHB4MLZ=,@[+.?N=04-?E=U&&=2!]E></G$QX(]CA/00(
M4#$G:^([L.$'Y?;?CU6S)28FIJ,'$-,3TM+!X].2OR6CKY<?Q\N3T1-247<3
M.=(J4IH>_P5._DC@OTY9C.-*%TO16&'%V 9E'G:/*/)0:3,T N,/82"QJ4].
M&8:S]BR/,'$;G\!_"+@8MCDS#3B.&?I*BL7A2U.+8_,1>91J=U;J]%R9FD?3
MH@S&V;W(3'X!5Z_K67)#2#U+N%\:GTN_KWU<>Y^S%?A.[+WT1;_(6_A%;N^(
M_<Y^"Z8K;;"&2)=4+5?M::5;/7T)I"VG.T;[@&K 2A\=!UYU\NEM(K>;)SC
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M>IWZ5W>PM#$MO150_RM>LI4>4J2(7=)R+#CD%/\A>N&YLI<$ $SP"">($B0
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MTO[M"P9A$7) F1Q]F*5G3\PC!"!X_X*"1<N5:.@L$_4> A .^V 1CD';E'-
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MZX%@LFJ1<Z47'9>61LM(RE\JN9)+J4]/D8)"Z D2X]SG+E-0.R',V[!^3!E
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M&)(3+/F^0L>M5I05U?YNOOL"+)(;_"EB.\NSH#!*FF37>6IN2*)#61$\WQB
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MG %CB_0N+^$V#(*=CEH&!WW:?7XWSB9.&[M:NF4_(_YA(C!^Q,$F;2%M&$9
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MO6+7+^/]4BU^LV=F5"UV94SM*)MC\=M+QA<+>;$AL@;/%NPND?H)+MNW*>[
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M!KW%(_CD]R\'(R5<D+A7(TV7W,/AXC766"0R[C:LE$A E5W%&OL(>C1[F9T
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M]#>Z[TB;&W35N9K?>%E]E3%]\ J.\1E#D"K"9JI%D*!#8AD+0]Q53+4:)?N
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M:YJJ#'ZX,GK=!]#DSJ^3:Z/6/3U[=G1V]'04-@\J;)[NB5IW'#TY?/+9>M9
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MI';Y+P[Y<V<J.$-8&MMD$Z/R!5W>X)#@/8->@6NR_;.:O)+R4@?0EMM.RSS
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MX#/T^HID=YW"10$=J-GT#F),$(=A8 DO5#Z:;]-U@[173*!L\[^UG,>WZ'(
M52F?8GU2#&["NKJ<?Z*G159KA _A#_^JH=D9*YN3K[_E1@+23H@9KU8  H\J
M3(+&HAEV4!GX#Z3#SLA'];;(KXIX^0V82O=DY;IDWHOPOO54*_*HP%C#[XJG
MV3A6M46%T:AEAS1Q! [5X</R@:4F\#22CJA,K:@3I;C)4\'%3&WG8JRI*43J
M'?TT?33U_:AD:\EV*H]#+-RN88 >7$^1[-1!'+&8U_R1H"!K[5ET<1V!0]<R
M^IH-$7I-G<=87[U<XHAFN>(;!*E3Z[+DNP%GB'E(76L5>P/B,S"R]=*I68@4
M\:ZLQF+0Z" F;GODF\26\,OHM\92K3#E0AR(#]*QG";%M%YB14RZ *C\8$GS
ML%[QC:!;+0.'RQ![BO-;%2KFAEC<ZWY#GR?AZT\QWH342EECS3K=E*;1"CN,
M'.I$$:,#%@>"914+V!K0S,TB)S=\5S]@GL!.IPV/4ZMY^#5+ETPU,=!_X,L6
M#A/VFV96$]GR([CU+^.2:\C3"CB&/9ONB[@,\#L4"7#Z\R^XQ+AX8-$TW5%?
M*%:%XA*65,6P,*S[F<O$;[KD[CZ\S>MJD<M<B(\#HQ95&1"W;CPEVQ#_C-Y[
MV(.?L+9J:<MDND/,0CBG)7/R?_!_HWKN%)VV ]/D;/:BGM6TV<GV(Z=/T-H"
MV$M^L=0JCC.D.\^5=R*@65U,5,J33DG_B?G 82G&EB1JE*IO#;BAT7'%1=&K
M>)5A_C\J6#30?;@0 W(V%_E<40.R 5';FBH)TM/V4)\6,4IOJC1)YQSD7)GH
M!9UZ-^86>'+N]S[9%E_.0]Z27\<PZ+X[ ]]*Z/$G3;R85M-<@-:3EKW0NKN[
M+ 5^TUX_@345PH<S%6XS"W98L6S8T]] 31Z$^GT^HG[;J-_C_4?]CF?G:XSF
M/Q0(^3@-7FJ@'Y*!A^^U86(-D&\SX#$,]!D%B\578JU(C,U<\4*G:T_;-JL.
MMUSD!&/%,"@D6')\\J,3?R2KAM1@*D./)I&4!2%]&Z.)NLX]&Y0@;A.NI$6F
M+P57X_ M&;-H/;UF-1RO:+AV[=\_J.DBR]/\"GW_[E,'L3&UM++]B)=2;%>C
M\5["8%(LHK9?:[R/^U;@7<$5^5IXSW!L.FM%U?7^HJWM;&A2+F7OJBOR5GA[
MG';J)/RG9T$V3.^(MB^_A$YQ78A&[RE&;$.G-%2KIV\:U97,PP2T4*70^Y 9
M-('5[4&Q)S?23^%!(ML87KB)?0!V8$3Q"SPE!XE^ENUS!DJ@3;@T5>[(K0)?
M-35H<+;4)U5,$['6!T9!M_46VZ\[^;?X)M#@DM<9NEZ<];S(9O!=L+H./F!-
MCT=1>/KL^.SQT=G3L^VYHD?[_F[V/98'^IR5CISKW-R6Z"0KF0=#O^FW^1NZ
MM,A!/5.8$G*-+:#T"RZAM7DB]2RU6.-&T'%FZAE]F\K!XP[[_!W6OQ7@AIWC
MK>#>9,TE-W<87WC-F^ZQOH6]1"$W9F&<V&>'/^*MM01[4]]*H@T*!@@O842U
M>^!Z5V'4H+@K&^M+\Q@+KVE5@?7*KM%8U5%CIM&Y1<I%PME.Z/WQ.A]R? ./
MD[1W#C:S(0['7D^Q3BQYT@VDC^:4O63L;"H5>8S"DW-+4L.3>$%CHX@F>]*P
MH0-<W?^C"O3V/@KAJ!]%70?<O# )S^\T7O09\GIKY459;9I6*8 G%F">:X6K
MM14P+%(B1!(6)5EA+5[4_[%H&<&^I)ZOK")GCYDF0.C,ZF_A.AM%QWTXGWT5
M6E\6H"<O<X07XGG%_T)2_^LX2748L^L&^6G?9NJ6]?\,2-U=1NX Y8Q#<PKK
M%:]*Z)G^M[^A!\Z!T=V]_0[ W=_$G6?!;8.[JTW&K=?#VXM*R+HO'_]Q"XKX
M(+T_>_KL[(5X7QUDX&?W_X$[#'($MMM?;&YC)S5T(B_)JE_5Q124"$4P!(RF
MPZ5(=2[QQ]KY.U[:'[/\YO$BOXDX^D.U1G0#=+]?Y3GH"C%>V7CSH]BJ2\F;
MYCO<9*]Q9S!L?(VWK9L$UWG;@O)R3037H<+^/::K< 6CSF>1+EWBE#GAFU+'
M^@FZ(..B7L^3HJRLO=Y>4$)Z;L41MT?F_O?95VEY>Z;R:PNW;18,.R?)2.FG
MWJ7),D&#PJTXC7(A%8- 9P5YI0 97E35A4U;XN1/:S2T52K.&]U.N? MC_0H
M+$9AL=4=5B[5K3[I#+:L+]-D"JH&6/X$0RU0+2$3&LT)3/;[;TSI!\6I)E#C
M-7E,"J6$&:!'UQ#=1;<[Z98:7NK(7EMG.SJJU_"]A"O&4Z# N&\MP&F#WR_1
MT-4,H5^$J5W!)N%Z? @Y9%B4];/A1A-(Z'H,%6W5:#[$GX*?]>I3)@176,1=
M\4Z5<.:G;.4XE!S;$R;:XXR)>QZ:P'0F=HCDW+\X)Z42O[Q2]'FY.M)U.*\Y
M5_8*4[\C"B=/$47/=XR$@>"NN8Z+1%7$8K9B1A0,"N68)HX;!YO!:V0%UQ-2
MC<%?H;<SC+(;#$BZ#N+9##'@AG]FG<%@IURR$^'3^$-&J?5R!Q'<DC',:#YG
M9/Q3SD &4HA49 7V_[JLU)*!U##:D/AUK)3KC9]A)IO>_Y''88-?]'$E%_:+
MXO WPO/H[/D3>H,!!:*+0S^*.E6EY"$CS$ 4_%P+7]TB1O@F5E5GEP0R]2!R
M1D^M(1N@$?J !AWU2).8!'YB0+%NORFRAT0 2 3$;SBH7NT183 .;@1Q<<!@
M3.2BK%=,#S0W7<'?9$;F1;Q4-WGQD6^'\-W_C)>K%Z_L[N"L*T*T_QTC)Y4@
M.&+<'\[,7)P_EB^I6?"_C:M&7I,.2[B@]",[!!#6*[<.[VTPP><,QAN(Z? 6
M1#=&F7K7H1D6I\# ':GH.@_Y'%0@2?Q O+O)(UMB>>!+S>;!PE3OL561V$VL
M/JEI[2:T.>#Z27BN&Y<]Z6"&CIZ]*"V/0V0=A+$!I\.<8.#M4F$($?/22@N]
M;[2(\4/X;J%**V*TIJ<E6P;3YK90PC=BRDM#O5!"F57\$0]'JJH*79Q3E"JI
MFEUID=\8@2>Q]!QY$FLK#HN#6_YFFWH0'/YLA,.WX? G(QQ^:\3J'M\8[_)U
MG(+-+?13SFUA-3RK% C[C%;J1 RS]AVOPX(:(WW. %W6N"-<?:=;S8A (E=)
M&LSK%%./46_1E\P5VG\:>).@%,X^VDOJG^_#&<:&N0;K-"X*3C)&ODJXU@[H
MFF*VR-\N?G[SSOZ$6K;\(BV R8$)8241-I#542XDE76A8U>SF.P*3+,5(B)B
MU!2<3\'8GQ"F@0P )<8+WQ ,KW'46)\NR]PST*N\EN#<HTGP3YR9\#]KT(2/
M#X^>11Z.G?[=S+O,'.J0)S_BSUK#M\@D.Q3'N\9YFR>3TQ_M0CVIS+"RF[B8
M38)S4M2'= 3GV(+V69G-*\HNOU99S9H_&S\_/#L,81NG-%&5=?#Y+*"2!$N&
MR(R2W!9H!9+B07OBY,>MN(1'^7.WH?T>9_4\1DT56>((LL:0*CUJWOS'AX<G
M: XZ#[/Y;P'LL/:@P\X0CJZS1=.UB]RCR/B\(CL;L6.T>YB6P6U6]R$XL G;
M<5FJY66Z?L2@,VAC2;@SF^K>:F:FIB!2^-P[2#PCT-R=C-;Q,JDJB=B+=,16
MQ(Z+-)N?-UWA*_L-]B<0NQ[6HR8B!_=1@VS+ZPIG3$,");G$S3<@:Q6U?M=]
M*I([8#0^0G0I!Y:E'4P4:!LX%2P UIK-D(4#3;S[E(@ _UDMX4UN0IQB<FS5
MG&:PC9D.+3"2JJFG;YBEE_62?!O73D-6!AT=_FAMBRRO#'NN,P74SU31LWD1
M$/S3O /"ZK&>MCV30]L2=[AO3*"^OYI;5T@:,&10PK9MG"<N)2#[.2XE]:7\
M*;S0J3!LUFHXL=[5@BG%N]+ ??(L70>V>;5134+E8L;A=SA#1S^:EJ$[-6%J
M#]3D:H(V=EFIF+0H&!+V^>3'R#TN_";J;4]^?&1SX8)D^ C @%B$[@B$FH8I
M2S</J*$WX&J @ G@2PMH7Q4LV=HBAIYD]@Z0I&N2G$:KT*R)VH/F+YZ6@0YQ
M"BS!!(QYG800V2Z99*E5G#AJ[#S!^2<N59"6S%Y#DYLFVB>+(2GS/*F=!EUN
M!#6]RT/T)IK(TJ')CTJM9/T".TND*R/.NT#E4_P@Z/+0DZ,]%6NP5!,LX#X*
MHZT?$PHC9YLK+8B2TKT+6S;$2A7HC8BOC!;>>?-[K*9L)LWP(+0/0T!_Y:;X
MII[:2[.W;1(!-M6 [OS+(H]G1&EA:62T!6*0V!29WP(,]8B@'@KS8;=1&^G3
M<+]=-MUO/&%WPV#N1-3ZK3F"0TL\]QXG.-48FE2S?[LL_OZ/8<TV#W3D'.!T
MW30CMQI/=#M6Z_XVV]?8*2CC<0!6SFLI;V,NW@+=-S2O[\QNS23M%#IOA[OZ
M +L*+ATX?%=%#L8T7CQY\5/X/UZ^?/WZEU_N(=/FR=F/#SY-_UQ1-^$LGH)U
M?S\K*]T_?OC>W^=^_(J3?G1\^*.;(B-8DAG[R<KP_[,N^P??P%LL&']6U8U2
MG$R$NQ,U[+-[VZ4[M#4?>CN>;L]V?!!Y^L#S=R;31YYB=([NQ*KOT 8].?RR
M#3IBX;=\5& G:!AA5T3,)V&.';]AN1!@DO8N(LS/][OJAKNLQ,J-(&E0V KL
M% IHJ%G@AO\%9Z4_;@BV?42 [ZUNVSH&1?F+4@U'D>$;3DK\-3P0Q%A:Y@%'
MM4M!_1(YOG5NQ9=@^.%Y:#OU']WF3*,P$7R:KEK' R9'RQPU=.L&S;G@1^>F
M<*,&8>JD&"'QMDXP'9S7:-;0"3EVG.Q'$:Q*6B6K-#%8C, IJ"6.:!NJZEAW
M%[9J-\//<9E,PW-*O1D]Q5L_)@'*=Z]?N$RRNNR\&2AXC7@*CHS@>3'PC:._
M/T.G$R%BEG04#:E;70@2Q$8S%,%S N8=!D%A-QIE@&(V%Z)BY'!.PG-$='+,
M&..G*C."AAQ?/3**H_5'AY(!)F0[.FC_*5G62WVR P>SJ@,V&-1Q#F;)!;BZ
M)F:5UA8S%,D,4KS'Q%RVXECL&K3SZ/!PQ':VL9U/1FSG=@C2A[H<;JD)U]YM
M6#=KB;59JG__V]_"LIC^^]^2)<SS_SL\>CKYU^KJ;W_?E[MK'^]C YT@A"*>
M2KR20"-C0!?&7@BF&./-0K<6PZCX!B-:!2G38W[GJURN*R<2W+K.FIHI7F6!
MOLJD4?F0-%HN8KX?LUP@%LQ,]Y2*HM[Q$Z']Q(4D9R";C:F_XF=%:2L!RY)0
M:5=H3FO'? "<T#'A<JLP5:A8G'#U TP[N39852=X[*:!NQI%OP8<=%@^C.C"
M;#.=9V8Z\.ST1\WN9_3YY2K-945,KW79='>]M"*BB3,0GLJ3' R<Y/TZ+_LH
M SXXNR^XJ\W=-D#]?"+7(!00EQC+J$07B/F9JK*,B_4CJFT5E_\_>^_^U+:6
MY8O_KK]"=:8S!7.-@\TC<-)SJAPP)^Y.@ ;2Z;[?^M:4;&^#.K+DEBP(\]??
M]=A/238V!XA-=&ONZ0#2UGZLO=[KLTQ-5,7U8S1)H,FJ0J9>IZ:RE5^3HC(L
M!M9> \37B!EB5('JR&HZMQ&5KH&SS*!P$MJ=W.1[F()/D@MKB<&B"K,L!T*V
MB^:&R2"GM%U/=G>+[DVQ:KEE7+&RM^CH<)NA.YXH>ZG*U6(U*&=/D[=:AEI-
MQ?/6U%%<3UGM03^Y9;L^$PYSDBV75!<Q%(@),4U49,B/<&=0["F7%EALDJ>#
M0J9: RC[.N#:5%,"*R'F;1]:IKLDW2&.K"'"W,#P5?E.35X\.4#]G#-[^]ST
MGJZ$R0RWB[BI0H;KVSTU!:)R>T[X"W*GEGRI#O]&5<QTE6H0YDEIM3(=O[H4
M.!EY57W5N3"=CF(,YP#, =NL*Z8A6ZC[E( K&P88S&*EPU"N2SJ];U@ S J_
M5X,4V" #5IEO("L2[E*LDH@I-=^DW!*',HYFYH<FD=MM "G]TYCRSY@BLVLF
MDM2;?>1-S/0&XAL%8>17L, BP[L3%;46@Q0T0SQ-.(OT^L5Y5PU%LP04S7K@
MS]3QM8=7I;H)R0ZQJ!$G=U2!BD)$P9,X*(<$8RCARN!&(RU05 >> 'TJL_69
M ?=\*?Q=0;JX^*CPFWLO2$WQ!G9^-:])D#0QIGQP#::6#5!GP]HDY+>&("V4
M5]3 D,G@S$9U<O4:)E<_(3SU6B5/U+C2#X;^<&ZBR"94D%[5Z.M6UTI+LYI,
MR(;!]PVGEO5>UC5AQP2J'&?6\K[&8:UQ6%>=:]1LHII-S-0/5'J/TDN >8P3
MN])9^@QK).:: ]0<X#5R ,J$,V6@(/[1\Q4#4[@)HE&!#?B9$.3VI8X.CC&T
MJHC+/SQ7YNG;%YFH,!V#!9]M4@PQA B_-@J=C"]2_ <L7"O$.+U)D_SZQM8,
MKPW6KBIRCSFED+YH+$_O0<NSZ9\FELFL$4XS,9LFS>.,1@JK(>,<783NHA%@
M*O-LA/%8;8*39HD)J%DFICKQ#7?+H*W*<G^3%F>^+2^ T\RL8)ZKE%,/*_T1
MO1QV1H5)Y.U1/@1V<2^->KX"P8S5N4O+99ZUZLRS<N;97IUYMBH,_77Z5D\H
M,1Z>H> ,_J\,?#!("S+%L]'(2E,_N@G%R+]DP:)0^52<#/DZ\O]*!RPF,LR4
M)+H1Q3!/G40AXVF]H@R*01#+7"B0$WE*XH[X.DD;&Z1+9?,$@X&8@'BI@S4K
MM9JY+:9E(W:_1ZH!!4ZQ]W +>P_OU5VFUVI55P]UF9Y_V \VFE8O%9I+J[@0
M,!!D5? 4D9L*]X3F8ZC6F?:P_B@8J'2&#95<X OJ=P(J(&FGV>:**'HU[3U,
M>RZ%$ PE9E815F \!:H"I8OZ5.AF$K*:YB]!G ?I/>],JX$8JBU=CX4_^!U\
MD\$0*4MCUFOO-" D_F!>XWQ?=RC,F2%BA!G%L%#=60=H/A43T&)1X&$?9#+^
MI-E4T0BZ*JE+[01=2+1F:,DN:KP['3W%=U53S-PIX@5S.UN8QI08EHV2^)K2
M,K@@$O0'2BJR.OJ^NGM5D-NO;G&8<U'1_,DEHM>X]M?+, O\:(!L)1*<R"F[
M:S-6H60K^O@50[)[@#F\5_,9^@2P3 U[V2BP/<_A*1(-FQ4!"6P>J(2U<ZT5
M'!E<V3:E]K._#$<I/5ON3[^!@H'<I8)Z#*7"*^6[V:O9G",FF&O2ZZ&*T@1^
M::8R#84RY@;F5ZK7^=#4*W#C'-DW#4'7[RD+4.Z$TRB-<X(;,O<6WKH),J=1
M.N(I Q]N^%6[ 5043'-.80PSE82(QP^_0=33X%JAPZO$NO,\S?+ U(F71&/5
MPC.>9Z3Z#2HOJ-OH75>[[K]1W4BS"4@L3$0-27,CPG":].#OJU:&"4.1R%AM
MK%PZ@M4;Z.? QT^QB] V5?\WB85IB>+).AIA 9R"T?FNN?<&\SN=Z=%9E?>"
MT_P5B5[B1^$8%R95=*P^0*AW*BM7[7G#EW9V8&XO-XFFW=Y6E3O8(A;+B46J
M#T@="]'^P1M2B/;>^"%7%\^;?6E_E8I>W-U7IP2\3EEQ'**E%0^!_#1TL+J#
M3/BZ!T0PU7^GV[X .T:/T3)W@E///6,LNJF[R#VPMQ!#F'['@C&9>"XKX$R1
M&E'WK_Y&N,GGIC)R5+(T_U8Q*E*PM_SM-PW^_480@7H.<H>0F3D&HC9*M5;+
MR)&+MH>]<\C38GHV#R)*; ]X2"MY6WU;PA*3]$6'&]_((=;K17R]X#-^QIV>
M,V\C5(M!O@X_J1^YN)"<?9L-WSQ6O69[>EO Y]_H,>7:S<"E.:N1<#+6,-0%
MQ-K*31BX@&Y/ ; )@]</;U6 "]L&1N&0F CCO@NK:<E5ASV1U-R.2*G(OQJ@
MYS#WHC/"J%4J\>\SE?HMG0FV1N-:57@(TN>(SH%ADN/_X">FV.CPI7N5UISL
M<:OZ*CSR,O.53$C)PCJ(F"\E=J>0I0DE\_BU;<7K/."YANJ[VE!=OU5)0]7V
M2J%G3\3!8,HM'K!Z29FH7;!C$NP&V\5@5HC]:,D@U1T\G>Y1QR!PQGV1\LZU
M#\FFVV\HFZC@)_2J''Z5;C,M3M!I9GN]V#=^!^+N?L**M51\9CO3G*HLB<'E
MD2Z@YUFHL:(Z3'9F2\^;-0=2KS0VURP#ON9V:[&JBKNAPR*< ^-;76QURA@H
M8-F(BM;+-36JLI.S9NY]0L<PZO@L.B6_]_E55WDC1"K "!;QOY+[AVW^]ANK
M+QW-6^7L8,.0L@U1[*F,[\EK0AWBYAK)LB&3^CY<GY+AFY!5+]5)6)1MS!9-
M6#6[CIP U7JJVPBSH??)6;#49JCHU36;S876Q-3=!"M'Y?').<B2..P;'4^Q
M$3;JJ!V*8\G9>1L/;<^F\M)P E>QV8SL03/G2_X=1N^I 6VJYAP4Q_$80:R*
MH;HP(Z>]2^PQQD_(+G2:QG@?##*'VQQ+[]9I($MS.SD8;"DZ-$OQ"\\J"YVD
MXC9,\@Q41"PSC74$4II*<_,D-LF7(CMF"0YDX@"K >.PKCEC[3IGK)PSME_G
MC*V*(/YIU LE*_^PFF$W<?012GOB3_,TICQ;]+?8 J"U[?69]6]6JB<SG8>S
MM!6M4V-+5I3-"RDLNB/=/HGH9=02&/ Z2(<4E7 3^'5OQ&N!.OD$!(?N=$F^
M3!T9*FD6BZ]7[=IB*LC^XAJ(M[0&\C3JA0B)"J4R9A"0E]@25!7F*RG^;"5E
MA@KB5:D@! #2669J?*<&$F-CWF;,T*Y&$I&5\>/P"NT5="@+P$5G/,F\K4RX
MYJJ^B@CP(<-%-E2&I "U:%+9=4#-J];!7QNG?)W\OSKN([O0S>=[2!E*7\X0
MJP9#,B+-9&@4;"(RKA:_% V"_?46^GA#4?>C8T2*%;:WWZ"D,CB*R6A&U,->
M9,-[F<"&/S^PX=F!#5ER8T(8)G9A]1CUJR-9A+C,M3P:6XA930,3M'&H,'/2
M-S7:/$Z"MANKUTW(;,:'GBYDQF#4A/F9(>%(BN  &&$$57R^\,6R1. T"SCE
M#,T$[&--:2[7@L01)2ZPY\U]$1T9V'Y#L67%%-V]))G"K]OU2?#\6$QY/47"
MI=,VK'SW#66R/ASG\N:0 Z4\2 &+--]XCC =3M$K$G2=;+L>J_HJ"!M'? _&
M#,I*\=($VUX@,P^!F@?:(U\P()3>-!376$QG^TJ01EVW(_H3Z1KK^LH9C-_K
M6<Y#.11UZC57RJ376L](Q<T0:BG_E5,&<JPKK.M*5FHU5\%WLI(0<A.Q\2XM
M";S^:WR=G$,A?"&ZEU$7@&$D&>=&6D9G1G)!@HXJCS?A(\J'N$(#-4J=<N(@
M/QI/-TH<)6QQT$F>TA?!BHZ'I4_PL);/7XUH7!89PR_JKX5&T#=P0M1TV<R*
MFX['6Q7SE+F*GDY"' !?%>.)K*16>;@1&ZR6F-;-<*S&SK0,$448T91N!4+D
M3.\E<!!^?2",]T8#:E)4Q'-JJDD;@L7FW+Y(?0X^'KG. 8I"QJ.(W>SPK0RV
M-\HSU2"^_!=:F(\@R!:PB6QIS2-[-#*JD:!5")-RJOJS&J1<B:9$IZ973?'.
M(+,2TEC)(156CU%2P^(L'ZO>[ZAOBN^@LI$^I#U883K(Q]D4-XCPY[2B1VDE
M@WLX/8G?R2JZW;)H**T*(#]X)A-&&,H_P(X#78:,WM"S-LZS-@YS5DP2BZV;
MH1INO$57M#W%PY)0]3!+RQ?E;#T_)PO>W?-3TZCUM+58%0A)67+G_4X,%>XW
M#-"QM/[$/[4 8R\42FQ1EJ(#RT:6U7"R&W<W;/O0O5(&&O,J*]MO$[2\Q&,O
M8E;@\J6HIF2N;**4OJB,)76)AGX^20CCEMUUS!6NT9(+;/:B6'9,Z<M7G<NN
MQ%5!P_I:]AV#4_LFIA5X\!M<=0R['V3#X-^;MO^,V+6=*<]"QDI"K_*E>K/6
MC5DJQ33:B4CAP*E^.D-6!BS90.CB&+9TT?T2,IL=:!/?P0CVI..VGPQ)1L"'
M,F"#=OZY$J(F5\01$PV5_*LJ'(Q3F9+0221BBHZ$,LXLG5P]L.F1%QXYFY6[
MKG@^LMCK!,6N)1E')<K@3%ZI]NMZ!GQ-MUU$)&'M%FUC,GO,QK*](T)"K:>4
M)4OVMRE^&81!&I+D)\<+F4%FN@T:5%GY6D3=BC@7Y+0 P4LVB,)ML>^4*N=
MW:'AJ7LU#,%&F;*C 2\8_^3& G@L1VW K0R<>Q[(L\6;B#6%YNZAQL"PRA;
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MC%@':#!2B#*;*FE.]\#6QISE$2ALJXQERJ-SVSE24&^8R+:1*K:I.DS H]%
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MQJ"=Y<)^\O1S4)_\:JIQM+Y\JA[=-"GB-"C=>DCK2PWT'&(V,.&<J32R(K*
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MYR/9/,X_L=J#UM5=Z[ FN.#>*(\'LDB(>*D.(*JF@,0Y94T0;P)?</+PA?$
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M\PG^..,UCZ& _.#Z&E7^J=5,'C,.R$M9S(UH;&]OP_]O-?T34Z5+';740FZ
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M<K&:YB%=ZQWS9SG2#ERP]J&T5/#[*"(2-6S&E C#YIPVYX_S*1;!,1D(V8X
M<04;!*W$.Q3=-SRG70%/#Z-O$_A?P1E]+O6UFX? [7#2J.^]:5 :LA[.0-ZZ
MO?WP>;4D_<L9YG9A58R[&^=T/Y-1<;(@3@QR,4$;RKZ"Q!"![P]D6_L^H@#?
MAO2)/X&V3\74_MU-"*_@HP%Q6M!C"'WY3SLD[K;+]$++]I.[6*3933CQHW <
MZHZ'0U6!5$E5,B]"<0-%35KF<FYU)&[A<UZQ/:(\XR2VNUXH%4TVAE"%(3O;
ME/6MX,2!)=&RA\$]@8K1+O,XTYLP'=H/^.%X#+R'#QMFEJ2>7+B<[LLQDX*+
M]0'?:FMM?:LG3?_H8^?T]Z[?._4ONK_W+J\N.J=7\N0O_:/NQ57OY)\8.S3(
MP'6<<#W6])/%"0N7LKVVE_)W[--R<7YVT;GJ^K^?_;U[@1VMNO6U6X\U(6;G
M99#V@UAD6V??(W&/O9B<!A<*E8MKH;*\GU'D%-L%8$<&DME.MZJ&RLQ!.2M@
M-2@?;]%\)DT&RYBX^4(&:E@#]05*2;KGLJO; (1ICG:][#3A7V,J<DR&\"1%
MY7& VHYC&X(JB0J<[LZ@QS0Z:5755M/_(DNPL#L!+;#A4?\*T)%0^<.!V.[T
M!V 1!Z3OSIL7&BU4W36<5=V%FD\4BAP5&9.*Q?.$L;E:C;)/*[_DU)115=@=
M1E7@)*AM@]OLRRU10ZWG2_.RZ0\3H F8KCJ/E<9'75V(Z=TZRZ(BR^*@SK)8
M#=;^&L55+_;FE+J1^:Q8,?<3S/O_DFR<F_B(\82LS8RM0'A?=2C<VV_M*>.R
MBGV2D*&B9)(,8  ;V4 %0ZH+4>8:]Y+M@U ,"/UN"E;YO(_@FJ2O0$W;>#YM
M[O_"U;\_F%R?*2??2;=W8><6'Z0B-[^,/+?TG-0.K[S%4SHY7OKZS;L2W^X1
MYS:SLN69*RH>/_7GMHG#W_Z6)VD^1FR.)DWSZTT8"9L/SN[<JLT)ZGB'K_R;
M!N/RICQ%S9>KKK#AF!!3R_6LVI?A7ZGWK1CZ!8\A30?K$T LW";T,G4^(R,(
M^7 X"HW#LNAN[-^#X(&E][$?F1]A'29Q^)T=O_5VYXUI2>>^9CMR^=LT#??[
M;$%8 @X[Z2BW;8@NRFDXC=C<T6V'<:+H] Z0)TGTBB#+DD$8,#:%XR4F;ZG5
MXXUF 38,*HJH"L$C^%<L-C'6%85%U2%@Y,8=1AX!]T*D#GLR\ )B;4JFY*RY
MR<HXF@2WF51?P6V\2[!6=PQZH?L].4&<220"3!38T_LN-Y0P(\GE+^MZ8: ^
M^FV3[[23SM*X5F5 4I:F F/U=2-,G-2UB$6*U3]JI1^3.T$M"2WJ=%0, MR;
ML>JBR,= V/!?\ 8V>Y2?D$1*""4\@%IL$A>V0X8DJA?KU,I4HU^^H!+1:ATV
M]U]#:=\:J!'/M<-K)#*IH9Z4FN%OZR(Y3Q.%3:"84:'E+"[FJW)SB>\#,5%
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M+DP'^1B-:PS'R:%MH=OP14@KXN0UQGP<R$@A/BS5$WZ\#!?'\ :4(@8CD(,
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M&)!CYDZC-!D3Z5P026 W:.DER_Q.'*/OZT),T$>&F2WHPFIO;YU04AN^=2^
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M\63Z8YQ>2*$_YCZ;0^;=XR69-LFPNP="*DWS%CFB=JVS/Z+R-'J1(VK4&AF
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M'/9XZSK/YHB-OK[^\+  --0^O7"+69(3M=-5\A,[&'I:*_E.NSOG4J\(U%B
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M 17D@/R*SH!5G]:[1T"@HP9?7LA9^$0"W,4^@F15,B,WL=0=B:JR:8&+J.;
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MM,-DQ-7-/R]N'OIW_]Z)) 1I@HSD7W:FV0+[X<N$PMF']?=A_5T)=._#^F^
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MHAJU>@)DHZ;&":@X1"4F3@X?N<8+V?T8/G;!CGY"C":?PB8X"YQYX#,, J*
M[8A@GS&&4U!#5B(IGYSYU)28(:>;1Z_EAO&"Y!]A5L)!]Q',$@L!=3X:#6TX
MC'N&<^;O^Y=WX3%.K<!;$H4]V53>\)\B%I4UI-TZ;LX7\WX047KK551*@).J
MM9(D8>2"KEC"=J=%V2[<Z36(07]\3D*0XJ:U$WA/B;[P^6$\J*>*%>WQ'P'\
M*%'8:8N&S='"EFSU;)4R#AST+G>Y')HM?:\3T[)HI#ON64O:<^2,S&=Q(M4T
M4Q3#XQT@$" ^IJ7WA[ZCEL. _V]9H70Y@8_Q!(H$+EJ'B+TJM388Q A+\?2N
M># O J;86 P)9=/S'-JG&?VD9GO&7BT,1?"-1T'-9Q;E6K#GY0\V@L4]]C#/
MLNJDAU7>L7E8@[.XG?;MXN[JG[V'JW]>Z-=7O:]7UU</5VL<^Y!:@EPT*K&6
M0Y3H VOBB-FZ[J2T\DIA#SZ%=1Q%.<@*G?(9,9X^?#+L1^;)^)Z2#G'&FA_%
M_V&?6";BX@4>90)&01B]HF#:H=IA^W&C8SIGX-K6&KY:R]FVULDHS97 +,XI
MS^B;</+DGNS@_)!5)T<>_/_MO7MSVTB2+_H_/P7"9_J&?992$WS3O<<1M"1W
MJ\<VM9(\GMD3)S8@LBAAF@38 *A'?_J;60\\BR#>!&3>N'NF39% 56965CY_
M^>$CKP!E^1Y>#*"P2[)30J-OD0,DU<Q>@IM$_$(T%"V4/AP9]LTP[VQB/3*S
M=+.%%\$;YW"LZ8' -DZP=H#U'S5;M]WY47ORD;5%AO_DUVL2108^R1UAN6.>
M9?:BO-N-R?([;UFBV6NQ/T2G;I;,2E 29LOO;/\N5V_-C^22[OW6I/V&=..I
MTLZ-;-@]HY<?*WD4\M'\=MU2I(>1ZM)(4)0PJE$C:DCK1])\3>NY/X!.EY5/
MU.FT1]]]*2IW/%5/#5P@AD$8(UA=)$OX'5(&.GDZKGCMU"?+7(LMN[H]KFVX
MW<TT_[.\VSE.#Y?$E?C1K%G8LE]-VK  >%PD:M0>=[-<J >9Q[K[+EUIMATH
M3_%5PM(8$IY ;:,[VJKQ=VQY@WVG+M&N@&:7QAFCV)FY7IO&C8/^VGZ)ZK5[
MZO[)/XE9FUK0$@)!Q-_->V'C:HT04;R$5'+U[U117;4PL(F0.!5:5)DX4)0(
MK?M D:-^D9&C7ITRSTWO"ZH7/L+4!BWB:/J*%8M^Q>C$^$X)%7*R)E),XK**
MQ+VUF\/,UD]2K**>Q$7TY<EH/3EO" AT+<&&\;\#%91NELP.]9-@#LO?2\))
M$? (PDTJ.BP3*VTWH-?U.7RX)#3 3?//D6X-\B<V3?%T-JT<%(X':]XHNX*\
MB5'Q09&ZK5]%@>@7MW@;3QNQUKJ! O7 VT5,D)1[U^;=T7W2\KI/+.+F7C1_
M<L6-1<8WQL3VQ4AZ-?S-+JW"FUWRN*^)31D[:,L$39FI;1.'QBYC/-[RVV1:
MM6R3H4K9.VFNV9>Q5R:F5::P$NA=J?VL+3%EKRIEC7/W6.,LJW%6CS7.><Y#
M,>^-96USJYXKIV.!]30MM_(Y0)E#DZ8".W%8I)U82<]B1K_NS0>W3[_%[M?I
M]AZ>J?0Z_L)'WFT8:&0$EZ--K8CX=GQ;>8L?\J)8-SER#D\2U;&!XLH63X.[
MCI)X*O>LL"!Z:\T?</8T*W&.=R<#<&F=]/V]KMO%RU@0&D*(@LAVS*S9A@:Z
M6!I;=2V<CL_"818XF(.==F<B0=[B_EJ@^C\K4P5R08LA%[05\DRLN6Y3IX#A
M%O!/N+>8P"_O9D>)X'2ZX*^\PC=>&G,+(;NEM )K\ JHSBG6/^U(NBT1'8)^
M([@[UEX)PD=KPFQ_[1D36N;AN.+UH('[,]?LAQ6Q[99+E37!VC3=7GM^="VL
MS$-YSJ,B-6(EK94SYC"YOJ5?=PGNM]&+17*QM(=-I0?L/W2@YH&44HN5BN-4
M#^77Z?2*><)KXC ="+K3WLX?VM$RQL#[N \371=]&OAZ_)V\E9PNI$#_)HY<
M"43O4+(W+E+VCKU0@5ZHK#<,PE3YH]%W'Y*W5%WN+(; $M[Y:KL0ZIK&7K65
M>UEA),L$2IU@\,EA^*STY@W:$.A\+N+M@DYVL^!&HX/9,!OZE<;7<$H;WE3L
M]K\T;N&LV^REL99 KSU21^W^2 *EB]^U6> W' U.>%]WTE_7#'&'OF[&WT:O
M:KB*Z0837=623!V]JO$'/-A%0U'X;URQK=N( X$%W_%)R^%NCN%<"-S4DVDM
M;&*$&7;Q/(>[G3+,SZA8WI@&B>X#I4]@0G'3PS!12+FV=TT2MPDL""'E&;QX
M9Z1(@QQFNZ)056P&#R@WY7RFNV>/[V'@X3<4Y$:;6\(B[9+6(N[VBK6(STD!
M%G%PBZ>*5]&Q>@GJ2.YGH23N5Y?!O=9/7XICV;*YPY/J7-J>./O=SC1^9BX"
M(6D8,<YI2\L5#=.SI5WQ1<R6--E@QU*HWU;[O79O+$EPAL'L)(?:)4.+@MBX
MF4I?73IA;7M/EHZ-MCR'Z5Y-:7WS6M!,'0_:8YE,A2F6T6\N6$ND\)L'IY)*
MRX"68/$!5Q:^>;QUH:+"LL'<9[\4<"-M]>+2AD'_TFQP0":"")9%VV>L+]U]
M?J0457I@NH/V1)4DZ(3TMV@\P72T%3-68-O,S]E_/>3(3G[<VMCZ:X.NO@-&
M.2S\A'82F+QG_G50 8_I?XY)/3).BNO K=5 <"DW_YLR!SM(&5\3_MR9:3NS
M)?IQY"N!_SK3[(=KOB!W<\-HNO!4LC_1Y\RP !9DL9U3 ]-UN.?PLI)WYB^.
MQB@BW92(?>)F[=V[ZIY&L5#%IJ1-S\4$I2:G0Z\ <W</<\W"4I,B0P/CBL)2
M7B_[2((N(#1OZ]%<P3X4-E86+35P?#'79^/5QZ\?S/)CX!(K0GA!D;B?EBN3
MX:BG4%-I891!B=(2#UPZ 1L.'\]NR^D6](RE_T46]%*AUS4+DE^MP-H+7&G7
M6+5^X<5P>3#].]_XE.T[\!-YB#V)D2S@]\3U "8R!2\$*4$+F8AT"-<?(:Q%
MQ])H<,+T("*5[IAQD24Z)AWP<'%IQ@+LSX4&AO9Z31:ZYA"X(8/1:&ELTF^0
M\;"&_Z,6#15J"Q0H$ IQ=4_MDZGX3&;2A;,TNL6 _A MF4=<&)R*86)GXEIG
M92%BF@E5HNS6\PM9RS6"PLO<7U(RS $[G=,PZIYVHE=^V%?R_N5MBM+>LX=I
M( /+\%C(]F[[@B52#Z:GZ?!;#^A=@?&X@M4Y\3[R<%"-V:-V.VUU(C%[ BQD
MP>J(G(=.C,2GE)'.;P=BSTF_/>@.PC;V:>L"21K]O?) (^PN&BD<)7RO#11@
M<BP0,W><@U\$BM*B#?QX(J!2VEX5'3X!MTJ"+V^)ES_![8L=NDO4"V\'[T1J
M213'!<\Q]:BW\FW0)^$1N\-:+;I*.BSCA<W@H%<4G"Z&BW"J(#5:,FJ 2*&H
MX=-$9:E-UOH)A]+GPZM\:-,6%IINX>$^T 16#<;,0&;B!G\.H@A:':U HQ6$
M7Z64EC#9A^^R9T"2>(4@K5O-JFV 4\\@X%1?QI^60$@P15':-2=&,FCZ[FG4
M.?PI!+?K7MHNG<4]PX@LN2T87HZ?/.QP^8UR6<FGC.X;3!UM%X2GC%K!W%4
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M=XT6WQD7]/V'2]Y] T5&H]-!%-CAIY/X_4Z:N]_QZ3CJ*/T4 .2I")/ZPT7
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M!XDA3S'(.&^5(((:ZW!HB7W0*F(F)+!.\2GN/N)<AK:#AX&:*DP7HUY=>75
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M3R(.=/+L1\TF"T24(H9-/[UXGA/;AA_P;"^;\)NH3&D_8'*,P780$N<QA@]
MXIYD7/+A25R:05HFA4,HT?O56W6&*0U3T G,REN@#/VO=PJ;4>8/5"@6L;<K
M'&^E+,%@#TZM>E\RT_=_L>; O[5:S"'N0IIE7.APQBRLB+ 5;;-9P2LQO>68
M."C/UA>Z9NG$;NPUZ"F.@-((-W&@6CGGE'!T?$R",FM95>ZA57$%]7^%4W*T
M/VSPBNZT N@8$L0L<EAY3 45#@;="1M<[.AKO+;\V@<':[)!FOX>(/C#$WQ#
M,4R'%EO<&_I?9/&ZO< 2%-X,; /+_<BXOW3(.B:4-TP@5)GB=Z^5925HUI0L
MZZL%CJOY$5A6@A)/R;(B8RH'-B9E^=.&&HNID/$OGAU+HS.C->N%LOLK,!]^
M:8$?AA* >71B9VV-.;055*LQ$@726MJ2<FABUVGB0Q9:)V@%R6*65ML7$BJ!
M3=(04EI-K)JF)E;M%%KQ[.%C<2L<1]ICO-S2;?B,%SJ7-R/]H,7(W52$5PNJ
M1A8$A_=-P5%RL$_XLZ[=@2GAZ,3^T0J1"RI5'!9?JA@SWJ%=_Q+&1I2"'LM\
MFR(UQ1Z_M&/!"Z)(-D]HSXZ82>._1A4-]7H-TP^U6DP!D/VCH71B,UBMFG&O
MX[5).1$1IT--JHZS_//,9(V8%+^:YN))7ZW M/"(P?X4$V%.$ W,3I-:$;MW
M<&(/<DY?/V0@B#N4X ZL:/::4AQ]A:U-*M%]I86&W)U]QHU=X]MFRV\VX^9T
M;0)5_^*%!Q0I83=_>S(L\%KHZI,:IHU\$F7:MC+7+.L%V/:D6:\\!Y1'ZWO"
M"C0[\Y$L1NV,)\>,3V4W118&J:/]BJ.&V8)$-K($^C%HGQWBNBC6[K* TS',
M;7?J>R]4:##%4ZG;S5(I4OF=A2 \+/:H8714,^;-[Q^)3P05>E1<\DT%]2JZ
MM?;."V\XEPH]JFFX5.C5]:XFM];N2J==EYFB+1UB*8^O4#U4IQV^DKBI-?V2
M;*37RII"54(L:Q*$-2IK"*UOZ+-6BSFXB@T%SU=>+K2&U*K58HZGH@:D+2:F
M>NXKD;XCSA,AM \(GF[KK)::!L4P1(:6!<%PZ\K4C++/2,IH87.\TW\O[ZSW
M/JI_9$3'7C(D^=18G'&"4[35V?(S4CM)\]ZH$97ZX2"^4+LOK]L4*BX[<*6]
M[$'*2!#K^=',U(@Z:68L,XU7^(,<K(+</U\E'"VS/YZNFCF!*1B4X"(\.H/U
M6DRU9F]4C?;Q@'TECC2P]M;G&NZ-XO:S'-7^CED.J4_JK@=5T!=(<03..9[
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M#OQ9%LD&GFJGC)^[4U_NFV\1$/Z!PMYH&QVS]Q3CAJ/?"&PD]I70J$[,5]"
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MPN;K$:!^"WP -LZ:+@=D9;ZE)=XM'A%ZXN%=16/Q76\_U,%S.1':[P.L'7Y
MV]BQL!O],+0-V$Y7Z-E1S/ 2CT2E<<ZZ8-97HIFS@U]4,W DHAGPW1K%F*=!
M !H1P/$%#DNR8HZ/!1'"23LWKQ:3I(@>;:D&T(.'';]!_X#8]SZ?>[FE-E@X
MI-)&\ D>TV"GV2;>=S5A/:$IY,OE,9U!$YG^F'IX:3C3 90@6.7$U0I\B)?[
MBK= &5V@^.-P!VO+8@8T0>W/TOR,Y,;  <J:^P*QK'V+:8F]O"M1KXR'.6Y:
M+T<64"9B'%]F#8)W3"1!T@[+ENM?ALB6+G^D=GK%4T ,)GR-.K1>$QL&ZK%.
M75*GWNN\ICKUPXX>.!:D'PO2:U.0GAWIJ9J19@$$%NDU+BN-FGJ%L=]E8< ]
M-_BA(H#=]KC;;P\D6+?1W- %^HC1?2H/M('W#M^'$8'5BUN4T.(0&,S[G-HG
M4V'4^(R@7]RJ\;:P"-M\-ADO(W$=5,G+Q;PR&G)X&Q_<V%]FQ;)S[EOX2UA9
M7J3BZ5W(FVCY0AH.83A%VYA5<Y-WI5.*<  Y6-368A.^1 /Z3LJS]D.03'Q<
MR\6M(VO]1#.,+:O1IH8],[\=$VNQ@W\"L=M@1:8HV_'*U%FE7_2=OF2OZ-<4
MU?PM;Y C=8GX*P2/W(!(("6R[V@$C-L4=?[7($F@I^QDB [=TV@0W,5S8/7\
MKK5N\2>[C0W<QZ2"$"V+HF&HEK_C 3]F+)$1F*,%@BN$3?B+4)9:X>EQZN#Y
M?#%?M,DBA/Z9'3L>J&L)\UZA]GT;F^E3C 2N+((Y/.U$@^AU]B8*OR"S8QY5
M,Y5P:D?#GZ(]W9/GEO<W/JG0)AN-S?WDNCV@+R/.L>RA2N"AP5F<M-K;TA\U
M"F'ABVIP6 J*O8)WI;[46;&AYIO:B>]:@\.[11P6#!YINL4AWP0L()]2"*_"
MB;;L_/J^%BQUC"=),#R+)YSF&I@N1I7IE0=B-M5R% ]*(T(YAB;J+00?'G^R
MAY,<59*?X$W47YVZQ29)BB3[[>$@"IFCI!GB/1Q7O^Q>>S")9E1:[K)#T[=K
MHJ=V*:I8VRC.!+(#X)[%Z[SL\%[JJ"*@-TDX+]A$$0XB^]264 I!UT&D<-RJ
MM]7*!Z?#"N\8M(;06[R<E]9C*-].;TZ57Z?3*U9%O2:.:Y#XU6@ 9*?M*HM6
M0&L%]2[5,U%#AJMM7R=CK]U3)W[P3:IIP]I-7@&-1J &]@A;B<;\+?PIFT\O
M5+2+)X4OI(:8:X?Y6@2]2"HEV*GR]AI')+-2-C"**#;*9/[.;PBS4IT@\"B^
M'TMD A4QREO=F*^V"\'H1!5#&U:*'2%9WR,7K.9OXW:W/_"JQ?']/.>\>FEI
MC@NWPK,,[NWBK[4'S>]3_^+>L43SAG@[C2I'GA@>;.<KZ_2-%L:?&JXT>A!?
MT\UF!5))T[.ATGWV5H[V]K=N6YWTW'VV<Y6SBZZ"8*T5+";09:NVU>$D2%G!
M:UFO@6\=85JS\GN;+=>53MUH!2T".A.0#B$GH@:*-C"LHF^(OETR8C#:$:VV
M.UU/?CP:MGR+$DRBA\=B)5Q>2GNCZ0N&N4L;<VMP7TG';%9B9V?'OE+'#;AS
MOK_2.V=/N&!P"!L1;L$8TS;_M=;BU]KACVMEQ[.;';A$G53D!J,AXY=F"L.F
MW8$0OVOCW<Q*CUKR(N5@3ZW/AI 'D!/4D88J;"H,(ZOC07N<H*#65_3I;M=V
M]RN*0%O^JB]IRW.I%:!EU1H-3KM1> VN*:U@J=L= 4&DMEND9:;+0JP]-F-%
M9P <.FO)]%?&=P>TM6;$+-YO$A/55^M( 0808I,67;C$7A.,0.OV.O(0WZ\3
MM7"VDK=P]O(@H'@=551M3(V%6.<GT[KA,#4S"UBLK^,Z.CLQ^MQO>X,[HX0:
M.MO%MFNVY.V:(6,WC5Y( Y8C[RJ(T&LPCB%7"98WC\6U*K.\8^G;ST+>@B4V
M+K;F$T9!P]8^1R$ ]%,WGZ$IE3W=8V6/K+)'/5;V)"ZRB:!,'DMZCB4]-2OI
MZ6;'(>L><<A"O;!ZAEY8)>AA^GU)'S)X]^%=6W2]KEZ$D\7[9+'#U6UP]08P
MNNZGSQX(Q&U2NZB= [FH?7"()C*DEK"+RMH&6(H@F!S8:PB.LX!2NN"-MDV<
MJ3?%X\S_;HI.SD9-QJ188U$J&?+.+CX6#<23BQ1%>7'9?;A6%9 [:7RXD%><
M+*)!7;@SU_6:VH*P9\C4W83K2'K$=_ESK03^W"ZAV^/>I4^L2!;C ST4)SR?
M>W=(TD<=N0P9G[*ZD">GPT%21 _UM%<\ID=6&^2(UQ2R0?Z=W ;!:FD*?TR/
MG.@?P\S1O4%-"6_2'8N.8T(>.=)2.PN&GQ# 2%4"&*GR@'HL] =M5Z,%M7Y0
MHC5#K%A@.9<I0(?;RA?KE#WL-^V/-=SP8CJ'PJ>!L:&U>RR:80Z+QL-!30Q?
MH;;[PUY[*,DXR4$;9 =^SRD[F%NRJSX)CV+ 2?'.\VSI1\*\)K3FA"I9#RI4
M(-!*4D5O% *TWJ!X6UL2YD_.UQ20AMKG=_9"?N?EUS-PO2__<:%<?9Y^=0E=
M&4>EZ?SDVKLXOAY@^J<ZB8&J:T6AZL N,C<.1ZJCV>Y+ R,Q6+_*6C(51&YU
MDV;X#Y$C ^.1^RC[4,IRY 0OUIN5^4((:Q)],C"7I6]P&1<WLRN!GCL5UE<"
M%#.UW>N,VIUN%,5,JKS$?#>*'K]HL98*=Q@=D@T7P[)3E%2Z3<=0&2+/CE6U
M@J0439NVCB\$!]H(+0/.!/X7X9N%_T3KE@)%<1N5@G/SZ=#8Z,%9&VY_4(+M
M#^)*0B@1K'^^1Z,7UX7#H6U>4.'N(8GUDU>B"U7!EWS<%\BLN2;@HXD/+IB)
M'INACU>[&1Y=P'GW:=6^T*J,6"RX>:&\!>TZ^W+Q3KGXY]7%UYN+MO+UXK8P
M'9M/G58A&U%]G4\(]@F<3$:H8W4S?P _!WM,/C&_D+V?O]3^2IQ;-'3\TI'*
MP.=YEKFY6FD;F[Q7Q'\%C/5?E*2T?H/9A!C+GKD#;WC.06YRAS,"0>,<5W+"
M\%WP<:O%+PK?IY<"P3Q1X/?NZV![0 7C_[Q1@TY.Z(FR1-'^E-2_B&8IP;$O
M8@QH>!?2)3,R!Y82I *:M@VA;[=X\N*%4PP=&[+;@J2F(;OM-/B,%*QLWGS
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M 6Q_\.5XNHO4O2F8,^SO-[F/S"E2]:9@3K>7OGJD8,V;N:Q()%O?LHJB=QY
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MT@\^'(02^LCS)/& _*Q1$AO'IX^:OJ*6F>D#?N6$IQ9<HEATM[,_4;R/1^E
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MN&''1[_)\YNZB?VF&2AGU.;=H5^=,\L9+\@K(+9RQFQ)A=9.TO'/C@DJ8,X
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MRTBPQ(&#X 760U'KF[E^ V;AG%4!\AJA[W FMO1$NMOV:H:PD'#-"D=-C-O
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MFU_IAW2Z-+,8U.=X.@-2Y?[%-[=%HMZCY3O^=02J=^#Z M>(OMM?F1!<@A
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MN38>#_)T>\?);_\'"AOVMW3[GVI_9_\ 4$L#!!0    ( +E#BE8GF[8_=@,
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M#69-(6*<B56Y)*/LM2M$2CC,:2*5 10<215#LUX90215)I*@'S($BNI#&-"
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MP_>.,,$<W!?^TH% *X;Y!:F/4V3WCV/T_R[!JM^;XP-4OU._ %!+ P04
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MTG)?@XU6?_[W?F5B]%!;P\ %/Y52F&9.G"\TB(Q(!D<4FM&"L3O2_R33A;7
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MUQ?V<G1P;T2@]Z;+0?(,O^MST/ZJB]JK?W=W'O2L^=[.WLZ@Y7:](=R<DXM
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MH);-C42!.]A-LF%%^*N5V^SM/MYY,%"0'^[OW&$YOK;(LH .# D>LN LB38
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MW$!^_-YF)*L<5 4_6P4I2/0$>0Y#F^(1B%X1+^,$#D>*;Q?P)B G!(; @[$
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MRYZY^8OB.8)BTRI/QTHI11PPVDCX)3(:X89.R)39MMB25,E::.]07NC'@8G
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M:^B2@2X]^4:A2X,EZ0L_R47V'+\-?CL^?7MT<A+\]O/1AZ-W/[$"\X+CR'3
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M/#RA>.*@5$[+.RL6VC09T.D<=&/$.G/H?T"\6LYCMUS]K-[J*7R^T"7(4_"
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MND"O7GSWBON$ OCK8U4(]=:M=UQ&I1<_F\/=,4!EH-\%GY U6UX!NZ4$WHQ
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M>X^5"L&[*8A-V/(2[/AH>MYT8$;\R99?C+2PT%1T!W=ND?>1OJ+,&#R3[]L
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M$+@9 S0/#L*6!W_LL,XKG0@(<*/]!#$ &UIT8-]PNLMJ(_=0.H\_"'M R,S
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MY(1#TWC:-G@# UC9<+!:P'<:%LS+] '+QYDZN=":L';Q@2A?20P0U4R!6L
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M?<S%Y"7Q]U\5OMIUVTU._L?W+3U/E<Y_%+Z[>O%1W>R3]9UW#L^[S[7Q_TT
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M/.X^3, L!K-7P'F-<'"P^)SQ.<I> I5B1(>""423%2LL:>4Q3,/.X<3AUG+
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M[FV4)S/9H+];@I#C0[__!M),"G\GO Y$P&;;:W1H_0S('D=<=$']@:)*@TW
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M,.%N>^4E%*SJM@:PR3W9+Q%#,+'QC0I 1K?JM)%$ #<>E%8=NE]F;I7&>A'
M+60ZO 4+=B<=8^JZ &"\F^(?$$M<:"KG?:K#;W?.#7!]N%MU,N9U0]F)!C"4
M_:%O:3.HKYE ^6L0"+:THT*(.?Y))+P)O1&8$Q0O<[+&\^E_W%)VB^(%Q BR
MTP=SB=XY7YPLD--V5S_+&J3>/6[&+K;<,8%>8 ?U2CX/</G$$2I7NF.74N:
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M&0/5 C    8.QND/\/,' Q,+&P<7#_\<P7F0H.P2@(F!A86)C86#@XT-MGJ
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MZI0>]I#KM)D'WF_>,Q@GCL.!F)(%=YTR-GJ%2-N.87!CCV7 "I2 2NQ*/\O
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M*\.#_^\$-FUXU]<H5]$]&-.YQQ4NET)#0\[1:OB8. <C);O4D'5,**!705_
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M9KVHS59U\$4>3FDJX_,*5NP \8#O>-F">-ZO9$S>D;WB$B\7_SB[=K7">J'
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MW93>H(!9O0'(2I\2 GOHG;,F4FJ<%5D?5I?UY_C2U0698$<!^BJC+Y&$**#
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MV:, \"]]%J,8Y)0#!M<_=&Q/R5Z2%R-:1S]\NH!< "=X\;>9G,Z9.$O.\7[
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M@<X^'8"NK!LB\ >M/.A$6.@^<34]JW9A;$N\EANNUV,_+((SK2_? AEA&+E
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M%(/< ^=]N6WMLFE;1.#<CZ>MYVR6>W+E"WB*GU5QV?&_*ZX?\^0697"?/T&
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M)P\WCP0OKX21HHRB$<G@_P$&00X&>09U9D8E!B9!1F9!QO]'@'P&1E9&,&"
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ML[S@7D"^*8Z3%N_))QG5-%@9[THX3/J:^<A&]-4O#>7?(6:V0L6]H@[F4-+
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M*^#-,'.*,!(9MBL_V#M83Q,SL%Q\6!_;I=2+FD 9@ZW.M6W(&J]-/\9!!==
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M>IZRBDW1UHJB@LN\4VM)Z:'AOHS)L-U-J P'20\);;RZ! 4MQ%^A!2HB&W&
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M18U ZCJO&.GJ\:DMJ\14=LLU%UZ2(LG)W 4,;!F<4?W\J:XV%I"BE'EF5]$
M'M1]+7*R?UDOS\Y!%52&5.PG*+ D;\HFYN+2WSG^L7]!LU\S69/J#14KL>PP
M0:6=]>]97Z@KL*V]E[N^8Y^+-%;N];^=Y?ADL+=[81A53"&O,>O&K/;"H)T#
MJ9*X9@J:<D$KKED,G<-^=_QD( ^V&4AILM(P/Z430?:I<2PGK/Y9E]Z!1B1'
M]RD)SH#)O=?T&Z$C.[O>C'3R3#>?<U]\DZE,I%',>@7VXB[B4)#@=SCJ]IP+
M>0#%='_OH%%R_.:UPP:W>F&>J[EJ2 LE\V1_T7Z#1PBW/F$C^56FY]&XU'<
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M?\V4C<BWW[2RG:29U='5<3GCPC+F^+B[[V \5A9V31[<(YK(P.L+ @O&*OJ
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M8BR&EQ4]'F3L<)]84[Y8H,G<<J6T-VHB+ ,2V8]1(\O6:XBUE(W7R30!<!3
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M)[1W-?6;J#">4WG$,T]^13S0D)I7A)C!V&P-_4JL+9;[NIFTILNS93GG4U^
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M^UX;]&85-?KE8J$!#/^I&BVB.HO)@+]\+\NX#7\P2C0K57B.) /W_L96%E%
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MZD+SI1P['56G Z%&*"\63PWN/Z*"%GY%I."SOSVV("J(535/,=F 3S$"7N%
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M2N_)((T5*+,6>&A8OUYEP@8F% PBB=FKGF2GY9I<W#T;E5U0KXF%PT55$MP
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MWR(U:E_#$P4O"H/N9L\PH[['?HWO+9]HK'.?W\@G>6D#2P9YY#X_?0!8JIU
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MROV]L*<B#2I1O>F>BE'^$Z XXGOAT^+=!LQ$9]5\B:ZB^UC7C8CQXZR$)%$
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M#H%^K*J)3GH_N6;#43>Y%2)^#"]=ZWQ:=YX>FD&?F9'JUQ.-K]LQNQU %?X
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MDSI>N\ZS&"NPF6\AN74[3KR+\!N@F37X@T#.RXA-E3_X[9Z^AF) ^M7VZ?M
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M125=RL_#C[X@9NC 8=1[%GF.Y=!8MO3@&$F@;5!/\UFQ-I;Z?&+*9T(UH!H
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MH?3)Z#TJB+'IF<'%<OX@7[+J^GWPX);:Q'UKHX)4N;>*=0=LB!QGK@UA>+5
MTR)\<K**X,PC?#M]K/[F=6$?[Y+O=&Z3Z=^:3('6HX&+V\1)ZH#^E+*<6\A]
M%)_2NWFO#F\KG/;6Q@^'\7FN:A>-SM;8I]*Z3>D*EG8*OJ37/>#U'V"=\<M*
M<UF^-+F]LKNV>*4_9Y%(*$9 85Q8!6PZEWN_O9T8Q_O6NUE^!N7NO $I:+N/
M3>>@K$EFDG??*Y9O4USB:_<#&Z.-A[#%3IX@4_?MR/\ =-=#;9Q-LV<TE9Z:
MU9M]XNGU%9>K^)! HAMD9Y)/N*HY;_ 4DB35U+5[;38F:1UW*.F>E8J3S:GM
MF;=@\C=V%5+72Y;DK/J;[R&W+&/NK72-IJP:+<ZA>7D>FVL:'9-(N>>V%[U2
M70I(;INE/.&DRL-O&-TMQ)PJBL/4/$5QKMT/#G@R.01.=L]Z.&E'?G^%?>N3
MT.'Q7XONIM%BU>[O-.,FX^8-B*G]YL?RKW?POX6T_P +::+:T0-*P_>SD?,Y
M_P /:M%&Q16\(>#;+PM9# $M\X_>SD?H/:NFP#7)Z]X\TO09IEF626*W*K<2
M1$$(QZ*/5N^!71:=J-KJNG07]E*)+>9=R,.XJAE+Q';?:=$G&,E/G'X4S2+P
M2:#!.QR57:?J.*T[E0]E<*1UC;^5<OX<W7&G+;9P%E)->?)<N-5OM1?X'6M<
M,_)_F;MC&=K7#_><_I61K7^F>(=/L3RH.XC]?Z5T84*@4#@5SBCS/'7/\$?]
M*,?K",>\D/"Z2E+LFSI1C.5Z=*YOQOI-QK>E6L%M L[1W*R,A(' !KI%4*,"
MG!1CI7>U=69RQERM-'E-EX6\2IXFL[V[M&>WA.0!*#M]@*CN?"OB#^T9[M=-
M8KY6Q!Y@!SDFO6BM %9>PCR\IO\ 69\RD^AYAX>\+ZTM^)[RS,0B&Y=S Y:M
M#5_#_B&^FD6."!HVX!9P,CWKO]H'05#<30VMN]Q<RI%$@RSN< "E2H1IPY(C
MQ&*G7J>TD>91^"=4TI?MLEH-2O%Y@MD8+&C>ISUQ7'3Z3J/APWVJZM;1QWMQ
M()+D+,K-R>!@&NV\8?$]M.NK>W\/FUO,IYCS%MP'^S]:\;N[F75KF:YN&S<R
M.78DG[W<?2G5H1J1Y6]!4,3*A+GBDWTOT.DEU&&ZT=E>>-8Y)07WMABV>F/2
MNQU6TNO$W@RRCTU(W@CE+L_G(H# \<DUY& )TZ8E7I_A0]PX@V;Y%YY16(4_
M441H1BN5;!+$SE)3>Z/?/!NBZGIVHM-=6VR(P;=ZRAAGTX-=TB JRGHPQ7D'
MP/U=I#J^DRR,Y&VX3<2< \$5['&M7&"2Y3*=1S?,]SEO#>;?4=1L#T1MRBNB
MR0:YRV/E^-;M1QN0G]*Z/^*N/+]*+CV;7XF^+UGS=TG^ IPW44QHC_#^5.%+
M7HG&1;3Z45+S12&.;[Y^M(>!2%P9&'O2TQ"=ZYX,(_&RD_QIQ^5="PXKG-<'
MV36;"]Z*&VL:\W'Z0C/^62?Z'9A=92CW3.J!'-4]3U*STFS>\O[E+>W099W.
M*L?*XR.AY%>/?&:_E74=.L)U*VOEF13V9O\ ZU>@CD-B\^-/AV.UF>UCN9YP
M<1QLFT/[Y["L)?CH3;.LNBA)S]UTDRH_"O-&M[64?(!GV-5I-,!^Y(0?]H4P
M-WQ#XM7Q!*3/<2L6ZF3@?@.PK,L_#-G<H'34U>21@L<,9&2QZ#%93V+QR 2$
M%?:G06ZPSK)&&,NX;-O4?3WH [;_ (1O[#;/H^FQI=ZW,-LDIY2WSVSW;^5=
MIX2^'MKX*A_MOQ%/'>74>/L\,:Y <]!@]6K.T;QGX<\&:G;:9>02->3(&GGZ
MB%CS@^_K7=:E+I'C_0Y[#1]95;U%+Q/$V&C;&,_3M0!Y-X\\8W.IZE+;1R;I
MS^[E*'(A7_GDGO\ WC^%=O\ "OP-_9MJNM:C'_I$@S#&1]P>M5/ WPCDL+\7
MNO-$[PG]W;JVX$^IKUM I^5&7"\87M2&2*.#]:E%1J.,4%U1&8\!1DT;(1S,
M&)/&]RP_@CY_*N@[USGAT-/?W]\W1WVJ?:NB]Z\_+_X3G_,V_P 3KQ>E11[)
M&/XJ7=H9/]V0&M6Q</IULPZ&-?Y55UBW%SI%Q$/O;=P^HJ/PU<>?HL0/WHB4
M-"?+CG_>C^3#?#+R?YG/>/?'^D>#47SDFN;]EREM$.H]6/:N:\._%O3O%&H1
M:>FBW_VJ7^!8Q(J^Y/85VWBCP39^)YTN7G>"=$V;@H((]Q7"W/PJUS39VN-(
MNH3)C[T3&)R/2O0.2[3.^N?#]G,#]HTN!QW_ '8K&NO!'A^;)-@8C_L,17&O
MJGQ&\.'$K7;QK_SVB$J_F*LVOQCU*$B/4](MY\=3&Q1OR-2XQ>Z+522ZGHNE
MZ9!:VJ6]G$L$"#D]!]2?6N"\<?$I+9GT/PPYDN&/ES72#//3:GJ?>L#Q=\3-
M2\3>5H>A64UHDP 9%YDE)[#'05V_P]^&</AR--4U55GU1QD(>5@^GJ?>J2TT
M(E)R(/A_\.39+'J^O)OO&^>.!N=A/=O5J],. ,D@ <_2@DYK@/&OB:)XKJS6
MY:#3+4?\3&[C/S,>T$?JQ[^@H!'.>-OB'87=_+IZ>9+86PW*BCY;R8'A2?[@
M/)]<5S_@+0+KQCXL?4M1)D@A<2SN1PS=E'M[>U<W++>^+]?ABM[98WEQ#:VT
M8^6"+L/RY)]:^CO"WAV#PSH-OI]N,LHS*_=V/4T#-@!57:HP , 5S_B]A_9T
M,?\ ?E%=#M!)%<QK[?:]:L+)?X6#,*X,PE:@X][+[SIPB_>I]M3>@&V"('L@
M'Z42#,$@]5/\J?THKMY?<Y?*QS7UN87A!O\ 09XSU64YJQXFL8[W2&+R11>2
M=^^5MJ@=\FJ6A_Z)KM_9G@2?,O\ .G>.O##^+/#,FG0LJR%PP#,0K8['%<.7
MN]!1[77W,Z<7_%;[ZGEP\4>&I;F2!-5MF=6*DYP#]#Z5J1PQ2PK-'EHF&5=>
M5(]C7$ZA\(M7TJ99QHQF6,[AY1\Q3CU'I71VOQ4UW18DLM0\/VCP1@*L?E&'
M:/8=*[7$XS0,*_PO5JTME9D;;OEZ+@<_2H8/B=X.U# U/1;FS8]7C7</TJY=
M_$'P5X<TR74-(F-]>OQ% V<J??/04N4=D:UX^E^$=,_M?Q%( ?\ EC:J<LY]
M,=Z\[@?Q%\7O$&<?9]*MVX _U<*_^S-5+0O#OB/XN>(&U;5II(M.1OFEZ#']
MR,?UKZ#T?2+'0M.BT_3[=8+:(84 =?<^IJTK 0Z!H&G^'-,6QL(MJKRSG[TA
M]2:P?&WC*WT0Q:3#>0P:A= YD<_+;Q]W/OZ#UK6\1Z]_9$45O:()]3N<BWA)
MX'J[>BCJ37SYXMU.UU&_-M WVKRI"UQ?$9:ZF/7'H@Z 4RB5OM'C+Q!::5IJ
M.MH'(A5CECD_-*_^T>OZ5]&Z/ID&C:3;:=;C$<"!1[GN:XKX6^#CH>E'5+R+
M%_=J" >L:=A]37H@Z4"*]RX2RN&/:-OY5A^$H@NE/,>KR&K?B.Y$&BS\X=_D
M'XTNCVYMM'MXB,$IN/U->=)\V-5OLQ?XG8O=PS\W^1H9KG5_=^.1G_EI'_3_
M .M6^>E<]KA-EKFG7_\ #G:Q_P _6JQ^E.,_Y9(6%UG*/=-'4 <5(OW:C!4K
MD=^:56XQ[UW[G(/)QS3!R:CFFCA1Y99%2-!EF8\ 5YUKWQ;T2"&\LM.:>2\*
M%+>55^0MZ@^U,#M=>UNVT#2;N_E=7^SKDQ!QN8]A7A7BCXB:IXFMUTV[MH8;
M8R>8IC)RP]#]*Y;4)[B25;N>XFE9V_>L[D[L]S3;@%[<.OWXSN']: &.H@N
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MHL8O-?FN&^[ ./Y5UR#:.*YGPC&#;W,IZO)C-=!/<):P232MMCC4LQQT%<&
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M [#UK*TRS,%N(R,NWS,:\VL_;XB-);1U?Z([*:]E2E4>[T7ZLT;:/<^3T%:
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MQ19 3'Q5IZ736\B3QNK"/)0$%CC@8],BK%]KME87EQ:RM)YMO;FY<*F1M'4
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M]V885B.V/:FVS>,GM1-)E9HSA8F5<2#)Y8_3%19\50.#;073F6Y5W>?;]W:
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MOOC>;U:M$"^O4V!1,F9^'*[6%&;II"G>!G@E9!5B;$\5-S_UL8<.W8F5)R:
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M;(,II?.WK=;#P\-KEY4AKH\A01%V(>$/P/8V:S!M<H A;_ MN$ AZ,\Q:.^
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M.6K9B%42JY^+\&KD62ADUMZ2RRH3 ]8(SS><TVQDI@D.JW2FKDRISI3<68H
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M'5D&]\0OCU:62%J!BZ*WZK6R% BF:XB!U<J(8-E&7@9522?0?7V+[EO$=ZN
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M=!W-YX'_-.0_T[JI FM,P"C>UVNQLTB-MWJ27&)^6[=E*D%J6-2U-2W: 57
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M\JC@?"$@+43'=M[A# Z5U^0FXNWX)E(*@;H<'H7NH.:_ID#J"C<* DNU"8X
MV>E(*DIP+C\_*RE="T[NX(6NI1O-$,A792_#1.K2>+Q)H\)@R',5[,O$/%[
M5QC:^.3I$OA>7>GA!J9[M^Q+A*Q>K-?%G$^*+FDGBDB+Z*S I%64YH0!YW;=
MKL\9X);VPT($1EZIJGAP&8"WT\7'\.^[HC:#@(/U/OG=10"WY)J29+QM#:OS
M$AE96J+F0$A$;YW"X)<W.V' ^<T.P1J$.KW@!-EG =Q(N(057P+8EI8[Q1"]
M<05VK"0C2Y:+TN;F\Z],WC=@=*VA@;3.: 0)[W.)#,;C;N.:(@>3"<)5>P+
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M*6U2UG?SVJG,F0,U;*6A-DVQ_J8^?^N#;5MK+&E%^*J=K.U,*G,^G!67-MZ
M$S!7B58U6085Q5Y;E?/83TD>F&5)"TDYK/)N+$XQ=BHER"9[2+]VT;8H3Z-&
MVG9"<\L(X%Y):T$;;5[<L^#[^2A+.10@/6#+.I&=EC6ET&W[VSA4YJC^N(A)
M W=M'E8G:&^'54-JCM(28Z<0]3NAV4^Y,$Z*M.SM%29!N6"NBM3?8/K+-:M8
MA9VV/\JTW34 ,C^P],!5Z>*JG_ T["VL%F/(^&Q.NXH[==N-5VM1U\63CI/M
M;1C3:SGQK6&9XVL#_E,6!K3<!L:+2-OR3M*E/A]KPQA?E=ZOTR/#LGRY_AD%
M=^@2X3^1YD1E'4KKAHDBT3GM45T\Y9UA#2MJ-2ULR/V?$JZ?%B Z;"@0G-W-
M3 5$H,:O]#"]'5:5KWHH%ODF2<//**"/&/0X+ATWI/I7UK.UKCVL2JJ?$$=K
MY> 9U'_I?6+;U>9T*K-;<VX%;[G#+86B:K.;\<H*<$PUQF=S.@:X4P?I0UO5
MO*3/;9S4:B[,K"_G\L8DFKR\D^PT,ZDAM5RW/[RT;@0K$)R=DE,!4:&)[)YK
MM9+J+&3V5!E7/7 G9L^)QAPA*-S':B.9:1?1V.K9<_)1]IX]IP5_HV\4X'"5
M/5??)SN%N0#BGWE4G.?,*2]4UAU\A!E,!A:+'/ECBF!RYN3TG"?.25:M3%@#
M]!R)S7J0M)K@',9+VQ0;: I=UT#L/*9F1T_=?P%0E!J$P7R7@)I3!U>I<*<*
M%D1Y,@@XUY;ZJYDG,]!,DC$AZQJ2(QV'*M&V;""323B\[D\-?FEZ3S%9SJ*L
MP'7>H244*ZQ9!4'!6HI"HJ Z\  3B&T*#,1&S-+\MU68DQ"\\S@([\.@\")5
M'8@_[L@(_ZV5#W_<>=V2!?A(0\0GRX&D"= E0<[03;A;):=Q'NK8>KH2DE!T
MH_VD:Y0K*!F 5BT_ P[4U"& $)TH12@Y0EJ)-R@-26F[EI?HZ7R[Q5HZ#;V(
M<:]GIA%.?T0V9<-=.J*RHZ_W_&L,MUUCIHPTVWJ?D]A/MAJ9H<-OG!9PY/L'
MVFBZX1PA^H&^1T%X5^@DV/:_<)N^K(#B8()6G3TE@?1G[],63SD.+LX7.D"R
M/CR812G,L1=,7+&OLVXB2(JJSM$7>:"!,?-#)QA/L"([22 L&(#Z$#$"0&]R
MM.LH^+(*1EU'^;PY0\"Z=%AAR6&HCO:CKEU9@+UB7'1J/5L6>6]H9U'4QH+K
M(Z.0'&Z&?Q+?U?7.;>/?'7J&^/>04>G<:)HZSFZT0PLW!0[:%HT(ST]V.JA"
M98.?$*A0<(1B_(><Q+*>%20^"U"B4H*N8NHF"%(.HC0YW*@J5GR/5\QP]5B6
M&(?(_/8;#RUI7K?AWCHCH* +DFN"+QL!VGKII^Q=FF36"]WP"3F*)C:6D0@S
M>2\FXTT4XW]^NDQB'Z2]!HO"[)0<$R:0CDWT7.RF^IR7!*N45T+?RS;+E%SC
M0R^J_@Y7 V,Z/^XRC:<9)].$($\Q-UD=M'O5^S!.TLY]$*2QUYC(_,X\'EHJ
MF>&FZK0D4C48HPPT39.:;N>V!:9*=89J5Q%.A3QTLZLW9KQ,F27OT[0@W,TN
M15ZPC.M.8\2,ZI8CL'Y%-V!A?EO5#&FXK/2F/6G9FG19Y%GNQ0&FO8PIKS>D
M2B#&];/UW'0MTK/;TGK RI/4S8PLXJ%'<9!U*CC;MIM8).9H"C&A4L@^GYCE
MV,GL [N:R*C-[?XH14\AS=KXMH]M96P*MRZ];/D0HV !UG%9B>3<)*B&HTHJ
MMWGYJHK=\LVI/&GK,H] U<>4R<Y0?ZI#*L\;-VW>4)=@K:H]ED4=FGJLMNMN
MR.G-\9%6 45YYKB-YZ=RN2Q\/Z5%.LL+$O#+$YOF_&X9BEC6@I36!]QC%8"5
M]XBR)#XG(6.HD_UOYJ4@@^ 1^4V&K7DF^)3,^S>MU\@O.RA6HY.;8;^(^_&&
MU*$YCT]C3 H%U>]8GMT$1MQ&UBDL@%[ITPF  \4OL5DJ:]@5Y#*YJ^K7V?:U
M:1!VV</(BH39<,H#C0S?XA'QL&/290%/PGOUL\K]=XU(VP:4+>* JFPORLZW
M.VP6$V5^D>"O['=JML*4T[!/S95@2PXJT5![/D*IM5!%6+8GJ':X*F.8D=$A
M#%L5#F#@L^0-JEXBA_LQE'N1719'!=DF7)8_X<E%<+[6>M 4IUK^GVR)3BSQ
M )A.^[7&P]<:#U]K/&@Y$JN6IL>1EV6 S>.Y=.!L+OO*3H 66%1_EQ2(>F,0
M<*[>I,NRY_%C(&0[_XE/R[I"X\C#H4*;* TU_66DO63=YVUI+RZ=66DO/EJJ
MET!]"2DW#09H!<8AZ+9"C73-\EI_\>!3475 LK.N^Q2EYU8;VA6@HG4WX;"J
MNL LTVM2VAU /?+IS$D]"M!2R5BS)R%(*X])"<[_K:01I<M4*B4-56A92E#6
M'U].3G6?+5$I*3W=TD*THX6ERESM6$"12?;TUV#J*CF89M"JU^U1 7</E4ND
M-;-&*Z:')U!EA\'X5BI<#1%U5+M*!4_K6W]T2RVCMTAWG"0F<7F0[BPF+2@)
M #JTV)BI](HV"@KH4P,Q>-@TH.),];Q:HA7:>^UGXP3BJF?2LF[><*5R& ZN
M28*!]--W@OI!RN>-QW<9%*-P+>J'?([ 47UJW/O4A*IOZJ2,8@ROEB KJAW7
M(=KJ[L=>-F,+"0CDRWN4+J(HH54>RKY[("+@TW$:Z&0F% %HJH\+KO08X^UN
MLOK2OG*\]Q[#;<&LU&ETY>B/YZR8'^-F6E\Z!C.V_21(2>")6@6U-]Y!@MJ?
M,92]\][[G18#Z"0.@*A(/IV#*0'*5QP"D*R>6V4=W+L441OY!&5^&N[&)4QX
M!7]9'[I+$-.*761/VGJL!Z5%ZIB@8!$'G53K+K.:[7$UAG.6'Z0E"QU\Y._9
M^N*A=;G*9'@U 70_F G$O3G*7[V,W'0T':\4IFVO7'?H@T><#8AU]WU9)+JJ
MK=,Y*316,O_KF:AQP?157)Q&Z[Q*5KSRGO!\(IH5>%RF]V,5!E8I096JJW(D
MNIM#&45Y>42CZC+>4YG:O]Y#)1()L</?:ZJH62Z1V%@'I K<<EVF[9/"4\IV
MTNC#P\=:,&EIN4-3E49Y._+P6,1_B>*L+(%.SZ]%D6^PCOV,@@\Q)D\E77II
M2*79[/016V=AAJ[2T$?T>GE9$ 26Z^I?R M5^?O6W^KVQ+7#8@E&)L<^!"DM
MKFB\#&\M<3_F^B,BKPWXIG&/4GR9N$8$>WS7($FV)!FS\"*RS]Y +-,#F-7A
MJ[Y#0TRM3.74NQ)E]8J45<0_ [PX]>G,;#6PL5(H.FDQ,+"WMII_S*I_S:Q7
M\3'B84:'E2'("B4GS>I-)CY"07:&)]2:7S5]VS<",;'Y;$X9:@KE(R?="8Z2
MN,A*#:%Y*>A^Z:A(G>&5H#=GA3J0!B\"=RFZ\W)4T]0 F/?M#/22>.[6*S=2
M<K2W0+V)E #N?S$76 ?S!*N?R#Q3.N\*^SBCN^1FXZR6 R>OCC@Q%PW4$.:1
MF8N_E(^3O.BAT:-82/HJ]*RQT\==.!0,]XF,^_DLSEK![!5*$QH7?BTOJ#VR
MD 5?1>1FH[CDP-5OQG9C_7ATZYJ6>Q)80V[V FN!JP5FL8OP(@@H(%Y4G7#*
MSPCL+^>@Q3ASKM&U&4-QC>Y17*!,,Y2%\=E<#%K6C&MDK3? ;"J/+X+?B[*'
M')AK0DQK+N:2!+%:4K:Z)[#W6Z8=42<<X="Q5P&A!MY^6$;K'RGK-L1!S<!9
MDMZ@]!X?,=DRQ?><<%@E<GI*A!;M^7CW-#&MA6O]5D_KH':Z<1\G<18&54%<
MFF10ED>U'7.C2G8^$E5'LA:F*)A#7T?6]%"PR'K]_93T(__KPY> ;/HUWG9[
M%W3"<P#C,WE49F#,28&JY2*^[^^[B#*^+&&3)KQ'Y-5[8C."MBSU<MU]<*]R
M%>CZ;)_DZQ@PH'X%$YDQ+V>_W47)$T+E[?0A1FFV"7<$W=.;Y54="D/RU'S"
M!^M%9'H.M1$/;AL9V%D\O11L,TFH9=;M<9]V4GU"E'7VJ,GUFC'42)U)KMK"
M(0R/<^:HZE7/!9\#.5C89<_5\.W<_?FSGESZW-1&_EK^7%I 1;Y:X0J@?RV!
M_K4$^M<2Z'LI@4ZRF5=A3MY+S^. )"H47F2I?!Q[7, M8U.S"8#9BPP^AOF&
M<DI6#+;I5LDIOL/H:#9=Z4@HNBD8+%V?7%G) +2JYPPXL%+RSD2(S@KC0<@1
M0B?RLB59M1?4DT4/OZ*";-X ]5B.$B\-2(9<BGS\&]GQAC3F\C0J 4DVB(2
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MM: $$J@+OST5>WVRW-$KKR"Z7T3K>(LOR;@CBUQ$86P'O5;V B8D&"A;YCA
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MUEH:Q.HA?<33N)FT_KQ!/$N^,NE7A68K=#K_L+BZ6EQ]0,L+M/IQCGZ>SVY
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M]ML[G P"1F<PQW!HTU>7'*?M$&\(N6W()-"L*=Z:E+6DBR-KE%UYVV$&I'!
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MLP^=M&DI>]?B%:QU*=;V+*SB:2[)7\+KAS@:PTG9&<SQ)M^F+PN#H\T0:W<
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M+ZDJ!W!I_&JYD25*6LQ.%Y>+U6)^BV97YVC^MT^+U<\@7GQCB91@T,ZW[P.
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M739D%<=H$T3/+N!QG1+!M$(J1-,:$-_.WZ9-A87FZ "'W!8+TOBR_&WC(>!
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MP:/'DG*)XR( =LS^$*AOE#V7RC:_RS.]?]T'Z0,U''DII&)@HOF6FY7W/#)
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M#:4UW1!%_=SZMP4<R,29MV01PD5;N,U)L>25>"63L[>2IR^L**NFZ/:X;EQ
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M$QD;TJ"2O#G"17OT#][CGY#78SI1E,I$.5][G7&Q3Z(@VR>T:MU%\$S_E8K
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M5A)OY!OHO2JVQV%6V^L6A^1O][/(_^@EOV)JR,R?Z5<QMG&AH^9:%VOX4;R
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M81QBET,\0F^G>\WH?<QXBPH8YKC&F6_* ;A\\HT6SSB^_:8*CG!6/Y:/O"I
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M%E-@LECU[L*[T6J8^% <CMN[]QS>J!'5!2]9?=>A?A<;E>XO_BX=E:- ZHJ
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ME81^?*K7O:;Z=/4E9+<NF#?A8R7$CNMF&^6=N%J7J4\!CN75]M_XYI9+ $R
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M '_BF^6C>#_=<A59KC,%'(BOKJB>3_:&'-/TW,A\B]S")&8LK.*#2<_SF=+
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M&GXXX6%Z9D.*:ESQ?&('SV0Q$4,)BK$48G<>9P]YD^UT5NP5;_:5."?U3[W
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ME?[7FJ^VIW63WV>-/]=(M)+N-M/N@*M"]QG"I(^QW%EO)H$#J(EL,[]?"0[
M]Q5ZD'5L&)ZD?[U/N]Q_)+T_G381FC5WI^(\D]Y&.,805BKV^8A/&E,V+4!G
M-+]^)W:\M"A?7EAL\[@9R!,3[K$&'4P >-@H%",*TETV\(!+L%?'#7Y9E6>
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M4\G(+G';56/GGVX,X6ZR>?HR:OWAXP<@QB*QIPY''T"L6MX)\& SX&; M I
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MUU06<NX;!HK7QFV5.8_2ST%-9^W*RD8INU\#W\4U,K4L.92.X2[AR)Q+^?>
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M_E!F]_Y\X6?TH:>G&<0UKBD#4SD%]4B]=>EK##%JB]@OY];>7ON';_4M9/=
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M:8".\\1-9PUC#CZG;5X#;[ * X!FO_).2LYYC+.(>BH/>Z[V RU./BL#8B
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M%YS=;<B)X*:M](M+VB*IA=%L;RWD#3U&G QVXYU'#,:\2,>-@A](<-=X#WB
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M'Z84+G3LLCXT]E;4#WXC_MA !/M=9,%N%!1QTWV0I5F*R87DAHGBNX>&4M7
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MK>@U?FY;LMF.B'W;\WKPYO2WG&;/ER2[CP.>M)=FDOYDP#$S%4UL$SI.VNH
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MR\QV.GL%KDMU*F>WWB6E#2%< 3VK0AW><_%T>7V >@T#Q":^5G4A0RJB5Q4
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M6R?J[Z\Y%[=>2OC?_C]02P$"% ,4    " "Y0XI6('&(:1J; P A.QP &
M            @ $     9C(P9C(P,C)?:F5F9G-B<F%N9',N:'1M4$L! A0#
M%     @ N4.*5EW6""G"!@  J2P  !X              ( !4)L# &8R,&8R
M,#(R97@Q,BTQ7VIE9F9S8G)A;F1S+FAT;5!+ 0(4 Q0    ( +E#BE8/J%,Q
M\P8  +\M   >              "  4ZB P!F,C!F,C R,F5X,3(M,E]J969F
M<V)R86YD<RYH=&U02P$"% ,4    " "Y0XI6_EW.ZX$#  #5#@  '@
M        @ %]J0, 9C(P9C(P,C)E>#$S+3%?:F5F9G-B<F%N9',N:'1M4$L!
M A0#%     @ N4.*5B>;MC]V P  Q X  !X              ( !.JT# &8R
M,&8R,#(R97@Q,RTR7VIE9F9S8G)A;F1S+FAT;5!+ 0(4 Q0    ( +E#BE:3
MRKV=&0(  *X&   >              "  >RP P!F,C!F,C R,F5X,34M,5]J
M969F<V)R86YD<RYH=&U02P$"% ,4    " "Y0XI6P%\?-\PU  "5'@$ '0
M            @ %!LP, 9C(P9C(P,C)E>#(M-5]J969F<V)R86YD<RYH=&U0
M2P$"% ,4    " "Y0XI6D]4K-8XY  #_<@$ '@              @ %(Z0,
M9C(P9C(P,C)E>#0M,C1?:F5F9G-B<F%N9',N:'1M4$L! A0#%     @ N4.*
M5G\%#;T^ @  6@@  !T              ( !$B,$ &8R,&8R,#(R97@X+3%?
M:F5F9G-B<F%N9',N:'1M4$L! A0#%     @ N4.*5I9^3B*.%@  JAL   T
M             ( !BR4$ &EM86=E7S P,2YJ<&=02P$"% ,4    " "Y0XI6
M:LUI0/,"  ": P  #0              @ %$/ 0 :6UA9V5?,# R+FIP9U!+
M 0(4 Q0    ( +E#BE;A]4:[D0,  #,$   -              "  6(_! !I
M;6%G95\P,#,N:G!G4$L! A0#%     @ N4.*5GU3+5MZ P  ' 0   T
M         ( !'D,$ &EM86=E7S P-"YJ<&=02P$"% ,4    " "Y0XI6&3H%
M!"8U  "&00  #0              @ '#1@0 :6UA9V5?,# U+FIP9U!+ 0(4
M Q0    ( +E#BE:)B[/^-$<  &E;   -              "  11\! !I;6%G
M95\P,#8N:G!G4$L! A0#%     @ N4.*5D:(P,/O @  F ,   T
M     ( !<\,$ &EM86=E7S P-RYJ<&=02P$"% ,4    " "Y0XI6X?5&NY$#
M   S!   #0              @ &-Q@0 :6UA9V5?,# X+FIP9U!+ 0(4 Q0
M   ( +E#BE9#^E*Q= ,  !<$   -              "  4G*! !I;6%G95\P
M,#DN:G!G4$L! A0#%     @ N4.*5A,#4V$D%P  JQ<   T
M ( !Z,T$ &EM86=E7S Q,"YJ<&=02P$"% ,4    " "Y0XI6'-7T2,L2  !M
M$P  #0              @ $WY00 :6UA9V5?,#$Q+FIP9U!+ 0(4 Q0    (
M +E#BE8[BY SBPL  !<,   -              "  2WX! !I;6%G95\P,3(N
M:G!G4$L! A0#%     @ N4.*5FK*=%7 &@  2AL   T              ( !
MXP,% &EM86=E7S Q,RYJ<&=02P$"% ,4    " "Y0XI6XBH1#+83  !6%
M#0              @ '.'@4 :6UA9V5?,#$T+FIP9U!+ 0(4 Q0    ( +E#
MBE8J$U@:_I<  (Z8   -              "  :\R!0!I;6%G95\P,34N:G!G
M4$L! A0#%     @ N4.*5OI,?G[5'   ZBD   T              ( !V,H%
M &EM86=E7S Q-BYJ<&=02P$"% ,4    " "Y0XI68H2F]#89  !H*@$ $0
M            @ '8YP4 :F9B<BTR,#(R,3(S,2YX<V102P$"% ,4    " "Y
M0XI6Q.>P_K\.   (J@  %0              @ $] 08 :F9B<BTR,#(R,3(S
M,5]C86PN>&UL4$L! A0#%     @ N4.*5LFG''8]3P  _I\$ !4
M     ( !+Q & &IF8G(M,C R,C$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( +E#
MBE8^,%DU+,T  'BC"0 5              "  9]?!@!J9F)R+3(P,C(Q,C,Q
M7VQA8BYX;6Q02P$"% ,4    " "Y0XI6;VBS&I5/  "7Y 0 %0
M    @ '^+ < :F9B<BTR,#(R,3(S,5]P<F4N>&UL4$L%!@     > !X GP<
' ,9\!P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
